Source,Target,Pvalue_Adjusted
AANAT,Colorectal Carcinoma,0.0034602840073026
AANAT,Breast Carcinoma,0.0042545616049287
AANAT,Colorectal Cancer,0.0149315928814189
AANAT,melanoma,0.0149315928814189
AANAT,Malignant neoplasm of breast,0.0191435238361999
AANAT,Malignant Neoplasms,0.0991201145654548
AANAT,Malignant neoplasm of large intestine,0.13167400689206
AANAT,Unipolar Depression,0.13167400689206
AANAT,Major Depressive Disorder,0.21122597829463
AANAT,Neoplasms,0.2714542429024338
AANAT,Primary malignant neoplasm,0.383941725017158
AANAT,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
AANAT,Shift-Work Sleep Disorder,0.3933196962529684
AANAT,Sleep Disorders Circadian Rhythm,0.3933196962529684
AANAT,Non-24 Hour Sleep-Wake Disorder,0.3933196962529684
AANAT,Nonorganic Sleep Wake Cycle Disorders,0.3933196962529684
AANAT,Asthma,0.3933196962529684
AANAT,Advanced Sleep Phase Syndrome,0.3941558617476422
AANAT,Autism Spectrum Disorders,0.3941558617476422
AANAT,Mental Depression,0.3941558617476422
AANAT,Delayed Sleep Phase Syndrome,0.3941558617476422
AANAT,Depressive disorder,0.3975960596292668
AANAT,Retinoblastoma,0.4115056600660309
AANAT,Depression Bipolar,0.4115056600660309
AANAT,Reticulocyte count (procedure),0.425419812815905
AANAT,Shift-Work Sleep Disorder,0.4286813331685578
AANAT,Non-24 Hour Sleep-Wake Disorder,0.4286813331685578
AANAT,Nonorganic Sleep Wake Cycle Disorders,0.4286813331685578
AANAT,Delayed Sleep Phase Syndrome,0.4286813331685578
AANAT,Advanced Sleep Phase Syndrome,0.4541466895915311
AANAT,Mental Depression,0.4560460337187313
AANAT,Bipolar Disorder,0.4875380732267193
ABCB1,Colorectal Carcinoma,0.0034602840073026
ABCB1,Mammary Neoplasms,0.0034602840073026
ABCB1,Ovarian Carcinoma,0.0034602840073026
ABCB1,Breast Carcinoma,0.0042545616049287
ABCB1,Invasive carcinoma of breast,0.0149002095788623
ABCB1,Epithelioma,0.0149002095788623
ABCB1,Colorectal Cancer,0.0149315928814189
ABCB1,Tumor Progression,0.0149315928814189
ABCB1,Stomach Carcinoma,0.0149315928814189
ABCB1,Retroviridae Infections,0.0149315928814189
ABCB1,melanoma,0.0149315928814189
ABCB1,Adenocarcinoma,0.0155921563748247
ABCB1,Proliferative vitreoretinopathy,0.0182265588252201
ABCB1,Squamous cell carcinoma,0.0182265588252201
ABCB1,Esophageal Neoplasms,0.0182265588252201
ABCB1,Malignant mesothelioma,0.0182265588252201
ABCB1,ovarian neoplasm,0.0191435238361999
ABCB1,Malignant neoplasm of breast,0.0191435238361999
ABCB1,Fibrosarcoma,0.0191435238361999
ABCB1,Malignant neoplasm of stomach,0.0191435238361999
ABCB1,Carcinogenesis,0.0228075668512991
ABCB1,Malignant neoplasm of esophagus,0.0248454592431097
ABCB1,Malignant neoplasm of ovary,0.0277695594716545
ABCB1,Carcinoma Spindle-Cell,0.0308703957553632
ABCB1,Hematopoietic Neoplasms,0.0334891258932371
ABCB1,Medulloblastoma,0.0354767239335874
ABCB1,Epithelial ovarian cancer,0.0387439397151409
ABCB1,Brain Tumor Primary,0.044151975756427
ABCB1,Malignant neoplasm of prostate,0.0569142010728473
ABCB1,Carcinoma,0.0593779966354549
ABCB1,Central neuroblastoma,0.0593779966354549
ABCB1,Carcinomatosis,0.0617471306652618
ABCB1,Primary malignant neoplasm of brain,0.064548079316548
ABCB1,Mammary Neoplasms Human,0.064548079316548
ABCB1,Brain Neoplasms,0.064548079316548
ABCB1,Neoplasm Metastasis,0.0648809611869375
ABCB1,Mucoepidermoid Carcinoma,0.0648809611869375
ABCB1,Renal Cell Carcinoma,0.0648809611869375
ABCB1,Neuroblastoma,0.0688152422187159
ABCB1,Malignant neoplasm of pancreas,0.0726340460169901
ABCB1,Glioma,0.0739788831250619
ABCB1,Osteoporosis,0.0739788831250619
ABCB1,Lymphoma,0.0739788831250619
ABCB1,Endometrial Neoplasms,0.0745502070959292
ABCB1,Glioblastoma,0.0745502070959292
ABCB1,Pancreatic carcinoma,0.0745502070959292
ABCB1,Carcinoma breast stage IV,0.0745502070959292
ABCB1,Liver Cirrhosis Experimental,0.0747863377072194
ABCB1,Liver Cirrhosis,0.0773771948186562
ABCB1,Prostate carcinoma,0.0773771948186562
ABCB1,Squamous cell carcinoma of the head and neck,0.0775520919998773
ABCB1,Colorectal Neoplasms,0.0827744840860166
ABCB1,Stage IV Bladder Cancer AJCC v6,0.084286432100041
ABCB1,Anaplastic carcinoma,0.084286432100041
ABCB1,Malignant neoplasm of urinary bladder,0.084286432100041
ABCB1,Bladder Neoplasm,0.0891725280554336
ABCB1,Adult Acute Lymphocytic Leukemia,0.0919714360040484
ABCB1,Squamous cell carcinoma of esophagus,0.0919714360040484
ABCB1,Liver carcinoma,0.095319386034013
ABCB1,Malignant Neoplasms,0.0991201145654548
ABCB1,Osteosarcoma,0.1029977559100099
ABCB1,Colon Carcinoma,0.1062239757831962
ABCB1,Adenocarcinoma of colon,0.1112281755580192
ABCB1,Skin toxicity,0.1138051695421299
ABCB1,Cardiac Carcinoma,0.1138051695421299
ABCB1,Chronic Lymphocytic Leukemia,0.1147307578771389
ABCB1,Small cell carcinoma of lung,0.1193558174333938
ABCB1,ADENOMAS AND ADENOCARCINOMAS,0.1193558174333938
ABCB1,Hematologic Neoplasms,0.1253114324938153
ABCB1,Secondary malignant neoplasm of bone,0.1253114324938153
ABCB1,MYELODYSPLASTIC SYNDROME,0.1254380558571286
ABCB1,Esophageal carcinoma,0.1254380558571286
ABCB1,Tumor Initiation,0.13167400689206
ABCB1,Undifferentiated carcinoma,0.13167400689206
ABCB1,Clear-cell metastatic renal cell carcinoma,0.13167400689206
ABCB1,Carcinoma Transitional Cell,0.13167400689206
ABCB1,Oral Cavity Carcinoma,0.13167400689206
ABCB1,Phototoxicity,0.13167400689206
ABCB1,Malignant neoplasm of large intestine,0.13167400689206
ABCB1,Carcinoma of bladder,0.13167400689206
ABCB1,Malignant neoplasm of endometrium,0.13167400689206
ABCB1,Papillary serous cystadenocarcinoma,0.13167400689206
ABCB1,Unipolar Depression,0.13167400689206
ABCB1,Uterine Corpus Cancer,0.1328002618052838
ABCB1,Myocardial Infarction,0.1352936728187231
ABCB1,Hyperactive behavior,0.1387448809655294
ABCB1,Solid Neoplasm,0.1413782599148022
ABCB1,Colonic Neoplasms,0.1454373331146953
ABCB1,Liver neoplasms,0.1454373331146953
ABCB1,Rheumatoid Arthritis,0.1537760235124317
ABCB1,Sarcoma,0.1537760235124317
ABCB1,Renal fibrosis,0.1602092191314262
ABCB1,Sickle Cell Dactylitis,0.1602092191314262
ABCB1,Palmar-plantar erythrodysesthesia syndrome,0.1602092191314262
ABCB1,Breast Cancer Familial,0.1602092191314262
ABCB1,Carcinoma testes,0.1653491983554358
ABCB1,Chronic leukemia (category),0.1653491983554358
ABCB1,Leukemia Myeloid Chronic-Phase,0.1662487420178625
ABCB1,Visual seizure,0.1735868515093891
ABCB1,stage ovarian epithelial cancer,0.1874735657311888
ABCB1,Dermatitis Phototoxic,0.1897991423047819
ABCB1,TARSAL-CARPAL COALITION SYNDROME,0.1906413554467301
ABCB1,Acute Myeloid Leukemia (AML-M2),0.2050045461627939
ABCB1,cervical cancer,0.2050045461627939
ABCB1,Seizures,0.2053083986145698
ABCB1,Malignant tumor of peritoneum,0.2062010908869036
ABCB1,Lung Neoplasms,0.2062010908869036
ABCB1,Osteosarcoma of bone,0.2109483801368481
ABCB1,Major Depressive Disorder,0.21122597829463
ABCB1,Connective Tissue Diseases,0.2139814021986384
ABCB1,Uterine Corpus Sarcoma,0.222537307875512
ABCB1,Cataract,0.223747154820789
ABCB1,Malignant tumor of colon,0.223747154820789
ABCB1,Prostatic Neoplasms,0.223747154820789
ABCB1,Adverse reaction to drug,0.223747154820789
ABCB1,Drug toxicity,0.223747154820789
ABCB1,Hodgkin Disease,0.2454476567103779
ABCB1,Burkitt Lymphoma,0.2521987644415915
ABCB1,Hepatoblastoma,0.2522264785494494
ABCB1,Malignant Head and Neck Neoplasm,0.2522264785494494
ABCB1,B-Cell Lymphomas,0.2522264785494494
ABCB1,Malignant neoplasm of liver,0.2643145809900195
ABCB1,Opiate Addiction,0.2643145809900195
ABCB1,Chondrosarcoma,0.2643145809900195
ABCB1,Neoplasms,0.2714542429024338
ABCB1,Malignant tumor of cervix,0.2714542429024338
ABCB1,Malignant ascites,0.2714542429024338
ABCB1,Parasitic Diseases,0.2714542429024338
ABCB1,Malignant neoplasm of lung,0.2714542429024338
ABCB1,Kidney Neoplasm,0.2714542429024338
ABCB1,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
ABCB1,510-Methylenetetrahydrofolate reductase deficiency,0.2714542429024338
ABCB1,Mental Disorders Severe,0.2714542429024338
ABCB1,Secondary malignant neoplasm of lung,0.2723545094624877
ABCB1,Cervix carcinoma,0.2834835531038365
ABCB1,Acute leukemia,0.2835142372342932
ABCB1,Neoplasms Intracranial,0.290158730291654
ABCB1,Adult Hepatocellular Carcinoma,0.290158730291654
ABCB1,Cirrhosis,0.2923761731100008
ABCB1,Gastrointestinal Diseases,0.2980670559114652
ABCB1,Hyperbilirubinemia,0.2980670559114652
ABCB1,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
ABCB1,Breast cancer lobular,0.2980670559114652
ABCB1,Pancolitis,0.2980670559114652
ABCB1,Triple Negative Breast Neoplasms,0.2980670559114652
ABCB1,Myeloid Leukemia,0.2980670559114652
ABCB1,Heart Septal Defects,0.3044782497745498
ABCB1,Endometrial Carcinoma,0.3044782497745498
ABCB1,Neuroepithelioma,0.3099246715197673
ABCB1,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
ABCB1,Malignant Squamous Cell Neoplasm,0.3104232675696299
ABCB1,Anaplastic Oligodendroglioma,0.3176684185973055
ABCB1,Gastrointestinal Stromal Tumors,0.3199171478489988
ABCB1,Cholangiocarcinoma,0.340892538685018
ABCB1,Marijuana Abuse,0.3418217363648192
ABCB1,Ischemic stroke,0.3486533561309259
ABCB1,Blast Phase,0.3494455519738624
ABCB1,Leukemogenesis,0.3510063969122338
ABCB1,Rhabdomyosarcoma,0.3510063969122338
ABCB1,Uterine Cancer,0.3544355608905275
ABCB1,Pregnancy in Diabetics,0.3638414818541592
ABCB1,Carcinoma of lung,0.3663130598151661
ABCB1,Tuberculosis,0.3706856725676674
ABCB1,Anaplastic astrocytoma,0.3763374964032415
ABCB1,Primary malignant neoplasm,0.383941725017158
ABCB1,Undifferentiated leukemia,0.383941725017158
ABCB1,Complex partial seizures,0.383941725017158
ABCB1,Tuberculosis Pulmonary,0.383941725017158
ABCB1,Cardiac Lymphoma,0.383941725017158
ABCB1,hiv-infection/aids,0.383941725017158
ABCB1,Primary malignant neoplasm of lung,0.3902116649640871
ABCB1,Bone necrosis,0.3933196962529684
ABCB1,Secondary malignant neoplasm of lymph node,0.3933196962529684
ABCB1,Amyloidosis,0.3933196962529684
ABCB1,Hallucinations,0.3933196962529684
ABCB1,Chronic myeloproliferative disorder,0.3933196962529684
ABCB1,Gallbladder Carcinoma,0.3933196962529684
ABCB1,Diagnosis Psychiatric,0.3933196962529684
ABCB1,Progressive intrahepatic cholestasis (disorder),0.3933196962529684
ABCB1,Epstein-Barr Virus Infections,0.3933196962529684
ABCB1,Bipolar Disorder,0.3933196962529684
ABCB1,Plaque Amyloid,0.3933196962529684
ABCB1,Peripheral T-Cell Lymphoma,0.3933196962529684
ABCB1,Adenocarcinoma of large intestine,0.3933196962529684
ABCB1,Columnar Cell Change of the Breast,0.3933196962529684
ABCB1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
ABCB1,Inflammation,0.3933196962529684
ABCB1,Harlequin Fetus,0.3933196962529684
ABCB1,Generalized seizures,0.3933196962529684
ABCB1,Pancreatitis Chronic,0.3933196962529684
ABCB1,Interstitial lung fibrosis,0.3933196962529684
ABCB1,Kidney Diseases,0.3933196962529684
ABCB1,Nasopharyngeal carcinoma,0.3933196962529684
ABCB1,Non-small cell lung cancer stage I,0.3933196962529684
ABCB1,Parathyroid Adenoma,0.3933196962529684
ABCB1,Nephroblastoma,0.3933196962529684
ABCB1,Schizophrenia,0.3933196962529684
ABCB1,Malignant Glioma,0.3933196962529684
ABCB1,Adrenocortical carcinoma,0.3933196962529684
ABCB1,Seizures Focal,0.3933196962529684
ABCB1,tumor vasculature,0.3933196962529684
ABCB1,Non-Small Cell Lung Carcinoma,0.3933196962529684
ABCB1,Infection caused by Helicobacter pylori,0.3933196962529684
ABCB1,HTLV-I Infections,0.3933196962529684
ABCB1,Hypertensive disease,0.3933196962529684
ABCB1,Secondary malignant neoplasm of liver,0.3933196962529684
ABCB1,Juvenile rheumatoid arthritis,0.3933196962529684
ABCB1,Leukemia Myelocytic Acute,0.3933196962529684
ABCB1,Splenic Neoplasms,0.3933196962529684
ABCB1,Sarcoma metastatic,0.3933196962529684
ABCB1,Visual disturbance,0.3933196962529684
ABCB1,Acute postoperative pain,0.3933196962529684
ABCB1,Central nervous system depression (disorder),0.3933196962529684
ABCB1,HIV Infections,0.3933196962529684
ABCB1,Milroy Disease,0.3933196962529684
ABCB1,Soft Tissue Neoplasms,0.3933196962529684
ABCB1,Hurthle Cell Tumor,0.3933196962529684
ABCB1,Stage 4S neuroblastoma,0.3933196962529684
ABCB1,Lymphoma T-Cell Cutaneous,0.3933196962529684
ABCB1,DOSAGE-SENSITIVE SEX REVERSAL,0.3933196962529684
ABCB1,Arthritis Psoriatic,0.3933196962529684
ABCB1,Chordoma,0.3933196962529684
ABCB1,Alzheimer's Disease,0.3933196962529684
ABCB1,Anxiety Disorders,0.3933196962529684
ABCB1,Coumarin Resistance,0.3933196962529684
ABCB1,Neonatal Abstinence Syndrome,0.3933196962529684
ABCB1,Prolymphocytic Leukemia,0.3933196962529684
ABCB1,Malaria Falciparum,0.3933196962529684
ABCB1,Creutzfeldt-Jakob disease,0.3933196962529684
ABCB1,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
ABCB1,Lymphoma Non-Hodgkin,0.3933196962529684
ABCB1,Epiretinal Membrane,0.3933196962529684
ABCB1,Acute lymphocytic leukemia,0.3933196962529684
ABCB1,Lip and Oral Cavity Carcinoma,0.3933196962529684
ABCB1,Stomach Neoplasms,0.3933196962529684
ABCB1,Inflammatory Bowel Diseases,0.3933196962529684
ABCB1,Acute Promyelocytic Leukemia,0.3933196962529684
ABCB1,Parkinson Disease,0.3933196962529684
ABCB1,Coronary heart disease,0.3933196962529684
ABCB1,Glomerulonephritis,0.3933196962529684
ABCB1,Postoperative Nausea and Vomiting,0.3933196962529684
ABCB1,Arthritis Adjuvant-Induced,0.3933196962529684
ABCB1,Arthritis Collagen-Induced,0.3933196962529684
ABCB1,Arthritis Experimental,0.3933196962529684
ABCB1,Behavior Disorders,0.3933196962529684
ABCB1,Granulomatous Disease Chronic X-Linked,0.3933196962529684
ABCB1,Cerebral Amyloid Angiopathy,0.3933196962529684
ABCB1,Lymphoid leukemia,0.3933196962529684
ABCB1,Adenoma,0.3933196962529684
ABCB1,Glioblastoma Multiforme,0.3933196962529684
ABCB1,synovial sarcoma,0.3933196962529684
ABCB1,Adult Soft Tissue Sarcoma,0.3933196962529684
ABCB1,Asthenia,0.3933196962529684
ABCB1,Childhood nephrotic syndrome,0.3933196962529684
ABCB1,Metaplastic breast carcinoma,0.3933196962529684
ABCB1,Disseminated neuroblastoma,0.3933196962529684
ABCB1,Anemia,0.3941558617476422
ABCB1,Malignant neoplasm of kidney,0.3941558617476422
ABCB1,Neoplasm Residual,0.3941558617476422
ABCB1,Fabry Disease,0.3941558617476422
ABCB1,Rash and Dermatitis Adverse Event Associated with Chemoradiation,0.3941558617476422
ABCB1,Single Seizure,0.3941558617476422
ABCB1,Seizures Auditory,0.3941558617476422
ABCB1,Seizures Clonic,0.3941558617476422
ABCB1,Seizures Sensory,0.3941558617476422
ABCB1,Seizures Somatosensory,0.3941558617476422
ABCB1,Vertiginous seizure,0.3941558617476422
ABCB1,Atonic Absence Seizures,0.3941558617476422
ABCB1,Generalized Absence Seizures,0.3941558617476422
ABCB1,Gustatory seizure,0.3941558617476422
ABCB1,Jacksonian Seizure,0.3941558617476422
ABCB1,Non-epileptic convulsion,0.3941558617476422
ABCB1,Nonepileptic Seizures,0.3941558617476422
ABCB1,Olfactory seizure,0.3941558617476422
ABCB1,Acute Erythroblastic Leukemia,0.3941558617476422
ABCB1,Epilepsy,0.3941558617476422
ABCB1,Variegate Porphyria,0.3941558617476422
ABCB1,COLCHICINE RESISTANCE,0.3941558617476422
ABCB1,Renal carcinoma,0.3941558617476422
ABCB1,Thyroid carcinoma,0.3941558617476422
ABCB1,Epileptic Seizures,0.3941558617476422
ABCB1,androgen independent prostate cancer,0.3941558617476422
ABCB1,Mental Depression,0.3941558617476422
ABCB1,Tonic Seizures,0.3941558617476422
ABCB1,Ki-1+ Anaplastic Large Cell Lymphoma,0.3941558617476422
ABCB1,Pituitary Neoplasms,0.3941558617476422
ABCB1,Malignant neoplasm of brain,0.3941558617476422
ABCB1,Recurrent Endometrial Cancer,0.3941558617476422
ABCB1,Parkinson Disease Secondary Vascular,0.3941558617476422
ABCB1,Sleep Apnea Mixed Central and Obstructive,0.3941558617476422
ABCB1,Atherosclerotic Parkinsonism,0.3941558617476422
ABCB1,Benign neoplasm of liver,0.3941558617476422
ABCB1,Cannabis-Related Disorder,0.3941558617476422
ABCB1,Hashish Abuse,0.3941558617476422
ABCB1,Hypersomnia with Periodic Respiration,0.3941558617476422
ABCB1,pediatric AIDS,0.3941558617476422
ABCB1,Pulmonary Blastoma,0.3941558617476422
ABCB1,Hereditary hemochromatosis,0.3941558617476422
ABCB1,Progressive Neoplastic Disease,0.3941558617476422
ABCB1,Progressive cGVHD,0.3975960596292668
ABCB1,Senile Plaques,0.3975960596292668
ABCB1,Dizziness,0.3975960596292668
ABCB1,Schizoaffective Disorder,0.3975960596292668
ABCB1,Convulsive Seizures,0.3975960596292668
ABCB1,Depressive disorder,0.3975960596292668
ABCB1,Secondary Parkinson Disease,0.3975960596292668
ABCB1,Childhood Absence Epilepsy,0.3975960596292668
ABCB1,Chronic Liver Failure,0.3975960596292668
ABCB1,Kernicterus,0.3975960596292668
ABCB1,Vertigo,0.4028066164685291
ABCB1,Meningioma benign no ICD-O subtype,0.4028066164685291
ABCB1,Chronic Kidney Diseases,0.4028066164685291
ABCB1,Kidney Failure Acute,0.4028066164685291
ABCB1,Neuroectodermal Tumor Primitive,0.4028066164685291
ABCB1,leiomyosarcoma,0.4028066164685291
ABCB1,Refractory cancer,0.4028066164685291
ABCB1,Carcinoma of larynx,0.4028066164685291
ABCB1,Intrahepatic Cholangiocarcinoma,0.4028066164685291
ABCB1,Celiac Disease,0.4028066164685291
ABCB1,Schizophrenia and related disorders,0.4028066164685291
ABCB1,Childhood Acute Megakaryoblastic Leukemia,0.4028066164685291
ABCB1,Gastric Adenocarcinoma,0.4028066164685291
ABCB1,Extrapyramidal Disorders,0.4028066164685291
ABCB1,Epileptic drop attack,0.4037249857069285
ABCB1,Cholestasis,0.4100901006059349
ABCB1,Drug Resistant Epilepsy,0.4100901006059349
ABCB1,Acute myocardial infarction,0.4103119460235835
ABCB1,Multiple Myeloma,0.4103119460235835
ABCB1,Epilepsy Temporal Lobe,0.4103119460235835
ABCB1,Convulsions,0.4103119460235835
ABCB1,Nephrotic Syndrome,0.4103119460235835
ABCB1,Xeroderma pigmentosum group B,0.4103119460235835
ABCB1,AIDS-Related Non-Hodgkin Lymphoma,0.4103119460235835
ABCB1,Cancer Relapse,0.4103119460235835
ABCB1,Anxiety,0.4115056600660309
ABCB1,Retinoblastoma,0.4115056600660309
ABCB1,MYELOPROLIFERATIVE SYNDROME TRANSIENT,0.4115056600660309
ABCB1,Viremia,0.4115056600660309
ABCB1,Aura,0.4115056600660309
ABCB1,Awakening Epilepsy,0.4115056600660309
ABCB1,Cerebrovascular accident,0.4115056600660309
ABCB1,Alzheimer Disease Late Onset,0.4115056600660309
ABCB1,Acute Megakaryocytic Leukemias,0.4115056600660309
ABCB1,Sphenoid Wing Meningioma,0.4115056600660309
ABCB1,Peroxisome Biogenesis Disorder Complementation Group D,0.4115056600660309
ABCB1,Core binding factor acute myeloid leukemia,0.4115056600660309
ABCB1,Malignant histiocytosis,0.4115056600660309
ABCB1,Epilepsy Cryptogenic,0.4118266358241932
ABCB1,Acute Coronary Syndrome,0.4118266358241932
ABCB1,Juvenile arthritis,0.4126392832024548
ABCB1,Absence Seizures,0.4126392832024548
ABCB1,Acquired Immunodeficiency Syndrome,0.4126392832024548
ABCB1,Malignant Peripheral Nerve Sheath Tumor,0.4126392832024548
ABCB1,Down Syndrome,0.4126392832024548
ABCB1,Mental disorders,0.4126392832024548
ABCB1,Balkan Nephropathy,0.4126392832024548
ABCB1,Cannabis Abuse,0.4126392832024548
ABCB1,Central nervous system lymphoma,0.4126392832024548
ABCB1,Multiple Chronic Conditions,0.4192169590514327
ABCB1,Oxyphilic Adenoma,0.4192169590514327
ABCB1,Liposarcoma Pleomorphic,0.4192169590514327
ABCB1,Aggressive natural killer-cell leukemia,0.4192169590514327
ABCB1,Erythema Multiforme,0.4192169590514327
ABCB1,Poisoning,0.4192169590514327
ABCB1,Lupus Erythematosus Systemic,0.4213286052188015
ABCB1,Simple Partial Status Epilepticus,0.4213286052188015
ABCB1,Status Epilepticus Subclinical,0.4213286052188015
ABCB1,Complex Partial Status Epilepticus,0.4213286052188015
ABCB1,Grand Mal Status Epilepticus,0.4213286052188015
ABCB1,Non-Convulsive Status Epilepticus,0.4213286052188015
ABCB1,Thrombocytopenia,0.4213286052188015
ABCB1,Malignant neoplasm of mouth,0.4213286052188015
ABCB1,Benign Neoplasm,0.4213286052188015
ABCB1,Ovarian adenocarcinoma,0.4213286052188015
ABCB1,PACHYONYCHIA CONGENITA 3,0.424575176503444
ABCB1,Congestive heart failure,0.425419812815905
ABCB1,Neurilemmoma,0.425419812815905
ABCB1,secondary acute myeloid leukemia,0.425419812815905
ABCB1,Tuberculosis Drug-Resistant,0.425419812815905
ABCB1,Intestinal Volvulus,0.425419812815905
ABCB1,Lipidemias,0.425419812815905
ABCB1,Rectal Carcinoma,0.429029854971378
ABCB1,Heart failure,0.4304973629098372
ABCB1,Infant Premature,0.4304973629098372
ABCB1,Psoriasis,0.4304973629098372
ABCB1,Undifferentiated (Embryonal) Sarcoma,0.4304973629098372
ABCB1,Idiopathic Nephrotic Syndrome,0.4304973629098372
ABCB1,Pouchitis,0.4304973629098372
ABCB1,Addictive Behavior,0.4314759856195063
ABCB1,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.4330362522463816
ABCB1,Malignant Fibrous Histiocytoma,0.4330362522463816
ABCB1,Early-Stage Breast Carcinoma,0.4335751357405352
ABCB1,Petit mal status,0.4335751357405352
ABCB1,Squamous cell carcinoma of lung,0.4335751357405352
ABCB1,Neurodegenerative Disorders,0.4335751357405352
ABCB1,Neuropathy,0.4335751357405352
ABCB1,Indolent Non-Hodgkin Lymphoma,0.4335751357405352
ABCB1,Infantile nystagmus syndrome,0.4335751357405352
ABCB1,Niemann-Pick Disease Type C,0.4352815161963393
ABCB1,Carcinoid Tumor,0.4381343267935581
ABCB1,Meningioma,0.4396723023384634
ABCB1,Encephalitis,0.4396723023384634
ABCB1,Dyslipidemias,0.4421745246585178
ABCB1,Depressive Symptoms,0.4459714599189374
ABCB1,Monosomy,0.4459714599189374
ABCB1,Leukemia secondary,0.4459714599189374
ABCB1,Peptic Ulcer,0.4459714599189374
ABCB1,Precancerous Conditions,0.4479115285676636
ABCB1,Status Epilepticus,0.4506578937113162
ABCB1,Lymphoma Large-Cell Follicular,0.4506578937113162
ABCB1,Acute myeloid leukemia minimal differentiation,0.4506578937113162
ABCB1,Alcohol or Other Drugs use,0.4506578937113162
ABCB1,Hyperlipoproteinemia Type IIa,0.4564472886428772
ABCB1,Steroid resistant nephrotic syndrome of childhood,0.4564472886428772
ABCB1,leukemia,0.4588513406515081
ABCB1,Chronic gastritis,0.4615352570710579
ABCB1,Myoclonic Seizures,0.4615352570710579
ABCB1,Hypotension Orthostatic,0.4615352570710579
ABCB1,Steroid-resistant nephrotic syndrome,0.4615352570710579
ABCB1,Increased drug resistance,0.4615352570710579
ABCB1,Klatskin Tumor,0.4615352570710579
ABCB1,Plasmablastic lymphoma,0.4615352570710579
ABCB1,Mesothelioma,0.4635211539849193
ABCB1,Malignant neoplasm of skin,0.466957409863091
ABCB1,Encephalopathy Toxic,0.4675904598629673
ABCB1,Toxic Encephalitis,0.4675904598629673
ABCB1,Primary Malignant Liver Neoplasm,0.4675904598629673
ABCB1,Chronic kidney disease stage 5,0.4704594475773637
ABCB1,Huntington Disease,0.4704594475773637
ABCB1,Uveal melanoma,0.472444704048021
ABCB1,Myeloid Leukemia Chronic,0.472444704048021
ABCB1,Lymphoma AIDS-Related,0.472444704048021
ABCB1,Pain Postoperative,0.472444704048021
ABCB1,Agranulocytosis,0.472444704048021
ABCB1,Febrile Neutropenia,0.472444704048021
ABCB1,Philadelphia chromosome positive chronic myelogenous leukemia,0.472444704048021
ABCB1,Adenomatous Polyposis Coli,0.4749780675672355
ABCB1,Manic,0.4753011022966241
ABCB1,Malignant melanoma of eye,0.4753011022966241
ABCB1,Psychotic Disorders,0.4753011022966241
ABCB1,Hypercholesterolemia,0.4755217870653703
ABCB1,Myelodysplasia,0.4790179402069343
ABCB1,Rheumatism,0.4790179402069343
ABCB1,Anorexia Nervosa,0.4790179402069343
ABCB1,Lymphadenitis,0.4790179402069343
ABCB1,Polydipsia,0.4790179402069343
ABCB1,Breast adenocarcinoma,0.4810435657134442
ABCB1,Steroid Sulfatase Deficiency Disease,0.4840863724482356
ABCB1,Cyst,0.4850576707687362
ABCB1,Kaposi Sarcoma,0.4851378030288289
ABCB1,Pain,0.4871698998714747
ABCB1,Cannabis Dependence,0.4906258721078565
ABCB1,Neurotoxicity Syndromes,0.4906258721078565
ABCB1,Tonic - clonic seizures,0.4919605488358906
ABCB1,Diarrhea,0.4923669467696064
ABCB1,Primary biliary cirrhosis,0.4923669467696064
ABCB1,Acute biphenotypic leukemia,0.4923669467696064
ABCB1,X-Linked Combined Immunodeficiency Diseases,0.4923669467696064
ABCB1,Oral cleft,0.4923669467696064
ABCB1,Pemphigus,0.4923669467696064
ABCB1,Primary Lesion,0.4923669467696064
ABCB1,Sleep disturbances,0.4929829683479762
ABCB1,Anaplastic thyroid carcinoma,0.4952592576151974
ABCB1,Adult Acute Myeloblastic Leukemia,0.4981941174985421
ABCB1,Crohn Disease,0.4981941174985421
ABCB1,Neutropenia,0.498994845947585
ABCB1,Ichthyosis X-Linked,0.4990401620718274
ABCB1,Ulcerative Colitis,0.5001612228394569
ABCB1,Juvenile Myoclonic Epilepsy,0.5019670090704682
ABCB1,M5b Acute differentiated monocytic leukemia,0.504136641473215
ABCB1,Hepatitis A,0.5090214163899865
ABCB1,Coronary Arteriosclerosis,0.5140447474168605
ABCB1,Obesity,0.5140447474168605
ABCB1,Tubular Aggregate Myopathy,0.5140447474168605
ABCB1,Escherichia coli Infections,0.5140447474168605
ABCB1,Immunoblastic Large-Cell Lymphoma,0.5140447474168605
ABCB1,Adenocarcinoma of lung (disorder),0.51550637274795
ABCB1,Reperfusion Injury,0.5188223685230745
ABCB1,Painful Bladder Syndrome,0.5188223685230745
ABCB1,Ewings sarcoma,0.5251317541886066
ABCB1,Malignant neoplasm of adrenal cortex,0.5251317541886066
ABCB1,nervous system disorder,0.5276472086074249
ABCB1,Kidney Failure Chronic,0.5299466034567416
ABCB1,Adenocarcinoma Clear Cell,0.5299466034567416
ABCB1,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.5299466034567416
ABCB1,Congenital Abnormality,0.5305233935923577
ABCB1,Colitis,0.5323590634832615
ABCB1,Bacterial Infections,0.5337853752290136
ABCB1,Nephrotic Syndrome Minimal Change,0.5337853752290136
ABCB1,Pancreatitis Alcoholic,0.5337853752290136
ABCB1,Gastrointestinal mucositis,0.5337853752290136
ABCB1,Lymphoma Follicular,0.533913711453195
ABCB1,Congenital Heart Defects,0.533913711453195
ABCB1,Tuberous Sclerosis,0.5359212109443033
ABCB1,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
ABCB1,Carcinoma of urinary bladder superficial,0.5393787854381349
ABCB1,Hyponatremia,0.5393787854381349
ABCB1,Pyruvate Carboxylase Deficiency Disease,0.5393787854381349
ABCB1,Precursor B-cell lymphoblastic leukemia,0.5451009374855866
ABCB1,Malignant neoplasm of gallbladder,0.5496357724684553
ABCB1,Delirium,0.549941235475765
ABCB1,Autoimmune Diseases,0.5512224939896888
ABCB1,Childhood Osteosarcoma,0.553002957824355
ABCB1,Sleep Apnea Central,0.553002957824355
ABCB1,Sleep Disorders,0.5619299124666532
ABCB1,Ependymoma,0.563120546412355
ABCB1,liposarcoma,0.5655222348249326
ABCB1,Malaria,0.5655222348249326
ABCB1,cardiac event,0.5655222348249326
ABCB1,Primary sclerosing cholangitis,0.5682392297191953
ABCB1,Lymphoproliferative Disorders,0.5696906826730043
ABCB1,Cockayne Syndrome Type I,0.5710095678317721
ABCB1,Pain Crushing,0.5710095678317721
ABCB1,Pain Migratory,0.5710095678317721
ABCB1,Pain Splitting,0.5710095678317721
ABCB1,Suffering Physical,0.5710095678317721
ABCB1,Ache,0.5710095678317721
ABCB1,Radiating pain,0.5710095678317721
ABCB1,Drug usage,0.5768212166102149
ABCB1,Nonorganic psychosis,0.578835730221474
ABCB1,Leukemia Lymphocytic Acute L2,0.582492855487907
ABCB1,Pain Burning,0.582492855487907
ABCB1,Peripheral Neuropathy,0.5851527280548257
ABCB1,Diffuse Large B-Cell Lymphoma,0.5913651925298382
ABCB1,Agnosia for Pain,0.5916904943304121
ABCB1,Thyroid Diseases,0.5936773368594411
ABCB1,Adult Cholangiocarcinoma,0.5956632182199403
ABCB1,Familial Mediterranean Fever,0.5956632182199403
ABCB1,Glucocorticoid Receptor Deficiency,0.5956632182199403
ABCB1,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.6035970790768342
ABCB1,Congenital chromosomal disease,0.6035970790768342
ABCB1,Hyperlipidemia,0.6035970790768342
ABCB1,Carcinoma Lobular,0.6035970790768342
ABCB1,Congenital defects,0.6035970790768342
ABCB1,Nausea,0.6035970790768342
ABCB1,Oncocytic Neoplasm,0.6035970790768342
ABCB1,Sleep Apnea Syndromes,0.6084642888478995
ABCB1,Herpes Simplex Infections,0.610971999959321
ABCB1,Hematological Disease,0.610971999959321
ABCB1,Hepatitis Toxic,0.610971999959321
ABCB1,Chemical and Drug Induced Liver Injury,0.610971999959321
ABCB1,Chemically-Induced Liver Toxicity,0.610971999959321
ABCB1,Drug-Induced Acute Liver Injury,0.610971999959321
ABCB1,Heart Diseases,0.610971999959321
ABCB1,Absence Epilepsy,0.610971999959321
ABCB1,Cystic Fibrosis,0.6124306570512981
ABCB1,Hepatitis B Chronic,0.6150955455771212
ABCB1,Hepatitis Drug-Induced,0.6189532555846575
ABCB1,Heroin Dependence,0.6196470808426647
ABCB1,Tumor Angiogenesis,0.6218520979526325
ABCB1,Viral hepatitis,0.6222451141623291
ABCB1,Monocytic leukemia,0.6222451141623291
ABCB1,Cytogenetically normal acute myeloid leukemia,0.625027955184583
ABCB1,Leukopenia,0.6274540883972485
ABCB1,Cocaine Dependence,0.6304655343580164
ABCB1,Brain Diseases,0.6319938293757544
ABCB1,Cervical Adenocarcinoma,0.6319938293757544
ABCB1,Metastatic Renal Cell Cancer,0.6319938293757544
ABCB1,Cockayne Syndrome,0.652707626880454
ABCB1,Withdrawal Symptoms,0.655573080043894
ABCB1,Childhood Leukemia,0.656104947944719
ABCB1,Renal Insufficiency,0.658736510383757
ABCB1,Myeloproliferative disease,0.6592493193460769
ABCB1,High-Grade Prostatic Intraepithelial Neoplasia,0.6691893635307453
ABCB1,Leukemia T-Cell,0.6691893635307453
ABCB1,Chronic granulomatous disease,0.6761967139251879
ABCB1,Myasthenia Gravis,0.6821087736355662
ABCB1,Sensory neuropathy,0.6841967398409226
ABCB1,Gastritis,0.6875373888914498
ABCB1,Drug-Induced Liver Disease,0.6910672612216457
ABCB1,Vomiting,0.6980473696540115
ABCB1,Lipoma,0.701831040553294
ABCB1,Age at menarche,0.7096959691931399
ABCB1,Influenza,0.7149953523738256
ABCB1,Coronary Artery Disease,0.7240930522443176
ABCB1,Childhood Neuroblastoma,0.738047882208201
ABCB1,Childhood Acute Myeloid Leukemia,0.7433468668038986
ABCB1,Congenital contractural arachnodactyly,0.7467967658079964
ABCB1,Hepatitis,0.7484342194688707
ABCB1,Benign Prostatic Hyperplasia,0.7491018580851883
ABCB1,T-Cell Lymphoma,0.7577323833810212
ABCB1,Fatigue,0.7658980225613361
ABCB1,Encephalopathies,0.7815030391631113
ABCB1,CNS disorder,0.7935206698366561
ABCB1,Hyperthyroidism,0.7935206698366561
ABCB1,Impaired cognition,0.8000044931629623
ABCB1,early pregnancy,0.8048897980514186
ABCB1,Nausea and vomiting,0.8109066403528201
ABCB1,Malignant neoplasm of gastrointestinal tract,0.8245140009975604
ABCB1,Disease Exacerbation,0.8306551823873084
ABCB1,Adult T-Cell Lymphoma/Leukemia,0.8367216325123092
ABCB1,Hypercholesterolemia Familial,0.8455269088566324
ABCB1,Hepatitis B,0.9169959402964138
ABCB1,Breast Carcinoma,0.0075861267486594
ABCB1,Esophagus Neoplasm,0.0102679590519094
ABCB1,Marfan Syndrome,0.0133304506157067
ABCB1,Mammary Neoplasms,0.0155248163763686
ABCB1,Anaplastic Carcinoma,0.0402286636010764
ABCB1,Breast Cancer,0.0402286636010764
ABCB1,Liver Carcinoma,0.0520696613701797
ABCB1,Schizophrenia,0.0531117779464085
ABCB1,Carcinoma,0.0534520155998091
ABCB1,Kidney Cancer,0.3094716280561038
ABCB1,Kidney Neoplasm,0.336287627428424
ABCB1,Epilepsy,0.3449614869411272
ABCB1,Parkinson Disease,0.4286813331685578
ABCB1,Carcinoma Of The Head And Neck,0.4286813331685578
ABCB1,Mental Disorders,0.4286813331685578
ABCB1,Colorectal Cancer,0.4286813331685578
ABCB1,Lung Carcinoma,0.4541466895915311
ABCB1,Rheumatoid Arthritis,0.4560460337187313
ABCB1,Mental Depression,0.4560460337187313
ABCB1,Nervous System Disorder,0.4560460337187313
ABCB1,Atherosclerotic Parkinsonism,0.4560460337187313
ABCB1,Behavior Disorders,0.4560460337187313
ABCB1,Psychosis,0.4560460337187313
ABCB1,Colorectal Neoplasms,0.4560460337187313
ABCB1,Hematologic Neoplasms,0.4602028929328057
ABCB1,Benign Neoplasm,0.4624858551053053
ABCB1,Neoplasms,0.4646409362700993
ABCB1,Neuroblastoma,0.5127628024019304
ABCB1,Lymphoblastic Leukemia,0.5129298662020659
ABCB1,Adrenocortical Carcinoma,0.525214105372123
ABCB1,Malignant Neoplasm,0.5973360026714207
ABCB1,Nervous System Diseases,0.6420878824691651
ABCB1,Ulcerative Colitis,0.6990462534407934
ABCB1,Diffuse Lymphoma,0.7300866884650863
ABCB1,Inflammatory Bowel Disease,0.7662135194687344
ABCB1,Congenital Heart Defects,0.776786668801341
ABCB1,Neutropenia,0.8373515856057342
ABCB1,Renal pseudohypoaldosteronism type 1 ORPHA:171871,0.3762014630157917
ABCB1,Low phospholipid-associated cholelithiasis ORPHA:69663,0.7068064785325423
ABCB1,Progressive familial intrahepatic cholestasis type 3 ORPHA:79305,0.7068064785325423
ABCB1,NON RARE IN EUROPE: Ulcerative colitis ORPHA:771,0.7068064785325423
ABCB1,Human adenovirus 18 IVa2 protein (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 31 IVa2 protein (gene: IVa2),0.6362779693488597
ABCB1,Human alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
ABCB1,Macacine alphaherpesvirus 1 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
ABCB1,Human adenovirus B3 protein IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Cercopithecine betaherpesvirus 5 helicase-primase helicase subunit (gene: UL105),0.6362779693488597
ABCB1,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human mastadenovirus F encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human alphaherpesvirus 3 helicase-primase helicase subunit (gene: ORF55),0.6362779693488597
ABCB1,Human herpesvirus 4 type 2 helicase-primase subunit BBLF4,0.6362779693488597
ABCB1,Human adenovirus 43 encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 68 maturation protein IVA2 (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 46 IVa2,0.6362779693488597
ABCB1,Monkeypox virus putative ATPase,0.6362779693488597
ABCB1,Human adenovirus 61 pIVa2,0.6362779693488597
ABCB1,Human adenovirus 6 maturation protein pIVa2 (gene: pIVa2),0.6362779693488597
ABCB1,Human adenovirus 14 IVa2 protein (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 55 pIVa2 50.9 kDa protein,0.6362779693488597
ABCB1,Human herpesvirus 3 strain Dumas helicase,0.6362779693488597
ABCB1,Human adenovirus 21 maturation protein IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 34 maturation protein IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 35 IVa2,0.6362779693488597
ABCB1,Human adenovirus 3+7 maturation protein IVA2 (gene: IVa2),0.6362779693488597
ABCB1,Cowpox virus CPXV167 protein (gene: CPXV167 CDS),0.6362779693488597
ABCB1,Human alphaherpesvirus 1 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
ABCB1,Human gammaherpesvirus 4 putative helicase (gene: BBLF4),0.6362779693488597
ABCB1,Cercopithecine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
ABCB1,Human adenovirus 52 IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 63 IVa2 protein (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 22 IVa2 (gene: IVa2),0.6362779693488597
ABCB1,Human adenovirus 64 IVa2 protein,0.6362779693488597
ABCB1,Human adenovirus D37 pIVa2 (gene: pIVa2),0.6362779693488597
ABCB1,Human adenovirus Chiba_E086/2012 pIVa2 (gene: pIVa2),0.6362779693488597
ABCB1,Human adenovirus 7d2 maturation protein IVA2 (gene: IVa2),0.6481498905276316
ABCB1,Human adenovirus 50 maturation protein IVa2 (gene: IVa2),0.7079503198328393
ABCC2,Colorectal Carcinoma,0.0034602840073026
ABCC2,Mammary Neoplasms,0.0034602840073026
ABCC2,Ovarian Carcinoma,0.0034602840073026
ABCC2,Breast Carcinoma,0.0042545616049287
ABCC2,Colorectal Cancer,0.0149315928814189
ABCC2,Stomach Carcinoma,0.0149315928814189
ABCC2,melanoma,0.0149315928814189
ABCC2,Adenocarcinoma,0.0155921563748247
ABCC2,Squamous cell carcinoma,0.0182265588252201
ABCC2,Malignant neoplasm of breast,0.0191435238361999
ABCC2,Fibrosarcoma,0.0191435238361999
ABCC2,Carcinogenesis,0.0228075668512991
ABCC2,Malignant neoplasm of ovary,0.0277695594716545
ABCC2,Hematopoietic Neoplasms,0.0334891258932371
ABCC2,Epithelial ovarian cancer,0.0387439397151409
ABCC2,Malignant neoplasm of prostate,0.0569142010728473
ABCC2,Renal Cell Carcinoma,0.0648809611869375
ABCC2,Malignant neoplasm of pancreas,0.0726340460169901
ABCC2,Pancreatic Neoplasm,0.0739788831250619
ABCC2,Lymphoma,0.0739788831250619
ABCC2,Pancreatic carcinoma,0.0745502070959292
ABCC2,Biliary tract abnormality,0.0745502070959292
ABCC2,Liver Cirrhosis Experimental,0.0747863377072194
ABCC2,Prostate carcinoma,0.0773771948186562
ABCC2,Squamous cell carcinoma of the head and neck,0.0775520919998773
ABCC2,Biliary Tract Diseases,0.0775520919998773
ABCC2,Colorectal Neoplasms,0.0827744840860166
ABCC2,Malignant neoplasm of urinary bladder,0.084286432100041
ABCC2,Bladder Neoplasm,0.0891725280554336
ABCC2,Squamous cell carcinoma of esophagus,0.0919714360040484
ABCC2,Liver carcinoma,0.095319386034013
ABCC2,Small cell carcinoma of lung,0.1193558174333938
ABCC2,Cholestasis Extrahepatic,0.13167400689206
ABCC2,Clear-cell metastatic renal cell carcinoma,0.13167400689206
ABCC2,Malignant neoplasm of large intestine,0.13167400689206
ABCC2,Carcinoma of bladder,0.13167400689206
ABCC2,Colonic Neoplasms,0.1454373331146953
ABCC2,Liver neoplasms,0.1454373331146953
ABCC2,Rheumatoid Arthritis,0.1537760235124317
ABCC2,Sarcoma,0.1537760235124317
ABCC2,Visual seizure,0.1735868515093891
ABCC2,stage ovarian epithelial cancer,0.1874735657311888
ABCC2,Seizures,0.2053083986145698
ABCC2,Malignant tumor of peritoneum,0.2062010908869036
ABCC2,Lung Neoplasms,0.2062010908869036
ABCC2,Connective Tissue Diseases,0.2139814021986384
ABCC2,Adverse reaction to drug,0.223747154820789
ABCC2,Drug toxicity,0.223747154820789
ABCC2,Hepatoblastoma,0.2522264785494494
ABCC2,B-Cell Lymphomas,0.2522264785494494
ABCC2,Malignant neoplasm of lung,0.2714542429024338
ABCC2,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
ABCC2,Gastrointestinal Diseases,0.2980670559114652
ABCC2,Hyperbilirubinemia,0.2980670559114652
ABCC2,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
ABCC2,Cholangiocarcinoma,0.340892538685018
ABCC2,Pregnancy in Diabetics,0.3638414818541592
ABCC2,Carcinoma of lung,0.3663130598151661
ABCC2,Complex partial seizures,0.383941725017158
ABCC2,Teratoma,0.383941725017158
ABCC2,Primary malignant neoplasm of lung,0.3902116649640871
ABCC2,Progressive intrahepatic cholestasis (disorder),0.3933196962529684
ABCC2,Adenocarcinoma of large intestine,0.3933196962529684
ABCC2,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
ABCC2,Generalized seizures,0.3933196962529684
ABCC2,Pancreatitis Chronic,0.3933196962529684
ABCC2,Nasopharyngeal carcinoma,0.3933196962529684
ABCC2,Adrenocortical carcinoma,0.3933196962529684
ABCC2,Seizures Focal,0.3933196962529684
ABCC2,Non-Small Cell Lung Carcinoma,0.3933196962529684
ABCC2,Hypertensive disease,0.3933196962529684
ABCC2,Leukemia Myelocytic Acute,0.3933196962529684
ABCC2,Oculocerebrorenal Syndrome,0.3933196962529684
ABCC2,HIV Infections,0.3933196962529684
ABCC2,Alzheimer's Disease,0.3933196962529684
ABCC2,Acute lymphocytic leukemia,0.3933196962529684
ABCC2,Non-small cell lung cancer metastatic,0.3933196962529684
ABCC2,Adenoma,0.3933196962529684
ABCC2,Hyperbilirubinemia Hereditary,0.3933196962529684
ABCC2,Urine color abnormal,0.3933196962529684
ABCC2,Bone marrow toxicity,0.3933196962529684
ABCC2,Cholestasis of pregnancy,0.3933196962529684
ABCC2,Malignant neoplasm of kidney,0.3941558617476422
ABCC2,Epilepsies Partial,0.3941558617476422
ABCC2,Single Seizure,0.3941558617476422
ABCC2,Seizures Auditory,0.3941558617476422
ABCC2,Seizures Clonic,0.3941558617476422
ABCC2,Seizures Sensory,0.3941558617476422
ABCC2,Seizures Somatosensory,0.3941558617476422
ABCC2,Vertiginous seizure,0.3941558617476422
ABCC2,Atonic Absence Seizures,0.3941558617476422
ABCC2,Generalized Absence Seizures,0.3941558617476422
ABCC2,Gustatory seizure,0.3941558617476422
ABCC2,Jacksonian Seizure,0.3941558617476422
ABCC2,Non-epileptic convulsion,0.3941558617476422
ABCC2,Nonepileptic Seizures,0.3941558617476422
ABCC2,Olfactory seizure,0.3941558617476422
ABCC2,Epilepsy,0.3941558617476422
ABCC2,De Toni-Debre-Fanconi Syndrome,0.3941558617476422
ABCC2,Renal carcinoma,0.3941558617476422
ABCC2,Epileptic Seizures,0.3941558617476422
ABCC2,Tonic Seizures,0.3941558617476422
ABCC2,Convulsive Seizures,0.3975960596292668
ABCC2,Refractory cancer,0.4028066164685291
ABCC2,Jaundice Chronic Idiopathic,0.4028066164685291
ABCC2,Cholera Infantum,0.4028066164685291
ABCC2,Fanconi Syndrome,0.4028066164685291
ABCC2,Epileptic drop attack,0.4037249857069285
ABCC2,Cholestasis,0.4100901006059349
ABCC2,Drug Resistant Epilepsy,0.4100901006059349
ABCC2,Multiple Myeloma,0.4103119460235835
ABCC2,Convulsions,0.4103119460235835
ABCC2,Female pattern alopecia (disorder),0.4103119460235835
ABCC2,Oral Mucositis,0.4103119460235835
ABCC2,Absence Seizures,0.4126392832024548
ABCC2,Acquired Immunodeficiency Syndrome,0.4126392832024548
ABCC2,Adenoma of large intestine,0.4126392832024548
ABCC2,stage non-small cell lung cancer,0.4186011760974318
ABCC2,Pseudopelade,0.4192169590514327
ABCC2,Lupus Erythematosus Systemic,0.4213286052188015
ABCC2,Simple Partial Status Epilepticus,0.4213286052188015
ABCC2,Status Epilepticus Subclinical,0.4213286052188015
ABCC2,Complex Partial Status Epilepticus,0.4213286052188015
ABCC2,Grand Mal Status Epilepticus,0.4213286052188015
ABCC2,Non-Convulsive Status Epilepticus,0.4213286052188015
ABCC2,Congestive heart failure,0.425419812815905
ABCC2,Jaundice Obstructive,0.4304973629098372
ABCC2,Adenocarcinoma of pancreas,0.4325044517055656
ABCC2,Petit mal status,0.4335751357405352
ABCC2,Severe diarrhea,0.4335751357405352
ABCC2,Stomatitis,0.4459714599189374
ABCC2,Functional Gastrointestinal Disorders,0.4459714599189374
ABCC2,Status Epilepticus,0.4506578937113162
ABCC2,leukemia,0.4588513406515081
ABCC2,Myoclonic Seizures,0.4615352570710579
ABCC2,Conjugated hyperbilirubinemia,0.4615352570710579
ABCC2,Mesothelioma,0.4635211539849193
ABCC2,Chronic kidney disease stage 5,0.4704594475773637
ABCC2,Alopecia Male Pattern,0.4852430673532381
ABCC2,Pain,0.4871698998714747
ABCC2,Gilbert Disease (disorder),0.4906258721078565
ABCC2,Tonic - clonic seizures,0.4919605488358906
ABCC2,Diarrhea,0.4923669467696064
ABCC2,Primary biliary cirrhosis,0.4923669467696064
ABCC2,Biliary Cirrhosis Secondary,0.4981941174985421
ABCC2,Neutropenia,0.498994845947585
ABCC2,Intrahepatic Cholestasis,0.5019670090704682
ABCC2,Hepatitis A,0.5090214163899865
ABCC2,Salmonella infections,0.5188223685230745
ABCC2,nervous system disorder,0.5276472086074249
ABCC2,Kidney Failure Chronic,0.5299466034567416
ABCC2,Adenocarcinoma Clear Cell,0.5299466034567416
ABCC2,Fatty Liver,0.533913711453195
ABCC2,Drug Allergy,0.5359212109443033
ABCC2,Renal tubular disorder,0.5619299124666532
ABCC2,Pancreatic Diseases,0.5885228491254589
ABCC2,Epilepsy Generalized,0.5916904943304121
ABCC2,Hepatitis Toxic,0.610971999959321
ABCC2,Chemical and Drug Induced Liver Injury,0.610971999959321
ABCC2,Chemically-Induced Liver Toxicity,0.610971999959321
ABCC2,Drug-Induced Acute Liver Injury,0.610971999959321
ABCC2,Heart Diseases,0.610971999959321
ABCC2,Fatty Liver Alcoholic,0.610971999959321
ABCC2,Androgenetic Alopecia,0.610971999959321
ABCC2,Hepatitis Drug-Induced,0.6189532555846575
ABCC2,Non-alcoholic Fatty Liver Disease,0.625027955184583
ABCC2,Icterus,0.625112405383346
ABCC2,Leukopenia,0.6274540883972485
ABCC2,Cholecystolithiasis,0.6878314377608323
ABCC2,Drug-Induced Liver Disease,0.6910672612216457
ABCC2,Spina Bifida,0.7045203904267408
ABCC2,Fanconi Anemia,0.7053337831155875
ABCC2,Cholestasis in newborn,0.7156410971578294
ABCC2,Hepatitis C,0.7169459458481418
ABCC2,Liver diseases,0.7337030585693298
ABCC2,Congenital contractural arachnodactyly,0.7467967658079964
ABCC2,Hepatitis,0.7484342194688707
ABCC2,Alopecia,0.7533159919746161
ABCC2,Cholelithiasis,0.8178117518835931
ABCC2,Biliary cirrhosis,0.8470105161823033
ABCC2,High density lipoprotein measurement,0.8913309410682808
ABCC2,Virus Diseases,0.9692165430561782
ABCC2,Esophagus Neoplasm,0.0102679590519094
ABCC2,Hyperbilirubinemia,0.3094716280561038
ABCC2,Cholestasis,0.336287627428424
ABCC2,Carcinoma Of The Head And Neck,0.4286813331685578
ABCC2,Pseudoxanthoma Elasticum,0.4286813331685578
ABCC2,Colorectal Cancer,0.4286813331685578
ABCC2,Cholestasis Of Pregnancy,0.4541466895915311
ABCC2,Rheumatoid Arthritis,0.4560460337187313
ABCC2,Nervous System Disorder,0.4560460337187313
ABCC2,Functional Gastrointestinal Disorders,0.4560460337187313
ABCC2,Colorectal Neoplasms,0.4560460337187313
ABCC2,Gastrointestinal Diseases,0.4560460337187313
ABCC2,Pseudopelade,0.4646409362700993
ABCC2,Conjugated Hyperbilirubinemia,0.4646409362700993
ABCC2,Non-Alcoholic Fatty Liver Disease,0.504364324740411
ABCC2,Jacksonian Seizure,0.5234357475824973
ABCC2,Seizure,0.5576425853515448
ABCC2,Clonic Seizures,0.5762801672039276
ABCC2,Biliary Cholangitis,0.6030919130927346
ABCC2,Heart Diseases,0.6030919130927346
ABCC2,Androgenetic Alopecia,0.6329251700753155
ABCC2,Hypotonic Seizures,0.6344671175966539
ABCC2,Alopecia Male Pattern,0.6524705037929849
ABCC2,Nonconvulsive Status Epilepticus,0.6798971073653743
ABCC2,Petit Mal Status,0.6798971073653743
ABCC2,Grand Mal Status Epilepticus,0.6798971073653743
ABCC2,Biliary Cirrhosis,0.6899894525110877
ABCC2,Status Epilepticus,0.7049836926927165
ABCC2,Alopecia,0.7167438233451096
ABCC2,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
ABCC2,Glutamate-cysteine ligase deficiency ORPHA:33574,0.0586579655822394
ABCC2,Dubin-Johnson syndrome ORPHA:234,0.6239678957896782
ABCC2,Hawkinsinuria ORPHA:2118,0.6239678957896782
ABCC2,Tyrosinemia type 3 ORPHA:69723,0.6239678957896782
ABCC2,Human adenovirus 18 IVa2 protein (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 31 IVa2 protein (gene: IVa2),0.6362779693488597
ABCC2,Human alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
ABCC2,Macacine alphaherpesvirus 1 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
ABCC2,Human adenovirus B3 protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Cercopithecine betaherpesvirus 5 helicase-primase helicase subunit (gene: UL105),0.6362779693488597
ABCC2,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Human mastadenovirus F encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Human alphaherpesvirus 3 helicase-primase helicase subunit (gene: ORF55),0.6362779693488597
ABCC2,Human mastadenovirus D encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus D10 pIVa2 (gene: pIVa2),0.6362779693488597
ABCC2,Human herpesvirus 4 type 2 helicase-primase subunit BBLF4,0.6362779693488597
ABCC2,Human adenovirus 68 maturation protein IVA2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 16 maturation protein IVA2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 6 maturation protein pIVa2 (gene: pIVa2),0.6362779693488597
ABCC2,Human mastadenovirus A IVa2,0.6362779693488597
ABCC2,Human adenovirus 14 IVa2 protein (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 55 pIVa2 50.9 kDa protein,0.6362779693488597
ABCC2,Human herpesvirus 3 strain Dumas helicase,0.6362779693488597
ABCC2,Titi monkey adenovirus ECC-2011 IVa2,0.6362779693488597
ABCC2,Human adenovirus 21 maturation protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 34 maturation protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 35 IVa2,0.6362779693488597
ABCC2,Cercopithecine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.6362779693488597
ABCC2,Human adenovirus 3+7 maturation protein IVA2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 11a IVa2,0.6362779693488597
ABCC2,Human adenovirus 1 IVa2,0.6362779693488597
ABCC2,Human adenovirus 5 IVa2,0.6362779693488597
ABCC2,Human mastadenovirus C encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
ABCC2,Human adenovirus 2 IVa2,0.6362779693488597
ABCC2,Human adenovirus 41 IVa2,0.6386053036162835
ABCC2,Macacine alphaherpesvirus 1 DNA replication origin-binding helicase (gene: UL9),0.6462089477181691
ABCC2,Human adenovirus 11+34 encapsidation protein IVa2 (gene: IVa2),0.6532977594572624
ABCC2,Papiine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.7748546750678369
ABHD14B,Neoplasm Metastasis,0.0648809611869375
ABHD14B,Carnitine palmitoyl transferase 1A deficiency ORPHA:156,0.1590470395003315
ABHD14B,Acatalasemia ORPHA:926,0.3762014630157917
ABHD14B,Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305,0.3762014630157917
ABHD14B,3-hydroxy-3-methylglutaric aciduria ORPHA:20,0.6239678957896782
ABHD14B,Acrodermatitis enteropathica ORPHA:37,0.6239678957896782
ABHD14B,B4GALT1-CDG ORPHA:79332,0.6239678957896782
ABHD14B,Mucopolysaccharidosis type 7 ORPHA:584,0.6239678957896782
ABHD14B,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.6239678957896782
ABHD14B,Carnitine-acylcarnitine translocase deficiency ORPHA:159,0.7068064785325423
ABHD14B,Ethylmalonic encephalopathy ORPHA:51188,0.7068064785325423
ABHD14B,Tyrosinemia type 1 ORPHA:882,0.7068064785325423
ABHD14B,Familial porphyria cutanea tarda ORPHA:443062,0.7068064785325423
ABHD14B,Yaba monkey tumor virus monoglyceride lipase,0.6362779693488597
ACBD7,15q13.3 microdeletion syndrome ORPHA:199318,0.1590470395003315
ACBD7,NON RARE IN EUROPE: Non rare obesity ORPHA:521399,0.1590470395003315
ACBD7,Bradyopsia ORPHA:75374,0.3762014630157917
ACBD7,Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805,0.4548046963946745
ACBD7,L-2-hydroxyglutaric aciduria ORPHA:79314,0.6239678957896782
ACBD7,Macular corneal dystrophy ORPHA:98969,0.7068064785325423
ACBD7,Hepatovirus A 3D mature peptide,0.6362779693488597
ACBD7,Human enterovirus C104 3D,0.6362779693488597
ACBD7,Human parainfluenza virus 4b nucleoprotein,0.6362779693488597
ACBD7,Echovirus E14 3D,0.6362779693488597
ACBD7,Echovirus E11 3D,0.6362779693488597
ACBD7,Echovirus E4 3D,0.6362779693488597
ACBD7,Coxsackievirus A22 3d,0.6362779693488597
ACBD7,Enterovirus C109 3D,0.6362779693488597
ACBD7,Coxsackievirus A1 3D,0.6362779693488597
ACBD7,Enterovirus B 3D,0.6362779693488597
ACBD7,Enterovirus H 3D,0.6362779693488597
ACBD7,Echovirus 9 strain Hill polyprotein region 11,0.6362779693488597
ACBD7,Echovirus E32 3D,0.6362779693488597
ACBD7,Echovirus E17 3D,0.6362779693488597
ACBD7,Yaba monkey tumor virus 72L,0.6362779693488597
ACBD7,Human enterovirus 94 3D,0.6362779693488597
ACBD7,Echovirus E3 3D,0.6362779693488597
ACBD7,Enterovirus D 3D-POL,0.6362779693488597
ACBD7,Echovirus 9 strain Barty polymerase,0.6362779693488597
ACBD7,Echovirus E6 3D,0.6362779693488597
ACBD7,Echovirus E21 3D,0.6362779693488597
ACBD7,Machupo mammarenavirus L protein,0.6362779693488597
ACBD7,Vaccinia virus ser/thr kinase (gene: B1R),0.6362779693488597
ACBD7,Vaccinia virus Ankara Serine/threonine-protein kinase,0.6362779693488597
ACBD7,Lassa mammarenavirus L protein,0.6362779693488597
ACBD7,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.6362779693488597
ACBD7,Norovirus Hu/GII.2/HS255/2011/USA NTPase (gene: POL),0.6362779693488597
ACBD7,Human rhinovirus QCE 3D,0.6362779693488597
ACBD7,Human T-cell leukemia virus type I p21 TM (gene: env),0.6362779693488597
ACBD7,Human rhinovirus A65 3D,0.6362779693488597
ACBD7,Human rhinovirus A71 3D,0.6362779693488597
ACBD7,Human immunodeficiency virus 2 vpx protein,0.6362779693488597
ACBD7,Human rhinovirus A20 3D,0.6362779693488597
ACBD7,Human rhinovirus A80 3D,0.6362779693488597
ACBD7,Influenza A virus (A/California/04/2009(H1N1)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/California/07/2009(H1N1)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/Korea/426/1968(H2N2)) PB1 polymerase subunit (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/New York/392/2004(H3N2)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/New York/599/1996(H3N2)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/New York/602/1996(H3N2)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/Northern Territory/60/1968(H3N2)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/Shanghai/02/2013(H7N9)) polymerase PB1 (gene: PB1),0.6362779693488597
ACBD7,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) polymerase (gene: PB1),0.6362779693488597
ACBD7,Human enterovirus C118 3D,0.6362779693488597
ACBD7,Influenza A virus (A/Korea/426/1968(H2N2)) nonstructural protein 1 (gene: NS1),0.6362779693488597
ACBD7,Junin mammarenavirus L protein,0.6362779693488597
ACBD7,Monkeypox virus cowpox A-type inclusion protein,0.6362779693488597
ACBD7,Guanarito mammarenavirus L protein,0.6362779693488597
ACBD7,Variola virus hypothetical protein (gene: A28L),0.6806291584193672
ACBD7,Influenza B virus nonstructural protein 1 (gene: NS1),0.7017760963861425
ACBD7,Influenza B virus (B/Memphis/12/97) NS protein,0.7017760963861425
ACBD7,Horsepox virus HSPV011c (ankyrin repeats),0.830387084488226
ACBD7,Influenza A virus (A/New York/599/1996(H3N2)) matrix protein 1 (gene: M1),0.8373747313517419
ACBD7,Influenza A virus (A/New York/602/1996(H3N2)) matrix protein 1 (gene: M1),0.8373747313517419
ACBD7,Influenza A virus (A/Northern Territory/60/1968(H3N2)) matrix protein 1 (gene: M1),0.8373747313517419
ACBD7,Influenza A virus (A/Korea/426/1968(H2N2)) membrane protein M1 (gene: M1),0.8390943852085586
ACBD7,Influenza A virus (A/Shanghai/02/2013(H7N9)) matrix protein 1 (gene: M1),0.8458935424065495
ACBD7,Vaccinia virus cowpox A-type inclusion protein,0.8834254233868516
ACBD7,Yaba-like disease virus 148R protein (gene: 148R),0.9055720084468104
ACSL5,Colorectal Carcinoma,0.0034602840073026
ACSL5,Epithelioma,0.0149002095788623
ACSL5,Colorectal Cancer,0.0149315928814189
ACSL5,Adenocarcinoma,0.0155921563748247
ACSL5,Carcinogenesis,0.0228075668512991
ACSL5,Glioma,0.0739788831250619
ACSL5,Glioblastoma,0.0745502070959292
ACSL5,Malignant Neoplasms,0.0991201145654548
ACSL5,ADENOMAS AND ADENOCARCINOMAS,0.1193558174333938
ACSL5,Neoplasms,0.2714542429024338
ACSL5,Malignant Glioma,0.3933196962529684
ACSL5,Arthritis Adjuvant-Induced,0.3933196962529684
ACSL5,Arthritis Collagen-Induced,0.3933196962529684
ACSL5,Arthritis Experimental,0.3933196962529684
ACSL5,Adenoma,0.3933196962529684
ACSL5,Anaplasia,0.3938591532700354
ACSL5,Lupus Erythematosus Systemic,0.4213286052188015
ACSL5,Nonalcoholic Steatohepatitis,0.4335751357405352
ACSL5,Steatohepatitis,0.4906258721078565
ACSL5,Platelet mean volume determination (procedure),0.4981941174985421
ACSL5,Obesity,0.5140447474168605
ACSL5,Fatty Liver,0.533913711453195
ACSL5,Metaplasia,0.5710095678317721
ACSL5,Hyperlipidemia,0.6035970790768342
ACSL5,Adenocarcinoma Endometrioid,0.625027955184583
ACSL5,Colorectal Cancer,0.4286813331685578
ACSL5,Galactose mutarotase deficiency ORPHA:570422,0.1590470395003315
ACSL5,Acatalasemia ORPHA:926,0.3762014630157917
ACSL5,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428,0.6239678957896782
ACSL5,Marfan syndrome type 2 ORPHA:284973,0.6239678957896782
ACSL5,Proteasome-associated autoinflammatory syndrome ORPHA:324977,0.6239678957896782
ACSL5,Imerslund-Grasbeck syndrome ORPHA:35858,0.6239678957896782
ACSL5,Coffin-Lowry syndrome ORPHA:192,0.7068064785325423
ACSL5,Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630,0.7068064785325423
ACSL5,Adenosine monophosphate deaminase deficiency ORPHA:45,0.7068064785325423
ACSL5,Hereditary renal hypouricemia ORPHA:94088,0.7068064785325423
ACSL5,Thyroid hypoplasia ORPHA:95720,0.7068064785325423
ACSL5,Squamous cell carcinoma of the esophagus ORPHA:99977,0.7068064785325423
ACTA2,Mammary Neoplasms,0.0034602840073026
ACTA2,Breast Carcinoma,0.0042545616049287
ACTA2,Adenocarcinoma,0.0155921563748247
ACTA2,Malignant neoplasm of breast,0.0191435238361999
ACTA2,Mammary Neoplasms Human,0.064548079316548
ACTA2,Neoplasm Metastasis,0.0648809611869375
ACTA2,Renal Cell Carcinoma,0.0648809611869375
ACTA2,AORTIC VALVE DISEASE 2,0.0745502070959292
ACTA2,Liver Cirrhosis Experimental,0.0747863377072194
ACTA2,Liver Cirrhosis,0.0773771948186562
ACTA2,Osteosarcoma,0.1029977559100099
ACTA2,Chronic Lymphocytic Leukemia,0.1147307578771389
ACTA2,Brain Aneurysm,0.1253114324938153
ACTA2,Dilatation of the cerebral artery,0.1254380558571286
ACTA2,Nephrogenic Fibrosing Dermopathy,0.1254380558571286
ACTA2,Cholestasis Extrahepatic,0.13167400689206
ACTA2,Myocardial Infarction,0.1352936728187231
ACTA2,Colonic Neoplasms,0.1454373331146953
ACTA2,Marfan Syndrome,0.1735868515093891
ACTA2,Intracranial Aneurysm,0.1735868515093891
ACTA2,Systemic Scleroderma,0.1900258729042946
ACTA2,Seizures,0.2053083986145698
ACTA2,Connective Tissue Diseases,0.2139814021986384
ACTA2,Malignant tumor of colon,0.223747154820789
ACTA2,Bicuspid aortic valve,0.2687300999130421
ACTA2,Aortic Aneurysm Thoracic,0.2980670559114652
ACTA2,Heart Septal Defects,0.3044782497745498
ACTA2,Ehlers-Danlos Syndrome,0.3283839486480793
ACTA2,Ischemic stroke,0.3486533561309259
ACTA2,Aortic root dilatation,0.3508665345292502
ACTA2,Metastatic malignant neoplasm to brain,0.3638414818541592
ACTA2,Endometriosis,0.383941725017158
ACTA2,Pulmonary arterial hypertension,0.3925783478421996
ACTA2,Cakut,0.3933196962529684
ACTA2,Cerebrovascular Disorders,0.3933196962529684
ACTA2,Fetal Growth Retardation,0.3933196962529684
ACTA2,Kidney Diseases,0.3933196962529684
ACTA2,Cerebral arterial aneurysm,0.3933196962529684
ACTA2,Hypertensive disease,0.3933196962529684
ACTA2,Aortic aneurysm and dissection,0.3933196962529684
ACTA2,Mydriasis,0.3933196962529684
ACTA2,Aortic Aneurysm Thoracoabdominal,0.3933196962529684
ACTA2,Ascending aorta dilatation,0.3933196962529684
ACTA2,Fibrosis Liver,0.3933196962529684
ACTA2,Coronary heart disease,0.3933196962529684
ACTA2,acute aortic dissection,0.3933196962529684
ACTA2,Aortic Aneurysm,0.3933196962529684
ACTA2,Telangiectasis,0.3933196962529684
ACTA2,Moyamoya disease 1,0.3933196962529684
ACTA2,Focal glomerulosclerosis,0.3933196962529684
ACTA2,Dupuytren Contracture,0.3941558617476422
ACTA2,Epilepsy,0.3941558617476422
ACTA2,Meningitis Cryptococcal,0.3941558617476422
ACTA2,Abnormality of the cerebral vasculature,0.3941558617476422
ACTA2,Dyspnea on exertion,0.3941558617476422
ACTA2,Moyamoya Disease,0.3941558617476422
ACTA2,Ischemia,0.3941558617476422
ACTA2,Endometrioma,0.3941558617476422
ACTA2,Cerebral Aneurysm,0.3975960596292668
ACTA2,Congenital aneurysm of ascending aorta,0.4028066164685291
ACTA2,Copper-Overload Cirrhosis,0.4103119460235835
ACTA2,Cerebrovascular accident,0.4115056600660309
ACTA2,Ascending aortic dissection,0.4115056600660309
ACTA2,Cystic medial necrosis of aorta,0.4115056600660309
ACTA2,Descending aortic dissection,0.4115056600660309
ACTA2,Patent ductus arteriosus - persisting type,0.4115056600660309
ACTA2,Vascular Diseases,0.4126392832024548
ACTA2,Dyspnea Paroxysmal,0.4126392832024548
ACTA2,Abnormality of the iris,0.4126392832024548
ACTA2,Obstructive Ureterocele,0.4126392832024548
ACTA2,Arteriopathic disease,0.4192169590514327
ACTA2,Adenocarcinoma of lung stage IV,0.425419812815905
ACTA2,Dilated ventricles (finding),0.425992946703162
ACTA2,Psoriasis,0.4304973629098372
ACTA2,Impaired left ventricular function,0.4396723023384634
ACTA2,Spider Veins,0.4459714599189374
ACTA2,Cryptogenic Chronic Hepatitis,0.4459714599189374
ACTA2,Dupuytren's Disease,0.4506578937113162
ACTA2,Aneurysm,0.4561717689698902
ACTA2,Aortic Diseases,0.4564472886428772
ACTA2,Chronic active hepatitis,0.4615352570710579
ACTA2,Tachypnea,0.4615352570710579
ACTA2,Cardiomyopathy Familial Idiopathic,0.4704594475773637
ACTA2,Hyalinosis Segmental Glomerular,0.4753011022966241
ACTA2,Atrial Septal Defects,0.4757083758251088
ACTA2,Myopathies Nemaline,0.4906258721078565
ACTA2,Chronic Persistent Hepatitis,0.4906258721078565
ACTA2,Congenital malrotation of intestine,0.4906258721078565
ACTA2,Increase in blood pressure,0.4923669467696064
ACTA2,Crohn Disease,0.4981941174985421
ACTA2,Ulcerative Colitis,0.5001612228394569
ACTA2,Coronary Arteriosclerosis,0.5140447474168605
ACTA2,Adenocarcinoma of lung (disorder),0.51550637274795
ACTA2,Dull intelligence,0.5300976305939776
ACTA2,Low intelligence,0.5300976305939776
ACTA2,Familial (FPAH),0.533913711453195
ACTA2,Congenital Heart Defects,0.533913711453195
ACTA2,Dissection of aorta,0.5393787854381349
ACTA2,Left-Sided Heart Failure,0.5568517196017908
ACTA2,Poor school performance,0.5610226870913673
ACTA2,Cutis marmorata,0.5619299124666532
ACTA2,Idiopathic pulmonary arterial hypertension,0.5655222348249326
ACTA2,Aortic Valve Insufficiency,0.5683976277847906
ACTA2,Mental deficiency,0.6035970790768342
ACTA2,Mental Retardation,0.6319938293757544
ACTA2,Cardiomegaly,0.6332132835539771
ACTA2,Patent ductus arteriosus,0.6334536292962906
ACTA2,Ankylosing spondylitis,0.6446807314576214
ACTA2,Cardiomyopathy Hypertrophic Familial,0.655573080043894
ACTA2,Chest Pain,0.6656356363792992
ACTA2,Cardiomyopathies,0.6989462176022242
ACTA2,Coronary Artery Disease,0.7240930522443176
ACTA2,Liver diseases,0.7337030585693298
ACTA2,Cryptorchidism,0.7417321496240817
ACTA2,Cholangitis Sclerosing,0.8244780048843707
ACTA2,Intellectual Disability,0.8352623613787349
ACTA2,Hepatitis Chronic,0.8867784885819414
ACTA2,Hypertrophic Cardiomyopathy,0.89450044231149
ACTA2,Liver Dysfunction,0.9114432287644624
ACTA2,Breast Carcinoma,0.0075861267486594
ACTA2,Marfan Syndrome,0.0133304506157067
ACTA2,Mammary Neoplasms,0.0155248163763686
ACTA2,Breast Cancer,0.0402286636010764
ACTA2,Lymphocytic Leukemia,0.0487679768343083
ACTA2,Pulmonary Fibrosis,0.0654534781440596
ACTA2,Alveolitis,0.1025546857843372
ACTA2,Thoracic Aortic Aneurysm And Aortic Dissection,0.1641294276675242
ACTA2,Endometriosis,0.2187610616307245
ACTA2,Nasopharyngeal Carcinoma,0.2278592962769385
ACTA2,Subarachnoid Hemorrhage,0.2627224344149009
ACTA2,Cholestasis,0.336287627428424
ACTA2,Connective Tissue Disease,0.425341435586089
ACTA2,Liver Cirrhosis,0.4286813331685578
ACTA2,Glomerular Hyalinosis,0.4286813331685578
ACTA2,Pulmonary Arterial Hypertension,0.4286813331685578
ACTA2,Aortic Valve Insufficiency,0.4286813331685578
ACTA2,Ischemic Stroke,0.4286813331685578
ACTA2,Lung Cancer,0.4402141802500753
ACTA2,Lung Carcinoma,0.4541466895915311
ACTA2,Aortic Aneurysm,0.4541466895915311
ACTA2,Copper-Overload Cirrhosis,0.4560460337187313
ACTA2,Transient Ischemic Attack,0.4560460337187313
ACTA2,Liver Fibrosis,0.4560460337187313
ACTA2,Nephrosclerosis,0.4560460337187313
ACTA2,Descending Aortic Dissection,0.4560460337187313
ACTA2,Dyspnea Paroxysmal,0.4560460337187313
ACTA2,Hypertension,0.4560460337187313
ACTA2,Bicuspid Aortic Valve,0.4646409362700993
ACTA2,Congenital Malrotation Of Intestine,0.4646409362700993
ACTA2,Colonic Neoplasms,0.4809179010794786
ACTA2,Scoliosis,0.4875380732267193
ACTA2,Coronary Arteriosclerosis,0.4875380732267193
ACTA2,Peripheral Arterial Stenosis,0.4968320901822731
ACTA2,Endometrioma,0.5036845352940079
ACTA2,Scleroderma,0.5162067638232762
ACTA2,Arachnodactyly,0.525214105372123
ACTA2,Moyamoya Disease,0.555382961603519
ACTA2,Myocardial Infarction,0.5632819212593052
ACTA2,Glomerulosclerosis,0.5924794904332197
ACTA2,Kidney Disease,0.6420878824691651
ACTA2,Patent Ductus Arteriosus,0.6596918765832213
ACTA2,Ulcerative Colitis,0.6990462534407934
ACTA2,Cholangitis,0.6999859437625926
ACTA2,Ankylosing Spondylitis,0.7049836926927165
ACTA2,Cutis Marmorata,0.7083841747135766
ACTA2,Psoriasis,0.7184623115342476
ACTA2,Crohn Disease,0.7414460416900516
ACTA2,Mental Retardation,0.7729545590606223
ACTA2,Cryptorchidism,0.776786668801341
ACTA2,Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387,0.0902044104910482
ACTA2,Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899,0.1590470395003315
ACTA2,Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857,0.1590470395003315
ACTA2,Osteogenesis imperfecta type 1 ORPHA:216796,0.1590470395003315
ACTA2,Periodontal Ehlers-Danlos syndrome ORPHA:75392,0.1590470395003315
ACTA2,Acrogeria ORPHA:2500,0.1590470395003315
ACTA2,Familial abdominal aortic aneurysm ORPHA:86,0.1590470395003315
ACTA2,Familial retinal arterial macroaneurysm ORPHA:284247,0.1590470395003315
ACTA2,Familial visceral myopathy ORPHA:2604,0.1590470395003315
ACTA2,Myopathic intestinal pseudoobstruction ORPHA:104077,0.1590470395003315
ACTA2,Pycnodysostosis ORPHA:763,0.1590470395003315
ACTA2,Vascular Ehlers-Danlos syndrome ORPHA:286,0.1590470395003315
ACTA2,Familial calcium pyrophosphate deposition ORPHA:1416,0.1590470395003315
ACTA2,Isolated ectopia lentis ORPHA:1885,0.1590470395003315
ACTA2,Congenital glaucoma ORPHA:98976,0.1614487935928034
ACTA2,Cardiac-valvular Ehlers-Danlos syndrome ORPHA:230851,0.3762014630157917
ACTA2,EMILIN-1-related connective tissue disease ORPHA:485418,0.3762014630157917
ACTA2,LIMS2-related limb-girdle muscular dystrophy ORPHA:466801,0.3762014630157917
ACTA2,Primary dystonia DYT27 type ORPHA:464440,0.3762014630157917
ACTA2,Autosomal dominant cutis laxa ORPHA:90348,0.3762014630157917
ACTA2,Geleophysic dysplasia ORPHA:2623,0.3762014630157917
ACTA2,Weill-Marchesani syndrome ORPHA:3449,0.3762014630157917
ACTA2,Familial cerebral saccular aneurysm ORPHA:231160,0.3826134188846508
ACTA2,Autosomal recessive cutis laxa type 1 ORPHA:90349,0.6239678957896782
ACTA2,Acroosteolysis-keloid-like lesions-premature aging syndrome ORPHA:363665,0.6239678957896782
ACTA2,Chronic myeloproliferative disease unclassifiable ORPHA:86830,0.6239678957896782
ACTA2,Dermatosparaxis Ehlers-Danlos syndrome ORPHA:1901,0.6239678957896782
ACTA2,Familial episodic pain syndrome with predominantly upper body involvement ORPHA:391389,0.6239678957896782
ACTA2,Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718,0.6239678957896782
ACTA2,Multisystemic smooth muscle dysfunction syndrome ORPHA:404463,0.6239678957896782
ACTA2,Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement ORPHA:168947,0.6239678957896782
ACTA2,Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement ORPHA:168950,0.6239678957896782
ACTA2,Pyle disease ORPHA:3005,0.6239678957896782
ACTA2,Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome ORPHA:477831,0.6239678957896782
ACTA2,Juvenile glaucoma ORPHA:98977,0.6239678957896782
ACTA2,Hereditary hemorrhagic telangiectasia ORPHA:774,0.6268296504510718
ACTA2,Primary hypereosinophilic syndrome ORPHA:314950,0.6279395134845649
ACTA2,Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3 ORPHA:62,0.7068064785325423
ACTA2,Congenital cornea plana ORPHA:53691,0.7068064785325423
ACTA2,Congenital stromal corneal dystrophy ORPHA:101068,0.7068064785325423
ACTA2,Delta-sarcoglycan-related  limb-girdle muscular dystrophy R6 ORPHA:219,0.7068064785325423
ACTA2,Desminopathy ORPHA:98909,0.7068064785325423
ACTA2,Familial aortic dissection ORPHA:229,0.7068064785325423
ACTA2,Hereditary sensorimotor neuropathy with hyperelastic skin ORPHA:280598,0.7068064785325423
ACTA2,Holt-Oram syndrome ORPHA:392,0.7068064785325423
ACTA2,Keutel syndrome ORPHA:85202,0.7068064785325423
ACTA2,Megacystis-microcolon-intestinal hypoperistalsis syndrome ORPHA:2241,0.7068064785325423
ACTA2,Multiple epiphyseal dysplasia type 1 ORPHA:93308,0.7068064785325423
ACTA2,NON RARE IN EUROPE: Patent arterial duct ORPHA:706,0.7068064785325423
ACTA2,Neurogenic scapuloperoneal syndrome Kaeser type ORPHA:85146,0.7068064785325423
ACTA2,Pseudoachondroplasia ORPHA:750,0.7068064785325423
ACTA2,Supravalvular aortic stenosis ORPHA:3193,0.7068064785325423
ACTA2,Moyamoya disease ORPHA:2573,0.7068064785325423
ACTA2,Salivirus NG-J1 3D,0.6362779693488597
ACTA2,Ectromelia virus ERPV profilin-like protein,0.6362779693488597
ACTA2,Variola virus hypothetical protein (gene: A47R),0.6362779693488597
ACTA2,Monkeypox virus profilin-like protein,0.6362779693488597
ACTA2,Monkeypox virus Zaire-96-I-16 A42R (gene: A42R),0.6362779693488597
ACTA2,Horsepox virus HSPV164 (Profilin),0.6362779693488597
ACTA2,Vaccinia virus profilin-like protein (gene: A42R),0.6362779693488597
ACTA2,Vaccinia virus Ankara Profilin-1-like,0.6362779693488597
ACTA2,Cowpox virus CPXV179 protein (gene: CPXV179 CDS),0.6362779693488597
ACTA2,Human T-cell leukemia virus type I p21 TM (gene: env),0.6362779693488597
ACTA2,Human immunodeficiency virus envelope glycoprotein (gene: env),0.6362779693488597
ACTA2,Human alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.6362779693488597
ACTA2,Human alphaherpesvirus 1 tegument protein VP22 (gene: UL49),0.6362779693488597
ADAM15,Colorectal Carcinoma,0.0034602840073026
ADAM15,Mammary Neoplasms,0.0034602840073026
ADAM15,Breast Carcinoma,0.0042545616049287
ADAM15,Epithelioma,0.0149002095788623
ADAM15,Tumor Progression,0.0149315928814189
ADAM15,Stomach Carcinoma,0.0149315928814189
ADAM15,melanoma,0.0149315928814189
ADAM15,Adenocarcinoma,0.0155921563748247
ADAM15,Squamous cell carcinoma,0.0182265588252201
ADAM15,ovarian neoplasm,0.0191435238361999
ADAM15,Malignant neoplasm of breast,0.0191435238361999
ADAM15,Malignant neoplasm of stomach,0.0191435238361999
ADAM15,Malignant neoplasm of prostate,0.0569142010728473
ADAM15,Neoplasm Metastasis,0.0648809611869375
ADAM15,Degenerative polyarthritis,0.0739788831250619
ADAM15,inflammatory joint disease,0.0745502070959292
ADAM15,Prostate carcinoma,0.0773771948186562
ADAM15,Stage IV Bladder Cancer AJCC v6,0.084286432100041
ADAM15,Malignant neoplasm of urinary bladder,0.084286432100041
ADAM15,Bladder Neoplasm,0.0891725280554336
ADAM15,Colon Carcinoma,0.1062239757831962
ADAM15,Carcinoma of bladder,0.13167400689206
ADAM15,Rheumatoid Arthritis,0.1537760235124317
ADAM15,Prostatic Neoplasms,0.223747154820789
ADAM15,Metastasis from malignant tumor of prostate,0.2454426921531692
ADAM15,Chondrosarcoma,0.2643145809900195
ADAM15,Metastatic Prostate Carcinoma,0.2643145809900195
ADAM15,Malignant Squamous Cell Neoplasm,0.3104232675696299
ADAM15,Carcinoma of lung,0.3663130598151661
ADAM15,Cardiac dilatation,0.3933196962529684
ADAM15,Genitourinary Cancer,0.3933196962529684
ADAM15,Inflammatory Bowel Diseases,0.3933196962529684
ADAM15,Anaplasia,0.3938591532700354
ADAM15,Atrial Fibrillation,0.3941558617476422
ADAM15,Pathologic Neovascularization,0.4192169590514327
ADAM15,Osteophyte,0.4459714599189374
ADAM15,Arteriosclerosis,0.5019670090704682
ADAM15,Atherosclerosis,0.5393787854381349
ADAM15,Bloom Syndrome,0.6802335864704374
ADAM15,Lupus Erythematosus,0.5087473896242481
ADAM15,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.1590470395003315
ADAM15,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.1590470395003315
ADAM15,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.1739455566145445
ADAM15,5-oxoprolinase deficiency ORPHA:33572,0.3762014630157917
ADAM15,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.3762014630157917
ADAM15,CLN10 disease ORPHA:228337,0.3762014630157917
ADAM15,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.3762014630157917
ADAM15,Fetal Gaucher disease ORPHA:85212,0.3762014630157917
ADAM15,Gaucher disease type 2 ORPHA:77260,0.3762014630157917
ADAM15,Gaucher disease type 3 ORPHA:77261,0.3762014630157917
ADAM15,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072,0.3762014630157917
ADAM15,Glycogen storage disease due to acid maltase deficiency infantile onset ORPHA:308552,0.3762014630157917
ADAM15,Glycogen storage disease due to acid maltase deficiency late-onset ORPHA:420429,0.3762014630157917
ADAM15,Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625,0.3762014630157917
ADAM15,NON RARE IN EUROPE: Parkinson disease ORPHA:319705,0.3762014630157917
ADAM15,Naxos disease ORPHA:34217,0.3762014630157917
ADAM15,Sanfilippo syndrome type B ORPHA:79270,0.3762014630157917
ADAM15,Gaucher disease type 1 ORPHA:77259,0.3762014630157917
ADAM15,NON RARE IN EUROPE: Paget disease of bone ORPHA:280110,0.3762014630157917
ADAM15,Idiopathic pulmonary fibrosis ORPHA:2032,0.43936148647173
ADAM15,Autosomal recessive spastic paraplegia type 76 ORPHA:488594,0.6239678957896782
ADAM15,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.6239678957896782
ADAM15,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837,0.6239678957896782
ADAM15,Jalili syndrome ORPHA:1873,0.6239678957896782
ADAM15,MAN1B1-CDG ORPHA:397941,0.6239678957896782
ADAM15,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.6239678957896782
ADAM15,Neurogenic arthrogryposis multiplex congenita ORPHA:1143,0.6239678957896782
ADAM15,Oxoglutaric aciduria ORPHA:31,0.6239678957896782
ADAM15,Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298,0.6239678957896782
ADAM15,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.6239678957896782
ADAM15,Autosomal recessive progressive external ophthalmoplegia ORPHA:254886,0.6239678957896782
ADAM15,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.6239678957896782
ADAM15,Multiple endocrine neoplasia type 1 ORPHA:652,0.6279395134845649
ADAM15,Acyl-CoA dehydrogenase 9 deficiency ORPHA:99901,0.7068064785325423
ADAM15,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.7068064785325423
ADAM15,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.7068064785325423
ADAM15,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.7068064785325423
ADAMTS14,Colorectal Carcinoma,0.0034602840073026
ADAMTS14,Colorectal Cancer,0.0149315928814189
ADAMTS14,Degenerative polyarthritis,0.0739788831250619
ADAMTS14,Liver carcinoma,0.095319386034013
ADAMTS14,Multiple Sclerosis,0.2835142372342932
ADAMTS14,EHLERS-DANLOS SYNDROME DERMATOSPARAXIS TYPE,0.3933196962529684
ADAMTS14,Asthma,0.3933196962529684
ADAMTS14,Asthma,0.504364324740411
ADAMTS14,Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752,0.3762014630157917
ADAMTS15,Colorectal Carcinoma,0.0034602840073026
ADAMTS15,Breast Carcinoma,0.0042545616049287
ADAMTS15,Colorectal Cancer,0.0149315928814189
ADAMTS15,Degenerative polyarthritis,0.0739788831250619
ADAMTS15,Colon Carcinoma,0.1062239757831962
ADAMTS15,Intracranial Aneurysm,0.1735868515093891
ADAMTS15,Malignant tumor of colon,0.223747154820789
ADAMTS15,Prostatic Neoplasms,0.223747154820789
ADAMTS15,Airway Obstruction,0.5655222348249326
ADAMTS15,Colorectal Cancer,0.4286813331685578
ADAMTS15,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
ADAMTS15,Peters anomaly ORPHA:708,0.00518481975049
ADAMTS15,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
ADAMTS15,Familial porencephaly ORPHA:99810,0.0083045131203191
ADAMTS15,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
ADAMTS15,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
ADAMTS15,Craniosynostosis Boston type ORPHA:1541,0.0180064224283883
ADAMTS15,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.0180064224283883
ADAMTS15,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.0180064224283883
ADAMTS15,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.0180064224283883
ADAMTS15,Dermatofibrosarcoma protuberans ORPHA:31112,0.0180064224283883
ADAMTS15,Tetralogy of Fallot ORPHA:3303,0.0277610005156803
ADAMTS15,Microphthalmia with brain and digit anomalies ORPHA:139471,0.0586579655822394
ADAMTS15,Autosomal recessive Robinow syndrome ORPHA:1507,0.0586579655822394
ADAMTS15,Postaxial polydactyly type B ORPHA:93335,0.0586579655822394
ADAMTS15,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.0640416108792758
ADAMTS15,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.1590470395003315
ADAMTS15,Lateral meningocele syndrome ORPHA:2789,0.1590470395003315
ADAMTS15,Enlarged parietal foramina ORPHA:60015,0.1590470395003315
ADAMTS15,Hyperostosis corticalis generalisata ORPHA:3416,0.1590470395003315
ADAMTS15,Acrocallosal syndrome ORPHA:36,0.1590470395003315
ADAMTS15,NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480,0.1590470395003315
ADAMTS15,Brachydactyly type B1 ORPHA:572385,0.3762014630157917
ADAMTS15,Familial bicuspid aortic valve ORPHA:402075,0.3775879467205478
ADAMTS15,Early-onset posterior polar cataract ORPHA:98993,0.4045231980457672
ADAMTS15,Craniofrontonasal dysplasia ORPHA:1520,0.6239678957896782
ADPRHL1,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.0640416108792758
ADPRHL1,Amish nemaline myopathy ORPHA:98902,0.1590470395003315
ADPRHL1,Cataract-glaucoma syndrome ORPHA:162,0.1590470395003315
ADPRHL1,Familial progressive cardiac conduction defect ORPHA:871,0.1614487935928034
ADPRHL1,Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601,0.6239678957896782
ADPRHL1,Congenital fiber-type disproportion myopathy ORPHA:2020,0.6279395134845649
ADPRHL1,Fetal akinesia deformation sequence ORPHA:994,0.6279395134845649
ADPRHL1,NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy ORPHA:155,0.7068064785325423
ADPRHL1,Familial isolated dilated cardiomyopathy ORPHA:154,0.7068064785325423
ADPRHL1,Congenital myopathy with excess of thin filaments ORPHA:98904,0.7068064785325423
ADPRHL1,Distal myopathy Tateyama type ORPHA:488650,0.7068064785325423
ADPRHL1,Isolated asymptomatic elevation of creatine phosphokinase ORPHA:206599,0.7068064785325423
ADPRHL1,Late-onset distal myopathy Markesbery-Griggs type ORPHA:98912,0.7068064785325423
ADPRHL1,Progressive scapulohumeroperoneal distal myopathy ORPHA:447977,0.7068064785325423
ADPRHL1,Rippling muscle disease ORPHA:97238,0.7068064785325423
ADPRHL1,Zebra body myopathy ORPHA:97240,0.7068064785325423
ADPRHL1,Glycogen storage disease due to muscle phosphorylase kinase deficiency ORPHA:715,0.7068064785325423
ADPRHL1,Rigid spine syndrome ORPHA:97244,0.7068064785325423
ADPRHL1,Childhood-onset nemaline myopathy ORPHA:171439,0.7068064785325423
AFAP1L2,Colorectal Carcinoma,0.0034602840073026
AFAP1L2,Colorectal Cancer,0.0149315928814189
AFAP1L2,Stomach Carcinoma,0.0149315928814189
AFAP1L2,melanoma,0.0149315928814189
AFAP1L2,Malignant neoplasm of stomach,0.0191435238361999
AFAP1L2,Carcinogenesis,0.0228075668512991
AFAP1L2,Squamous cell carcinoma of esophagus,0.0919714360040484
AFAP1L2,Malignant neoplasm of large intestine,0.13167400689206
AFAP1L2,Neoplasms,0.2714542429024338
AFAP1L2,Malignant neoplasm of lung,0.2714542429024338
AFAP1L2,Carcinoma of lung,0.3663130598151661
AFAP1L2,Thyroid Neoplasm,0.383941725017158
AFAP1L2,Primary malignant neoplasm of lung,0.3902116649640871
AFAP1L2,Papillary thyroid carcinoma,0.3933196962529684
AFAP1L2,Thyroid carcinoma,0.3941558617476422
AFAP1L2,Chronic Obstructive Airway Disease,0.5049674142533507
AFAP1L2,Carcinoma,0.0534520155998091
AFAP1L2,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.0586579655822394
ALDH3B1,Renal Cell Carcinoma,0.0648809611869375
ALDH3B1,Hallucinations,0.3933196962529684
ALDH3B1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
ALDH3B1,Schizophrenia,0.3933196962529684
ALDH3B1,Paranoid Schizophrenia,0.5090214163899865
ALDH3B1,Schizophrenia,0.0531117779464085
ALDH3B1,Paranoid Schizophrenia,0.4560460337187313
ALDH3B1,Mucopolysaccharidosis type 4A ORPHA:309297,0.0586579655822394
ALDH3B1,Carnitine palmitoyl transferase 1A deficiency ORPHA:156,0.1590470395003315
ALDH3B1,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.1590470395003315
ALDH3B1,Galactosialidosis ORPHA:351,0.1590470395003315
ALDH3B1,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.1590470395003315
ALDH3B1,Embryonal rhabdomyosarcoma ORPHA:99757,0.3762014630157917
ALDH3B1,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.3762014630157917
ALDH3B1,Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634,0.3762014630157917
ALDH3B1,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.3762014630157917
ALDH3B1,Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369,0.6239678957896782
ALDH3B1,Multiple sulfatase deficiency ORPHA:585,0.6239678957896782
ALDH3B1,NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498,0.6239678957896782
ALDH3B1,Sporadic porphyria cutanea tarda ORPHA:443057,0.6239678957896782
ALDH3B1,Symptomatic form of hemochromatosis type 1 ORPHA:465508,0.6239678957896782
ALKBH6,Autosomal dominant spondylocostal dysostosis ORPHA:1797,0.7068064785325423
AMOTL2,Glioblastoma,0.0745502070959292
AMOTL2,Colon Carcinoma,0.1062239757831962
AMOTL2,Malignant tumor of colon,0.223747154820789
AMOTL2,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
AMOTL2,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
AMOTL2,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
AMOTL2,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
AMOTL2,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
AMOTL2,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
AMOTL2,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
AMOTL2,Peters anomaly ORPHA:708,0.00518481975049
AMOTL2,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
AMOTL2,Familial porencephaly ORPHA:99810,0.0083045131203191
AMOTL2,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
AMOTL2,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
AMOTL2,Chondrosarcoma ORPHA:55880,0.0083045131203191
AMOTL2,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
AMOTL2,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
AMOTL2,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
AMOTL2,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
AMOTL2,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
AMOTL2,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
AMOTL2,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
AMOTL2,Polysyndactyly ORPHA:93338,0.0083045131203191
AMOTL2,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
AMOTL2,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
AMOTL2,Tibial hemimelia ORPHA:93322,0.0083045131203191
AMOTL2,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
AMOTL2,Axenfeld anomaly ORPHA:98978,0.0083045131203191
AMOTL2,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
AMOTL2,Branchiootic syndrome ORPHA:52429,0.0083045131203191
AMOTL2,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
AMOTL2,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
AMOTL2,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
AMOTL2,Rieger anomaly ORPHA:91483,0.0083045131203191
AMOTL2,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
AMOTL2,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
AMOTL2,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
AMOTL2,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
AMOTL2,Bruck syndrome ORPHA:2771,0.0180064224283883
AMOTL2,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.0180064224283883
AMOTL2,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.0180064224283883
AMOTL2,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.0180064224283883
AMOTL2,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.0180064224283883
AMOTL2,CHST3-related skeletal dysplasia ORPHA:263463,0.0180064224283883
AMOTL2,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.0180064224283883
AMOTL2,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.0180064224283883
AMOTL2,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.0180064224283883
AMOTL2,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.0180064224283883
AMOTL2,Craniosynostosis Boston type ORPHA:1541,0.0180064224283883
AMOTL2,Diaphanospondylodysostosis ORPHA:66637,0.0180064224283883
AMOTL2,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451,0.0180064224283883
AMOTL2,Familial schizencephaly ORPHA:481986,0.0180064224283883
AMOTL2,GAPO syndrome ORPHA:2067,0.0180064224283883
AMOTL2,HANAC syndrome ORPHA:73229,0.0180064224283883
AMOTL2,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.0180064224283883
AMOTL2,Hereditary papillary renal cell carcinoma ORPHA:47044,0.0180064224283883
AMOTL2,Ischiovertebral syndrome ORPHA:85200,0.0180064224283883
AMOTL2,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.0180064224283883
AMOTL2,Mandibulofacial dysostosis with alopecia ORPHA:443995,0.0180064224283883
AMOTL2,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.0180064224283883
AMOTL2,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.0180064224283883
AMOTL2,Nance-Horan syndrome ORPHA:627,0.0180064224283883
AMOTL2,Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303,0.0180064224283883
AMOTL2,Oculocutaneous albinism type 3 ORPHA:79433,0.0180064224283883
AMOTL2,Osteofibrous dysplasia ORPHA:488265,0.0180064224283883
AMOTL2,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.0180064224283883
AMOTL2,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.0180064224283883
AMOTL2,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.0180064224283883
AMOTL2,Primary CD59 deficiency ORPHA:169464,0.0180064224283883
AMOTL2,Retinal arterial tortuosity ORPHA:75326,0.0180064224283883
AMOTL2,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.0180064224283883
AMOTL2,Steel syndrome ORPHA:438117,0.0180064224283883
AMOTL2,Synpolydactyly type 2 ORPHA:295197,0.0180064224283883
AMOTL2,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.0180064224283883
AMOTL2,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.0180064224283883
AMOTL2,X-linked osteoporosis with fractures ORPHA:391330,0.0180064224283883
AMOTL2,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.0180064224283883
AMOTL2,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.0180064224283883
AMOTL2,Congenital diaphragmatic hernia ORPHA:2140,0.0180064224283883
AMOTL2,Dermatofibrosarcoma protuberans ORPHA:31112,0.0180064224283883
AMOTL2,Hypoplastic left heart syndrome ORPHA:2248,0.0180064224283883
AMOTL2,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.0180064224283883
AMOTL2,Matthew-Wood syndrome ORPHA:2470,0.0180064224283883
AMOTL2,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.0180064224283883
AMOTL2,Pediatric hepatocellular carcinoma ORPHA:33402,0.0180064224283883
AMOTL2,Posterior hypospadias ORPHA:95706,0.0180064224283883
AMOTL2,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.0180064224283883
AMOTL2,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.0180064224283883
AMOTL2,BOR syndrome ORPHA:107,0.0183145313768111
AMOTL2,Erythrokeratodermia variabilis ORPHA:317,0.0183145313768111
AMOTL2,Tetralogy of Fallot ORPHA:3303,0.0277610005156803
AMOTL2,Classical Ehlers-Danlos syndrome ORPHA:287,0.0586579655822394
AMOTL2,Multiple osteochondromas ORPHA:321,0.0586579655822394
AMOTL2,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.0586579655822394
AMOTL2,15q14 microdeletion syndrome ORPHA:261190,0.0586579655822394
AMOTL2,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.0586579655822394
AMOTL2,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.0586579655822394
AMOTL2,Alopecia universalis ORPHA:701,0.0586579655822394
AMOTL2,Atrichia with papular lesions ORPHA:86819,0.0586579655822394
AMOTL2,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.0586579655822394
AMOTL2,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.0586579655822394
AMOTL2,Caffey disease ORPHA:1310,0.0586579655822394
AMOTL2,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.0586579655822394
AMOTL2,Childhood-onset benign chorea with striatal involvement ORPHA:494541,0.0586579655822394
AMOTL2,Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641,0.0586579655822394
AMOTL2,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.0586579655822394
AMOTL2,Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181,0.0586579655822394
AMOTL2,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.0586579655822394
AMOTL2,Familial generalized lentiginosis ORPHA:231040,0.0586579655822394
AMOTL2,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.0586579655822394
AMOTL2,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.0586579655822394
AMOTL2,Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381,0.0586579655822394
AMOTL2,Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526,0.0586579655822394
AMOTL2,Kuskokwim syndrome ORPHA:1149,0.0586579655822394
AMOTL2,Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528,0.0586579655822394
AMOTL2,Lymphedema-distichiasis syndrome ORPHA:33001,0.0586579655822394
AMOTL2,Microphthalmia with brain and digit anomalies ORPHA:139471,0.0586579655822394
AMOTL2,Monoamine oxidase A deficiency ORPHA:3057,0.0586579655822394
AMOTL2,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.0586579655822394
AMOTL2,Muscle filaminopathy ORPHA:171445,0.0586579655822394
AMOTL2,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.0586579655822394
AMOTL2,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.0586579655822394
AMOTL2,Non-immune hydrops fetalis ORPHA:363999,0.0586579655822394
AMOTL2,Oculodentodigital dysplasia ORPHA:2710,0.0586579655822394
AMOTL2,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.0586579655822394
AMOTL2,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.0586579655822394
AMOTL2,Syndactyly type 3 ORPHA:93404,0.0586579655822394
AMOTL2,X-linked Alport syndrome ORPHA:88917,0.0586579655822394
AMOTL2,Autosomal recessive Robinow syndrome ORPHA:1507,0.0586579655822394
AMOTL2,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.0586579655822394
AMOTL2,Malignant peripheral nerve sheath tumor ORPHA:3148,0.0586579655822394
AMOTL2,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.0586579655822394
AMOTL2,Phakomatosis cesioflammea ORPHA:79483,0.0586579655822394
AMOTL2,Sclerosteosis ORPHA:3152,0.0586579655822394
AMOTL2,Brachydactyly type A1 ORPHA:93388,0.0599424746210022
AMOTL2,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.0621182671032116
AMOTL2,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.0640416108792758
AMOTL2,Osteogenesis imperfecta type 3 ORPHA:216812,0.0683063362547733
AMOTL2,Hirschsprung disease ORPHA:388,0.0706635700002548
AMOTL2,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.0783959336694202
AMOTL2,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.0783959336694202
AMOTL2,ABeta amyloidosis Arctic type ORPHA:324723,0.1590470395003315
AMOTL2,ABeta amyloidosis Dutch type ORPHA:100006,0.1590470395003315
AMOTL2,ABeta amyloidosis Iowa type ORPHA:324708,0.1590470395003315
AMOTL2,ABeta amyloidosis Italian type ORPHA:324713,0.1590470395003315
AMOTL2,ABetaA21G amyloidosis ORPHA:324718,0.1590470395003315
AMOTL2,ABetaL34V amyloidosis ORPHA:324703,0.1590470395003315
AMOTL2,Allan-Herndon-Dudley syndrome ORPHA:59,0.1590470395003315
AMOTL2,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.1590470395003315
AMOTL2,Branchio-oculo-facial syndrome ORPHA:1297,0.1590470395003315
AMOTL2,Campomelic dysplasia ORPHA:140,0.1590470395003315
AMOTL2,Carbamoyl-phosphate synthetase 1 deficiency ORPHA:147,0.1590470395003315
AMOTL2,Carvajal syndrome ORPHA:65282,0.1590470395003315
AMOTL2,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.1590470395003315
AMOTL2,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.1590470395003315
AMOTL2,Dicarboxylic aminoaciduria ORPHA:2195,0.1590470395003315
AMOTL2,Dyssegmental dysplasia Silverman-Handmaker type ORPHA:1865,0.1590470395003315
AMOTL2,Endosteal hyperostosis Worth type ORPHA:2790,0.1590470395003315
AMOTL2,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.1590470395003315
AMOTL2,Fibronectin glomerulopathy ORPHA:84090,0.1590470395003315
AMOTL2,Glutaric acidemia type 3 ORPHA:35706,0.1590470395003315
AMOTL2,Hot water reflex epilepsy ORPHA:166412,0.1590470395003315
AMOTL2,Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561,0.1590470395003315
AMOTL2,Isolated Pierre Robin syndrome ORPHA:718,0.1590470395003315
AMOTL2,LRP5-related primary osteoporosis ORPHA:498481,0.1590470395003315
AMOTL2,Lateral meningocele syndrome ORPHA:2789,0.1590470395003315
AMOTL2,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.1590470395003315
AMOTL2,Multiple myeloma ORPHA:29073,0.1590470395003315
AMOTL2,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.1590470395003315
AMOTL2,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.1590470395003315
AMOTL2,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.1590470395003315
AMOTL2,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012,0.1590470395003315
AMOTL2,Ring dermoid of cornea ORPHA:91481,0.1590470395003315
AMOTL2,Schwartz-Jampel syndrome ORPHA:800,0.1590470395003315
AMOTL2,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.1590470395003315
AMOTL2,Split hand-split foot-deafness syndrome ORPHA:71271,0.1590470395003315
AMOTL2,Stuve-Wiedemann syndrome ORPHA:3206,0.1590470395003315
AMOTL2,Trehalase deficiency ORPHA:103909,0.1590470395003315
AMOTL2,Acromesomelic dysplasia Grebe type ORPHA:2098,0.1590470395003315
AMOTL2,Autosomal recessive hypophosphatemic rickets ORPHA:289176,0.1590470395003315
AMOTL2,Brachydactyly type C ORPHA:93384,0.1590470395003315
AMOTL2,Enlarged parietal foramina ORPHA:60015,0.1590470395003315
AMOTL2,Familial patent arterial duct ORPHA:466729,0.1590470395003315
AMOTL2,Fibular aplasia-complex brachydactyly syndrome ORPHA:2639,0.1590470395003315
AMOTL2,Hyperostosis corticalis generalisata ORPHA:3416,0.1590470395003315
AMOTL2,Pfeiffer syndrome type 1 ORPHA:93258,0.1590470395003315
AMOTL2,Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144,0.1590470395003315
AMOTL2,Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140,0.1590470395003315
AMOTL2,Spondylometaphyseal dysplasia 'corner fracture' type ORPHA:93315,0.1590470395003315
AMOTL2,Acrocallosal syndrome ORPHA:36,0.1590470395003315
AMOTL2,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.1590470395003315
AMOTL2,Butterfly-shaped pigment dystrophy ORPHA:99001,0.1590470395003315
AMOTL2,Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067,0.1590470395003315
AMOTL2,Isolated aniridia ORPHA:250923,0.1590470395003315
AMOTL2,Isolated hemihyperplasia ORPHA:2128,0.1590470395003315
AMOTL2,Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659,0.1590470395003315
AMOTL2,Partial atrioventricular septal defect ORPHA:1330,0.1590470395003315
AMOTL2,Persistent hyperplastic primary vitreous ORPHA:91495,0.1590470395003315
AMOTL2,Retinopathy of prematurity ORPHA:90050,0.1590470395003315
AMOTL2,Epithelioid hemangioendothelioma ORPHA:157791,0.1614487935928034
AMOTL2,Familial progressive cardiac conduction defect ORPHA:871,0.1614487935928034
AMOTL2,Isolated brachycephaly ORPHA:35099,0.1614487935928034
AMOTL2,Isolated plagiocephaly ORPHA:35098,0.1614487935928034
AMOTL2,Autosomal dominant polycystic kidney disease ORPHA:730,0.1697334635963512
AMOTL2,Colobomatous microphthalmia ORPHA:98938,0.1782034488938806
AMOTL2,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.1981653781243822
AMOTL2,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.3762014630157917
AMOTL2,Action myoclonus-renal failure syndrome ORPHA:163696,0.3762014630157917
AMOTL2,Acute neonatal citrullinemia type I ORPHA:247546,0.3762014630157917
AMOTL2,Adult-onset citrullinemia type I ORPHA:247573,0.3762014630157917
AMOTL2,Arterial tortuosity syndrome ORPHA:3342,0.3762014630157917
AMOTL2,Atelosteogenesis type I ORPHA:1190,0.3762014630157917
AMOTL2,Atelosteogenesis type III ORPHA:56305,0.3762014630157917
AMOTL2,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.3762014630157917
AMOTL2,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.3762014630157917
AMOTL2,Autosomal recessive omodysplasia ORPHA:93329,0.3762014630157917
AMOTL2,Autosomal spastic paraplegia type 58 ORPHA:397946,0.3762014630157917
AMOTL2,Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119,0.3762014630157917
AMOTL2,Boomerang dysplasia ORPHA:1263,0.3762014630157917
AMOTL2,Charcot-Marie-Tooth disease type 2R ORPHA:397968,0.3762014630157917
AMOTL2,Craniofacial dysplasia-osteopenia syndrome ORPHA:314555,0.3762014630157917
AMOTL2,Curry-Jones syndrome ORPHA:1553,0.3762014630157917
AMOTL2,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.3762014630157917
AMOTL2,Frank-Ter Haar syndrome ORPHA:137834,0.3762014630157917
AMOTL2,Goldberg-Shprintzen megacolon syndrome ORPHA:66629,0.3762014630157917
AMOTL2,Growth delay due to insulin-like growth factor I resistance ORPHA:73273,0.3762014630157917
AMOTL2,Hartsfield syndrome ORPHA:2117,0.3762014630157917
AMOTL2,Isolated biliary atresia ORPHA:30391,0.3762014630157917
AMOTL2,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.3762014630157917
AMOTL2,Larsen syndrome ORPHA:503,0.3762014630157917
AMOTL2,Legius syndrome ORPHA:137605,0.3762014630157917
AMOTL2,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.3762014630157917
AMOTL2,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.3762014630157917
AMOTL2,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.3762014630157917
AMOTL2,Malignant epithelial tumor of salivary glands ORPHA:276145,0.3762014630157917
AMOTL2,Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430,0.3762014630157917
AMOTL2,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.3762014630157917
AMOTL2,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953,0.3762014630157917
AMOTL2,Osteoglosphonic dysplasia ORPHA:2645,0.3762014630157917
AMOTL2,Pierson syndrome ORPHA:2670,0.3762014630157917
AMOTL2,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.3762014630157917
AMOTL2,Scalp-ear-nipple syndrome ORPHA:2036,0.3762014630157917
AMOTL2,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.3762014630157917
AMOTL2,Sjogren-Larsson syndrome ORPHA:816,0.3762014630157917
AMOTL2,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.3762014630157917
AMOTL2,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386,0.3762014630157917
AMOTL2,Autosomal recessive polycystic kidney disease ORPHA:731,0.3762014630157917
AMOTL2,Alopecia-intellectual disability syndrome ORPHA:2850,0.3762014630157917
AMOTL2,Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068,0.3762014630157917
AMOTL2,Hereditary diffuse gastric cancer ORPHA:26106,0.3762014630157917
AMOTL2,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3762014630157917
AMOTL2,Milroy disease ORPHA:79452,0.3762014630157917
AMOTL2,NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293,0.3762014630157917
AMOTL2,Saethre-Chotzen syndrome ORPHA:794,0.3762014630157917
AMOTL2,Aplasia cutis congenita ORPHA:1114,0.3775879467205478
AMOTL2,Familial exudative vitreoretinopathy ORPHA:891,0.3900898302534297
AMOTL2,Renal agenesis unilateral ORPHA:93100,0.3969770464111636
AMOTL2,Early-onset posterior polar cataract ORPHA:98993,0.4045231980457672
AMOTL2,Cleft lip/palate ORPHA:199306,0.4101640425710954
AMOTL2,Midline interhemispheric variant of holoprosencephaly ORPHA:93926,0.43936148647173
AMOTL2,Septopreoptic holoprosencephaly ORPHA:280195,0.43936148647173
AMOTL2,Aarskog-Scott syndrome ORPHA:915,0.6239678957896782
AMOTL2,Achondroplasia ORPHA:15,0.6239678957896782
AMOTL2,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333,0.6239678957896782
AMOTL2,Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335,0.6239678957896782
AMOTL2,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.6239678957896782
AMOTL2,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.6239678957896782
AMOTL2,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135,0.6239678957896782
AMOTL2,Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164,0.6239678957896782
AMOTL2,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.6239678957896782
AMOTL2,Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262,0.6239678957896782
AMOTL2,Dent disease type 2 ORPHA:93623,0.6239678957896782
AMOTL2,Familial hypocalciuric hypercalcemia type 2 ORPHA:101049,0.6239678957896782
AMOTL2,Hypochondroplasia ORPHA:429,0.6239678957896782
AMOTL2,Hypodontia-dysplasia of nails syndrome ORPHA:2228,0.6239678957896782
AMOTL2,Keipert syndrome ORPHA:2662,0.6239678957896782
AMOTL2,LAMA5-related multisystemic syndrome ORPHA:521450,0.6239678957896782
AMOTL2,Microcystic stromal tumor ORPHA:569248,0.6239678957896782
AMOTL2,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.6239678957896782
AMOTL2,Monosomy 22q13.3 ORPHA:48652,0.6239678957896782
AMOTL2,Muenke syndrome ORPHA:53271,0.6239678957896782
AMOTL2,Multiple epiphyseal dysplasia Al-Gazali type ORPHA:166024,0.6239678957896782
AMOTL2,Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997,0.6239678957896782
AMOTL2,Muscular dystrophy Selcen type ORPHA:199340,0.6239678957896782
AMOTL2,Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382,0.6239678957896782
AMOTL2,OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594,0.6239678957896782
AMOTL2,Oculocerebrorenal syndrome of Lowe ORPHA:534,0.6239678957896782
AMOTL2,PGM1-CDG ORPHA:319646,0.6239678957896782
AMOTL2,Phakomatosis cesiomarmorata ORPHA:79484,0.6239678957896782
AMOTL2,Pilomatrixoma ORPHA:91414,0.6239678957896782
AMOTL2,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673,0.6239678957896782
AMOTL2,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274,0.6239678957896782
AMOTL2,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165,0.6239678957896782
AMOTL2,Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473,0.6239678957896782
AMOTL2,Thanatophoric dysplasia type 1 ORPHA:1860,0.6239678957896782
AMOTL2,Thanatophoric dysplasia type 2 ORPHA:93274,0.6239678957896782
AMOTL2,Vein of Galen aneurysmal malformation ORPHA:1053,0.6239678957896782
AMOTL2,Wolfram-like syndrome ORPHA:411590,0.6239678957896782
AMOTL2,3M syndrome ORPHA:2616,0.6239678957896782
AMOTL2,Brachydactyly type E ORPHA:93387,0.6239678957896782
AMOTL2,Familial avascular necrosis of femoral head ORPHA:86820,0.6239678957896782
AMOTL2,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.6239678957896782
AMOTL2,Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359,0.6239678957896782
AMOTL2,46XX testicular disorder of sex development ORPHA:393,0.6279395134845649
AMOTL2,Periventricular nodular heterotopia ORPHA:98892,0.639029370164481
AMOTL2,Oligodontia ORPHA:99798,0.6723027000992685
AMOTL2,Lobar holoprosencephaly ORPHA:93924,0.6787273931204523
AMOTL2,Microform holoprosencephaly ORPHA:280200,0.6857161253678724
AMOTL2,Total early-onset cataract ORPHA:98994,0.7002194990845196
AMOTL2,Autosomal dominant neovascular inflammatory vitreoretinopathy ORPHA:329211,0.7068064785325423
AMOTL2,Autosomal recessive dopa-responsive dystonia ORPHA:101150,0.7068064785325423
AMOTL2,Desmosterolosis ORPHA:35107,0.7068064785325423
AMOTL2,Dystonia-parkinsonism-hypermanganesemia syndrome ORPHA:521406,0.7068064785325423
AMOTL2,Familial congenital nasolacrimal duct obstruction ORPHA:451612,0.7068064785325423
AMOTL2,Familial cortical myoclonus ORPHA:319189,0.7068064785325423
AMOTL2,Glycogen storage disease due to muscle phosphofructokinase deficiency ORPHA:371,0.7068064785325423
AMOTL2,POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559,0.7068064785325423
AMOTL2,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.7068064785325423
AMOTL2,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.7068064785325423
AMOTL2,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.7068064785325423
AMOTL2,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188,0.7068064785325423
AMOTL2,X-linked intellectual disability Najm type ORPHA:163937,0.7068064785325423
AMOTL2,Autosomal dominant hypocalcemia ORPHA:428,0.7068064785325423
AMOTL2,Carpenter syndrome ORPHA:65759,0.7068064785325423
AMOTL2,46XX ovotesticular disorder of sex development ORPHA:2138,0.7068064785325423
AMOTL2,Familial hypercholanemia ORPHA:238475,0.7068064785325423
AMOTL2,Juvenile nephronophthisis ORPHA:93592,0.7072638369101406
AMOTL2,Walker-Warburg syndrome ORPHA:899,0.7195544063051836
APOBEC3B,Mammary Neoplasms,0.0034602840073026
APOBEC3B,Ovarian Carcinoma,0.0034602840073026
APOBEC3B,Breast Carcinoma,0.0042545616049287
APOBEC3B,Stomach Carcinoma,0.0149315928814189
APOBEC3B,Retroviridae Infections,0.0149315928814189
APOBEC3B,melanoma,0.0149315928814189
APOBEC3B,Adenocarcinoma,0.0155921563748247
APOBEC3B,Squamous cell carcinoma,0.0182265588252201
APOBEC3B,Malignant mesothelioma,0.0182265588252201
APOBEC3B,Malignant neoplasm of breast,0.0191435238361999
APOBEC3B,Malignant neoplasm of stomach,0.0191435238361999
APOBEC3B,Carcinogenesis,0.0228075668512991
APOBEC3B,Malignant neoplasm of ovary,0.0277695594716545
APOBEC3B,Epithelial ovarian cancer,0.0387439397151409
APOBEC3B,Mammary Neoplasms Human,0.064548079316548
APOBEC3B,Neoplasm Metastasis,0.0648809611869375
APOBEC3B,Renal Cell Carcinoma,0.0648809611869375
APOBEC3B,Malignant neoplasm of pancreas,0.0726340460169901
APOBEC3B,Lymphoma,0.0739788831250619
APOBEC3B,Pancreatic carcinoma,0.0745502070959292
APOBEC3B,Squamous cell carcinoma of the head and neck,0.0775520919998773
APOBEC3B,Malignant neoplasm of urinary bladder,0.084286432100041
APOBEC3B,Bladder Neoplasm,0.0891725280554336
APOBEC3B,Liver carcinoma,0.095319386034013
APOBEC3B,Malignant Neoplasms,0.0991201145654548
APOBEC3B,Clear-cell metastatic renal cell carcinoma,0.13167400689206
APOBEC3B,Solid Neoplasm,0.1413782599148022
APOBEC3B,Sickle Cell Dactylitis,0.1602092191314262
APOBEC3B,Palmar-plantar erythrodysesthesia syndrome,0.1602092191314262
APOBEC3B,Neck Neoplasms,0.1614820148711231
APOBEC3B,cervical cancer,0.2050045461627939
APOBEC3B,Malignant Head and Neck Neoplasm,0.2522264785494494
APOBEC3B,Malignant neoplasm of liver,0.2643145809900195
APOBEC3B,Neoplasms,0.2714542429024338
APOBEC3B,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
APOBEC3B,Head and Neck Neoplasms,0.3412203844672238
APOBEC3B,Primary malignant neoplasm,0.383941725017158
APOBEC3B,Human papilloma virus infection,0.383941725017158
APOBEC3B,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
APOBEC3B,Uterine Cervical Neoplasm,0.3933196962529684
APOBEC3B,Non-Small Cell Lung Carcinoma,0.3933196962529684
APOBEC3B,Infection caused by Helicobacter pylori,0.3933196962529684
APOBEC3B,Leukemia Myelocytic Acute,0.3933196962529684
APOBEC3B,HIV Infections,0.3933196962529684
APOBEC3B,Malaria Falciparum,0.3933196962529684
APOBEC3B,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
APOBEC3B,Neoplastic Processes,0.4028066164685291
APOBEC3B,Down Syndrome,0.4126392832024548
APOBEC3B,Stromal Neoplasm,0.4213286052188015
APOBEC3B,Benign Neoplasm,0.4213286052188015
APOBEC3B,leukemia,0.4588513406515081
APOBEC3B,Upper Aerodigestive Tract Neoplasms,0.4753011022966241
APOBEC3B,Head Neoplasms,0.4753011022966241
APOBEC3B,Cancer of Head,0.4790179402069343
APOBEC3B,Cancer of Neck,0.4790179402069343
APOBEC3B,Coinfection,0.489336365264797
APOBEC3B,Adenocarcinoma of lung (disorder),0.51550637274795
APOBEC3B,Malaria,0.5655222348249326
APOBEC3B,Xeroderma Pigmentosum Complementation Group D,0.5885228491254589
APOBEC3B,Malnutrition,0.5916904943304121
APOBEC3B,Hepatitis B Chronic,0.6150955455771212
APOBEC3B,Hepatitis C,0.7169459458481418
APOBEC3B,Hepatitis B,0.9169959402964138
APOBEC3B,Breast Carcinoma,0.0075861267486594
APOBEC3B,Marfan Syndrome,0.0133304506157067
APOBEC3B,Mammary Neoplasms,0.0155248163763686
APOBEC3B,Breast Cancer,0.0402286636010764
APOBEC3B,Carcinoma,0.0534520155998091
APOBEC3B,Cervical Cancer,0.4402141802500753
APOBEC3B,Uterine Cervix Neoplasm,0.4541466895915311
APOBEC3B,Benign Neoplasm,0.4624858551053053
APOBEC3B,Neoplasms,0.4646409362700993
APOBEC3B,Bladder Neoplasm,0.4723647227028846
APOBEC3B,Upper Aerodigestive Tract Neoplasms,0.4875380732267193
APOBEC3B,Head Neoplasms,0.4875380732267193
APOBEC3B,Neoplasm Of Head,0.4875380732267193
APOBEC3B,Urinary Bladder Cancer,0.4875380732267193
APOBEC3B,Neck Neoplasms,0.4875380732267193
APOBEC3B,Neck Cancer,0.4875380732267193
APOBEC3B,Head And Neck Neoplasms,0.5632819212593052
APOBEC3B,Malignant Neoplasm,0.5973360026714207
APOBEC3B,Head And Neck Cancer,0.6003406542362493
APOBEC3B,Lung Adenocarcinoma,0.7979764766391754
APOBEC3B,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.3762014630157917
APOBEC3B,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.3762014630157917
APOLD1,Adenocarcinoma,0.0155921563748247
APOLD1,Birth Weight,0.3933196962529684
APOLD1,Cardiovascular Diseases,0.554079268109006
APOLD1,Prostate Cancer,0.6104715460837368
ARL2BP,Stomach Carcinoma,0.0149315928814189
ARL2BP,Carcinogenesis,0.0228075668512991
ARL2BP,Carcinoma,0.0593779966354549
ARL2BP,Neoplasm Metastasis,0.0648809611869375
ARL2BP,Malignant neoplasm of pancreas,0.0726340460169901
ARL2BP,Pancreatic carcinoma,0.0745502070959292
ARL2BP,Cataract,0.223747154820789
ARL2BP,Burkitt Lymphoma,0.2521987644415915
ARL2BP,Glaucoma,0.3105909001629992
ARL2BP,Nasopharyngeal carcinoma,0.3933196962529684
ARL2BP,Secondary malignant neoplasm of liver,0.3933196962529684
ARL2BP,Lens Opacities,0.4213286052188015
ARL2BP,Obesity,0.5140447474168605
ARL2BP,Dull intelligence,0.5300976305939776
ARL2BP,Low intelligence,0.5300976305939776
ARL2BP,Poor school performance,0.5610226870913673
ARL2BP,Mental deficiency,0.6035970790768342
ARL2BP,Broad flat nasal bridge,0.6196470808426647
ARL2BP,Pallor of optic disc,0.6222451141623291
ARL2BP,Nasal bridge wide,0.6238969878903416
ARL2BP,Mental Retardation,0.6319938293757544
ARL2BP,Keratoconus,0.652707626880454
ARL2BP,Retinal pigment epithelial abnormality,0.6545439509404224
ARL2BP,Abnormality of retinal pigmentation,0.6545439509404224
ARL2BP,Congenital anomaly of testis,0.6691893635307453
ARL2BP,Progressive night blindness,0.6691893635307453
ARL2BP,Sensorineural Hearing Loss (disorder),0.6891882956008074
ARL2BP,Abnormality of the retinal vasculature,0.6959870102453846
ARL2BP,Congenital hypoplasia of penis,0.6974821940437801
ARL2BP,Atypical scarring of skin,0.7045203904267408
ARL2BP,Retinitis Pigmentosa,0.7352133686428474
ARL2BP,Reduced visual acuity,0.7577323833810212
ARL2BP,Optic Atrophy,0.809878589520458
ARL2BP,Hyperinsulinism,0.8245140009975604
ARL2BP,Electroretinogram abnormal,0.8257883659984262
ARL2BP,Ophthalmoplegia,0.8306551823873084
ARL2BP,Intellectual Disability,0.8352623613787349
ARL2BP,Anteverted nostril,0.8472019892490944
ARL2BP,Blindness Legal,0.8515974315972522
ARL2BP,Blindness,0.8612829843327843
ARL2BP,Retinal Dystrophies,0.8815334766742503
ARL2BP,Conductive hearing loss,0.8849686999768298
ARL2BP,Photodysphoria,0.8849686999768298
ARL2BP,Photophobia,0.8921715172820168
ARL2BP,Hypogonadism,0.9100787832273576
ARL2BP,Nystagmus,0.926001913794773
ARL2BP,Hereditary Retinal Dystrophy,0.4541466895915311
ARL2BP,Glaucoma,0.4646409362700993
ARL2BP,Anetoderma,0.4875380732267193
ARL2BP,Hearing Loss,0.5632819212593052
ARL2BP,Congenital Hypoplasia Of Penis,0.6572113517052336
ARL2BP,Cataract,0.6660731887258019
ARL2BP,Optic Atrophy,0.675936313627625
ARL2BP,Rod-cone Dystrophy,0.7062235569782704
ARL2BP,Mental Retardation,0.7729545590606223
ARL2BP,Keratoconus,0.7893608212024619
ARL2BP,Hypogonadism,0.8536040084512244
ARL2BP,Hyperinsulinism,0.8570285304674955
ARL2BP,Retinal Dystrophy,0.8570285304674955
ARL2BP,Nystagmus,0.9146877763175152
ARL2BP,Retinitis Pigmentosa,0.9538309557027852
ARL2BP,Obesity,0.9568083835980838
ARL2BP,Diabetes Mellitus,0.9683912711598086
ARL2BP,X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328,0.3762014630157917
ARL2BP,Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936,0.7068064785325423
ARL2BP,Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714,0.7068064785325423
ARL2BP,Hyperbiliverdinemia ORPHA:276405,0.7068064785325423
ARL2BP,X-linked intellectual disability Nascimento type ORPHA:163956,0.7068064785325423
ARL2BP,Retinitis pigmentosa ORPHA:791,0.8578236036529228
ARRDC4,Congenital diaphragmatic hernia,0.4790179402069343
ARRDC4,Enterovirus Infections,0.5019670090704682
ARRDC4,Acidosis Lactic,0.8867784885819414
ARRDC4,Familial multiple nevi flammei ORPHA:624,0.0180064224283883
ARRDC4,Sturge-Weber syndrome ORPHA:3205,0.0180064224283883
ARRDC4,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.6239678957896782
B3GLCT,Biliary tract abnormality,0.0745502070959292
B3GLCT,Biliary Tract Diseases,0.0775520919998773
B3GLCT,Clouding of corneal stroma,0.1859959283872542
B3GLCT,Seizures,0.2053083986145698
B3GLCT,Corneal Opacity,0.2085938372806741
B3GLCT,Cataract,0.223747154820789
B3GLCT,Heart Septal Defects,0.3044782497745498
B3GLCT,Proximal placement of thumb,0.3099246715197673
B3GLCT,Glaucoma,0.3105909001629992
B3GLCT,Round face,0.3706856725676674
B3GLCT,Round full face,0.3706856725676674
B3GLCT,Abnormality of the skull,0.3933196962529684
B3GLCT,Fetal Growth Retardation,0.3933196962529684
B3GLCT,Hydrocephalus,0.3933196962529684
B3GLCT,Anomalous pulmonary artery,0.3933196962529684
B3GLCT,Polio and Post-Polio Syndrome,0.3933196962529684
B3GLCT,Popliteal pterygium syndrome,0.3933196962529684
B3GLCT,Infant Small for Gestational Age,0.3933196962529684
B3GLCT,Intrauterine retardation,0.3933196962529684
B3GLCT,Craniosynostosis,0.3933196962529684
B3GLCT,Birth length less than 3rd percentile,0.3933196962529684
B3GLCT,Anemia,0.3941558617476422
B3GLCT,Epilepsy,0.3941558617476422
B3GLCT,Broad neck,0.3941558617476422
B3GLCT,Autism Spectrum Disorders,0.3941558617476422
B3GLCT,Single transverse palmar crease,0.3941558617476422
B3GLCT,Bulging forehead,0.3941558617476422
B3GLCT,Prominent forehead,0.3941558617476422
B3GLCT,Conical incisor,0.3941558617476422
B3GLCT,Limited elbow movement,0.3941558617476422
B3GLCT,Peg shaped front tooth,0.3941558617476422
B3GLCT,Pointed front tooth,0.3941558617476422
B3GLCT,Pointed incisor,0.3941558617476422
B3GLCT,Umbilical hernia,0.3986414839122469
B3GLCT,Short columella,0.4028066164685291
B3GLCT,Hypoplasia of columella,0.4028066164685291
B3GLCT,Agenesis of corpus callosum,0.4103119460235835
B3GLCT,Polyhydramnios,0.4115056600660309
B3GLCT,Cleft palate with cleft lip,0.4186011760974318
B3GLCT,Pulmonary Stenosis,0.4186011760974318
B3GLCT,Double ureter,0.4192169590514327
B3GLCT,Short palpebral fissure,0.4209380602168584
B3GLCT,Brachycephaly,0.4213286052188015
B3GLCT,Lens Opacities,0.4213286052188015
B3GLCT,Rudimentary vagina,0.4213286052188015
B3GLCT,Hypoplasia of vagina,0.4213286052188015
B3GLCT,Narrowing of ear canal,0.4213286052188015
B3GLCT,Aortopulmonary Septal Defect,0.425419812815905
B3GLCT,Dilated ventricles (finding),0.425992946703162
B3GLCT,Stenosis of external auditory canal,0.4304973629098372
B3GLCT,Diastasis recti,0.4335751357405352
B3GLCT,Supratentorial atrophy,0.4381343267935581
B3GLCT,Irido-corneo-trabecular dysgenesis (disorder),0.4459714599189374
B3GLCT,Reduced fetal movement,0.4459714599189374
B3GLCT,Skin tag on the posterior cheek,0.4506578937113162
B3GLCT,Ventricular Septal Defects,0.4564472886428772
B3GLCT,Syndactyly,0.4564472886428772
B3GLCT,Preauricular skin tag,0.4564472886428772
B3GLCT,Postnatal growth retardation,0.4615352570710579
B3GLCT,Curvature of little finger,0.4635211539849193
B3GLCT,Clinodactyly of the 5th finger,0.4675904598629673
B3GLCT,Micromelia,0.4714226702518064
B3GLCT,Weight decreased,0.472444704048021
B3GLCT,Small labia majora,0.472444704048021
B3GLCT,Retrusion of lower jaw,0.4753011022966241
B3GLCT,Decreased projection of lower jaw,0.4753011022966241
B3GLCT,Decreased projection of mandible,0.4753011022966241
B3GLCT,Hypoplastic mandible condyle,0.4753011022966241
B3GLCT,Atrial Septal Defects,0.4757083758251088
B3GLCT,Aplasia/Hypoplasia of the mandible,0.4790179402069343
B3GLCT,Degenerative brain disorder,0.4790179402069343
B3GLCT,Micrognathism,0.479747709091007
B3GLCT,Cleft upper lip,0.4850576707687362
B3GLCT,Clitoral hypoplasia,0.4852430673532381
B3GLCT,Small head,0.4906258721078565
B3GLCT,Short metatarsal,0.4923669467696064
B3GLCT,Preauricular Fistulae Congenital,0.4923669467696064
B3GLCT,Congenital preauricular sinus,0.4923669467696064
B3GLCT,Disproportionate short-limb short stature,0.4923669467696064
B3GLCT,Preauricular dimple,0.4923669467696064
B3GLCT,Underweight,0.4981941174985421
B3GLCT,Hypoplastic feet,0.4990401620718274
B3GLCT,Acquired scoliosis,0.5019670090704682
B3GLCT,Penile hypospadias,0.5019670090704682
B3GLCT,Congenital hemivertebra,0.5019670090704682
B3GLCT,Fundus coloboma,0.5140447474168605
B3GLCT,Infantile uterus,0.5140447474168605
B3GLCT,Weight less than 3rd percentile,0.5188223685230745
B3GLCT,Myopia,0.5239792328442205
B3GLCT,Short toe,0.5251317541886066
B3GLCT,Rhizomelia,0.5299466034567416
B3GLCT,Dull intelligence,0.5300976305939776
B3GLCT,Low intelligence,0.5300976305939776
B3GLCT,Hypospadias,0.533913711453195
B3GLCT,exudative macular degeneration,0.5359212109443033
B3GLCT,Wide skull shape,0.5462489630068115
B3GLCT,Broad cranium shape,0.5462489630068115
B3GLCT,Brachydactyly,0.549941235475765
B3GLCT,Thin upper lip vermilion,0.5557519470957561
B3GLCT,Abnormality of the cornea,0.5568517196017908
B3GLCT,Poor school performance,0.5610226870913673
B3GLCT,Neck webbing,0.5655222348249326
B3GLCT,Frontal bossing,0.5710095678317721
B3GLCT,Pectus excavatum,0.5956632182199403
B3GLCT,Geographic Atrophy,0.6002127202571572
B3GLCT,Curvature of spine,0.6035970790768342
B3GLCT,Mental deficiency,0.6035970790768342
B3GLCT,Wide anterior fontanel,0.6035970790768342
B3GLCT,Coloboma of iris,0.6196470808426647
B3GLCT,Short metacarpal,0.625027955184583
B3GLCT,Syndactyly of the toes,0.6274540883972485
B3GLCT,Cerebral atrophy,0.6294837700416086
B3GLCT,Wide spaced nipples,0.6304655343580164
B3GLCT,Mental Retardation,0.6319938293757544
B3GLCT,Decreased corneal diameter,0.6588479076808555
B3GLCT,Microcornea,0.6656356363792992
B3GLCT,Protruding ear,0.672336954961104
B3GLCT,Uranostaphyloschisis,0.6784817526917547
B3GLCT,Prominent ear,0.6802335864704374
B3GLCT,Short palm,0.7096959691931399
B3GLCT,Joint laxity,0.717484976234209
B3GLCT,Cryptorchidism,0.7417321496240817
B3GLCT,Big calvaria,0.7484342194688707
B3GLCT,Increased size of skull,0.7484342194688707
B3GLCT,Increased head circumference,0.7511668779991656
B3GLCT,Hydronephrosis,0.7651930135295156
B3GLCT,Feeding difficulties in infancy,0.7797826088609066
B3GLCT,Congenital Disorders of Glycosylation,0.7891530777939482
B3GLCT,Upward slant of palpebral fissure,0.7935206698366561
B3GLCT,Congenital pes cavus,0.8065625879493252
B3GLCT,Orbital separation excessive,0.8157137944879093
B3GLCT,Age related macular degeneration,0.8304052766033214
B3GLCT,Intellectual Disability,0.8352623613787349
B3GLCT,Long philtrum,0.8943302762243359
B3GLCT,Mental and motor retardation,0.897310588550617
B3GLCT,Cognitive delay,0.9238745269736108
B3GLCT,Nystagmus,0.926001913794773
B3GLCT,Global developmental delay,0.9327689937867868
B3GLCT,Blepharoptosis,0.9781217366509172
B3GLCT,Anomalous Pulmonary Artery,0.0075861267486594
B3GLCT,Hydrocephalus,0.3657224783929353
B3GLCT,Craniosynostosis,0.4286813331685578
B3GLCT,Hypoplastic Left Heart Syndrome,0.4402141802500753
B3GLCT,Pulmonary Stenosis,0.4541466895915311
B3GLCT,Mental Depression,0.4560460337187313
B3GLCT,Hypopituitarism,0.4560460337187313
B3GLCT,Frontal Bossing,0.4560460337187313
B3GLCT,Brachycephaly,0.4560460337187313
B3GLCT,Hypoplasia Of Vagina,0.4602028929328057
B3GLCT,Spina Bifida Occulta,0.4646409362700993
B3GLCT,Multicystic Renal Dysplasia,0.4646409362700993
B3GLCT,Glaucoma,0.4646409362700993
B3GLCT,Accessory Kidney,0.4646409362700993
B3GLCT,Anterior Segment Dysgenesis,0.4867879381749835
B3GLCT,Spade-Like Hand,0.4875380732267193
B3GLCT,Renal Hypoplasia,0.4875380732267193
B3GLCT,Stenosis Of External Auditory Canal,0.4875380732267193
B3GLCT,Scoliosis,0.4875380732267193
B3GLCT,Double Ureter,0.4968320901822731
B3GLCT,Syndactyly,0.5123947823327547
B3GLCT,Microcephaly,0.5123947823327547
B3GLCT,Talipes Transversoplanus,0.5127628024019304
B3GLCT,Cerebral Atrophy,0.5129298662020659
B3GLCT,Cerebral Cortical Atrophy,0.5129298662020659
B3GLCT,Micrognathism,0.5234357475824973
B3GLCT,Congenital Hypothyroidism,0.5234357475824973
B3GLCT,Posteriorly Rotated Ear,0.5248691614865011
B3GLCT,Micromelia,0.525214105372123
B3GLCT,Atrial Septal Defect,0.5254133486377646
B3GLCT,Hypoplasia Of The Maxilla,0.5576425853515448
B3GLCT,Hearing Loss,0.5632819212593052
B3GLCT,Geographic Atrophy,0.5796489603182782
B3GLCT,Exudative Macular Degeneration,0.6003406542362493
B3GLCT,Microcornea,0.6030919130927346
B3GLCT,Brachydactyly,0.6198128018123746
B3GLCT,Agenesis Of Corpus Callosum,0.6252040071965056
B3GLCT,Congenital Exomphalos,0.6270755162143985
B3GLCT,Fundus Coloboma,0.6329251700753155
B3GLCT,Heart Septal Defects,0.6340319940404294
B3GLCT,Retinal Coloboma,0.6340319940404294
B3GLCT,Rhizomelia,0.6340319940404294
B3GLCT,Congenital Coloboma Of Iris,0.6572113517052336
B3GLCT,Patent Ductus Arteriosus,0.6596918765832213
B3GLCT,Cataract,0.6660731887258019
B3GLCT,Optic Atrophy,0.675936313627625
B3GLCT,Neck Webbing,0.7112499273451761
B3GLCT,Camptodactyly Of Fingers,0.7328159476505643
B3GLCT,Myopia,0.7405519560111998
B3GLCT,Hydronephrosis,0.7412420740397021
B3GLCT,Ventricular Septal Defect,0.7729545590606223
B3GLCT,Mental Retardation,0.7729545590606223
B3GLCT,Disorder Of Eye,0.7729545590606223
B3GLCT,Cryptorchidism,0.776786668801341
B3GLCT,Macrocephaly,0.800821840688695
B3GLCT,Imperforate Anus,0.8225549273532161
B3GLCT,Ptosis,0.8357787380041017
B3GLCT,Congenital Pectus Excavatum,0.8407264689819682
B3GLCT,Macrostomia,0.8569751017318014
B3GLCT,Hypospadias,0.8570285304674955
B3GLCT,Syndactyly Of The Toes,0.9096190669068288
B3GLCT,Nystagmus,0.9146877763175152
B3GLCT,Developmental Delay,0.96477535147595
B3GLCT,Christianson syndrome ORPHA:85278,0.3762014630157917
B3GLCT,Peters plus syndrome ORPHA:709,0.6239678957896782
BBC3,Colorectal Carcinoma,0.0034602840073026
BBC3,Ovarian Carcinoma,0.0034602840073026
BBC3,Breast Carcinoma,0.0042545616049287
BBC3,Colorectal Cancer,0.0149315928814189
BBC3,Tumor Progression,0.0149315928814189
BBC3,Stomach Carcinoma,0.0149315928814189
BBC3,melanoma,0.0149315928814189
BBC3,Adenocarcinoma,0.0155921563748247
BBC3,Squamous cell carcinoma,0.0182265588252201
BBC3,Esophageal Neoplasms,0.0182265588252201
BBC3,Malignant neoplasm of breast,0.0191435238361999
BBC3,Malignant neoplasm of stomach,0.0191435238361999
BBC3,Carcinogenesis,0.0228075668512991
BBC3,Malignant neoplasm of esophagus,0.0248454592431097
BBC3,Malignant neoplasm of ovary,0.0277695594716545
BBC3,Hematopoietic Neoplasms,0.0334891258932371
BBC3,Epithelial ovarian cancer,0.0387439397151409
BBC3,Malignant neoplasm of prostate,0.0569142010728473
BBC3,Central neuroblastoma,0.0593779966354549
BBC3,Renal Cell Carcinoma,0.0648809611869375
BBC3,Neuroblastoma,0.0688152422187159
BBC3,Malignant neoplasm of pancreas,0.0726340460169901
BBC3,Glioma,0.0739788831250619
BBC3,Degenerative polyarthritis,0.0739788831250619
BBC3,Lymphoma,0.0739788831250619
BBC3,Glioblastoma,0.0745502070959292
BBC3,Pancreatic carcinoma,0.0745502070959292
BBC3,Prostate carcinoma,0.0773771948186562
BBC3,Squamous cell carcinoma of the head and neck,0.0775520919998773
BBC3,Colorectal Neoplasms,0.0827744840860166
BBC3,Liver carcinoma,0.095319386034013
BBC3,Colon Carcinoma,0.1062239757831962
BBC3,Chronic Lymphocytic Leukemia,0.1147307578771389
BBC3,Hyperactive behavior,0.1387448809655294
BBC3,Liver neoplasms,0.1454373331146953
BBC3,Rheumatoid Arthritis,0.1537760235124317
BBC3,cervical cancer,0.2050045461627939
BBC3,Malignant tumor of colon,0.223747154820789
BBC3,Burkitt Lymphoma,0.2521987644415915
BBC3,Malignant Head and Neck Neoplasm,0.2522264785494494
BBC3,B-Cell Lymphomas,0.2522264785494494
BBC3,Malignant neoplasm of liver,0.2643145809900195
BBC3,Malignant tumor of cervix,0.2714542429024338
BBC3,Malignant neoplasm of lung,0.2714542429024338
BBC3,Cervix carcinoma,0.2834835531038365
BBC3,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
BBC3,Head and Neck Neoplasms,0.3412203844672238
BBC3,Leukemogenesis,0.3510063969122338
BBC3,African Burkitt's lymphoma,0.3933196962529684
BBC3,Amyloidosis,0.3933196962529684
BBC3,Gallbladder Carcinoma,0.3933196962529684
BBC3,Fulminant hepatitis,0.3933196962529684
BBC3,Leukemia Myelocytic Acute,0.3933196962529684
BBC3,Cystadenocarcinoma Serous,0.3933196962529684
BBC3,Lip and Oral Cavity Carcinoma,0.3933196962529684
BBC3,Alcoholic Steatohepatitis,0.3941558617476422
BBC3,refractory plasma cell neoplasm,0.4028066164685291
BBC3,Liver Neoplasms Experimental,0.4100742336915555
BBC3,Experimental Hepatoma,0.4100742336915555
BBC3,AICARDI-GOUTIERES SYNDROME 1,0.4100901006059349
BBC3,Multiple Myeloma,0.4103119460235835
BBC3,Hepatoma Novikoff,0.4115056600660309
BBC3,Retinoblastoma,0.4115056600660309
BBC3,Hepatoma Morris,0.4115056600660309
BBC3,SPHEROCYTOSIS TYPE 1 (disorder),0.4126392832024548
BBC3,Malignant neoplasm of mouth,0.4213286052188015
BBC3,Addictive Behavior,0.4314759856195063
BBC3,Pulmonary Fibrosis,0.4335751357405352
BBC3,Machado-Joseph Disease,0.4335751357405352
BBC3,Choriocarcinoma,0.4564472886428772
BBC3,Intermittent Claudication,0.4753011022966241
BBC3,Steatohepatitis,0.4906258721078565
BBC3,Hepatitis A,0.5090214163899865
BBC3,Malignant neoplasm of oropharynx,0.5140447474168605
BBC3,Ewings sarcoma,0.5251317541886066
BBC3,Lymphoma Follicular,0.533913711453195
BBC3,Malignant neoplasm of gallbladder,0.5496357724684553
BBC3,Infection,0.5959654688257199
BBC3,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.6035970790768342
BBC3,Silicosis,0.6035970790768342
BBC3,Oropharyngeal Carcinoma,0.610971999959321
BBC3,Other specified transient cerebral ischemias,0.6274540883972485
BBC3,Sepsis,0.6395767498329145
BBC3,Brain Ischemia,0.6592493193460769
BBC3,Van der Woude syndrome,0.6910672612216457
BBC3,Transient Ischemic Attack,0.7061487180640408
BBC3,Hepatitis,0.7484342194688707
BBC3,Septicemia,0.8064248359603999
BBC3,Cerebral Ischemia,0.839057838231319
BBC3,Esophagus Neoplasm,0.0102679590519094
BBC3,African Burkitt`s Lymphoma,0.2960946950751588
BBC3,Burkitt`s Lymphoma,0.4541466895915311
BBC3,Cerebral Ischemia,0.6798971073653743
BBC3,Oculootodental syndrome ORPHA:99806,0.3762014630157917
BBC3,Peutz-Jeghers syndrome ORPHA:2869,0.6239678957896782
BBC3,Multiple endocrine neoplasia type 1 ORPHA:652,0.6279395134845649
BBC3,Primary familial polycythemia ORPHA:90042,0.7068064785325423
BBC3,Human gammaherpesvirus 4 hypothetical protein (gene: BHRF1),0.6362779693488597
BBC3,Human herpesvirus 4 type 2 BHRF1,0.6362779693488597
BBC3,Yaba monkey tumor virus anti-apoptotic membrane protein,0.6362779693488597
BBC3,Monkeypox virus Zaire-96-I-16 Hypothetical protein (gene: C7L),0.6362779693488597
BBC3,Vaccinia virus Ankara apoptosis inhibitor,0.6362779693488597
BBC3,Yaba monkey tumor virus putative transmembrane protein,0.6362779693488597
BBC3,Horsepox virus HSPV032 (putative alpha aminitin-sensitive protein provisional),0.6362779693488597
BBC3,Human gammaherpesvirus 4 hypothetical BALF1 protein (gene: BALF1),0.6362779693488597
BBC3,Human herpesvirus 4 type 2 BALF1,0.6362779693488597
BBC3,Variola virus hypothetical protein (gene: D9L),0.6362779693488597
BBC3,Yaba-like disease virus 16L protein (gene: 16L),0.6362779693488597
BBC3,Yaba-like disease virus 3L protein (gene: 3L),0.6362779693488597
BBC3,Cowpox virus CPXV190 protein (gene: CPXV190 CDS),0.6362779693488597
BBC3,Vaccinia virus Toll/IL-receptor-like protein (gene: A52R),0.6362779693488597
BBC3,Vaccinia virus Ankara Toll/IL1-receptor signalling inhibitor,0.6362779693488597
BBC3,Horsepox virus HSPV174 (Toll/IL-receptor-like protein,0.6362779693488597
BBC3,Provisional),0.6362779693488597
BBC3,Yaba-like disease virus 139R protein (gene: 139R),0.6362779693488597
BBC3,Monkeypox virus virokine protein,0.6362779693488597
BBC3,Monkeypox virus Zaire-96-I-16 putative virulence factor (gene: P1L),0.6362779693488597
BBC3,Ectromelia virus ERPV virokine/NFKb inhibitor,0.6362779693488597
BBC3,Variola virus putative virulence factor (gene: P1L),0.6362779693488597
BBC3,Cowpox virus CPXV037 protein (gene: CPXV037 CDS),0.6362779693488597
BBC3,Human gammaherpesvirus 8 ORF16 (gene: ORF16),0.6362779693488597
BBC3,Ectromelia virus ERPV apoptosis inhibitor,0.6362779693488597
BBC3,Yaba monkey tumor virus hypothetical protein,0.6362779693488597
BBC3,Variola virus hypothetical protein (gene: C5L),0.6362779693488597
BBC3,Cowpox virus CPXV048 (gene: CPXV048 CDS),0.6362779693488597
BBC3,Horsepox virus HSPV041 (Hypothetical protein),0.6362779693488597
BBC3,Vaccinia virus Hypothetical protein (gene: F1L),0.6362779693488597
BFSP1,Cataract,0.223747154820789
BFSP1,Nuclear cataract,0.3933196962529684
BFSP1,Bilateral cataracts (disorder),0.4028066164685291
BFSP1,Cortical cataract,0.4126392832024548
BFSP1,Nuclear non-senile cataract,0.4790179402069343
BFSP1,Cortical Cataract,0.4286813331685578
BFSP1,Congenital Cataract,0.6340319940404294
BFSP1,Cataract,0.6660731887258019
BFSP1,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
BFSP1,Craniosynostosis Boston type ORPHA:1541,0.0180064224283883
BFSP1,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.0180064224283883
BFSP1,Idiopathic juvenile osteoporosis ORPHA:85193,0.1590470395003315
BMF,Colorectal Carcinoma,0.0034602840073026
BMF,Colorectal Cancer,0.0149315928814189
BMF,Liver Cirrhosis Experimental,0.0747863377072194
BMF,Colon Carcinoma,0.1062239757831962
BMF,Chronic Lymphocytic Leukemia,0.1147307578771389
BMF,Malignant tumor of colon,0.223747154820789
BMF,Diabetes,0.2277108302018961
BMF,Hodgkin Disease,0.2454476567103779
BMF,B-Cell Lymphomas,0.2522264785494494
BMF,Diabetes Mellitus,0.2522264785494494
BMF,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
BMF,Non-Small Cell Lung Carcinoma,0.3933196962529684
BMF,Multiple Myeloma,0.4103119460235835
BMF,Leukemia B-Cell,0.5359212109443033
BMF,Lymphocytic Leukemia,0.0487679768343083
BMF,Hodgkin Disease,0.2627224344149009
BMF,Multiple Myeloma,0.4560460337187313
BMF,Human gammaherpesvirus 4 hypothetical protein (gene: BHRF1),0.6362779693488597
BMF,Human herpesvirus 4 type 2 BHRF1,0.6362779693488597
BMF,Human gammaherpesvirus 4 hypothetical BALF1 protein (gene: BALF1),0.6362779693488597
BMF,Human herpesvirus 4 type 2 BALF1,0.6362779693488597
C11ORF71,Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159,0.7068064785325423
C11ORF71,Mitochondrial pyruvate carrier deficiency ORPHA:447784,0.7068064785325423
C1QL1,Breast Carcinoma,0.0042545616049287
C1QL1,Malignant neoplasm of breast,0.0191435238361999
C1QL1,Central neuroblastoma,0.0593779966354549
C1QL1,Neoplasm Metastasis,0.0648809611869375
C1QL1,Neuroblastoma,0.0688152422187159
C1QL1,Liver carcinoma,0.095319386034013
C1QL1,Small cell carcinoma of lung,0.1193558174333938
C1QL1,Unipolar Depression,0.13167400689206
C1QL1,Hyperactive behavior,0.1387448809655294
C1QL1,Liver neoplasms,0.1454373331146953
C1QL1,Major Depressive Disorder,0.21122597829463
C1QL1,hiv-infection/aids,0.383941725017158
C1QL1,Alzheimer's Disease,0.3933196962529684
C1QL1,Anxiety Disorders,0.3933196962529684
C1QL1,Adenoma,0.3933196962529684
C1QL1,Focal glomerulosclerosis,0.3933196962529684
C1QL1,Mental Depression,0.3941558617476422
C1QL1,Pituitary Neoplasms,0.3941558617476422
C1QL1,Depressive disorder,0.3975960596292668
C1QL1,Chronic Kidney Diseases,0.4028066164685291
C1QL1,Familial hematuria,0.4028066164685291
C1QL1,Anxiety,0.4115056600660309
C1QL1,Mood Disorders,0.4192169590514327
C1QL1,Precocious Puberty,0.4209380602168584
C1QL1,Addictive Behavior,0.4314759856195063
C1QL1,Choriocarcinoma,0.4564472886428772
C1QL1,Chronic kidney disease stage 5,0.4704594475773637
C1QL1,Anorexia Nervosa,0.4790179402069343
C1QL1,Bulimia,0.4852430673532381
C1QL1,Coinfection,0.489336365264797
C1QL1,Kidney Failure Chronic,0.5299466034567416
C1QL1,Adrenal Cushing's syndrome,0.5710095678317721
C1QL1,Cushing Syndrome,0.6319938293757544
C1QL1,Renal Insufficiency,0.658736510383757
C1QL1,X-linked adrenal hypoplasia congenita ORPHA:95702,0.1590470395003315
C1QL1,WAGR syndrome ORPHA:893,0.1590470395003315
C1QL1,Partial pancreatic agenesis ORPHA:2805,0.3762014630157917
C1QL1,Autosomal spastic paraplegia type 72 ORPHA:401849,0.3762014630157917
C1QL1,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.3762014630157917
C1QL1,MASA syndrome ORPHA:2466,0.3762014630157917
C1QL1,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.3762014630157917
C1QL1,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.3762014630157917
C1QL1,Aarskog-Scott syndrome ORPHA:915,0.6239678957896782
C1QL1,Anterior segment developmental anomaly ORPHA:88632,0.6239678957896782
C1QL1,Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479,0.6239678957896782
C1QL1,Congenital primary aphakia ORPHA:83461,0.6239678957896782
C1QL1,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.6239678957896782
C1QL1,Oculoauricular syndrome Schorderet type ORPHA:157962,0.6239678957896782
C1QL1,Renal coloboma syndrome ORPHA:1475,0.6239678957896782
C1QL1,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.6239678957896782
C1QL1,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.6239678957896782
C1QL1,Autosomal recessive spastic paraplegia type 26 ORPHA:101006,0.7068064785325423
C1QL1,Mazabraud syndrome ORPHA:57782,0.7068064785325423
C1QL1,McCune-Albright syndrome ORPHA:562,0.7068064785325423
C1QL1,Monostotic fibrous dysplasia ORPHA:93277,0.7068064785325423
C1QL1,Polyostotic fibrous dysplasia ORPHA:93276,0.7068064785325423
C1QL1,Progressive myoclonic epilepsy type 8 ORPHA:424027,0.7068064785325423
C1QL1,Progressive osseous heteroplasia ORPHA:2762,0.7068064785325423
C1QL1,Pseudohypoparathyroidism type 1A ORPHA:79443,0.7068064785325423
C1QL1,Pseudohypoparathyroidism type 1C ORPHA:79444,0.7068064785325423
C1QL1,Pseudopseudohypoparathyroidism ORPHA:79445,0.7068064785325423
C1QL1,Right sided atrial isomerism ORPHA:97548,0.7068064785325423
C1QL1,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.7068064785325423
C1QL1,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.7068064785325423
C1QL1,Coloboma of choroid and retina ORPHA:98942,0.7068064785325423
C1QL1,Coloboma of iris ORPHA:98944,0.7068064785325423
C1QL1,Myoclonus-dystonia syndrome ORPHA:36899,0.7068064785325423
C6ORF141,Nail-patella syndrome ORPHA:2614,0.6239678957896782
C6ORF141,Nail-patella-like renal disease ORPHA:2613,0.6239678957896782
CA11,Breast Carcinoma,0.0042545616049287
CA11,Stomach Carcinoma,0.0149315928814189
CA11,Malignant neoplasm of breast,0.0191435238361999
CA11,Malignant neoplasm of stomach,0.0191435238361999
CA11,Carcinogenesis,0.0228075668512991
CA11,cervical cancer,0.2050045461627939
CA11,Malignant tumor of cervix,0.2714542429024338
CA11,Cervix carcinoma,0.2834835531038365
CA11,Gastrointestinal Stromal Tumors,0.3199171478489988
CA11,Malaria,0.5655222348249326
CA11,Febrile Convulsions,0.625027955184583
CA11,Granulocyte count,0.6841967398409226
CA11,Neutrophil count (procedure),0.7631684472516962
CA11,Eosinophil count procedure,0.905697116584928
CA11,Eosinophil count result,0.905697116584928
CA11,Blood basophil count (lab test),0.9263023523923462
CA11,Primary dystonia DYT4 type ORPHA:98805,0.6239678957896782
CA11,Benign Samaritan congenital myopathy ORPHA:324581,0.7068064785325423
CA11,Central core disease ORPHA:597,0.7068064785325423
CA11,Congenital multicore myopathy with external ophthalmoplegia ORPHA:98905,0.7068064785325423
CA11,Congenital myopathy with myasthenic-like onset ORPHA:424107,0.7068064785325423
CA11,Exercise-induced malignant hyperthermia ORPHA:466650,0.7068064785325423
CA11,King-Denborough syndrome ORPHA:99741,0.7068064785325423
CA11,Moderate multiminicore disease with hand involvement ORPHA:178145,0.7068064785325423
CA11,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.7068064785325423
CA11,Vaccinia virus Ankara IMV chondroitin-binding membrane protein,0.6362779693488597
CA11,Variola virus hypothetical protein (gene: F8L),0.6362779693488597
CA11,Horsepox virus HSPV114 (Eukaryotic-type carbonic anhydrase),0.6362779693488597
CA2,Breast Carcinoma,0.0042545616049287
CA2,melanoma,0.0149315928814189
CA2,Adenocarcinoma,0.0155921563748247
CA2,Malignant neoplasm of stomach,0.0191435238361999
CA2,Central neuroblastoma,0.0593779966354549
CA2,Neoplasm Metastasis,0.0648809611869375
CA2,Renal Cell Carcinoma,0.0648809611869375
CA2,Neuroblastoma,0.0688152422187159
CA2,Pancreatic Neoplasm,0.0739788831250619
CA2,Osteoporosis,0.0739788831250619
CA2,Pancreatic carcinoma,0.0745502070959292
CA2,Malignant neoplasm of urinary bladder,0.084286432100041
CA2,Squamous cell carcinoma of esophagus,0.0919714360040484
CA2,Liver carcinoma,0.095319386034013
CA2,Colon Carcinoma,0.1062239757831962
CA2,Peroxisome Biogenesis Disorder Complementation Group C,0.1254380558571286
CA2,Rheumatoid Arthritis,0.1537760235124317
CA2,TARSAL-CARPAL COALITION SYNDROME,0.1906413554467301
CA2,Malignant tumor of colon,0.223747154820789
CA2,Diabetes Mellitus,0.2522264785494494
CA2,Distal Renal Tubular Acidosis,0.2643145809900195
CA2,Malignant neoplasm of lung,0.2714542429024338
CA2,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
CA2,Basal ganglia calcification,0.286740104053178
CA2,Sjogren's Syndrome,0.3099246715197673
CA2,Glaucoma,0.3105909001629992
CA2,Post-Traumatic Osteoporosis,0.3233418869346274
CA2,Leukemogenesis,0.3510063969122338
CA2,Osteoporosis Senile,0.3544355608905275
CA2,Endometriosis,0.383941725017158
CA2,ST segment elevation myocardial infarction,0.3933196962529684
CA2,Bone necrosis,0.3933196962529684
CA2,Bipolar Disorder,0.3933196962529684
CA2,Columnar Cell Change of the Breast,0.3933196962529684
CA2,Fibrillation,0.3933196962529684
CA2,High altitude pulmonary edema,0.3933196962529684
CA2,Kidney Diseases,0.3933196962529684
CA2,Schizophrenia,0.3933196962529684
CA2,Osteoporosis Age-Related,0.3933196962529684
CA2,OSTEOPETROSIS AUTOSOMAL RECESSIVE 3,0.3933196962529684
CA2,Extramedullary erythropoiesis,0.3933196962529684
CA2,Cystadenocarcinoma Serous,0.3933196962529684
CA2,Alzheimer's Disease,0.3933196962529684
CA2,Stomach Neoplasms,0.3933196962529684
CA2,Coronary heart disease,0.3933196962529684
CA2,Compression of optic nerve,0.3933196962529684
CA2,Atypical Teratoid Rhabdoid Tumor,0.3933196962529684
CA2,Thick skull bones,0.3933196962529684
CA2,Cranial hyperostosis,0.3933196962529684
CA2,Enlargement of skull bones,0.3933196962529684
CA2,Excessive growth of skull bones,0.3933196962529684
CA2,Hypertrophy of cranial bones,0.3933196962529684
CA2,Periodic hypokalemic paresis,0.3933196962529684
CA2,Anemia,0.3941558617476422
CA2,Abnormality of the renal tubule,0.3941558617476422
CA2,Premature coronary artery disease,0.3941558617476422
CA2,Aseptic necrosis,0.3941558617476422
CA2,Bone infarction,0.3941558617476422
CA2,Bone pain,0.3975960596292668
CA2,Aseptic Necrosis of Bone,0.3975960596292668
CA2,Hemoglobin low,0.4028066164685291
CA2,Hepatosplenomegaly,0.4028066164685291
CA2,Splenomegaly,0.4103119460235835
CA2,Cerebral calcification,0.4103119460235835
CA2,Abnormal mental state,0.4103119460235835
CA2,Phobic anxiety disorder,0.4115056600660309
CA2,Osteopetrosis,0.4126392832024548
CA2,Down Syndrome,0.4126392832024548
CA2,Angle class 2 malocclusion,0.4209380602168584
CA2,Angle class 3 malocclusion,0.4209380602168584
CA2,Thrombocytopenia,0.4213286052188015
CA2,Knee joint valgus deformity,0.4213286052188015
CA2,Malocclusion,0.425419812815905
CA2,Varying degree of multiple fractures,0.425419812815905
CA2,Frequent fractures,0.425419812815905
CA2,Increased fracture rate,0.425419812815905
CA2,Fractures Multiple,0.4297858918260954
CA2,Psoriasis,0.4304973629098372
CA2,Adenocarcinoma of pancreas,0.4325044517055656
CA2,Neuropathy,0.4335751357405352
CA2,Mental handicap,0.4335751357405352
CA2,Carcinoid Tumor,0.4381343267935581
CA2,Short stature,0.439389586518055
CA2,Abnormal vision,0.4396723023384634
CA2,Camurati-Engelmann Syndrome,0.4459714599189374
CA2,Hepatomegaly,0.4506578937113162
CA2,Decreased platelet count,0.4561717689698902
CA2,Extramedullary Hematopoiesis (disorder),0.4675904598629673
CA2,Rotting teeth,0.4790179402069343
CA2,Dental caries,0.4852430673532381
CA2,Acute interstitial pneumonia,0.4852430673532381
CA2,Metabolic Bone Disorder,0.4923669467696064
CA2,Cholangitis,0.4981941174985421
CA2,Ulcerative Colitis,0.5001612228394569
CA2,Coronary Arteriosclerosis,0.5140447474168605
CA2,Renal tubular acidosis,0.5140447474168605
CA2,Dull intelligence,0.5300976305939776
CA2,Low intelligence,0.5300976305939776
CA2,Carcinoma Cribriform,0.5337853752290136
CA2,Carcinoma Granular Cell,0.5337853752290136
CA2,Adenocarcinoma Basal Cell,0.5359212109443033
CA2,Reduced bone mineral density,0.5359212109443033
CA2,Tooth Abnormalities,0.5393787854381349
CA2,Acute intermittent porphyria,0.5393787854381349
CA2,Adenocarcinoma Oxyphilic,0.549941235475765
CA2,Adenocarcinoma Tubular,0.5557519470957561
CA2,Poor school performance,0.5610226870913673
CA2,beta^+^ Thalassemia,0.563120546412355
CA2,Hereditary Diffuse Gastric Cancer,0.5696906826730043
CA2,Peripheral Neuropathy,0.5851527280548257
CA2,Malnutrition,0.5916904943304121
CA2,Abnormality of epiphysis morphology,0.6002127202571572
CA2,Mental deficiency,0.6035970790768342
CA2,Cystic Fibrosis,0.6124306570512981
CA2,Mental Retardation,0.6319938293757544
CA2,Migraine with Aura,0.6355866602993508
CA2,Inborn Errors of Metabolism,0.655573080043894
CA2,Dermatitis Atopic,0.7045203904267408
CA2,Developmental delay (disorder),0.7096959691931399
CA2,Hypertrophy of lower jaw,0.7433468668038986
CA2,mandibular excess (physical finding),0.7433468668038986
CA2,Mandibular hyperplasia,0.7433468668038986
CA2,Increased size of the mandible,0.7484342194688707
CA2,Class III malocclusion,0.7577323833810212
CA2,Encephalopathies,0.7815030391631113
CA2,Eczema,0.7893058450619891
CA2,Intellectual Disability,0.8352623613787349
CA2,Mental and motor retardation,0.897310588550617
CA2,Cognitive delay,0.9238745269736108
CA2,Global developmental delay,0.9327689937867868
CA2,Undergrowth,0.9401531131388324
CA2,Failure to gain weight,0.9449543840411656
CA2,Pediatric failure to thrive,0.9465829057944656
CA2,Pancreatitis,0.95412990454283
CA2,Esophagus Neoplasm,0.0102679590519094
CA2,Liver Carcinoma,0.0520696613701797
CA2,Carcinoma,0.0534520155998091
CA2,Osteopetrosis,0.336287627428424
CA2,Autism Spectrum Disorder,0.425341435586089
CA2,Distal Renal Tubular Acidosis,0.4402141802500753
CA2,Diaphyseal Dysplasia,0.4541466895915311
CA2,Periodic Hypokalemic Paresis,0.4541466895915311
CA2,Osteoporosis,0.4541466895915311
CA2,Renal Tubular Acidosis,0.4560460337187313
CA2,Anemia,0.4780231573499264
CA2,Adenocarcinoma,0.4780231573499264
CA2,Dwarfism,0.5796489603182782
CA2,Nervous System Diseases,0.6420878824691651
CA2,Gastric Cancer,0.6524705037929849
CA2,Malocclusion,0.6564901877271138
CA2,Stomach Neoplasms,0.669817442578862
CA2,Optic Atrophy,0.675936313627625
CA2,Mental Retardation,0.7729545590606223
CA2,Developmental Delay,0.96477535147595
CA2,McLeod neuroacanthocytosis syndrome ORPHA:59306,0.6239678957896782
CA2,Osteopetrosis with renal tubular acidosis ORPHA:2785,0.7068064785325423
CA2,Vaccinia virus Ankara IMV chondroitin-binding membrane protein,0.6362779693488597
CA2,Variola virus hypothetical protein (gene: F8L),0.6362779693488597
CA2,Vaccinia virus Ankara Haemagglutinin,0.6362779693488597
CA2,Cowpox virus CPXV125 protein (gene: CPV125 CDS),0.6362779693488597
CA2,Ectromelia virus ERPV carbonic anhydrase,0.6362779693488597
CA2,Horsepox virus HSPV177 (Immunoglobulin like),0.691145768348025
CALHM3,Endometriosis,0.383941725017158
CALHM3,Endometriosis,0.2187610616307245
CASP7,Colorectal Carcinoma,0.0034602840073026
CASP7,Mammary Neoplasms,0.0034602840073026
CASP7,Breast Carcinoma,0.0042545616049287
CASP7,Colorectal Cancer,0.0149315928814189
CASP7,Stomach Carcinoma,0.0149315928814189
CASP7,melanoma,0.0149315928814189
CASP7,Malignant neoplasm of breast,0.0191435238361999
CASP7,Malignant neoplasm of stomach,0.0191435238361999
CASP7,Carcinogenesis,0.0228075668512991
CASP7,Malignant neoplasm of prostate,0.0569142010728473
CASP7,Mammary Neoplasms Human,0.064548079316548
CASP7,Neoplasm Metastasis,0.0648809611869375
CASP7,Glioma,0.0739788831250619
CASP7,Osteoporosis,0.0739788831250619
CASP7,Lymphoma,0.0739788831250619
CASP7,Glioblastoma,0.0745502070959292
CASP7,Liver Cirrhosis Experimental,0.0747863377072194
CASP7,Prostate carcinoma,0.0773771948186562
CASP7,Squamous cell carcinoma of the head and neck,0.0775520919998773
CASP7,Liver carcinoma,0.095319386034013
CASP7,Malignant neoplasm of endometrium,0.13167400689206
CASP7,Uterine Corpus Cancer,0.1328002618052838
CASP7,Myocardial Infarction,0.1352936728187231
CASP7,Liver neoplasms,0.1454373331146953
CASP7,Rheumatoid Arthritis,0.1537760235124317
CASP7,Acute Myeloid Leukemia (AML-M2),0.2050045461627939
CASP7,cervical cancer,0.2050045461627939
CASP7,Prostatic Neoplasms,0.223747154820789
CASP7,Adenocarcinoma Of Esophagus,0.2679411586077776
CASP7,Malignant tumor of cervix,0.2714542429024338
CASP7,Malignant neoplasm of lung,0.2714542429024338
CASP7,Cervix carcinoma,0.2834835531038365
CASP7,Endometrial Carcinoma,0.3044782497745498
CASP7,Leukoplakia,0.333745294913745
CASP7,Carcinoma of lung,0.3663130598151661
CASP7,Primary malignant neoplasm of lung,0.3902116649640871
CASP7,Spinocerebellar Ataxia Type 7,0.3933196962529684
CASP7,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
CASP7,Non-Small Cell Lung Carcinoma,0.3933196962529684
CASP7,Leukemia Myelocytic Acute,0.3933196962529684
CASP7,Alzheimer's Disease,0.3933196962529684
CASP7,Lip and Oral Cavity Carcinoma,0.3933196962529684
CASP7,Stomach Neoplasms,0.3933196962529684
CASP7,Glioblastoma Multiforme,0.3933196962529684
CASP7,Luminal A Breast Carcinoma,0.3975960596292668
CASP7,Gastric Adenocarcinoma,0.4028066164685291
CASP7,Acute Myeloid Leukemia M1,0.4100742336915555
CASP7,Refractory anemias,0.421267417774367
CASP7,Malignant neoplasm of mouth,0.4213286052188015
CASP7,Breast adenocarcinoma,0.4810435657134442
CASP7,Myocardial Reperfusion Injury,0.6980473696540115
CASP7,Vitiligo,0.7965733310657268
CASP7,Breast Carcinoma,0.0075861267486594
CASP7,Marfan Syndrome,0.0133304506157067
CASP7,Mammary Neoplasms,0.0155248163763686
CASP7,Breast Cancer,0.0402286636010764
CASP7,Myeloid Leukemia,0.525214105372123
CASP7,Vitiligo,0.5576425853515448
CASP7,Leukemia,0.7167438233451096
CASP7,Carnitine palmitoyl transferase 1A deficiency ORPHA:156,0.1590470395003315
CASP7,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.1590470395003315
CASP7,Chondrodysplasia-disorder of sex development syndrome ORPHA:1422,0.3762014630157917
CASP7,Herpes simplex virus encephalitis ORPHA:1930,0.3826134188846508
CASP7,B4GALT1-CDG ORPHA:79332,0.6239678957896782
CASP7,USP18 deficiency ORPHA:481665,0.6239678957896782
CASP7,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome ORPHA:445062,0.7068064785325423
CASP7,Human papillomavirus 201 E7 (gene: E7),0.6362779693488597
CASP7,Human papillomavirus type 147 transforming protein (gene: E7),0.6362779693488597
CASP7,Horsepox virus HSPV020e (ankyrin repeats),0.7079503198328393
CASP7,Horsepox virus HSPV011a,0.776311155917498
CASP7,Vaccinia virus hypothetical protein,0.7975886343350181
CASP7,Variola virus hypothetical protein (gene: B21R),0.7988086321880973
CASP7,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.8031136315766868
CASP7,Horsepox virus HSPV011c (ankyrin repeats),0.830387084488226
CASP7,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8315214238833722
CASP7,Horsepox virus HSPV194 (ankyrin repeats),0.8320620882218038
CASP7,Orf virus ORF123 ankyrin repeat protein,0.8390943852085586
CASP7,Monkeypox virus ankyrin-like protein,0.8426793553344071
CASP7,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.8507994162096807
CASP7,Vaccinia virus Ankara CP77 host range protein f2,0.8509394234802752
CASP7,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8565042041973229
CASP7,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.8665950357166999
CASP7,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.876049415394169
CASP7,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.8784689389733535
CASP7,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8826243651582266
CASP7,Horsepox virus HSPV033c (ankyrin repeats),0.8826243651582266
CASP7,Vaccinia virus ankyrin-like protein,0.8912506515619287
CASP7,Vaccinia virus ankyrin-like protein (gene: C9L),0.8962695058306248
CASP7,Horsepox virus HSPV005c (Ankyrin repeats),0.9005654634109755
CASP7,Yaba-like disease virus 148R protein (gene: 148R),0.9055720084468104
CASP7,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.9097056179628632
CASP7,Yaba-like disease virus 8L protein (gene: 8L),0.9102852214746716
CASP7,Vaccinia virus Ankara CP77 host range protein f4,0.9135411983375344
CASP7,Horsepox virus HSPV196 (ankyrin-like protein,0.9195586782304176
CASP7,Provisional),0.9199249371723298
CASP7,Ectromelia virus ERPV ankyrin,0.920189880588384
CASP7,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.920189880588384
CASP7,Vaccinia virus Ankara CP77 Host range protein f1,0.924238809115565
CASP7,Yaba-like disease virus 146R protein (gene: 146R),0.9271250260824724
CASP7,Vaccinia virus ankyin-like protein (gene: M1L),0.9285312497152513
CASP7,Orf virus ORF008 ankyrin repeat protein,0.9285312497152513
CASP7,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.9317407101292444
CASP7,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L),0.9394149990743936
CASP7,Cowpox virus CPXV017 protein (gene: CPXV017 CDS),0.9407405842467907
CASP7,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.945966103627342
CASP7,Horsepox virus HSPV005b (ankyrin repeats),0.9475760000797028
CASP7,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9475760000797028
CASP7,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9475760000797028
CASP7,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D1L),0.9517968639566384
CASP7,Horsepox virus HSPV181 (ankyrin repeats),0.9518028028273808
CASP7,Vaccinia virus ankyrin-like protein (gene: B4R),0.9566905696255492
CASP7,Variola virus hypothetical protein (gene: B19R),0.9566905696255492
CASP7,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.9566905696255492
CASP7,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.960637237597315
CASP7,Yaba monkey tumor virus ankyrin repeat protein,0.960637237597315
CASP7,Horsepox virus HSPV014c (ankyrin repeats),0.9621839893030432
CASP7,Vaccinia virus ankyrin-like protein (gene: B18R),0.9621839893030432
CASP7,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.9621839893030432
CASP7,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9621839893030432
CASP7,Horsepox virus HSPV033b (Ankyrin repeats),0.9621839893030432
CASP7,Variola virus hypothetical protein (gene: G3R),0.9621839893030432
CASP7,Variola virus hypothetical protein (gene: D6L),0.9621839893030432
CASP7,Orf virus ORF129 ankyrin repeat protein,0.9621839893030432
CASP7,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9621839893030432
CASP7,Horsepox virus HSPV201a (ankyrin repeats),0.9624639844306644
CASP7,Yaba-like disease virus 147R protein (gene: 147R),0.9624639844306644
CASP7,Variola virus ankyin-like protein (gene: O1L),0.9624639844306644
CASP7,Vaccinia virus Ankara Host range protein,0.9624639844306644
CASP7,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.9624639844306644
CASP7,Yaba-like disease virus 11L protein (gene: 11L),0.9624639844306644
CASP7,Cowpox virus CPXV027 protein (gene: CPXV027 CDS),0.9624639844306644
CASP7,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9624639844306644
CASP7,Horsepox virus HSPV012 (ankyrin-like protein,0.9624639844306644
CASP7,Provisional),0.9676678660011035
CASP7,Orf virus ORF128 ankyrin repeat protein,0.9687365967836944
CASP7,Orf virus ORF126 ankyrin repeat protein,0.9695158706192956
CASP7,Horsepox virus HSPV022 (ankyrin-like protein,0.970789305792858
CASP7,Provisional),0.9776389019841476
CASP7,Horsepox virus HSPV020b (ankyrin repeats),0.9782376397065295
CASP7,Variola virus hypothetical protein (gene: B6R),0.9784209964188774
CASP7,Horsepox virus HSPV004 (ankyrin repeats),0.9810164003109842
CASP7,Horsepox virus HSPV014b (ankyrin repeats),0.986358730247118
CCN2,Carcinoma,0.0534520155998091
CCN2,Pulmonary Fibrosis,0.0654534781440596
CCN2,Alveolitis,0.1025546857843372
CCN2,Cholestasis,0.336287627428424
CCN2,Liver Cirrhosis,0.4286813331685578
CCN2,Glomerular Hyalinosis,0.4286813331685578
CCN2,Pulmonary Arterial Hypertension,0.4286813331685578
CCN2,Aortic Valve Insufficiency,0.4286813331685578
CCN2,Diffuse Cutaneous Systemic Sclerosis,0.4286813331685578
CCN2,Limited Systemic Sclerosis,0.4286813331685578
CCN2,CREST Syndrome,0.4286813331685578
CCN2,Lung Cancer,0.4402141802500753
CCN2,Arthritis,0.4541466895915311
CCN2,Lung Neoplasms,0.4560460337187313
CCN2,Rheumatoid Arthritis,0.4560460337187313
CCN2,Liver Fibrosis,0.4560460337187313
CCN2,Lung Diseases,0.4560460337187313
CCN2,Hypertension,0.4560460337187313
CCN2,Posterolateral Diaphragmatic Hernia,0.4646409362700993
CCN2,Morgagni Diaphragmatic Hernia,0.4646409362700993
CCN2,Gastroesophageal Reflux Disease,0.4742592264758768
CCN2,Adenocarcinoma,0.4780231573499264
CCN2,Dysphagia,0.5127628024019304
CCN2,Lymphoblastic Leukemia,0.5129298662020659
CCN2,Scleroderma,0.5162067638232762
CCN2,Congenital Diaphragmatic Hernia,0.5162067638232762
CCN2,Subfertility,0.5207800595599322
CCN2,Dermatitis,0.525214105372123
CCN2,Myocardial Infarction,0.5632819212593052
CCN2,Glomerulosclerosis,0.5924794904332197
CCN2,Renal Insufficiency,0.7112499273451761
CCN2,Heart Failure,0.7360789997461612
CCN2,Congestive Heart Failure,0.7532174466905212
CCN2,Malabsorption Syndrome,0.8934893385336675
CCN2,Diffuse cutaneous systemic sclerosis ORPHA:220393,0.6279395134845649
CCN2,Limited cutaneous systemic sclerosis ORPHA:220402,0.6340773186521831
CCND1,Colorectal Carcinoma,0.0034602840073026
CCND1,Mammary Neoplasms,0.0034602840073026
CCND1,Ovarian Carcinoma,0.0034602840073026
CCND1,Breast Carcinoma,0.0042545616049287
CCND1,Invasive carcinoma of breast,0.0149002095788623
CCND1,Invasive Ductal Breast Carcinoma,0.0149002095788623
CCND1,Colorectal Cancer,0.0149315928814189
CCND1,Tumor Progression,0.0149315928814189
CCND1,Stomach Carcinoma,0.0149315928814189
CCND1,Retroviridae Infections,0.0149315928814189
CCND1,melanoma,0.0149315928814189
CCND1,Adenocarcinoma,0.0155921563748247
CCND1,Proliferative vitreoretinopathy,0.0182265588252201
CCND1,Squamous cell carcinoma,0.0182265588252201
CCND1,Esophageal Neoplasms,0.0182265588252201
CCND1,Malignant mesothelioma,0.0182265588252201
CCND1,Pre B-cell acute lymphoblastic leukemia,0.0189794808441368
CCND1,ovarian neoplasm,0.0191435238361999
CCND1,Malignant neoplasm of breast,0.0191435238361999
CCND1,Fibrosarcoma,0.0191435238361999
CCND1,Malignant neoplasm of stomach,0.0191435238361999
CCND1,Carcinogenesis,0.0228075668512991
CCND1,Malignant neoplasm of esophagus,0.0248454592431097
CCND1,Malignant neoplasm of ovary,0.0277695594716545
CCND1,Carcinoma Spindle-Cell,0.0308703957553632
CCND1,Urologic Neoplasms,0.0314665934969085
CCND1,Hematopoietic Neoplasms,0.0334891258932371
CCND1,Medulloblastoma,0.0354767239335874
CCND1,Epithelial ovarian cancer,0.0387439397151409
CCND1,Brain Tumor Primary,0.044151975756427
CCND1,Skin carcinoma,0.0482468351695405
CCND1,Cancer of Urinary Tract,0.0492766532827251
CCND1,Malignant neoplasm of prostate,0.0569142010728473
CCND1,Carcinoma,0.0593779966354549
CCND1,Central neuroblastoma,0.0593779966354549
CCND1,Cervical intraepithelial neoplasia grade 1,0.0593779966354549
CCND1,Well Differentiated Oligodendroglioma,0.0617471306652618
CCND1,Carcinomatosis,0.0617471306652618
CCND1,Primary malignant neoplasm of brain,0.064548079316548
CCND1,Mammary Neoplasms Human,0.064548079316548
CCND1,Brain Neoplasms,0.064548079316548
CCND1,Neoplasm Metastasis,0.0648809611869375
CCND1,Barrett Esophagus,0.0648809611869375
CCND1,Mucoepidermoid Carcinoma,0.0648809611869375
CCND1,Renal Cell Carcinoma,0.0648809611869375
CCND1,oligodendroglioma,0.0648809611869375
CCND1,Neuroblastoma,0.0688152422187159
CCND1,Malignant neoplasm of pancreas,0.0726340460169901
CCND1,Pancreatic Neoplasm,0.0739788831250619
CCND1,Glioma,0.0739788831250619
CCND1,Squamous cell carcinoma of penis,0.0739788831250619
CCND1,Osteoporosis,0.0739788831250619
CCND1,Lymphoma,0.0739788831250619
CCND1,Endometrial Neoplasms,0.0745502070959292
CCND1,Glioblastoma,0.0745502070959292
CCND1,Pancreatic carcinoma,0.0745502070959292
CCND1,Carcinoma breast stage IV,0.0745502070959292
CCND1,Prostate carcinoma,0.0773771948186562
CCND1,Squamous cell carcinoma of the head and neck,0.0775520919998773
CCND1,Adenoid cystic carcinoma of salivary gland,0.0775520919998773
CCND1,Genomic Instability,0.0775520919998773
CCND1,Colorectal Neoplasms,0.0827744840860166
CCND1,Anaplastic carcinoma,0.084286432100041
CCND1,Malignant neoplasm of urinary bladder,0.084286432100041
CCND1,Bladder Neoplasm,0.0891725280554336
CCND1,Adult Acute Lymphocytic Leukemia,0.0919714360040484
CCND1,Squamous cell carcinoma of esophagus,0.0919714360040484
CCND1,Anus Neoplasms,0.095319386034013
CCND1,Liver carcinoma,0.095319386034013
CCND1,Malignant Neoplasms,0.0991201145654548
CCND1,Osteosarcoma,0.1029977559100099
CCND1,Colon Carcinoma,0.1062239757831962
CCND1,Adenocarcinoma of colon,0.1112281755580192
CCND1,Ganglioneuroma,0.1138051695421299
CCND1,Skin toxicity,0.1138051695421299
CCND1,Cardiac Carcinoma,0.1138051695421299
CCND1,Chondromyxoid fibroma,0.1138051695421299
CCND1,Chronic Lymphocytic Leukemia,0.1147307578771389
CCND1,Small cell carcinoma of lung,0.1193558174333938
CCND1,Hematologic Neoplasms,0.1253114324938153
CCND1,MYELODYSPLASTIC SYNDROME,0.1254380558571286
CCND1,Esophageal carcinoma,0.1254380558571286
CCND1,Ductal Breast Carcinoma,0.13167400689206
CCND1,Hamman-Rich syndrome,0.13167400689206
CCND1,Tumor Initiation,0.13167400689206
CCND1,Undifferentiated carcinoma,0.13167400689206
CCND1,Clear-cell metastatic renal cell carcinoma,0.13167400689206
CCND1,Carcinoma Transitional Cell,0.13167400689206
CCND1,Oral Cavity Carcinoma,0.13167400689206
CCND1,Malignant neoplasm of large intestine,0.13167400689206
CCND1,Carcinoma of bladder,0.13167400689206
CCND1,Malignant neoplasm of endometrium,0.13167400689206
CCND1,Papillary serous cystadenocarcinoma,0.13167400689206
CCND1,Unipolar Depression,0.13167400689206
CCND1,Uterine Corpus Cancer,0.1328002618052838
CCND1,Myocardial Infarction,0.1352936728187231
CCND1,Mammary Carcinoma Animal,0.1352936728187231
CCND1,Animal Mammary Neoplasms,0.1352936728187231
CCND1,Solid Neoplasm,0.1413782599148022
CCND1,Colonic Neoplasms,0.1454373331146953
CCND1,Jaw Keratocyst,0.1454373331146953
CCND1,Mixed Salivary Gland Tumor,0.1454373331146953
CCND1,Liver neoplasms,0.1454373331146953
CCND1,Chromophobe Renal Cell Carcinoma,0.1461248774859792
CCND1,Rheumatoid Arthritis,0.1537760235124317
CCND1,Sarcoma,0.1537760235124317
CCND1,Benign neoplasm of brain unspecified,0.1602092191314262
CCND1,Breast Cancer Familial,0.1602092191314262
CCND1,Invasive Carcinoma,0.1602092191314262
CCND1,Neck Neoplasms,0.1614820148711231
CCND1,Chronic leukemia (category),0.1653491983554358
CCND1,Visual seizure,0.1735868515093891
CCND1,Comedone,0.1735868515093891
CCND1,Testicular Germ Cell Tumor,0.1735868515093891
CCND1,Head and Neck Carcinoma,0.1735868515093891
CCND1,Recurrent Brain Neoplasm,0.1770067065899052
CCND1,Benign Ovarian Neoplasm,0.1770067065899052
CCND1,Low Grade Cervical Squamous Intraepithelial Neoplasia,0.1897991423047819
CCND1,TARSAL-CARPAL COALITION SYNDROME,0.1906413554467301
CCND1,Cervical intraepithelial neoplasia grade 2,0.2050045461627939
CCND1,cervical cancer,0.2050045461627939
CCND1,Seizures,0.2053083986145698
CCND1,Lung Neoplasms,0.2062010908869036
CCND1,Osteosarcoma of bone,0.2109483801368481
CCND1,Major Depressive Disorder,0.21122597829463
CCND1,Malignant tumor of colon,0.223747154820789
CCND1,Prostatic Neoplasms,0.223747154820789
CCND1,Hodgkin Disease,0.2454476567103779
CCND1,Anoxia,0.2462384927636234
CCND1,Burkitt Lymphoma,0.2521987644415915
CCND1,Hepatoblastoma,0.2522264785494494
CCND1,Malignant Head and Neck Neoplasm,0.2522264785494494
CCND1,B-Cell Lymphomas,0.2522264785494494
CCND1,B-CELL MALIGNANCY LOW-GRADE,0.2522264785494494
CCND1,Thymus Hyperplasia,0.2522264785494494
CCND1,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.2522264785494494
CCND1,MIXED LINEAGE LEUKEMIA,0.2605479444258003
CCND1,Malignant neoplasm of liver,0.2643145809900195
CCND1,Small Lymphocytic Lymphoma,0.2643145809900195
CCND1,Chondrosarcoma,0.2643145809900195
CCND1,Squamous cell carcinoma of vulva,0.2643145809900195
CCND1,Adenocarcinoma Of Esophagus,0.2679411586077776
CCND1,Malignant tumor of cervix,0.2714542429024338
CCND1,Malignant neoplasm of lung,0.2714542429024338
CCND1,Kidney Neoplasm,0.2714542429024338
CCND1,Peyronie Disease,0.2714542429024338
CCND1,Cervix carcinoma,0.2834835531038365
CCND1,Multiple Sclerosis,0.2835142372342932
CCND1,Fibroid Tumor,0.290158730291654
CCND1,Neoplasms Intracranial,0.290158730291654
CCND1,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
CCND1,Triple Negative Breast Neoplasms,0.2980670559114652
CCND1,Myeloid Leukemia,0.2980670559114652
CCND1,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
CCND1,Endometrial Carcinoma,0.3044782497745498
CCND1,Idiopathic Pulmonary Fibrosis,0.3099246715197673
CCND1,Hemangioma,0.3099246715197673
CCND1,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
CCND1,Malignant Squamous Cell Neoplasm,0.3104232675696299
CCND1,Embryonal Carcinoma,0.3112516166225269
CCND1,Anaplastic Oligodendroglioma,0.3176684185973055
CCND1,Cervical Squamous Cell Carcinoma,0.3199171478489988
CCND1,Gastrointestinal Stromal Tumors,0.3199171478489988
CCND1,Epithelial hyperplasia of skin,0.333745294913745
CCND1,Cholangiocarcinoma,0.340892538685018
CCND1,Hairy Cell Leukemia,0.3412203844672238
CCND1,Head and Neck Neoplasms,0.3412203844672238
CCND1,Blast Phase,0.3494455519738624
CCND1,Mammary Neoplasms Experimental,0.3508665345292502
CCND1,Ataxia Telangiectasia,0.3508665345292502
CCND1,Pathological fracture,0.3508665345292502
CCND1,Leukemogenesis,0.3510063969122338
CCND1,Uterine Cancer,0.3544355608905275
CCND1,Severe Combined Immunodeficiency,0.3553621627681198
CCND1,Cutaneous lymphoma,0.3638414818541592
CCND1,Carcinoma of lung,0.3663130598151661
CCND1,Pheochromocytoma,0.3712878513813393
CCND1,Anaplastic astrocytoma,0.3763374964032415
CCND1,Adenomatous polyp of colon,0.383941725017158
CCND1,Human papilloma virus infection,0.383941725017158
CCND1,Endometriosis,0.383941725017158
CCND1,Thyroid Neoplasm,0.383941725017158
CCND1,Cardiac Lymphoma,0.383941725017158
CCND1,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
CCND1,Uterine Fibroids,0.383941725017158
CCND1,Noninfiltrating Intraductal Carcinoma,0.383941725017158
CCND1,Primary malignant neoplasm of lung,0.3902116649640871
CCND1,Chromosome 8 trisomy,0.3925783478421996
CCND1,Von Hippel-Lindau Syndrome,0.3933196962529684
CCND1,Secondary malignant neoplasm of lymph node,0.3933196962529684
CCND1,Epstein-Barr Virus Infections,0.3933196962529684
CCND1,Dysplastic Nevus,0.3933196962529684
CCND1,Peripheral T-Cell Lymphoma,0.3933196962529684
CCND1,Adenocarcinoma of large intestine,0.3933196962529684
CCND1,Cerebrovascular Disorders,0.3933196962529684
CCND1,Verrucous carcinoma,0.3933196962529684
CCND1,Hamartoma,0.3933196962529684
CCND1,Uterine Cervical Neoplasm,0.3933196962529684
CCND1,Laryngeal Squamous Cell Carcinoma,0.3933196962529684
CCND1,Pancreatitis Chronic,0.3933196962529684
CCND1,Kidney Diseases,0.3933196962529684
CCND1,Nasopharyngeal carcinoma,0.3933196962529684
CCND1,Parathyroid Adenoma,0.3933196962529684
CCND1,Papillary thyroid carcinoma,0.3933196962529684
CCND1,Hereditary Nonpolyposis Colorectal Cancer,0.3933196962529684
CCND1,Nephroblastoma,0.3933196962529684
CCND1,Schizophrenia,0.3933196962529684
CCND1,Malignant Glioma,0.3933196962529684
CCND1,Non-Small Cell Lung Carcinoma,0.3933196962529684
CCND1,Gastroesophageal reflux disease,0.3933196962529684
CCND1,Hypertensive disease,0.3933196962529684
CCND1,Secondary malignant neoplasm of liver,0.3933196962529684
CCND1,Leukemia Myelocytic Acute,0.3933196962529684
CCND1,Inflammatory Myofibroblastic Tumor,0.3933196962529684
CCND1,Large cell neuroendocrine carcinoma,0.3933196962529684
CCND1,Lichen Sclerosus et Atrophicus,0.3933196962529684
CCND1,Skin Carcinogenesis,0.3933196962529684
CCND1,Bone Marrow Diseases,0.3933196962529684
CCND1,Abnormality of bone marrow cell morphology,0.3933196962529684
CCND1,Virchow's node (disorder),0.3933196962529684
CCND1,Adrenal incidentaloma,0.3933196962529684
CCND1,Cecal Neoplasms,0.3933196962529684
CCND1,Centrocytic lymphoma,0.3933196962529684
CCND1,Intermediate Grade Ductal Breast Carcinoma In Situ,0.3933196962529684
CCND1,Lentigo maligna melanoma,0.3933196962529684
CCND1,Malignant neoplasm of cecum,0.3933196962529684
CCND1,Milroy Disease,0.3933196962529684
CCND1,Skin Neoplasms,0.3933196962529684
CCND1,Urothelial Carcinoma,0.3933196962529684
CCND1,Carcinoma Papillary,0.3933196962529684
CCND1,Hurthle Cell Tumor,0.3933196962529684
CCND1,Stage 4S neuroblastoma,0.3933196962529684
CCND1,Astrocytoma,0.3933196962529684
CCND1,Lymphoma T-Cell Cutaneous,0.3933196962529684
CCND1,Aplasia Cutis Congenita,0.3933196962529684
CCND1,Hemangiosarcoma,0.3933196962529684
CCND1,Osteoarthritis of the hand,0.3933196962529684
CCND1,Arthritis Psoriatic,0.3933196962529684
CCND1,Alzheimer's Disease,0.3933196962529684
CCND1,Anxiety Disorders,0.3933196962529684
CCND1,Peroxisome Biogenesis Disorder Complementation Group H,0.3933196962529684
CCND1,Heart Neoplasm,0.3933196962529684
CCND1,impaired motor coordination,0.3933196962529684
CCND1,Non-small cell lung cancer stage III,0.3933196962529684
CCND1,Papillary cystic tumor,0.3933196962529684
CCND1,Endometrioid carcinoma ovary,0.3933196962529684
CCND1,Intestinal Polyps,0.3933196962529684
CCND1,Prolymphocytic Leukemia,0.3933196962529684
CCND1,Bronchioloalveolar Adenocarcinoma,0.3933196962529684
CCND1,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
CCND1,Thrombocythemia Essential,0.3933196962529684
CCND1,Generalized osteopenia,0.3933196962529684
CCND1,Lymphoma Non-Hodgkin,0.3933196962529684
CCND1,Prolactinoma,0.3933196962529684
CCND1,Acute lymphocytic leukemia,0.3933196962529684
CCND1,Lip and Oral Cavity Carcinoma,0.3933196962529684
CCND1,High Grade Lymphoma (neoplasm),0.3933196962529684
CCND1,Primary Carcinoma,0.3933196962529684
CCND1,Stomach Neoplasms,0.3933196962529684
CCND1,Adenoid Cystic Carcinoma,0.3933196962529684
CCND1,Inflammatory Bowel Diseases,0.3933196962529684
CCND1,Endometrial stromal sarcoma high grade,0.3933196962529684
CCND1,Transitional Cell Neoplasm,0.3933196962529684
CCND1,Adenomyoma,0.3933196962529684
CCND1,Endometrial Stromal Tumors,0.3933196962529684
CCND1,CARCINOMA OF VULVA,0.3933196962529684
CCND1,Atypical Teratoid Rhabdoid Tumor,0.3933196962529684
CCND1,Cerebral Amyloid Angiopathy,0.3933196962529684
CCND1,Mammary adenocarcinoma,0.3933196962529684
CCND1,Squamous cell carcinoma of tongue,0.3933196962529684
CCND1,Adenoma,0.3933196962529684
CCND1,Basal Cell Nevus Syndrome,0.3933196962529684
CCND1,Malignant neoplasm of male breast,0.3933196962529684
CCND1,Glioblastoma Multiforme,0.3933196962529684
CCND1,synovial sarcoma,0.3933196962529684
CCND1,Renal medullary carcinoma,0.3933196962529684
CCND1,Atypical polypoid adenomyoma,0.3933196962529684
CCND1,Burkitt-like lymphoma,0.3933196962529684
CCND1,psychosocial stressor,0.3933196962529684
CCND1,Carcinoma in situ of uterine cervix,0.3933196962529684
CCND1,Disseminated neuroblastoma,0.3933196962529684
CCND1,Anaplasia,0.3938591532700354
CCND1,Anemia,0.3941558617476422
CCND1,Malignant neoplasm of kidney,0.3941558617476422
CCND1,Neoplasm Residual,0.3941558617476422
CCND1,keratoacanthoma,0.3941558617476422
CCND1,Familial multiple trichoepitheliomata,0.3941558617476422
CCND1,Stage 0 Skin Melanoma,0.3941558617476422
CCND1,stage endometrial cancer,0.3941558617476422
CCND1,Epithelioid and spindle cell nevus,0.3941558617476422
CCND1,Pilomatrixoma,0.3941558617476422
CCND1,Renal carcinoma,0.3941558617476422
CCND1,Thyroid carcinoma,0.3941558617476422
CCND1,androgen independent prostate cancer,0.3941558617476422
CCND1,Pituitary Adenoma,0.3941558617476422
CCND1,Ki-1+ Anaplastic Large Cell Lymphoma,0.3941558617476422
CCND1,Drug abuse,0.3941558617476422
CCND1,Pituitary Neoplasms,0.3941558617476422
CCND1,Lymphocytic infiltration,0.3941558617476422
CCND1,Malignant neoplasm of brain,0.3941558617476422
CCND1,Serum creatinine raised,0.3941558617476422
CCND1,Nevus Blue,0.3941558617476422
CCND1,extranodal lymphoma,0.3941558617476422
CCND1,HYPERPARATHYROIDISM 3,0.3941558617476422
CCND1,Malignant tumor of parathyroid gland,0.3941558617476422
CCND1,Alcohol abuse,0.39623320406434
CCND1,Hyperparathyroidism Primary,0.39623320406434
CCND1,Waldenstrom Macroglobulinemia,0.3975960596292668
CCND1,Fibrosis,0.3975960596292668
CCND1,Senile Plaques,0.3975960596292668
CCND1,Luminal A Breast Carcinoma,0.3975960596292668
CCND1,Bone pain,0.3975960596292668
CCND1,Lymphoma Lymphocytic Intermediate,0.3975960596292668
CCND1,hyperparathyroid,0.3975960596292668
CCND1,HYPERPARATHYROIDISM 1,0.3975960596292668
CCND1,Papillary Thyroid Microcarcinoma,0.3975960596292668
CCND1,Multiple Endocrine Neoplasia Type 1,0.3986414839122469
CCND1,HER2 gene amplification,0.4028066164685291
CCND1,Merkel cell carcinoma,0.4028066164685291
CCND1,Pituitary Diseases,0.4028066164685291
CCND1,Meningioma benign no ICD-O subtype,0.4028066164685291
CCND1,Kidney Failure Acute,0.4028066164685291
CCND1,Mammary Tumorigenesis,0.4028066164685291
CCND1,Neuroectodermal Tumor Primitive,0.4028066164685291
CCND1,leiomyosarcoma,0.4028066164685291
CCND1,Carcinoma of larynx,0.4028066164685291
CCND1,Hemoglobin low,0.4028066164685291
CCND1,Intrahepatic Cholangiocarcinoma,0.4028066164685291
CCND1,Gastric Adenocarcinoma,0.4028066164685291
CCND1,Carcinoma of Male Breast,0.4028066164685291
CCND1,Liver Neoplasms Experimental,0.4100742336915555
CCND1,Experimental Hepatoma,0.4100742336915555
CCND1,Fibromatosis Aggressive,0.4100901006059349
CCND1,Squamous cell carcinoma of mouth,0.4100901006059349
CCND1,AICARDI-GOUTIERES SYNDROME 1,0.4100901006059349
CCND1,Splenomegaly,0.4103119460235835
CCND1,Acute myocardial infarction,0.4103119460235835
CCND1,Agenesis of corpus callosum,0.4103119460235835
CCND1,Multiple Myeloma,0.4103119460235835
CCND1,Nephrotic Syndrome,0.4103119460235835
CCND1,Trisomy 11,0.4103119460235835
CCND1,Hypochondroplasia (disorder),0.4103119460235835
CCND1,Anxiety,0.4115056600660309
CCND1,Hepatoma Novikoff,0.4115056600660309
CCND1,Retinoblastoma,0.4115056600660309
CCND1,MYELOPROLIFERATIVE SYNDROME TRANSIENT,0.4115056600660309
CCND1,Ulcer,0.4115056600660309
CCND1,Phyllodes Tumor,0.4115056600660309
CCND1,Hepatoma Morris,0.4115056600660309
CCND1,Leukemia Prolymphocytic B-Cell,0.4115056600660309
CCND1,Triglyceride storage disease with ichthyosis,0.4115056600660309
CCND1,Group B streptococcal pneumonia,0.4115056600660309
CCND1,Malignant melanoma of ciliary body,0.4115056600660309
CCND1,Metaphyseal chondrodysplasia,0.4115056600660309
CCND1,Nevi and Melanomas,0.4115056600660309
CCND1,Familial Alzheimer Disease (FAD),0.4126392832024548
CCND1,Malignant Peripheral Nerve Sheath Tumor,0.4126392832024548
CCND1,Down Syndrome,0.4126392832024548
CCND1,Adenoma of large intestine,0.4126392832024548
CCND1,Melanocytic nevus of skin,0.4126392832024548
CCND1,HYPERTRICHOSIS CONGENITAL GENERALIZED,0.4126392832024548
CCND1,Benign neurologic neoplasms,0.4126392832024548
CCND1,Lepidic Predominant Adenocarcinoma,0.4126392832024548
CCND1,premalignant lesion,0.4126392832024548
CCND1,stage non-small cell lung cancer,0.4186011760974318
CCND1,SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,0.4192169590514327
CCND1,Mature B-Cell Non-Hodgkin Lymphoma,0.4192169590514327
CCND1,Malignant neoplasm of larynx,0.4192169590514327
CCND1,Refractory anemias,0.421267417774367
CCND1,Immunologic Deficiency Syndromes,0.4213286052188015
CCND1,Malignant neoplasm of salivary gland,0.4213286052188015
CCND1,Mouth Neoplasms,0.4213286052188015
CCND1,Smoldering myeloma,0.4213286052188015
CCND1,Coxsackievirus Infections,0.4213286052188015
CCND1,Hyperlipoproteinemia Type I,0.4213286052188015
CCND1,Papillomatosis,0.4213286052188015
CCND1,Malignant neoplasm of mouth,0.4213286052188015
CCND1,Rhabdoid Tumor,0.425419812815905
CCND1,Splenic Marginal Zone B-Cell Lymphoma,0.425419812815905
CCND1,Melanocytic nevus,0.425419812815905
CCND1,Mycoses,0.425419812815905
CCND1,Neurilemmoma,0.425419812815905
CCND1,Benign melanocytic nevus,0.425419812815905
CCND1,Papilloma Squamous Cell,0.425419812815905
CCND1,Apert syndrome,0.425419812815905
CCND1,Carcinoma of extrahepatic bile duct,0.425419812815905
CCND1,Parathyroid hyperplasia,0.425419812815905
CCND1,Papilloma,0.425992946703162
CCND1,Follicular adenoma,0.4269926086051838
CCND1,Rectal Carcinoma,0.429029854971378
CCND1,Squamous cell carcinoma of skin,0.4297858918260954
CCND1,Marginal Zone B-Cell Lymphoma,0.4304973629098372
CCND1,Solitary fibrous tumor,0.4304973629098372
CCND1,Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type,0.4304973629098372
CCND1,Vulval intraepithelial neoplasia,0.4304973629098372
CCND1,Carcinoma ex pleomorphic adenoma,0.4304973629098372
CCND1,malignant neoplasm of breast staging,0.4304973629098372
CCND1,Malignant neoplasm of thyroid,0.4307603335611732
CCND1,Adenocarcinoma of pancreas,0.4325044517055656
CCND1,Breast Fibrocystic Disease,0.4330362522463816
CCND1,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.4330362522463816
CCND1,Trisomy,0.4335751357405352
CCND1,Germ cell tumor,0.4335751357405352
CCND1,Neurofibromatosis 1,0.4335751357405352
CCND1,Early-Stage Breast Carcinoma,0.4335751357405352
CCND1,Squamous cell carcinoma of lung,0.4335751357405352
CCND1,Oncocytoma renal,0.4335751357405352
CCND1,Fibrolamellar Hepatocellular Carcinoma,0.4335751357405352
CCND1,Nodular Goiter,0.4335751357405352
CCND1,Peripheral Vascular Diseases,0.4396723023384634
CCND1,Meningioma,0.4396723023384634
CCND1,Squamous cell carcinoma of tonsil,0.4396723023384634
CCND1,Pancreatic carcinoma familial,0.4396723023384634
CCND1,Fibromyxosarcoma,0.4396723023384634
CCND1,Adenocarcinoma of prostate,0.4421745246585178
CCND1,Luminal B Breast Carcinoma,0.4459714599189374
CCND1,Monosomy,0.4459714599189374
CCND1,Squamous Cell Neoplasms,0.4459714599189374
CCND1,Superficial spreading malignant melanoma of skin,0.4459714599189374
CCND1,Hemimegalencephaly,0.4459714599189374
CCND1,Peptic Ulcer,0.4459714599189374
CCND1,Precancerous Conditions,0.4479115285676636
CCND1,Salivary Gland Neoplasms,0.4506578937113162
CCND1,Malignant neoplasm of tongue,0.4506578937113162
CCND1,Status Epilepticus,0.4506578937113162
CCND1,Myocardial Ischemia,0.4506578937113162
CCND1,Lymphoma Large-Cell Follicular,0.4506578937113162
CCND1,Gardner Syndrome,0.4506578937113162
CCND1,Ovarian Diseases,0.4506578937113162
CCND1,Cicatrix Hypertrophic,0.4564472886428772
CCND1,Malignant lymphoma - lymphoplasmacytic,0.4564472886428772
CCND1,leukemia,0.4588513406515081
CCND1,Generalized muscle weakness,0.4615352570710579
CCND1,Cyclic neutropenia,0.4615352570710579
CCND1,Malignant neoplasm of skin,0.466957409863091
CCND1,Intestinal Neoplasms,0.4675904598629673
CCND1,Cardiovascular Diseases,0.4675904598629673
CCND1,Promyelocytic leukemia,0.4675904598629673
CCND1,Hereditary Leiomyomatosis and Renal Cell Cancer,0.4675904598629673
CCND1,Premenopausal breast cancer,0.4675904598629673
CCND1,Primary amyloidosis,0.4675904598629673
CCND1,Cardiomyopathy Familial Idiopathic,0.4704594475773637
CCND1,Weight decreased,0.472444704048021
CCND1,Uveal melanoma,0.472444704048021
CCND1,Myeloid Leukemia Chronic,0.472444704048021
CCND1,Plasma cell dyscrasia,0.472444704048021
CCND1,Adenomatous Polyposis Coli,0.4749780675672355
CCND1,Acute kidney injury,0.4753011022966241
CCND1,XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP C,0.4753011022966241
CCND1,Lymphoid hyperplasia,0.4753011022966241
CCND1,Transitional cell carcinoma of bladder,0.4790179402069343
CCND1,Thymic Carcinoma,0.4790179402069343
CCND1,TUBEROUS SCLEROSIS 2 (disorder),0.4790179402069343
CCND1,Lymphoid neoplasm,0.4790179402069343
CCND1,Kaposi Sarcoma,0.4851378030288289
CCND1,ESTROGEN RESISTANCE,0.4852430673532381
CCND1,Plasma Cell Neoplasm,0.4852430673532381
CCND1,Steatohepatitis,0.4906258721078565
CCND1,Hyperglycemia,0.4906258721078565
CCND1,Osteopenia,0.4923669467696064
CCND1,Epithelial hyperplasia,0.4923669467696064
CCND1,Anaplastic thyroid carcinoma,0.4952592576151974
CCND1,Richter's syndrome,0.4981941174985421
CCND1,Parathyroid Gland Adenocarcinoma,0.4981941174985421
CCND1,Metastatic melanoma,0.5001612228394569
CCND1,Ulcerative Colitis,0.5001612228394569
CCND1,Neuroendocrine Tumors,0.5017066790423467
CCND1,Deficiency of glucose-6-phosphate dehydrogenase,0.5019670090704682
CCND1,Chronic Obstructive Airway Disease,0.5049674142533507
CCND1,Obesity,0.5140447474168605
CCND1,ACTH-Secreting Pituitary Adenoma,0.5140447474168605
CCND1,Adenocarcinoma of lung (disorder),0.51550637274795
CCND1,Keratosis,0.5188223685230745
CCND1,Ewings sarcoma,0.5251317541886066
CCND1,Carcinoma Cribriform,0.5337853752290136
CCND1,Carcinoma Granular Cell,0.5337853752290136
CCND1,Pancreatic intraepithelial neoplasia,0.5337853752290136
CCND1,Laryngeal neoplasm,0.5337853752290136
CCND1,Monoclonal B-Cell Lymphocytosis,0.5337853752290136
CCND1,Lymphoma Follicular,0.533913711453195
CCND1,Hepatocarcinogenesis,0.533913711453195
CCND1,Fatty Liver,0.533913711453195
CCND1,Condition Preneoplastic,0.533913711453195
CCND1,Adenocarcinoma Basal Cell,0.5359212109443033
CCND1,Carcinoma Small Cell,0.5359212109443033
CCND1,Leukemia B-Cell,0.5359212109443033
CCND1,Tuberous Sclerosis,0.5359212109443033
CCND1,Erectile dysfunction,0.5393787854381349
CCND1,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
CCND1,Sarcoma Epithelioid,0.5393787854381349
CCND1,Cardiac Arrest,0.5453394612016188
CCND1,Adenocarcinoma Oxyphilic,0.549941235475765
CCND1,Leukemia Plasma Cell,0.549941235475765
CCND1,Liposarcoma Dedifferentiated,0.549941235475765
CCND1,Endometrial Stromal Sarcoma,0.549941235475765
CCND1,Hyperplasia,0.5514573300659174
CCND1,Thymoma,0.5523521032803237
CCND1,Adult Diffuse Large B-Cell Lymphoma,0.553002957824355
CCND1,Childhood Diffuse Large B-Cell Lymphoma,0.553002957824355
CCND1,Adenocarcinoma Tubular,0.5557519470957561
CCND1,Peripheral Arterial Diseases,0.5557519470957561
CCND1,Ataxia,0.5568517196017908
CCND1,Colorectal cancer metastatic,0.5568517196017908
CCND1,Metabolic Syndrome X,0.5568517196017908
CCND1,Hemangioblastoma,0.5568517196017908
CCND1,Hyperparathyroidism,0.5568517196017908
CCND1,Kidney damage,0.5568517196017908
CCND1,liposarcoma,0.5655222348249326
CCND1,Female Breast Carcinoma,0.5655222348249326
CCND1,Multiple Endocrine Neoplasia,0.5655222348249326
CCND1,Aortic Valve Insufficiency,0.5683976277847906
CCND1,Hereditary Diffuse Gastric Cancer,0.5696906826730043
CCND1,Lymphoproliferative Disorders,0.5696906826730043
CCND1,Neoplastic Cell Transformation,0.5696906826730043
CCND1,Atypical Ductal Breast Hyperplasia,0.5696906826730043
CCND1,Carcinosarcoma,0.5696906826730043
CCND1,Erythroblastosis,0.5696906826730043
CCND1,Giant Cell Tumors,0.5696906826730043
CCND1,Cutaneous Melanoma,0.5710095678317721
CCND1,precancerous lesions,0.5710095678317721
CCND1,Breast Diseases,0.5710095678317721
CCND1,Malignant neoplasm of female breast,0.5710095678317721
CCND1,Cerebellar Ataxia,0.5754799679683854
CCND1,Decreased antibody level in blood,0.5768212166102149
CCND1,Invasive Lobular Breast Carcinoma,0.5768212166102149
CCND1,Interstitial Cystitis,0.582492855487907
CCND1,Diffuse Large B-Cell Lymphoma,0.5913651925298382
CCND1,Laryngeal Diseases,0.5956632182199403
CCND1,Parathyroid Neoplasms,0.5956632182199403
CCND1,Pituitary-dependent Cushing's disease,0.5956632182199403
CCND1,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.6002127202571572
CCND1,Malignant neoplasm of colon stage IV,0.6002127202571572
CCND1,Ductal Carcinoma,0.6002127202571572
CCND1,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.6035970790768342
CCND1,Congenital chromosomal disease,0.6035970790768342
CCND1,Precursor cell lymphoblastic lymphoma,0.6196470808426647
CCND1,Sezary Syndrome,0.6248356417853507
CCND1,Lymphocytosis,0.6274540883972485
CCND1,Tongue Carcinoma,0.6319938293757544
CCND1,Sporadic Breast Carcinoma,0.6332132835539771
CCND1,Persistent infection,0.6355866602993508
CCND1,Leukoplakia Oral,0.6447029562500783
CCND1,invasive cancer,0.652707626880454
CCND1,Familial primary gastric lymphoma,0.652707626880454
CCND1,Retinal Diseases,0.655573080043894
CCND1,ECTRODACTYLY ECTODERMAL DYSPLASIA AND CLEFT LIP/PALATE SYNDROME 1,0.655573080043894
CCND1,Acoustic Neuroma,0.6588479076808555
CCND1,Fever,0.6677140893034832
CCND1,Leukemia T-Cell,0.6691893635307453
CCND1,Prostatic Intraepithelial Neoplasias,0.6693434807212948
CCND1,Mucosa-Associated Lymphoid Tissue Lymphoma,0.6740259274935673
CCND1,Neoplasms Experimental,0.6841967398409226
CCND1,Hypogammaglobulinemia,0.6959870102453846
CCND1,Hashimoto Disease,0.6962828901009075
CCND1,polyps,0.6974821940437801
CCND1,Nevus,0.701831040553294
CCND1,Hemophilia A,0.7068844070911514
CCND1,Lymphadenopathy,0.7129583530027284
CCND1,Coronary Artery Disease,0.7240930522443176
CCND1,Leukoencephalopathy Progressive Multifocal,0.7511652060995492
CCND1,Plasmacytoma,0.7651930135295156
CCND1,Fatigue,0.7658980225613361
CCND1,Anorexia,0.7796824214131131
CCND1,Familial M??ni??re disease,0.7961936196098257
CCND1,Thyroid Gland Follicular Adenoma,0.8148412516612868
CCND1,Hyperinsulinism,0.8245140009975604
CCND1,Mycosis Fungoides,0.827626149232917
CCND1,Hepatitis C Chronic,0.8343509960860942
CCND1,Adult T-Cell Lymphoma/Leukemia,0.8367216325123092
CCND1,Monoclonal Gammopathy of Undetermined Significance,0.839057838231319
CCND1,Dwarfism,0.8405066264419017
CCND1,Familial lichen amyloidosis,0.8441962785769224
CCND1,Breast Carcinoma,0.0075861267486594
CCND1,Esophagus Neoplasm,0.0102679590519094
CCND1,Urinary Tract Cancer,0.0102679590519094
CCND1,Marfan Syndrome,0.0133304506157067
CCND1,Mammary Neoplasms,0.0155248163763686
CCND1,Anaplastic Carcinoma,0.0402286636010764
CCND1,Breast Cancer,0.0402286636010764
CCND1,Lymphocytic Leukemia,0.0487679768343083
CCND1,Liver Carcinoma,0.0520696613701797
CCND1,Schizophrenia,0.0531117779464085
CCND1,Carcinoma,0.0534520155998091
CCND1,Urologic Neoplasms,0.0839188440969517
CCND1,Brain Neoplasms,0.1534453668959814
CCND1,Intracranial Neoplasm,0.2038801271174535
CCND1,Nasopharyngeal Carcinoma,0.2278592962769385
CCND1,Kidney Cancer,0.3094716280561038
CCND1,Kidney Neoplasm,0.336287627428424
CCND1,Polycythemia,0.3528591516609595
CCND1,Endometrial Carcinoma,0.4286813331685578
CCND1,Amyloidosis,0.4286813331685578
CCND1,Carcinoma Of The Head And Neck,0.4286813331685578
CCND1,Colorectal Cancer,0.4286813331685578
CCND1,Papillary Cystadenoma Of The Epididymis,0.4286813331685578
CCND1,Lung Cancer,0.4402141802500753
CCND1,Cervical Cancer,0.4402141802500753
CCND1,Renal Carcinoma,0.4541466895915311
CCND1,Paraproteinemia,0.4541466895915311
CCND1,Uterine Cervix Neoplasm,0.4541466895915311
CCND1,Lung Neoplasms,0.4560460337187313
CCND1,Osteopenia,0.4560460337187313
CCND1,Multiple Myeloma,0.4560460337187313
CCND1,Mental Depression,0.4560460337187313
CCND1,Lymphoma Lymphocytic Intermediate,0.4560460337187313
CCND1,Papillomatosis,0.4560460337187313
CCND1,Myocardial Ischemia,0.4560460337187313
CCND1,Hypercalcemia,0.4560460337187313
CCND1,Capillary Hemangioma Of Retina,0.4560460337187313
CCND1,Hypertension,0.4560460337187313
CCND1,Malignant Lymphoma Lymphocytic Intermediate Differentiation,0.4646409362700993
CCND1,Spinal Cord Compression,0.4646409362700993
CCND1,Melanoma,0.4646409362700993
CCND1,Paraganglioma,0.4723647227028846
CCND1,Hemangiosarcoma,0.4723647227028846
CCND1,Liver Cancer,0.4723647227028846
CCND1,Anemia,0.4780231573499264
CCND1,Adenocarcinoma,0.4780231573499264
CCND1,Colonic Neoplasms,0.4809179010794786
CCND1,Pheochromocytoma,0.4867879381749835
CCND1,Pancreatic Cyst,0.4875380732267193
CCND1,Prostatic Neoplasms,0.4875380732267193
CCND1,Endometrial Neoplasms,0.4931425946912698
CCND1,Hyperparathyroidism,0.504364324740411
CCND1,Papilloma,0.5127628024019304
CCND1,Liver Neoplasms,0.5129298662020659
CCND1,B-Cell Lymphoma,0.5576425853515448
CCND1,Hearing Loss,0.5632819212593052
CCND1,Multiple Renal Cysts,0.5681293104170607
CCND1,Malignant Neoplasm Of Salivary Gland,0.5940503504528969
CCND1,Malignant Neoplasm,0.5973360026714207
CCND1,Prostate Cancer,0.6104715460837368
CCND1,Thyroid Gland Follicular Adenoma,0.6198254949034767
CCND1,Salivary Gland Neoplasm,0.6252040071965056
CCND1,Kidney Disease,0.6420878824691651
CCND1,Pancreatic Neoplasm,0.6508151871447407
CCND1,Pleural Effusion,0.6508151871447407
CCND1,Gastric Cancer,0.6524705037929849
CCND1,Thyroid Neoplasm,0.6524705037929849
CCND1,Stomach Neoplasms,0.669817442578862
CCND1,Leukemia,0.7167438233451096
CCND1,Thyroid Carcinoma,0.7414460416900516
CCND1,Anorexia,0.8373515856057342
CCND1,Nephrotic Syndrome,0.8825528876115188
CCND1,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
CCND1,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
CCND1,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
CCND1,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
CCND1,Chondrosarcoma ORPHA:55880,0.0083045131203191
CCND1,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
CCND1,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
CCND1,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
CCND1,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
CCND1,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
CCND1,Axenfeld anomaly ORPHA:98978,0.0083045131203191
CCND1,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
CCND1,Rieger anomaly ORPHA:91483,0.0083045131203191
CCND1,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
CCND1,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
CCND1,Bruck syndrome ORPHA:2771,0.0180064224283883
CCND1,CHST3-related skeletal dysplasia ORPHA:263463,0.0180064224283883
CCND1,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.0180064224283883
CCND1,Craniosynostosis Boston type ORPHA:1541,0.0180064224283883
CCND1,Hereditary papillary renal cell carcinoma ORPHA:47044,0.0180064224283883
CCND1,Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303,0.0180064224283883
CCND1,Osteofibrous dysplasia ORPHA:488265,0.0180064224283883
CCND1,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.0180064224283883
CCND1,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.0180064224283883
CCND1,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.0180064224283883
CCND1,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.0180064224283883
CCND1,X-linked osteoporosis with fractures ORPHA:391330,0.0180064224283883
CCND1,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.0180064224283883
CCND1,Dermatofibrosarcoma protuberans ORPHA:31112,0.0180064224283883
CCND1,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.0180064224283883
CCND1,Pediatric hepatocellular carcinoma ORPHA:33402,0.0180064224283883
CCND1,BOR syndrome ORPHA:107,0.0183145313768111
CCND1,Multiple osteochondromas ORPHA:321,0.0586579655822394
CCND1,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.0586579655822394
CCND1,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.0586579655822394
CCND1,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.0586579655822394
CCND1,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.0586579655822394
CCND1,Kuskokwim syndrome ORPHA:1149,0.0586579655822394
CCND1,Microphthalmia with brain and digit anomalies ORPHA:139471,0.0586579655822394
CCND1,Juvenile Paget disease ORPHA:2801,0.0586579655822394
CCND1,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.0586579655822394
CCND1,ABeta amyloidosis Arctic type ORPHA:324723,0.1590470395003315
CCND1,ABeta amyloidosis Dutch type ORPHA:100006,0.1590470395003315
CCND1,ABeta amyloidosis Iowa type ORPHA:324708,0.1590470395003315
CCND1,ABeta amyloidosis Italian type ORPHA:324713,0.1590470395003315
CCND1,ABetaA21G amyloidosis ORPHA:324718,0.1590470395003315
CCND1,ABetaL34V amyloidosis ORPHA:324703,0.1590470395003315
CCND1,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.1590470395003315
CCND1,Branchio-oculo-facial syndrome ORPHA:1297,0.1590470395003315
CCND1,Campomelic dysplasia ORPHA:140,0.1590470395003315
CCND1,Carvajal syndrome ORPHA:65282,0.1590470395003315
CCND1,Dyssegmental dysplasia Silverman-Handmaker type ORPHA:1865,0.1590470395003315
CCND1,Endosteal hyperostosis Worth type ORPHA:2790,0.1590470395003315
CCND1,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.1590470395003315
CCND1,Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561,0.1590470395003315
CCND1,Isolated Pierre Robin syndrome ORPHA:718,0.1590470395003315
CCND1,LRP5-related primary osteoporosis ORPHA:498481,0.1590470395003315
CCND1,Multiple myeloma ORPHA:29073,0.1590470395003315
CCND1,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.1590470395003315
CCND1,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.1590470395003315
CCND1,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012,0.1590470395003315
CCND1,Schwartz-Jampel syndrome ORPHA:800,0.1590470395003315
CCND1,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.1590470395003315
CCND1,Autosomal recessive hypophosphatemic rickets ORPHA:289176,0.1590470395003315
CCND1,Hyperostosis corticalis generalisata ORPHA:3416,0.1590470395003315
CCND1,Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067,0.1590470395003315
CCND1,Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659,0.1590470395003315
CCND1,Partial atrioventricular septal defect ORPHA:1330,0.1590470395003315
CCND1,Retinopathy of prematurity ORPHA:90050,0.1590470395003315
CCND1,Epithelioid hemangioendothelioma ORPHA:157791,0.1614487935928034
CCND1,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.3762014630157917
CCND1,Atelosteogenesis type I ORPHA:1190,0.3762014630157917
CCND1,Atelosteogenesis type III ORPHA:56305,0.3762014630157917
CCND1,Autosomal spastic paraplegia type 58 ORPHA:397946,0.3762014630157917
CCND1,Boomerang dysplasia ORPHA:1263,0.3762014630157917
CCND1,Craniofacial dysplasia-osteopenia syndrome ORPHA:314555,0.3762014630157917
CCND1,Frank-Ter Haar syndrome ORPHA:137834,0.3762014630157917
CCND1,Isolated biliary atresia ORPHA:30391,0.3762014630157917
CCND1,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.3762014630157917
CCND1,Larsen syndrome ORPHA:503,0.3762014630157917
CCND1,Legius syndrome ORPHA:137605,0.3762014630157917
CCND1,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.3762014630157917
CCND1,Pierson syndrome ORPHA:2670,0.3762014630157917
CCND1,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.3762014630157917
CCND1,Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068,0.3762014630157917
CCND1,Aplasia cutis congenita ORPHA:1114,0.3775879467205478
CCND1,Familial exudative vitreoretinopathy ORPHA:891,0.3900898302534297
CCND1,Early-onset posterior polar cataract ORPHA:98993,0.4045231980457672
CCND1,Giant cell glioblastoma ORPHA:251579,0.433039750392822
CCND1,Gliosarcoma ORPHA:251576,0.433039750392822
CCND1,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333,0.6239678957896782
CCND1,Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937,0.6239678957896782
CCND1,Autosomal dominant brachyolmia ORPHA:93304,0.6239678957896782
CCND1,Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216,0.6239678957896782
CCND1,Dent disease type 2 ORPHA:93623,0.6239678957896782
CCND1,Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594,0.6239678957896782
CCND1,Familial digital arthropathy-brachydactyly ORPHA:85169,0.6239678957896782
CCND1,Familial hypocalciuric hypercalcemia type 2 ORPHA:101049,0.6239678957896782
CCND1,LAMA5-related multisystemic syndrome ORPHA:521450,0.6239678957896782
CCND1,Metatropic dysplasia ORPHA:2635,0.6239678957896782
CCND1,Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997,0.6239678957896782
CCND1,Muscular dystrophy Selcen type ORPHA:199340,0.6239678957896782
CCND1,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.6239678957896782
CCND1,Oculocerebrorenal syndrome of Lowe ORPHA:534,0.6239678957896782
CCND1,Parastremmatic dwarfism ORPHA:2646,0.6239678957896782
CCND1,Phakomatosis cesiomarmorata ORPHA:79484,0.6239678957896782
CCND1,Scapuloperoneal spinal muscular atrophy ORPHA:431255,0.6239678957896782
CCND1,Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298,0.6239678957896782
CCND1,Spondyloepiphyseal dysplasia Maroteaux type ORPHA:263482,0.6239678957896782
CCND1,Spondylometaphyseal dysplasia Kozlowski type ORPHA:93314,0.6239678957896782
CCND1,Vein of Galen aneurysmal malformation ORPHA:1053,0.6239678957896782
CCND1,Wolfram-like syndrome ORPHA:411590,0.6239678957896782
CCND1,Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359,0.6239678957896782
CCND1,Periventricular nodular heterotopia ORPHA:98892,0.639029370164481
CCND1,B-cell chronic lymphocytic leukemia ORPHA:67038,0.6581690778726346
CCND1,Atypical Werner syndrome ORPHA:79474,0.7068064785325423
CCND1,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.7068064785325423
CCND1,Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855,0.7068064785325423
CCND1,Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365,0.7068064785325423
CCND1,Charcot-Marie-Tooth disease type 2B1 ORPHA:98856,0.7068064785325423
CCND1,Congenital hereditary endothelial dystrophy type II ORPHA:293603,0.7068064785325423
CCND1,Congenital muscular dystrophy due to LMNA mutation ORPHA:157973,0.7068064785325423
CCND1,Corneal dystrophy-perceptive deafness syndrome ORPHA:1490,0.7068064785325423
CCND1,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229,0.7068064785325423
CCND1,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751,0.7068064785325423
CCND1,Familial partial lipodystrophy Dunnigan type ORPHA:2348,0.7068064785325423
CCND1,Familial partial lipodystrophy Kobberling type ORPHA:79084,0.7068064785325423
CCND1,Heart-hand syndrome Slovenian type ORPHA:168796,0.7068064785325423
CCND1,LMNA-related cardiocutaneous progeria syndrome ORPHA:363618,0.7068064785325423
CCND1,Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153,0.7068064785325423
CCND1,Hutchinson-Gilford progeria syndrome ORPHA:740,0.7068064785325423
CCND1,Restrictive dermopathy ORPHA:1662,0.7068064785325423
CCND1,Mantle cell lymphoma ORPHA:52416,0.7068064785325423
CCND1,Osteogenesis imperfecta ORPHA:666,0.7068064785325423
CCND1,Trichodysplasia spinulosa-associated polyomavirus large T antigen (gene: T),0.6362779693488597
CCND1,Human polyomavirus 10 large T Antigen,0.6362779693488597
CCND1,WU Polyomavirus large T antigen,0.6362779693488597
CCND1,Yaba-like disease virus 142R protein (gene: 142R),0.6362779693488597
CCND1,Vaccinia virus ser/thr kinase (gene: B1R),0.6362779693488597
CCND1,Vaccinia virus Ankara Serine/threonine-protein kinase,0.6362779693488597
CCND1,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.6362779693488597
CCND1,Human polyomavirus 6 large T antigen,0.6362779693488597
CCND1,Human polyomavirus 9 large T antigen,0.6362779693488597
CCND1,Human polyomavirus IPPyV large T antigen protein (gene: large T antigen),0.6362779693488597
CCND1,BK polyomavirus large T antigen,0.6362779693488597
CCND1,Variola virus hypothetical protein (gene: B1R),0.6362779693488597
CCND1,Monkeypox virus ser/thr protein kinase-like protein,0.6362779693488597
CCND1,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.6362779693488597
CCND1,Banna virus strain JKT-6423 Vp7,0.6362779693488597
CCND1,Monkeypox virus Zaire-96-I-16 B11R (gene: B11R),0.6362779693488597
CCND1,MW polyomavirus large T antigen,0.6362779693488597
CCND1,MX polyomavirus large T-antigen,0.6362779693488597
CCND1,Horsepox virus HSPV189 (Serine/threonine protein kinase),0.6362779693488597
CCND1,JC polyomavirus hypothetical protein,0.664689610422691
CCND1,Orf virus ORF130 putative serine/threonine protein kinase,0.6761714078632568
CCND1,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.691145768348025
CCND1,Vaccinia virus ser/thr protein kinase-like protein (gene: B12R),0.6920622798772148
CCND1,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.6980058392556946
CCND1,KI polyomavirus Stockholm 350 large T antigen,0.7054555693277184
CCND1,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.7108466056279036
CCND1,KI polyomavirus large T antigen,0.7108466056279036
CCND1,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.7553529087917877
CCND1,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.7975886343350181
CCND1,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8090912655264054
CCND1,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8090912655264054
CCND1,Human gammaherpesvirus 8 ORF72,0.8164631368980444
CCND1,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8400145987535752
CCND1,Yaba monkey tumor virus 142R,0.8412554142619568
CCND1,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8458935424065495
CCND1,Ectromelia virus ERPV serine/threonine kinase,0.8567113603862105
CCND1,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8623814598290633
CCND1,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8826243651582266
CCND1,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.9049668877841942
CCND1,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.9320456693098416
CCND1,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.93590945176733
CCND1,Monkeypox virus ser/thr kinase,0.960637237597315
CCND1,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.9621839893030432
CCND1,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.9621839893030432
CCND1,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.9621839893030432
CCND1,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.9621839893030432
CCND1,Human herpesvirus 4 type 2 BGLF4,0.9621839893030432
CCND1,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.9624639844306644
CCND1,Horsepox virus HSPV050 (Ser/Thr kinase,0.9624639844306644
CCND1,Provisional),0.9658028592930472
CCND1,Variola virus Ser/Thr kinase (gene: C14L),0.9687365967836944
CCND1,Vaccinia virus Ser/Thr kinase (gene: F10L),0.9782376397065295
CCND1,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.9782376397065295
CCND1,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.978680518510813
CCND1,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.985687915361386
CCND1,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.9867877113290736
CCND1,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.988150003801932
CCND1,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.9886132556795868
CCND1,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.9886132556795868
CCSAP,Christianson syndrome ORPHA:85278,0.3762014630157917
CCSAP,Alkaline ceramidase 3 deficiency ORPHA:502444,0.6239678957896782
CCSAP,Distal 22q11.2 microdeletion syndrome ORPHA:261330,0.7068064785325423
CCSAP,Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065,0.7068064785325423
CD22,Neoplasm Metastasis,0.0648809611869375
CD22,Lymphoma,0.0739788831250619
CD22,Liver carcinoma,0.095319386034013
CD22,Chronic Lymphocytic Leukemia,0.1147307578771389
CD22,Hematologic Neoplasms,0.1253114324938153
CD22,MYELODYSPLASTIC SYNDROME,0.1254380558571286
CD22,Systemic Scleroderma,0.1900258729042946
CD22,Connective Tissue Diseases,0.2139814021986384
CD22,Burkitt Lymphoma,0.2521987644415915
CD22,B-Cell Lymphomas,0.2522264785494494
CD22,Small Lymphocytic Lymphoma,0.2643145809900195
CD22,Malignant neoplasm of lung,0.2714542429024338
CD22,Acute leukemia,0.2835142372342932
CD22,Myeloid Leukemia,0.2980670559114652
CD22,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
CD22,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.3105909001629992
CD22,Hairy Cell Leukemia,0.3412203844672238
CD22,Cutaneous lymphoma,0.3638414818541592
CD22,Carcinoma of lung,0.3663130598151661
CD22,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
CD22,Primary malignant neoplasm of lung,0.3902116649640871
CD22,Chromosome 8 trisomy,0.3925783478421996
CD22,Lymphoma T-Cell Cutaneous,0.3933196962529684
CD22,Lymphoma Non-Hodgkin,0.3933196962529684
CD22,Acute lymphocytic leukemia,0.3933196962529684
CD22,High Grade Lymphoma (neoplasm),0.3933196962529684
CD22,Lymphoid leukemia,0.3933196962529684
CD22,Neoplasm Residual,0.3941558617476422
CD22,Waldenstrom Macroglobulinemia,0.3975960596292668
CD22,Multiple Myeloma,0.4103119460235835
CD22,Hemolytic-Uremic Syndrome,0.4115056600660309
CD22,Mental disorders,0.4126392832024548
CD22,Lupus Erythematosus Systemic,0.4213286052188015
CD22,Splenic Marginal Zone B-Cell Lymphoma,0.425419812815905
CD22,Trisomy,0.4335751357405352
CD22,Monosomy,0.4459714599189374
CD22,Infant Leukemia,0.4506578937113162
CD22,leukemia,0.4588513406515081
CD22,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
CD22,Precursor B-cell lymphoblastic leukemia,0.5451009374855866
CD22,Autoimmune Diseases,0.5512224939896888
CD22,Diffuse Large B-Cell Lymphoma,0.5913651925298382
CD22,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.6035970790768342
CD22,Bullous pemphigoid,0.610971999959321
CD22,Vasculitis,0.8178117518835931
CD22,High density lipoprotein measurement,0.8913309410682808
CD22,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.3762014630157917
CD22,NON RARE IN EUROPE: Immunoglobulin A deficiency ORPHA:69127,0.7068064785325423
CD22,Short stature due to growth hormone qualitative anomaly ORPHA:629,0.7068064785325423
CEACAM19,Breast Carcinoma,0.0042545616049287
CEACAM19,Malignant neoplasm of breast,0.0191435238361999
CEACAM19,Alzheimer Disease,0.4560460337187313
CEACAM19,Molluscum contagiosum virus subtype 1 MC157R (gene: MC157R),0.6362779693488597
CEACAM19,Vaccinia virus Ankara Haemagglutinin,0.6362779693488597
CEACAM19,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
CEACAM19,Human adenovirus 41 E3 31.6K,0.6362779693488597
CEACAM19,Human adenovirus 23 CR1 b protein (gene: E3),0.6362779693488597
CEACAM19,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
CEACAM19,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
CEACAM19,Human gammaherpesvirus 8 K14,0.6386053036162835
CEACAM19,Molluscum contagiosum virus subtype 1 MC162R (gene: MC162R),0.6462089477181691
CEACAM19,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.6621265548536891
CEACAM19,Cercopithecine betaherpesvirus 5 membrane protein RL11M (gene: RL11M),0.6743504588964037
CEACAM19,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.6806291584193672
CEACAM19,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.6806291584193672
CEACAM19,Human alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.6859529108680942
CEACAM19,Horsepox virus HSPV177 (Immunoglobulin like),0.691145768348025
CEACAM19,Cowpox virus CPXV209 protein (gene: CPXV209 CDS),0.6920622798772148
CEACAM19,Human adenovirus 64 E3 48.9 kDa protein,0.7184028158722842
CEACAM19,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.7212352368560536
CEACAM19,Cercopithecine betaherpesvirus 5 membrane protein RL11Q (gene: RL11Q),0.7286961934616806
CEACAM19,Variola virus hypothetical protein (gene: J9R),0.7651942752688915
CEACAM19,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.776311155917498
CEACAM19,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.8071041616616108
CEACAM19,Human betaherpesvirus 5 membrane glycoprotein UL7 (gene: UL7),0.8205168751208474
CEACAM19,Human mastadenovirus A E3 CR1-beta1,0.8285661572509389
CEACAM19,Vaccinia virus IL-beta-binding protein (gene: VACWR-B15R),0.8498604215998952
CEACAM19,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.870986154363754
CEACAM19,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.875442055263636
CEACAM19,Human adenovirus 61 E3 CR1 beta,0.8784689389733535
CEACAM19,Human betaherpesvirus 5 membrane protein UL6 (gene: UL6),0.8826243651582266
CEACAM19,Yaba-like disease virus 141R protein (gene: 141R),0.8884451411763671
CEACAM19,Human betaherpesvirus 5 envelope glycoprotein UL4 (gene: UL4),0.8981524065835117
CEACAM19,Vaccinia virus Ankara Interleukin-1 beta receptor,0.9097056179628632
CEACAM19,Horsepox virus HSPV192 (IL-beta-binding protein,0.9188516474257704
CEACAM19,Provisional),0.920189880588384
CEACAM19,Yaba monkey tumor virus Ig domain OX-2-like protein,0.9353779004188908
CEACAM19,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9353779004188908
CEACAM19,Human mastadenovirus A E3 CR1-alpha1,0.9445347004229157
CEACAM19,Human adenovirus 18 CR1-beta protein (gene: E3),0.9621839893030432
CEACAM19,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.9646199311883896
CEACAM19,Human herpesvirus 4 type 2 BARF1,0.9646199311883896
CEACAM19,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.988150003801932
CENPE,Colorectal Carcinoma,0.0034602840073026
CENPE,Breast Carcinoma,0.0042545616049287
CENPE,Colorectal Cancer,0.0149315928814189
CENPE,melanoma,0.0149315928814189
CENPE,Malignant neoplasm of breast,0.0191435238361999
CENPE,Carcinogenesis,0.0228075668512991
CENPE,Malignant neoplasm of prostate,0.0569142010728473
CENPE,Central neuroblastoma,0.0593779966354549
CENPE,Neuroblastoma,0.0688152422187159
CENPE,Prostate carcinoma,0.0773771948186562
CENPE,Liver carcinoma,0.095319386034013
CENPE,Breast Cancer Familial,0.1602092191314262
CENPE,Carcinoma testes,0.1653491983554358
CENPE,Absent earlobe,0.1735868515093891
CENPE,Testicular Germ Cell Tumor,0.1735868515093891
CENPE,Systemic Scleroderma,0.1900258729042946
CENPE,Seizures,0.2053083986145698
CENPE,Partial or complete agenesis of corpus callosum,0.2062010908869036
CENPE,Partial agenesis of corpus callosum,0.222537307875512
CENPE,Triple Negative Breast Neoplasms,0.2980670559114652
CENPE,Glaucoma,0.3105909001629992
CENPE,Round face,0.3706856725676674
CENPE,Round full face,0.3706856725676674
CENPE,Recurrent tumor,0.383941725017158
CENPE,Abnormality of the skull,0.3933196962529684
CENPE,Chronic myeloproliferative disorder,0.3933196962529684
CENPE,Fetal Growth Retardation,0.3933196962529684
CENPE,Metaphyseal sclerosis,0.3933196962529684
CENPE,Defective tooth enamel,0.3933196962529684
CENPE,Dystrophic tooth enamel,0.3933196962529684
CENPE,Infant Small for Gestational Age,0.3933196962529684
CENPE,Intrauterine retardation,0.3933196962529684
CENPE,Craniosynostosis,0.3933196962529684
CENPE,Cachexia,0.3933196962529684
CENPE,Abnormality of dental enamel,0.3933196962529684
CENPE,Epilepsy,0.3941558617476422
CENPE,Microcephaly,0.3975960596292668
CENPE,Pituitary Diseases,0.4028066164685291
CENPE,Mild global developmental delay,0.4335751357405352
CENPE,Short stature,0.439389586518055
CENPE,Psychomotor retardation mild,0.4396723023384634
CENPE,Sloping forehead,0.4561717689698902
CENPE,Hip Dislocation Congenital,0.4564472886428772
CENPE,Prematurely aged appearance,0.4564472886428772
CENPE,Cortical gyral simplification,0.4615352570710579
CENPE,Curvature of little finger,0.4635211539849193
CENPE,Clinodactyly of the 5th finger,0.4675904598629673
CENPE,Retrusion of lower jaw,0.4753011022966241
CENPE,Decreased projection of lower jaw,0.4753011022966241
CENPE,Decreased projection of mandible,0.4753011022966241
CENPE,Hypoplastic mandible condyle,0.4753011022966241
CENPE,Aplasia/Hypoplasia of the mandible,0.4790179402069343
CENPE,Micrognathism,0.479747709091007
CENPE,Reduced number of teeth,0.4852430673532381
CENPE,Small head,0.4906258721078565
CENPE,Hypoplastic feet,0.4990401620718274
CENPE,Sandal gap,0.5019670090704682
CENPE,Tooth agenesis,0.5019670090704682
CENPE,Seckel syndrome,0.5090214163899865
CENPE,Cone-shaped epiphysis,0.5140447474168605
CENPE,Dull intelligence,0.5300976305939776
CENPE,Low intelligence,0.5300976305939776
CENPE,Joint hyperflexibility,0.5305233935923577
CENPE,Hyperplasia of nose,0.5393787854381349
CENPE,Hypertrophy of nose,0.5393787854381349
CENPE,Large nose,0.5393787854381349
CENPE,Poor school performance,0.5610226870913673
CENPE,Convex nasal ridge,0.5710095678317721
CENPE,Mental deficiency,0.6035970790768342
CENPE,Sparse scalp hair,0.6196470808426647
CENPE,Thin face,0.6222451141623291
CENPE,Narrow face,0.6222451141623291
CENPE,Small hand,0.6274540883972485
CENPE,Mental Retardation,0.6319938293757544
CENPE,Delayed bone age,0.6910672612216457
CENPE,Developmental delay (disorder),0.7096959691931399
CENPE,Downward slant of palpebral fissure,0.7634367398642647
CENPE,Primary microcephaly,0.7756460653898786
CENPE,Impaired cognition,0.8000044931629623
CENPE,Cerebellar Hypoplasia,0.8306551823873084
CENPE,Intellectual Disability,0.8352623613787349
CENPE,Mental impairment,0.8861753047262128
CENPE,Global developmental delay,0.9327689937867868
CENPE,Liver Carcinoma,0.0520696613701797
CENPE,Partial Agenesis Of Corpus Callosum,0.2187610616307245
CENPE,Testicular Neoplasms,0.4286813331685578
CENPE,Craniosynostosis,0.4286813331685578
CENPE,Testicular Germ Cell Tumor,0.4560460337187313
CENPE,Glaucoma,0.4646409362700993
CENPE,Seckel Syndrome,0.4875380732267193
CENPE,Scoliosis,0.4875380732267193
CENPE,Microcephaly,0.5123947823327547
CENPE,Micrognathism,0.5234357475824973
CENPE,Myeloproliferative Disorder,0.5681293104170607
CENPE,Dwarfism,0.5796489603182782
CENPE,Camptodactyly Of Fingers,0.7328159476505643
CENPE,Mental Retardation,0.7729545590606223
CENPE,Impaired Cognition,0.781505274734613
CENPE,Cardiomyopathy,0.8407264689819682
CENPE,Cerebellar Hypoplasia,0.9055059991400024
CENPE,Nystagmus,0.9146877763175152
CENPE,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
CENPE,Hereditary breast cancer ORPHA:227535,0.0106988445340883
CENPE,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.0180064224283883
CENPE,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0180064224283883
CENPE,Filippi syndrome ORPHA:3255,0.0180064224283883
CENPE,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0180064224283883
CENPE,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0180064224283883
CENPE,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0180064224283883
CENPE,Roberts syndrome ORPHA:3103,0.0180064224283883
CENPE,Stromme syndrome ORPHA:506307,0.0180064224283883
CENPE,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.0180064224283883
CENPE,Dedifferentiated liposarcoma ORPHA:99970,0.0183145313768111
CENPE,Well-differentiated liposarcoma ORPHA:99971,0.0183145313768111
CENPE,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.0586579655822394
CENPE,Bloom syndrome ORPHA:125,0.0586579655822394
CENPE,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0586579655822394
CENPE,Microcephaly-micromelia syndrome ORPHA:572768,0.0586579655822394
CENPE,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0586579655822394
CENPE,Primary peritoneal carcinoma ORPHA:168829,0.0586579655822394
CENPE,VACTERL with hydrocephalus ORPHA:3412,0.0586579655822394
CENPE,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0599424746210022
CENPE,Osteosarcoma ORPHA:668,0.0599424746210022
CENPE,Seckel syndrome ORPHA:808,0.0683063362547733
CENPE,Fanconi anemia ORPHA:84,0.0930156564388357
CENPE,Autosomal recessive primary microcephaly ORPHA:2512,0.1026843275212335
CENPE,Combined immunodeficiency with granulomatosis ORPHA:157949,0.1590470395003315
CENPE,Pleomorphic salivary gland adenoma ORPHA:454821,0.1590470395003315
CENPE,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.1590470395003315
CENPE,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.1590470395003315
CENPE,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.1590470395003315
CENPE,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.1590470395003315
CENPE,Jawad syndrome ORPHA:313795,0.1590470395003315
CENPE,Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894,0.1590470395003315
CENPE,Hereditary breast and ovarian cancer syndrome ORPHA:145,0.1936858543871029
CENPE,Familial prostate cancer ORPHA:1331,0.1981653781243822
CENPE,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404,0.3762014630157917
CENPE,Chudley-McCullough syndrome ORPHA:314597,0.3762014630157917
CENPE,Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318,0.3762014630157917
CENPE,ICF syndrome ORPHA:2268,0.3775879467205478
CENPE,Weaver syndrome ORPHA:3447,0.3775879467205478
CENPE,Familial pancreatic carcinoma ORPHA:1333,0.4101640425710954
CENPE,Nephroblastoma ORPHA:654,0.4101640425710954
CENPE,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476,0.6239678957896782
CENPE,Charcot-Marie-Tooth disease type 4B1 ORPHA:99955,0.6239678957896782
CENPE,X-linked intellectual disability Van Esch type ORPHA:163976,0.6239678957896782
CENPE,X-linked reticulate pigmentary disorder ORPHA:85453,0.6239678957896782
CENPE,Neuroendocrine tumor of stomach ORPHA:100075,0.6239678957896782
CENPE,Borjeson-Forssman-Lehmann syndrome ORPHA:127,0.7068064785325423
CENPE,Severe combined immunodeficiency due to DNA-PKcs deficiency ORPHA:317425,0.7068064785325423
CENPE,NON RARE IN EUROPE: FG syndrome phenotypic spectrum ORPHA:323,0.7068064785325423
CENPE,Juvenile myelomonocytic leukemia ORPHA:86834,0.7068064785325423
CENPE,Genetic steroid-resistant nephrotic syndrome ORPHA:656,0.765572103905398
CHST1,Cataract,0.223747154820789
CHST1,Parkinson Disease,0.3933196962529684
CHST1,Bilateral cataracts (disorder),0.4028066164685291
CHST1,Osteochondrodysplasias,0.4561717689698902
CHST1,Female restricted epilepsy with intellectual disability ORPHA:101039,0.1590470395003315
CHST1,46XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563,0.6239678957896782
CHST1,Familial dyskinesia and facial myokymia ORPHA:324588,0.6239678957896782
CHST1,Anterior maxillary protrusion-strabismus-intellectual disability syndrome ORPHA:562559,0.7068064785325423
CHST1,NON RARE IN EUROPE: Dementia with Lewy body ORPHA:1648,0.7068064785325423
CHST11,Ovarian Carcinoma,0.0034602840073026
CHST11,Breast Carcinoma,0.0042545616049287
CHST11,Invasive carcinoma of breast,0.0149002095788623
CHST11,Tumor Progression,0.0149315928814189
CHST11,Malignant neoplasm of breast,0.0191435238361999
CHST11,Malignant neoplasm of ovary,0.0277695594716545
CHST11,Neoplasm Metastasis,0.0648809611869375
CHST11,Degenerative polyarthritis,0.0739788831250619
CHST11,Chronic Lymphocytic Leukemia,0.1147307578771389
CHST11,Costello syndrome (disorder),0.1253114324938153
CHST11,Schizophrenia,0.3933196962529684
CHST11,Calcification of coronary artery,0.6881884194440517
CHST11,Schizophrenia,0.0531117779464085
CHST11,Hypoplasia Of Thumb,0.3094716280561038
CHST11,Scoliosis,0.4875380732267193
CHST11,Brachydactyly,0.6198128018123746
CHST11,Early-onset Lafora body disease ORPHA:324290,0.1590470395003315
CHST11,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670,0.3762014630157917
CHST11,Combined immunodeficiency due to Moesin deficiency ORPHA:504530,0.3762014630157917
CHST11,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972,0.6239678957896782
CHST11,Temtamy preaxial brachydactyly syndrome ORPHA:363417,0.6239678957896782
CHST11,Angiocentric glioma ORPHA:251671,0.6239678957896782
CLSPN,Mammary Neoplasms,0.0034602840073026
CLSPN,Ovarian Carcinoma,0.0034602840073026
CLSPN,Breast Carcinoma,0.0042545616049287
CLSPN,Malignant neoplasm of breast,0.0191435238361999
CLSPN,Carcinogenesis,0.0228075668512991
CLSPN,Neoplasm Metastasis,0.0648809611869375
CLSPN,Malignant Neoplasms,0.0991201145654548
CLSPN,Solid Neoplasm,0.1413782599148022
CLSPN,Breast Cancer Familial,0.1602092191314262
CLSPN,cervical cancer,0.2050045461627939
CLSPN,Malignant tumor of cervix,0.2714542429024338
CLSPN,Malignant neoplasm of lung,0.2714542429024338
CLSPN,Cervix carcinoma,0.2834835531038365
CLSPN,Ataxia Telangiectasia,0.3508665345292502
CLSPN,Metastatic malignant neoplasm to brain,0.3638414818541592
CLSPN,Carcinoma of lung,0.3663130598151661
CLSPN,Primary malignant neoplasm,0.383941725017158
CLSPN,Primary malignant neoplasm of lung,0.3902116649640871
CLSPN,Breast Cancer,0.0402286636010764
CLSPN,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
CLSPN,Hereditary breast cancer ORPHA:227535,0.0106988445340883
CLSPN,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.0180064224283883
CLSPN,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0180064224283883
CLSPN,Filippi syndrome ORPHA:3255,0.0180064224283883
CLSPN,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0180064224283883
CLSPN,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0180064224283883
CLSPN,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0180064224283883
CLSPN,Roberts syndrome ORPHA:3103,0.0180064224283883
CLSPN,Stromme syndrome ORPHA:506307,0.0180064224283883
CLSPN,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.0180064224283883
CLSPN,Dedifferentiated liposarcoma ORPHA:99970,0.0183145313768111
CLSPN,Well-differentiated liposarcoma ORPHA:99971,0.0183145313768111
CLSPN,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.0586579655822394
CLSPN,Bloom syndrome ORPHA:125,0.0586579655822394
CLSPN,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0586579655822394
CLSPN,Microcephaly-micromelia syndrome ORPHA:572768,0.0586579655822394
CLSPN,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0586579655822394
CLSPN,Primary peritoneal carcinoma ORPHA:168829,0.0586579655822394
CLSPN,VACTERL with hydrocephalus ORPHA:3412,0.0586579655822394
CLSPN,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0599424746210022
CLSPN,Osteosarcoma ORPHA:668,0.0599424746210022
CLSPN,Seckel syndrome ORPHA:808,0.0683063362547733
CLSPN,Fanconi anemia ORPHA:84,0.0930156564388357
CLSPN,Autosomal recessive primary microcephaly ORPHA:2512,0.1026843275212335
CLSPN,Pleomorphic salivary gland adenoma ORPHA:454821,0.1590470395003315
CLSPN,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.1590470395003315
CLSPN,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1590470395003315
CLSPN,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.1590470395003315
CLSPN,Denys-Drash syndrome ORPHA:220,0.1590470395003315
CLSPN,Frasier syndrome ORPHA:347,0.1590470395003315
CLSPN,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.1590470395003315
CLSPN,Jawad syndrome ORPHA:313795,0.1590470395003315
CLSPN,Meacham syndrome ORPHA:3097,0.1590470395003315
CLSPN,Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894,0.1590470395003315
CLSPN,Xeroderma pigmentosum variant ORPHA:90342,0.1590470395003315
CLSPN,Li-Fraumeni syndrome ORPHA:524,0.1614487935928034
CLSPN,Ear-patella-short stature syndrome ORPHA:2554,0.1659988674007724
CLSPN,Hereditary breast and ovarian cancer syndrome ORPHA:145,0.1936858543871029
CLSPN,Familial prostate cancer ORPHA:1331,0.1981653781243822
CLSPN,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404,0.3762014630157917
CLSPN,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.3762014630157917
CLSPN,Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318,0.3762014630157917
CLSPN,Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139,0.3762014630157917
CLSPN,ICF syndrome ORPHA:2268,0.3775879467205478
CLSPN,Weaver syndrome ORPHA:3447,0.3775879467205478
CLSPN,Familial pancreatic carcinoma ORPHA:1333,0.4101640425710954
CLSPN,Nephroblastoma ORPHA:654,0.4101640425710954
CLSPN,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.6239678957896782
CLSPN,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476,0.6239678957896782
CLSPN,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.6239678957896782
CLSPN,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome ORPHA:494439,0.6239678957896782
CLSPN,X-linked intellectual disability Van Esch type ORPHA:163976,0.6239678957896782
CLSPN,X-linked reticulate pigmentary disorder ORPHA:85453,0.6239678957896782
CLSPN,Neuroendocrine tumor of stomach ORPHA:100075,0.6239678957896782
CLSPN,Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307,0.6279395134845649
CLSPN,46XX gonadal dysgenesis ORPHA:243,0.6522156347158065
CLSPN,Facial dysmorphism-immunodeficiency-livedo-short stature syndrome ORPHA:352712,0.7068064785325423
CLSPN,Acute myeloid leukemia with t(6,0.7068064785325423
CLSPN,9)(p23,0.7068064785325423
CNTNAP1,Breast Carcinoma,0.0042545616049287
CNTNAP1,Pre B-cell acute lymphoblastic leukemia,0.0189794808441368
CNTNAP1,Carcinogenesis,0.0228075668512991
CNTNAP1,Well Differentiated Oligodendroglioma,0.0617471306652618
CNTNAP1,Flexion contracture of the knee,0.064548079316548
CNTNAP1,Neoplasm Metastasis,0.0648809611869375
CNTNAP1,oligodendroglioma,0.0648809611869375
CNTNAP1,Malignant neoplasm of pancreas,0.0726340460169901
CNTNAP1,Glioma,0.0739788831250619
CNTNAP1,Lymphoma,0.0739788831250619
CNTNAP1,Pancreatic carcinoma,0.0745502070959292
CNTNAP1,Adult Acute Lymphocytic Leukemia,0.0919714360040484
CNTNAP1,Hematologic Neoplasms,0.1253114324938153
CNTNAP1,MYELODYSPLASTIC SYNDROME,0.1254380558571286
CNTNAP1,Chronic leukemia (category),0.1653491983554358
CNTNAP1,Leukemia Myeloid Chronic-Phase,0.1662487420178625
CNTNAP1,Acute leukemia,0.2835142372342932
CNTNAP1,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
CNTNAP1,Blast Phase,0.3494455519738624
CNTNAP1,Leukemogenesis,0.3510063969122338
CNTNAP1,Undifferentiated leukemia,0.383941725017158
CNTNAP1,Leukemia Myelocytic Acute,0.3933196962529684
CNTNAP1,Childhood Chronic Myelogenous Leukemia BCR-ABL1 Positive,0.3933196962529684
CNTNAP1,Malaria Falciparum,0.3933196962529684
CNTNAP1,Acute lymphocytic leukemia,0.3933196962529684
CNTNAP1,Lymphoid leukemia,0.3933196962529684
CNTNAP1,Congenital hypomyelinating neuropathy,0.3933196962529684
CNTNAP1,Neoplasm Residual,0.3941558617476422
CNTNAP1,B Acute Lymphoblastic Leukemia with t(9,0.3941558617476422
CNTNAP1,22)(q34.1,0.3975960596292668
CNTNAP1,q11.2),0.4103119460235835
CNTNAP1,BCR-ABL1,0.4103119460235835
CNTNAP1,Reduced tendon reflexes,0.4103119460235835
CNTNAP1,Primary Myelofibrosis,0.4115056600660309
CNTNAP1,Facial diplegia,0.4126392832024548
CNTNAP1,Oropharyngeal Dysphagia,0.4192169590514327
CNTNAP1,Polyhydramnios,0.425419812815905
CNTNAP1,Dyspnea,0.4396723023384634
CNTNAP1,Early severe fetal akinesia sequence,0.4459714599189374
CNTNAP1,secondary acute myeloid leukemia,0.4588513406515081
CNTNAP1,Electromyogram abnormal,0.472444704048021
CNTNAP1,Pena-Shokeir syndrome type I,0.4981941174985421
CNTNAP1,leukemia,0.5019670090704682
CNTNAP1,Myeloid Leukemia Chronic,0.5090214163899865
CNTNAP1,Monocytosis,0.5140447474168605
CNTNAP1,Respiratory distress,0.5251317541886066
CNTNAP1,Leukemia Myeloid Chronic Atypical BCR-ABL Negative,0.5284231402423694
CNTNAP1,Leukemia Myelomonocytic Chronic,0.5393787854381349
CNTNAP1,Cerebellar atrophy,0.5568517196017908
CNTNAP1,Deglutition Disorders,0.5768212166102149
CNTNAP1,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.586007951376766
CNTNAP1,Neurodevelopmental Disorders,0.586007951376766
CNTNAP1,Absent tendon reflex,0.6274540883972485
CNTNAP1,Reflex Deep Tendon Absent,0.6447029562500783
CNTNAP1,Absent reflex,0.7309076068378124
CNTNAP1,Limitation of joint mobility,0.7317475852509061
CNTNAP1,Philadelphia chromosome-positive acute lymphoblastic leukemia,0.7631684472516962
CNTNAP1,Leukodystrophy,0.7965733310657268
CNTNAP1,Arthrogryposis,0.8064248359603999
CNTNAP1,Breast Carcinoma,0.0075861267486594
CNTNAP1,Hydrocephalus,0.3657224783929353
CNTNAP1,Congenital Muscular Dystrophy,0.4286813331685578
CNTNAP1,Mental Depression,0.4560460337187313
CNTNAP1,Lethal Congenital Contracture Syndrome,0.4560460337187313
CNTNAP1,Frontal Bossing,0.4560460337187313
CNTNAP1,Atrophy Of Corpus Callosum,0.4646409362700993
CNTNAP1,Hemangioma,0.4723647227028846
CNTNAP1,Gastroesophageal Reflux Disease,0.4742592264758768
CNTNAP1,Distal Arthrogryposis,0.4867879381749835
CNTNAP1,Spinal Muscular Atrophy,0.5087473896242481
CNTNAP1,Hypotonia,0.5087473896242481
CNTNAP1,Microcephaly,0.5123947823327547
CNTNAP1,Pena Shokeir Syndrome,0.5127628024019304
CNTNAP1,Dysphagia,0.5127628024019304
CNTNAP1,Cerebral Atrophy,0.5129298662020659
CNTNAP1,Cerebral Cortical Atrophy,0.5129298662020659
CNTNAP1,Neuropathy,0.5129298662020659
CNTNAP1,Oropharyngeal Dysphagia,0.5129298662020659
CNTNAP1,Micrognathism,0.5234357475824973
CNTNAP1,Bulbar Palsy,0.5875654081009305
CNTNAP1,Optic Atrophy,0.675936313627625
CNTNAP1,Cerebellar Atrophy,0.7112499273451761
CNTNAP1,Congenital Epicanthus,0.7729545590606223
CNTNAP1,Ptosis,0.8357787380041017
CNTNAP1,Arthrogryposis Multiplex Congenita,0.8536040084512244
CNTNAP1,Myopathy,0.8607543198108836
CNTNAP1,Dolichocephaly,0.8646787810763381
CNTNAP1,High Palate,0.9334417262711258
CNTNAP1,Hypoplasia Of Corpus Callosum,0.9807964358467072
CNTNAP1,Shprintzen-Goldberg syndrome ORPHA:2462,0.1590470395003315
CNTNAP1,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.3762014630157917
CNTNAP1,Fibrochondrogenesis ORPHA:2021,0.3762014630157917
CNTNAP1,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3762014630157917
CNTNAP1,Acromesomelic dysplasia Maroteaux type ORPHA:40,0.6239678957896782
CNTNAP1,Spinocerebellar ataxia type 21 ORPHA:98773,0.6239678957896782
CNTNAP1,Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191,0.6239678957896782
CNTNAP1,Freeman-Sheldon syndrome ORPHA:2053,0.6239678957896782
CNTNAP1,Potocki-Shaffer syndrome ORPHA:52022,0.6239678957896782
CNTNAP1,Congenital muscular dystrophy without intellectual disability ORPHA:370980,0.6268296504510718
CNTNAP1,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.7068064785325423
CNTNAP1,Gorlin syndrome ORPHA:377,0.7068064785325423
CNTNAP1,Myoclonic-astatic epilepsy ORPHA:1942,0.7072638369101406
CNTNAP2,Well Differentiated Oligodendroglioma,0.0617471306652618
CNTNAP2,oligodendroglioma,0.0648809611869375
CNTNAP2,Glioma,0.0739788831250619
CNTNAP2,Liver Cirrhosis,0.0773771948186562
CNTNAP2,Small cell carcinoma of lung,0.1193558174333938
CNTNAP2,Unipolar Depression,0.13167400689206
CNTNAP2,Hyperactive behavior,0.1387448809655294
CNTNAP2,Visual seizure,0.1735868515093891
CNTNAP2,Seizures,0.2053083986145698
CNTNAP2,Major Depressive Disorder,0.21122597829463
CNTNAP2,Mental Disorders Severe,0.2714542429024338
CNTNAP2,Language Disorders,0.2747883228704706
CNTNAP2,Multiple Sclerosis,0.2835142372342932
CNTNAP2,Cirrhosis,0.2923761731100008
CNTNAP2,Apraxia Developmental Verbal,0.340892538685018
CNTNAP2,Diagnosis Psychiatric,0.3933196962529684
CNTNAP2,Bipolar Disorder,0.3933196962529684
CNTNAP2,Hyperkinesia Generalized,0.3933196962529684
CNTNAP2,Schizophrenia,0.3933196962529684
CNTNAP2,Androgen-Insensitivity Syndrome,0.3933196962529684
CNTNAP2,Hypertensive disease,0.3933196962529684
CNTNAP2,Social Communication Disorder,0.3933196962529684
CNTNAP2,High-functioning autism,0.3933196962529684
CNTNAP2,Behavior Disorders,0.3933196962529684
CNTNAP2,Epilepsies Partial,0.3941558617476422
CNTNAP2,Epilepsy,0.3941558617476422
CNTNAP2,Apraxia Verbal,0.3941558617476422
CNTNAP2,Stuttering,0.3941558617476422
CNTNAP2,Stuttering Developmental,0.3941558617476422
CNTNAP2,Autism Spectrum Disorders,0.3941558617476422
CNTNAP2,Isaacs syndrome,0.3941558617476422
CNTNAP2,NEUROTICISM,0.39623320406434
CNTNAP2,Reduced tendon reflexes,0.3975960596292668
CNTNAP2,Schizoaffective Disorder,0.3975960596292668
CNTNAP2,Auditory Processing Disorder Central,0.3975960596292668
CNTNAP2,Semantic-Pragmatic Disorder,0.3975960596292668
CNTNAP2,Social Anxiety,0.3975960596292668
CNTNAP2,Language Development Disorders,0.4028066164685291
CNTNAP2,Limbic Encephalitis,0.4103119460235835
CNTNAP2,Aura,0.4115056600660309
CNTNAP2,Awakening Epilepsy,0.4115056600660309
CNTNAP2,Epilepsy Cryptogenic,0.4118266358241932
CNTNAP2,Cortical Dysplasia,0.4126392832024548
CNTNAP2,Mental disorders,0.4126392832024548
CNTNAP2,Rhabdoid Tumor,0.425419812815905
CNTNAP2,Substance Use Disorders,0.4381343267935581
CNTNAP2,Encephalitis,0.4396723023384634
CNTNAP2,Psychosis Brief Reactive,0.4396723023384634
CNTNAP2,Benign Rolandic Epilepsy,0.4396723023384634
CNTNAP2,Dyslexia,0.4459714599189374
CNTNAP2,Exfoliation Syndrome,0.4459714599189374
CNTNAP2,Specific language impairment,0.4564472886428772
CNTNAP2,Schizophreniform Disorders,0.4615352570710579
CNTNAP2,Psychotic Disorders,0.4753011022966241
CNTNAP2,Epilepsy Rolandic,0.4906258721078565
CNTNAP2,Alcoholic Intoxication Chronic,0.5097818625871164
CNTNAP2,Gross motor development delay,0.5188223685230745
CNTNAP2,nervous system disorder,0.5276472086074249
CNTNAP2,Dull intelligence,0.5300976305939776
CNTNAP2,Low intelligence,0.5300976305939776
CNTNAP2,Obsessive-Compulsive Disorder,0.5305233935923577
CNTNAP2,Neurodevelopmental Disorders,0.5568517196017908
CNTNAP2,Poor school performance,0.5610226870913673
CNTNAP2,Pervasive Development Disorder,0.5655222348249326
CNTNAP2,Autistic behavior,0.5885228491254589
CNTNAP2,Mental deficiency,0.6035970790768342
CNTNAP2,Mental Retardation,0.6319938293757544
CNTNAP2,Brain Diseases,0.6319938293757544
CNTNAP2,Calcification of coronary artery,0.6881884194440517
CNTNAP2,Pachygyria,0.7240930522443176
CNTNAP2,Gilles de la Tourette syndrome,0.7294281406818208
CNTNAP2,Malformations of Cortical Development,0.7347935459099629
CNTNAP2,Severe mental retardation (I.Q. 20-34),0.7668324850675137
CNTNAP2,Impaired cognition,0.8000044931629623
CNTNAP2,Autistic Disorder,0.8064248359603999
CNTNAP2,Intellectual Disability,0.8352623613787349
CNTNAP2,Attention deficit hyperactivity disorder,0.8600100703665297
CNTNAP2,Decreased tendon reflex,0.8997473146038651
CNTNAP2,Epileptic encephalopathy,0.905697116584928
CNTNAP2,Language Delay,0.9109170915079636
CNTNAP2,Hepatitis B,0.9169959402964138
CNTNAP2,Speech Delay,0.9170233981501684
CNTNAP2,Abnormal behavior,0.9274396272108874
CNTNAP2,Schizophrenia,0.0531117779464085
CNTNAP2,Language Disorders,0.3094716280561038
CNTNAP2,Epilepsy,0.3449614869411272
CNTNAP2,Autism Spectrum Disorder,0.425341435586089
CNTNAP2,Mental Disorders,0.4286813331685578
CNTNAP2,Lung Carcinoma,0.4541466895915311
CNTNAP2,Pulmonary Stenosis,0.4541466895915311
CNTNAP2,Mental Depression,0.4560460337187313
CNTNAP2,Language Development Disorders,0.4560460337187313
CNTNAP2,Alzheimer Disease,0.4560460337187313
CNTNAP2,Psychosis,0.4560460337187313
CNTNAP2,Auditory Processing Disorder,0.4560460337187313
CNTNAP2,Frontal Bossing,0.4560460337187313
CNTNAP2,Brachycephaly,0.4560460337187313
CNTNAP2,Glaucoma,0.4646409362700993
CNTNAP2,Speech Delay,0.4723647227028846
CNTNAP2,Gastroesophageal Reflux Disease,0.4742592264758768
CNTNAP2,Social Communication Disorder,0.4867879381749835
CNTNAP2,Bipolar Disorder,0.4875380732267193
CNTNAP2,Scoliosis,0.4875380732267193
CNTNAP2,Dementia,0.4875380732267193
CNTNAP2,Tricuspid Valve Insufficiency,0.5127628024019304
CNTNAP2,Dysphagia,0.5127628024019304
CNTNAP2,Cerebral Cortical Atrophy,0.5129298662020659
CNTNAP2,Seizure,0.5576425853515448
CNTNAP2,Celiac Disease,0.6485812088066297
CNTNAP2,Malocclusion,0.6564901877271138
CNTNAP2,Plagiocephaly,0.7015979603136192
CNTNAP2,Precocious Puberty,0.7328159476505643
CNTNAP2,Ventricular Septal Defect,0.7729545590606223
CNTNAP2,Mental Retardation,0.7729545590606223
CNTNAP2,Cryptorchidism,0.776786668801341
CNTNAP2,Stereotyped Behavior,0.8374871697490577
CNTNAP2,Strabismus,0.9568083835980838
CNTNAP2,Epileptic Encephalopathy,0.9589164573822424
CNTNAP2,Developmental Delay,0.96477535147595
CNTNAP2,Autism,0.9783327858636056
CNTNAP2,NON RARE IN EUROPE: Non rare obesity ORPHA:521399,0.1590470395003315
CNTNAP2,ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996,0.6239678957896782
CNTNAP2,Donnai-Barrow syndrome ORPHA:2143,0.6239678957896782
CNTNAP2,Syndromic microphthalmia type 5 ORPHA:178364,0.6239678957896782
CNTNAP2,X-linked central congenital hypothyroidism with late-onset testicular enlargement ORPHA:329235,0.6239678957896782
CNTNAP2,PEHO syndrome ORPHA:2836,0.6239678957896782
CNTNAP2,Pitt-Hopkins-like syndrome ORPHA:221150,0.7068064785325423
CNTNAP2,Autosomal dominant focal dystonia DYT25 type ORPHA:329466,0.7068064785325423
CNTNAP2,Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency ORPHA:363432,0.7068064785325423
CNTNAP2,Cortical dysplasia-focal epilepsy syndrome ORPHA:163681,0.7068064785325423
CNTNAP2,Gamma-aminobutyric acid transaminase deficiency ORPHA:2066,0.7068064785325423
CNTNAP2,Hyperprolinemia type 1 ORPHA:419,0.7068064785325423
CNTNAP2,Prune belly syndrome ORPHA:2970,0.7068064785325423
CNTNAP2,CHARGE syndrome ORPHA:138,0.7068064785325423
CNTNAP2,Isolated congenitally uncorrected transposition of the great arteries ORPHA:216718,0.7068064785325423
CNTNAP2,Spinocerebellar ataxia type 37 ORPHA:363710,0.7068064785325423
CNTNAP2,Usher syndrome type 2 ORPHA:231178,0.7068064785325423
CNTNAP2,Lennox-Gastaut syndrome ORPHA:2382,0.7072638369101406
CNTNAP2,Situs ambiguus ORPHA:157769,0.7120423847116372
CNTNAP2,NON RARE IN EUROPE: Autism ORPHA:106,0.7277121423170946
COL12A1,Colorectal Carcinoma,0.0034602840073026
COL12A1,Breast Carcinoma,0.0042545616049287
COL12A1,Colorectal Cancer,0.0149315928814189
COL12A1,Malignant mesothelioma,0.0182265588252201
COL12A1,Malignant neoplasm of breast,0.0191435238361999
COL12A1,Flexion contracture of the knee,0.064548079316548
COL12A1,Liver Cirrhosis Experimental,0.0747863377072194
COL12A1,Chondromyxoid fibroma,0.1138051695421299
COL12A1,contracture of elbow,0.2522264785494494
COL12A1,Flexion contracture - elbow,0.2714542429024338
COL12A1,Ehlers-Danlos Syndrome,0.3283839486480793
COL12A1,Endometriosis,0.383941725017158
COL12A1,Exostoses,0.383941725017158
COL12A1,Adducted thumb,0.3933196962529684
COL12A1,Increased endomysial connective tissue,0.3933196962529684
COL12A1,Diaphragmatic paresis,0.3933196962529684
COL12A1,Diminished diaphragmatic motion,0.3933196962529684
COL12A1,Cachexia,0.3933196962529684
COL12A1,Flexion contracture of proximal interphalangeal joint,0.3975960596292668
COL12A1,Slender finger,0.3975960596292668
COL12A1,Valgus deformities of feet,0.4028066164685291
COL12A1,Bethlem myopathy,0.4028066164685291
COL12A1,Long toe,0.4028066164685291
COL12A1,Scleroatonic muscular dystrophy,0.4192169590514327
COL12A1,Electromyogram abnormal,0.4396723023384634
COL12A1,Reduced fetal movement,0.4459714599189374
COL12A1,Spinal rigidity,0.4506578937113162
COL12A1,Frequent falls,0.4564472886428772
COL12A1,Generalized muscle weakness,0.4615352570710579
COL12A1,Spasmodic torticollis,0.4615352570710579
COL12A1,Abnormality of the palate,0.4615352570710579
COL12A1,Retrusion of lower jaw,0.4753011022966241
COL12A1,Decreased projection of lower jaw,0.4753011022966241
COL12A1,Decreased projection of mandible,0.4753011022966241
COL12A1,Hypoplastic mandible condyle,0.4753011022966241
COL12A1,Torticollis,0.4753011022966241
COL12A1,Generalized amyotrophy,0.4753011022966241
COL12A1,Aplasia/Hypoplasia of the mandible,0.4790179402069343
COL12A1,Increased variability in muscle fiber diameter,0.4790179402069343
COL12A1,Overlap syndrome,0.4790179402069343
COL12A1,Micrognathism,0.479747709091007
COL12A1,Acquired scoliosis,0.5019670090704682
COL12A1,Cervical Dystonia,0.5019670090704682
COL12A1,Respiratory Failure,0.5140447474168605
COL12A1,Congenital myopathy (disorder),0.5188223685230745
COL12A1,Esotropia,0.5251317541886066
COL12A1,Joint stiffness,0.5359212109443033
COL12A1,EMG: myopathic abnormalities,0.5359212109443033
COL12A1,Short neck,0.549941235475765
COL12A1,Absent tendon reflex,0.5768212166102149
COL12A1,Range of joint movement increased,0.5768212166102149
COL12A1,Reflex Deep Tendon Absent,0.586007951376766
COL12A1,Absent reflex,0.586007951376766
COL12A1,Curvature of spine,0.6035970790768342
COL12A1,Elevated creatine kinase,0.6294837700416086
COL12A1,Hip Dislocation,0.6304655343580164
COL12A1,Congenital muscular dystrophy (disorder),0.6319938293757544
COL12A1,Creatine phosphokinase serum increased,0.6332132835539771
COL12A1,Contracture,0.652707626880454
COL12A1,Respiratory function loss,0.6606366664484469
COL12A1,Respiratory Insufficiency,0.6891882956008074
COL12A1,Kyphoscoliosis deformity of spine,0.6925751397474874
COL12A1,Facial muscle weakness of muscles innervated by CN VII,0.7045203904267408
COL12A1,Bell Palsy,0.7156410971578294
COL12A1,Facial Paresis,0.7156410971578294
COL12A1,Arthrogryposis,0.7317475852509061
COL12A1,Generalized hypotonia,0.7631684472516962
COL12A1,Muscle hypotonia,0.7965733310657268
COL12A1,Flexion contractures of joints,0.8163430347375975
COL12A1,Flexion contracture,0.8178117518835931
COL12A1,Contracture of joint,0.8244780048843707
COL12A1,Byzanthine arch palate,0.8441962785769224
COL12A1,Hyperkyphosis,0.8499037334512025
COL12A1,Kyphosis deformity of spine,0.8675929025638992
COL12A1,Muscle Weakness,0.9042453170318407
COL12A1,No development of motor milestones,0.930169779950098
COL12A1,Motor delay,0.932126049986882
COL12A1,Myopathy,0.9503327807211356
COL12A1,Endometriosis,0.2187610616307245
COL12A1,Congenital Muscular Dystrophy,0.4286813331685578
COL12A1,Elbow Flexion Contracture,0.4286813331685578
COL12A1,Respiratory Failure,0.4560460337187313
COL12A1,Alzheimer Disease,0.4560460337187313
COL12A1,Phrynoderma,0.4560460337187313
COL12A1,Scoliosis,0.4875380732267193
COL12A1,Hypotonia,0.5087473896242481
COL12A1,Micrognathism,0.5234357475824973
COL12A1,Malignant Mesothelioma,0.555382961603519
COL12A1,Facial Paralysis,0.696610260564548
COL12A1,Amyotrophy,0.6999859437625926
COL12A1,Muscular Dystrophy,0.7112499273451761
COL12A1,Esotropia,0.817609416385332
COL12A1,Motor Delay,0.8371848756758566
COL12A1,Acquired Kyphoscoliosis,0.8374871697490577
COL12A1,Congenital Kyphoscoliosis,0.8388613222538848
COL12A1,Myopathy,0.8607543198108836
COL12A1,High Palate,0.9334417262711258
COL12A1,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
COL12A1,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
COL12A1,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
COL12A1,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
COL12A1,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
COL12A1,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
COL12A1,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
COL12A1,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
COL12A1,Peters anomaly ORPHA:708,0.00518481975049
COL12A1,Familial porencephaly ORPHA:99810,0.0083045131203191
COL12A1,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
COL12A1,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
COL12A1,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
COL12A1,Chondrosarcoma ORPHA:55880,0.0083045131203191
COL12A1,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
COL12A1,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
COL12A1,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
COL12A1,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
COL12A1,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
COL12A1,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
COL12A1,Polysyndactyly ORPHA:93338,0.0083045131203191
COL12A1,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
COL12A1,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
COL12A1,Tibial hemimelia ORPHA:93322,0.0083045131203191
COL12A1,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
COL12A1,Axenfeld anomaly ORPHA:98978,0.0083045131203191
COL12A1,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
COL12A1,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
COL12A1,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
COL12A1,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
COL12A1,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
COL12A1,Rieger anomaly ORPHA:91483,0.0083045131203191
COL12A1,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
COL12A1,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
COL12A1,Bruck syndrome ORPHA:2771,0.0180064224283883
COL12A1,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.0180064224283883
COL12A1,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.0180064224283883
COL12A1,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.0180064224283883
COL12A1,Autosomal recessive brachyolmia ORPHA:448242,0.0180064224283883
COL12A1,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.0180064224283883
COL12A1,CHST3-related skeletal dysplasia ORPHA:263463,0.0180064224283883
COL12A1,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.0180064224283883
COL12A1,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.0180064224283883
COL12A1,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.0180064224283883
COL12A1,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.0180064224283883
COL12A1,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.0180064224283883
COL12A1,Diaphanospondylodysostosis ORPHA:66637,0.0180064224283883
COL12A1,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451,0.0180064224283883
COL12A1,Familial drusen ORPHA:75376,0.0180064224283883
COL12A1,Familial schizencephaly ORPHA:481986,0.0180064224283883
COL12A1,GAPO syndrome ORPHA:2067,0.0180064224283883
COL12A1,HANAC syndrome ORPHA:73229,0.0180064224283883
COL12A1,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.0180064224283883
COL12A1,Hereditary papillary renal cell carcinoma ORPHA:47044,0.0180064224283883
COL12A1,Ischiovertebral syndrome ORPHA:85200,0.0180064224283883
COL12A1,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.0180064224283883
COL12A1,Mandibulofacial dysostosis with alopecia ORPHA:443995,0.0180064224283883
COL12A1,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.0180064224283883
COL12A1,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.0180064224283883
COL12A1,Nance-Horan syndrome ORPHA:627,0.0180064224283883
COL12A1,Oculocutaneous albinism type 3 ORPHA:79433,0.0180064224283883
COL12A1,Osteofibrous dysplasia ORPHA:488265,0.0180064224283883
COL12A1,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.0180064224283883
COL12A1,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.0180064224283883
COL12A1,Primary CD59 deficiency ORPHA:169464,0.0180064224283883
COL12A1,Retinal arterial tortuosity ORPHA:75326,0.0180064224283883
COL12A1,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.0180064224283883
COL12A1,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.0180064224283883
COL12A1,Steel syndrome ORPHA:438117,0.0180064224283883
COL12A1,Synpolydactyly type 2 ORPHA:295197,0.0180064224283883
COL12A1,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.0180064224283883
COL12A1,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.0180064224283883
COL12A1,X-linked osteoporosis with fractures ORPHA:391330,0.0180064224283883
COL12A1,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.0180064224283883
COL12A1,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.0180064224283883
COL12A1,Congenital diaphragmatic hernia ORPHA:2140,0.0180064224283883
COL12A1,Dermatofibrosarcoma protuberans ORPHA:31112,0.0180064224283883
COL12A1,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.0180064224283883
COL12A1,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.0180064224283883
COL12A1,Pediatric hepatocellular carcinoma ORPHA:33402,0.0180064224283883
COL12A1,Piebaldism ORPHA:2884,0.0180064224283883
COL12A1,Posterior hypospadias ORPHA:95706,0.0180064224283883
COL12A1,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.0180064224283883
COL12A1,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.0180064224283883
COL12A1,Erythrokeratodermia variabilis ORPHA:317,0.0183145313768111
COL12A1,Ondine syndrome ORPHA:661,0.020072786018028
COL12A1,Classical Ehlers-Danlos syndrome ORPHA:287,0.0586579655822394
COL12A1,Multiple osteochondromas ORPHA:321,0.0586579655822394
COL12A1,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.0586579655822394
COL12A1,Alopecia universalis ORPHA:701,0.0586579655822394
COL12A1,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.0586579655822394
COL12A1,Atrichia with papular lesions ORPHA:86819,0.0586579655822394
COL12A1,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.0586579655822394
COL12A1,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.0586579655822394
COL12A1,Caffey disease ORPHA:1310,0.0586579655822394
COL12A1,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.0586579655822394
COL12A1,Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641,0.0586579655822394
COL12A1,Congenital alveolar capillary dysplasia ORPHA:210122,0.0586579655822394
COL12A1,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.0586579655822394
COL12A1,Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181,0.0586579655822394
COL12A1,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.0586579655822394
COL12A1,Familial generalized lentiginosis ORPHA:231040,0.0586579655822394
COL12A1,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.0586579655822394
COL12A1,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763,0.0586579655822394
COL12A1,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.0586579655822394
COL12A1,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.0586579655822394
COL12A1,Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381,0.0586579655822394
COL12A1,Kuskokwim syndrome ORPHA:1149,0.0586579655822394
COL12A1,Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528,0.0586579655822394
COL12A1,Lymphedema-distichiasis syndrome ORPHA:33001,0.0586579655822394
COL12A1,Microphthalmia with brain and digit anomalies ORPHA:139471,0.0586579655822394
COL12A1,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.0586579655822394
COL12A1,Muscle filaminopathy ORPHA:171445,0.0586579655822394
COL12A1,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.0586579655822394
COL12A1,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.0586579655822394
COL12A1,Non-immune hydrops fetalis ORPHA:363999,0.0586579655822394
COL12A1,Oculodentodigital dysplasia ORPHA:2710,0.0586579655822394
COL12A1,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.0586579655822394
COL12A1,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.0586579655822394
COL12A1,Posterior urethral valve ORPHA:93110,0.0586579655822394
COL12A1,Syndactyly type 3 ORPHA:93404,0.0586579655822394
COL12A1,X-linked Alport syndrome ORPHA:88917,0.0586579655822394
COL12A1,Autosomal recessive Robinow syndrome ORPHA:1507,0.0586579655822394
COL12A1,Griscelli syndrome type 3 ORPHA:79478,0.0586579655822394
COL12A1,Juvenile Paget disease ORPHA:2801,0.0586579655822394
COL12A1,Malignant peripheral nerve sheath tumor ORPHA:3148,0.0586579655822394
COL12A1,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.0586579655822394
COL12A1,Postaxial polydactyly type B ORPHA:93335,0.0586579655822394
COL12A1,Brachydactyly type A1 ORPHA:93388,0.0599424746210022
COL12A1,Hennekam syndrome ORPHA:2136,0.0599424746210022
COL12A1,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.0621182671032116
COL12A1,Osteogenesis imperfecta type 3 ORPHA:216812,0.0683063362547733
COL12A1,Hirschsprung disease ORPHA:388,0.0706635700002548
COL12A1,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.0783959336694202
COL12A1,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.0783959336694202
COL12A1,Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387,0.0902044104910482
COL12A1,Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899,0.1590470395003315
COL12A1,Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857,0.1590470395003315
COL12A1,Osteogenesis imperfecta type 1 ORPHA:216796,0.1590470395003315
COL12A1,Periodontal Ehlers-Danlos syndrome ORPHA:75392,0.1590470395003315
COL12A1,Ablepharon macrostomia syndrome ORPHA:920,0.1590470395003315
COL12A1,Acrogeria ORPHA:2500,0.1590470395003315
COL12A1,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.1590470395003315
COL12A1,Adenocarcinoma of ovary ORPHA:213504,0.1590470395003315
COL12A1,Allan-Herndon-Dudley syndrome ORPHA:59,0.1590470395003315
COL12A1,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.1590470395003315
COL12A1,Barber-Say syndrome ORPHA:1231,0.1590470395003315
COL12A1,Carbamoyl-phosphate synthetase 1 deficiency ORPHA:147,0.1590470395003315
COL12A1,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.1590470395003315
COL12A1,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.1590470395003315
COL12A1,Complete androgen insensitivity syndrome ORPHA:99429,0.1590470395003315
COL12A1,Dicarboxylic aminoaciduria ORPHA:2195,0.1590470395003315
COL12A1,Dyssegmental dysplasia Silverman-Handmaker type ORPHA:1865,0.1590470395003315
COL12A1,Familial abdominal aortic aneurysm ORPHA:86,0.1590470395003315
COL12A1,Familial visceral myopathy ORPHA:2604,0.1590470395003315
COL12A1,Fibronectin glomerulopathy ORPHA:84090,0.1590470395003315
COL12A1,Focal facial dermal dysplasia type III ORPHA:1807,0.1590470395003315
COL12A1,Glutaric acidemia type 3 ORPHA:35706,0.1590470395003315
COL12A1,Hot water reflex epilepsy ORPHA:166412,0.1590470395003315
COL12A1,Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561,0.1590470395003315
COL12A1,Kennedy disease ORPHA:481,0.1590470395003315
COL12A1,Lateral meningocele syndrome ORPHA:2789,0.1590470395003315
COL12A1,Lipoid proteinosis ORPHA:530,0.1590470395003315
COL12A1,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.1590470395003315
COL12A1,Multiple myeloma ORPHA:29073,0.1590470395003315
COL12A1,Myopathic intestinal pseudoobstruction ORPHA:104077,0.1590470395003315
COL12A1,Partial androgen insensitivity syndrome ORPHA:90797,0.1590470395003315
COL12A1,Ring dermoid of cornea ORPHA:91481,0.1590470395003315
COL12A1,Schwartz-Jampel syndrome ORPHA:800,0.1590470395003315
COL12A1,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358,0.1590470395003315
COL12A1,Stuve-Wiedemann syndrome ORPHA:3206,0.1590470395003315
COL12A1,Trehalase deficiency ORPHA:103909,0.1590470395003315
COL12A1,Vascular Ehlers-Danlos syndrome ORPHA:286,0.1590470395003315
COL12A1,Acromesomelic dysplasia Grebe type ORPHA:2098,0.1590470395003315
COL12A1,Autosomal recessive hypophosphatemic rickets ORPHA:289176,0.1590470395003315
COL12A1,Brachydactyly type C ORPHA:93384,0.1590470395003315
COL12A1,Familial calcium pyrophosphate deposition ORPHA:1416,0.1590470395003315
COL12A1,Fibular aplasia-complex brachydactyly syndrome ORPHA:2639,0.1590470395003315
COL12A1,Hereditary mixed polyposis syndrome ORPHA:157794,0.1590470395003315
COL12A1,Isolated ectopia lentis ORPHA:1885,0.1590470395003315
COL12A1,Shprintzen-Goldberg syndrome ORPHA:2462,0.1590470395003315
COL12A1,Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659,0.1590470395003315
COL12A1,Congenital glaucoma ORPHA:98976,0.1614487935928034
COL12A1,Epithelioid hemangioendothelioma ORPHA:157791,0.1614487935928034
COL12A1,Autosomal dominant polycystic kidney disease ORPHA:730,0.1697334635963512
COL12A1,NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279,0.1739455566145445
COL12A1,Heritable pulmonary arterial hypertension ORPHA:275777,0.1782034488938806
COL12A1,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.1981653781243822
COL12A1,Bethlem myopathy ORPHA:610,0.3762014630157917
COL12A1,Congenital muscular dystrophy Ullrich type ORPHA:75840,0.3762014630157917
COL12A1,Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428,0.3762014630157917
COL12A1,Arterial tortuosity syndrome ORPHA:3342,0.3762014630157917
COL12A1,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.3762014630157917
COL12A1,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.3762014630157917
COL12A1,Autosomal spastic paraplegia type 58 ORPHA:397946,0.3762014630157917
COL12A1,Brachydactyly type B1 ORPHA:572385,0.3762014630157917
COL12A1,Cardiac-valvular Ehlers-Danlos syndrome ORPHA:230851,0.3762014630157917
COL12A1,Congenital vertical talus bilateral ORPHA:295203,0.3762014630157917
COL12A1,Congenital vertical talus unilateral ORPHA:295201,0.3762014630157917
COL12A1,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.3762014630157917
COL12A1,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome ORPHA:2084,0.3762014630157917
COL12A1,High bone mass osteogenesis imperfecta ORPHA:314029,0.3762014630157917
COL12A1,Isolated biliary atresia ORPHA:30391,0.3762014630157917
COL12A1,Laminin subunit alpha 2-related congenital muscular dystrophy ORPHA:258,0.3762014630157917
COL12A1,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.3762014630157917
COL12A1,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.3762014630157917
COL12A1,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.3762014630157917
COL12A1,Marfan syndrome type 1 ORPHA:284963,0.3762014630157917
COL12A1,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome ORPHA:521445,0.3762014630157917
COL12A1,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.3762014630157917
COL12A1,Neonatal Marfan syndrome ORPHA:284979,0.3762014630157917
COL12A1,Pelviscapular dysplasia ORPHA:93333,0.3762014630157917
COL12A1,Pierson syndrome ORPHA:2670,0.3762014630157917
COL12A1,Primary dystonia DYT27 type ORPHA:464440,0.3762014630157917
COL12A1,Progeroid and marfanoid aspect-lipodystrophy syndrome ORPHA:300382,0.3762014630157917
COL12A1,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.3762014630157917
COL12A1,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.3762014630157917
COL12A1,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.3762014630157917
COL12A1,Stiff skin syndrome ORPHA:2833,0.3762014630157917
COL12A1,X-linked spondyloepimetaphyseal dysplasia ORPHA:93349,0.3762014630157917
COL12A1,Acromicric dysplasia ORPHA:969,0.3762014630157917
COL12A1,Autosomal recessive polycystic kidney disease ORPHA:731,0.3762014630157917
COL12A1,Craniometaphyseal dysplasia ORPHA:1522,0.3762014630157917
COL12A1,Autosomal dominant cutis laxa ORPHA:90348,0.3762014630157917
COL12A1,Geleophysic dysplasia ORPHA:2623,0.3762014630157917
COL12A1,Milroy disease ORPHA:79452,0.3762014630157917
COL12A1,Weill-Marchesani syndrome ORPHA:3449,0.3762014630157917
COL12A1,Osteogenesis imperfecta type 2 ORPHA:216804,0.3826134188846508
COL12A1,Osteogenesis imperfecta type 4 ORPHA:216820,0.4101640425710954
COL12A1,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.6239678957896782
COL12A1,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.6239678957896782
COL12A1,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135,0.6239678957896782
COL12A1,Branchioskeletogenital syndrome ORPHA:1299,0.6239678957896782
COL12A1,Generalized epilepsy-paroxysmal dyskinesia syndrome ORPHA:79137,0.6239678957896782
COL12A1,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179,0.6239678957896782
COL12A1,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.6239678957896782
COL12A1,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274,0.6239678957896782
COL12A1,Cap myopathy ORPHA:171881,0.6239678957896782
COL12A1,Infantile myofibromatosis ORPHA:2591,0.6239678957896782
COL12A1,Punctate palmoplantar keratoderma type 1 ORPHA:79501,0.6239678957896782
COL12A1,NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225,0.6340773186521831
COL12A1,Ectromelia virus ERPV hemagglutinin,0.6362779693488597
COL12A1,Vaccinia virus Ankara Haemagglutinin,0.6362779693488597
COL12A1,Human adenovirus 41 E3 31.6K,0.6362779693488597
COL12A1,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
COL12A1,Human gammaherpesvirus 8 K14,0.6386053036162835
COL12A1,Horsepox virus HSPV177 (Immunoglobulin like),0.691145768348025
COL12A1,Variola virus hypothetical protein (gene: J9R),0.7651942752688915
COL12A1,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.776311155917498
COL12A1,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.875442055263636
COL12A1,Human adenovirus 61 E3 CR1 beta,0.8784689389733535
COL12A1,Human adenovirus 18 CR1-beta protein (gene: E3),0.9445347004229157
COL12A1,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.9646199311883896
COL5A2,Colorectal Carcinoma,0.0034602840073026
COL5A2,Colorectal Cancer,0.0149315928814189
COL5A2,Carcinogenesis,0.0228075668512991
COL5A2,Degenerative polyarthritis,0.0739788831250619
COL5A2,Liver Cirrhosis Experimental,0.0747863377072194
COL5A2,Liver Cirrhosis,0.0773771948186562
COL5A2,Malignant neoplasm of urinary bladder,0.084286432100041
COL5A2,Bladder Neoplasm,0.0891725280554336
COL5A2,Malignant Neoplasms,0.0991201145654548
COL5A2,Carcinoma of bladder,0.13167400689206
COL5A2,Myocardial Infarction,0.1352936728187231
COL5A2,Neoplasms,0.2714542429024338
COL5A2,Atrophic scar,0.286740104053178
COL5A2,Aortic Aneurysm Thoracic,0.2980670559114652
COL5A2,Ehlers-Danlos Syndrome,0.3283839486480793
COL5A2,Aortic root dilatation,0.3508665345292502
COL5A2,Ectopia Lentis,0.3638414818541592
COL5A2,Primary malignant neoplasm,0.383941725017158
COL5A2,Noninfiltrating Intraductal Carcinoma,0.383941725017158
COL5A2,Hernia Inguinal,0.3933196962529684
COL5A2,Gastroesophageal reflux disease,0.3933196962529684
COL5A2,Bat ear,0.3933196962529684
COL5A2,Cigarette-paper scars,0.3933196962529684
COL5A2,Bowel diverticula,0.3933196962529684
COL5A2,Bowel diverticulosis,0.3933196962529684
COL5A2,Ehlers-Danlos syndrome type 1,0.3933196962529684
COL5A2,Molluscoid pseudotumors,0.3933196962529684
COL5A2,Fibrosis Liver,0.3933196962529684
COL5A2,Blue sclera,0.3933196962529684
COL5A2,Aortic Aneurysm,0.3933196962529684
COL5A2,eyelids (symptom),0.3933196962529684
COL5A2,Poor wound healing,0.3941558617476422
COL5A2,Hernia Femoral,0.3941558617476422
COL5A2,Abortion Tubal,0.3975960596292668
COL5A2,Umbilical hernia,0.3986414839122469
COL5A2,Congenital aneurysm of ascending aorta,0.4028066164685291
COL5A2,Hyperextensibility of the finger joints,0.4103119460235835
COL5A2,Genu recurvatum,0.4192169590514327
COL5A2,Thin skin,0.4209380602168584
COL5A2,Spontaneous abortion,0.4304973629098372
COL5A2,Soft skin,0.4304973629098372
COL5A2,Velvety skin,0.4304973629098372
COL5A2,Congenital pectus carinatum,0.4335751357405352
COL5A2,Short stature,0.439389586518055
COL5A2,Fragile skin,0.4396723023384634
COL5A2,Infantile muscular hypotonia,0.4396723023384634
COL5A2,Myocardial Ischemia,0.4506578937113162
COL5A2,Lens dislocation,0.4506578937113162
COL5A2,Increased tendency to bruise,0.4564472886428772
COL5A2,Cardiovascular Diseases,0.4675904598629673
COL5A2,Cardiomyopathy Familial Idiopathic,0.4704594475773637
COL5A2,Congenital diaphragmatic hernia,0.4790179402069343
COL5A2,Hallux Valgus,0.4852430673532381
COL5A2,Bunion,0.4906258721078565
COL5A2,Acquired scoliosis,0.5019670090704682
COL5A2,Myopia,0.5239792328442205
COL5A2,Dislocations,0.5251317541886066
COL5A2,Joint hyperflexibility,0.5305233935923577
COL5A2,Hyperextensible skin,0.5359212109443033
COL5A2,Metabolic Syndrome X,0.5568517196017908
COL5A2,Acid reflux,0.5936773368594411
COL5A2,Pectus excavatum,0.5956632182199403
COL5A2,Curvature of spine,0.6035970790768342
COL5A2,Mitral Valve Prolapse Syndrome,0.625027955184583
COL5A2,Heartburn,0.641532117799187
COL5A2,Varicosity,0.6656356363792992
COL5A2,Acquired flat foot,0.7484342194688707
COL5A2,Flatfoot,0.7577323833810212
COL5A2,Congenital Epicanthus,0.8152796510476865
COL5A2,Thoracic Aortic Aneurysm And Aortic Dissection,0.1641294276675242
COL5A2,Blood Coagulation Disorders,0.3094716280561038
COL5A2,Connective Tissue Disease,0.425341435586089
COL5A2,Liver Cirrhosis,0.4286813331685578
COL5A2,Classical-Like Ehlers-Danlos Syndrome,0.4402141802500753
COL5A2,Arthritis,0.4541466895915311
COL5A2,Shagreen Patch,0.4541466895915311
COL5A2,Aortic Aneurysm,0.4541466895915311
COL5A2,Miscarriage,0.4560460337187313
COL5A2,Autoimmune Lymphoproliferative Disorder,0.4560460337187313
COL5A2,Liver Fibrosis,0.4560460337187313
COL5A2,Tricuspid Valve Prolapse,0.4560460337187313
COL5A2,Venous Insufficiency,0.4560460337187313
COL5A2,Migraine,0.4560460337187313
COL5A2,Hypertension,0.4560460337187313
COL5A2,Ehlers-Danlos Syndrome,0.4560460337187313
COL5A2,Spina Bifida Occulta,0.4646409362700993
COL5A2,Glaucoma,0.4646409362700993
COL5A2,Atrophy,0.4646409362700993
COL5A2,Retinal Detachment,0.4867879381749835
COL5A2,Corneal Dystrophy,0.4875380732267193
COL5A2,Scoliosis,0.4875380732267193
COL5A2,Asthma,0.504364324740411
COL5A2,Ectopia Lentis,0.5087473896242481
COL5A2,Hiatal Hernia,0.5129298662020659
COL5A2,Arachnodactyly,0.525214105372123
COL5A2,Atrial Septal Defect,0.5254133486377646
COL5A2,Congenital Keratoglobus,0.5681293104170607
COL5A2,Dwarfism,0.5796489603182782
COL5A2,Microcornea,0.6030919130927346
COL5A2,Congenital Pectus Carinatum,0.6104715460837368
COL5A2,Congenital Exomphalos,0.6270755162143985
COL5A2,Urticaria,0.6420878824691651
COL5A2,Eczema,0.6899894525110877
COL5A2,Mitral Valve Prolapse,0.7112499273451761
COL5A2,Myopia,0.7405519560111998
COL5A2,Congenital Epicanthus,0.7729545590606223
COL5A2,Microdontia,0.7729545590606223
COL5A2,Impaired Cognition,0.781505274734613
COL5A2,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
COL5A2,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
COL5A2,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
COL5A2,Familial porencephaly ORPHA:99810,0.0083045131203191
COL5A2,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
COL5A2,Chondrosarcoma ORPHA:55880,0.0083045131203191
COL5A2,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
COL5A2,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
COL5A2,Polysyndactyly ORPHA:93338,0.0083045131203191
COL5A2,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
COL5A2,Tibial hemimelia ORPHA:93322,0.0083045131203191
COL5A2,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
COL5A2,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
COL5A2,Bruck syndrome ORPHA:2771,0.0180064224283883
COL5A2,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.0180064224283883
COL5A2,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.0180064224283883
COL5A2,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.0180064224283883
COL5A2,Diaphanospondylodysostosis ORPHA:66637,0.0180064224283883
COL5A2,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451,0.0180064224283883
COL5A2,Familial drusen ORPHA:75376,0.0180064224283883
COL5A2,Familial schizencephaly ORPHA:481986,0.0180064224283883
COL5A2,GAPO syndrome ORPHA:2067,0.0180064224283883
COL5A2,HANAC syndrome ORPHA:73229,0.0180064224283883
COL5A2,Ischiovertebral syndrome ORPHA:85200,0.0180064224283883
COL5A2,Mandibulofacial dysostosis with alopecia ORPHA:443995,0.0180064224283883
COL5A2,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.0180064224283883
COL5A2,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.0180064224283883
COL5A2,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.0180064224283883
COL5A2,Retinal arterial tortuosity ORPHA:75326,0.0180064224283883
COL5A2,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.0180064224283883
COL5A2,Steel syndrome ORPHA:438117,0.0180064224283883
COL5A2,Synpolydactyly type 2 ORPHA:295197,0.0180064224283883
COL5A2,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.0180064224283883
COL5A2,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.0180064224283883
COL5A2,Dermatofibrosarcoma protuberans ORPHA:31112,0.0180064224283883
COL5A2,Hypoplastic left heart syndrome ORPHA:2248,0.0180064224283883
COL5A2,Matthew-Wood syndrome ORPHA:2470,0.0180064224283883
COL5A2,Piebaldism ORPHA:2884,0.0180064224283883
COL5A2,Posterior hypospadias ORPHA:95706,0.0180064224283883
COL5A2,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.0180064224283883
COL5A2,Ondine syndrome ORPHA:661,0.020072786018028
COL5A2,Tetralogy of Fallot ORPHA:3303,0.0277610005156803
COL5A2,Classical Ehlers-Danlos syndrome ORPHA:287,0.0586579655822394
COL5A2,Multiple osteochondromas ORPHA:321,0.0586579655822394
COL5A2,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.0586579655822394
COL5A2,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.0586579655822394
COL5A2,Caffey disease ORPHA:1310,0.0586579655822394
COL5A2,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.0586579655822394
COL5A2,Congenital alveolar capillary dysplasia ORPHA:210122,0.0586579655822394
COL5A2,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.0586579655822394
COL5A2,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.0586579655822394
COL5A2,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763,0.0586579655822394
COL5A2,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.0586579655822394
COL5A2,Kuskokwim syndrome ORPHA:1149,0.0586579655822394
COL5A2,Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528,0.0586579655822394
COL5A2,Lymphedema-distichiasis syndrome ORPHA:33001,0.0586579655822394
COL5A2,Muscle filaminopathy ORPHA:171445,0.0586579655822394
COL5A2,Non-immune hydrops fetalis ORPHA:363999,0.0586579655822394
COL5A2,Oculodentodigital dysplasia ORPHA:2710,0.0586579655822394
COL5A2,Posterior urethral valve ORPHA:93110,0.0586579655822394
COL5A2,Syndactyly type 3 ORPHA:93404,0.0586579655822394
COL5A2,Malignant peripheral nerve sheath tumor ORPHA:3148,0.0586579655822394
COL5A2,Postaxial polydactyly type B ORPHA:93335,0.0586579655822394
COL5A2,Sclerosteosis ORPHA:3152,0.0586579655822394
COL5A2,Hennekam syndrome ORPHA:2136,0.0599424746210022
COL5A2,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.0621182671032116
COL5A2,Osteogenesis imperfecta type 3 ORPHA:216812,0.0683063362547733
COL5A2,Hirschsprung disease ORPHA:388,0.0706635700002548
COL5A2,Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387,0.0902044104910482
COL5A2,Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899,0.1590470395003315
COL5A2,Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857,0.1590470395003315
COL5A2,Osteogenesis imperfecta type 1 ORPHA:216796,0.1590470395003315
COL5A2,Periodontal Ehlers-Danlos syndrome ORPHA:75392,0.1590470395003315
COL5A2,Ablepharon macrostomia syndrome ORPHA:920,0.1590470395003315
COL5A2,Acrogeria ORPHA:2500,0.1590470395003315
COL5A2,Allan-Herndon-Dudley syndrome ORPHA:59,0.1590470395003315
COL5A2,Barber-Say syndrome ORPHA:1231,0.1590470395003315
COL5A2,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.1590470395003315
COL5A2,Complete androgen insensitivity syndrome ORPHA:99429,0.1590470395003315
COL5A2,Dyssegmental dysplasia Silverman-Handmaker type ORPHA:1865,0.1590470395003315
COL5A2,Familial abdominal aortic aneurysm ORPHA:86,0.1590470395003315
COL5A2,Familial visceral myopathy ORPHA:2604,0.1590470395003315
COL5A2,Fibronectin glomerulopathy ORPHA:84090,0.1590470395003315
COL5A2,Focal facial dermal dysplasia type III ORPHA:1807,0.1590470395003315
COL5A2,Glutaric acidemia type 3 ORPHA:35706,0.1590470395003315
COL5A2,Kennedy disease ORPHA:481,0.1590470395003315
COL5A2,Lateral meningocele syndrome ORPHA:2789,0.1590470395003315
COL5A2,Myopathic intestinal pseudoobstruction ORPHA:104077,0.1590470395003315
COL5A2,Partial androgen insensitivity syndrome ORPHA:90797,0.1590470395003315
COL5A2,Schwartz-Jampel syndrome ORPHA:800,0.1590470395003315
COL5A2,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358,0.1590470395003315
COL5A2,Vascular Ehlers-Danlos syndrome ORPHA:286,0.1590470395003315
COL5A2,Hereditary mixed polyposis syndrome ORPHA:157794,0.1590470395003315
COL5A2,Isolated ectopia lentis ORPHA:1885,0.1590470395003315
COL5A2,Shprintzen-Goldberg syndrome ORPHA:2462,0.1590470395003315
COL5A2,Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144,0.1590470395003315
COL5A2,Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140,0.1590470395003315
COL5A2,Spondylometaphyseal dysplasia 'corner fracture' type ORPHA:93315,0.1590470395003315
COL5A2,Acrocallosal syndrome ORPHA:36,0.1590470395003315
COL5A2,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.1590470395003315
COL5A2,Isolated hemihyperplasia ORPHA:2128,0.1590470395003315
COL5A2,Congenital glaucoma ORPHA:98976,0.1614487935928034
COL5A2,Isolated brachycephaly ORPHA:35099,0.1614487935928034
COL5A2,Isolated plagiocephaly ORPHA:35098,0.1614487935928034
COL5A2,Autosomal dominant polycystic kidney disease ORPHA:730,0.1697334635963512
COL5A2,Bilateral striopallidodentate calcinosis ORPHA:1980,0.1697334635963512
COL5A2,NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279,0.1739455566145445
COL5A2,Colobomatous microphthalmia ORPHA:98938,0.1782034488938806
COL5A2,Heritable pulmonary arterial hypertension ORPHA:275777,0.1782034488938806
COL5A2,Bethlem myopathy ORPHA:610,0.3762014630157917
COL5A2,Congenital muscular dystrophy Ullrich type ORPHA:75840,0.3762014630157917
COL5A2,Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428,0.3762014630157917
COL5A2,Arterial tortuosity syndrome ORPHA:3342,0.3762014630157917
COL5A2,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154,0.3762014630157917
COL5A2,Autosomal recessive omodysplasia ORPHA:93329,0.3762014630157917
COL5A2,Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119,0.3762014630157917
COL5A2,Butyrylcholinesterase deficiency ORPHA:132,0.3762014630157917
COL5A2,Cardiac-valvular Ehlers-Danlos syndrome ORPHA:230851,0.3762014630157917
COL5A2,Curry-Jones syndrome ORPHA:1553,0.3762014630157917
COL5A2,EMILIN-1-related connective tissue disease ORPHA:485418,0.3762014630157917
COL5A2,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome ORPHA:2084,0.3762014630157917
COL5A2,Gordon syndrome ORPHA:376,0.3762014630157917
COL5A2,Hartsfield syndrome ORPHA:2117,0.3762014630157917
COL5A2,High bone mass osteogenesis imperfecta ORPHA:314029,0.3762014630157917
COL5A2,Laminin subunit alpha 2-related congenital muscular dystrophy ORPHA:258,0.3762014630157917
COL5A2,Malignant epithelial tumor of salivary glands ORPHA:276145,0.3762014630157917
COL5A2,Marden-Walker syndrome ORPHA:2461,0.3762014630157917
COL5A2,Marfan syndrome type 1 ORPHA:284963,0.3762014630157917
COL5A2,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome ORPHA:521445,0.3762014630157917
COL5A2,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953,0.3762014630157917
COL5A2,Neonatal Marfan syndrome ORPHA:284979,0.3762014630157917
COL5A2,Osteoglosphonic dysplasia ORPHA:2645,0.3762014630157917
COL5A2,Pelviscapular dysplasia ORPHA:93333,0.3762014630157917
COL5A2,Primary dystonia DYT27 type ORPHA:464440,0.3762014630157917
COL5A2,Progeroid and marfanoid aspect-lipodystrophy syndrome ORPHA:300382,0.3762014630157917
COL5A2,Stiff skin syndrome ORPHA:2833,0.3762014630157917
COL5A2,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386,0.3762014630157917
COL5A2,X-linked spondyloepimetaphyseal dysplasia ORPHA:93349,0.3762014630157917
COL5A2,Acromicric dysplasia ORPHA:969,0.3762014630157917
COL5A2,Craniometaphyseal dysplasia ORPHA:1522,0.3762014630157917
COL5A2,Fibrochondrogenesis ORPHA:2021,0.3762014630157917
COL5A2,Autosomal dominant cutis laxa ORPHA:90348,0.3762014630157917
COL5A2,Ellis Van Creveld syndrome ORPHA:289,0.3762014630157917
COL5A2,Geleophysic dysplasia ORPHA:2623,0.3762014630157917
COL5A2,Milroy disease ORPHA:79452,0.3762014630157917
COL5A2,NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293,0.3762014630157917
COL5A2,Weill-Marchesani syndrome ORPHA:3449,0.3762014630157917
COL5A2,Familial cerebral saccular aneurysm ORPHA:231160,0.3826134188846508
COL5A2,Osteogenesis imperfecta type 2 ORPHA:216804,0.3826134188846508
COL5A2,Osteogenesis imperfecta type 4 ORPHA:216820,0.4101640425710954
COL5A2,Acrofacial dysostosis Weyers type ORPHA:952,0.6239678957896782
COL5A2,Autosomal recessive cutis laxa type 1 ORPHA:90349,0.6239678957896782
COL5A2,Acromesomelic dysplasia Maroteaux type ORPHA:40,0.6239678957896782
COL5A2,Acroosteolysis-keloid-like lesions-premature aging syndrome ORPHA:363665,0.6239678957896782
COL5A2,Aplasia of lacrimal and salivary glands ORPHA:86815,0.6239678957896782
COL5A2,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome ORPHA:440354,0.6239678957896782
COL5A2,Blue rubber bleb nevus ORPHA:1059,0.6239678957896782
COL5A2,Branchioskeletogenital syndrome ORPHA:1299,0.6239678957896782
COL5A2,Chronic myeloproliferative disease unclassifiable ORPHA:86830,0.6239678957896782
COL5A2,Dermatosparaxis Ehlers-Danlos syndrome ORPHA:1901,0.6239678957896782
COL5A2,Generalized epilepsy-paroxysmal dyskinesia syndrome ORPHA:79137,0.6239678957896782
COL5A2,Late-onset retinal degeneration ORPHA:67042,0.6239678957896782
COL5A2,Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718,0.6239678957896782
COL5A2,Marshall syndrome ORPHA:560,0.6239678957896782
COL5A2,Mucocutaneous venous malformations ORPHA:2451,0.6239678957896782
COL5A2,Multisystemic smooth muscle dysfunction syndrome ORPHA:404463,0.6239678957896782
COL5A2,Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement ORPHA:168947,0.6239678957896782
COL5A2,Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement ORPHA:168950,0.6239678957896782
COL5A2,Myosclerosis ORPHA:289380,0.6239678957896782
COL5A2,Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome ORPHA:477831,0.6239678957896782
COL5A2,Stickler syndrome type 2 ORPHA:90654,0.6239678957896782
COL5A2,Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191,0.6239678957896782
COL5A2,3M syndrome ORPHA:2616,0.6239678957896782
COL5A2,Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990,0.6239678957896782
COL5A2,Infantile myofibromatosis ORPHA:2591,0.6239678957896782
COL5A2,Isolated trigonocephaly ORPHA:3366,0.6239678957896782
COL5A2,Punctate palmoplantar keratoderma type 1 ORPHA:79501,0.6239678957896782
COL5A2,Generalized juvenile polyposis/juvenile polyposis coli ORPHA:329971,0.6239678957896782
COL5A2,Isolated Klippel-Feil syndrome ORPHA:2345,0.6239678957896782
COL5A2,Primary hypereosinophilic syndrome ORPHA:314950,0.6279395134845649
COL5A2,Skeletal Ewing sarcoma ORPHA:319,0.6279395134845649
COL5A2,Classical-like Ehlers-Danlos syndrome type 2 ORPHA:536532,0.7068064785325423
COL5A2,Congenital factor X deficiency ORPHA:328,0.7068064785325423
COL5A2,Isolated Dandy-Walker malformation ORPHA:217,0.7068064785325423
COL5A2,Cerebrofacioarticular syndrome ORPHA:314679,0.7068064785325423
COL5A2,X-linked hypohidrotic ectodermal dysplasia ORPHA:181,0.7068064785325423
CORO1A,Colorectal Carcinoma,0.0034602840073026
CORO1A,Mammary Neoplasms,0.0034602840073026
CORO1A,Ovarian Carcinoma,0.0034602840073026
CORO1A,Breast Carcinoma,0.0042545616049287
CORO1A,Colorectal Cancer,0.0149315928814189
CORO1A,Squamous cell carcinoma,0.0182265588252201
CORO1A,ovarian neoplasm,0.0191435238361999
CORO1A,Malignant neoplasm of breast,0.0191435238361999
CORO1A,Carcinogenesis,0.0228075668512991
CORO1A,Malignant neoplasm of ovary,0.0277695594716545
CORO1A,Carcinoma Spindle-Cell,0.0308703957553632
CORO1A,Carcinoma,0.0593779966354549
CORO1A,Carcinomatosis,0.0617471306652618
CORO1A,Neoplasm Metastasis,0.0648809611869375
CORO1A,Lymphoma,0.0739788831250619
CORO1A,Anaplastic carcinoma,0.084286432100041
CORO1A,Adult Acute Lymphocytic Leukemia,0.0919714360040484
CORO1A,Liver carcinoma,0.095319386034013
CORO1A,Malignant Neoplasms,0.0991201145654548
CORO1A,Colon Carcinoma,0.1062239757831962
CORO1A,Undifferentiated carcinoma,0.13167400689206
CORO1A,Malignant neoplasm of large intestine,0.13167400689206
CORO1A,Mammary Carcinoma Animal,0.1352936728187231
CORO1A,Animal Mammary Neoplasms,0.1352936728187231
CORO1A,Hyperactive behavior,0.1387448809655294
CORO1A,Hydatidiform Mole Partial,0.1897991423047819
CORO1A,Malignant tumor of colon,0.223747154820789
CORO1A,Neoplasms,0.2714542429024338
CORO1A,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
CORO1A,Severe Combined Immunodeficiency,0.3553621627681198
CORO1A,Tuberculosis,0.3706856725676674
CORO1A,Primary malignant neoplasm,0.383941725017158
CORO1A,Complete hydatidiform mole,0.3933196962529684
CORO1A,Nephroblastoma,0.3933196962529684
CORO1A,Hydrocephalus,0.3933196962529684
CORO1A,Triploidy syndrome,0.3933196962529684
CORO1A,HYDATIDIFORM MOLE RECURRENT 1,0.3933196962529684
CORO1A,Cerebellar malformation,0.4126392832024548
CORO1A,Lupus Erythematosus Systemic,0.4213286052188015
CORO1A,Immunologic Deficiency Syndromes,0.4213286052188015
CORO1A,Lupus Vulgaris,0.4335751357405352
CORO1A,Epidermodysplasia Verruciformis,0.4396723023384634
CORO1A,Hydatidiform Mole,0.4506578937113162
CORO1A,leukemia,0.4588513406515081
CORO1A,Lupus Erythematosus,0.4615352570710579
CORO1A,Lupus Erythematosus Discoid,0.4675904598629673
CORO1A,Gestational Trophoblastic Neoplasms,0.5337853752290136
CORO1A,Lymphoma Follicular,0.533913711453195
CORO1A,Lymphopenia,0.586007951376766
CORO1A,Primary immune deficiency disorder,0.6841967398409226
CORO1A,insulinoma,0.6875373888914498
CORO1A,Muscular Dystrophy Duchenne,0.7045203904267408
CORO1A,Recurrent respiratory infections,0.7484342194688707
CORO1A,Attention deficit hyperactivity disorder,0.8600100703665297
CORO1A,Mental and motor retardation,0.897310588550617
CORO1A,Cognitive delay,0.9238745269736108
CORO1A,Global developmental delay,0.9327689937867868
CORO1A,Virus Diseases,0.9692165430561782
CORO1A,Anaplastic Carcinoma,0.0402286636010764
CORO1A,Carcinoma,0.0534520155998091
CORO1A,Omenn Syndrome,0.4646409362700993
CORO1A,Lymphopenia,0.4780231573499264
CORO1A,Immunodeficiency,0.6899894525110877
CORO1A,Severe Combined Immunodeficiency Disease,0.6952142233667052
CORO1A,Immunologic Deficiency Syndromes,0.903598527417506
CORO1A,Developmental Delay,0.96477535147595
CORO1A,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.3762014630157917
CORO1A,Congenital non-communicating hydrocephalus ORPHA:269510,0.3762014630157917
CORO1A,Spinocerebellar ataxia type 40 ORPHA:423275,0.3762014630157917
CORO1A,Coats plus syndrome ORPHA:313838,0.3762014630157917
CORO1A,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.6239678957896782
CORO1A,BENTA disease ORPHA:464336,0.6239678957896782
CORO1A,Combined immunodeficiency due to CD27 deficiency ORPHA:238505,0.6239678957896782
CORO1A,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.6239678957896782
CORO1A,Multiple intestinal atresia ORPHA:2300,0.6239678957896782
CORO1A,Neutrophil immunodeficiency syndrome ORPHA:183707,0.6239678957896782
CORO1A,Persistent polyclonal B-cell lymphocytosis ORPHA:300324,0.6239678957896782
CORO1A,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.6239678957896782
CORO1A,Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237,0.6239678957896782
CORO1A,Severe combined immunodeficiency due to LCK deficiency ORPHA:280142,0.6239678957896782
CORO1A,Cystic leukoencephalopathy without megalencephaly ORPHA:85136,0.6239678957896782
CORO1A,Recurrent infection due to specific granule deficiency ORPHA:169142,0.6239678957896782
CORO1A,Epidermodysplasia verruciformis ORPHA:302,0.6268296504510718
CORO1A,Aicardi-Goutieres syndrome ORPHA:51,0.639029370164481
CORO1A,Narcolepsy type 1 ORPHA:2073,0.64564126367818
CORO1A,Primary biliary cholangitis ORPHA:186,0.64564126367818
CORO1A,Precursor B-cell acute lymphoblastic leukemia ORPHA:99860,0.7068064785325423
CORO1A,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.7068064785325423
CORO1A,Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942,0.7068064785325423
CORO1A,Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943,0.7068064785325423
CORO1A,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046,0.7068064785325423
CORO1A,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585,0.7068064785325423
CORO1A,Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566,0.7068064785325423
CORO1A,Charcot-Marie-Tooth disease type 1B ORPHA:101082,0.7068064785325423
CORO1A,Combined immunodeficiency due to IL21R deficiency ORPHA:357329,0.7068064785325423
CORO1A,Combined immunodeficiency due to OX40 deficiency ORPHA:431149,0.7068064785325423
CORO1A,Combined immunodeficiency due to ZAP70 deficiency ORPHA:911,0.7068064785325423
CORO1A,DOCK2 deficiency ORPHA:447737,0.7068064785325423
CORO1A,Grange syndrome ORPHA:79094,0.7068064785325423
CORO1A,Hermansky-Pudlak syndrome type 7 ORPHA:231531,0.7068064785325423
CORO1A,Hyperinsulinism due to UCP2 deficiency ORPHA:276556,0.7068064785325423
CORO1A,Hyperzincemia and hypercalprotectinemia ORPHA:251523,0.7068064785325423
CORO1A,LIPE-related familial partial lipodystrophy ORPHA:435660,0.7068064785325423
CORO1A,Leukocyte adhesion deficiency type I ORPHA:99842,0.7068064785325423
CORO1A,Leukocyte adhesion deficiency type III ORPHA:99844,0.7068064785325423
CORO1A,NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050,0.7068064785325423
CORO1A,Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606,0.7068064785325423
CORO1A,Pancytopenia due to IKZF1 mutations ORPHA:317473,0.7068064785325423
CORO1A,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.7068064785325423
CORO1A,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126,0.7068064785325423
CORO1A,Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301,0.7068064785325423
CORO1A,Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003,0.7068064785325423
CORO1A,T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078,0.7068064785325423
CORO1A,T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276,0.7068064785325423
CORO1A,WHIM syndrome ORPHA:51636,0.7068064785325423
CORO1A,X-linked severe congenital neutropenia ORPHA:86788,0.7068064785325423
CORO1A,X-linked thrombocytopenia with normal platelets ORPHA:852,0.7068064785325423
CORO1A,Acute basophilic leukemia ORPHA:86849,0.7068064785325423
CORO1A,Familial isolated pituitary adenoma ORPHA:314777,0.7068064785325423
CORO1A,Stevens-Johnson syndrome ORPHA:36426,0.7068064785325423
CORO1A,Wiskott-Aldrich syndrome ORPHA:906,0.7068064785325423
CORO1A,Familial focal epilepsy with variable foci ORPHA:98820,0.7068064785325423
CORO1A,Immunodeficiency by defective expression of MHC class II ORPHA:572,0.7068064785325423
CORO1A,Autosomal dominant severe congenital neutropenia ORPHA:486,0.7068064785325423
CORO1A,Autosomal recessive malignant osteopetrosis ORPHA:667,0.7068064785325423
CORO1A,Complete hydatidiform mole ORPHA:254688,0.7068064785325423
CORO1A,Familial hemophagocytic lymphohistiocytosis ORPHA:540,0.7068064785325423
CORO1A,Narcolepsy type 2 ORPHA:83465,0.7068064785325423
CORO1A,Autosomal agammaglobulinemia ORPHA:33110,0.7068064785325423
CORO1A,Common variable immunodeficiency ORPHA:1572,0.7143653415082738
CPA4,Malignant neoplasm of prostate,0.0569142010728473
CPA4,Prostate carcinoma,0.0773771948186562
CPA4,Eosinophilic esophagitis,0.2085938372806741
CPA4,Asthma,0.3933196962529684
CPA4,Mastocytosis,0.4126392832024548
CPA4,Nasal Polyps,0.4459714599189374
CPA4,Pulmonary Eosinophilia,0.4852430673532381
CPA4,Prostate Cancer Hereditary 7,0.5019670090704682
CPA4,Russell-Silver syndrome,0.5916904943304121
CPA4,Rheumatoid Arthritis,0.4560460337187313
CPA4,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
CPA4,Bamforth-Lazarus syndrome ORPHA:1226,0.0180064224283883
CPA4,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.0180064224283883
CPA4,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.0586579655822394
CPA4,Athyreosis ORPHA:95713,0.0640416108792758
CPA4,X-linked hypophosphatemia ORPHA:89936,0.1590470395003315
CPA4,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.3762014630157917
CPA4,Familial isolated trichomegaly ORPHA:411788,0.3762014630157917
CPA4,Palmoplantar keratoderma Nagashima type ORPHA:140966,0.3762014630157917
CPA4,Proximal symphalangism ORPHA:3250,0.3762014630157917
CPEB4,Colorectal Carcinoma,0.0034602840073026
CPEB4,Breast Carcinoma,0.0042545616049287
CPEB4,Colorectal Cancer,0.0149315928814189
CPEB4,Tumor Progression,0.0149315928814189
CPEB4,Adenocarcinoma,0.0155921563748247
CPEB4,Malignant neoplasm of breast,0.0191435238361999
CPEB4,Neoplasm Metastasis,0.0648809611869375
CPEB4,Liver Cirrhosis,0.0773771948186562
CPEB4,Malignant Neoplasms,0.0991201145654548
CPEB4,Hypertension Portal,0.1328002618052838
CPEB4,Malignant neoplasm of liver,0.2643145809900195
CPEB4,Cirrhosis,0.2923761731100008
CPEB4,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
CPEB4,Gallbladder Carcinoma,0.3933196962529684
CPEB4,Chronic liver disease,0.3933196962529684
CPEB4,Astrocytoma,0.3933196962529684
CPEB4,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
CPEB4,Inflammatory Bowel Diseases,0.3933196962529684
CPEB4,Mean Corpuscular Volume (result),0.4192169590514327
CPEB4,Crohn Disease,0.4981941174985421
CPEB4,Diastolic blood pressure,0.5359212109443033
CPEB4,Body mass index,0.5496357724684553
CPEB4,Finding of body mass index,0.5496357724684553
CPEB4,Waist-Hip Ratio,0.549941235475765
CPEB4,Smoking Behaviors,0.5580691945487462
CPEB4,Waist Circumference,0.7129583530027284
CPEB4,Liver diseases,0.7337030585693298
CPEB4,Red cell distribution width determination,0.7577323833810212
CPEB4,RDW - Red blood cell distribution width result,0.7577323833810212
CPEB4,Erythrocyte Mean Corpuscular Hemoglobin Test,0.8352423037513227
CPEB4,Finding of Mean Corpuscular Hemoglobin,0.8352423037513227
CPEB4,Ulcerative Colitis,0.6990462534407934
CPEB4,Cholangitis,0.6999859437625926
CPEB4,Ankylosing Spondylitis,0.7049836926927165
CPEB4,Psoriasis,0.7184623115342476
CPEB4,Crohn Disease,0.7414460416900516
CPEB4,Inflammatory Bowel Disease,0.7662135194687344
CPEB4,Spinocerebellar ataxia type 1 ORPHA:98755,0.1590470395003315
CPEB4,Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971,0.3762014630157917
CPEB4,Acrodysostosis ORPHA:950,0.3762014630157917
CPEB4,Acrodysostosis with multiple hormone resistance ORPHA:280651,0.3762014630157917
CPEB4,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3775879467205478
CPEB4,Charcot-Marie-Tooth disease type 4H ORPHA:99954,0.6239678957896782
CPEB4,Complex lethal osteochondrodysplasia ORPHA:457378,0.6239678957896782
CPEB4,Gingival fibromatosis-hypertrichosis syndrome ORPHA:2026,0.6239678957896782
CPEB4,Chylomicron retention disease ORPHA:71,0.7068064785325423
CPEB4,Intermediate epidermolysis bullosa simplex with cardiomyopathy ORPHA:508529,0.7068064785325423
CPEB4,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation ORPHA:438216,0.7068064785325423
CPEB4,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion ORPHA:314655,0.7068064785325423
CPEB4,Human adenovirus 7d2 100 kDa hexon assembly-associated protein (gene: L4),0.6362779693488597
CPEB4,Human adenovirus 66 100 kDa hexon assembly-associated protein (gene: L4),0.6362779693488597
CPEB4,Human adenovirus 7 100K,0.6362779693488597
CPEB4,Human adenovirus 68 100 kDa hexon assembly-associated protein (gene: L4),0.6520551900793279
CPEB4,Titi monkey adenovirus ECC-2011 100K,0.7477109270664255
CPEB4,Human mastadenovirus B hexon assembly protein 100K (gene: L4),0.8031136315766868
CPEB4,Human adenovirus B3 L4 100-kDa protein (gene: L4),0.8031136315766868
CPEB4,Human adenovirus 21a 100 kDa hexon-assembly associated protein (gene: L4),0.8656146801545769
CPEB4,Cercopithecine betaherpesvirus 5 tegument protein UL37 (gene: UL47),0.9591706521139316
CTSD,Colorectal Carcinoma,0.0034602840073026
CTSD,Mammary Neoplasms,0.0034602840073026
CTSD,Ovarian Carcinoma,0.0034602840073026
CTSD,Breast Carcinoma,0.0042545616049287
CTSD,Invasive carcinoma of breast,0.0149002095788623
CTSD,Invasive Ductal Breast Carcinoma,0.0149002095788623
CTSD,Colorectal Cancer,0.0149315928814189
CTSD,Tumor Progression,0.0149315928814189
CTSD,Stomach Carcinoma,0.0149315928814189
CTSD,melanoma,0.0149315928814189
CTSD,Adenocarcinoma,0.0155921563748247
CTSD,Squamous cell carcinoma,0.0182265588252201
CTSD,ovarian neoplasm,0.0191435238361999
CTSD,Malignant neoplasm of breast,0.0191435238361999
CTSD,Malignant neoplasm of stomach,0.0191435238361999
CTSD,Carcinogenesis,0.0228075668512991
CTSD,Malignant neoplasm of ovary,0.0277695594716545
CTSD,Malignant neoplasm of prostate,0.0569142010728473
CTSD,Central neuroblastoma,0.0593779966354549
CTSD,Neoplasm Metastasis,0.0648809611869375
CTSD,Barrett Esophagus,0.0648809611869375
CTSD,Renal Cell Carcinoma,0.0648809611869375
CTSD,Neuroblastoma,0.0688152422187159
CTSD,Malignant neoplasm of pancreas,0.0726340460169901
CTSD,Pancreatic Neoplasm,0.0739788831250619
CTSD,Glioma,0.0739788831250619
CTSD,Degenerative polyarthritis,0.0739788831250619
CTSD,Glioblastoma,0.0745502070959292
CTSD,Pancreatic carcinoma,0.0745502070959292
CTSD,Prostate carcinoma,0.0773771948186562
CTSD,Malignant neoplasm of urinary bladder,0.084286432100041
CTSD,Bladder Neoplasm,0.0891725280554336
CTSD,Liver carcinoma,0.095319386034013
CTSD,Malignant Neoplasms,0.0991201145654548
CTSD,Osteosarcoma,0.1029977559100099
CTSD,Colon Carcinoma,0.1062239757831962
CTSD,Secondary malignant neoplasm of bone,0.1253114324938153
CTSD,Carcinoma of bladder,0.13167400689206
CTSD,Malignant neoplasm of endometrium,0.13167400689206
CTSD,Uterine Corpus Cancer,0.1328002618052838
CTSD,Myocardial Infarction,0.1352936728187231
CTSD,Liver neoplasms,0.1454373331146953
CTSD,Chromophobe Renal Cell Carcinoma,0.1461248774859792
CTSD,Rheumatoid Arthritis,0.1537760235124317
CTSD,Seizures,0.2053083986145698
CTSD,Prostatic Neoplasms,0.223747154820789
CTSD,Diabetes Mellitus,0.2522264785494494
CTSD,Adenocarcinoma Of Esophagus,0.2679411586077776
CTSD,Neoplasms,0.2714542429024338
CTSD,Malignant neoplasm of lung,0.2714542429024338
CTSD,Secondary malignant neoplasm of lung,0.2723545094624877
CTSD,Diabetic Retinopathy,0.2723545094624877
CTSD,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
CTSD,Endometrial Carcinoma,0.3044782497745498
CTSD,Sjogren's Syndrome,0.3099246715197673
CTSD,Cervical Squamous Cell Carcinoma,0.3199171478489988
CTSD,Carcinoma of lung,0.3663130598151661
CTSD,Anaplastic astrocytoma,0.3763374964032415
CTSD,Primary malignant neoplasm,0.383941725017158
CTSD,Acquired CJD,0.383941725017158
CTSD,Primary malignant neoplasm of lung,0.3902116649640871
CTSD,Muscle Rigidity,0.3933196962529684
CTSD,Secondary malignant neoplasm of lymph node,0.3933196962529684
CTSD,Amyloidosis,0.3933196962529684
CTSD,Spinocerebellar Ataxia Type 7,0.3933196962529684
CTSD,Dysplastic Nevus,0.3933196962529684
CTSD,Plaque Amyloid,0.3933196962529684
CTSD,Harlequin Fetus,0.3933196962529684
CTSD,Neuronal loss in central nervous system,0.3933196962529684
CTSD,Kidney Diseases,0.3933196962529684
CTSD,Nasopharyngeal carcinoma,0.3933196962529684
CTSD,Sarcomatoid Renal Cell Carcinoma,0.3933196962529684
CTSD,Non-Small Cell Lung Carcinoma,0.3933196962529684
CTSD,Oculocerebrorenal Syndrome,0.3933196962529684
CTSD,Amyotrophic Lateral Sclerosis Sporadic,0.3933196962529684
CTSD,HIV Infections,0.3933196962529684
CTSD,Collecting Duct Carcinoma of the Kidney,0.3933196962529684
CTSD,Astrocytoma,0.3933196962529684
CTSD,Alzheimer's Disease,0.3933196962529684
CTSD,Creutzfeldt-Jakob disease,0.3933196962529684
CTSD,Adenoid Cystic Carcinoma,0.3933196962529684
CTSD,Parkinson Disease,0.3933196962529684
CTSD,Increased neuronal autofluorescent lipopigment,0.3933196962529684
CTSD,Neuronal lipopigments,0.3933196962529684
CTSD,AMYOTROPHIC LATERAL SCLEROSIS 1,0.3933196962529684
CTSD,Craniosynostosis,0.3933196962529684
CTSD,Asthma,0.3933196962529684
CTSD,Ovarian cancer stage III,0.3933196962529684
CTSD,Epilepsy,0.3941558617476422
CTSD,Lafora Disease,0.3941558617476422
CTSD,Diabetic macular edema,0.3941558617476422
CTSD,Mental deterioration,0.39623320406434
CTSD,Amyotrophic Lateral Sclerosis,0.3975960596292668
CTSD,Papillary Renal Cell Carcinoma,0.3975960596292668
CTSD,Senile Plaques,0.3975960596292668
CTSD,Microcephaly,0.3975960596292668
CTSD,Weight Gain,0.3975960596292668
CTSD,Exaggerated startle response,0.3975960596292668
CTSD,Refractory cancer,0.4028066164685291
CTSD,Cerebral Amyloid Angiopathy Hereditary,0.4028066164685291
CTSD,Epilepsy Temporal Lobe,0.4103119460235835
CTSD,Neoplasm Invasiveness,0.4115056600660309
CTSD,Alzheimer Disease Late Onset,0.4115056600660309
CTSD,Familial Alzheimer Disease (FAD),0.4126392832024548
CTSD,Adult Neuronal Ceroid Lipofuscinosis,0.4126392832024548
CTSD,Nephropathic cystinosis,0.4126392832024548
CTSD,Late-Infantile Neuronal Ceroid Lipfuscinosis,0.4213286052188015
CTSD,Melanocytic nevus,0.425419812815905
CTSD,Mycoses,0.425419812815905
CTSD,Amyloid angiopathy,0.425419812815905
CTSD,Atrophic retina,0.425419812815905
CTSD,Dent's disease,0.425419812815905
CTSD,Other Creutzfeldt-Jakob disease,0.4304973629098372
CTSD,Apnea,0.4330362522463816
CTSD,Neurodegenerative Disorders,0.4335751357405352
CTSD,Supratentorial atrophy,0.4381343267935581
CTSD,Abnormal vision,0.4396723023384634
CTSD,Adenocarcinoma of prostate,0.4421745246585178
CTSD,Prion Diseases,0.4459714599189374
CTSD,Cholesteatoma,0.4459714599189374
CTSD,Status Epilepticus,0.4506578937113162
CTSD,Sloping forehead,0.4561717689698902
CTSD,Type II Mucolipidosis,0.4564472886428772
CTSD,Retinal Degeneration,0.4675904598629673
CTSD,Osteoarthrosis Deformans,0.4675904598629673
CTSD,Creutzfeldt-Jakob Disease Sporadic,0.472444704048021
CTSD,Adult Fanconi syndrome,0.4753011022966241
CTSD,Juvenile Neuronal Ceroid Lipofuscinosis,0.4753011022966241
CTSD,Degenerative brain disorder,0.4790179402069343
CTSD,Welts,0.4790179402069343
CTSD,Small head,0.4906258721078565
CTSD,Obesity,0.5140447474168605
CTSD,Respiratory Failure,0.5140447474168605
CTSD,Adenocarcinoma of lung (disorder),0.51550637274795
CTSD,Cerebellar atrophy,0.5251317541886066
CTSD,Neuronal Ceroid-Lipofuscinoses,0.5251317541886066
CTSD,Bacterial Infections,0.5337853752290136
CTSD,Cardiac Arrest,0.5453394612016188
CTSD,Intellectual disability progressive,0.5453394612016188
CTSD,Low set ears,0.5578737381206628
CTSD,Barrett Epithelium,0.5619299124666532
CTSD,Endometrial adenocarcinoma,0.5655222348249326
CTSD,Cerebellar Ataxia,0.5754799679683854
CTSD,Lymphopenia,0.586007951376766
CTSD,Frontotemporal dementia,0.6064571148125548
CTSD,Broad flat nasal bridge,0.6196470808426647
CTSD,Nasal bridge wide,0.6238969878903416
CTSD,Primary Effusion Lymphoma,0.6248356417853507
CTSD,Abnormality of metabolism/homeostasis,0.6274540883972485
CTSD,Cerebral atrophy,0.6294837700416086
CTSD,Infratentorial atrophy,0.6545439509404224
CTSD,MYOTONIC DYSTROPHY 1,0.6627865715415371
CTSD,Dementia Vascular,0.6802335864704374
CTSD,Cardiomyopathies,0.6989462176022242
CTSD,Cerebellar degeneration,0.7096959691931399
CTSD,Lung diseases,0.7128284704851243
CTSD,Retinitis Pigmentosa,0.7352133686428474
CTSD,Tumor Promotion,0.7577323833810212
CTSD,Severe mental retardation (I.Q. 20-34),0.7668324850675137
CTSD,Cholera,0.7670529315163258
CTSD,Urticaria,0.7706351321777464
CTSD,Gingival Diseases,0.7706351321777464
CTSD,Muscle Spasticity,0.7965501584766118
CTSD,Nodule,0.7977380842181487
CTSD,Autistic Disorder,0.8064248359603999
CTSD,Periodontal Diseases,0.8195255693608234
CTSD,Intellectual Disability,0.8352623613787349
CTSD,Epileptic encephalopathy,0.905697116584928
CTSD,Liver Carcinoma,0.0520696613701797
CTSD,Chromophobe Carcinoma,0.4286813331685578
CTSD,Papillary Renal Carcinoma,0.4286813331685578
CTSD,Arthritis,0.4541466895915311
CTSD,Renal Carcinoma,0.4541466895915311
CTSD,Rheumatoid Arthritis,0.4560460337187313
CTSD,Respiratory Failure,0.4560460337187313
CTSD,Lateral Sclerosis,0.4867879381749835
CTSD,Prostatic Neoplasms,0.4875380732267193
CTSD,Osteoarthrosis Deformans,0.5087473896242481
CTSD,Microcephaly,0.5123947823327547
CTSD,Cerebral Atrophy,0.5129298662020659
CTSD,Prostate Cancer,0.6104715460837368
CTSD,Kidney Disease,0.6420878824691651
CTSD,Status Epilepticus,0.7049836926927165
CTSD,Rod-cone Dystrophy,0.7062235569782704
CTSD,Cerebellar Atrophy,0.7112499273451761
CTSD,Mental Retardation,0.7729545590606223
CTSD,Disorder Of Eye,0.7729545590606223
CTSD,AGel amyloidosis ORPHA:85448,0.0586579655822394
CTSD,Keratolytic winter erythema ORPHA:50943,0.0586579655822394
CTSD,Mucopolysaccharidosis type 4A ORPHA:309297,0.0586579655822394
CTSD,Carnitine palmitoyl transferase 1A deficiency ORPHA:156,0.1590470395003315
CTSD,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.1590470395003315
CTSD,Galactosialidosis ORPHA:351,0.1590470395003315
CTSD,Sanfilippo syndrome type D ORPHA:79272,0.1590470395003315
CTSD,Tay-Sachs disease B variant adult form ORPHA:309192,0.1590470395003315
CTSD,Tay-Sachs disease B variant infantile form ORPHA:309178,0.1590470395003315
CTSD,Tay-Sachs disease B variant juvenile form ORPHA:309185,0.1590470395003315
CTSD,Tay-Sachs disease B1 variant ORPHA:309239,0.1590470395003315
CTSD,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.1739455566145445
CTSD,5-oxoprolinase deficiency ORPHA:33572,0.3762014630157917
CTSD,ACys amyloidosis ORPHA:100008,0.3762014630157917
CTSD,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.3762014630157917
CTSD,CLN10 disease ORPHA:228337,0.3762014630157917
CTSD,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3762014630157917
CTSD,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.3762014630157917
CTSD,Embryonal rhabdomyosarcoma ORPHA:99757,0.3762014630157917
CTSD,Fetal Gaucher disease ORPHA:85212,0.3762014630157917
CTSD,Gaucher disease type 2 ORPHA:77260,0.3762014630157917
CTSD,Gaucher disease type 3 ORPHA:77261,0.3762014630157917
CTSD,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072,0.3762014630157917
CTSD,Glycogen storage disease due to acid maltase deficiency infantile onset ORPHA:308552,0.3762014630157917
CTSD,Glycogen storage disease due to acid maltase deficiency late-onset ORPHA:420429,0.3762014630157917
CTSD,NON RARE IN EUROPE: Parkinson disease ORPHA:319705,0.3762014630157917
CTSD,Neutral lipid storage myopathy ORPHA:98908,0.3762014630157917
CTSD,Sanfilippo syndrome type B ORPHA:79270,0.3762014630157917
CTSD,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.3762014630157917
CTSD,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.3762014630157917
CTSD,Gaucher disease type 1 ORPHA:77259,0.3762014630157917
CTSD,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.3762014630157917
CTSD,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.3762014630157917
CTSD,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.3762014630157917
CTSD,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.3762014630157917
CTSD,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.3762014630157917
CTSD,Dysosteosclerosis ORPHA:1782,0.3762014630157917
CTSD,NON RARE IN EUROPE: Paget disease of bone ORPHA:280110,0.3762014630157917
CTSD,Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937,0.6239678957896782
CTSD,Autosomal dominant brachyolmia ORPHA:93304,0.6239678957896782
CTSD,Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216,0.6239678957896782
CTSD,Autosomal recessive spastic paraplegia type 76 ORPHA:488594,0.6239678957896782
CTSD,CLN11 disease ORPHA:314629,0.6239678957896782
CTSD,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.6239678957896782
CTSD,Clear cell renal carcinoma ORPHA:319276,0.6239678957896782
CTSD,Familial digital arthropathy-brachydactyly ORPHA:85169,0.6239678957896782
CTSD,Fucosidosis ORPHA:349,0.6239678957896782
CTSD,GM2 gangliosidosis AB variant ORPHA:309246,0.6239678957896782
CTSD,Infantile nephropathic cystinosis ORPHA:411629,0.6239678957896782
CTSD,Juvenile nephropathic cystinosis ORPHA:411634,0.6239678957896782
CTSD,Metatropic dysplasia ORPHA:2635,0.6239678957896782
CTSD,Mucolipidosis type III gamma ORPHA:423470,0.6239678957896782
CTSD,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.6239678957896782
CTSD,Niemann-Pick disease type A ORPHA:77292,0.6239678957896782
CTSD,Niemann-Pick disease type B ORPHA:77293,0.6239678957896782
CTSD,Ocular cystinosis ORPHA:411641,0.6239678957896782
CTSD,Parastremmatic dwarfism ORPHA:2646,0.6239678957896782
CTSD,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848,0.6239678957896782
CTSD,Sanfilippo syndrome type A ORPHA:79269,0.6239678957896782
CTSD,Scapuloperoneal spinal muscular atrophy ORPHA:431255,0.6239678957896782
CTSD,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.6239678957896782
CTSD,Spondyloepiphyseal dysplasia Maroteaux type ORPHA:263482,0.6239678957896782
CTSD,Spondylometaphyseal dysplasia Kozlowski type ORPHA:93314,0.6239678957896782
CTSD,Transcobalamin deficiency ORPHA:859,0.6239678957896782
CTSD,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.6239678957896782
CTSD,Rare isolated myopia ORPHA:98619,0.6239678957896782
CTSD,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.6268296504510718
CTSD,Semantic dementia ORPHA:100069,0.639029370164481
CTSD,Behavioral variant of frontotemporal dementia ORPHA:275864,0.6522156347158065
CTSD,Metachromatic leukodystrophy adult form ORPHA:309271,0.7068064785325423
CTSD,Metachromatic leukodystrophy juvenile form ORPHA:309263,0.7068064785325423
CTSD,Metachromatic leukodystrophy late infantile form ORPHA:309256,0.7068064785325423
CTSD,Atypical Gaucher disease due to saposin C deficiency ORPHA:309252,0.7068064785325423
CTSD,Cerebrotendinous xanthomatosis ORPHA:909,0.7068064785325423
CTSD,Cholesteryl ester storage disease ORPHA:75234,0.7068064785325423
CTSD,Encephalopathy due to prosaposin deficiency ORPHA:139406,0.7068064785325423
CTSD,FTH1-related iron overload ORPHA:247790,0.7068064785325423
CTSD,Genetic hyperferritinemia without iron overload ORPHA:254704,0.7068064785325423
CTSD,Heme oxygenase-1 deficiency ORPHA:562509,0.7068064785325423
CTSD,Hereditary hyperferritinemia-cataract syndrome ORPHA:163,0.7068064785325423
CTSD,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.7068064785325423
CTSD,L-ferritin deficiency ORPHA:440731,0.7068064785325423
CTSD,Neuroferritinopathy ORPHA:157846,0.7068064785325423
CTSD,Prolidase deficiency ORPHA:742,0.7068064785325423
CTSD,Wolman disease ORPHA:75233,0.7068064785325423
CTSD,CADDS ORPHA:369942,0.7068064785325423
CTSD,Infantile Krabbe disease ORPHA:206436,0.7068064785325423
CTSD,Pediatric systemic lupus erythematosus ORPHA:93552,0.7068064785325423
CTSD,Congenital generalized lipodystrophy ORPHA:528,0.7068064785325423
CTSD,Progressive non-fluent aphasia ORPHA:100070,0.7100092263364535
CTSD,Human adenovirus 41 E4 hypothetical protein 3,0.6362779693488597
CTSD,Human mastadenovirus F control protein E4orf3 (gene: E4),0.6362779693488597
CTSD,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.6481498905276316
CYP24A1,Colorectal Carcinoma,0.0034602840073026
CYP24A1,Mammary Neoplasms,0.0034602840073026
CYP24A1,Ovarian Carcinoma,0.0034602840073026
CYP24A1,Breast Carcinoma,0.0042545616049287
CYP24A1,Colorectal Cancer,0.0149315928814189
CYP24A1,Tumor Progression,0.0149315928814189
CYP24A1,melanoma,0.0149315928814189
CYP24A1,Adenocarcinoma,0.0155921563748247
CYP24A1,Esophageal Neoplasms,0.0182265588252201
CYP24A1,ovarian neoplasm,0.0191435238361999
CYP24A1,Malignant neoplasm of breast,0.0191435238361999
CYP24A1,Carcinogenesis,0.0228075668512991
CYP24A1,Malignant neoplasm of esophagus,0.0248454592431097
CYP24A1,Malignant neoplasm of ovary,0.0277695594716545
CYP24A1,Malignant neoplasm of prostate,0.0569142010728473
CYP24A1,Mammary Neoplasms Human,0.064548079316548
CYP24A1,Neoplasm Metastasis,0.0648809611869375
CYP24A1,Renal Cell Carcinoma,0.0648809611869375
CYP24A1,Malignant neoplasm of pancreas,0.0726340460169901
CYP24A1,Osteoporosis,0.0739788831250619
CYP24A1,Pancreatic carcinoma,0.0745502070959292
CYP24A1,Prostate carcinoma,0.0773771948186562
CYP24A1,Colorectal Neoplasms,0.0827744840860166
CYP24A1,Liver carcinoma,0.095319386034013
CYP24A1,Malignant Neoplasms,0.0991201145654548
CYP24A1,Colon Carcinoma,0.1062239757831962
CYP24A1,Esophageal carcinoma,0.1254380558571286
CYP24A1,Ductal Breast Carcinoma,0.13167400689206
CYP24A1,Malignant neoplasm of large intestine,0.13167400689206
CYP24A1,Solid Neoplasm,0.1413782599148022
CYP24A1,Liver neoplasms,0.1454373331146953
CYP24A1,Lung Neoplasms,0.2062010908869036
CYP24A1,Malignant tumor of colon,0.223747154820789
CYP24A1,Prostatic Neoplasms,0.223747154820789
CYP24A1,Diabetes,0.2277108302018961
CYP24A1,Diabetes Mellitus,0.2522264785494494
CYP24A1,Malignant neoplasm of lung,0.2714542429024338
CYP24A1,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
CYP24A1,Tumor-Associated Vasculature,0.2747883228704706
CYP24A1,Multiple Sclerosis,0.2835142372342932
CYP24A1,Wasting,0.2980670559114652
CYP24A1,Post-Traumatic Osteoporosis,0.3233418869346274
CYP24A1,Cholangiocarcinoma,0.340892538685018
CYP24A1,Osteoporosis Senile,0.3544355608905275
CYP24A1,Carcinoma of lung,0.3663130598151661
CYP24A1,Primary malignant neoplasm,0.383941725017158
CYP24A1,Primary malignant neoplasm of lung,0.3902116649640871
CYP24A1,Secondary malignant neoplasm of lymph node,0.3933196962529684
CYP24A1,Amyloidosis,0.3933196962529684
CYP24A1,Pancreatitis Chronic,0.3933196962529684
CYP24A1,Kidney Diseases,0.3933196962529684
CYP24A1,Papillary thyroid carcinoma,0.3933196962529684
CYP24A1,Non-Small Cell Lung Carcinoma,0.3933196962529684
CYP24A1,Osteoporosis Age-Related,0.3933196962529684
CYP24A1,Hypercalcemia Infantile,0.3933196962529684
CYP24A1,Vitamin D-resistant rickets,0.3933196962529684
CYP24A1,Abnormality of the eye,0.3933196962529684
CYP24A1,Deficiency of monooxygenase,0.3933196962529684
CYP24A1,Lymphoma Non-Hodgkin,0.3933196962529684
CYP24A1,Acute anterior uveitis,0.3933196962529684
CYP24A1,Cutaneous Mastocytosis,0.3933196962529684
CYP24A1,Asthma,0.3933196962529684
CYP24A1,Diabetic Nephropathy,0.3938591532700354
CYP24A1,Thyroid carcinoma,0.3941558617476422
CYP24A1,Bone Diseases,0.3941558617476422
CYP24A1,Elfin facies,0.3941558617476422
CYP24A1,Abortion Tubal,0.3975960596292668
CYP24A1,Multiple Endocrine Neoplasia Type 1,0.3986414839122469
CYP24A1,Chronic Kidney Diseases,0.4028066164685291
CYP24A1,Calcium measurement,0.4028066164685291
CYP24A1,Milk-Alkali Syndrome,0.4103119460235835
CYP24A1,Ulcer,0.4115056600660309
CYP24A1,Melanocytic nevus of skin,0.4126392832024548
CYP24A1,Pulmonary Stenosis,0.4186011760974318
CYP24A1,Arteriopathic disease,0.4192169590514327
CYP24A1,Cleft palate isolated,0.4192169590514327
CYP24A1,Aortic Valve Stenosis,0.4213286052188015
CYP24A1,Disorder of eye,0.4213286052188015
CYP24A1,Melanocytic nevus,0.425419812815905
CYP24A1,Infant Premature,0.4304973629098372
CYP24A1,Spontaneous abortion,0.4304973629098372
CYP24A1,Psoriasis,0.4304973629098372
CYP24A1,Hypophosphatemic Rickets,0.4304973629098372
CYP24A1,Malignant neoplasm of thyroid,0.4307603335611732
CYP24A1,Thick lower lip vermilion,0.4396723023384634
CYP24A1,Full lower lip,0.4396723023384634
CYP24A1,Adult Rickets,0.4396723023384634
CYP24A1,Cerebral Palsy,0.4675904598629673
CYP24A1,Chronic kidney disease stage 5,0.4704594475773637
CYP24A1,Dehydration,0.4714226702518064
CYP24A1,Weight decreased,0.472444704048021
CYP24A1,Familial Hypophosphatemic Rickets,0.472444704048021
CYP24A1,Alport Syndrome,0.4753011022966241
CYP24A1,Hypophosphatemic Rickets X-Linked Dominant,0.4852430673532381
CYP24A1,Osteomalacia,0.4923669467696064
CYP24A1,Rickets,0.4981941174985421
CYP24A1,Multinodular goiter,0.5019670090704682
CYP24A1,Polyuria,0.5019670090704682
CYP24A1,Obesity,0.5140447474168605
CYP24A1,Increased calcium level in kidney,0.5140447474168605
CYP24A1,Adenocarcinoma of lung (disorder),0.51550637274795
CYP24A1,Hyperparathyroidism Secondary,0.5188223685230745
CYP24A1,Kidney Failure Chronic,0.5299466034567416
CYP24A1,Dull intelligence,0.5300976305939776
CYP24A1,Low intelligence,0.5300976305939776
CYP24A1,Autoimmune Diseases,0.5512224939896888
CYP24A1,Poor school performance,0.5610226870913673
CYP24A1,Uveitis,0.5682392297191953
CYP24A1,Hypercalciuria,0.5696906826730043
CYP24A1,Mental deficiency,0.6035970790768342
CYP24A1,Nephrocalcinosis,0.6084642888478995
CYP24A1,Kidney Calculi,0.6222451141623291
CYP24A1,Mental Retardation,0.6319938293757544
CYP24A1,Ankylosing spondylitis,0.6446807314576214
CYP24A1,Behcet Syndrome,0.6496433426951205
CYP24A1,Renal Insufficiency,0.658736510383757
CYP24A1,Uveomeningoencephalitic Syndrome,0.6588479076808555
CYP24A1,Vomiting,0.6980473696540115
CYP24A1,Muscle Cramp,0.6980473696540115
CYP24A1,Dermatitis Atopic,0.7045203904267408
CYP24A1,Hypercalcemia,0.7317475852509061
CYP24A1,Nephrolithiasis,0.7347935459099629
CYP24A1,Lethargy,0.7631684472516962
CYP24A1,Generalized hypotonia,0.7631684472516962
CYP24A1,Eczema,0.7893058450619891
CYP24A1,Age related macular degeneration,0.8304052766033214
CYP24A1,Hepatitis C Chronic,0.8343509960860942
CYP24A1,Intellectual Disability,0.8352623613787349
CYP24A1,Undergrowth,0.9401531131388324
CYP24A1,Failure to gain weight,0.9449543840411656
CYP24A1,Pediatric failure to thrive,0.9465829057944656
CYP24A1,Kidney Failure,0.9661303320799302
CYP24A1,Breast Carcinoma,0.0075861267486594
CYP24A1,Marfan Syndrome,0.0133304506157067
CYP24A1,Mammary Neoplasms,0.0155248163763686
CYP24A1,Breast Cancer,0.0402286636010764
CYP24A1,Aortic Valve Sclerosis,0.3182746822082389
CYP24A1,Lung Cancer,0.4402141802500753
CYP24A1,Pulmonary Stenosis,0.4541466895915311
CYP24A1,Osteoporosis,0.4541466895915311
CYP24A1,Lung Neoplasms,0.4560460337187313
CYP24A1,Miscarriage,0.4560460337187313
CYP24A1,Milk-Alkali Syndrome,0.4560460337187313
CYP24A1,Hypercalcemia,0.4560460337187313
CYP24A1,Nephrolithiasis,0.4875380732267193
CYP24A1,Nephrocalcinosis,0.6792162876553974
CYP24A1,Kidney Failure,0.6899894525110877
CYP24A1,Renal Insufficiency,0.7112499273451761
CYP24A1,Mental Retardation,0.7729545590606223
CYP24A1,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
CYP24A1,Bamforth-Lazarus syndrome ORPHA:1226,0.0180064224283883
CYP24A1,Athyreosis ORPHA:95713,0.0640416108792758
CYP24A1,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.1590470395003315
CYP24A1,Monilethrix ORPHA:573,0.1590470395003315
CYP24A1,Idiopathic juvenile osteoporosis ORPHA:85193,0.1590470395003315
CYP4F2,Ovarian Carcinoma,0.0034602840073026
CYP4F2,Malignant neoplasm of ovary,0.0277695594716545
CYP4F2,Liver carcinoma,0.095319386034013
CYP4F2,Myocardial Infarction,0.1352936728187231
CYP4F2,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
CYP4F2,Ischemic stroke,0.3486533561309259
CYP4F2,Hypertensive disease,0.3933196962529684
CYP4F2,Vitamin E Assay,0.3941558617476422
CYP4F2,Celiac Disease,0.4028066164685291
CYP4F2,Cerebrovascular accident,0.4115056600660309
CYP4F2,Vascular Diseases,0.4126392832024548
CYP4F2,response to anticoagulant,0.4335751357405352
CYP4F2,Hypercholesterolemia,0.4755217870653703
CYP4F2,Crohn Disease,0.4981941174985421
CYP4F2,Metabolic Syndrome X,0.5568517196017908
CYP4F2,Non-alcoholic Fatty Liver Disease,0.625027955184583
CYP4F2,Patent ductus arteriosus,0.6334536292962906
CYP4F2,Calcification of coronary artery,0.6881884194440517
CYP4F2,Low density lipoprotein cholesterol measurement,0.6941270729825465
CYP4F2,Essential Hypertension,0.8418436641268439
CYP4F2,Cerebral Infarction,0.8472019892490944
CYP4F2,Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971,0.3762014630157917
CYP4F2,Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305,0.3762014630157917
CYP4F2,Dubin-Johnson syndrome ORPHA:234,0.6239678957896782
CYP4F2,Alkaptonuria ORPHA:56,0.7068064785325423
CYP4F2,Cystinuria type B ORPHA:93613,0.7068064785325423
CYP4F2,Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766,0.7068064785325423
CYP4F2,Hereditary fructose intolerance ORPHA:469,0.7068064785325423
CYP4F2,Ornithine transcarbamylase deficiency ORPHA:664,0.7068064785325423
CYP4F2,Progressive familial intrahepatic cholestasis type 5 ORPHA:480476,0.7068064785325423
CYP4F2,Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057,0.7068064785325423
CYP4F2,Severe hereditary thrombophilia due to congenital protein C deficiency ORPHA:745,0.7068064785325423
CYP4F2,Cholesterol-ester transfer protein deficiency ORPHA:79506,0.7068064785325423
CYP4F2,Hartnup disease ORPHA:2116,0.7068064785325423
CYP4F2,Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880,0.7068064785325423
DEPDC1B,Lip and Oral Cavity Carcinoma,0.3933196962529684
DEPDC1B,Malignant neoplasm of mouth,0.4213286052188015
DEPDC1B,Intelligence,0.5683976277847906
DEPDC1B,Liver Carcinoma,0.0520696613701797
DEPDC1B,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
DEPDC1B,Hereditary breast cancer ORPHA:227535,0.0106988445340883
DEPDC1B,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.0180064224283883
DEPDC1B,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0180064224283883
DEPDC1B,Filippi syndrome ORPHA:3255,0.0180064224283883
DEPDC1B,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0180064224283883
DEPDC1B,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0180064224283883
DEPDC1B,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0180064224283883
DEPDC1B,Roberts syndrome ORPHA:3103,0.0180064224283883
DEPDC1B,Stromme syndrome ORPHA:506307,0.0180064224283883
DEPDC1B,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.0180064224283883
DEPDC1B,Dedifferentiated liposarcoma ORPHA:99970,0.0183145313768111
DEPDC1B,Well-differentiated liposarcoma ORPHA:99971,0.0183145313768111
DEPDC1B,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.0586579655822394
DEPDC1B,Bloom syndrome ORPHA:125,0.0586579655822394
DEPDC1B,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0586579655822394
DEPDC1B,Microcephaly-micromelia syndrome ORPHA:572768,0.0586579655822394
DEPDC1B,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0586579655822394
DEPDC1B,Primary peritoneal carcinoma ORPHA:168829,0.0586579655822394
DEPDC1B,VACTERL with hydrocephalus ORPHA:3412,0.0586579655822394
DEPDC1B,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0599424746210022
DEPDC1B,Osteosarcoma ORPHA:668,0.0599424746210022
DEPDC1B,Seckel syndrome ORPHA:808,0.0683063362547733
DEPDC1B,Fanconi anemia ORPHA:84,0.0930156564388357
DEPDC1B,Autosomal recessive primary microcephaly ORPHA:2512,0.1026843275212335
DEPDC1B,Combined immunodeficiency with granulomatosis ORPHA:157949,0.1590470395003315
DEPDC1B,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.1590470395003315
DEPDC1B,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.1590470395003315
DEPDC1B,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1590470395003315
DEPDC1B,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.1590470395003315
DEPDC1B,Jawad syndrome ORPHA:313795,0.1590470395003315
DEPDC1B,Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894,0.1590470395003315
DEPDC1B,Ear-patella-short stature syndrome ORPHA:2554,0.1659988674007724
DEPDC1B,Chudley-McCullough syndrome ORPHA:314597,0.3762014630157917
DEPDC1B,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.3762014630157917
DEPDC1B,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.3762014630157917
DEPDC1B,ICF syndrome ORPHA:2268,0.3775879467205478
DEPDC1B,Nephroblastoma ORPHA:654,0.4101640425710954
DEPDC1B,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.6239678957896782
DEPDC1B,Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026,0.6239678957896782
DEPDC1B,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.6239678957896782
DEPDC1B,Autosomal dominant spastic paraplegia type 13 ORPHA:100994,0.6239678957896782
DEPDC1B,Citrullinemia type II ORPHA:247585,0.6239678957896782
DEPDC1B,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.6239678957896782
DEPDC1B,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.6239678957896782
DEPDC1B,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.6239678957896782
DEPDC1B,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.6239678957896782
DEPDC1B,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288,0.6239678957896782
DEPDC1B,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.6239678957896782
DEPDC1B,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.6239678957896782
DEPDC1B,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.6239678957896782
DEPDC1B,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.6239678957896782
DEPDC1B,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.6239678957896782
DEPDC1B,Small cell lung cancer ORPHA:70573,0.6239678957896782
DEPDC1B,46XY complete gonadal dysgenesis ORPHA:242,0.6581690778726346
DEPDC1B,Hereditary orotic aciduria ORPHA:30,0.7068064785325423
DEPDC1B,Muir-Torre syndrome ORPHA:587,0.7068064785325423
DMBX1,Proliferative vitreoretinopathy,0.0182265588252201
DMBX1,Seizures,0.2053083986145698
DMBX1,Cataract,0.223747154820789
DMBX1,Hyperopia,0.6959870102453846
DMBX1,Muscle hypotonia,0.7965733310657268
DMBX1,Hearing Loss Partial,0.8209296131179464
DMBX1,Mental and motor retardation,0.897310588550617
DMBX1,Strabismus,0.9894915051452228
DMBX1,Epilepsy,0.3449614869411272
DMBX1,Hyperopia,0.8323347200926986
DMBX1,Strabismus,0.9568083835980838
DMBX1,Developmental Delay,0.96477535147595
DMBX1,Nail-patella syndrome ORPHA:2614,0.6239678957896782
DMBX1,Nail-patella-like renal disease ORPHA:2613,0.6239678957896782
DMBX1,Yaba monkey tumor virus 72L,0.6362779693488597
DMBX1,Machupo mammarenavirus L protein,0.6362779693488597
DMBX1,Lassa mammarenavirus L protein,0.6362779693488597
DMBX1,Human immunodeficiency virus envelope glycoprotein (gene: env),0.6362779693488597
DMBX1,Human alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.6362779693488597
DMBX1,Human alphaherpesvirus 1 tegument protein VP22 (gene: UL49),0.6362779693488597
DMBX1,Junin mammarenavirus L protein,0.6362779693488597
DMBX1,Guanarito mammarenavirus L protein,0.6362779693488597
DNHD1,Renal Cell Carcinoma,0.0648809611869375
DNHD1,Chromophobe Renal Cell Carcinoma,0.1461248774859792
DNHD1,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
DNHD1,Sarcomatoid Renal Cell Carcinoma,0.3933196962529684
DNHD1,Collecting Duct Carcinoma of the Kidney,0.3933196962529684
DNHD1,Papillary Renal Cell Carcinoma,0.3975960596292668
DNHD1,Chromophobe Carcinoma,0.4286813331685578
DNHD1,Papillary Renal Carcinoma,0.4286813331685578
DNHD1,Renal Carcinoma,0.4541466895915311
DNHD1,Coats plus syndrome ORPHA:313838,0.3762014630157917
DNHD1,2q37 microdeletion syndrome ORPHA:1001,0.6239678957896782
DNHD1,Adult-onset dystonia-parkinsonism ORPHA:199351,0.6239678957896782
DNHD1,Autosomal dominant multiple pterygium syndrome ORPHA:65743,0.6239678957896782
DNHD1,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.6239678957896782
DNHD1,Birt-Hogg-Dube syndrome ORPHA:122,0.6239678957896782
DNHD1,Familial spontaneous pneumothorax ORPHA:2903,0.6239678957896782
DNHD1,Infantile neuroaxonal dystrophy ORPHA:35069,0.6239678957896782
DNHD1,Huntington disease ORPHA:399,0.6239678957896782
DNHD1,Autosomal recessive multiple pterygium syndrome ORPHA:2990,0.7068064785325423
DNHD1,17q21.31 microdeletion syndrome ORPHA:363958,0.7068064785325423
DNHD1,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964,0.7068064785325423
DNHD1,Autosomal recessive spastic paraplegia type 15 ORPHA:100996,0.7068064785325423
DNHD1,Combined malonic and methylmalonic acidemia ORPHA:289504,0.7068064785325423
DNHD1,Immunodeficiency due to MASP-2 deficiency ORPHA:331187,0.7068064785325423
DNHD1,Koolen-De Vries syndrome due to a point mutation ORPHA:363965,0.7068064785325423
DNHD1,NEK9-related lethal skeletal dysplasia ORPHA:464366,0.7068064785325423
DNHD1,Nevus comedonicus syndrome ORPHA:64754,0.7068064785325423
DNHD1,Perlman syndrome ORPHA:2849,0.7068064785325423
DNHD1,Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220,0.7068064785325423
DNHD1,Kabuki syndrome ORPHA:2322,0.7068064785325423
DOCK11,Breast Carcinoma,0.0042545616049287
DOCK11,Neoplasm Metastasis,0.0648809611869375
DOCK11,Chronic Lymphocytic Leukemia,0.1147307578771389
DOCK11,Diabetes Mellitus,0.2522264785494494
DOCK11,Wasting,0.2980670559114652
DOCK11,Pheochromocytoma,0.3712878513813393
DOCK11,pseudohermaphrodite (non-specific),0.3933196962529684
DOCK11,West Nile viral infection,0.425419812815905
DOCK11,Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome,0.4459714599189374
DOCK11,Graves Disease,0.4981941174985421
DOCK11,Penile hypospadias,0.5019670090704682
DOCK11,Familial medullary thyroid carcinoma,0.5090214163899865
DOCK11,Hypospadias,0.533913711453195
DOCK11,Encephalitis St. Louis,0.553002957824355
DOCK11,beta^+^ Thalassemia,0.563120546412355
DOCK11,alpha^+^ Thalassemia,0.652707626880454
DOCK11,Intellectual Disability,0.8352623613787349
DOCK11,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670,0.3762014630157917
DOCK11,Combined immunodeficiency due to Moesin deficiency ORPHA:504530,0.3762014630157917
DOCK11,Fried syndrome ORPHA:85335,0.3762014630157917
DOCK11,Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552,0.3762014630157917
DOCK11,Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537,0.3762014630157917
DOCK11,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568,0.3762014630157917
DOCK11,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329,0.3762014630157917
DOCK11,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972,0.6239678957896782
DOCK11,XYLT1-CDG ORPHA:370930,0.6239678957896782
DOCK11,Angiocentric glioma ORPHA:251671,0.6239678957896782
DOCK11,Huntington disease ORPHA:399,0.6239678957896782
DOCK11,Loeys-Dietz syndrome ORPHA:60030,0.6239678957896782
DOCK11,Bilateral parasagittal parieto-occipital polymicrogyria ORPHA:208441,0.7068064785325423
DOCK11,Charcot-Marie-Tooth disease type 4J ORPHA:139515,0.7068064785325423
DOCK11,Microcephalic primordial dwarfism Dauber type ORPHA:319675,0.7068064785325423
DOCK11,Multiple self-healing squamous epithelioma ORPHA:65748,0.7068064785325423
DOCK11,Acute promyelocytic leukemia ORPHA:520,0.7224251630156712
DRAXIN,15q13.3 microdeletion syndrome ORPHA:199318,0.1590470395003315
DRAXIN,Lissencephaly type 1 due to doublecortin gene mutation ORPHA:2148,0.6239678957896782
DRAXIN,CLN8 disease ORPHA:228354,0.7068064785325423
DRAXIN,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement ORPHA:2196,0.7068064785325423
DRAXIN,Focal facial dermal dysplasia type IV ORPHA:398189,0.7068064785325423
DRAXIN,Progressive epilepsy-intellectual disability syndrome Finnish type ORPHA:1947,0.7068064785325423
DRAXIN,Tatton-Brown-Rahman syndrome ORPHA:404443,0.7068064785325423
E2F7,Breast Carcinoma,0.0042545616049287
E2F7,Squamous cell carcinoma,0.0182265588252201
E2F7,ovarian neoplasm,0.0191435238361999
E2F7,Malignant neoplasm of breast,0.0191435238361999
E2F7,Squamous cell carcinoma of the head and neck,0.0775520919998773
E2F7,Liver carcinoma,0.095319386034013
E2F7,Chronic Lymphocytic Leukemia,0.1147307578771389
E2F7,Leukemogenesis,0.3510063969122338
E2F7,Leukemia Myelocytic Acute,0.3933196962529684
E2F7,Lung Carcinoma,0.4541466895915311
E2F7,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0180064224283883
E2F7,Filippi syndrome ORPHA:3255,0.0180064224283883
E2F7,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0180064224283883
E2F7,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0180064224283883
E2F7,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0180064224283883
E2F7,Stromme syndrome ORPHA:506307,0.0180064224283883
E2F7,Dedifferentiated liposarcoma ORPHA:99970,0.0183145313768111
E2F7,Well-differentiated liposarcoma ORPHA:99971,0.0183145313768111
E2F7,Combined pituitary hormone deficiencies genetic forms ORPHA:95494,0.0683063362547733
E2F7,Combined immunodeficiency with granulomatosis ORPHA:157949,0.1590470395003315
E2F7,Pleomorphic salivary gland adenoma ORPHA:454821,0.1590470395003315
E2F7,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.1590470395003315
E2F7,Branchio-oculo-facial syndrome ORPHA:1297,0.1590470395003315
E2F7,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542,0.1590470395003315
E2F7,Jawad syndrome ORPHA:313795,0.1590470395003315
E2F7,Xeroderma pigmentosum variant ORPHA:90342,0.1590470395003315
E2F7,Li-Fraumeni syndrome ORPHA:524,0.1614487935928034
E2F7,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.3762014630157917
E2F7,Melanoma and neural system tumor syndrome ORPHA:252206,0.3762014630157917
E2F7,Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938,0.6239678957896782
E2F7,Charcot-Marie-Tooth disease type 4B1 ORPHA:99955,0.6239678957896782
E2F7,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.6239678957896782
E2F7,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.6239678957896782
E2F7,12q14 microdeletion syndrome ORPHA:94063,0.6239678957896782
E2F7,Large congenital melanocytic nevus ORPHA:626,0.6239678957896782
E2F7,Small cell lung cancer ORPHA:70573,0.6239678957896782
E2F7,46XX gonadal dysgenesis ORPHA:243,0.6522156347158065
E2F7,46XY complete gonadal dysgenesis ORPHA:242,0.6581690778726346
E2F7,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.7068064785325423
E2F7,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.7068064785325423
E2F7,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.7068064785325423
E2F7,Geroderma osteodysplastica ORPHA:2078,0.7068064785325423
E2F7,Hydrolethalus ORPHA:2189,0.7068064785325423
EFR3B,Breast Carcinoma,0.0042545616049287
EFR3B,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
EFR3B,Schizophrenia,0.3933196962529684
EFR3B,Body mass index,0.5496357724684553
EFR3B,Finding of body mass index,0.5496357724684553
EFR3B,Body Height,0.5936773368594411
EFR3B,Breast Carcinoma,0.0075861267486594
EFR3B,Schizophrenia,0.0531117779464085
EFR3B,Diabetes Mellitus,0.9683912711598086
EFR3B,NON RARE IN EUROPE: Non rare obesity ORPHA:521399,0.1590470395003315
EFR3B,Autosomal spastic paraplegia type 72 ORPHA:401849,0.3762014630157917
EFR3B,Male infertility with teratozoospermia due to single gene mutation ORPHA:399808,0.3762014630157917
EFR3B,Bradyopsia ORPHA:75374,0.3762014630157917
EFR3B,Autosomal recessive cerebellar ataxia-psychomotor delay syndrome ORPHA:284271,0.6239678957896782
EFR3B,Cerebellar ataxia Cayman type ORPHA:94122,0.6239678957896782
EFR3B,DOORS syndrome ORPHA:79500,0.6239678957896782
EFR3B,Donnai-Barrow syndrome ORPHA:2143,0.6239678957896782
EFR3B,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587,0.6239678957896782
EFR3B,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome ORPHA:369970,0.6239678957896782
EFR3B,Progressive myoclonic epilepsy with dystonia ORPHA:352596,0.6239678957896782
EFR3B,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727,0.6239678957896782
EFR3B,X-linked central congenital hypothyroidism with late-onset testicular enlargement ORPHA:329235,0.6239678957896782
EFR3B,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.6239678957896782
EFR3B,PEHO syndrome ORPHA:2836,0.6239678957896782
EFR3B,Acquired schizencephaly ORPHA:485275,0.6239678957896782
EFR3B,Subcortical band heterotopia ORPHA:99796,0.6239678957896782
EFR3B,Thyrotoxic periodic paralysis ORPHA:79102,0.6239678957896782
EFR3B,Autosomal dominant non-syndromic intellectual disability ORPHA:178469,0.7068064785325423
EFR3B,Isolated Dandy-Walker malformation with hydrocephalus ORPHA:269212,0.7068064785325423
EFR3B,Isolated Dandy-Walker malformation without hydrocephalus ORPHA:269215,0.7068064785325423
EFR3B,Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946,0.7068064785325423
EFR3B,Autosomal dominant primary microcephaly ORPHA:2514,0.7068064785325423
EFR3B,Autosomal dominant spastic paraplegia type 73 ORPHA:444099,0.7068064785325423
EFR3B,Classic progressive supranuclear palsy syndrome ORPHA:240071,0.7068064785325423
EFR3B,Corpus callosum agenesis-abnormal genitalia syndrome ORPHA:2508,0.7068064785325423
EFR3B,Infant acute respiratory distress syndrome ORPHA:70587,0.7068064785325423
EFR3B,Infantile epileptic-dyskinetic encephalopathy ORPHA:364063,0.7068064785325423
EFR3B,Isolated oxycephaly ORPHA:63440,0.7068064785325423
EFR3B,Partington syndrome ORPHA:94083,0.7068064785325423
EFR3B,Pigmented paravenous retinochoroidal atrophy ORPHA:251295,0.7068064785325423
EFR3B,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome ORPHA:457212,0.7068064785325423
EFR3B,Progressive supranuclear palsy-corticobasal syndrome ORPHA:240103,0.7068064785325423
EFR3B,Progressive supranuclear palsy-parkinsonism syndrome ORPHA:240085,0.7068064785325423
EFR3B,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome ORPHA:240112,0.7068064785325423
EFR3B,Progressive supranuclear palsy-pure akinesia with gait freezing syndrome ORPHA:240094,0.7068064785325423
EFR3B,Spinocerebellar ataxia type 42 ORPHA:458803,0.7068064785325423
EFR3B,X-linked lissencephaly with abnormal genitalia ORPHA:452,0.7068064785325423
EFR3B,X-linked spasticity-intellectual disability-epilepsy syndrome ORPHA:3175,0.7068064785325423
EFR3B,Idiopathic ventricular fibrillation non Brugada type ORPHA:228140,0.7068064785325423
EFR3B,Occipital pachygyria and polymicrogyria ORPHA:280640,0.7068064785325423
EFR3B,Atypical Rett syndrome ORPHA:3095,0.7068064785325423
EFR3B,Nanophthalmos ORPHA:35612,0.7068064785325423
EHF,Ovarian Carcinoma,0.0034602840073026
EHF,Tumor Progression,0.0149315928814189
EHF,Stomach Carcinoma,0.0149315928814189
EHF,Malignant mesothelioma,0.0182265588252201
EHF,Malignant neoplasm of stomach,0.0191435238361999
EHF,Carcinogenesis,0.0228075668512991
EHF,Epithelial ovarian cancer,0.0387439397151409
EHF,Malignant neoplasm of prostate,0.0569142010728473
EHF,Prostate carcinoma,0.0773771948186562
EHF,Squamous cell carcinoma of esophagus,0.0919714360040484
EHF,Prostatic Neoplasms,0.223747154820789
EHF,Inflammation,0.3933196962529684
EHF,Ovarian Serous Adenocarcinoma,0.3933196962529684
EHF,Asthma,0.3933196962529684
EHF,Aortic Aneurysm Abdominal,0.3941558617476422
EHF,response to risperidone,0.4335751357405352
EHF,Cystic Fibrosis,0.6124306570512981
EHF,Lung diseases,0.7128284704851243
EHF,airway disease,0.721596134343186
EHF,Prostatic Neoplasms,0.4875380732267193
EHF,Prostate Cancer,0.6104715460837368
EHF,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
EHF,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
EHF,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
EHF,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
EHF,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.0180064224283883
EHF,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.0180064224283883
EHF,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.0586579655822394
EHF,Localized junctional epidermolysis bullosa ORPHA:251393,0.0586579655822394
EHF,AA amyloidosis ORPHA:85445,0.0586579655822394
EHF,Bartsocas-Papas syndrome ORPHA:1234,0.0586579655822394
EHF,Benign familial mesial temporal lobe epilepsy ORPHA:163717,0.0586579655822394
EHF,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.0586579655822394
EHF,CHAND syndrome ORPHA:1401,0.0586579655822394
EHF,Epithelial recurrent erosion dystrophy ORPHA:293381,0.0586579655822394
EHF,Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805,0.0586579655822394
EHF,Glutamate-cysteine ligase deficiency ORPHA:33574,0.0586579655822394
EHF,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.0586579655822394
EHF,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.0586579655822394
EHF,Neuropathy with hearing impairment ORPHA:139512,0.0586579655822394
EHF,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.0586579655822394
EHF,Marie Unna hereditary hypotrichosis ORPHA:444,0.0586579655822394
EHF,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.0586579655822394
EHF,White sponge nevus ORPHA:171723,0.1590470395003315
EHF,Cholangiocarcinoma ORPHA:70567,0.1590470395003315
EHF,Familial expansile osteolysis ORPHA:85195,0.1590470395003315
EHF,Harlequin ichthyosis ORPHA:457,0.1590470395003315
EHF,High myopia-sensorineural deafness syndrome ORPHA:363396,0.1590470395003315
EHF,Keratoderma hereditarium mutilans ORPHA:494,0.1590470395003315
EHF,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.1590470395003315
EHF,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1590470395003315
EHF,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.1590470395003315
EHF,Xanthinuria type I ORPHA:93601,0.1590470395003315
EHF,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.1590470395003315
EHF,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.1590470395003315
EHF,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.1590470395003315
EHF,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.1697334635963512
EHF,Autosomal recessive spastic paraplegia type 35 ORPHA:171629,0.3762014630157917
EHF,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3762014630157917
EHF,Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681,0.3762014630157917
EHF,Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308,0.3762014630157917
EHF,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3762014630157917
EHF,Genetic transient congenital hypothyroidism ORPHA:226316,0.3762014630157917
EHF,Glucose-galactose malabsorption ORPHA:35710,0.3762014630157917
EHF,MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949,0.3762014630157917
EHF,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.3762014630157917
EHF,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3762014630157917
EHF,Microvillus inclusion disease ORPHA:2290,0.3762014630157917
EHF,Cleft lip and alveolus ORPHA:141291,0.3775879467205478
EHF,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.3775879467205478
EHF,Isolated cleft lip ORPHA:199302,0.3775879467205478
EHF,Posterior polymorphous corneal dystrophy ORPHA:98973,0.3826134188846508
EHF,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.6239678957896782
EHF,KID syndrome ORPHA:477,0.6239678957896782
EHF,Liddle syndrome ORPHA:526,0.6239678957896782
EHF,Van der Woude syndrome ORPHA:888,0.6239678957896782
EHF,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.6239678957896782
EHF,Autosomal recessive cerebral atrophy ORPHA:363969,0.6239678957896782
EHF,Ectodermal dysplasia-syndactyly syndrome ORPHA:247820,0.6239678957896782
EHF,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043,0.6239678957896782
EHF,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334,0.6239678957896782
EHF,Ichthyosis-hypotrichosis syndrome ORPHA:91132,0.6239678957896782
EHF,Idiopathic bronchiectasis ORPHA:60033,0.6239678957896782
EHF,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.6239678957896782
EHF,Mullerian aplasia and hyperandrogenism ORPHA:247768,0.6239678957896782
EHF,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.6239678957896782
EHF,Non-epidermolytic palmoplantar keratoderma ORPHA:2337,0.6239678957896782
EHF,REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330,0.6239678957896782
EHF,SERKAL syndrome ORPHA:139466,0.6239678957896782
EHF,Syndromic congenital sodium diarrhea ORPHA:563708,0.6239678957896782
EHF,Systemic primary carnitine deficiency ORPHA:158,0.6239678957896782
EHF,Diffuse panbronchiolitis ORPHA:171700,0.6239678957896782
EHF,Hypotrichosis simplex ORPHA:55654,0.639029370164481
EHF,Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189,0.7068064785325423
EHF,Microcytic anemia with liver iron overload ORPHA:83642,0.7068064785325423
EHF,Acrodermatitis continua of Hallopeau ORPHA:163931,0.7068064785325423
EHF,Generalized pustular psoriasis ORPHA:247353,0.7068064785325423
EHF,Neonatal severe primary hyperparathyroidism ORPHA:417,0.7068064785325423
EHF,Pustulosis palmaris et plantaris ORPHA:163927,0.7068064785325423
EHF,Horsepox virus HSPV020e (ankyrin repeats),0.7079503198328393
EHF,Orf virus ORF123 ankyrin repeat protein,0.8390943852085586
EHF,Monkeypox virus ankyrin-like protein,0.8426793553344071
EHF,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.876049415394169
EHF,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.9097056179628632
EHF,Ectromelia virus ERPV ankyrin,0.9199249371723298
EHF,Orf virus ORF008 ankyrin repeat protein,0.9285312497152513
EHF,Horsepox virus HSPV181 (ankyrin repeats),0.9517968639566384
EHF,Vaccinia virus ankyrin-like protein (gene: B4R),0.9518028028273808
EHF,Yaba monkey tumor virus ankyrin repeat protein,0.960637237597315
EHF,Yaba-like disease virus 11L protein (gene: 11L),0.9624639844306644
ELFN2,Brain-lung-thyroid syndrome ORPHA:209905,0.3762014630157917
ELFN2,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.3762014630157917
ELFN2,MASA syndrome ORPHA:2466,0.3762014630157917
ELFN2,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.3762014630157917
ELFN2,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.3762014630157917
ENC1,Colorectal Carcinoma,0.0034602840073026
ENC1,Mammary Neoplasms,0.0034602840073026
ENC1,Carcinogenesis,0.0228075668512991
ENC1,Central neuroblastoma,0.0593779966354549
ENC1,Brain Neoplasms,0.064548079316548
ENC1,Neuroblastoma,0.0688152422187159
ENC1,Liver Cirrhosis Experimental,0.0747863377072194
ENC1,Colon Carcinoma,0.1062239757831962
ENC1,Malignant tumor of colon,0.223747154820789
ENC1,Nervous System Neoplasms,0.2569222032997501
ENC1,Hairy Cell Leukemia,0.3412203844672238
ENC1,Hurthle Cell Tumor,0.3933196962529684
ENC1,Adenoma,0.3933196962529684
ENC1,Multiple Myeloma,0.4103119460235835
ENC1,Non-Functioning Pituitary Gland Neoplasm,0.4192169590514327
ENC1,Adrenal Cortical Adenoma,0.7156410971578294
ENC1,Pyruvate dehydrogenase phosphatase deficiency ORPHA:79246,0.6239678957896782
ENC1,Yaba-like disease virus 140R protein (gene: 140R),0.6362779693488597
ENC1,Yaba monkey tumor virus kelch-like protein,0.6362779693488597
ENC1,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.6362779693488597
ENC1,Vaccinia virus Kelch-like protein (gene: F3L),0.6362779693488597
ENC1,Vaccinia virus Ankara Kelch-like protein,0.6362779693488597
ENC1,Horsepox virus HSPV008,0.6362779693488597
ENC1,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.6362779693488597
ENC1,Horsepox virus HSPV176 (kelch-like protein,0.6362779693488597
ENC1,Provisional),0.6362779693488597
ENC1,Yaba-like disease virus 19L protein (gene: 19L),0.6362779693488597
ENC1,Horsepox virus HSPV043 (Kelch-like protein,0.6362779693488597
ENC1,Vaccinia virus kelch-like protein (gene: A55R),0.6362779693488597
ENC1,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.6362779693488597
ENC1,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.6362779693488597
ENC1,Horsepox virus HSPV197 (Hypothetical protein),0.6362779693488597
ENC1,Monkeypox virus Zaire-96-I-16 B18R (gene: B18R),0.6362779693488597
ENC1,Monkeypox virus Zaire-96-I-16 B1R (gene: B1R),0.6362779693488597
ENC1,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.6362779693488597
ENC1,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.6362779693488597
ENC1,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.6362779693488597
ENC1,Vaccinia virus Ankara 64.7k Kelch-like protein f2,0.6362779693488597
ENC1,Monkeypox virus kelch-like protein,0.6362779693488597
ENC1,Horsepox virus HSPV029 (kelch-like protein,0.6362779693488597
ENC1,Ectromelia virus ERPV kelch-like protein,0.6362779693488597
ENC1,Monkeypox virus Zaire-96-I-16 D15L (gene: D15L),0.6362779693488597
ENC1,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.6362779693488597
ENC1,Vaccinia virus kelch-like protein (gene: C2L),0.6362779693488597
ENC1,Monkeypox virus Zaire-96-I-16 D17L (gene: D17L),0.6362779693488597
ENC1,Variola virus hypothetical protein (gene: J8R),0.6362779693488597
ENC1,Variola virus hypothetical protein (gene: D13L),0.6362779693488597
ENC1,Vaccinia virus Ankara 18.9k Kelch-like protein,0.6362779693488597
ENC1,Cowpox virus CPXV204 protein (gene: CPXV204 CDS),0.6624448726460891
ENC1,Variola virus hypothetical protein (gene: C7L),0.7648879200949484
ENC1,Variola virus hypothetical protein (gene: B24R),0.776311155917498
ENC1,Variola virus hypothetical protein (gene: J7R),0.7975886343350181
ENG,Colorectal Carcinoma,0.0034602840073026
ENG,Mammary Neoplasms,0.0034602840073026
ENG,Ovarian Carcinoma,0.0034602840073026
ENG,Breast Carcinoma,0.0042545616049287
ENG,Colorectal Cancer,0.0149315928814189
ENG,Tumor Progression,0.0149315928814189
ENG,Stomach Carcinoma,0.0149315928814189
ENG,melanoma,0.0149315928814189
ENG,Adenocarcinoma,0.0155921563748247
ENG,Squamous cell carcinoma,0.0182265588252201
ENG,Esophageal Neoplasms,0.0182265588252201
ENG,Malignant neoplasm of breast,0.0191435238361999
ENG,Malignant neoplasm of stomach,0.0191435238361999
ENG,Carcinogenesis,0.0228075668512991
ENG,Malignant neoplasm of esophagus,0.0248454592431097
ENG,Malignant neoplasm of ovary,0.0277695594716545
ENG,Carcinoma Spindle-Cell,0.0308703957553632
ENG,Epithelial ovarian cancer,0.0387439397151409
ENG,Malignant neoplasm of prostate,0.0569142010728473
ENG,Neoplasm Metastasis,0.0648809611869375
ENG,Barrett Esophagus,0.0648809611869375
ENG,Mucoepidermoid Carcinoma,0.0648809611869375
ENG,Renal Cell Carcinoma,0.0648809611869375
ENG,Malignant neoplasm of pancreas,0.0726340460169901
ENG,Pancreatic Neoplasm,0.0739788831250619
ENG,Glioma,0.0739788831250619
ENG,Degenerative polyarthritis,0.0739788831250619
ENG,Endometrial Neoplasms,0.0745502070959292
ENG,Glioblastoma,0.0745502070959292
ENG,Pancreatic carcinoma,0.0745502070959292
ENG,Carcinoma breast stage IV,0.0745502070959292
ENG,AORTIC VALVE DISEASE 2,0.0745502070959292
ENG,Liver Cirrhosis,0.0773771948186562
ENG,Prostate carcinoma,0.0773771948186562
ENG,Squamous cell carcinoma of the head and neck,0.0775520919998773
ENG,Colorectal Neoplasms,0.0827744840860166
ENG,Squamous cell carcinoma of esophagus,0.0919714360040484
ENG,Liver carcinoma,0.095319386034013
ENG,Osteosarcoma,0.1029977559100099
ENG,Colon Carcinoma,0.1062239757831962
ENG,Hematologic Neoplasms,0.1253114324938153
ENG,MYELODYSPLASTIC SYNDROME,0.1254380558571286
ENG,Esophageal carcinoma,0.1254380558571286
ENG,Carcinoma Transitional Cell,0.13167400689206
ENG,Hypertension Portal,0.1328002618052838
ENG,Myocardial Infarction,0.1352936728187231
ENG,Solid Neoplasm,0.1413782599148022
ENG,Colonic Neoplasms,0.1454373331146953
ENG,Mixed Salivary Gland Tumor,0.1454373331146953
ENG,Rheumatoid Arthritis,0.1537760235124317
ENG,Sarcoma,0.1537760235124317
ENG,Renal fibrosis,0.1602092191314262
ENG,Intracranial Aneurysm,0.1735868515093891
ENG,Systemic Scleroderma,0.1900258729042946
ENG,cervical cancer,0.2050045461627939
ENG,Seizures,0.2053083986145698
ENG,Gastrointestinal Neoplasms,0.2062010908869036
ENG,Lung Neoplasms,0.2062010908869036
ENG,Osteosarcoma of bone,0.2109483801368481
ENG,Prostatic Neoplasms,0.223747154820789
ENG,Metastasis from malignant tumor of prostate,0.2454426921531692
ENG,Anoxia,0.2462384927636234
ENG,Malignant neoplasm of liver,0.2643145809900195
ENG,Chondrosarcoma,0.2643145809900195
ENG,Metastatic Prostate Carcinoma,0.2643145809900195
ENG,Arteriovenous Malformations Cerebral,0.2643145809900195
ENG,Adenocarcinoma Of Esophagus,0.2679411586077776
ENG,Bicuspid aortic valve,0.2687300999130421
ENG,Malignant tumor of cervix,0.2714542429024338
ENG,Malignant neoplasm of lung,0.2714542429024338
ENG,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
ENG,Secondary malignant neoplasm of lung,0.2723545094624877
ENG,Diabetic Retinopathy,0.2723545094624877
ENG,Tumor-Associated Vasculature,0.2747883228704706
ENG,Cervix carcinoma,0.2834835531038365
ENG,Adult Hepatocellular Carcinoma,0.290158730291654
ENG,Aortic Aneurysm Thoracic,0.2980670559114652
ENG,Hemangioma,0.3099246715197673
ENG,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.3105909001629992
ENG,Gastrointestinal Stromal Tumors,0.3199171478489988
ENG,Ischemic stroke,0.3486533561309259
ENG,Ataxia Telangiectasia,0.3508665345292502
ENG,Severe Combined Immunodeficiency,0.3553621627681198
ENG,Carcinoma of lung,0.3663130598151661
ENG,Uterine Fibroids,0.383941725017158
ENG,Primary malignant neoplasm of lung,0.3902116649640871
ENG,Pulmonary arterial hypertension,0.3925783478421996
ENG,Secondary malignant neoplasm of lymph node,0.3933196962529684
ENG,Chronic myeloproliferative disorder,0.3933196962529684
ENG,Cerebrovascular Disorders,0.3933196962529684
ENG,Generalized seizures,0.3933196962529684
ENG,Interstitial lung fibrosis,0.3933196962529684
ENG,Kidney Diseases,0.3933196962529684
ENG,Papillary thyroid carcinoma,0.3933196962529684
ENG,Hereditary Nonpolyposis Colorectal Cancer,0.3933196962529684
ENG,tumor vasculature,0.3933196962529684
ENG,Cerebral arterial aneurysm,0.3933196962529684
ENG,Hypertensive disease,0.3933196962529684
ENG,Juvenile rheumatoid arthritis,0.3933196962529684
ENG,Bronchopulmonary Dysplasia,0.3933196962529684
ENG,Skin Carcinogenesis,0.3933196962529684
ENG,Hemorrhage,0.3933196962529684
ENG,Refractory cytopenia with multilineage dysplasia,0.3933196962529684
ENG,Saccular Aneurysm,0.3933196962529684
ENG,Dural Arteriovenous Fistula,0.3933196962529684
ENG,OSLER-RENDU-WEBER SYNDROME 2,0.3933196962529684
ENG,Urothelial Carcinoma,0.3933196962529684
ENG,Aplasia Cutis Congenita,0.3933196962529684
ENG,Associated Pulmonary Arterial Hypertension,0.3933196962529684
ENG,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
ENG,Acute lymphocytic leukemia,0.3933196962529684
ENG,Adenoid Cystic Carcinoma,0.3933196962529684
ENG,Fibrosis Liver,0.3933196962529684
ENG,Grade III Chondrosarcoma,0.3933196962529684
ENG,Mammary adenocarcinoma,0.3933196962529684
ENG,Telangiectasis,0.3933196962529684
ENG,Spontaneous hematomas,0.3933196962529684
ENG,Familial pulmonary arterial hypertension,0.3933196962529684
ENG,Polyglobulia,0.3933196962529684
ENG,Anaplasia,0.3938591532700354
ENG,Diabetic Nephropathy,0.3938591532700354
ENG,Anemia,0.3941558617476422
ENG,Malignant neoplasm of kidney,0.3941558617476422
ENG,Familial multiple trichoepitheliomata,0.3941558617476422
ENG,Epilepsy,0.3941558617476422
ENG,Pulmonary Veno-Occlusive Disease (disorder),0.3941558617476422
ENG,Renal carcinoma,0.3941558617476422
ENG,Abnormality of brainstem morphology,0.3941558617476422
ENG,Cerebral abscess,0.3941558617476422
ENG,Amyotrophic Lateral Sclerosis,0.3975960596292668
ENG,Senile Plaques,0.3975960596292668
ENG,Brain Abscess,0.3975960596292668
ENG,Intracranial Arteriovenous Malformation,0.3975960596292668
ENG,Plaque build-up in arteries,0.3975960596292668
ENG,Glomerulosclerosis (disorder),0.4028066164685291
ENG,Hemoglobin low,0.4028066164685291
ENG,Erythrocytosis,0.4028066164685291
ENG,Extramedullary Plasmacytoma,0.4028066164685291
ENG,Cholestasis,0.4100901006059349
ENG,Agenesis of corpus callosum,0.4103119460235835
ENG,Multiple Myeloma,0.4103119460235835
ENG,Primary Myelofibrosis,0.4103119460235835
ENG,Cerebrovascular accident,0.4115056600660309
ENG,Clubbing,0.4115056600660309
ENG,Conjunctival telangiectasis,0.4115056600660309
ENG,Hematochezia,0.4115056600660309
ENG,Dyspnea,0.4126392832024548
ENG,Vascular Diseases,0.4126392832024548
ENG,Visceral angiomatosis,0.4126392832024548
ENG,Congenital arteriovenous malformation,0.4186011760974318
ENG,Triglycerides measurement,0.4192169590514327
ENG,Lupus Erythematosus Systemic,0.4213286052188015
ENG,Myoma,0.4213286052188015
ENG,Congestive heart failure,0.425419812815905
ENG,Cholecystitis,0.425419812815905
ENG,Heart failure,0.4304973629098372
ENG,Squamous cell carcinoma of lung,0.4335751357405352
ENG,Meningioma,0.4396723023384634
ENG,Migraine Disorders,0.4450743762496232
ENG,Salivary Gland Neoplasms,0.4506578937113162
ENG,Signs and Symptoms Respiratory,0.4506578937113162
ENG,Familial primary pulmonary hypertension,0.4506578937113162
ENG,Aneurysm,0.4561717689698902
ENG,Choriocarcinoma,0.4564472886428772
ENG,Hemangioma Cavernous,0.4564472886428772
ENG,Cyanosis,0.4564472886428772
ENG,Menkes Kinky Hair Syndrome,0.4615352570710579
ENG,Cardiovascular Diseases,0.4675904598629673
ENG,Vascular anomaly,0.4675904598629673
ENG,Visual field defects,0.4675904598629673
ENG,Congenital vascular anomaly,0.4675904598629673
ENG,Hereditary hemorrhagic telangiectasia,0.4753011022966241
ENG,Intermittent migraine headaches,0.4790179402069343
ENG,Brain hemorrhage,0.4790179402069343
ENG,Thrombosis,0.4906258721078565
ENG,Juvenile polyposis syndrome,0.4906258721078565
ENG,Increase in blood pressure,0.4923669467696064
ENG,Central Diabetes Insipidus,0.4923669467696064
ENG,Iron-Refractory Iron Deficiency Anemia,0.4923669467696064
ENG,Ulcerative Colitis,0.5001612228394569
ENG,Scleroderma,0.5019670090704682
ENG,Arteriosclerosis,0.5019670090704682
ENG,Borderline Personality Disorder,0.5188223685230745
ENG,Arteriovenous hemangioma,0.5188223685230745
ENG,Ewings sarcoma,0.5251317541886066
ENG,Congenital Abnormality,0.5305233935923577
ENG,Congenital Heart Defects,0.533913711453195
ENG,Atherosclerosis,0.5393787854381349
ENG,Transient Cerebral Ischemia,0.5393787854381349
ENG,Telangiectasia of the skin,0.553002957824355
ENG,Hereditary Diseases,0.553002957824355
ENG,Idiopathic pulmonary arterial hypertension,0.5655222348249326
ENG,Angioimmunoblastic Lymphadenopathy,0.5710095678317721
ENG,Epistaxis,0.5710095678317721
ENG,Frequent nosebleeds,0.5710095678317721
ENG,Ureteral obstruction,0.589345563575654
ENG,Infection,0.5959654688257199
ENG,Vascular inflammations,0.5995952178307736
ENG,Hemiparesis,0.6150955455771212
ENG,Multiple polyps,0.6196470808426647
ENG,Tumor Angiogenesis,0.6218520979526325
ENG,Pre-Eclampsia,0.6222451141623291
ENG,Polyp of large intestine,0.625027955184583
ENG,Cerebral Hemorrhage,0.6319938293757544
ENG,Polycythemia,0.6627865715415371
ENG,Blood Coagulation Disorders,0.6631086714705082
ENG,polyps,0.6974821940437801
ENG,Lung diseases,0.7128284704851243
ENG,Subarachnoid Hemorrhage,0.717484976234209
ENG,Idiopathic pulmonary hypertension,0.726789939981526
ENG,Endothelial dysfunction,0.82379775978369
ENG,Hepatitis C Chronic,0.8343509960860942
ENG,Eclampsia,0.898753604719554
ENG,Trichohepatoenteric Syndrome,0.9533233478887546
ENG,Anomalous Pulmonary Artery,0.0075861267486594
ENG,Thoracic Aortic Aneurysm And Aortic Dissection,0.1641294276675242
ENG,Subarachnoid Hemorrhage,0.2627224344149009
ENG,Blood Coagulation Disorders,0.3094716280561038
ENG,Retinal Telangiectasia,0.336287627428424
ENG,Oculomotor Nerve Palsy,0.336287627428424
ENG,Polycythemia,0.3528591516609595
ENG,Esophageal Varix,0.4286813331685578
ENG,Pulmonary Arterial Hypertension,0.4286813331685578
ENG,Hematomas,0.4286813331685578
ENG,Ischemic Stroke,0.4286813331685578
ENG,Lactose Intolerance,0.4286813331685578
ENG,Cerebral Saccular Aneurysm,0.4286813331685578
ENG,Encephalomalacia,0.4286813331685578
ENG,Rectal Polyp,0.4286813331685578
ENG,Cerebral Arteriovenous Malformation,0.4286813331685578
ENG,Gastric Polyposis,0.4286813331685578
ENG,Heritable Pulmonary Arterial Hypertension,0.4541466895915311
ENG,Cystic Fibrosis Of Pancreas,0.4541466895915311
ENG,Pulmonary Cystic Fibrosis,0.4541466895915311
ENG,Osteopenia,0.4560460337187313
ENG,Intracranial Aneurysm,0.4560460337187313
ENG,Portal Hypertension,0.4560460337187313
ENG,Transient Ischemic Attack,0.4560460337187313
ENG,Bronchiectasis,0.4560460337187313
ENG,Lung Diseases,0.4560460337187313
ENG,Migraine,0.4560460337187313
ENG,Hypertension,0.4560460337187313
ENG,Cholecystitis,0.4560460337187313
ENG,Visceral Angiomatosis,0.4602028929328057
ENG,Pulmonary Hypertension,0.4646409362700993
ENG,Conjunctival Telangiectasis,0.4646409362700993
ENG,Cystic Fibrosis,0.4646409362700993
ENG,Anemia,0.4780231573499264
ENG,Nephrolithiasis,0.4875380732267193
ENG,Cirrhosis,0.4875380732267193
ENG,Lupus Erythematosus,0.5087473896242481
ENG,Aortic Dissection,0.5129298662020659
ENG,Hemangioma Cavernous,0.5129298662020659
ENG,Liver Failure,0.5162067638232762
ENG,Intestinal Polyposis,0.5498080544456183
ENG,Eczema,0.6899894525110877
ENG,Cholelithiasis,0.7167438233451096
ENG,Atherosclerosis,0.7300866884650863
ENG,Stroke,0.7429124769329748
ENG,Leukopenia,0.7472134648605725
ENG,Congestive Heart Failure,0.7532174466905212
ENG,AGel amyloidosis ORPHA:85448,0.0586579655822394
ENG,Keratolytic winter erythema ORPHA:50943,0.0586579655822394
ENG,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.1590470395003315
ENG,Epithelial basement membrane dystrophy ORPHA:98956,0.1590470395003315
ENG,Familial cavitary optic disc anomaly ORPHA:464760,0.1590470395003315
ENG,Familial retinal arterial macroaneurysm ORPHA:284247,0.1590470395003315
ENG,Galactosialidosis ORPHA:351,0.1590470395003315
ENG,Granular corneal dystrophy type I ORPHA:98962,0.1590470395003315
ENG,Granular corneal dystrophy type II ORPHA:98963,0.1590470395003315
ENG,Lattice corneal dystrophy type I ORPHA:98964,0.1590470395003315
ENG,Lipoid proteinosis ORPHA:530,0.1590470395003315
ENG,Pycnodysostosis ORPHA:763,0.1590470395003315
ENG,Reis-Bucklers corneal dystrophy ORPHA:98961,0.1590470395003315
ENG,Thiel-Behnke corneal dystrophy ORPHA:98960,0.1590470395003315
ENG,Isolated ectopia lentis ORPHA:1885,0.1590470395003315
ENG,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.1590470395003315
ENG,Heritable pulmonary arterial hypertension ORPHA:275777,0.1782034488938806
ENG,Amyloidosis cutis dyschromia ORPHA:319635,0.3762014630157917
ENG,EMILIN-1-related connective tissue disease ORPHA:485418,0.3762014630157917
ENG,LIMS2-related limb-girdle muscular dystrophy ORPHA:466801,0.3762014630157917
ENG,Truncus arteriosus ORPHA:3384,0.3762014630157917
ENG,Familial cerebral saccular aneurysm ORPHA:231160,0.3826134188846508
ENG,Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588,0.6239678957896782
ENG,Diencephalic-mesencephalic junction dysplasia ORPHA:319192,0.6239678957896782
ENG,Marfan syndrome type 2 ORPHA:284973,0.6239678957896782
ENG,NON RARE IN EUROPE: Berger disease ORPHA:34145,0.6239678957896782
ENG,Niemann-Pick disease type A ORPHA:77292,0.6239678957896782
ENG,Niemann-Pick disease type B ORPHA:77293,0.6239678957896782
ENG,Sanfilippo syndrome type C ORPHA:79271,0.6239678957896782
ENG,Roussy-Levy syndrome ORPHA:3115,0.6239678957896782
ENG,Generalized juvenile polyposis/juvenile polyposis coli ORPHA:329971,0.6239678957896782
ENG,Dejerine-Sottas syndrome ORPHA:64748,0.6268296504510718
ENG,Hereditary hemorrhagic telangiectasia ORPHA:774,0.6268296504510718
ENG,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.6268296504510718
ENG,Adams-Oliver syndrome ORPHA:974,0.6340773186521831
ENG,CLN13 disease ORPHA:352709,0.7068064785325423
ENG,CLN2 disease ORPHA:228349,0.7068064785325423
ENG,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324,0.7068064785325423
ENG,Paternal uniparental disomy of chromosome 6 ORPHA:96191,0.7068064785325423
ENG,Chronic myelomonocytic leukemia ORPHA:98823,0.7068064785325423
ESCO2,Stomach Carcinoma,0.0149315928814189
ESCO2,Malignant neoplasm of stomach,0.0191435238361999
ESCO2,Carcinogenesis,0.0228075668512991
ESCO2,Flexion contracture of the knee,0.064548079316548
ESCO2,Biliary tract abnormality,0.0745502070959292
ESCO2,Biliary Tract Diseases,0.0775520919998773
ESCO2,Absent earlobe,0.1735868515093891
ESCO2,Seizures,0.2053083986145698
ESCO2,Cataract,0.223747154820789
ESCO2,contracture of elbow,0.2522264785494494
ESCO2,Neoplasms,0.2714542429024338
ESCO2,Flexion contracture - elbow,0.2714542429024338
ESCO2,Kidney Neoplasm,0.2714542429024338
ESCO2,Proximal placement of thumb,0.3099246715197673
ESCO2,Abnormality of the skull,0.3933196962529684
ESCO2,Fetal Growth Retardation,0.3933196962529684
ESCO2,Hydrocephalus,0.3933196962529684
ESCO2,Talipes Equinovalgus,0.3933196962529684
ESCO2,Equinovalgus deformity,0.3933196962529684
ESCO2,Phocomelia,0.3933196962529684
ESCO2,Hypoplasia of thumb,0.3933196962529684
ESCO2,Cloudy cornea,0.3933196962529684
ESCO2,Corneal stromal opacities,0.3933196962529684
ESCO2,Roberts-SC phocomelia syndrome,0.3933196962529684
ESCO2,Complete duplication of thumb phalanx,0.3933196962529684
ESCO2,Flexion contracture - wrist,0.3933196962529684
ESCO2,Birthmark,0.3933196962529684
ESCO2,Blue sclera,0.3933196962529684
ESCO2,Infant Small for Gestational Age,0.3933196962529684
ESCO2,Cafe-au-Lait Spots,0.3933196962529684
ESCO2,Intrauterine retardation,0.3933196962529684
ESCO2,Craniosynostosis,0.3933196962529684
ESCO2,Malignant neoplasm of kidney,0.3941558617476422
ESCO2,Epilepsy,0.3941558617476422
ESCO2,Absent finger,0.3941558617476422
ESCO2,Accessory spleen,0.3941558617476422
ESCO2,Increased size of penis,0.3941558617476422
ESCO2,Ectromelia,0.3941558617476422
ESCO2,Polycystic Kidney - body part,0.39623320406434
ESCO2,Fair hair,0.3975960596292668
ESCO2,Blonde hair,0.4028066164685291
ESCO2,Polyhydramnios,0.4115056600660309
ESCO2,Aplasia/Hypoplasia of the thumb,0.4115056600660309
ESCO2,Polycystic Kidney Diseases,0.4126392832024548
ESCO2,Ankle contracture,0.4126392832024548
ESCO2,Bicornuate uterus,0.4192169590514327
ESCO2,Cranial nerve palsies,0.4192169590514327
ESCO2,Aortic Valve Stenosis,0.4213286052188015
ESCO2,Brachycephaly,0.4213286052188015
ESCO2,Lens Opacities,0.4213286052188015
ESCO2,Shallow orbits,0.425419812815905
ESCO2,absence of radius and ulna,0.425419812815905
ESCO2,Absent radius,0.4304973629098372
ESCO2,Radial aplasia,0.4304973629098372
ESCO2,Coloboma of eyelid,0.4335751357405352
ESCO2,Short stature,0.439389586518055
ESCO2,Flexion contracture of hip,0.4396723023384634
ESCO2,Congenital ear anomaly NOS (disorder),0.4459714599189374
ESCO2,Ventricular Septal Defects,0.4564472886428772
ESCO2,Syndactyly,0.4564472886428772
ESCO2,Postnatal growth retardation,0.4615352570710579
ESCO2,Curvature of little finger,0.4635211539849193
ESCO2,Clinodactyly of the 5th finger,0.4675904598629673
ESCO2,Hypotrophic malar bone,0.4704594475773637
ESCO2,Malar flattening,0.4704594475773637
ESCO2,Radial ray hypoplasia,0.472444704048021
ESCO2,Retrusion of lower jaw,0.4753011022966241
ESCO2,Decreased projection of lower jaw,0.4753011022966241
ESCO2,Decreased projection of mandible,0.4753011022966241
ESCO2,Hypoplastic mandible condyle,0.4753011022966241
ESCO2,Lymphangioma Cystic,0.4753011022966241
ESCO2,Congenital hypoplasia of radius,0.4753011022966241
ESCO2,Atrial Septal Defects,0.4757083758251088
ESCO2,Aplasia/Hypoplasia of the mandible,0.4790179402069343
ESCO2,Cornelia De Lange Syndrome,0.4790179402069343
ESCO2,Horseshoe Kidney,0.4790179402069343
ESCO2,Micrognathism,0.479747709091007
ESCO2,Cleft upper lip,0.4850576707687362
ESCO2,Small head,0.4906258721078565
ESCO2,Penile hypospadias,0.5019670090704682
ESCO2,Abnormality of the metacarpal bones,0.5019670090704682
ESCO2,Radioulnar Synostosis,0.5188223685230745
ESCO2,Dull intelligence,0.5300976305939776
ESCO2,Low intelligence,0.5300976305939776
ESCO2,Bowing of the long bones,0.5337853752290136
ESCO2,Hypospadias,0.533913711453195
ESCO2,Congenital Heart Defects,0.533913711453195
ESCO2,Radial deviation of finger,0.5393787854381349
ESCO2,Wide skull shape,0.5462489630068115
ESCO2,Broad cranium shape,0.5462489630068115
ESCO2,Short neck,0.549941235475765
ESCO2,Brachydactyly,0.549941235475765
ESCO2,Abnormality of the outer ear,0.5568517196017908
ESCO2,Low set ears,0.5578737381206628
ESCO2,Poor school performance,0.5610226870913673
ESCO2,Underdeveloped brows,0.5619299124666532
ESCO2,Underdeveloped supraorbital ridges,0.5619299124666532
ESCO2,Microphthalmos,0.5839588826096398
ESCO2,Hypertrophy of clitoris,0.6002127202571572
ESCO2,Mental deficiency,0.6035970790768342
ESCO2,Abnormally small eyeball,0.6064571148125548
ESCO2,Decreased size of eyeball,0.6064571148125548
ESCO2,Radial club hand,0.6084642888478995
ESCO2,Broad flat nasal bridge,0.6196470808426647
ESCO2,Nasal bridge wide,0.6238969878903416
ESCO2,Mental Retardation,0.6319938293757544
ESCO2,Abnormality of cardiovascular system morphology,0.6319938293757544
ESCO2,Patent ductus arteriosus,0.6334536292962906
ESCO2,Underdeveloped nasal alae,0.6403143122455015
ESCO2,Uranostaphyloschisis,0.6784817526917547
ESCO2,Curvature of digit,0.6980473696540115
ESCO2,Congenital clinodactyly,0.7068844070911514
ESCO2,Sparse hair,0.726789939981526
ESCO2,Thin sparse hair,0.726789939981526
ESCO2,Cryptorchidism,0.7417321496240817
ESCO2,Downward slant of palpebral fissure,0.7634367398642647
ESCO2,Posteriorly rotated ear,0.7706351321777464
ESCO2,Premature Birth,0.7815030391631113
ESCO2,Orbital separation excessive,0.8157137944879093
ESCO2,Prominent eyes,0.8195255693608234
ESCO2,Protruding eyes,0.8195255693608234
ESCO2,Prominent globes,0.8228582885461879
ESCO2,Exophthalmos,0.827626149232917
ESCO2,Intellectual Disability,0.8352623613787349
ESCO2,Byzanthine arch palate,0.8441962785769224
ESCO2,Craniofacial Abnormalities,0.8913309410682808
ESCO2,Mental and motor retardation,0.897310588550617
ESCO2,Cognitive delay,0.9238745269736108
ESCO2,Global developmental delay,0.9327689937867868
ESCO2,Kidney Cancer,0.3094716280561038
ESCO2,Hypoplasia Of Thumb,0.3094716280561038
ESCO2,Aortic Valve Sclerosis,0.3182746822082389
ESCO2,Kidney Neoplasm,0.336287627428424
ESCO2,Hydrocephalus,0.3657224783929353
ESCO2,Craniosynostosis,0.4286813331685578
ESCO2,Elbow Flexion Contracture,0.4286813331685578
ESCO2,Talipes Equinovalgus,0.4286813331685578
ESCO2,Phocomelia,0.4286813331685578
ESCO2,Horseshoe Kidney,0.4560460337187313
ESCO2,Brachycephaly,0.4560460337187313
ESCO2,Flexion Contracture Of Wrist,0.4560460337187313
ESCO2,Radioulnar Synostosis,0.4560460337187313
ESCO2,Polycystic Kidney Disease,0.4646409362700993
ESCO2,Glaucoma,0.4646409362700993
ESCO2,Cranial Nerve Paralysis,0.4867879381749835
ESCO2,Syndactyly,0.5123947823327547
ESCO2,Microcephaly,0.5123947823327547
ESCO2,Micrognathism,0.5234357475824973
ESCO2,Hip Contracture,0.5234357475824973
ESCO2,Posteriorly Rotated Ear,0.5248691614865011
ESCO2,Atrial Septal Defect,0.5254133486377646
ESCO2,Congenital Hypoplasia Of Radius,0.5414559855274098
ESCO2,Cystic Hygroma,0.5498080544456183
ESCO2,Dwarfism,0.5796489603182782
ESCO2,Brachydactyly,0.6198128018123746
ESCO2,Hypertrophy Of Clitoris,0.6524705037929849
ESCO2,Patent Ductus Arteriosus,0.6596918765832213
ESCO2,Cataract,0.6660731887258019
ESCO2,Congenital Ocular Coloboma,0.6883874961919009
ESCO2,Camptodactyly Of Fingers,0.7328159476505643
ESCO2,Proptosis,0.7558828942158288
ESCO2,Ventricular Septal Defect,0.7729545590606223
ESCO2,Mental Retardation,0.7729545590606223
ESCO2,Cryptorchidism,0.776786668801341
ESCO2,Microphthalmos,0.7875494303517502
ESCO2,Hypospadias,0.8570285304674955
ESCO2,Clinodactyly,0.8876319700740651
ESCO2,Syndactyly Of Fingers,0.8988523790817545
ESCO2,Nystagmus,0.9146877763175152
ESCO2,High Palate,0.9334417262711258
ESCO2,Developmental Delay,0.96477535147595
ESCO2,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
ESCO2,Hereditary breast cancer ORPHA:227535,0.0106988445340883
ESCO2,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.0180064224283883
ESCO2,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0180064224283883
ESCO2,Filippi syndrome ORPHA:3255,0.0180064224283883
ESCO2,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0180064224283883
ESCO2,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0180064224283883
ESCO2,Roberts syndrome ORPHA:3103,0.0180064224283883
ESCO2,Stromme syndrome ORPHA:506307,0.0180064224283883
ESCO2,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.0180064224283883
ESCO2,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.0586579655822394
ESCO2,Bloom syndrome ORPHA:125,0.0586579655822394
ESCO2,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0586579655822394
ESCO2,Primary peritoneal carcinoma ORPHA:168829,0.0586579655822394
ESCO2,VACTERL with hydrocephalus ORPHA:3412,0.0586579655822394
ESCO2,Osteosarcoma ORPHA:668,0.0599424746210022
ESCO2,Seckel syndrome ORPHA:808,0.0683063362547733
ESCO2,Fanconi anemia ORPHA:84,0.0930156564388357
ESCO2,Autosomal recessive primary microcephaly ORPHA:2512,0.1026843275212335
ESCO2,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1590470395003315
ESCO2,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.1590470395003315
ESCO2,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.1590470395003315
ESCO2,Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894,0.1590470395003315
ESCO2,Xeroderma pigmentosum variant ORPHA:90342,0.1590470395003315
ESCO2,Li-Fraumeni syndrome ORPHA:524,0.1614487935928034
ESCO2,Ear-patella-short stature syndrome ORPHA:2554,0.1659988674007724
ESCO2,Hereditary breast and ovarian cancer syndrome ORPHA:145,0.1936858543871029
ESCO2,Familial prostate cancer ORPHA:1331,0.1981653781243822
ESCO2,Chudley-McCullough syndrome ORPHA:314597,0.3762014630157917
ESCO2,Weaver syndrome ORPHA:3447,0.3775879467205478
ESCO2,Familial pancreatic carcinoma ORPHA:1333,0.4101640425710954
ESCO2,Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805,0.4548046963946745
ESCO2,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome ORPHA:494439,0.6239678957896782
ESCO2,Combined oxidative phosphorylation defect type 13 ORPHA:319514,0.7068064785325423
ESCO2,Congenital lactase deficiency ORPHA:53690,0.7068064785325423
ESCO2,Posterior column ataxia-retinitis pigmentosa syndrome ORPHA:88628,0.7068064785325423
FAM111B,Renal Cell Carcinoma,0.0648809611869375
FAM111B,Chromophobe Renal Cell Carcinoma,0.1461248774859792
FAM111B,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
FAM111B,Sarcomatoid Renal Cell Carcinoma,0.3933196962529684
FAM111B,Collecting Duct Carcinoma of the Kidney,0.3933196962529684
FAM111B,Diminished sweating,0.3933196962529684
FAM111B,Hypohidrosis,0.3933196962529684
FAM111B,Erythrokeratodermia variabilis,0.3941558617476422
FAM111B,Papillary Renal Cell Carcinoma,0.3975960596292668
FAM111B,Poikiloderma,0.4304973629098372
FAM111B,Pulmonary Fibrosis,0.4335751357405352
FAM111B,Hepatomegaly,0.4506578937113162
FAM111B,Rothmund-Thomson syndrome,0.4675904598629673
FAM111B,Congenital myopathy (disorder),0.5188223685230745
FAM111B,Elevated creatine kinase,0.6294837700416086
FAM111B,Creatine phosphokinase serum increased,0.6332132835539771
FAM111B,Contracture,0.652707626880454
FAM111B,Arthrogryposis,0.7317475852509061
FAM111B,Skeletal muscle atrophy,0.7511668779991656
FAM111B,Neurogenic muscle atrophy especially in the lower limbs,0.7511668779991656
FAM111B,Alopecia,0.7533159919746161
FAM111B,Neurogenic Muscular Atrophy,0.7720422491171346
FAM111B,Muscle degeneration,0.8198848943907875
FAM111B,Intellectual Disability,0.8352623613787349
FAM111B,Liver Carcinoma,0.0520696613701797
FAM111B,Pulmonary Fibrosis,0.0654534781440596
FAM111B,Myositis,0.425341435586089
FAM111B,Chromophobe Carcinoma,0.4286813331685578
FAM111B,Papillary Renal Carcinoma,0.4286813331685578
FAM111B,Renal Carcinoma,0.4541466895915311
FAM111B,Hypohidrosis,0.4560460337187313
FAM111B,Poikiloderma,0.4602028929328057
FAM111B,Alopecia,0.7167438233451096
FAM111B,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
FAM219A,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.1590470395003315
FAM219A,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.1590470395003315
FAM219A,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.3762014630157917
FAM219A,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613,0.6239678957896782
FAM219A,Spinocerebellar ataxia type 21 ORPHA:98773,0.6239678957896782
FAM219A,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.7068064785325423
FAM219A,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.7068064785325423
FAM219A,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.7068064785325423
FAM219A,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.7068064785325423
FAM219A,Perry syndrome ORPHA:178509,0.7068064785325423
FAM219A,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.7068064785325423
FAM219A,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.7068064785325423
FAM219A,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.7068064785325423
FAM219A,Miller-Dieker syndrome ORPHA:531,0.7068064785325423
FAM234B,Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944,0.6239678957896782
FAM234B,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097,0.6239678957896782
FAM234B,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055,0.6239678957896782
FAM234B,Charcot-Marie-Tooth disease type 2H ORPHA:101102,0.6239678957896782
FAM234B,Charcot-Marie-Tooth disease type 4A ORPHA:99948,0.6239678957896782
FAM234B,DOORS syndrome ORPHA:79500,0.6239678957896782
FAM234B,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587,0.6239678957896782
FAM234B,Progressive myoclonic epilepsy with dystonia ORPHA:352596,0.6239678957896782
FAM234B,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727,0.6239678957896782
FAM234B,Mulibrey nanism ORPHA:2576,0.7068064785325423
FAM234B,Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852,0.7068064785325423
FAM43A,Liver Cirrhosis Experimental,0.0747863377072194
FAM43A,Autistic Disorder,0.8064248359603999
FAM43A,Atrial septal defect sinus venosus type ORPHA:99105,0.3762014630157917
FGF19,Breast Carcinoma,0.0042545616049287
FGF19,Tumor Progression,0.0149315928814189
FGF19,Squamous cell carcinoma,0.0182265588252201
FGF19,Malignant neoplasm of breast,0.0191435238361999
FGF19,Carcinogenesis,0.0228075668512991
FGF19,Malignant neoplasm of prostate,0.0569142010728473
FGF19,Liver Cirrhosis,0.0773771948186562
FGF19,Prostate carcinoma,0.0773771948186562
FGF19,Squamous cell carcinoma of esophagus,0.0919714360040484
FGF19,Liver carcinoma,0.095319386034013
FGF19,Malignant Neoplasms,0.0991201145654548
FGF19,Colon Carcinoma,0.1062239757831962
FGF19,Adenocarcinoma of colon,0.1112281755580192
FGF19,Colonic Neoplasms,0.1454373331146953
FGF19,Liver neoplasms,0.1454373331146953
FGF19,Malignant tumor of colon,0.223747154820789
FGF19,Diabetes,0.2277108302018961
FGF19,Metastasis from malignant tumor of prostate,0.2454426921531692
FGF19,Diabetes Mellitus,0.2522264785494494
FGF19,Malignant neoplasm of liver,0.2643145809900195
FGF19,Metastatic Prostate Carcinoma,0.2643145809900195
FGF19,Neoplasms,0.2714542429024338
FGF19,Cirrhosis,0.2923761731100008
FGF19,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
FGF19,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
FGF19,Chronic liver disease,0.3933196962529684
FGF19,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
FGF19,Fibrosis Liver,0.3933196962529684
FGF19,Retinal defect,0.3933196962529684
FGF19,Osteoporosis with pseudoglioma,0.3933196962529684
FGF19,Cholestasis of pregnancy,0.3933196962529684
FGF19,Insulin Sensitivity,0.3975960596292668
FGF19,Cholestasis,0.4100901006059349
FGF19,Squamous cell carcinoma of lung,0.4335751357405352
FGF19,Insulin Resistance,0.4459714599189374
FGF19,Steatohepatitis,0.4906258721078565
FGF19,Diarrhea,0.4923669467696064
FGF19,Primary biliary cirrhosis,0.4923669467696064
FGF19,Obesity,0.5140447474168605
FGF19,Colitis,0.5323590634832615
FGF19,Pancreatic intraepithelial neoplasia,0.5337853752290136
FGF19,Polycystic Ovary Syndrome,0.5337853752290136
FGF19,Hepatocarcinogenesis,0.533913711453195
FGF19,Fatty Liver,0.533913711453195
FGF19,Metabolic Syndrome X,0.5568517196017908
FGF19,Necrosis,0.6002127202571572
FGF19,Hypertriglyceridemia,0.6304655343580164
FGF19,Irritable Bowel Syndrome,0.6545439509404224
FGF19,Crohn's disease of large bowel,0.672336954961104
FGF19,Liver diseases,0.7337030585693298
FGF19,Metabolic Diseases,0.750779529196619
FGF19,Lipodystrophy,0.7683326132740758
FGF19,Liver Carcinoma,0.0520696613701797
FGF19,Combined pituitary hormone deficiencies genetic forms ORPHA:95494,0.0683063362547733
FGF19,Partial pancreatic agenesis ORPHA:2805,0.3762014630157917
FGF19,Oculootodental syndrome ORPHA:99806,0.3762014630157917
FGF19,Midline interhemispheric variant of holoprosencephaly ORPHA:93926,0.43936148647173
FGF19,Septopreoptic holoprosencephaly ORPHA:280195,0.43936148647173
FGF19,Semilobar holoprosencephaly ORPHA:220386,0.4470672161388242
FGF19,Anterior segment developmental anomaly ORPHA:88632,0.6239678957896782
FGF19,Congenital primary aphakia ORPHA:83461,0.6239678957896782
FGF19,Deafness with labyrinthine aplasia microtia and microdontia ORPHA:90024,0.6239678957896782
FGF19,Otodental syndrome ORPHA:2791,0.6239678957896782
FGF19,Alobar holoprosencephaly ORPHA:93925,0.6787273931204523
FGF19,Acro-renal-ocular syndrome ORPHA:959,0.7068064785325423
FGF19,Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530,0.7068064785325423
FGF19,IVIC syndrome ORPHA:2307,0.7068064785325423
FGF19,Infantile dystonia-parkinsonism ORPHA:238455,0.7068064785325423
FGF19,Okihiro syndrome due to 20q13 microdeletion ORPHA:261638,0.7068064785325423
FGF19,Okihiro syndrome due to a point mutation ORPHA:261647,0.7068064785325423
FGF19,17q12 microdeletion syndrome ORPHA:261265,0.7068064785325423
FHIT,Colorectal Carcinoma,0.0034602840073026
FHIT,Mammary Neoplasms,0.0034602840073026
FHIT,Ovarian Carcinoma,0.0034602840073026
FHIT,Breast Carcinoma,0.0042545616049287
FHIT,Invasive carcinoma of breast,0.0149002095788623
FHIT,Epithelioma,0.0149002095788623
FHIT,Invasive Ductal Breast Carcinoma,0.0149002095788623
FHIT,Colorectal Cancer,0.0149315928814189
FHIT,Tumor Progression,0.0149315928814189
FHIT,Stomach Carcinoma,0.0149315928814189
FHIT,Adenocarcinoma,0.0155921563748247
FHIT,Squamous cell carcinoma,0.0182265588252201
FHIT,Esophageal Neoplasms,0.0182265588252201
FHIT,Malignant mesothelioma,0.0182265588252201
FHIT,ovarian neoplasm,0.0191435238361999
FHIT,Malignant neoplasm of breast,0.0191435238361999
FHIT,Malignant neoplasm of stomach,0.0191435238361999
FHIT,Carcinogenesis,0.0228075668512991
FHIT,Malignant neoplasm of esophagus,0.0248454592431097
FHIT,Malignant neoplasm of ovary,0.0277695594716545
FHIT,Carcinoma Spindle-Cell,0.0308703957553632
FHIT,Urologic Neoplasms,0.0314665934969085
FHIT,Hematopoietic Neoplasms,0.0334891258932371
FHIT,Medulloblastoma,0.0354767239335874
FHIT,Epithelial ovarian cancer,0.0387439397151409
FHIT,Brain Tumor Primary,0.044151975756427
FHIT,Skin carcinoma,0.0482468351695405
FHIT,Cancer of Urinary Tract,0.0492766532827251
FHIT,Malignant neoplasm of prostate,0.0569142010728473
FHIT,Cervical Squamous Intraepithelial Neoplasia 1,0.0593779966354549
FHIT,Carcinoma,0.0593779966354549
FHIT,Cervical intraepithelial neoplasia grade 1,0.0593779966354549
FHIT,Carcinomatosis,0.0617471306652618
FHIT,Brain Neoplasms,0.064548079316548
FHIT,Neoplasm Metastasis,0.0648809611869375
FHIT,Barrett Esophagus,0.0648809611869375
FHIT,Mucoepidermoid Carcinoma,0.0648809611869375
FHIT,Renal Cell Carcinoma,0.0648809611869375
FHIT,Malignant neoplasm of pancreas,0.0726340460169901
FHIT,Pancreatic Neoplasm,0.0739788831250619
FHIT,Squamous cell carcinoma of penis,0.0739788831250619
FHIT,Lymphoma,0.0739788831250619
FHIT,Endometrial Neoplasms,0.0745502070959292
FHIT,Pancreatic carcinoma,0.0745502070959292
FHIT,Liver Cirrhosis,0.0773771948186562
FHIT,Prostate carcinoma,0.0773771948186562
FHIT,Squamous cell carcinoma of the head and neck,0.0775520919998773
FHIT,Adenoid cystic carcinoma of salivary gland,0.0775520919998773
FHIT,Colorectal Neoplasms,0.0827744840860166
FHIT,Anaplastic carcinoma,0.084286432100041
FHIT,Malignant neoplasm of urinary bladder,0.084286432100041
FHIT,Bladder Neoplasm,0.0891725280554336
FHIT,Adult Acute Lymphocytic Leukemia,0.0919714360040484
FHIT,Squamous cell carcinoma of esophagus,0.0919714360040484
FHIT,Anus Neoplasms,0.095319386034013
FHIT,Liver carcinoma,0.095319386034013
FHIT,Malignant Neoplasms,0.0991201145654548
FHIT,Colon Carcinoma,0.1062239757831962
FHIT,Adenocarcinoma of colon,0.1112281755580192
FHIT,Chronic Lymphocytic Leukemia,0.1147307578771389
FHIT,Small cell carcinoma of lung,0.1193558174333938
FHIT,Hematologic Neoplasms,0.1253114324938153
FHIT,Brain Aneurysm,0.1253114324938153
FHIT,MYELODYSPLASTIC SYNDROME,0.1254380558571286
FHIT,Esophageal carcinoma,0.1254380558571286
FHIT,Ductal Breast Carcinoma,0.13167400689206
FHIT,Hamman-Rich syndrome,0.13167400689206
FHIT,Undifferentiated carcinoma,0.13167400689206
FHIT,Clear-cell metastatic renal cell carcinoma,0.13167400689206
FHIT,Carcinoma Transitional Cell,0.13167400689206
FHIT,Oral Cavity Carcinoma,0.13167400689206
FHIT,Carcinoma of bladder,0.13167400689206
FHIT,Malignant neoplasm of endometrium,0.13167400689206
FHIT,Unipolar Depression,0.13167400689206
FHIT,Uterine Corpus Cancer,0.1328002618052838
FHIT,Solid Neoplasm,0.1413782599148022
FHIT,Colonic Neoplasms,0.1454373331146953
FHIT,Liver neoplasms,0.1454373331146953
FHIT,Breast Cancer Familial,0.1602092191314262
FHIT,Invasive Carcinoma,0.1602092191314262
FHIT,Testicular Germ Cell Tumor,0.1735868515093891
FHIT,Head and Neck Carcinoma,0.1735868515093891
FHIT,Benign Ovarian Neoplasm,0.1770067065899052
FHIT,Low Grade Cervical Squamous Intraepithelial Neoplasia,0.1897991423047819
FHIT,TARSAL-CARPAL COALITION SYNDROME,0.1906413554467301
FHIT,Cervical intraepithelial neoplasia grade 2,0.2050045461627939
FHIT,cervical cancer,0.2050045461627939
FHIT,Gastrointestinal Neoplasms,0.2062010908869036
FHIT,Lung Neoplasms,0.2062010908869036
FHIT,Malignant tumor of colon,0.223747154820789
FHIT,Prostatic Neoplasms,0.223747154820789
FHIT,Hodgkin Disease,0.2454476567103779
FHIT,Burkitt Lymphoma,0.2521987644415915
FHIT,Malignant Head and Neck Neoplasm,0.2522264785494494
FHIT,B-Cell Lymphomas,0.2522264785494494
FHIT,Malignant neoplasm of liver,0.2643145809900195
FHIT,Adenocarcinoma Of Esophagus,0.2679411586077776
FHIT,Malignant tumor of cervix,0.2714542429024338
FHIT,Malignant ascites,0.2714542429024338
FHIT,Malignant neoplasm of lung,0.2714542429024338
FHIT,Kidney Neoplasm,0.2714542429024338
FHIT,Cervix carcinoma,0.2834835531038365
FHIT,Acute leukemia,0.2835142372342932
FHIT,Adult Hepatocellular Carcinoma,0.290158730291654
FHIT,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
FHIT,Breast cancer lobular,0.2980670559114652
FHIT,Myeloid Leukemia,0.2980670559114652
FHIT,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
FHIT,Endometrial Carcinoma,0.3044782497745498
FHIT,Idiopathic Pulmonary Fibrosis,0.3099246715197673
FHIT,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
FHIT,Malignant Squamous Cell Neoplasm,0.3104232675696299
FHIT,Cervical Squamous Cell Carcinoma,0.3199171478489988
FHIT,Penis carcinoma,0.3220099003872086
FHIT,Leukoplakia,0.333745294913745
FHIT,Cholangiocarcinoma,0.340892538685018
FHIT,Blast Phase,0.3494455519738624
FHIT,Leukemogenesis,0.3510063969122338
FHIT,Mammary Ductal Carcinoma,0.3638414818541592
FHIT,Carcinoma of lung,0.3663130598151661
FHIT,Tuberculosis,0.3706856725676674
FHIT,Classical Hodgkin's Lymphoma,0.3763374964032415
FHIT,Adenomatous polyp of colon,0.383941725017158
FHIT,Thyroid Neoplasm,0.383941725017158
FHIT,Tuberculosis Pulmonary,0.383941725017158
FHIT,Teratoma,0.383941725017158
FHIT,Noninfiltrating Intraductal Carcinoma,0.383941725017158
FHIT,Primary malignant neoplasm of lung,0.3902116649640871
FHIT,Von Hippel-Lindau Syndrome,0.3933196962529684
FHIT,Secondary malignant neoplasm of lymph node,0.3933196962529684
FHIT,Gallbladder Carcinoma,0.3933196962529684
FHIT,Epstein-Barr Virus Infections,0.3933196962529684
FHIT,Adenocarcinoma of large intestine,0.3933196962529684
FHIT,Uterine Cervical Neoplasm,0.3933196962529684
FHIT,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
FHIT,Nasopharyngeal carcinoma,0.3933196962529684
FHIT,Non-small cell lung cancer stage I,0.3933196962529684
FHIT,Infant Acute Lymphoblastic Leukemia,0.3933196962529684
FHIT,Schizophrenia,0.3933196962529684
FHIT,Non-Small Cell Lung Carcinoma,0.3933196962529684
FHIT,Infection caused by Helicobacter pylori,0.3933196962529684
FHIT,Leukemia Myelocytic Acute,0.3933196962529684
FHIT,HIV Infections,0.3933196962529684
FHIT,Urothelial Carcinoma,0.3933196962529684
FHIT,Chordoma,0.3933196962529684
FHIT,Anxiety Disorders,0.3933196962529684
FHIT,Torre-Muir syndrome,0.3933196962529684
FHIT,Bronchioloalveolar Adenocarcinoma,0.3933196962529684
FHIT,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
FHIT,Acute lymphocytic leukemia,0.3933196962529684
FHIT,Lip and Oral Cavity Carcinoma,0.3933196962529684
FHIT,Stomach Neoplasms,0.3933196962529684
FHIT,Inflammatory Bowel Diseases,0.3933196962529684
FHIT,Coronary heart disease,0.3933196962529684
FHIT,Familial renal cell carcinoma,0.3933196962529684
FHIT,Hereditary Clear Cell Renal Cell Carcinoma,0.3933196962529684
FHIT,Hereditary Renal Cell Carcinoma,0.3933196962529684
FHIT,Krukenberg Tumor,0.3933196962529684
FHIT,Non-small cell lung cancer stage II,0.3933196962529684
FHIT,Adenoma,0.3933196962529684
FHIT,Anemia,0.3941558617476422
FHIT,Malignant neoplasm of kidney,0.3941558617476422
FHIT,Familial multiple trichoepitheliomata,0.3941558617476422
FHIT,Autism Spectrum Disorders,0.3941558617476422
FHIT,Renal carcinoma,0.3941558617476422
FHIT,Cervical Squamous Intraepithelial Neoplasia,0.3941558617476422
FHIT,Thyroid carcinoma,0.3941558617476422
FHIT,Drug abuse,0.3941558617476422
FHIT,Progressive Neoplastic Disease,0.3941558617476422
FHIT,Fibrosis,0.3975960596292668
FHIT,Progressive cGVHD,0.3975960596292668
FHIT,Physical Activity Measurement,0.3986414839122469
FHIT,Merkel cell carcinoma,0.4028066164685291
FHIT,Drug Dependence,0.4028066164685291
FHIT,Intrahepatic Cholangiocarcinoma,0.4028066164685291
FHIT,Squamous cell carcinoma of mouth,0.4100901006059349
FHIT,Multiple Myeloma,0.4103119460235835
FHIT,ALZHEIMER DISEASE 5,0.4103119460235835
FHIT,Anxiety,0.4115056600660309
FHIT,Phyllodes Tumor,0.4115056600660309
FHIT,Breast Fibrocystic Change Proliferative Type,0.4115056600660309
FHIT,Acute Coronary Syndrome,0.4118266358241932
FHIT,High-Grade Squamous Intraepithelial Lesions,0.4126392832024548
FHIT,Adenoma of large intestine,0.4126392832024548
FHIT,Focal Nodular Hyperplasia,0.4126392832024548
FHIT,Non-small cell carcinoma,0.4126392832024548
FHIT,Immunologic Deficiency Syndromes,0.4213286052188015
FHIT,Mouth Neoplasms,0.4213286052188015
FHIT,Disease due to Papilloma virus,0.4213286052188015
FHIT,Malignant neoplasm of mouth,0.4213286052188015
FHIT,Papilloma,0.425992946703162
FHIT,Autosomal dominant compelling helio ophthalmic outburst syndrome,0.4304973629098372
FHIT,Malignant neoplasm of thyroid,0.4307603335611732
FHIT,Breast Fibrocystic Disease,0.4330362522463816
FHIT,Germ cell tumor,0.4335751357405352
FHIT,Amphetamine-Related Disorders,0.4335751357405352
FHIT,Amphetamine Abuse,0.4335751357405352
FHIT,Squamous cell carcinoma of lung,0.4335751357405352
FHIT,Amphetamine Addiction,0.4352815161963393
FHIT,Substance Use Disorders,0.4381343267935581
FHIT,Carcinoid Tumor,0.4381343267935581
FHIT,Personality Traits,0.4396723023384634
FHIT,Precancerous Conditions,0.4479115285676636
FHIT,Malignant neoplasm of tongue,0.4506578937113162
FHIT,bilateral breast cancer,0.4506578937113162
FHIT,Dyspepsia,0.4564472886428772
FHIT,Perianal Squamous Intraepithelial Neoplasia,0.4564472886428772
FHIT,leukemia,0.4588513406515081
FHIT,Substance abuse problem,0.4615352570710579
FHIT,Chronic active hepatitis,0.4615352570710579
FHIT,MOHR-TRANEBJAERG SYNDROME,0.4615352570710579
FHIT,Mesothelioma,0.4635211539849193
FHIT,Myeloid Leukemia Chronic,0.472444704048021
FHIT,Adenomatous Polyposis Coli,0.4749780675672355
FHIT,Treatment related leukaemia,0.4753011022966241
FHIT,Transitional cell carcinoma of bladder,0.4790179402069343
FHIT,Follicular thyroid carcinoma,0.4790179402069343
FHIT,High grade serous carcinoma,0.4790179402069343
FHIT,PARKINSON DISEASE 2 AUTOSOMAL RECESSIVE JUVENILE,0.4840863724482356
FHIT,Sebaceous Adenocarcinoma,0.4852430673532381
FHIT,Bowen's Disease,0.4906258721078565
FHIT,Cervical high grade squamous intraepithelial lesion,0.4906258721078565
FHIT,Pleural Tuberculosis,0.4923669467696064
FHIT,Crohn Disease,0.4981941174985421
FHIT,Ulcerative Colitis,0.5001612228394569
FHIT,Neuroendocrine Tumors,0.5017066790423467
FHIT,Low Grade Squamous Intraepithelial Neoplasia,0.5019670090704682
FHIT,Squamous intraepithelial lesion,0.5090214163899865
FHIT,Organic Mental Disorders Substance-Induced,0.533913711453195
FHIT,Prescription Drug Abuse,0.533913711453195
FHIT,Carcinoma Small Cell,0.5359212109443033
FHIT,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
FHIT,Drug Use Disorders,0.5393787854381349
FHIT,Precursor B-cell lymphoblastic leukemia,0.5451009374855866
FHIT,Body mass index,0.5496357724684553
FHIT,Finding of body mass index,0.5496357724684553
FHIT,Substance-Related Disorders,0.5514573300659174
FHIT,Thymoma,0.5523521032803237
FHIT,Cervical Intraepithelial Neoplasia,0.5523521032803237
FHIT,Hypoalbuminemia,0.553002957824355
FHIT,Congenital hypoplasia of lung,0.5557519470957561
FHIT,Smoking Behaviors,0.5580691945487462
FHIT,Hereditary Diffuse Gastric Cancer,0.5696906826730043
FHIT,precancerous lesions,0.5710095678317721
FHIT,Drug habituation,0.589345563575654
FHIT,Diffuse Large B-Cell Lymphoma,0.5913651925298382
FHIT,Substance Dependence,0.5936773368594411
FHIT,Infection,0.5959654688257199
FHIT,Seminoma,0.5990568578129436
FHIT,Ductal Carcinoma,0.6002127202571572
FHIT,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.6035970790768342
FHIT,Congenital chromosomal disease,0.6035970790768342
FHIT,Primary Effusion Lymphoma,0.6248356417853507
FHIT,Sporadic Breast Carcinoma,0.6332132835539771
FHIT,Carcinoma Large Cell,0.6355866602993508
FHIT,Tracheal Diseases,0.6496433426951205
FHIT,Narcolepsy,0.6496433426951205
FHIT,invasive cancer,0.652707626880454
FHIT,Systemic arterial pressure,0.6656356363792992
FHIT,Blood Pressure,0.6656356363792992
FHIT,Blood pressure finding,0.6656356363792992
FHIT,Fanconi Anemia,0.7053337831155875
FHIT,Hepatitis C,0.7169459458481418
FHIT,Pleural effusion disorder,0.7564787632115322
FHIT,Exanthema,0.7674304683279349
FHIT,Gastrointestinal Carcinoid Tumor,0.7674304683279349
FHIT,Systolic Pressure,0.7796824214131131
FHIT,Gastritis Atrophic,0.8000044931629623
FHIT,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8064248359603999
FHIT,Urinary Tract Cancer,0.0102679590519094
FHIT,Anaplastic Carcinoma,0.0402286636010764
FHIT,Schizophrenia,0.0531117779464085
FHIT,Carcinoma,0.0534520155998091
FHIT,Urologic Neoplasms,0.0839188440969517
FHIT,Development Disorder,0.4372065554432662
FHIT,Lung Cancer,0.4402141802500753
FHIT,Hereditary Renal Carcinoma,0.4402141802500753
FHIT,Lung Carcinoma,0.4541466895915311
FHIT,Lip And Oral Cavity Carcinoma,0.4541466895915311
FHIT,Lung Neoplasms,0.4560460337187313
FHIT,Intracranial Aneurysm,0.4560460337187313
FHIT,Mental Depression,0.4560460337187313
FHIT,Coronary Syndrome,0.4560460337187313
FHIT,Colorectal Neoplasms,0.4560460337187313
FHIT,Liver Cancer,0.4723647227028846
FHIT,Narcolepsy,0.4875380732267193
FHIT,Prostatic Neoplasms,0.4875380732267193
FHIT,Achoo Syndrome,0.4875380732267193
FHIT,Liver Neoplasms,0.5129298662020659
FHIT,Mesothelioma,0.5796489603182782
FHIT,Prostate Cancer,0.6104715460837368
FHIT,Gastric Cancer,0.6524705037929849
FHIT,Stomach Neoplasms,0.669817442578862
FHIT,Leukemia,0.7167438233451096
FHIT,Coronary Heart Disease,0.7726217084209973
FHIT,Hereditary clear cell renal cell carcinoma ORPHA:422526,0.639029370164481
FRAT2,Stomach Carcinoma,0.0149315928814189
FRAT2,Malignant neoplasm of stomach,0.0191435238361999
FRAT2,Carcinogenesis,0.0228075668512991
FRAT2,MIXED LINEAGE LEUKEMIA,0.2605479444258003
FRAT2,leukemia,0.4588513406515081
FRAT2,Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480,0.3762014630157917
FRAT2,Recurrent infection due to specific granule deficiency ORPHA:169142,0.6239678957896782
FRAT2,Squamous cell carcinoma of salivary glands ORPHA:500481,0.6239678957896782
FRAT2,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.6239678957896782
FRAT2,Squamous cell carcinoma of the larynx ORPHA:494550,0.6239678957896782
FRAT2,Squamous cell carcinoma of the lip ORPHA:502366,0.6239678957896782
FRAT2,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.6239678957896782
FRAT2,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.6239678957896782
FRAT2,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.6239678957896782
FRAT2,Congenital dyserythropoietic anemia type IV ORPHA:293825,0.7068064785325423
FRMD8,Leukemia,0.7167438233451096
FRMD8,Mucopolysaccharidosis type 4A ORPHA:309297,0.0586579655822394
FRMD8,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.1590470395003315
FRMD8,Hydranencephaly ORPHA:2177,0.3762014630157917
FRMD8,NDE1-related microhydranencephaly ORPHA:443162,0.3762014630157917
FRMD8,Dehydrated hereditary stomatocytosis ORPHA:3202,0.3762014630157917
FRMD8,Autosomal recessive spastic paraplegia type 48 ORPHA:306511,0.6239678957896782
FRMD8,Infantile nephropathic cystinosis ORPHA:411629,0.6239678957896782
FRMD8,Juvenile nephropathic cystinosis ORPHA:411634,0.6239678957896782
FRMD8,MYH9-related disease ORPHA:182050,0.6239678957896782
FRMD8,Ocular cystinosis ORPHA:411641,0.6239678957896782
FRMD8,Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428,0.7068064785325423
FRMD8,Hermansky-Pudlak syndrome type 8 ORPHA:231537,0.7068064785325423
FRMD8,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome ORPHA:85167,0.7068064785325423
FRMD8,Ependymoma ORPHA:251636,0.7068064785325423
FRMD8,RELA fusion-positive ependymoma ORPHA:530792,0.7068064785325423
FRMD8,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.7068064785325423
FRMD8,Yaba monkey tumor virus kelch-like protein,0.6362779693488597
FRMD8,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.6433049303988263
FRMD8,SARS coronavirus excised_polyprotein 1..4369 (gene: orf1ab),0.7568193074461791
FRMD8,SARS coronavirus P2 full_polyprotein 1..4382,0.7651942752688915
FRMD8,SARS coronavirus Tor2 replicase 1AB,0.7988086321880973
FRMD8,SARS coronavirus P2 full_polyprotein 1..7073,0.8020079067482934
FRMD8,Vaccinia virus Ankara serine proteinase inhibitor / SPI-2 f2,0.8220964101663402
FRMD8,SARS coronavirus nsp3-pp1a/pp1ab (gene: orf1ab),0.8220964101663402
FRMD8,Dugbe virus L protein,0.875442055263636
FZD1,Breast Carcinoma,0.0042545616049287
FZD1,Invasive carcinoma of breast,0.0149002095788623
FZD1,Esophageal Neoplasms,0.0182265588252201
FZD1,ovarian neoplasm,0.0191435238361999
FZD1,Malignant neoplasm of breast,0.0191435238361999
FZD1,Malignant neoplasm of esophagus,0.0248454592431097
FZD1,Medulloblastoma,0.0354767239335874
FZD1,Central neuroblastoma,0.0593779966354549
FZD1,Neoplasm Metastasis,0.0648809611869375
FZD1,Neuroblastoma,0.0688152422187159
FZD1,Osteosarcoma,0.1029977559100099
FZD1,Colon Carcinoma,0.1062239757831962
FZD1,Esophageal carcinoma,0.1254380558571286
FZD1,Osteosarcoma of bone,0.2109483801368481
FZD1,Malignant tumor of colon,0.223747154820789
FZD1,Smith-Lemli-Opitz Syndrome,0.2522264785494494
FZD1,Triple Negative Breast Neoplasms,0.2980670559114652
FZD1,Idiopathic Pulmonary Fibrosis,0.3099246715197673
FZD1,Adenomatous polyp of colon,0.383941725017158
FZD1,Thyroid Neoplasm,0.383941725017158
FZD1,Parathyroid Adenoma,0.3933196962529684
FZD1,Nephroblastoma,0.3933196962529684
FZD1,Non-Small Cell Lung Carcinoma,0.3933196962529684
FZD1,NAIL DISORDER NONSYNDROMIC CONGENITAL 9,0.3933196962529684
FZD1,Mental Depression,0.3941558617476422
FZD1,Teratocarcinoma,0.3941558617476422
FZD1,Hyperparathyroidism Primary,0.39623320406434
FZD1,Depressive disorder,0.3975960596292668
FZD1,Refractory cancer,0.4028066164685291
FZD1,Familial Exudative Vitreoretinopathy,0.4103119460235835
FZD1,Nail dysplasia,0.4192169590514327
FZD1,Follicular thyroid carcinoma,0.4790179402069343
FZD1,Rhabdoid Tumor of the Kidney,0.4981941174985421
FZD1,Ulcerative Colitis,0.5001612228394569
FZD1,Williams Syndrome,0.6403143122455015
FZD1,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
FZD1,19p13.3 microduplication syndrome ORPHA:447980,0.0586579655822394
FZD1,Malan overgrowth syndrome ORPHA:420179,0.0586579655822394
FZD1,Marshall-Smith syndrome ORPHA:561,0.0586579655822394
FZD1,Sanfilippo syndrome type D ORPHA:79272,0.1590470395003315
FZD1,Atrial septal defect sinus venosus type ORPHA:99105,0.3762014630157917
FZD1,Chondrodysplasia-disorder of sex development syndrome ORPHA:1422,0.3762014630157917
FZD1,Lethal osteosclerotic bone dysplasia ORPHA:1832,0.6239678957896782
GABRQ,Liver carcinoma,0.095319386034013
GABRQ,Liver neoplasms,0.1454373331146953
GABRQ,Malignant neoplasm of lung,0.2714542429024338
GABRQ,Carcinoma of lung,0.3663130598151661
GABRQ,Primary malignant neoplasm of lung,0.3902116649640871
GABRQ,Asthma,0.3933196962529684
GABRQ,Essential Tremor,0.425419812815905
GABRQ,Migraine Disorders,0.4450743762496232
GABRQ,Tremor,0.4564472886428772
GABRQ,Intellectual Disability,0.8352623613787349
GABRQ,Schizophrenia,0.0531117779464085
GABRQ,Autism Spectrum Disorder,0.425341435586089
GABRQ,Migraine,0.4560460337187313
GABRQ,Atrial Septal Defect,0.5254133486377646
GABRQ,Neuroblastoma ORPHA:635,0.3969770464111636
GABRQ,Thyrotoxic periodic paralysis ORPHA:79102,0.6239678957896782
GABRQ,Anonychia congenita totalis ORPHA:94150,0.7068064785325423
GABRQ,Ectromelia virus ERPV hemagglutinin,0.6362779693488597
GABRQ,Vaccinia virus Ankara Haemagglutinin,0.6362779693488597
GABRQ,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
GABRQ,Horsepox virus HSPV177 (Immunoglobulin like),0.691145768348025
GABRQ,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.776311155917498
GAL,Colorectal Carcinoma,0.0034602840073026
GAL,Mammary Neoplasms,0.0034602840073026
GAL,Ovarian Carcinoma,0.0034602840073026
GAL,Breast Carcinoma,0.0042545616049287
GAL,Colorectal Cancer,0.0149315928814189
GAL,Tumor Progression,0.0149315928814189
GAL,Stomach Carcinoma,0.0149315928814189
GAL,melanoma,0.0149315928814189
GAL,Proliferative vitreoretinopathy,0.0182265588252201
GAL,Squamous cell carcinoma,0.0182265588252201
GAL,Malignant mesothelioma,0.0182265588252201
GAL,Malignant neoplasm of breast,0.0191435238361999
GAL,Fibrosarcoma,0.0191435238361999
GAL,Malignant neoplasm of stomach,0.0191435238361999
GAL,Carcinogenesis,0.0228075668512991
GAL,Central neuroblastoma,0.0593779966354549
GAL,Brain Neoplasms,0.064548079316548
GAL,Renal Cell Carcinoma,0.0648809611869375
GAL,Neuroblastoma,0.0688152422187159
GAL,Glioma,0.0739788831250619
GAL,Glioblastoma,0.0745502070959292
GAL,Squamous cell carcinoma of the head and neck,0.0775520919998773
GAL,Lysosomal Storage Diseases,0.0798053340865682
GAL,Colorectal Neoplasms,0.0827744840860166
GAL,Liver carcinoma,0.095319386034013
GAL,Colon Carcinoma,0.1062239757831962
GAL,Adenocarcinoma of colon,0.1112281755580192
GAL,Ganglioneuroma,0.1138051695421299
GAL,Small cell carcinoma of lung,0.1193558174333938
GAL,Unipolar Depression,0.13167400689206
GAL,Head and Neck Carcinoma,0.1735868515093891
GAL,Seizures,0.2053083986145698
GAL,Major Depressive Disorder,0.21122597829463
GAL,Malignant tumor of colon,0.223747154820789
GAL,Diabetes,0.2277108302018961
GAL,Neuroblastic tumors,0.2522264785494494
GAL,Malignant Head and Neck Neoplasm,0.2522264785494494
GAL,Diabetes Mellitus,0.2522264785494494
GAL,MIXED LINEAGE LEUKEMIA,0.2605479444258003
GAL,Opiate Addiction,0.2643145809900195
GAL,Neoplasms,0.2714542429024338
GAL,Malignant ascites,0.2714542429024338
GAL,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
GAL,Multiple Sclerosis,0.2835142372342932
GAL,Embryonal Carcinoma,0.3112516166225269
GAL,Acute pancreatitis,0.3220099003872086
GAL,Apraxia Developmental Verbal,0.340892538685018
GAL,Marijuana Abuse,0.3418217363648192
GAL,Pheochromocytoma,0.3712878513813393
GAL,Classical Hodgkin's Lymphoma,0.3763374964032415
GAL,Rat Insulinoma,0.3778347117514905
GAL,Complex partial seizures,0.383941725017158
GAL,Amyloidosis,0.3933196962529684
GAL,Bipolar Disorder,0.3933196962529684
GAL,Plaque Amyloid,0.3933196962529684
GAL,Inflammation,0.3933196962529684
GAL,Seizures Focal,0.3933196962529684
GAL,Hypertensive disease,0.3933196962529684
GAL,Alzheimer's Disease,0.3933196962529684
GAL,Anxiety Disorders,0.3933196962529684
GAL,Fabry Disease,0.3941558617476422
GAL,Epilepsy,0.3941558617476422
GAL,Intrauterine infection,0.3941558617476422
GAL,Mental Depression,0.3941558617476422
GAL,Pituitary Adenoma,0.3941558617476422
GAL,Drug abuse,0.3941558617476422
GAL,Pituitary Neoplasms,0.3941558617476422
GAL,Alcohol abuse,0.39623320406434
GAL,Mechanical Allodynia,0.3975960596292668
GAL,Depressive disorder,0.3975960596292668
GAL,Nicotine withdrawal,0.3975960596292668
GAL,Drug Dependence,0.4028066164685291
GAL,Epilepsy Temporal Lobe,0.4103119460235835
GAL,Drug-induced depressive state,0.4103119460235835
GAL,Anxiety,0.4115056600660309
GAL,Complex partial seizure with impairment of consciousness,0.4115056600660309
GAL,Neuralgia Atypical,0.4126392832024548
GAL,Neuralgia Iliohypogastric Nerve,0.4126392832024548
GAL,Neuralgia Ilioinguinal,0.4126392832024548
GAL,Neuralgia Perineal,0.4126392832024548
GAL,Neuralgia Stump,0.4126392832024548
GAL,Neuralgia Supraorbital,0.4126392832024548
GAL,Neuralgia Vidian,0.4126392832024548
GAL,Paroxysmal Nerve Pain,0.4126392832024548
GAL,Mood Disorders,0.4192169590514327
GAL,Nerve Pain,0.4192169590514327
GAL,Cleft palate isolated,0.4192169590514327
GAL,Lupus Erythematosus Systemic,0.4213286052188015
GAL,Tachyarrhythmia,0.425419812815905
GAL,Galactosemias,0.425419812815905
GAL,Encephalomyelitis,0.4254307049060398
GAL,Psychosis Involutional,0.4304973629098372
GAL,Involutional Depression,0.4304973629098372
GAL,Involutional paraphrenia,0.4304973629098372
GAL,Addictive Behavior,0.4314759856195063
GAL,Central Nervous System Neoplasms,0.4330362522463816
GAL,Myxoid cyst,0.4335751357405352
GAL,Classical galactosemia,0.4335751357405352
GAL,PANIC DISORDER 1,0.4352815161963393
GAL,Herpes zoster disease,0.4396723023384634
GAL,Migraine Disorders,0.4450743762496232
GAL,Mild cognitive disorder,0.4506578937113162
GAL,Hyperalgesia Secondary,0.4561717689698902
GAL,Allodynia,0.4561717689698902
GAL,Hyperalgesia Primary,0.4564472886428772
GAL,leukemia,0.4588513406515081
GAL,Diabetic Neuropathies,0.4615352570710579
GAL,Tactile Allodynia,0.4675904598629673
GAL,Cerebral Palsy,0.4675904598629673
GAL,Panic Disorder,0.4753011022966241
GAL,Pain,0.4871698998714747
GAL,Neuralgia,0.4923669467696064
GAL,Ovarian Failure Premature,0.4923669467696064
GAL,Alcoholic Intoxication Chronic,0.5097818625871164
GAL,Obesity,0.5140447474168605
GAL,Hyperalgesia Thermal,0.5178072301085912
GAL,Syncope,0.5299466034567416
GAL,Hyperalgesia,0.5393787854381349
GAL,Autoimmune Diseases,0.5512224939896888
GAL,Encephalitis St. Louis,0.553002957824355
GAL,Hirschsprung Disease,0.5794721015064842
GAL,Tachycardia,0.582492855487907
GAL,Graft-vs-Host Disease,0.5922440535658843
GAL,Premature Menopause,0.625112405383346
GAL,Stress Psychological,0.6274540883972485
GAL,Hypertriglyceridemia,0.6304655343580164
GAL,Sepsis,0.6395767498329145
GAL,Brain Ischemia,0.6592493193460769
GAL,Gastric ulcer,0.7240930522443176
GAL,T-Cell Lymphoma,0.7577323833810212
GAL,Nicotine Dependence,0.7935206698366561
GAL,Hodgkin Disease,0.2627224344149009
GAL,Epilepsy,0.3449614869411272
GAL,Mental Depression,0.4560460337187313
GAL,Psychosis,0.4560460337187313
GAL,Hypertension,0.4560460337187313
GAL,Mood Disorder,0.4646409362700993
GAL,Hirschsprung Disease,0.4875380732267193
GAL,Involutional Depression,0.4875380732267193
GAL,Involutional Paraphrenia,0.4875380732267193
GAL,Bipolar Disorder,0.4875380732267193
GAL,Huntington Disease,0.4875380732267193
GAL,Seizure,0.5576425853515448
GAL,Dyscognitive Seizures,0.5632819212593052
GAL,Deafness-lymphedema-leukemia syndrome ORPHA:3226,0.3762014630157917
GAL,Monocytopenia with susceptibility to infections ORPHA:228423,0.3762014630157917
GAL,Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333,0.6239678957896782
GAL,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354,0.6239678957896782
GAL,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361,0.6239678957896782
GANAB,Degenerative polyarthritis,0.0739788831250619
GANAB,Lymphoma,0.0739788831250619
GANAB,Brain Aneurysm,0.1253114324938153
GANAB,Dilatation of the cerebral artery,0.1254380558571286
GANAB,Intracranial Aneurysm,0.1735868515093891
GANAB,Cerebral arterial aneurysm,0.3933196962529684
GANAB,Polycystic Kidney Type 1 Autosomal Dominant Disease,0.3933196962529684
GANAB,Polycystic Kidney Autosomal Dominant,0.3941558617476422
GANAB,Polycystic Kidney - body part,0.39623320406434
GANAB,Cerebral Aneurysm,0.3975960596292668
GANAB,Physical Activity Measurement,0.3986414839122469
GANAB,Polycystic kidney disease type 2,0.4028066164685291
GANAB,Polycystic Kidney Diseases,0.4126392832024548
GANAB,Polycystic liver disease,0.4192169590514327
GANAB,Liver cyst,0.4459714599189374
GANAB,Liver Cyst,0.4560460337187313
GANAB,Polycystic Kidney Disease,0.4646409362700993
GANAB,Polycystic Liver Disease,0.4875380732267193
GANAB,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.1590470395003315
GANAB,Endosteal hyperostosis Worth type ORPHA:2790,0.1590470395003315
GANAB,LRP5-related primary osteoporosis ORPHA:498481,0.1590470395003315
GANAB,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.1590470395003315
GANAB,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.1590470395003315
GANAB,Autosomal dominant polycystic kidney disease ORPHA:730,0.1697334635963512
GANAB,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.3762014630157917
GANAB,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.3762014630157917
GANAB,Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625,0.3762014630157917
GANAB,Sanfilippo syndrome type B ORPHA:79270,0.3762014630157917
GANAB,Giant cell glioblastoma ORPHA:251579,0.433039750392822
GANAB,Gliosarcoma ORPHA:251576,0.433039750392822
GANAB,Idiopathic pulmonary fibrosis ORPHA:2032,0.43936148647173
GANAB,Adult-onset distal myopathy due to VCP mutation ORPHA:329478,0.6239678957896782
GANAB,Autosomal dominant Charcot-Marie-Tooth disease type 2N ORPHA:228174,0.6239678957896782
GANAB,Autosomal dominant Charcot-Marie-Tooth disease type 2Y ORPHA:435387,0.6239678957896782
GANAB,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.6239678957896782
GANAB,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome ORPHA:436174,0.6239678957896782
GANAB,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.6239678957896782
GANAB,DDOST-CDG ORPHA:300536,0.6239678957896782
GANAB,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613,0.6239678957896782
GANAB,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837,0.6239678957896782
GANAB,Jalili syndrome ORPHA:1873,0.6239678957896782
GANAB,MAN1B1-CDG ORPHA:397941,0.6239678957896782
GANAB,Neurogenic arthrogryposis multiplex congenita ORPHA:1143,0.6239678957896782
GANAB,Oxoglutaric aciduria ORPHA:31,0.6239678957896782
GANAB,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848,0.6239678957896782
GANAB,STT3A-CDG ORPHA:370921,0.6239678957896782
GANAB,Schimke immuno-osseous dysplasia ORPHA:1830,0.6239678957896782
GANAB,Smith-Lemli-Opitz syndrome ORPHA:818,0.6239678957896782
GANAB,Spastic paraplegia-Paget disease of bone syndrome ORPHA:329475,0.6239678957896782
GANAB,Spinocerebellar ataxia type 4 ORPHA:98765,0.6239678957896782
GANAB,Caudal regression sequence ORPHA:3027,0.6239678957896782
GANAB,Frontometaphyseal dysplasia ORPHA:1826,0.6239678957896782
GANAB,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.6239678957896782
GANAB,Lujan-Fryns syndrome ORPHA:776,0.6239678957896782
GANAB,Myxofibrosarcoma ORPHA:79105,0.6239678957896782
GANAB,Potocki-Shaffer syndrome ORPHA:52022,0.6239678957896782
GANAB,Congenital muscular dystrophy without intellectual disability ORPHA:370980,0.6268296504510718
GANAB,Familial multiple meningioma ORPHA:263662,0.6279395134845649
GANAB,Meningioma ORPHA:2495,0.6581690778726346
GANAB,Total early-onset cataract ORPHA:98994,0.7002194990845196
GANAB,ALDH18A1-related De Barsy syndrome ORPHA:35664,0.7068064785325423
GANAB,Autoimmune interstitial lung disease-arthritis syndrome ORPHA:444092,0.7068064785325423
GANAB,Autosomal dominant Charcot-Marie-Tooth disease type 2A2 ORPHA:99947,0.7068064785325423
GANAB,Autosomal dominant Charcot-Marie-Tooth disease type 2DD ORPHA:521414,0.7068064785325423
GANAB,Autosomal dominant spastic paraplegia type 9A ORPHA:447753,0.7068064785325423
GANAB,Autosomal dominant spastic paraplegia type 9B ORPHA:447757,0.7068064785325423
GANAB,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency ORPHA:331176,0.7068064785325423
GANAB,Autosomal recessive spastic paraplegia type 18 ORPHA:209951,0.7068064785325423
GANAB,Autosomal recessive spastic paraplegia type 9B ORPHA:447760,0.7068064785325423
GANAB,COG4-CDG ORPHA:263501,0.7068064785325423
GANAB,DPAGT1-CDG ORPHA:86309,0.7068064785325423
GANAB,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome ORPHA:404437,0.7068064785325423
GANAB,Distal hereditary motor neuropathy Jerash type ORPHA:139552,0.7068064785325423
GANAB,FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877,0.7068064785325423
GANAB,Frontorhiny ORPHA:391474,0.7068064785325423
GANAB,Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome ORPHA:480898,0.7068064785325423
GANAB,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib ORPHA:79259,0.7068064785325423
GANAB,Hereditary motor and sensory neuropathy type 5 ORPHA:64751,0.7068064785325423
GANAB,Infantile-onset X-linked spinal muscular atrophy ORPHA:1145,0.7068064785325423
GANAB,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome ORPHA:457279,0.7068064785325423
GANAB,Isolated sedoheptulokinase deficiency ORPHA:440713,0.7068064785325423
GANAB,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.7068064785325423
GANAB,MOGS-CDG ORPHA:79330,0.7068064785325423
GANAB,Melnick-Needles syndrome ORPHA:2484,0.7068064785325423
GANAB,Microcephalic osteodysplastic dysplasia Saul-Wilson type ORPHA:85172,0.7068064785325423
GANAB,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome ORPHA:423306,0.7068064785325423
GANAB,Multiple symmetric lipomatosis ORPHA:2398,0.7068064785325423
GANAB,Neuronal intestinal pseudoobstruction ORPHA:99811,0.7068064785325423
GANAB,Opsismodysplasia ORPHA:2746,0.7068064785325423
GANAB,Orofaciodigital syndrome type 4 ORPHA:2753,0.7068064785325423
GANAB,Otopalatodigital syndrome type 1 ORPHA:90650,0.7068064785325423
GANAB,Otopalatodigital syndrome type 2 ORPHA:90652,0.7068064785325423
GANAB,POMGNT1-related  limb-girdle muscular dystrophy R15 ORPHA:206564,0.7068064785325423
GANAB,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome ORPHA:280384,0.7068064785325423
GANAB,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.7068064785325423
GANAB,Seizures-scoliosis-macrocephaly syndrome ORPHA:466926,0.7068064785325423
GANAB,Severe early-onset axonal neuropathy due to MFN2 deficiency ORPHA:90118,0.7068064785325423
GANAB,Spinocerebellar ataxia type 26 ORPHA:101112,0.7068064785325423
GANAB,Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630,0.7068064785325423
GANAB,X-linked Ehlers-Danlos syndrome ORPHA:75497,0.7068064785325423
GANAB,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606,0.7068064785325423
GANAB,Cole-Carpenter syndrome ORPHA:2050,0.7068064785325423
GANAB,MEDNIK syndrome ORPHA:171851,0.7068064785325423
GANAB,Schneckenbecken dysplasia ORPHA:3144,0.7068064785325423
GANAB,Syndromic diarrhea ORPHA:84064,0.7068064785325423
GANAB,Isolated polycystic liver disease ORPHA:2924,0.7068064785325423
GANAB,Triple A syndrome ORPHA:869,0.7068064785325423
GANAB,Juvenile amyotrophic lateral sclerosis ORPHA:300605,0.7068064785325423
GANAB,Extraskeletal myxoid chondrosarcoma ORPHA:209916,0.7068064785325423
GANAB,Cervical spina bifida aperta ORPHA:268392,0.7068064785325423
GANAB,Cervical spina bifida cystica ORPHA:268762,0.7068064785325423
GANAB,Cervicothoracic spina bifida aperta ORPHA:268397,0.7068064785325423
GANAB,Cervicothoracic spina bifida cystica ORPHA:268766,0.7068064785325423
GANAB,Lumbosacral spina bifida aperta ORPHA:268388,0.7068064785325423
GANAB,Lumbosacral spina bifida cystica ORPHA:268758,0.7068064785325423
GANAB,Muscle-eye-brain disease ORPHA:588,0.7068064785325423
GANAB,Perrault syndrome ORPHA:2855,0.7068064785325423
GANAB,Thoracolumbosacral spina bifida aperta ORPHA:268384,0.7068064785325423
GANAB,Thoracolumbosacral spina bifida cystica ORPHA:268752,0.7068064785325423
GANAB,Total spina bifida aperta ORPHA:268377,0.7068064785325423
GANAB,Total spina bifida cystica ORPHA:268748,0.7068064785325423
GANAB,Upper thoracic spina bifida aperta ORPHA:268740,0.7068064785325423
GANAB,Upper thoracic spina bifida cystica ORPHA:268770,0.7068064785325423
GANAB,Frontotemporal dementia with motor neuron disease ORPHA:275872,0.7072638369101406
GANAB,MiT family translocation renal cell carcinoma ORPHA:319308,0.7072638369101406
GANAB,Williams syndrome ORPHA:904,0.7522711230011014
GANAB,Amyotrophic lateral sclerosis ORPHA:803,0.7851555354466673
GANAB,Autosomal recessive non-syndromic intellectual disability ORPHA:88616,0.7919417912871124
GANAB,Human betaherpesvirus 5 membrane glycoprotein UL18 (gene: UL18),0.6906952981256558
GLI2,Mammary Neoplasms,0.0034602840073026
GLI2,Ovarian Carcinoma,0.0034602840073026
GLI2,Breast Carcinoma,0.0042545616049287
GLI2,Invasive Ductal Breast Carcinoma,0.0149002095788623
GLI2,Tumor Progression,0.0149315928814189
GLI2,Stomach Carcinoma,0.0149315928814189
GLI2,melanoma,0.0149315928814189
GLI2,Squamous cell carcinoma,0.0182265588252201
GLI2,Malignant mesothelioma,0.0182265588252201
GLI2,Malignant neoplasm of breast,0.0191435238361999
GLI2,Malignant neoplasm of stomach,0.0191435238361999
GLI2,Carcinogenesis,0.0228075668512991
GLI2,Malignant neoplasm of ovary,0.0277695594716545
GLI2,Medulloblastoma,0.0354767239335874
GLI2,Skin carcinoma,0.0482468351695405
GLI2,Malignant neoplasm of prostate,0.0569142010728473
GLI2,Central neuroblastoma,0.0593779966354549
GLI2,Neoplasm Metastasis,0.0648809611869375
GLI2,Neuroblastoma,0.0688152422187159
GLI2,Glioma,0.0739788831250619
GLI2,Glioblastoma,0.0745502070959292
GLI2,Carcinoma breast stage IV,0.0745502070959292
GLI2,Liver Cirrhosis,0.0773771948186562
GLI2,Prostate carcinoma,0.0773771948186562
GLI2,Stage IV Bladder Cancer AJCC v6,0.084286432100041
GLI2,Malignant neoplasm of urinary bladder,0.084286432100041
GLI2,Bladder Neoplasm,0.0891725280554336
GLI2,Liver carcinoma,0.095319386034013
GLI2,Osteosarcoma,0.1029977559100099
GLI2,Colon Carcinoma,0.1062239757831962
GLI2,Secondary malignant neoplasm of bone,0.1253114324938153
GLI2,Tumor Initiation,0.13167400689206
GLI2,Carcinoma Transitional Cell,0.13167400689206
GLI2,Carcinoma of bladder,0.13167400689206
GLI2,Colonic Neoplasms,0.1454373331146953
GLI2,Jaw Keratocyst,0.1454373331146953
GLI2,Liver neoplasms,0.1454373331146953
GLI2,Renal fibrosis,0.1602092191314262
GLI2,Seizures,0.2053083986145698
GLI2,Partial or complete agenesis of corpus callosum,0.2062010908869036
GLI2,Osteosarcoma of bone,0.2109483801368481
GLI2,Partial agenesis of corpus callosum,0.222537307875512
GLI2,Malignant tumor of colon,0.223747154820789
GLI2,Prostatic Neoplasms,0.223747154820789
GLI2,B-Cell Lymphomas,0.2522264785494494
GLI2,Chondrosarcoma,0.2643145809900195
GLI2,Cirrhosis,0.2923761731100008
GLI2,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
GLI2,Idiopathic Pulmonary Fibrosis,0.3099246715197673
GLI2,Gastrointestinal Stromal Tumors,0.3199171478489988
GLI2,Rhabdomyosarcoma,0.3510063969122338
GLI2,Undifferentiated leukemia,0.383941725017158
GLI2,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
GLI2,Muscle Rigidity,0.3933196962529684
GLI2,Non-Small Cell Lung Carcinoma,0.3933196962529684
GLI2,Infection caused by Helicobacter pylori,0.3933196962529684
GLI2,Hydrocephalus,0.3933196962529684
GLI2,Short palate,0.3933196962529684
GLI2,HIV Infections,0.3933196962529684
GLI2,Skin Neoplasms,0.3933196962529684
GLI2,Anxiety Disorders,0.3933196962529684
GLI2,SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR,0.3933196962529684
GLI2,Pituitary Hormone Deficiency Combined 1,0.3933196962529684
GLI2,Prominent antihelix,0.3933196962529684
GLI2,Generalized osteopenia,0.3933196962529684
GLI2,Acute Promyelocytic Leukemia,0.3933196962529684
GLI2,Parkinson Disease,0.3933196962529684
GLI2,Childhood Medulloblastoma,0.3933196962529684
GLI2,Abnormality of secondary sexual hair,0.3933196962529684
GLI2,Anterior pituitary agenesis,0.3933196962529684
GLI2,Cleft palate and bilateral cleft lip,0.3933196962529684
GLI2,Basal Cell Nevus Syndrome,0.3933196962529684
GLI2,Chronic schizophrenia,0.3941558617476422
GLI2,Epilepsy,0.3941558617476422
GLI2,Abnormal prolactin level,0.3941558617476422
GLI2,androgen independent prostate cancer,0.3941558617476422
GLI2,Ectopic posterior pituitary,0.3941558617476422
GLI2,Hereditary hemochromatosis,0.3941558617476422
GLI2,Waldenstrom Macroglobulinemia,0.3975960596292668
GLI2,Abnormal cortical gyration,0.3975960596292668
GLI2,Pituitary Diseases,0.4028066164685291
GLI2,Chronic Kidney Diseases,0.4028066164685291
GLI2,Spondylarthropathies,0.4028066164685291
GLI2,Axenfeld-Rieger syndrome,0.4028066164685291
GLI2,Anxiety,0.4115056600660309
GLI2,Reiter Syndrome,0.4115056600660309
GLI2,Anterior pituitary hypoplasia,0.4115056600660309
GLI2,Aplasia/Hypoplasia of the breasts,0.4115056600660309
GLI2,Congenital Foot Deformity,0.4115056600660309
GLI2,Decreased circulating ACTH level,0.4115056600660309
GLI2,Alobar Holoprosencephaly,0.4126392832024548
GLI2,Mood Disorders,0.4192169590514327
GLI2,Semilobar Holoprosencephaly,0.4192169590514327
GLI2,Split foot,0.4192169590514327
GLI2,Cleft palate isolated,0.4192169590514327
GLI2,Angle class 2 malocclusion,0.4209380602168584
GLI2,Angle class 3 malocclusion,0.4209380602168584
GLI2,Immunologic Deficiency Syndromes,0.4213286052188015
GLI2,PACHYONYCHIA CONGENITA 3,0.424575176503444
GLI2,Malocclusion,0.425419812815905
GLI2,Hypoplasia of the pituitary gland,0.4304973629098372
GLI2,Arhinencephaly,0.4335751357405352
GLI2,Short stature,0.439389586518055
GLI2,bone destruction,0.4506578937113162
GLI2,Secondary hypothyroidism,0.4506578937113162
GLI2,Septo-Optic Dysplasia,0.4615352570710579
GLI2,Ectrodactyly,0.4615352570710579
GLI2,Abnormality of the skeletal system,0.466957409863091
GLI2,Malignant neoplasm of skin,0.466957409863091
GLI2,Hypotrophic malar bone,0.4704594475773637
GLI2,Malar flattening,0.4704594475773637
GLI2,Esophageal atresia with or without tracheoesophageal fistula,0.472444704048021
GLI2,Pigmented Basal Cell Carcinoma,0.4753011022966241
GLI2,Hypoplasia of the optic nerve,0.4790179402069343
GLI2,Small head,0.4906258721078565
GLI2,POLYDACTYLY POSTAXIAL,0.4906258721078565
GLI2,Lobar Holoprosencephaly,0.4906258721078565
GLI2,Osteopenia,0.4923669467696064
GLI2,Split-Hand/Foot Malformation,0.5019670090704682
GLI2,Chronic graft-versus-host disease,0.5090214163899865
GLI2,Alcoholic Intoxication Chronic,0.5097818625871164
GLI2,Arthritis Reactive,0.5188223685230745
GLI2,Pituitary dwarfism,0.5188223685230745
GLI2,Orbital separation diminished,0.5251317541886066
GLI2,Concave bridge of nose,0.5337853752290136
GLI2,Depressed nasal root/bridge,0.5337853752290136
GLI2,Depressed nasal bridge,0.533913711453195
GLI2,Split hand foot deformity 1,0.5453394612016188
GLI2,Hypopituitarism,0.549941235475765
GLI2,Panhypopituitarism,0.549941235475765
GLI2,Childhood Osteosarcoma,0.553002957824355
GLI2,Amenorrhea,0.5655222348249326
GLI2,Tardive Dyskinesia,0.5710095678317721
GLI2,Drug-induced tardive dyskinesia,0.5710095678317721
GLI2,Microphthalmos,0.5839588826096398
GLI2,Anophthalmos,0.5916904943304121
GLI2,Body Height,0.5936773368594411
GLI2,Holoprosencephaly,0.5956632182199403
GLI2,Congenital chromosomal disease,0.6035970790768342
GLI2,Abnormally small eyeball,0.6064571148125548
GLI2,Decreased size of eyeball,0.6064571148125548
GLI2,Gastrointestinal Stromal Sarcoma,0.610971999959321
GLI2,Disorders of Sex Development,0.6150955455771212
GLI2,Idiopathic hypogonadotropic hypogonadism,0.6222451141623291
GLI2,Shigella Infections,0.6304655343580164
GLI2,Small midface,0.6319938293757544
GLI2,Decreased projection of midface,0.6319938293757544
GLI2,Hypotrophic midface,0.6319938293757544
GLI2,Midface retrusion,0.6319938293757544
GLI2,Isolated somatotropin deficiency,0.652707626880454
GLI2,Infertility,0.655573080043894
GLI2,Acute Undifferentiated Leukemia,0.6656356363792992
GLI2,Ulnar polydactyly of fingers,0.6691893635307453
GLI2,Uranostaphyloschisis,0.6784817526917547
GLI2,Depressed nasal ridge,0.6802335864704374
GLI2,Retrusion of upper jaw bones,0.6925751397474874
GLI2,Short philtrum,0.6925751397474874
GLI2,Decreased projection of maxilla,0.6925751397474874
GLI2,Deficiency of upper jaw bones,0.6925751397474874
GLI2,Hypoplasia of the maxilla,0.6925751397474874
GLI2,Hypotrophic maxilla,0.6925751397474874
GLI2,Maxillary retrognathia,0.6925751397474874
GLI2,Congenital hypoplasia of penis,0.6974821940437801
GLI2,Hypotension,0.7068844070911514
GLI2,Osteogenesis Imperfecta,0.7309076068378124
GLI2,Cryptorchidism,0.7417321496240817
GLI2,Benign Prostatic Hyperplasia,0.7491018580851883
GLI2,Biliary Atresia,0.7511652060995492
GLI2,Basal cell carcinoma,0.7564787632115322
GLI2,Small testicle,0.7631684472516962
GLI2,Fatigue,0.7658980225613361
GLI2,Cleft Palate,0.7670529315163258
GLI2,Hypogonadism Isolated Hypogonadotropic,0.7780887836634591
GLI2,Hypoglycemia,0.7790800975250889
GLI2,Hypogonadotropic hypogonadism,0.7977380842181487
GLI2,Large auricle,0.8148412516612868
GLI2,Large pinnae,0.8148412516612868
GLI2,Macrotia,0.8148412516612868
GLI2,Intellectual Disability,0.8352623613787349
GLI2,Polydactyly,0.8352623613787349
GLI2,Dwarfism,0.8405066264419017
GLI2,Mental and motor retardation,0.897310588550617
GLI2,Cognitive delay,0.9238745269736108
GLI2,Global developmental delay,0.9327689937867868
GLI2,Medullary carcinoma of thyroid,0.9368645815921308
GLI2,Experimental Organism Basal Cell Carcinoma,0.9601817390493856
GLI2,Genetic Diseases Inborn,0.9781572866315434
GLI2,Carcinoma,0.0534520155998091
GLI2,Partial Agenesis Of Corpus Callosum,0.2187610616307245
GLI2,Hydrocephalus,0.3657224783929353
GLI2,Ectopic Anterior Pituitary Gland,0.4402141802500753
GLI2,Skin Neoplasms,0.4541466895915311
GLI2,Pituitary Hormone Deficiency,0.4541466895915311
GLI2,Osteopenia,0.4560460337187313
GLI2,Cleft Palate And Bilateral Cleft Lip,0.4560460337187313
GLI2,Hypopituitarism,0.4560460337187313
GLI2,Basal Cell Neoplasm,0.4560460337187313
GLI2,Septopreoptic Holoprosencephaly,0.4560460337187313
GLI2,Midline Interhemispheric Variant Of Holoprosencephaly,0.4560460337187313
GLI2,Osteoporosis Of Vertebrae,0.4560460337187313
GLI2,Alobar Holoprosencephaly,0.4560460337187313
GLI2,Microform Holoprosencephaly,0.4560460337187313
GLI2,Semilobar Holoprosencephaly,0.4646409362700993
GLI2,Cyclocephaly,0.4646409362700993
GLI2,Septo-Optic Dysplasia,0.4646409362700993
GLI2,Fused Incisors,0.4646409362700993
GLI2,Hemangioma,0.4723647227028846
GLI2,Pituitary Dwarfism,0.4809179010794786
GLI2,Panhypopituitarism,0.4867879381749835
GLI2,Scoliosis,0.4875380732267193
GLI2,Ambiguous Genitalia,0.5021774953934145
GLI2,Asthma,0.504364324740411
GLI2,Microcephaly,0.5123947823327547
GLI2,Renal Agenesis,0.5207800595599322
GLI2,Lobar Holoprosencephaly,0.5234357475824973
GLI2,Arrhinencephaly,0.5316139823120088
GLI2,Duodenal Atresia,0.5414559855274098
GLI2,Hypoplasia Of The Maxilla,0.5576425853515448
GLI2,Dwarfism,0.5796489603182782
GLI2,Promyelocytic Leukemia,0.6030919130927346
GLI2,Agenesis Of Corpus Callosum,0.6252040071965056
GLI2,Hypogonadotropic Hypogonadism,0.6325735973587235
GLI2,Hypoplasia Of The Optic Nerve,0.6340319940404294
GLI2,Holoprosencephaly,0.6400187225075934
GLI2,Skin Cancer,0.6524705037929849
GLI2,Congenital Coloboma Of Iris,0.6572113517052336
GLI2,Congenital Hypoplasia Of Penis,0.6572113517052336
GLI2,Gastrointestinal Stromal Tumor,0.669025484259299
GLI2,Syndromic Microphthalmia,0.6798971073653743
GLI2,Somatotropin Deficiency,0.7049836926927165
GLI2,Isolated Somatotropin Deficiency,0.7378537370641419
GLI2,Postaxial Hand Polydactyly,0.7472134648605725
GLI2,Penis Agenesis,0.7662135194687344
GLI2,Mental Retardation,0.7729545590606223
GLI2,Choanal Atresia,0.7729545590606223
GLI2,Cryptorchidism,0.776786668801341
GLI2,Microphthalmos,0.7875494303517502
GLI2,Hypothyroidism,0.7921294370722203
GLI2,Multiple Congenital Anomalies,0.836331547891711
GLI2,Hypogonadism,0.8536040084512244
GLI2,Tetralogy Of Fallot,0.8570285304674955
GLI2,Polydactyly,0.8938134940770912
GLI2,Macrotia,0.9055059991400024
GLI2,Hypoglycemia,0.9096190669068288
GLI2,Dysmorphic Features,0.91146174923533
GLI2,Strabismus,0.9568083835980838
GLI2,Developmental Delay,0.96477535147595
GLI2,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
GLI2,Peters anomaly ORPHA:708,0.00518481975049
GLI2,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
GLI2,Familial porencephaly ORPHA:99810,0.0083045131203191
GLI2,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
GLI2,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
GLI2,Polysyndactyly ORPHA:93338,0.0083045131203191
GLI2,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
GLI2,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
GLI2,Tibial hemimelia ORPHA:93322,0.0083045131203191
GLI2,Axenfeld anomaly ORPHA:98978,0.0083045131203191
GLI2,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
GLI2,Branchiootic syndrome ORPHA:52429,0.0083045131203191
GLI2,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
GLI2,Rieger anomaly ORPHA:91483,0.0083045131203191
GLI2,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
GLI2,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.0180064224283883
GLI2,CHST3-related skeletal dysplasia ORPHA:263463,0.0180064224283883
GLI2,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.0180064224283883
GLI2,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451,0.0180064224283883
GLI2,Familial schizencephaly ORPHA:481986,0.0180064224283883
GLI2,GAPO syndrome ORPHA:2067,0.0180064224283883
GLI2,HANAC syndrome ORPHA:73229,0.0180064224283883
GLI2,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.0180064224283883
GLI2,Nance-Horan syndrome ORPHA:627,0.0180064224283883
GLI2,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.0180064224283883
GLI2,Retinal arterial tortuosity ORPHA:75326,0.0180064224283883
GLI2,Steel syndrome ORPHA:438117,0.0180064224283883
GLI2,Synpolydactyly type 2 ORPHA:295197,0.0180064224283883
GLI2,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.0180064224283883
GLI2,Hypoplastic left heart syndrome ORPHA:2248,0.0180064224283883
GLI2,Matthew-Wood syndrome ORPHA:2470,0.0180064224283883
GLI2,Piebaldism ORPHA:2884,0.0180064224283883
GLI2,BOR syndrome ORPHA:107,0.0183145313768111
GLI2,Ondine syndrome ORPHA:661,0.020072786018028
GLI2,Tetralogy of Fallot ORPHA:3303,0.0277610005156803
GLI2,Classical Ehlers-Danlos syndrome ORPHA:287,0.0586579655822394
GLI2,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.0586579655822394
GLI2,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.0586579655822394
GLI2,Caffey disease ORPHA:1310,0.0586579655822394
GLI2,Childhood-onset benign chorea with striatal involvement ORPHA:494541,0.0586579655822394
GLI2,Congenital alveolar capillary dysplasia ORPHA:210122,0.0586579655822394
GLI2,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.0586579655822394
GLI2,Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526,0.0586579655822394
GLI2,Kuskokwim syndrome ORPHA:1149,0.0586579655822394
GLI2,Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528,0.0586579655822394
GLI2,Lymphedema-distichiasis syndrome ORPHA:33001,0.0586579655822394
GLI2,Muscle filaminopathy ORPHA:171445,0.0586579655822394
GLI2,Oculodentodigital dysplasia ORPHA:2710,0.0586579655822394
GLI2,Posterior urethral valve ORPHA:93110,0.0586579655822394
GLI2,Syndactyly type 3 ORPHA:93404,0.0586579655822394
GLI2,Autosomal recessive Robinow syndrome ORPHA:1507,0.0586579655822394
GLI2,Postaxial polydactyly type B ORPHA:93335,0.0586579655822394
GLI2,Sclerosteosis ORPHA:3152,0.0586579655822394
GLI2,Hennekam syndrome ORPHA:2136,0.0599424746210022
GLI2,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.0640416108792758
GLI2,Combined pituitary hormone deficiencies genetic forms ORPHA:95494,0.0683063362547733
GLI2,Osteogenesis imperfecta type 3 ORPHA:216812,0.0683063362547733
GLI2,Ablepharon macrostomia syndrome ORPHA:920,0.1590470395003315
GLI2,Barber-Say syndrome ORPHA:1231,0.1590470395003315
GLI2,Focal facial dermal dysplasia type III ORPHA:1807,0.1590470395003315
GLI2,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542,0.1590470395003315
GLI2,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.1590470395003315
GLI2,Ring dermoid of cornea ORPHA:91481,0.1590470395003315
GLI2,X-linked adrenal hypoplasia congenita ORPHA:95702,0.1590470395003315
GLI2,Enlarged parietal foramina ORPHA:60015,0.1590470395003315
GLI2,Hereditary mixed polyposis syndrome ORPHA:157794,0.1590470395003315
GLI2,Pfeiffer syndrome type 1 ORPHA:93258,0.1590470395003315
GLI2,Spondylometaphyseal dysplasia 'corner fracture' type ORPHA:93315,0.1590470395003315
GLI2,Acrocallosal syndrome ORPHA:36,0.1590470395003315
GLI2,Butterfly-shaped pigment dystrophy ORPHA:99001,0.1590470395003315
GLI2,NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480,0.1590470395003315
GLI2,WAGR syndrome ORPHA:893,0.1590470395003315
GLI2,Isolated brachycephaly ORPHA:35099,0.1614487935928034
GLI2,Isolated plagiocephaly ORPHA:35098,0.1614487935928034
GLI2,Colobomatous microphthalmia ORPHA:98938,0.1782034488938806
GLI2,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome ORPHA:370022,0.3762014630157917
GLI2,Brachydactyly type B1 ORPHA:572385,0.3762014630157917
GLI2,Congenital vertical talus bilateral ORPHA:295203,0.3762014630157917
GLI2,Congenital vertical talus unilateral ORPHA:295201,0.3762014630157917
GLI2,Craniodiaphyseal dysplasia ORPHA:1513,0.3762014630157917
GLI2,Curry-Jones syndrome ORPHA:1553,0.3762014630157917
GLI2,Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390,0.3762014630157917
GLI2,Hartsfield syndrome ORPHA:2117,0.3762014630157917
GLI2,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953,0.3762014630157917
GLI2,Osteoglosphonic dysplasia ORPHA:2645,0.3762014630157917
GLI2,Congenital ptosis ORPHA:91411,0.3762014630157917
GLI2,Fibrochondrogenesis ORPHA:2021,0.3762014630157917
GLI2,Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752,0.3762014630157917
GLI2,Renal hypoplasia bilateral ORPHA:97362,0.3762014630157917
GLI2,Ellis Van Creveld syndrome ORPHA:289,0.3762014630157917
GLI2,Familial bicuspid aortic valve ORPHA:402075,0.3775879467205478
GLI2,Midline interhemispheric variant of holoprosencephaly ORPHA:93926,0.43936148647173
GLI2,Septopreoptic holoprosencephaly ORPHA:280195,0.43936148647173
GLI2,Semilobar holoprosencephaly ORPHA:220386,0.4470672161388242
GLI2,Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479,0.6239678957896782
GLI2,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome ORPHA:440354,0.6239678957896782
GLI2,Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333,0.6239678957896782
GLI2,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354,0.6239678957896782
GLI2,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361,0.6239678957896782
GLI2,Congenital contractural arachnodactyly ORPHA:115,0.6239678957896782
GLI2,Craniofacial-deafness-hand syndrome ORPHA:1529,0.6239678957896782
GLI2,Marshall syndrome ORPHA:560,0.6239678957896782
GLI2,Multiple epiphyseal dysplasia Al-Gazali type ORPHA:166024,0.6239678957896782
GLI2,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome ORPHA:85112,0.6239678957896782
GLI2,Stickler syndrome type 2 ORPHA:90654,0.6239678957896782
GLI2,Waardenburg syndrome type 1 ORPHA:894,0.6239678957896782
GLI2,Waardenburg syndrome type 3 ORPHA:896,0.6239678957896782
GLI2,Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990,0.6239678957896782
GLI2,Encephalocraniocutaneous lipomatosis ORPHA:2396,0.6239678957896782
GLI2,Isolated Klippel-Feil syndrome ORPHA:2345,0.6239678957896782
GLI2,Myxofibrosarcoma ORPHA:79105,0.6239678957896782
GLI2,Silver-Russell syndrome due to a point mutation ORPHA:397590,0.6268296504510718
GLI2,46XX testicular disorder of sex development ORPHA:393,0.6279395134845649
GLI2,Alobar holoprosencephaly ORPHA:93925,0.6787273931204523
GLI2,Lobar holoprosencephaly ORPHA:93924,0.6787273931204523
GLI2,Microform holoprosencephaly ORPHA:280200,0.6857161253678724
GLI2,Classic Bartter syndrome ORPHA:93605,0.7068064785325423
GLI2,Townes-Brocks syndrome ORPHA:857,0.7068064785325423
GLI2,Pituitary stalk interruption syndrome ORPHA:95496,0.7072638369101406
GLI2,Human papillomavirus type 6 E5B (gene: E5B),0.9829721238496356
GPNMB,Colorectal Carcinoma,0.0034602840073026
GPNMB,Mammary Neoplasms,0.0034602840073026
GPNMB,Ovarian Carcinoma,0.0034602840073026
GPNMB,Breast Carcinoma,0.0042545616049287
GPNMB,Invasive carcinoma of breast,0.0149002095788623
GPNMB,Epithelioma,0.0149002095788623
GPNMB,Colorectal Cancer,0.0149315928814189
GPNMB,Tumor Progression,0.0149315928814189
GPNMB,melanoma,0.0149315928814189
GPNMB,Adenocarcinoma,0.0155921563748247
GPNMB,Squamous cell carcinoma,0.0182265588252201
GPNMB,Malignant neoplasm of breast,0.0191435238361999
GPNMB,Carcinogenesis,0.0228075668512991
GPNMB,Malignant neoplasm of ovary,0.0277695594716545
GPNMB,Malignant neoplasm of prostate,0.0569142010728473
GPNMB,Mammary Neoplasms Human,0.064548079316548
GPNMB,Brain Neoplasms,0.064548079316548
GPNMB,Neoplasm Metastasis,0.0648809611869375
GPNMB,Renal Cell Carcinoma,0.0648809611869375
GPNMB,Malignant neoplasm of pancreas,0.0726340460169901
GPNMB,Glioma,0.0739788831250619
GPNMB,Degenerative polyarthritis,0.0739788831250619
GPNMB,Glioblastoma,0.0745502070959292
GPNMB,Pancreatic carcinoma,0.0745502070959292
GPNMB,Carcinoma breast stage IV,0.0745502070959292
GPNMB,Liver Cirrhosis Experimental,0.0747863377072194
GPNMB,Liver Cirrhosis,0.0773771948186562
GPNMB,Prostate carcinoma,0.0773771948186562
GPNMB,Squamous cell carcinoma of the head and neck,0.0775520919998773
GPNMB,Colorectal Neoplasms,0.0827744840860166
GPNMB,Malignant neoplasm of urinary bladder,0.084286432100041
GPNMB,Bladder Neoplasm,0.0891725280554336
GPNMB,Liver carcinoma,0.095319386034013
GPNMB,Malignant Neoplasms,0.0991201145654548
GPNMB,Osteosarcoma,0.1029977559100099
GPNMB,Hematologic Neoplasms,0.1253114324938153
GPNMB,Secondary malignant neoplasm of bone,0.1253114324938153
GPNMB,Carcinoma of bladder,0.13167400689206
GPNMB,Hyperactive behavior,0.1387448809655294
GPNMB,Solid Neoplasm,0.1413782599148022
GPNMB,Liver neoplasms,0.1454373331146953
GPNMB,Osteosarcoma of bone,0.2109483801368481
GPNMB,Metastasis from malignant tumor of prostate,0.2454426921531692
GPNMB,Metastatic Prostate Carcinoma,0.2643145809900195
GPNMB,Squamous cell carcinoma of vulva,0.2643145809900195
GPNMB,Secondary malignant neoplasm of lung,0.2723545094624877
GPNMB,Cervix carcinoma,0.2834835531038365
GPNMB,Cirrhosis,0.2923761731100008
GPNMB,Triple Negative Breast Neoplasms,0.2980670559114652
GPNMB,Ataxia Telangiectasia,0.3508665345292502
GPNMB,Primary malignant neoplasm,0.383941725017158
GPNMB,Endometriosis,0.383941725017158
GPNMB,Secondary malignant neoplasm of lymph node,0.3933196962529684
GPNMB,Amyloidosis,0.3933196962529684
GPNMB,Fulminant hepatitis,0.3933196962529684
GPNMB,Malignant Glioma,0.3933196962529684
GPNMB,Bronchopulmonary Dysplasia,0.3933196962529684
GPNMB,Skin Carcinogenesis,0.3933196962529684
GPNMB,Pigment dispersion syndrome (disorder),0.3933196962529684
GPNMB,HIV Infections,0.3933196962529684
GPNMB,Alzheimer's Disease,0.3933196962529684
GPNMB,Parkinson Disease,0.3933196962529684
GPNMB,Glioblastoma Multiforme,0.3933196962529684
GPNMB,Malignant epithelioma,0.3933196962529684
GPNMB,Malignant neoplasm of kidney,0.3941558617476422
GPNMB,Polycystic Kidney Autosomal Dominant,0.3941558617476422
GPNMB,Renal carcinoma,0.3941558617476422
GPNMB,Pituitary Adenoma,0.3941558617476422
GPNMB,Amyotrophic Lateral Sclerosis,0.3975960596292668
GPNMB,Kidney Failure Acute,0.4028066164685291
GPNMB,Hemolytic-Uremic Syndrome,0.4115056600660309
GPNMB,Alzheimer Disease Late Onset,0.4115056600660309
GPNMB,Down Syndrome,0.4126392832024548
GPNMB,Immunologic Deficiency Syndromes,0.4213286052188015
GPNMB,Encephalomyelitis,0.4254307049060398
GPNMB,Neurodegenerative Disorders,0.4335751357405352
GPNMB,leukemia,0.4588513406515081
GPNMB,Motor neuron atrophy,0.4714226702518064
GPNMB,Acute kidney injury,0.4753011022966241
GPNMB,LEOPARD Syndrome,0.4753011022966241
GPNMB,Cyst,0.4850576707687362
GPNMB,Diarrhea,0.4923669467696064
GPNMB,Metastatic melanoma,0.5001612228394569
GPNMB,Obesity,0.5140447474168605
GPNMB,Bacterial Infections,0.5337853752290136
GPNMB,Human immunodeficiency virus type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site,0.5337853752290136
GPNMB,Disseminated Malignant Neoplasm,0.533913711453195
GPNMB,Autoimmune Diseases,0.5512224939896888
GPNMB,Cutaneous Melanoma,0.5710095678317721
GPNMB,Turner Syndrome Male,0.582492855487907
GPNMB,Microphthalmos,0.5839588826096398
GPNMB,Noonan Syndrome,0.6150955455771212
GPNMB,Lymphangioleiomyomatosis,0.6222451141623291
GPNMB,Brain Ischemia,0.6592493193460769
GPNMB,Myasthenia Gravis,0.6821087736355662
GPNMB,Acute Kidney Insufficiency,0.7068844070911514
GPNMB,Muscular Dystrophies Limb-Girdle,0.717484976234209
GPNMB,Muscular Dystrophy,0.7294281406818208
GPNMB,Liver Failure Acute,0.7840911880051142
GPNMB,Cerebral Ischemia,0.839057838231319
GPNMB,Cerebral Infarction,0.8472019892490944
GPNMB,Breast Carcinoma,0.0075861267486594
GPNMB,Marfan Syndrome,0.0133304506157067
GPNMB,Mammary Neoplasms,0.0155248163763686
GPNMB,Breast Cancer,0.0402286636010764
GPNMB,Endometriosis,0.2187610616307245
GPNMB,Amyloidosis,0.4286813331685578
GPNMB,Colorectal Cancer,0.4286813331685578
GPNMB,Colorectal Neoplasms,0.4560460337187313
GPNMB,Liver Failure,0.5162067638232762
GPNMB,Kidney Failure,0.6899894525110877
GPNMB,Acute Kidney Insufficiency,0.7729545590606223
GPNMB,AGel amyloidosis ORPHA:85448,0.0586579655822394
GPNMB,Keratolytic winter erythema ORPHA:50943,0.0586579655822394
GPNMB,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.0586579655822394
GPNMB,Griscelli syndrome type 3 ORPHA:79478,0.0586579655822394
GPNMB,Familial cavitary optic disc anomaly ORPHA:464760,0.1590470395003315
GPNMB,Lipoid proteinosis ORPHA:530,0.1590470395003315
GPNMB,MITF-related melanoma and renal cell carcinoma predisposition syndrome ORPHA:293822,0.1590470395003315
GPNMB,Pycnodysostosis ORPHA:763,0.1590470395003315
GPNMB,Tay-Sachs disease B variant adult form ORPHA:309192,0.1590470395003315
GPNMB,Tay-Sachs disease B variant infantile form ORPHA:309178,0.1590470395003315
GPNMB,Tay-Sachs disease B variant juvenile form ORPHA:309185,0.1590470395003315
GPNMB,Tay-Sachs disease B1 variant ORPHA:309239,0.1590470395003315
GPNMB,Tietz syndrome ORPHA:42665,0.1590470395003315
GPNMB,Familial calcium pyrophosphate deposition ORPHA:1416,0.1590470395003315
GPNMB,Amyloidosis cutis dyschromia ORPHA:319635,0.3762014630157917
GPNMB,Aromatase deficiency ORPHA:91,0.3762014630157917
GPNMB,Aromatase excess syndrome ORPHA:178345,0.3762014630157917
GPNMB,Complement component 3 deficiency ORPHA:280133,0.3762014630157917
GPNMB,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.3762014630157917
GPNMB,Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472,0.3762014630157917
GPNMB,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.3762014630157917
GPNMB,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.3762014630157917
GPNMB,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.3762014630157917
GPNMB,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.3762014630157917
GPNMB,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.3762014630157917
GPNMB,Keratosis follicularis spinulosa decalvans ORPHA:2340,0.3762014630157917
GPNMB,Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588,0.6239678957896782
GPNMB,Ocular albinism with congenital sensorineural deafness ORPHA:352740,0.6239678957896782
GPNMB,Dysbetalipoproteinemia ORPHA:412,0.6239678957896782
GPNMB,Familial episodic pain syndrome with predominantly upper body involvement ORPHA:391389,0.6239678957896782
GPNMB,GM2 gangliosidosis AB variant ORPHA:309246,0.6239678957896782
GPNMB,Lipoprotein glomerulopathy ORPHA:329481,0.6239678957896782
GPNMB,Sea-blue histiocytosis ORPHA:158029,0.6239678957896782
GPNMB,Juvenile glaucoma ORPHA:98977,0.6239678957896782
GPNMB,Semantic dementia ORPHA:100069,0.639029370164481
GPNMB,Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147,0.7068064785325423
GPNMB,Minimal pigment oculocutaneous albinism type 1 ORPHA:352734,0.7068064785325423
GPNMB,Oculocutaneous albinism type 1A ORPHA:79431,0.7068064785325423
GPNMB,Oculocutaneous albinism type 1B ORPHA:79434,0.7068064785325423
GPNMB,Temperature-sensitive oculocutaneous albinism type 1 ORPHA:352737,0.7068064785325423
GPNMB,NON RARE IN EUROPE: Barrett esophagus ORPHA:1232,0.7068064785325423
GPR137C,Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527,0.0586579655822394
GPR137C,15q13.3 microdeletion syndrome ORPHA:199318,0.1590470395003315
GPR137C,NON RARE IN EUROPE: Non rare obesity ORPHA:521399,0.1590470395003315
GPR137C,Bradyopsia ORPHA:75374,0.3762014630157917
GPR137C,Autosomal recessive cerebellar ataxia-psychomotor delay syndrome ORPHA:284271,0.6239678957896782
GPR137C,Colobomatous microphthalmia-rhizomelic dysplasia syndrome ORPHA:424099,0.6239678957896782
GPR137C,Goldmann-Favre syndrome ORPHA:53540,0.6239678957896782
GPR137C,NON RARE IN EUROPE: Isolated keratoconus ORPHA:2335,0.6239678957896782
GPR137C,ALG9-CDG ORPHA:79328,0.7068064785325423
GPR137C,CDKL5-related epileptic encephalopathy ORPHA:505652,0.7068064785325423
GPR137C,Episodic ataxia type 5 ORPHA:211067,0.7068064785325423
GPR137C,GNB5-related intellectual disability-cardiac arrhythmia syndrome ORPHA:542306,0.7068064785325423
GPR137C,Keppen-Lubinsky syndrome ORPHA:435628,0.7068064785325423
GPR137C,MEGDEL syndrome ORPHA:352328,0.7068064785325423
GPR137C,Spastic paraplegia-severe developmental delay-epilepsy syndrome ORPHA:464282,0.7068064785325423
GPR137C,X-linked intellectual disability-cerebellar hypoplasia syndrome ORPHA:137831,0.7068064785325423
GPR137C,Hypotonia-speech impairment-severe cognitive delay syndrome ORPHA:371364,0.7068064785325423
GPR137C,Otofaciocervical syndrome ORPHA:2792,0.7068064785325423
GPR137C,Autosomal dominant epilepsy with auditory features ORPHA:101046,0.7068064785325423
GPR137C,Progressive cone dystrophy ORPHA:1871,0.7068064785325423
GPR137C,Juvenile myoclonic epilepsy ORPHA:307,0.7100092263364535
GPR137C,Leber congenital amaurosis ORPHA:65,0.7443958988603572
GPR15,Barrett Esophagus,0.0648809611869375
GPR15,Rheumatoid Arthritis,0.1537760235124317
GPR15,Colitis,0.5323590634832615
GPR15,Odonto-onycho-dermal dysplasia ORPHA:2721,0.0180064224283883
GPR15,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.0180064224283883
GPR15,Combined immunodeficiency due to MALT1 deficiency ORPHA:397964,0.7068064785325423
GPR37,melanoma,0.0149315928814189
GPR37,Malignant mesothelioma,0.0182265588252201
GPR37,Chronic Lymphocytic Leukemia,0.1147307578771389
GPR37,Parkinson Disease,0.3933196962529684
GPR37,Autism Spectrum Disorders,0.3941558617476422
GPR37,PARKINSON DISEASE 2 AUTOSOMAL RECESSIVE JUVENILE,0.4840863724482356
GPR37,Pervasive Development Disorder,0.5655222348249326
GPR37,Cutaneous Melanoma,0.5710095678317721
GPR37,Autistic Disorder,0.8064248359603999
GPR37,Lymphocytic Leukemia,0.0487679768343083
GPR37,Malignant Melanoma Of Skin,0.4286813331685578
GPR37,Melanoma,0.4646409362700993
GPR37,Malignant Mesothelioma,0.555382961603519
GPR37,Oculocutaneous albinism type 3 ORPHA:79433,0.0180064224283883
GPR37,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.0180064224283883
GPR37,X-linked adrenal hypoplasia congenita ORPHA:95702,0.1590470395003315
GPR37,Persistent hyperplastic primary vitreous ORPHA:91495,0.1590470395003315
GPR37,Butyrylcholinesterase deficiency ORPHA:132,0.3762014630157917
GPR37,Scalp-ear-nipple syndrome ORPHA:2036,0.3762014630157917
GPR37,Tetraamelia-multiple malformations syndrome ORPHA:3301,0.3762014630157917
GPR37,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077,0.6239678957896782
GPR37,Microphthalmia with limb anomalies ORPHA:1106,0.6239678957896782
GPR37,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673,0.6239678957896782
GPR37,NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651,0.6239678957896782
GPR37,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.6239678957896782
GPR37,Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403,0.7068064785325423
GPR37,Spinocerebellar ataxia type 5 ORPHA:98766,0.7068064785325423
GPR37,X-linked recessive ocular albinism ORPHA:54,0.7068064785325423
GPR37,Atypical glycine encephalopathy ORPHA:289863,0.7068064785325423
GPR37,Infantile glycine encephalopathy ORPHA:289860,0.7068064785325423
GRAMD1B,Chronic Lymphocytic Leukemia,0.1147307578771389
GRAMD1B,Hodgkin Disease,0.2454476567103779
GRAMD1B,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
GRAMD1B,Bipolar Disorder,0.3933196962529684
GRAMD1B,Schizophrenia,0.3933196962529684
GRAMD1B,Nasopharyngeal Neoplasms,0.3933196962529684
GRAMD1B,Multiple Myeloma,0.4103119460235835
GRAMD1B,Breast Carcinoma,0.0075861267486594
GRAMD1B,Lymphocytic Leukemia,0.0487679768343083
GRAMD1B,Schizophrenia,0.0531117779464085
GRAMD1B,Nasopharyngeal Carcinoma,0.2278592962769385
GRAMD1B,Hodgkin Disease,0.2627224344149009
GRAMD1B,B-Cell Neoplasm,0.4286813331685578
GRAMD1B,Development Disorder,0.4372065554432662
GRAMD1B,Multiple Myeloma,0.4560460337187313
GRAMD1B,Erectile Dysfunction,0.4602028929328057
GRAMD1B,Bipolar Disorder,0.4875380732267193
GRAMD1B,Lymphoma,0.8794964218770293
GRAMD1B,Pseudohypoaldosteronism type 2D ORPHA:300525,0.6239678957896782
H2AX,Breast Carcinoma,0.0075861267486594
H2AX,Marfan Syndrome,0.0133304506157067
H2AX,Mammary Neoplasms,0.0155248163763686
H2AX,Breast Cancer,0.0402286636010764
H2AX,Schizophrenia,0.0531117779464085
H2AX,Giant Cell Glioblastoma,0.4875380732267193
H2AX,Glioblastoma,0.4875380732267193
HABP4,Autosomal recessive spastic paraplegia type 56 ORPHA:320411,0.6239678957896782
HABP4,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.8071041616616108
HPSE,Colorectal Carcinoma,0.0034602840073026
HPSE,Mammary Neoplasms,0.0034602840073026
HPSE,Ovarian Carcinoma,0.0034602840073026
HPSE,Breast Carcinoma,0.0042545616049287
HPSE,Invasive carcinoma of breast,0.0149002095788623
HPSE,Epithelioma,0.0149002095788623
HPSE,Invasive Ductal Breast Carcinoma,0.0149002095788623
HPSE,Colorectal Cancer,0.0149315928814189
HPSE,Tumor Progression,0.0149315928814189
HPSE,Stomach Carcinoma,0.0149315928814189
HPSE,Retroviridae Infections,0.0149315928814189
HPSE,melanoma,0.0149315928814189
HPSE,Adenocarcinoma,0.0155921563748247
HPSE,Squamous cell carcinoma,0.0182265588252201
HPSE,Esophageal Neoplasms,0.0182265588252201
HPSE,Malignant mesothelioma,0.0182265588252201
HPSE,ovarian neoplasm,0.0191435238361999
HPSE,Malignant neoplasm of breast,0.0191435238361999
HPSE,Fibrosarcoma,0.0191435238361999
HPSE,Malignant neoplasm of stomach,0.0191435238361999
HPSE,Carcinogenesis,0.0228075668512991
HPSE,Malignant neoplasm of esophagus,0.0248454592431097
HPSE,Malignant neoplasm of ovary,0.0277695594716545
HPSE,Medulloblastoma,0.0354767239335874
HPSE,Epithelial ovarian cancer,0.0387439397151409
HPSE,Malignant neoplasm of prostate,0.0569142010728473
HPSE,Central neuroblastoma,0.0593779966354549
HPSE,Well Differentiated Oligodendroglioma,0.0617471306652618
HPSE,Mammary Neoplasms Human,0.064548079316548
HPSE,Brain Neoplasms,0.064548079316548
HPSE,Neoplasm Metastasis,0.0648809611869375
HPSE,Barrett Esophagus,0.0648809611869375
HPSE,Renal Cell Carcinoma,0.0648809611869375
HPSE,oligodendroglioma,0.0648809611869375
HPSE,Neuroblastoma,0.0688152422187159
HPSE,Malignant neoplasm of pancreas,0.0726340460169901
HPSE,Pancreatic Neoplasm,0.0739788831250619
HPSE,Glioma,0.0739788831250619
HPSE,Degenerative polyarthritis,0.0739788831250619
HPSE,Osteoporosis,0.0739788831250619
HPSE,Lymphoma,0.0739788831250619
HPSE,Endometrial Neoplasms,0.0745502070959292
HPSE,Glioblastoma,0.0745502070959292
HPSE,Pancreatic carcinoma,0.0745502070959292
HPSE,Carcinoma breast stage IV,0.0745502070959292
HPSE,Liver Cirrhosis Experimental,0.0747863377072194
HPSE,Prostate carcinoma,0.0773771948186562
HPSE,Squamous cell carcinoma of the head and neck,0.0775520919998773
HPSE,Colorectal Neoplasms,0.0827744840860166
HPSE,Malignant neoplasm of urinary bladder,0.084286432100041
HPSE,Bladder Neoplasm,0.0891725280554336
HPSE,Squamous cell carcinoma of esophagus,0.0919714360040484
HPSE,Liver carcinoma,0.095319386034013
HPSE,Colon Carcinoma,0.1062239757831962
HPSE,Adenocarcinoma of colon,0.1112281755580192
HPSE,Ameloblastoma,0.1208020277850109
HPSE,Hematologic Neoplasms,0.1253114324938153
HPSE,Secondary malignant neoplasm of bone,0.1253114324938153
HPSE,MYELODYSPLASTIC SYNDROME,0.1254380558571286
HPSE,Esophageal carcinoma,0.1254380558571286
HPSE,Tumor Initiation,0.13167400689206
HPSE,Carcinoma of bladder,0.13167400689206
HPSE,Unipolar Depression,0.13167400689206
HPSE,Myocardial Infarction,0.1352936728187231
HPSE,Solid Neoplasm,0.1413782599148022
HPSE,Liver neoplasms,0.1454373331146953
HPSE,Rheumatoid Arthritis,0.1537760235124317
HPSE,Sarcoma,0.1537760235124317
HPSE,Renal fibrosis,0.1602092191314262
HPSE,Invasive Carcinoma,0.1602092191314262
HPSE,Comedone,0.1735868515093891
HPSE,Head and Neck Carcinoma,0.1735868515093891
HPSE,Benign Ovarian Neoplasm,0.1770067065899052
HPSE,von Willebrand Disease Type 1,0.1897991423047819
HPSE,Lung Neoplasms,0.2062010908869036
HPSE,Desmoplastic,0.2085938372806741
HPSE,Major Depressive Disorder,0.21122597829463
HPSE,Malignant tumor of colon,0.223747154820789
HPSE,Prostatic Neoplasms,0.223747154820789
HPSE,Diabetes,0.2277108302018961
HPSE,Hodgkin Disease,0.2454476567103779
HPSE,Hepatoblastoma,0.2522264785494494
HPSE,Malignant Head and Neck Neoplasm,0.2522264785494494
HPSE,Diabetes Mellitus,0.2522264785494494
HPSE,Malignant neoplasm of liver,0.2643145809900195
HPSE,Neoplasms,0.2714542429024338
HPSE,Malignant neoplasm of lung,0.2714542429024338
HPSE,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
HPSE,Diabetic Retinopathy,0.2723545094624877
HPSE,Cervix carcinoma,0.2834835531038365
HPSE,Acute leukemia,0.2835142372342932
HPSE,Neonatal Alloimmune Thrombocytopenia,0.3099246715197673
HPSE,Cholangiocarcinoma,0.340892538685018
HPSE,Head and Neck Neoplasms,0.3412203844672238
HPSE,Coronary Thrombosis,0.3508665345292502
HPSE,Rhabdomyosarcoma,0.3510063969122338
HPSE,Severe Combined Immunodeficiency,0.3553621627681198
HPSE,Metastatic malignant neoplasm to brain,0.3638414818541592
HPSE,Carcinoma of lung,0.3663130598151661
HPSE,Tuberculosis,0.3706856725676674
HPSE,Anaplastic astrocytoma,0.3763374964032415
HPSE,Endometriosis,0.383941725017158
HPSE,Thyroid Neoplasm,0.383941725017158
HPSE,Recurrent tumor,0.383941725017158
HPSE,Exostoses,0.383941725017158
HPSE,Noninfiltrating Intraductal Carcinoma,0.383941725017158
HPSE,Primary malignant neoplasm of lung,0.3902116649640871
HPSE,Secondary malignant neoplasm of lymph node,0.3933196962529684
HPSE,Amyloidosis,0.3933196962529684
HPSE,Bipolar Disorder,0.3933196962529684
HPSE,Cerebrovascular Disorders,0.3933196962529684
HPSE,Verrucous carcinoma,0.3933196962529684
HPSE,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
HPSE,Laryngeal Squamous Cell Carcinoma,0.3933196962529684
HPSE,Renal glomerular disease,0.3933196962529684
HPSE,Non-Small Cell Lung Carcinoma,0.3933196962529684
HPSE,Secondary malignant neoplasm of liver,0.3933196962529684
HPSE,Leukemia Myelocytic Acute,0.3933196962529684
HPSE,Carcinoma Papillary,0.3933196962529684
HPSE,Astrocytoma,0.3933196962529684
HPSE,Alzheimer's Disease,0.3933196962529684
HPSE,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
HPSE,Thrombocythemia Essential,0.3933196962529684
HPSE,Acute lymphocytic leukemia,0.3933196962529684
HPSE,Lip and Oral Cavity Carcinoma,0.3933196962529684
HPSE,Stomach Neoplasms,0.3933196962529684
HPSE,Inflammatory Bowel Diseases,0.3933196962529684
HPSE,Coronary heart disease,0.3933196962529684
HPSE,Glioblastoma Multiforme,0.3933196962529684
HPSE,synovial sarcoma,0.3933196962529684
HPSE,Anaplasia,0.3938591532700354
HPSE,Diabetic Nephropathy,0.3938591532700354
HPSE,Aortic Aneurysm Abdominal,0.3941558617476422
HPSE,Thyroid carcinoma,0.3941558617476422
HPSE,Rabies (disorder),0.3941558617476422
HPSE,Bone Diseases,0.3941558617476422
HPSE,Pituitary Neoplasms,0.3941558617476422
HPSE,Depressive episode unspecified,0.3941558617476422
HPSE,Tuberculosis of intestines,0.3941558617476422
HPSE,Depressive disorder,0.3975960596292668
HPSE,IGA Glomerulonephritis,0.3975960596292668
HPSE,Kidney Failure Acute,0.4028066164685291
HPSE,Carcinoma of larynx,0.4028066164685291
HPSE,Dengue Fever,0.4028066164685291
HPSE,Acute myocardial infarction,0.4103119460235835
HPSE,Multiple Myeloma,0.4103119460235835
HPSE,Nephrotic Syndrome,0.4103119460235835
HPSE,Neoplasm Invasiveness,0.4115056600660309
HPSE,Cerebrovascular accident,0.4115056600660309
HPSE,Neonatal thrombocytopenia (disorder),0.4115056600660309
HPSE,Vascular Diseases,0.4126392832024548
HPSE,Steroid-sensitive nephrotic syndrome,0.4126392832024548
HPSE,Malignant neoplasm of larynx,0.4192169590514327
HPSE,Immunologic Deficiency Syndromes,0.4213286052188015
HPSE,Thrombocytopenia,0.4213286052188015
HPSE,Hyperlipoproteinemia Type III,0.4213286052188015
HPSE,Malignant neoplasm of mouth,0.4213286052188015
HPSE,PACHYONYCHIA CONGENITA 3,0.424575176503444
HPSE,Benign melanocytic nevus,0.425419812815905
HPSE,Encephalomyelitis,0.4254307049060398
HPSE,Follicular adenoma,0.4269926086051838
HPSE,Psoriasis,0.4304973629098372
HPSE,Malignant neoplasm of thyroid,0.4307603335611732
HPSE,Adenocarcinoma of pancreas,0.4325044517055656
HPSE,External exotoses,0.4335751357405352
HPSE,Hereditary Multiple Exostoses,0.4335751357405352
HPSE,Lymphatic Metastasis,0.4342056919538745
HPSE,Sicca Syndrome,0.4396723023384634
HPSE,Migraine Disorders,0.4450743762496232
HPSE,bone destruction,0.4506578937113162
HPSE,Choriocarcinoma,0.4564472886428772
HPSE,Hepatic Veno-Occlusive Disease,0.4564472886428772
HPSE,Embryonal Rhabdomyosarcoma,0.472444704048021
HPSE,Myeloid Leukemia Chronic,0.472444704048021
HPSE,Chronic colitis,0.472444704048021
HPSE,Acute GVH disease,0.4790179402069343
HPSE,Membranous glomerulonephritis,0.4790179402069343
HPSE,Breast adenocarcinoma,0.4810435657134442
HPSE,Steroid Sulfatase Deficiency Disease,0.4840863724482356
HPSE,Hyperglycemia,0.4906258721078565
HPSE,Crohn Disease,0.4981941174985421
HPSE,Secondary malignant neoplasm of pancreas,0.4981941174985421
HPSE,Ichthyosis X-Linked,0.4990401620718274
HPSE,Metastatic melanoma,0.5001612228394569
HPSE,Neuroendocrine Tumors,0.5017066790423467
HPSE,Arteriosclerosis,0.5019670090704682
HPSE,Carotid Atherosclerosis,0.504136641473215
HPSE,Chronic graft-versus-host disease,0.5090214163899865
HPSE,Coronary Arteriosclerosis,0.5140447474168605
HPSE,Secondary Neoplasm,0.5140447474168605
HPSE,Obesity,0.5140447474168605
HPSE,Respiratory Failure,0.5140447474168605
HPSE,Adenocarcinoma of lung (disorder),0.51550637274795
HPSE,Sweet Syndrome,0.5251317541886066
HPSE,Disseminated Malignant Neoplasm,0.533913711453195
HPSE,Atherosclerosis,0.5393787854381349
HPSE,Autoimmune Diseases,0.5512224939896888
HPSE,Thrombasthenia,0.553002957824355
HPSE,Thromboangiitis Obliterans,0.5655222348249326
HPSE,Nephrosis,0.5696906826730043
HPSE,Graft-vs-Host Disease,0.5922440535658843
HPSE,Tumor Angiogenesis,0.6218520979526325
HPSE,Chronic Fatigue Syndrome,0.625027955184583
HPSE,Sepsis,0.6395767498329145
HPSE,Inflammatory dermatosis,0.6447029562500783
HPSE,Retinal Diseases,0.655573080043894
HPSE,Myeloproliferative disease,0.6592493193460769
HPSE,Proliferative diabetic retinopathy,0.6627865715415371
HPSE,Blood Coagulation Disorders,0.6631086714705082
HPSE,Stable angina,0.6656356363792992
HPSE,Proteinuria,0.6925751397474874
HPSE,Dermatitis,0.7045203904267408
HPSE,Inflammatory disorder,0.7075286941606513
HPSE,Mucinous Adenocarcinoma,0.717484976234209
HPSE,Coronary Artery Disease,0.7240930522443176
HPSE,Benign Prostatic Hyperplasia,0.7491018580851883
HPSE,Septicemia,0.8064248359603999
HPSE,Melanoma B16,0.8178117518835931
HPSE,Malignant Pleural Mesothelioma,0.8209296131179464
HPSE,Immune thrombocytopenic purpura,0.8867784885819414
HPSE,Hepatitis B,0.9169959402964138
HPSE,Anemia Sickle Cell,0.931585270977292
HPSE,Breast Carcinoma,0.0075861267486594
HPSE,Marfan Syndrome,0.0133304506157067
HPSE,Mammary Neoplasms,0.0155248163763686
HPSE,Breast Cancer,0.0402286636010764
HPSE,Liver Carcinoma,0.0520696613701797
HPSE,Mental Depression,0.4560460337187313
HPSE,Nephrosis,0.4560460337187313
HPSE,Melanoma,0.4646409362700993
HPSE,Glomerulonephritis,0.8277709367020475
HPSE,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.1590470395003315
HPSE,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.1590470395003315
HPSE,Haim-Munk syndrome ORPHA:2342,0.3762014630157917
HPSE,Papillon-Lefevre ORPHA:678,0.3762014630157917
HS3ST1,Tumor Progression,0.0149315928814189
HS3ST1,Malignant neoplasm of pancreas,0.0726340460169901
HS3ST1,Pancreatic carcinoma,0.0745502070959292
HS3ST1,Chondrosarcoma,0.2643145809900195
HS3ST1,Alzheimer's Disease,0.3933196962529684
HS3ST1,Arteriosclerosis,0.5019670090704682
HS3ST1,Atherosclerosis,0.5393787854381349
HS3ST1,Herpes Simplex Infections,0.610971999959321
HS3ST1,Coronary Artery Disease,0.7240930522443176
HS3ST1,Arteriosclerosis,0.4723647227028846
HS3ST1,Coronary Artery Disease,0.7729545590606223
HSDL2,Glioma,0.0739788831250619
HSDL2,Glioblastoma,0.0745502070959292
HSDL2,Liver neoplasms,0.1454373331146953
HSDL2,Malignant neoplasm of liver,0.2643145809900195
HSDL2,Creatinine measurement serum (procedure),0.383941725017158
HSDL2,Liver Cancer,0.4723647227028846
HSDL2,Liver Neoplasms,0.5129298662020659
HSDL2,Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971,0.3762014630157917
HSDL2,Mild hemophilia A ORPHA:169808,0.6239678957896782
HSDL2,Moderately severe hemophilia A ORPHA:169805,0.6239678957896782
HSDL2,PGM1-CDG ORPHA:319646,0.6239678957896782
HSDL2,Severe hemophilia A ORPHA:169802,0.6239678957896782
HSDL2,Symptomatic form of hemophilia A in female carriers ORPHA:177926,0.6239678957896782
HSDL2,Bifunctional enzyme deficiency ORPHA:300,0.7068064785325423
HSDL2,Mitochondrial trifunctional protein deficiency ORPHA:746,0.7068064785325423
HSDL2,3-methylglutaconic aciduria type 1 ORPHA:67046,0.7068064785325423
HSDL2,Beta-ketothiolase deficiency ORPHA:134,0.7068064785325423
HSDL2,Congenital bile acid synthesis defect type 4 ORPHA:79095,0.7068064785325423
HSDL2,Proximal myopathy with extrapyramidal signs ORPHA:401768,0.7068064785325423
HSDL2,Vitamin B12-unresponsive methylmalonic acidemia type mut- ORPHA:79312,0.7068064785325423
HSDL2,Vitamin B12-unresponsive methylmalonic acidemia type mut0 ORPHA:289916,0.7068064785325423
HSDL2,Classic maple syrup urine disease ORPHA:268145,0.7068064785325423
HSDL2,Intermittent maple syrup urine disease ORPHA:268173,0.7068064785325423
HSDL2,Thiamine-responsive maple syrup urine disease ORPHA:268184,0.7068064785325423
HSDL2,Ectromelia virus ERPV hydroxysteroid dehydrogenase,0.6362779693488597
HSDL2,Monkeypox virus bifunctional hydroxysteroid dehydrogenase/deletion attenuates intradermal lesion in VAC-mouse model,0.6947065917563796
HSDL2,Cowpox virus CPXV182 protein (gene: CPXV182 CDS),0.7017760963861425
HSDL2,Monkeypox virus Zaire-96-I-16 A45L (gene: A45L),0.7054555693277184
HSDL2,Vaccinia virus hydroxysteroid dehydrogenase (gene: A44L),0.7108466056279036
HSDL2,Horsepox virus HSPV166 (Rossmann-fold NAD(P)(+)-binding proteins),0.7108466056279036
HSDL2,Vaccinia virus Ankara 3 beta-hydroxysteroid dehydrogenase,0.7148278327249904
HSDL2,Molluscum contagiosum virus subtype 1 MC152R (gene: MC152R),0.7398997088314572
HSDL2,Yaba-like disease virus 133L protein (gene: 133L),0.7477109270664255
HTATIP2,Colorectal Carcinoma,0.0034602840073026
HTATIP2,Breast Carcinoma,0.0042545616049287
HTATIP2,Colorectal Cancer,0.0149315928814189
HTATIP2,Tumor Progression,0.0149315928814189
HTATIP2,melanoma,0.0149315928814189
HTATIP2,Squamous cell carcinoma,0.0182265588252201
HTATIP2,Malignant neoplasm of breast,0.0191435238361999
HTATIP2,Carcinogenesis,0.0228075668512991
HTATIP2,Malignant neoplasm of prostate,0.0569142010728473
HTATIP2,Neoplasm Metastasis,0.0648809611869375
HTATIP2,Malignant neoplasm of pancreas,0.0726340460169901
HTATIP2,Glioma,0.0739788831250619
HTATIP2,Pancreatic carcinoma,0.0745502070959292
HTATIP2,Prostate carcinoma,0.0773771948186562
HTATIP2,Squamous cell carcinoma of esophagus,0.0919714360040484
HTATIP2,Liver carcinoma,0.095319386034013
HTATIP2,Small cell carcinoma of lung,0.1193558174333938
HTATIP2,ADENOMAS AND ADENOCARCINOMAS,0.1193558174333938
HTATIP2,Esophageal carcinoma,0.1254380558571286
HTATIP2,Lung Neoplasms,0.2062010908869036
HTATIP2,Prostatic Neoplasms,0.223747154820789
HTATIP2,Hepatoblastoma,0.2522264785494494
HTATIP2,Malignant neoplasm of lung,0.2714542429024338
HTATIP2,Secondary malignant neoplasm of lung,0.2723545094624877
HTATIP2,Multiple Sclerosis,0.2835142372342932
HTATIP2,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
HTATIP2,Carcinoma of lung,0.3663130598151661
HTATIP2,Primary malignant neoplasm of lung,0.3902116649640871
HTATIP2,Secondary malignant neoplasm of lymph node,0.3933196962529684
HTATIP2,Non-Small Cell Lung Carcinoma,0.3933196962529684
HTATIP2,Stomach Neoplasms,0.3933196962529684
HTATIP2,Mammary Tumorigenesis,0.4028066164685291
HTATIP2,Immunologic Deficiency Syndromes,0.4213286052188015
HTATIP2,Adenocarcinoma of lung (disorder),0.51550637274795
HTATIP2,Hepatocarcinogenesis,0.533913711453195
HTATIP2,Liver Carcinoma,0.0520696613701797
HTATIP2,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.1590470395003315
HYAL1,Mammary Neoplasms,0.0034602840073026
HYAL1,Ovarian Carcinoma,0.0034602840073026
HYAL1,Breast Carcinoma,0.0042545616049287
HYAL1,Tumor Progression,0.0149315928814189
HYAL1,Squamous cell carcinoma,0.0182265588252201
HYAL1,ovarian neoplasm,0.0191435238361999
HYAL1,Malignant neoplasm of breast,0.0191435238361999
HYAL1,Malignant neoplasm of ovary,0.0277695594716545
HYAL1,Epithelial ovarian cancer,0.0387439397151409
HYAL1,Malignant neoplasm of prostate,0.0569142010728473
HYAL1,Neoplasm Metastasis,0.0648809611869375
HYAL1,Glioma,0.0739788831250619
HYAL1,Degenerative polyarthritis,0.0739788831250619
HYAL1,Prostate carcinoma,0.0773771948186562
HYAL1,Squamous cell carcinoma of the head and neck,0.0775520919998773
HYAL1,Lysosomal Storage Diseases,0.0798053340865682
HYAL1,Malignant neoplasm of urinary bladder,0.084286432100041
HYAL1,Bladder Neoplasm,0.0891725280554336
HYAL1,Small cell carcinoma of lung,0.1193558174333938
HYAL1,Clear-cell metastatic renal cell carcinoma,0.13167400689206
HYAL1,Carcinoma of bladder,0.13167400689206
HYAL1,Neck Neoplasms,0.1614820148711231
HYAL1,Lung Neoplasms,0.2062010908869036
HYAL1,Prostatic Neoplasms,0.223747154820789
HYAL1,Metastatic Prostate Carcinoma,0.2643145809900195
HYAL1,Malignant neoplasm of lung,0.2714542429024338
HYAL1,Endometrial Carcinoma,0.3044782497745498
HYAL1,Metastatic malignant neoplasm to brain,0.3638414818541592
HYAL1,Carcinoma of lung,0.3663130598151661
HYAL1,Primary malignant neoplasm of lung,0.3902116649640871
HYAL1,Non-Small Cell Lung Carcinoma,0.3933196962529684
HYAL1,Juvenile rheumatoid arthritis,0.3933196962529684
HYAL1,Heparan sulfate excretion in urine,0.3933196962529684
HYAL1,Pulmonary Hypertension,0.3933196962529684
HYAL1,Allergic sensitization,0.3941558617476422
HYAL1,Hyperammonemia,0.4115056600660309
HYAL1,Juvenile arthritis,0.4126392832024548
HYAL1,Submucous clefting,0.425419812815905
HYAL1,Recurrent otitis media,0.4352815161963393
HYAL1,Short stature,0.439389586518055
HYAL1,Submucous cleft of hard palate,0.4396723023384634
HYAL1,Dermatologic disorders,0.4906258721078565
HYAL1,Concave bridge of nose,0.5337853752290136
HYAL1,Depressed nasal root/bridge,0.5337853752290136
HYAL1,Depressed nasal bridge,0.533913711453195
HYAL1,Cleft uvula,0.5393787854381349
HYAL1,Skin Abnormalities,0.6084642888478995
HYAL1,Intellectual Disability,0.8352623613787349
HYAL1,Dwarfism,0.5796489603182782
HYAL1,Submucosal Cleft Palate,0.6420878824691651
HYAL1,Otitis Media,0.7979559493902503
HYAL1,Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601,0.6239678957896782
HYAL1,Hawkinsinuria ORPHA:2118,0.6239678957896782
HYAL1,Isolated sulfite oxidase deficiency ORPHA:99731,0.6239678957896782
HYAL1,Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293,0.6239678957896782
HYAL1,Tyrosinemia type 3 ORPHA:69723,0.6239678957896782
HYAL1,Autosomal dominant secondary polycythemia ORPHA:247511,0.6239678957896782
HYAL1,Congenital alpha2-antiplasmin deficiency ORPHA:79,0.7068064785325423
HYAL1,Hyaluronidase deficiency ORPHA:67041,0.7068064785325423
HYAL1,Immunodeficiency due to ficolin3 deficiency ORPHA:331190,0.7068064785325423
ICA1,Colorectal Carcinoma,0.0034602840073026
ICA1,Colorectal Cancer,0.0149315928814189
ICA1,Malignant neoplasm of prostate,0.0569142010728473
ICA1,Central neuroblastoma,0.0593779966354549
ICA1,Neuroblastoma,0.0688152422187159
ICA1,Prostate carcinoma,0.0773771948186562
ICA1,Rheumatoid Arthritis,0.1537760235124317
ICA1,Diabetes,0.2277108302018961
ICA1,Metastasis from malignant tumor of prostate,0.2454426921531692
ICA1,Diabetes Mellitus,0.2522264785494494
ICA1,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
ICA1,Multiple Sclerosis,0.2835142372342932
ICA1,Sjogren's Syndrome,0.3099246715197673
ICA1,Glaucoma,0.3105909001629992
ICA1,Inflammatory Bowel Diseases,0.3933196962529684
ICA1,Autism Spectrum Disorders,0.3941558617476422
ICA1,Lupus Erythematosus Systemic,0.4213286052188015
ICA1,Primary Sj??gren's syndrome,0.451408428170596
ICA1,Graves Disease,0.4981941174985421
ICA1,Autoimmune Diseases,0.5512224939896888
ICA1,Autoimmune thyroid disease,0.5710095678317721
ICA1,Lupus Erythematosus,0.5087473896242481
ICA1,Isolated sulfite oxidase deficiency ORPHA:99731,0.6239678957896782
ID2,Ovarian Carcinoma,0.0034602840073026
ID2,Epithelioma,0.0149002095788623
ID2,Squamous cell carcinoma,0.0182265588252201
ID2,ovarian neoplasm,0.0191435238361999
ID2,Carcinogenesis,0.0228075668512991
ID2,Malignant neoplasm of ovary,0.0277695594716545
ID2,Malignant neoplasm of prostate,0.0569142010728473
ID2,Central neuroblastoma,0.0593779966354549
ID2,Neuroblastoma,0.0688152422187159
ID2,Malignant neoplasm of pancreas,0.0726340460169901
ID2,Glioma,0.0739788831250619
ID2,Glioblastoma,0.0745502070959292
ID2,Pancreatic carcinoma,0.0745502070959292
ID2,Liver Cirrhosis Experimental,0.0747863377072194
ID2,Prostate carcinoma,0.0773771948186562
ID2,Squamous cell carcinoma of the head and neck,0.0775520919998773
ID2,Liver carcinoma,0.095319386034013
ID2,Colon Carcinoma,0.1062239757831962
ID2,Small cell carcinoma of lung,0.1193558174333938
ID2,Arsenic Poisoning Inorganic,0.13167400689206
ID2,Nervous System Organic Arsenic Poisoning,0.13167400689206
ID2,Arsenic Encephalopathy,0.13167400689206
ID2,Arsenic Induced Polyneuropathy,0.13167400689206
ID2,Arsenic Poisoning,0.13167400689206
ID2,Myocardial Infarction,0.1352936728187231
ID2,Sarcoma,0.1537760235124317
ID2,Acute Myeloid Leukemia (AML-M2),0.2050045461627939
ID2,Lung Neoplasms,0.2062010908869036
ID2,Prostatic Neoplasms,0.223747154820789
ID2,Hodgkin Disease,0.2454476567103779
ID2,B-Cell Lymphomas,0.2522264785494494
ID2,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.2522264785494494
ID2,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
ID2,Diabetic Retinopathy,0.2723545094624877
ID2,Classical Hodgkin's Lymphoma,0.3763374964032415
ID2,Peripheral T-Cell Lymphoma,0.3933196962529684
ID2,Renal glomerular disease,0.3933196962529684
ID2,Hypertensive disease,0.3933196962529684
ID2,Leukemia Myelocytic Acute,0.3933196962529684
ID2,Acute Promyelocytic Leukemia,0.3933196962529684
ID2,Diabetic Nephropathy,0.3938591532700354
ID2,Polycystic Kidney Autosomal Dominant,0.3941558617476422
ID2,Ki-1+ Anaplastic Large Cell Lymphoma,0.3941558617476422
ID2,Acute Myeloid Leukemia M1,0.4100742336915555
ID2,Multiple Myeloma,0.4103119460235835
ID2,Retinoblastoma,0.4115056600660309
ID2,Congestive heart failure,0.425419812815905
ID2,Heart failure,0.4304973629098372
ID2,Myxoid cyst,0.4335751357405352
ID2,Restenosis,0.4396723023384634
ID2,Dyslipidemias,0.4421745246585178
ID2,Intestinal Diseases,0.4459714599189374
ID2,Chronic kidney disease stage 5,0.4704594475773637
ID2,T-Cell Prolymphocytic Leukemia,0.4753011022966241
ID2,Dermatologic disorders,0.4906258721078565
ID2,Ovarian Failure Premature,0.4923669467696064
ID2,Kidney Failure Chronic,0.5299466034567416
ID2,Proliferative retinopathy,0.5393787854381349
ID2,Thyroid Diseases,0.5936773368594411
ID2,Hyperlipidemia,0.6035970790768342
ID2,T-Cell Lymphoma,0.7577323833810212
ID2,Impaired cognition,0.8000044931629623
ID2,Rett Syndrome,0.8048897980514186
ID2,Turner Syndrome,0.8552002762584644
ID2,Pneumonia,0.924303335582991
ID2,Arsenic Encephalopathy,0.185736315425117
ID2,Dermatologic Disorders,0.2895940391390291
ID2,Lung Carcinoma,0.4541466895915311
ID2,Thyroid Diseases,0.4560460337187313
ID2,Myeloid Leukemia,0.525214105372123
ID2,Leukemia,0.7167438233451096
IL22RA1,Colorectal Carcinoma,0.0034602840073026
IL22RA1,Colorectal Cancer,0.0149315928814189
IL22RA1,Lymphoma T-Cell Cutaneous,0.3933196962529684
IL22RA1,Nasal Polyps,0.4459714599189374
IL22RA1,Colitis,0.5323590634832615
IL22RA1,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
IL22RA1,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
IL22RA1,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
IL22RA1,Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303,0.0180064224283883
IL22RA1,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.0180064224283883
IL22RA1,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.0180064224283883
IL22RA1,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.0586579655822394
IL22RA1,Localized junctional epidermolysis bullosa ORPHA:251393,0.0586579655822394
IL22RA1,AA amyloidosis ORPHA:85445,0.0586579655822394
IL22RA1,Bartsocas-Papas syndrome ORPHA:1234,0.0586579655822394
IL22RA1,Benign familial mesial temporal lobe epilepsy ORPHA:163717,0.0586579655822394
IL22RA1,CHAND syndrome ORPHA:1401,0.0586579655822394
IL22RA1,Epithelial recurrent erosion dystrophy ORPHA:293381,0.0586579655822394
IL22RA1,Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805,0.0586579655822394
IL22RA1,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.0586579655822394
IL22RA1,Neuropathy with hearing impairment ORPHA:139512,0.0586579655822394
IL22RA1,Marie Unna hereditary hypotrichosis ORPHA:444,0.0586579655822394
IL22RA1,Cholangiocarcinoma ORPHA:70567,0.1590470395003315
IL22RA1,Familial expansile osteolysis ORPHA:85195,0.1590470395003315
IL22RA1,Keratoderma hereditarium mutilans ORPHA:494,0.1590470395003315
IL22RA1,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.1590470395003315
IL22RA1,Monilethrix ORPHA:573,0.1590470395003315
IL22RA1,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1590470395003315
IL22RA1,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.1590470395003315
IL22RA1,Xanthinuria type I ORPHA:93601,0.1590470395003315
IL22RA1,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.1590470395003315
IL22RA1,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.1590470395003315
IL22RA1,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.1697334635963512
IL22RA1,Apparent mineralocorticoid excess ORPHA:320,0.3762014630157917
IL22RA1,Genetic transient congenital hypothyroidism ORPHA:226316,0.3762014630157917
IL22RA1,Glucose-galactose malabsorption ORPHA:35710,0.3762014630157917
IL22RA1,Xanthinuria type II ORPHA:93602,0.3762014630157917
IL22RA1,Meesmann corneal dystrophy ORPHA:98954,0.3762014630157917
IL22RA1,Alopecia-intellectual disability syndrome ORPHA:2850,0.3762014630157917
IL22RA1,Pachydermoperiostosis ORPHA:2796,0.6239678957896782
IL22RA1,Acrocapitofemoral dysplasia ORPHA:63446,0.7068064785325423
IL22RA1,CIDEC-related familial partial lipodystrophy ORPHA:435651,0.7068064785325423
IL22RA1,Early-onset anterior polar cataract ORPHA:98988,0.7068064785325423
IQCG,Myeloid Leukemia,0.2980670559114652
IQCG,Leukemogenesis,0.3510063969122338
IQCG,Diamond-Blackfan Anemia,0.4646409362700993
IQCG,Anemia,0.4780231573499264
IQCG,Primary ciliary dyskinesia ORPHA:244,0.7068064785325423
IQCG,Situs inversus totalis ORPHA:101063,0.7120423847116372
IQCG,Meckel syndrome ORPHA:564,0.7166448869866529
IQCG,Non-syndromic male infertility due to sperm motility disorder ORPHA:276234,0.7249187045096473
IQGAP2,Ovarian Carcinoma,0.0034602840073026
IQGAP2,Stomach Carcinoma,0.0149315928814189
IQGAP2,Malignant neoplasm of stomach,0.0191435238361999
IQGAP2,Carcinogenesis,0.0228075668512991
IQGAP2,Malignant neoplasm of ovary,0.0277695594716545
IQGAP2,Brain Tumor Primary,0.044151975756427
IQGAP2,Malignant neoplasm of prostate,0.0569142010728473
IQGAP2,Primary malignant neoplasm of brain,0.064548079316548
IQGAP2,Brain Neoplasms,0.064548079316548
IQGAP2,Prostate carcinoma,0.0773771948186562
IQGAP2,Liver carcinoma,0.095319386034013
IQGAP2,Malignant Neoplasms,0.0991201145654548
IQGAP2,Liver neoplasms,0.1454373331146953
IQGAP2,Benign neoplasm of brain unspecified,0.1602092191314262
IQGAP2,Recurrent Brain Neoplasm,0.1770067065899052
IQGAP2,Neoplasms Intracranial,0.290158730291654
IQGAP2,Adult Hepatocellular Carcinoma,0.290158730291654
IQGAP2,Stomach Neoplasms,0.3933196962529684
IQGAP2,Inflammatory Bowel Diseases,0.3933196962529684
IQGAP2,Malignant neoplasm of brain,0.3941558617476422
IQGAP2,Platelet distribution width measurement,0.4115056600660309
IQGAP2,Platelet distribution width result,0.4115056600660309
IQGAP2,Reticulocyte count (procedure),0.425419812815905
IQGAP2,Rectal Carcinoma,0.429029854971378
IQGAP2,Platelet mean volume determination (procedure),0.4981941174985421
IQGAP2,Colitis,0.5323590634832615
IQGAP2,Prostatic Intraepithelial Neoplasias,0.6693434807212948
IQGAP2,Venous Thromboembolism,0.6925751397474874
IQGAP2,Platelet Count measurement,0.7061487180640408
IQGAP2,hearing impairment,0.8612168330350624
IQGAP2,Liver Carcinoma,0.0520696613701797
IQGAP2,Schizophrenia,0.0531117779464085
IQGAP2,Brain Neoplasms,0.1534453668959814
IQGAP2,Intracranial Neoplasm,0.2038801271174535
IQGAP2,Galactose mutarotase deficiency ORPHA:570422,0.1590470395003315
IQGAP2,Congenital non-communicating hydrocephalus ORPHA:269510,0.3762014630157917
IQGAP2,Spinocerebellar ataxia type 40 ORPHA:423275,0.3762014630157917
IQGAP2,Cranio-osteoarthropathy ORPHA:1525,0.6239678957896782
IQGAP2,Isolated congenital digital clubbing ORPHA:217059,0.6239678957896782
IQGAP2,Brain dopamine-serotonin vesicular transport disease ORPHA:352649,0.7068064785325423
ISL1,Breast Carcinoma,0.0042545616049287
ISL1,Stomach Carcinoma,0.0149315928814189
ISL1,Malignant neoplasm of breast,0.0191435238361999
ISL1,Malignant neoplasm of stomach,0.0191435238361999
ISL1,Carcinogenesis,0.0228075668512991
ISL1,Central neuroblastoma,0.0593779966354549
ISL1,Neuroblastoma,0.0688152422187159
ISL1,Lymphoma,0.0739788831250619
ISL1,Malignant neoplasm of urinary bladder,0.084286432100041
ISL1,Bladder Neoplasm,0.0891725280554336
ISL1,Ameloblastoma,0.1208020277850109
ISL1,Carcinoma of bladder,0.13167400689206
ISL1,Rheumatoid Arthritis,0.1537760235124317
ISL1,Gastrointestinal Neoplasms,0.2062010908869036
ISL1,Diabetes,0.2277108302018961
ISL1,Hodgkin Disease,0.2454476567103779
ISL1,Diabetes Mellitus,0.2522264785494494
ISL1,Triple Negative Breast Neoplasms,0.2980670559114652
ISL1,Rat Insulinoma,0.3778347117514905
ISL1,Secondary malignant neoplasm of lymph node,0.3933196962529684
ISL1,Bipolar Disorder,0.3933196962529684
ISL1,Hernia Inguinal,0.3933196962529684
ISL1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
ISL1,Truncus Arteriosus Persistent,0.3933196962529684
ISL1,Congenital atresia of pulmonary valve,0.3933196962529684
ISL1,Lymphoma Non-Hodgkin,0.3933196962529684
ISL1,Coronary heart disease,0.3933196962529684
ISL1,Epispadias male (disorder),0.3933196962529684
ISL1,Abnormality of the anus,0.3933196962529684
ISL1,Anemia,0.3941558617476422
ISL1,Bladder Exstrophy,0.3941558617476422
ISL1,Umbilical hernia,0.3986414839122469
ISL1,Pituitary Diseases,0.4028066164685291
ISL1,Gastric Adenocarcinoma,0.4028066164685291
ISL1,Down Syndrome,0.4126392832024548
ISL1,Congenital atresia of pulmonary artery,0.4192169590514327
ISL1,Congestive heart failure,0.425419812815905
ISL1,Heart failure,0.4304973629098372
ISL1,Myxoid cyst,0.4335751357405352
ISL1,Maturity onset diabetes mellitus in young,0.4506578937113162
ISL1,Ventricular Septal Defects,0.4564472886428772
ISL1,Conotruncal defect,0.4675904598629673
ISL1,Muscular Dystrophy Emery-Dreifuss,0.4923669467696064
ISL1,Obesity,0.5140447474168605
ISL1,Neoplasm Recurrence Local,0.5299466034567416
ISL1,Congenital Abnormality,0.5305233935923577
ISL1,Arrhythmogenic Right Ventricular Dysplasia,0.5359212109443033
ISL1,Congenital heart disease,0.549941235475765
ISL1,Biliary Tract Cancer,0.563120546412355
ISL1,Congenital hypoplasia of penis,0.6974821940437801
ISL1,Recurrent urinary tract infection,0.6980473696540115
ISL1,Agenesis,0.7240930522443176
ISL1,Vesico-Ureteral Reflux,0.7577323833810212
ISL1,Bladder Exstrophy,0.4541466895915311
ISL1,Congenital Malrotation Of Intestine,0.4646409362700993
ISL1,Vesicoureteral Reflux,0.4714699023601434
ISL1,Bladder Neoplasm,0.4723647227028846
ISL1,Urinary Bladder Cancer,0.4875380732267193
ISL1,Epispadias,0.4875380732267193
ISL1,Neuroblastoma,0.5127628024019304
ISL1,Bowel Incontinence,0.6130153808924363
ISL1,Congenital Exomphalos,0.6270755162143985
ISL1,Congenital Hypoplasia Of Penis,0.6572113517052336
ISL1,Congenital Omphalocele,0.6712925710975606
ISL1,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542,0.1590470395003315
ISL1,Split hand-split foot-deafness syndrome ORPHA:71271,0.1590470395003315
ISL1,Bladder exstrophy ORPHA:93930,0.1590470395003315
ISL1,Partial pancreatic agenesis ORPHA:2805,0.3762014630157917
ISL1,Brain-lung-thyroid syndrome ORPHA:209905,0.3762014630157917
ISL1,Brachydactyly-syndactyly Zhao type ORPHA:93409,0.7068064785325423
ISL1,Hirschsprung disease-ganglioneuroblastoma syndrome ORPHA:2151,0.7068064785325423
ISL1,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome ORPHA:293864,0.7068064785325423
ISL1,NON RARE IN EUROPE: Brachydactyly type D ORPHA:93385,0.7068064785325423
ISL1,Syndactyly type 5 ORPHA:93406,0.7068064785325423
ISL1,Synpolydactyly type 1 ORPHA:295195,0.7068064785325423
ISL1,VACTERL/VATER association ORPHA:887,0.7068064785325423
ISL1,Zygodactyly type 3 ORPHA:295191,0.7068064785325423
ISL1,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
ISL1,Variola virus hypothetical protein (gene: B21R),0.7988086321880973
ISL1,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.8031136315766868
ISL1,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8315214238833722
ISL1,Horsepox virus HSPV194 (ankyrin repeats),0.8320620882218038
ISL1,Orf virus ORF123 ankyrin repeat protein,0.8390943852085586
ISL1,Monkeypox virus ankyrin-like protein,0.8426793553344071
ISL1,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.8507994162096807
ISL1,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.8665950357166999
ISL1,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.876049415394169
ISL1,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.8784689389733535
ISL1,Horsepox virus HSPV005c (Ankyrin repeats),0.9005654634109755
ISL1,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.9097056179628632
ISL1,Yaba-like disease virus 8L protein (gene: 8L),0.9102852214746716
ISL1,Ectromelia virus ERPV ankyrin,0.9199249371723298
ISL1,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.920189880588384
ISL1,Vaccinia virus ankyin-like protein (gene: M1L),0.9271250260824724
ISL1,Orf virus ORF008 ankyrin repeat protein,0.9285312497152513
ISL1,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.9285312497152513
ISL1,Horsepox virus HSPV181 (ankyrin repeats),0.9517968639566384
ISL1,Vaccinia virus ankyrin-like protein (gene: B4R),0.9518028028273808
ISL1,Yaba monkey tumor virus ankyrin repeat protein,0.960637237597315
ISL1,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9621839893030432
ISL1,Orf virus ORF129 ankyrin repeat protein,0.9621839893030432
ISL1,Yaba-like disease virus 11L protein (gene: 11L),0.9624639844306644
ISL1,Orf virus ORF128 ankyrin repeat protein,0.9624639844306644
ISL1,Orf virus ORF126 ankyrin repeat protein,0.9676678660011035
ISL1,Variola virus hypothetical protein (gene: B6R),0.970789305792858
ITGA2,Mammary Neoplasms,0.0034602840073026
ITGA2,Ovarian Carcinoma,0.0034602840073026
ITGA2,Breast Carcinoma,0.0042545616049287
ITGA2,Tumor Progression,0.0149315928814189
ITGA2,Stomach Carcinoma,0.0149315928814189
ITGA2,melanoma,0.0149315928814189
ITGA2,Adenocarcinoma,0.0155921563748247
ITGA2,Malignant neoplasm of breast,0.0191435238361999
ITGA2,Fibrosarcoma,0.0191435238361999
ITGA2,Malignant neoplasm of stomach,0.0191435238361999
ITGA2,Malignant neoplasm of ovary,0.0277695594716545
ITGA2,Medulloblastoma,0.0354767239335874
ITGA2,Malignant neoplasm of prostate,0.0569142010728473
ITGA2,Central neuroblastoma,0.0593779966354549
ITGA2,Neoplasm Metastasis,0.0648809611869375
ITGA2,Neuroblastoma,0.0688152422187159
ITGA2,Pancreatic Neoplasm,0.0739788831250619
ITGA2,Degenerative polyarthritis,0.0739788831250619
ITGA2,Prostate carcinoma,0.0773771948186562
ITGA2,Squamous cell carcinoma of the head and neck,0.0775520919998773
ITGA2,Malignant Neoplasms,0.0991201145654548
ITGA2,Osteosarcoma,0.1029977559100099
ITGA2,Adenocarcinoma of colon,0.1112281755580192
ITGA2,Ameloblastoma,0.1208020277850109
ITGA2,Secondary malignant neoplasm of bone,0.1253114324938153
ITGA2,Myocardial Infarction,0.1352936728187231
ITGA2,Colonic Neoplasms,0.1454373331146953
ITGA2,Rheumatoid Arthritis,0.1537760235124317
ITGA2,Renal fibrosis,0.1602092191314262
ITGA2,von Willebrand Disease Type 1,0.1897991423047819
ITGA2,Systemic Scleroderma,0.1900258729042946
ITGA2,Lung Neoplasms,0.2062010908869036
ITGA2,Osteosarcoma of bone,0.2109483801368481
ITGA2,Prostatic Neoplasms,0.223747154820789
ITGA2,Parasitic Diseases,0.2714542429024338
ITGA2,Malignant neoplasm of lung,0.2714542429024338
ITGA2,Diabetic Retinopathy,0.2723545094624877
ITGA2,Fibroid Tumor,0.290158730291654
ITGA2,Idiopathic Pulmonary Fibrosis,0.3099246715197673
ITGA2,Neonatal Alloimmune Thrombocytopenia,0.3099246715197673
ITGA2,Ischemic stroke,0.3486533561309259
ITGA2,Coronary Thrombosis,0.3508665345292502
ITGA2,Rhabdomyosarcoma,0.3510063969122338
ITGA2,Carcinoma of lung,0.3663130598151661
ITGA2,Endometriosis,0.383941725017158
ITGA2,Collagen Diseases,0.383941725017158
ITGA2,Uterine Fibroids,0.383941725017158
ITGA2,Primary malignant neoplasm of lung,0.3902116649640871
ITGA2,Secondary malignant neoplasm of lymph node,0.3933196962529684
ITGA2,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
ITGA2,Nasopharyngeal carcinoma,0.3933196962529684
ITGA2,Non-Small Cell Lung Carcinoma,0.3933196962529684
ITGA2,Hypertensive disease,0.3933196962529684
ITGA2,Coronary heart disease,0.3933196962529684
ITGA2,Glomerulonephritis,0.3933196962529684
ITGA2,FNAITP,0.3933196962529684
ITGA2,Cardiac fibrosis,0.3933196962529684
ITGA2,Arthritis Bacterial,0.3933196962529684
ITGA2,Atrial Fibrillation,0.3941558617476422
ITGA2,Endometrioma,0.3941558617476422
ITGA2,Mechanical Allodynia,0.3975960596292668
ITGA2,Arthritis Infectious,0.3975960596292668
ITGA2,Glomerulosclerosis (disorder),0.4028066164685291
ITGA2,Chronic Kidney Diseases,0.4028066164685291
ITGA2,Acute myocardial infarction,0.4103119460235835
ITGA2,Cerebrovascular accident,0.4115056600660309
ITGA2,Triglycerides measurement,0.4192169590514327
ITGA2,Lupus Erythematosus Systemic,0.4213286052188015
ITGA2,Thrombocytopenia,0.4213286052188015
ITGA2,Mouth Neoplasms,0.4213286052188015
ITGA2,Alloimmunisation,0.425419812815905
ITGA2,Destructive Arthritis,0.4304973629098372
ITGA2,Retinal Vein Occlusion,0.4459714599189374
ITGA2,Decreased platelet count,0.4561717689698902
ITGA2,Hyperalgesia Secondary,0.4561717689698902
ITGA2,Allodynia,0.4561717689698902
ITGA2,Hyperalgesia Primary,0.4564472886428772
ITGA2,Increased tendency to bruise,0.4564472886428772
ITGA2,Astrocytosis,0.4564472886428772
ITGA2,Tactile Allodynia,0.4675904598629673
ITGA2,Myeloid Leukemia Chronic,0.472444704048021
ITGA2,von Willebrand Disease,0.472444704048021
ITGA2,Placental Insufficiency,0.472444704048021
ITGA2,Acute GVH disease,0.4790179402069343
ITGA2,Thrombosis,0.4906258721078565
ITGA2,Coronary Arteriosclerosis,0.5140447474168605
ITGA2,Hyperalgesia Thermal,0.5178072301085912
ITGA2,Skin Erosion,0.5252711504839724
ITGA2,Rheumatic Heart Disease,0.5337853752290136
ITGA2,Ewings sarcoma-primitive neuroectodermal tumor (PNET),0.5359212109443033
ITGA2,Hyperalgesia,0.5393787854381349
ITGA2,Arthritis,0.553002957824355
ITGA2,Osteomyelitis,0.6196470808426647
ITGA2,Behcet Syndrome,0.6496433426951205
ITGA2,Superficial ulcer,0.6691893635307453
ITGA2,Gliosis,0.6761967139251879
ITGA2,Coronary Artery Disease,0.7240930522443176
ITGA2,Neurologic Symptoms,0.7840911880051142
ITGA2,Endometriosis,0.2187610616307245
ITGA2,Subarachnoid Hemorrhage,0.2627224344149009
ITGA2,Hematomas,0.4286813331685578
ITGA2,Fetal And Neonatal Alloimmune Thrombocytopenia,0.4286813331685578
ITGA2,Retinal Vein Occlusion,0.4402141802500753
ITGA2,Alloimmune Thrombocytopenia,0.4560460337187313
ITGA2,Endometrioma,0.5036845352940079
ITGA2,Cerebral Palsy,0.6340319940404294
ITGA2,Sensorineural Hearing Loss,0.7559892870751337
ITGA2,Developmental Delay,0.96477535147595
ITGA2,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
ITGA2,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
ITGA2,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
ITGA2,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
ITGA2,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
ITGA2,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
ITGA2,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
ITGA2,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
ITGA2,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
ITGA2,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
ITGA2,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
ITGA2,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
ITGA2,Hereditary papillary renal cell carcinoma ORPHA:47044,0.0180064224283883
ITGA2,Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303,0.0180064224283883
ITGA2,Osteofibrous dysplasia ORPHA:488265,0.0180064224283883
ITGA2,PPARG-related familial partial lipodystrophy ORPHA:79083,0.0180064224283883
ITGA2,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.0180064224283883
ITGA2,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.0180064224283883
ITGA2,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.0180064224283883
ITGA2,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.0180064224283883
ITGA2,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.0180064224283883
ITGA2,Pediatric hepatocellular carcinoma ORPHA:33402,0.0180064224283883
ITGA2,Erythrokeratodermia variabilis ORPHA:317,0.0183145313768111
ITGA2,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.0586579655822394
ITGA2,Localized junctional epidermolysis bullosa ORPHA:251393,0.0586579655822394
ITGA2,Benign familial mesial temporal lobe epilepsy ORPHA:163717,0.0586579655822394
ITGA2,Epithelial recurrent erosion dystrophy ORPHA:293381,0.0586579655822394
ITGA2,Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805,0.0586579655822394
ITGA2,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.0586579655822394
ITGA2,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.0586579655822394
ITGA2,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.0586579655822394
ITGA2,Griscelli syndrome type 3 ORPHA:79478,0.0586579655822394
ITGA2,Juvenile Paget disease ORPHA:2801,0.0586579655822394
ITGA2,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.0586579655822394
ITGA2,Athyreosis ORPHA:95713,0.0640416108792758
ITGA2,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.1590470395003315
ITGA2,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.1590470395003315
ITGA2,X-linked hypophosphatemia ORPHA:89936,0.1590470395003315
ITGA2,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.3762014630157917
ITGA2,Palmoplantar keratoderma Nagashima type ORPHA:140966,0.3762014630157917
ITGA2,Xanthinuria type II ORPHA:93602,0.3762014630157917
ITGA2,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.3826134188846508
ITGA2,Cystic fibrosis ORPHA:586,0.6279395134845649
ITGA2,Achondrogenesis type 1B ORPHA:93298,0.7068064785325423
ITGA2,Atelosteogenesis type II ORPHA:56304,0.7068064785325423
ITGA2,Diastrophic dwarfism ORPHA:628,0.7068064785325423
ITGA2,Multiple epiphyseal dysplasia type 4 ORPHA:93307,0.7068064785325423
ITGA2,Ectromelia virus ERPV hemagglutinin,0.6362779693488597
ITGA2,Vaccinia virus Ankara Haemagglutinin,0.6362779693488597
ITGA2,Human adenovirus 41 E3 31.6K,0.6362779693488597
ITGA2,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
ITGA2,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
ITGA2,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.6621265548536891
ITGA2,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.6806291584193672
ITGA2,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.6806291584193672
ITGA2,Horsepox virus HSPV177 (Immunoglobulin like),0.691145768348025
ITGA2,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.7212352368560536
ITGA2,Variola virus hypothetical protein (gene: J9R),0.7651942752688915
ITGA2,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.776311155917498
ITGA2,Human mastadenovirus A E3 CR1-beta1,0.8285661572509389
ITGA2,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.875442055263636
ITGA2,Human adenovirus 61 E3 CR1 beta,0.8784689389733535
ITGA2,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9353779004188908
ITGA2,Human adenovirus 18 CR1-beta protein (gene: E3),0.9445347004229157
KAT2B,Colorectal Carcinoma,0.0034602840073026
KAT2B,Mammary Neoplasms,0.0034602840073026
KAT2B,Ovarian Carcinoma,0.0034602840073026
KAT2B,Breast Carcinoma,0.0042545616049287
KAT2B,Invasive carcinoma of breast,0.0149002095788623
KAT2B,Colorectal Cancer,0.0149315928814189
KAT2B,Stomach Carcinoma,0.0149315928814189
KAT2B,Pre B-cell acute lymphoblastic leukemia,0.0189794808441368
KAT2B,Malignant neoplasm of breast,0.0191435238361999
KAT2B,Malignant neoplasm of stomach,0.0191435238361999
KAT2B,Carcinogenesis,0.0228075668512991
KAT2B,Malignant neoplasm of ovary,0.0277695594716545
KAT2B,Medulloblastoma,0.0354767239335874
KAT2B,Malignant neoplasm of prostate,0.0569142010728473
KAT2B,Neoplasm Metastasis,0.0648809611869375
KAT2B,Glioma,0.0739788831250619
KAT2B,Glioblastoma,0.0745502070959292
KAT2B,Prostate carcinoma,0.0773771948186562
KAT2B,Malignant neoplasm of urinary bladder,0.084286432100041
KAT2B,Squamous cell carcinoma of esophagus,0.0919714360040484
KAT2B,Liver carcinoma,0.095319386034013
KAT2B,Malignant Neoplasms,0.0991201145654548
KAT2B,Colon Carcinoma,0.1062239757831962
KAT2B,Carcinoma Transitional Cell,0.13167400689206
KAT2B,Carcinoma of bladder,0.13167400689206
KAT2B,Malignant tumor of colon,0.223747154820789
KAT2B,Diabetes,0.2277108302018961
KAT2B,Anoxia,0.2462384927636234
KAT2B,Diabetes Mellitus,0.2522264785494494
KAT2B,Neoplasms,0.2714542429024338
KAT2B,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
KAT2B,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
KAT2B,Ataxia Telangiectasia,0.3508665345292502
KAT2B,Rhabdomyosarcoma,0.3510063969122338
KAT2B,Primary malignant neoplasm,0.383941725017158
KAT2B,Secondary malignant neoplasm of lymph node,0.3933196962529684
KAT2B,Spinocerebellar Ataxia Type 7,0.3933196962529684
KAT2B,Kidney Diseases,0.3933196962529684
KAT2B,Secondary malignant neoplasm of liver,0.3933196962529684
KAT2B,Urothelial Carcinoma,0.3933196962529684
KAT2B,Acute lymphocytic leukemia,0.3933196962529684
KAT2B,Stomach Neoplasms,0.3933196962529684
KAT2B,Coronary heart disease,0.3933196962529684
KAT2B,Asthma,0.3933196962529684
KAT2B,Aortic Aneurysm Abdominal,0.3941558617476422
KAT2B,Atrial Fibrillation,0.3941558617476422
KAT2B,Drug Dependence,0.4028066164685291
KAT2B,Bulbo-Spinal Atrophy X-Linked,0.4118266358241932
KAT2B,Mean Corpuscular Volume (result),0.4192169590514327
KAT2B,Mood Disorders,0.4192169590514327
KAT2B,stage gastric cancer,0.4304973629098372
KAT2B,Central Nervous System Neoplasms,0.4330362522463816
KAT2B,Neurodegenerative Disorders,0.4335751357405352
KAT2B,Impaired glucose tolerance,0.4900770016856776
KAT2B,Hyperglycemia,0.4906258721078565
KAT2B,Mean blood pressure,0.4923669467696064
KAT2B,Secondary Neoplasm,0.5140447474168605
KAT2B,Obesity,0.5140447474168605
KAT2B,Adenocarcinoma of lung (disorder),0.51550637274795
KAT2B,Alcohol consumption,0.5251317541886066
KAT2B,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
KAT2B,Vascular inflammations,0.5995952178307736
KAT2B,Paroxysmal atrial fibrillation,0.6304655343580164
KAT2B,Leukemia T-Cell,0.6691893635307453
KAT2B,Metabolic Diseases,0.750779529196619
KAT2B,Pilocytic Astrocytoma,0.7891530777939482
KAT2B,Erythrocyte Mean Corpuscular Hemoglobin Test,0.8352423037513227
KAT2B,Finding of Mean Corpuscular Hemoglobin,0.8352423037513227
KAT2B,Mood Disorder,0.4646409362700993
KAT2B,Generalized glucocorticoid resistance syndrome ORPHA:786,0.1590470395003315
KAT2B,Spinocerebellar ataxia type 1 ORPHA:98755,0.1590470395003315
KAT2B,Attenuated Chediak-Higashi syndrome ORPHA:352723,0.3762014630157917
KAT2B,Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267,0.3762014630157917
KAT2B,Chediak-Higashi syndrome ORPHA:167,0.3762014630157917
KAT2B,GM3 synthase deficiency ORPHA:370933,0.3762014630157917
KAT2B,Renal pseudohypoaldosteronism type 1 ORPHA:171871,0.3762014630157917
KAT2B,Acrodysostosis ORPHA:950,0.3762014630157917
KAT2B,Acrodysostosis with multiple hormone resistance ORPHA:280651,0.3762014630157917
KAT2B,X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328,0.3762014630157917
KAT2B,Bietti crystalline dystrophy ORPHA:41751,0.6239678957896782
KAT2B,Complex lethal osteochondrodysplasia ORPHA:457378,0.6239678957896782
KAT2B,External auditory canal aplasia/hypoplasia ORPHA:141074,0.6239678957896782
KAT2B,Gingival fibromatosis-hypertrichosis syndrome ORPHA:2026,0.6239678957896782
KAT2B,Mild hemophilia A ORPHA:169808,0.6239678957896782
KAT2B,Moderately severe hemophilia A ORPHA:169805,0.6239678957896782
KAT2B,Multiple endocrine neoplasia type 4 ORPHA:276152,0.6239678957896782
KAT2B,Nicolaides-Baraitser syndrome ORPHA:3051,0.6239678957896782
KAT2B,PDE4D haploinsufficiency syndrome ORPHA:439822,0.6239678957896782
KAT2B,Severe hemophilia A ORPHA:169802,0.6239678957896782
KAT2B,Symptomatic form of hemophilia A in female carriers ORPHA:177926,0.6239678957896782
KAT2B,Autosomal recessive ataxia Beauce type ORPHA:88644,0.7068064785325423
KAT2B,Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332,0.7068064785325423
KAT2B,Estrogen resistance syndrome ORPHA:785,0.7068064785325423
KAT2B,Methylmalonic acidemia with homocystinuria type cblF ORPHA:79284,0.7068064785325423
KAT2B,Polycythemia vera ORPHA:729,0.7068064785325423
KAT2B,SHORT syndrome ORPHA:3163,0.7068064785325423
KAT2B,Familial thrombocytosis ORPHA:71493,0.7068064785325423
KAT2B,Human papillomavirus type 48 regulatory protein E2 (gene: E2),0.6362779693488597
KAT2B,Trichodysplasia spinulosa-associated polyomavirus large T antigen (gene: T),0.6362779693488597
KAT2B,Human papillomavirus 116 E2 protein,0.6362779693488597
KAT2B,Reston ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
KAT2B,Ebola virus - Mayinga Zaire 1976 virion spike glycoprotein precursor (gene: GP),0.6362779693488597
KAT2B,Zaire ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
KAT2B,Modoc virus non-structural protein 2A,0.6362779693488597
KAT2B,Human alphaherpesvirus 2 multifunctional expression regulator (gene: UL54),0.6362779693488597
KAT2B,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
KAT2B,BK polyomavirus large T antigen,0.6362779693488597
KAT2B,Human adenovirus 11a IVa2,0.6362779693488597
KAT2B,Human coronavirus HKU1 small membrane protein (gene: E),0.6362779693488597
KAT2B,Human papillomavirus type 128 E2 (gene: E2),0.6362779693488597
KAT2B,Monkeypox virus sulfhydryl oxidase,0.6362779693488597
KAT2B,Horsepox virus HSPV067 (sulfhydryl oxidase),0.6761714078632568
KAT2B,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8919745352546131
KAT2B,Nipah henipavirus P phosphoprotein,0.9511894303546532
KBTBD8,Malignant neoplasm of breast,0.0191435238361999
KBTBD8,Mandibulofacial Dysostosis,0.2643145809900195
KBTBD8,Breast Cancer,0.0402286636010764
KBTBD8,Fried syndrome ORPHA:85335,0.3762014630157917
KBTBD8,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568,0.3762014630157917
KBTBD8,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329,0.3762014630157917
KBTBD8,Fetal encasement syndrome ORPHA:465824,0.6239678957896782
KBTBD8,Yaba-like disease virus 140R protein (gene: 140R),0.6362779693488597
KBTBD8,Yaba monkey tumor virus kelch-like protein,0.6362779693488597
KBTBD8,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.6362779693488597
KBTBD8,Vaccinia virus Kelch-like protein (gene: F3L),0.6362779693488597
KBTBD8,Vaccinia virus Ankara Kelch-like protein,0.6362779693488597
KBTBD8,Horsepox virus HSPV008,0.6362779693488597
KBTBD8,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.6362779693488597
KBTBD8,Horsepox virus HSPV176 (kelch-like protein,0.6362779693488597
KBTBD8,Provisional),0.6362779693488597
KBTBD8,Yaba-like disease virus 19L protein (gene: 19L),0.6362779693488597
KBTBD8,Horsepox virus HSPV043 (Kelch-like protein,0.6362779693488597
KBTBD8,Vaccinia virus kelch-like protein (gene: A55R),0.6362779693488597
KBTBD8,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.6362779693488597
KBTBD8,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.6362779693488597
KBTBD8,Horsepox virus HSPV197 (Hypothetical protein),0.6362779693488597
KBTBD8,Monkeypox virus Zaire-96-I-16 B1R (gene: B1R),0.6362779693488597
KBTBD8,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.6362779693488597
KBTBD8,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.6362779693488597
KBTBD8,Vaccinia virus Ankara 64.7k Kelch-like protein f2,0.6362779693488597
KBTBD8,Monkeypox virus kelch-like protein,0.6362779693488597
KBTBD8,Horsepox virus HSPV029 (kelch-like protein,0.6362779693488597
KBTBD8,Ectromelia virus ERPV kelch-like protein,0.6362779693488597
KBTBD8,Monkeypox virus Zaire-96-I-16 D15L (gene: D15L),0.6362779693488597
KBTBD8,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.6362779693488597
KBTBD8,Vaccinia virus kelch-like protein (gene: C2L),0.6362779693488597
KBTBD8,Monkeypox virus Zaire-96-I-16 D17L (gene: D17L),0.6362779693488597
KBTBD8,Variola virus hypothetical protein (gene: J8R),0.6362779693488597
KBTBD8,Variola virus hypothetical protein (gene: D13L),0.6362779693488597
KBTBD8,Vaccinia virus Ankara 18.9k Kelch-like protein,0.6362779693488597
KBTBD8,Cowpox virus CPXV204 protein (gene: CPXV204 CDS),0.7975886343350181
KCNN4,Breast Carcinoma,0.0042545616049287
KCNN4,Malignant neoplasm of prostate,0.0569142010728473
KCNN4,Malignant neoplasm of pancreas,0.0726340460169901
KCNN4,Glioma,0.0739788831250619
KCNN4,Endometrial Neoplasms,0.0745502070959292
KCNN4,Pancreatic carcinoma,0.0745502070959292
KCNN4,Prostate carcinoma,0.0773771948186562
KCNN4,Malignant neoplasm of endometrium,0.13167400689206
KCNN4,Uterine Corpus Cancer,0.1328002618052838
KCNN4,Endometrial Carcinoma,0.3044782497745498
KCNN4,Non-Small Cell Lung Carcinoma,0.3933196962529684
KCNN4,Anisopoikilocytosis,0.3933196962529684
KCNN4,Inflammatory Bowel Diseases,0.3933196962529684
KCNN4,Increased mean corpuscular volume,0.3933196962529684
KCNN4,Xerocytosis,0.3941558617476422
KCNN4,Acanthocytosis,0.3975960596292668
KCNN4,Splenomegaly,0.4103119460235835
KCNN4,Mean Corpuscular Volume (result),0.4192169590514327
KCNN4,Hepatomegaly,0.4506578937113162
KCNN4,Reticulocytosis,0.4615352570710579
KCNN4,Cardiovascular Diseases,0.4675904598629673
KCNN4,Hemoglobin measurement,0.4852430673532381
KCNN4,Increased bilirubin level (finding),0.4906258721078565
KCNN4,Crohn Disease,0.4981941174985421
KCNN4,Hamartoma Syndrome Multiple,0.589345563575654
KCNN4,Cystic Fibrosis,0.6124306570512981
KCNN4,Icterus,0.625112405383346
KCNN4,Monocyte count procedure,0.6274540883972485
KCNN4,Monocyte count result,0.6274540883972485
KCNN4,Mean corpuscular hemoglobin concentration determination,0.7412504828119304
KCNN4,Anemia Hemolytic,0.7796824214131131
KCNN4,Breast Carcinoma,0.0075861267486594
KCNN4,Hyperbilirubinemia,0.3094716280561038
KCNN4,Abetalipoproteinemia,0.4560460337187313
KCNN4,Anemia,0.4780231573499264
KCNN4,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.1590470395003315
KCNN4,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.1590470395003315
KCNN4,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.1590470395003315
KCNN4,Dehydrated hereditary stomatocytosis ORPHA:3202,0.3762014630157917
KCNN4,Dysosteosclerosis ORPHA:1782,0.3762014630157917
KCNN4,Herpes simplex virus encephalitis ORPHA:1930,0.3826134188846508
KCNN4,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.6239678957896782
KCNN4,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.6239678957896782
KCNN4,Multiple intestinal atresia ORPHA:2300,0.6239678957896782
KITLG,Colorectal Carcinoma,0.0034602840073026
KITLG,Mammary Neoplasms,0.0034602840073026
KITLG,Ovarian Carcinoma,0.0034602840073026
KITLG,Breast Carcinoma,0.0042545616049287
KITLG,Invasive carcinoma of breast,0.0149002095788623
KITLG,Epithelioma,0.0149002095788623
KITLG,Colorectal Cancer,0.0149315928814189
KITLG,Tumor Progression,0.0149315928814189
KITLG,Stomach Carcinoma,0.0149315928814189
KITLG,melanoma,0.0149315928814189
KITLG,Adenocarcinoma,0.0155921563748247
KITLG,Squamous cell carcinoma,0.0182265588252201
KITLG,ovarian neoplasm,0.0191435238361999
KITLG,Malignant neoplasm of breast,0.0191435238361999
KITLG,Fibrosarcoma,0.0191435238361999
KITLG,Malignant neoplasm of stomach,0.0191435238361999
KITLG,Carcinogenesis,0.0228075668512991
KITLG,Malignant neoplasm of ovary,0.0277695594716545
KITLG,Carcinoma Spindle-Cell,0.0308703957553632
KITLG,Malignant neoplasm of prostate,0.0569142010728473
KITLG,Carcinoma,0.0593779966354549
KITLG,Central neuroblastoma,0.0593779966354549
KITLG,Carcinomatosis,0.0617471306652618
KITLG,Neoplasm Metastasis,0.0648809611869375
KITLG,Renal Cell Carcinoma,0.0648809611869375
KITLG,Neuroblastoma,0.0688152422187159
KITLG,Malignant neoplasm of pancreas,0.0726340460169901
KITLG,Glioblastoma,0.0745502070959292
KITLG,Pancreatic carcinoma,0.0745502070959292
KITLG,Colorectal Neoplasms,0.0827744840860166
KITLG,Anaplastic carcinoma,0.084286432100041
KITLG,Liver carcinoma,0.095319386034013
KITLG,Osteosarcoma,0.1029977559100099
KITLG,Colon Carcinoma,0.1062239757831962
KITLG,Premature canities,0.1193558174333938
KITLG,MYELODYSPLASTIC SYNDROME,0.1254380558571286
KITLG,Waardenburg Syndrome Type 2,0.1254380558571286
KITLG,Undifferentiated carcinoma,0.13167400689206
KITLG,Mammary Carcinoma Animal,0.1352936728187231
KITLG,Animal Mammary Neoplasms,0.1352936728187231
KITLG,Colonic Neoplasms,0.1454373331146953
KITLG,Rheumatoid Arthritis,0.1537760235124317
KITLG,Sarcoma,0.1537760235124317
KITLG,Heterochromia iridis,0.1602092191314262
KITLG,Carcinoma testes,0.1653491983554358
KITLG,Leukemia Myeloid Chronic-Phase,0.1662487420178625
KITLG,White forelock,0.1735868515093891
KITLG,Testicular Germ Cell Tumor,0.1735868515093891
KITLG,cervical cancer,0.2050045461627939
KITLG,Lung Neoplasms,0.2062010908869036
KITLG,Eosinophilic esophagitis,0.2085938372806741
KITLG,Osteosarcoma of bone,0.2109483801368481
KITLG,Adverse reaction to drug,0.223747154820789
KITLG,Drug toxicity,0.223747154820789
KITLG,Diabetes,0.2277108302018961
KITLG,Anoxia,0.2462384927636234
KITLG,Neuroblastic tumors,0.2522264785494494
KITLG,Diabetes Mellitus,0.2522264785494494
KITLG,Malignant neoplasm of liver,0.2643145809900195
KITLG,Malignant neoplasm of lung,0.2714542429024338
KITLG,Mastocytoma,0.2714542429024338
KITLG,Piebaldism,0.2714542429024338
KITLG,Benign Mastocytoma,0.2980670559114652
KITLG,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
KITLG,Endometrial Carcinoma,0.3044782497745498
KITLG,Gastrointestinal Stromal Tumors,0.3199171478489988
KITLG,Mammary Neoplasms Experimental,0.3508665345292502
KITLG,Mast Cell Neoplasm,0.3508665345292502
KITLG,Rhabdomyosarcoma,0.3510063969122338
KITLG,Carcinoma of lung,0.3663130598151661
KITLG,Endometriosis,0.383941725017158
KITLG,Teratoma,0.383941725017158
KITLG,Primary malignant neoplasm of lung,0.3902116649640871
KITLG,Chronic myeloproliferative disorder,0.3933196962529684
KITLG,Nasopharyngeal carcinoma,0.3933196962529684
KITLG,Non-Small Cell Lung Carcinoma,0.3933196962529684
KITLG,Leukemia Myelocytic Acute,0.3933196962529684
KITLG,Germ Cell Cancer,0.3933196962529684
KITLG,Large cell neuroendocrine carcinoma,0.3933196962529684
KITLG,Tumor of Rete Testis,0.3933196962529684
KITLG,Nasopharyngeal Neoplasms,0.3933196962529684
KITLG,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
KITLG,Acute lymphocytic leukemia,0.3933196962529684
KITLG,Glomerulonephritis,0.3933196962529684
KITLG,Birthmark,0.3933196962529684
KITLG,Cafe-au-Lait Spots,0.3933196962529684
KITLG,Cachexia,0.3933196962529684
KITLG,Cardiac fibrosis,0.3933196962529684
KITLG,Cutaneous Mastocytosis,0.3933196962529684
KITLG,Asthma,0.3933196962529684
KITLG,synovial sarcoma,0.3933196962529684
KITLG,Anaplasia,0.3938591532700354
KITLG,Renal carcinoma,0.3941558617476422
KITLG,Thyroid carcinoma,0.3941558617476422
KITLG,Drug abuse,0.3941558617476422
KITLG,Progressive Neoplastic Disease,0.3941558617476422
KITLG,Amyotrophic Lateral Sclerosis,0.3975960596292668
KITLG,Progressive cGVHD,0.3975960596292668
KITLG,Menstrual spotting,0.3975960596292668
KITLG,Multiple lentigines,0.3975960596292668
KITLG,Merkel cell carcinoma,0.4028066164685291
KITLG,Multiple Myeloma,0.4103119460235835
KITLG,Urticaria Pigmentosa,0.4103119460235835
KITLG,Pigmented lesions,0.4103119460235835
KITLG,Mastocytosis,0.4126392832024548
KITLG,Cancer Embryonal and Mixed,0.4126392832024548
KITLG,Neoplasms Embryonal and Mixed,0.4126392832024548
KITLG,Hyperkeratosis,0.4192169590514327
KITLG,Oxyphilic Adenoma,0.4192169590514327
KITLG,Histiocytosis Langerhans-Cell,0.4213286052188015
KITLG,Cancer Embryonal,0.4213286052188015
KITLG,Hypopigmentation disorder,0.4297858918260954
KITLG,hypopigmented skin patch,0.4297858918260954
KITLG,Malignant neoplasm of thyroid,0.4307603335611732
KITLG,Germ cell tumor,0.4335751357405352
KITLG,Neurofibromatosis 1,0.4335751357405352
KITLG,Machado-Joseph Disease,0.4335751357405352
KITLG,Neurodegenerative Disorders,0.4335751357405352
KITLG,Nasal Polyps,0.4459714599189374
KITLG,Myocardial Ischemia,0.4506578937113162
KITLG,Senile lentigo,0.4506578937113162
KITLG,Leukemia Mast-Cell,0.4506578937113162
KITLG,leukemia,0.4588513406515081
KITLG,Mesothelioma,0.4635211539849193
KITLG,Non-obstructive azoospermia,0.4675904598629673
KITLG,Cardiomyopathy Familial Idiopathic,0.4704594475773637
KITLG,Huntington Disease,0.4704594475773637
KITLG,Myeloid Leukemia Chronic,0.472444704048021
KITLG,Myelodysplasia,0.4790179402069343
KITLG,ALBINOIDISM OCULOCUTANEOUS AUTOSOMAL DOMINANT,0.4790179402069343
KITLG,Ovarian Failure Premature,0.4923669467696064
KITLG,Chromosome 5 trisomy 5q,0.4923669467696064
KITLG,Adult Acute Myeloblastic Leukemia,0.4981941174985421
KITLG,Myelodysplastic Syndrome with Isolated del(5q),0.4981941174985421
KITLG,Metastatic melanoma,0.5001612228394569
KITLG,Neoplasms Germ Cell and Embryonal,0.5019670090704682
KITLG,5q-syndrome,0.5090214163899865
KITLG,Leukemia Myelomonocytic Chronic,0.5140447474168605
KITLG,Obesity,0.5140447474168605
KITLG,Oligospermia,0.5178072301085912
KITLG,Synovitis,0.5252711504839724
KITLG,Anemia severe,0.5299466034567416
KITLG,Polycystic Ovary Syndrome,0.5337853752290136
KITLG,Lymphoma Follicular,0.533913711453195
KITLG,Arthritis,0.553002957824355
KITLG,Embryonal Neoplasm,0.5619299124666532
KITLG,Hyperpigmentation,0.5710095678317721
KITLG,Seminoma,0.5990568578129436
KITLG,Congenital chromosomal disease,0.6035970790768342
KITLG,Hepatitis Toxic,0.610971999959321
KITLG,Chemical and Drug Induced Liver Injury,0.610971999959321
KITLG,Chemically-Induced Liver Toxicity,0.610971999959321
KITLG,Drug-Induced Acute Liver Injury,0.610971999959321
KITLG,Hepatitis Drug-Induced,0.6189532555846575
KITLG,Premature Menopause,0.625112405383346
KITLG,Anemia Diamond-Blackfan,0.6447029562500783
KITLG,Myeloproliferative disease,0.6592493193460769
KITLG,Gastritis,0.6875373888914498
KITLG,Sensorineural Hearing Loss (disorder),0.6891882956008074
KITLG,Testicular Neoplasms,0.6910672612216457
KITLG,Drug-Induced Liver Disease,0.6910672612216457
KITLG,Dermatitis Atopic,0.7045203904267408
KITLG,Left Ventricular Hypertrophy,0.7294281406818208
KITLG,Muscular Dystrophy,0.7294281406818208
KITLG,Leigh Disease,0.7347935459099629
KITLG,Malignant Testicular Germ Cell Tumor,0.7533159919746161
KITLG,Gastrointestinal Carcinoid Tumor,0.7674304683279349
KITLG,Vitiligo,0.7965733310657268
KITLG,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),0.8646232927091104
KITLG,Cardiomyopathy Dilated,0.8670707879649133
KITLG,Malignant neoplasm of testis,0.8891038160665995
KITLG,Polycythemia Vera,0.9114432287644624
KITLG,Male infertility,0.9513218044829236
KITLG,Anomalous Pulmonary Artery,0.0075861267486594
KITLG,Anaplastic Carcinoma,0.0402286636010764
KITLG,Carcinoma,0.0534520155998091
KITLG,Nasopharyngeal Carcinoma,0.2278592962769385
KITLG,Testicular Neoplasms,0.4286813331685578
KITLG,Tumor Of Rete Testis,0.4286813331685578
KITLG,Malignant Testicular Germ Cell Tumor,0.4541466895915311
KITLG,Testicular Germ Cell Tumor,0.4560460337187313
KITLG,Malignant Neoplasm Of Testis,0.4560460337187313
KITLG,Melanosis,0.4560460337187313
KITLG,Myocardial Ischemia,0.4560460337187313
KITLG,Multiple Lentigines,0.4560460337187313
KITLG,Embryonal Neoplasm,0.4560460337187313
KITLG,Nasal Polyposis,0.4560460337187313
KITLG,Tumor,0.4602028929328057
KITLG,Multicystic Renal Dysplasia,0.4646409362700993
KITLG,Neoplasm,0.4646409362700993
KITLG,Hirschsprung Disease,0.4875380732267193
KITLG,Hyperkeratosis,0.4875380732267193
KITLG,Hearing Loss,0.5632819212593052
KITLG,Nonsyndromic Deafness,0.7273481622222765
KITLG,Non-Syndromic Sensorineural Deafness,0.7820056260843418
KITLG,Ptosis,0.8357787380041017
KITLG,Deafness,0.8371848756758566
KITLG,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
KITLG,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
KITLG,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
KITLG,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
KITLG,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
KITLG,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
KITLG,Peters anomaly ORPHA:708,0.00518481975049
KITLG,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
KITLG,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
KITLG,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
KITLG,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
KITLG,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
KITLG,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
KITLG,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
KITLG,Axenfeld anomaly ORPHA:98978,0.0083045131203191
KITLG,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
KITLG,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
KITLG,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
KITLG,Rieger anomaly ORPHA:91483,0.0083045131203191
KITLG,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
KITLG,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
KITLG,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
KITLG,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
KITLG,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.0180064224283883
KITLG,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.0180064224283883
KITLG,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.0180064224283883
KITLG,Autosomal recessive brachyolmia ORPHA:448242,0.0180064224283883
KITLG,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.0180064224283883
KITLG,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.0180064224283883
KITLG,Craniosynostosis Boston type ORPHA:1541,0.0180064224283883
KITLG,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.0180064224283883
KITLG,Hereditary papillary renal cell carcinoma ORPHA:47044,0.0180064224283883
KITLG,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.0180064224283883
KITLG,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.0180064224283883
KITLG,Nance-Horan syndrome ORPHA:627,0.0180064224283883
KITLG,Osteofibrous dysplasia ORPHA:488265,0.0180064224283883
KITLG,PPARG-related familial partial lipodystrophy ORPHA:79083,0.0180064224283883
KITLG,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.0180064224283883
KITLG,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.0180064224283883
KITLG,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.0180064224283883
KITLG,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.0180064224283883
KITLG,X-linked osteoporosis with fractures ORPHA:391330,0.0180064224283883
KITLG,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.0180064224283883
KITLG,Pediatric hepatocellular carcinoma ORPHA:33402,0.0180064224283883
KITLG,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.0586579655822394
KITLG,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.0586579655822394
KITLG,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.0586579655822394
KITLG,Alopecia universalis ORPHA:701,0.0586579655822394
KITLG,Atrichia with papular lesions ORPHA:86819,0.0586579655822394
KITLG,Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181,0.0586579655822394
KITLG,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.0586579655822394
KITLG,Familial generalized lentiginosis ORPHA:231040,0.0586579655822394
KITLG,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.0586579655822394
KITLG,Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381,0.0586579655822394
KITLG,Microphthalmia with brain and digit anomalies ORPHA:139471,0.0586579655822394
KITLG,Monoamine oxidase A deficiency ORPHA:3057,0.0586579655822394
KITLG,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.0586579655822394
KITLG,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.0586579655822394
KITLG,X-linked Alport syndrome ORPHA:88917,0.0586579655822394
KITLG,Juvenile Paget disease ORPHA:2801,0.0586579655822394
KITLG,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.0586579655822394
KITLG,Phakomatosis cesioflammea ORPHA:79483,0.0586579655822394
KITLG,Brachydactyly type A1 ORPHA:93388,0.0599424746210022
KITLG,ABeta amyloidosis Arctic type ORPHA:324723,0.1590470395003315
KITLG,ABeta amyloidosis Dutch type ORPHA:100006,0.1590470395003315
KITLG,ABeta amyloidosis Iowa type ORPHA:324708,0.1590470395003315
KITLG,ABeta amyloidosis Italian type ORPHA:324713,0.1590470395003315
KITLG,ABetaA21G amyloidosis ORPHA:324718,0.1590470395003315
KITLG,ABetaL34V amyloidosis ORPHA:324703,0.1590470395003315
KITLG,Campomelic dysplasia ORPHA:140,0.1590470395003315
KITLG,Dicarboxylic aminoaciduria ORPHA:2195,0.1590470395003315
KITLG,Hot water reflex epilepsy ORPHA:166412,0.1590470395003315
KITLG,Isolated Pierre Robin syndrome ORPHA:718,0.1590470395003315
KITLG,Multiple myeloma ORPHA:29073,0.1590470395003315
KITLG,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012,0.1590470395003315
KITLG,Persistent hyperplastic primary vitreous ORPHA:91495,0.1590470395003315
KITLG,Retinopathy of prematurity ORPHA:90050,0.1590470395003315
KITLG,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.3762014630157917
KITLG,Action myoclonus-renal failure syndrome ORPHA:163696,0.3762014630157917
KITLG,Acute neonatal citrullinemia type I ORPHA:247546,0.3762014630157917
KITLG,Adult-onset citrullinemia type I ORPHA:247573,0.3762014630157917
KITLG,Aromatase deficiency ORPHA:91,0.3762014630157917
KITLG,Aromatase excess syndrome ORPHA:178345,0.3762014630157917
KITLG,Frank-Ter Haar syndrome ORPHA:137834,0.3762014630157917
KITLG,Goldberg-Shprintzen megacolon syndrome ORPHA:66629,0.3762014630157917
KITLG,Legius syndrome ORPHA:137605,0.3762014630157917
KITLG,Sjogren-Larsson syndrome ORPHA:816,0.3762014630157917
KITLG,Familial exudative vitreoretinopathy ORPHA:891,0.3900898302534297
KITLG,Keipert syndrome ORPHA:2662,0.6239678957896782
KITLG,Microcystic stromal tumor ORPHA:569248,0.6239678957896782
KITLG,Pilomatrixoma ORPHA:91414,0.6239678957896782
KITLG,Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473,0.6239678957896782
KRT13,Breast Carcinoma,0.0042545616049287
KRT13,Tumor Progression,0.0149315928814189
KRT13,Adenocarcinoma,0.0155921563748247
KRT13,Squamous cell carcinoma,0.0182265588252201
KRT13,Malignant neoplasm of breast,0.0191435238361999
KRT13,Neoplasm Metastasis,0.0648809611869375
KRT13,Squamous cell carcinoma of esophagus,0.0919714360040484
KRT13,Oral Cavity Carcinoma,0.13167400689206
KRT13,Adenocarcinoma Of Esophagus,0.2679411586077776
KRT13,Cervical Squamous Cell Carcinoma,0.3199171478489988
KRT13,Leukoplakia,0.333745294913745
KRT13,Lip and Oral Cavity Carcinoma,0.3933196962529684
KRT13,Waisman syndrome,0.4028066164685291
KRT13,Hyperkeratosis,0.4192169590514327
KRT13,Acanthosis,0.5019670090704682
KRT13,Intraepithelial Neoplasia,0.717484976234209
KRT13,Esophagus Neoplasm,0.0102679590519094
KRT13,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
KRT13,Bamforth-Lazarus syndrome ORPHA:1226,0.0180064224283883
KRT13,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.0586579655822394
KRT13,Neuropathy with hearing impairment ORPHA:139512,0.0586579655822394
KRT13,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.0586579655822394
KRT13,White sponge nevus ORPHA:171723,0.1590470395003315
KRT13,Bladder exstrophy ORPHA:93930,0.1590470395003315
KRT13,Uncombable hair syndrome ORPHA:1410,0.1590470395003315
KRT13,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.1697334635963512
KRT13,Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681,0.3762014630157917
KRT13,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3762014630157917
KRT13,Sebocystomatosis ORPHA:841,0.3762014630157917
KRT13,Bifid uvula ORPHA:99771,0.3762014630157917
KRT13,Cleft hard palate ORPHA:101023,0.3762014630157917
KRT13,Cleft velum ORPHA:99772,0.3762014630157917
KRT13,Meesmann corneal dystrophy ORPHA:98954,0.3762014630157917
KRT13,Submucosal cleft palate ORPHA:155878,0.3762014630157917
KRT13,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.3775879467205478
KRT13,Autosomal dominant generalized epidermolysis bullosa simplex intermediate form ORPHA:79399,0.6239678957896782
KRT13,Autosomal dominant generalized epidermolysis bullosa simplex severe form ORPHA:79396,0.6239678957896782
KRT13,Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397,0.6239678957896782
KRT13,Localized epidermolysis bullosa simplex ORPHA:79400,0.6239678957896782
KRT13,Pachyonychia congenita ORPHA:2309,0.6239678957896782
KRT13,ADULT syndrome ORPHA:978,0.6239678957896782
KRT13,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome ORPHA:1071,0.6239678957896782
KRT13,EEC syndrome ORPHA:1896,0.6239678957896782
KRT13,Limb-mammary syndrome ORPHA:69085,0.6239678957896782
KRT23,Colorectal Carcinoma,0.0034602840073026
KRT23,Colorectal Cancer,0.0149315928814189
KRT23,Adenocarcinoma,0.0155921563748247
KRT23,Malignant neoplasm of pancreas,0.0726340460169901
KRT23,Pancreatic carcinoma,0.0745502070959292
KRT23,Colon Carcinoma,0.1062239757831962
KRT23,Malignant neoplasm of large intestine,0.13167400689206
KRT23,Malignant tumor of colon,0.223747154820789
KRT23,Steatohepatitis,0.4906258721078565
KRT23,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.0586579655822394
KRT23,Uncombable hair syndrome ORPHA:1410,0.1590470395003315
KRT23,Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369,0.6239678957896782
KRT23,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105,0.6239678957896782
KRT23,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814,0.7068064785325423
LAMA3,Mammary Neoplasms,0.0034602840073026
LAMA3,Ovarian Carcinoma,0.0034602840073026
LAMA3,Stomach Carcinoma,0.0149315928814189
LAMA3,Adenocarcinoma,0.0155921563748247
LAMA3,Malignant neoplasm of breast,0.0191435238361999
LAMA3,Malignant neoplasm of stomach,0.0191435238361999
LAMA3,Epithelial ovarian cancer,0.0387439397151409
LAMA3,Malignant neoplasm of prostate,0.0569142010728473
LAMA3,Neoplasm Metastasis,0.0648809611869375
LAMA3,Glioblastoma,0.0745502070959292
LAMA3,Squamous cell carcinoma of the head and neck,0.0775520919998773
LAMA3,Myocardial Infarction,0.1352936728187231
LAMA3,Cataract,0.223747154820789
LAMA3,Atrophic scar,0.286740104053178
LAMA3,EPIDERMOLYSIS BULLOSA JUNCTIONAL LOCALISATA VARIANT (disorder),0.3933196962529684
LAMA3,Adult junctional epidermolysis bullosa (disorder),0.3933196962529684
LAMA3,Epidermolysis Bullosa Progressiva,0.3933196962529684
LAMA3,Herlitz Disease,0.3933196962529684
LAMA3,Hoarse cry,0.3933196962529684
LAMA3,JEB-I,0.3933196962529684
LAMA3,Palmar hyperhidrosis,0.3933196962529684
LAMA3,Abnormality of the eye,0.3933196962529684
LAMA3,Aplasia Cutis Congenita,0.3933196962529684
LAMA3,Congenital localized absence of skin,0.3933196962529684
LAMA3,Epidermolysis bullosa inversa dystrophica,0.3933196962529684
LAMA3,Junctional split,0.3933196962529684
LAMA3,Laryngismus,0.3933196962529684
LAMA3,Plantar hyperkeratosis,0.3933196962529684
LAMA3,Pyloric Atresia,0.3933196962529684
LAMA3,Adenoma,0.3933196962529684
LAMA3,Ovarian Serous Adenocarcinoma,0.3933196962529684
LAMA3,Late-onset muscular dystrophy,0.3933196962529684
LAMA3,Anemia,0.3941558617476422
LAMA3,Laryngostenosis,0.3941558617476422
LAMA3,Cervical Squamous Intraepithelial Neoplasia,0.3941558617476422
LAMA3,Hoarseness,0.3941558617476422
LAMA3,Oral mucosal blisters,0.3941558617476422
LAMA3,Amyotrophic Lateral Sclerosis,0.3975960596292668
LAMA3,Flexion contracture of proximal interphalangeal joint,0.3975960596292668
LAMA3,Paronychia Inflammation,0.3975960596292668
LAMA3,Hemoglobin low,0.4028066164685291
LAMA3,Junctional Epidermolysis Bullosa,0.4103119460235835
LAMA3,Scarring alopecia of scalp,0.4115056600660309
LAMA3,Dyspnea,0.4126392832024548
LAMA3,Nail dysplasia,0.4192169590514327
LAMA3,Disorder of eye,0.4213286052188015
LAMA3,Congenital scar,0.4213286052188015
LAMA3,Reticulocyte count (procedure),0.425419812815905
LAMA3,Research-Related Injuries,0.425419812815905
LAMA3,Traumatic injury,0.425419812815905
LAMA3,Wounds and Injuries,0.425419812815905
LAMA3,Fragile nails,0.425419812815905
LAMA3,Injury wounds,0.425419812815905
LAMA3,Milium Cyst,0.425419812815905
LAMA3,Esophageal Stenosis,0.4335751357405352
LAMA3,Weak cry,0.4396723023384634
LAMA3,Prion Diseases,0.4459714599189374
LAMA3,Skin Ulcer,0.4561717689698902
LAMA3,ANONYCHIA,0.4615352570710579
LAMA3,Dehydration,0.4714226702518064
LAMA3,Rotting teeth,0.4790179402069343
LAMA3,Dental caries,0.4852430673532381
LAMA3,Dermatologic disorders,0.4906258721078565
LAMA3,Abnormal pigmentation,0.5019670090704682
LAMA3,Epidermolysis Bullosa,0.5019670090704682
LAMA3,Skin Erosion,0.5252711504839724
LAMA3,Nail Diseases,0.5359212109443033
LAMA3,Thin dental enamel,0.5393787854381349
LAMA3,Defective enamel matrix,0.5393787854381349
LAMA3,Dysplasia of tooth enamel,0.5393787854381349
LAMA3,Amelogenesis Imperfecta,0.5453394612016188
LAMA3,Cervical Intraepithelial Neoplasia,0.5523521032803237
LAMA3,Pyloric Stenosis,0.553002957824355
LAMA3,Sparse body hair,0.5655222348249326
LAMA3,Dental Enamel Hypoplasia,0.5655222348249326
LAMA3,Skin blisters,0.6319938293757544
LAMA3,Abnormal blistering of the skin,0.6319938293757544
LAMA3,Skin bullae,0.6355866602993508
LAMA3,Dystrophia unguium,0.6355866602993508
LAMA3,Death in infancy,0.7467090191923123
LAMA3,Death in early childhood,0.7484342194688707
LAMA3,Hypodontia,0.7867131318906807
LAMA3,Feeding difficulties,0.7900704408991807
LAMA3,Allergic rhinitis (disorder),0.8600100703665297
LAMA3,Undergrowth,0.9401531131388324
LAMA3,Failure to gain weight,0.9449543840411656
LAMA3,Pediatric failure to thrive,0.9465829057944656
LAMA3,Junctional Epidermolysis Bullosa Gravis Of Herlitz,0.4286813331685578
LAMA3,Junctional Split,0.4286813331685578
LAMA3,Congenital Localized Absence Of Skin,0.4286813331685578
LAMA3,Junctional Epidermolysis Bullosa,0.4402141802500753
LAMA3,Osteoporosis,0.4541466895915311
LAMA3,Paronychia Inflammation,0.4560460337187313
LAMA3,Laryngostenosis,0.4560460337187313
LAMA3,Respiratory Failure,0.4560460337187313
LAMA3,Ovarian Serous Adenocarcinoma,0.4560460337187313
LAMA3,Allergic Rhinitis,0.4560460337187313
LAMA3,Esophageal Stricture,0.4560460337187313
LAMA3,Ankyloglossia,0.4560460337187313
LAMA3,Onycholysis,0.4560460337187313
LAMA3,Skin Erosion,0.4560460337187313
LAMA3,Epidermolysis Bullosa,0.4646409362700993
LAMA3,Anemia,0.4780231573499264
LAMA3,Anonychia,0.5087473896242481
LAMA3,Amelogenesis Imperfecta,0.5234357475824973
LAMA3,Aplasia Cutis Congenita,0.5316139823120088
LAMA3,Myocardial Infarction,0.5632819212593052
LAMA3,Skin Carcinoma,0.5764868917478859
LAMA3,Laryngospasm,0.6098159321331
LAMA3,Dental Enamel Hypoplasia,0.6564901877271138
LAMA3,Nail Diseases,0.696610260564548
LAMA3,Nail Dysplasia,0.696610260564548
LAMA3,Nail Dystrophy,0.7112499273451761
LAMA3,Alopecia,0.7167438233451096
LAMA3,Amyotrophic Lateral Sclerosis,0.7506125843857363
LAMA3,Ovarian Neoplasm,0.7921294370722203
LAMA3,Cardiomyopathy,0.8407264689819682
LAMA3,Palmoplantar Keratoderma,0.8536040084512244
LAMA3,Microstomia,0.8880601774083273
LAMA3,Hypodontia,0.903750316592452
LAMA3,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
LAMA3,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
LAMA3,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
LAMA3,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
LAMA3,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
LAMA3,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
LAMA3,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
LAMA3,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
LAMA3,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
LAMA3,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
LAMA3,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
LAMA3,Bamforth-Lazarus syndrome ORPHA:1226,0.0180064224283883
LAMA3,Hereditary papillary renal cell carcinoma ORPHA:47044,0.0180064224283883
LAMA3,Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303,0.0180064224283883
LAMA3,Osteofibrous dysplasia ORPHA:488265,0.0180064224283883
LAMA3,PPARG-related familial partial lipodystrophy ORPHA:79083,0.0180064224283883
LAMA3,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.0180064224283883
LAMA3,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.0180064224283883
LAMA3,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.0180064224283883
LAMA3,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.0180064224283883
LAMA3,Erythrokeratodermia variabilis ORPHA:317,0.0183145313768111
LAMA3,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.0586579655822394
LAMA3,Localized junctional epidermolysis bullosa ORPHA:251393,0.0586579655822394
LAMA3,AA amyloidosis ORPHA:85445,0.0586579655822394
LAMA3,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.0586579655822394
LAMA3,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.0586579655822394
LAMA3,Alopecia universalis ORPHA:701,0.0586579655822394
LAMA3,Atrichia with papular lesions ORPHA:86819,0.0586579655822394
LAMA3,Bartsocas-Papas syndrome ORPHA:1234,0.0586579655822394
LAMA3,Benign familial mesial temporal lobe epilepsy ORPHA:163717,0.0586579655822394
LAMA3,CHAND syndrome ORPHA:1401,0.0586579655822394
LAMA3,Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641,0.0586579655822394
LAMA3,Epithelial recurrent erosion dystrophy ORPHA:293381,0.0586579655822394
LAMA3,Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805,0.0586579655822394
LAMA3,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.0586579655822394
LAMA3,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.0586579655822394
LAMA3,Monoamine oxidase A deficiency ORPHA:3057,0.0586579655822394
LAMA3,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.0586579655822394
LAMA3,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.0586579655822394
LAMA3,Neuropathy with hearing impairment ORPHA:139512,0.0586579655822394
LAMA3,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.0586579655822394
LAMA3,Juvenile Paget disease ORPHA:2801,0.0586579655822394
LAMA3,Marie Unna hereditary hypotrichosis ORPHA:444,0.0586579655822394
LAMA3,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.0586579655822394
LAMA3,Athyreosis ORPHA:95713,0.0640416108792758
LAMA3,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.0783959336694202
LAMA3,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.0783959336694202
LAMA3,Branchio-oculo-facial syndrome ORPHA:1297,0.1590470395003315
LAMA3,Carvajal syndrome ORPHA:65282,0.1590470395003315
LAMA3,Cholangiocarcinoma ORPHA:70567,0.1590470395003315
LAMA3,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.1590470395003315
LAMA3,Familial expansile osteolysis ORPHA:85195,0.1590470395003315
LAMA3,Harlequin ichthyosis ORPHA:457,0.1590470395003315
LAMA3,High myopia-sensorineural deafness syndrome ORPHA:363396,0.1590470395003315
LAMA3,Keratoderma hereditarium mutilans ORPHA:494,0.1590470395003315
LAMA3,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.1590470395003315
LAMA3,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1590470395003315
LAMA3,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.1590470395003315
LAMA3,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.1590470395003315
LAMA3,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.1590470395003315
LAMA3,Xanthinuria type I ORPHA:93601,0.1590470395003315
LAMA3,Bladder exstrophy ORPHA:93930,0.1590470395003315
LAMA3,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.1590470395003315
LAMA3,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.1590470395003315
LAMA3,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.1590470395003315
LAMA3,Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659,0.1590470395003315
LAMA3,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.3762014630157917
LAMA3,Lethal acantholytic erosive disorder ORPHA:158687,0.3762014630157917
LAMA3,Acute neonatal citrullinemia type I ORPHA:247546,0.3762014630157917
LAMA3,Adult-onset citrullinemia type I ORPHA:247573,0.3762014630157917
LAMA3,Atelosteogenesis type I ORPHA:1190,0.3762014630157917
LAMA3,Atelosteogenesis type III ORPHA:56305,0.3762014630157917
LAMA3,Boomerang dysplasia ORPHA:1263,0.3762014630157917
LAMA3,Larsen syndrome ORPHA:503,0.3762014630157917
LAMA3,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.3762014630157917
LAMA3,Sebocystomatosis ORPHA:841,0.3762014630157917
LAMA3,Sjogren-Larsson syndrome ORPHA:816,0.3762014630157917
LAMA3,Xanthinuria type II ORPHA:93602,0.3762014630157917
LAMA3,Hereditary diffuse gastric cancer ORPHA:26106,0.3762014630157917
LAMA3,Aplasia cutis congenita ORPHA:1114,0.3775879467205478
LAMA3,Cleft lip and alveolus ORPHA:141291,0.3775879467205478
LAMA3,Isolated cleft lip ORPHA:199302,0.3775879467205478
LAMA3,Posterior polymorphous corneal dystrophy ORPHA:98973,0.3826134188846508
LAMA3,Cleft lip/palate ORPHA:199306,0.4101640425710954
LAMA3,Ectodermal dysplasia-skin fragility syndrome ORPHA:158668,0.6239678957896782
LAMA3,Systemic primary carnitine deficiency ORPHA:158,0.6239678957896782
LAMP3,Mammary Neoplasms,0.0034602840073026
LAMP3,Ovarian Carcinoma,0.0034602840073026
LAMP3,Breast Carcinoma,0.0042545616049287
LAMP3,Tumor Progression,0.0149315928814189
LAMP3,Stomach Carcinoma,0.0149315928814189
LAMP3,melanoma,0.0149315928814189
LAMP3,Adenocarcinoma,0.0155921563748247
LAMP3,Malignant neoplasm of breast,0.0191435238361999
LAMP3,Malignant neoplasm of stomach,0.0191435238361999
LAMP3,Malignant neoplasm of ovary,0.0277695594716545
LAMP3,Epithelial ovarian cancer,0.0387439397151409
LAMP3,Neoplasm Metastasis,0.0648809611869375
LAMP3,Colorectal Neoplasms,0.0827744840860166
LAMP3,Squamous cell carcinoma of esophagus,0.0919714360040484
LAMP3,Chronic Lymphocytic Leukemia,0.1147307578771389
LAMP3,Solid Neoplasm,0.1413782599148022
LAMP3,Rheumatoid Arthritis,0.1537760235124317
LAMP3,cervical cancer,0.2050045461627939
LAMP3,Malignant tumor of cervix,0.2714542429024338
LAMP3,Cervix carcinoma,0.2834835531038365
LAMP3,Tuberculosis,0.3706856725676674
LAMP3,Tuberculosis Pulmonary,0.383941725017158
LAMP3,Bipolar Disorder,0.3933196962529684
LAMP3,Uterine Cervical Neoplasm,0.3933196962529684
LAMP3,Schizophrenia,0.3933196962529684
LAMP3,Glycogen Storage Disease Type IIb,0.3933196962529684
LAMP3,Parkinson Disease,0.3933196962529684
LAMP3,Adenoma,0.3933196962529684
LAMP3,Sialuria,0.3941558617476422
LAMP3,IGA Glomerulonephritis,0.3975960596292668
LAMP3,Dengue Fever,0.4028066164685291
LAMP3,Cerebrovascular accident,0.4115056600660309
LAMP3,Sialic Acid Storage Disease Finnish Type (disorder),0.4126392832024548
LAMP3,Mucolipidosis Type IV,0.4126392832024548
LAMP3,Multiple Chronic Conditions,0.4192169590514327
LAMP3,Gastroenteritis,0.4675904598629673
LAMP3,Hemorrhagic Fevers Viral,0.4790179402069343
LAMP3,African Trypanosomiasis,0.4906258721078565
LAMP3,Rubella,0.5140447474168605
LAMP3,Adenocarcinoma of lung (disorder),0.51550637274795
LAMP3,Chikungunya Fever,0.5337853752290136
LAMP3,Malaria,0.5655222348249326
LAMP3,Gaucher Disease,0.7096959691931399
LAMP3,Influenza,0.7149953523738256
LAMP3,Hepatitis C,0.7169459458481418
LAMP3,Virus Diseases,0.9692165430561782
LAMP3,Schizophrenia,0.0531117779464085
LAMP3,Bipolar Disorder,0.4875380732267193
LAMP3,Odonto-onycho-dermal dysplasia ORPHA:2721,0.0180064224283883
LAMP3,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.0180064224283883
LAMP3,Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248,0.3775879467205478
LAMP3,USP18 deficiency ORPHA:481665,0.6239678957896782
LIFR,Colorectal Carcinoma,0.0034602840073026
LIFR,Mammary Neoplasms,0.0034602840073026
LIFR,Ovarian Carcinoma,0.0034602840073026
LIFR,Breast Carcinoma,0.0042545616049287
LIFR,Colorectal Cancer,0.0149315928814189
LIFR,Stomach Carcinoma,0.0149315928814189
LIFR,melanoma,0.0149315928814189
LIFR,Malignant neoplasm of breast,0.0191435238361999
LIFR,Malignant neoplasm of stomach,0.0191435238361999
LIFR,Carcinogenesis,0.0228075668512991
LIFR,Medulloblastoma,0.0354767239335874
LIFR,Malignant neoplasm of prostate,0.0569142010728473
LIFR,Central neuroblastoma,0.0593779966354549
LIFR,Flexion contracture of the knee,0.064548079316548
LIFR,Neoplasm Metastasis,0.0648809611869375
LIFR,Neuroblastoma,0.0688152422187159
LIFR,Osteoporosis,0.0739788831250619
LIFR,Glioblastoma,0.0745502070959292
LIFR,Squamous cell carcinoma of esophagus,0.0919714360040484
LIFR,Liver carcinoma,0.095319386034013
LIFR,Colon Carcinoma,0.1062239757831962
LIFR,Skin toxicity,0.1138051695421299
LIFR,Myocardial Infarction,0.1352936728187231
LIFR,Mixed Salivary Gland Tumor,0.1454373331146953
LIFR,Liver neoplasms,0.1454373331146953
LIFR,Systemic Scleroderma,0.1900258729042946
LIFR,Malignant tumor of colon,0.223747154820789
LIFR,Prostatic Neoplasms,0.223747154820789
LIFR,contracture of elbow,0.2522264785494494
LIFR,Flexion contracture - elbow,0.2714542429024338
LIFR,Pathological fracture,0.3508665345292502
LIFR,Rhabdomyosarcoma,0.3510063969122338
LIFR,Pulmonary arterial hypertension,0.3925783478421996
LIFR,Cakut,0.3933196962529684
LIFR,Amyloidosis,0.3933196962529684
LIFR,Fetal Growth Retardation,0.3933196962529684
LIFR,Adducted thumb,0.3933196962529684
LIFR,Schizophrenia,0.3933196962529684
LIFR,Adrenocortical carcinoma,0.3933196962529684
LIFR,Leukemia Myelocytic Acute,0.3933196962529684
LIFR,Crisponi syndrome,0.3933196962529684
LIFR,Lacrimation abnormality,0.3933196962529684
LIFR,Alzheimer's Disease,0.3933196962529684
LIFR,Thickened cortex of long bones,0.3933196962529684
LIFR,Enlarged joints,0.3933196962529684
LIFR,Prominent joints,0.3933196962529684
LIFR,Cloudy cornea,0.3933196962529684
LIFR,Corneal stromal opacities,0.3933196962529684
LIFR,Generalized osteopenia,0.3933196962529684
LIFR,Defective tooth enamel,0.3933196962529684
LIFR,Dystrophic tooth enamel,0.3933196962529684
LIFR,Prolactinoma,0.3933196962529684
LIFR,Parkinson Disease,0.3933196962529684
LIFR,Infant Small for Gestational Age,0.3933196962529684
LIFR,Diminished sweating,0.3933196962529684
LIFR,Intrauterine retardation,0.3933196962529684
LIFR,Abnormality of dental enamel,0.3933196962529684
LIFR,Hypohidrosis,0.3933196962529684
LIFR,Asthma,0.3933196962529684
LIFR,Flexion contracture of toe,0.3933196962529684
LIFR,Hypomenorrhea,0.3933196962529684
LIFR,Decrease in jaw opening,0.3941558617476422
LIFR,Limited jaw mobility,0.3941558617476422
LIFR,Limited jaw opening,0.3941558617476422
LIFR,Single transverse palmar crease,0.3941558617476422
LIFR,Hoarseness,0.3941558617476422
LIFR,Congenital Pain Insensitivity,0.3941558617476422
LIFR,Flexion contracture of proximal interphalangeal joint,0.3975960596292668
LIFR,Short tibia,0.3975960596292668
LIFR,Trismus,0.3975960596292668
LIFR,Myotonia,0.3975960596292668
LIFR,Achromatopsia 1,0.4103119460235835
LIFR,Dyspnea,0.4126392832024548
LIFR,Oligohydramnios,0.4126392832024548
LIFR,Achromatopsia,0.4126392832024548
LIFR,Hereditary Sensory and Autonomic Neuropathies,0.4126392832024548
LIFR,Short palpebral fissure,0.4209380602168584
LIFR,Thin skin,0.4209380602168584
LIFR,Knee joint valgus deformity,0.4213286052188015
LIFR,Congestive heart failure,0.425419812815905
LIFR,Varying degree of multiple fractures,0.425419812815905
LIFR,Frequent fractures,0.425419812815905
LIFR,Increased fracture rate,0.425419812815905
LIFR,Intermittent fever,0.425419812815905
LIFR,Fractures Multiple,0.4297858918260954
LIFR,Heart failure,0.4304973629098372
LIFR,Apnea,0.4330362522463816
LIFR,Short stature,0.439389586518055
LIFR,Abnormal skeletal development,0.4396723023384634
LIFR,Osteochondrodysplasias,0.4561717689698902
LIFR,Ulnar deviation of the fingers,0.4564472886428772
LIFR,leukemia,0.4588513406515081
LIFR,Thin rib,0.4615352570710579
LIFR,Tibial bowing,0.4615352570710579
LIFR,Malignant neoplasm of skin,0.466957409863091
LIFR,Flared metaphysis,0.4675904598629673
LIFR,Hypotrophic malar bone,0.4704594475773637
LIFR,Malar flattening,0.4704594475773637
LIFR,Micromelia,0.4714226702518064
LIFR,Reactive airway disease,0.472444704048021
LIFR,Retrusion of lower jaw,0.4753011022966241
LIFR,Decreased projection of lower jaw,0.4753011022966241
LIFR,Decreased projection of mandible,0.4753011022966241
LIFR,Hypoplastic mandible condyle,0.4753011022966241
LIFR,Aplasia/Hypoplasia of the mandible,0.4790179402069343
LIFR,Femoral bowing,0.4790179402069343
LIFR,Micrognathism,0.479747709091007
LIFR,Impaired pain sensation,0.4852430673532381
LIFR,Osteopenia,0.4923669467696064
LIFR,Metaphyseal widening,0.4923669467696064
LIFR,Dysautonomia,0.4981941174985421
LIFR,Acquired scoliosis,0.5019670090704682
LIFR,Respiratory distress,0.5019670090704682
LIFR,Talipes foot deformities,0.5251317541886066
LIFR,Deglutition Disorders,0.5284231402423694
LIFR,Talipes,0.5299466034567416
LIFR,Congenital Abnormality,0.5305233935923577
LIFR,Polycystic Ovary Syndrome,0.5337853752290136
LIFR,Short phalanx of finger,0.5359212109443033
LIFR,Autonomic nervous system disorders,0.5453394612016188
LIFR,Short neck,0.549941235475765
LIFR,Arthritis,0.553002957824355
LIFR,Congenital hypoplasia of lung,0.5557519470957561
LIFR,Low set ears,0.5578737381206628
LIFR,Paresthesia,0.5619299124666532
LIFR,Idiopathic pulmonary arterial hypertension,0.5655222348249326
LIFR,Abnormality of vision,0.5655222348249326
LIFR,Frontal bossing,0.5710095678317721
LIFR,Curvature of spine,0.6035970790768342
LIFR,Maternal oligohydramnios,0.6035970790768342
LIFR,Hypernasal voice,0.6150955455771212
LIFR,Nasal voice,0.6150955455771212
LIFR,Skeletal dysplasia,0.6304655343580164
LIFR,Small midface,0.6319938293757544
LIFR,Decreased projection of midface,0.6319938293757544
LIFR,Hypotrophic midface,0.6319938293757544
LIFR,Midface retrusion,0.6319938293757544
LIFR,Sclerocystic Ovaries,0.652707626880454
LIFR,Respiratory function loss,0.6606366664484469
LIFR,Respiratory Insufficiency,0.6891882956008074
LIFR,Sweating,0.7294281406818208
LIFR,Hyperhidrosis disorder,0.7294281406818208
LIFR,Increased sweating,0.7294281406818208
LIFR,Osteogenesis Imperfecta,0.7309076068378124
LIFR,Generalized hypotonia,0.7631684472516962
LIFR,Feeding difficulties in infancy,0.7797826088609066
LIFR,Feeding difficulties,0.7900704408991807
LIFR,Cardiomyopathy Dilated,0.8670707879649133
LIFR,Small nose,0.8789568302467123
LIFR,Short nose,0.882794167859443
LIFR,Congenital clubfoot,0.903232380243832
LIFR,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594
LIFR,Liver Carcinoma,0.0520696613701797
LIFR,Schizophrenia,0.0531117779464085
LIFR,Elbow Flexion Contracture,0.4286813331685578
LIFR,Pulmonary Arterial Hypertension,0.4286813331685578
LIFR,Colorectal Cancer,0.4286813331685578
LIFR,Hemophagocytic Lymphohistiocytosis,0.4402141802500753
LIFR,Osteoporosis,0.4541466895915311
LIFR,Osteopenia,0.4560460337187313
LIFR,Frontal Bossing,0.4560460337187313
LIFR,Hypohidrosis,0.4560460337187313
LIFR,Trismus,0.4560460337187313
LIFR,Scoliosis,0.4875380732267193
LIFR,Prostatic Neoplasms,0.4875380732267193
LIFR,Asthma,0.504364324740411
LIFR,Dysphagia,0.5127628024019304
LIFR,Micrognathism,0.5234357475824973
LIFR,Micromelia,0.525214105372123
LIFR,Dwarfism,0.5796489603182782
LIFR,Skeletal Dysplasia,0.5796489603182782
LIFR,Osteochondrodysplasia,0.5878255556245724
LIFR,Prostate Cancer,0.6104715460837368
LIFR,Sclerocystic Ovaries,0.6508151871447407
LIFR,Talipes,0.696610260564548
LIFR,Dysautonomia,0.7414460416900516
LIFR,Polycystic Ovary Syndrome,0.7729545590606223
LIFR,Pulmonary Hypoplasia,0.7893608212024619
LIFR,Hypothyroidism,0.7921294370722203
LIFR,Congenital Clubfoot,0.950211794897412
LIFR,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
LIFR,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
LIFR,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
LIFR,Familial porencephaly ORPHA:99810,0.0083045131203191
LIFR,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
LIFR,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
LIFR,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
LIFR,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
LIFR,Polysyndactyly ORPHA:93338,0.0083045131203191
LIFR,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
LIFR,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
LIFR,Tibial hemimelia ORPHA:93322,0.0083045131203191
LIFR,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
LIFR,Branchiootic syndrome ORPHA:52429,0.0083045131203191
LIFR,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
LIFR,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
LIFR,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
LIFR,Bruck syndrome ORPHA:2771,0.0180064224283883
LIFR,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.0180064224283883
LIFR,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.0180064224283883
LIFR,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.0180064224283883
LIFR,CHST3-related skeletal dysplasia ORPHA:263463,0.0180064224283883
LIFR,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.0180064224283883
LIFR,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.0180064224283883
LIFR,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.0180064224283883
LIFR,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.0180064224283883
LIFR,Diaphanospondylodysostosis ORPHA:66637,0.0180064224283883
LIFR,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451,0.0180064224283883
LIFR,Familial drusen ORPHA:75376,0.0180064224283883
LIFR,Familial schizencephaly ORPHA:481986,0.0180064224283883
LIFR,GAPO syndrome ORPHA:2067,0.0180064224283883
LIFR,HANAC syndrome ORPHA:73229,0.0180064224283883
LIFR,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.0180064224283883
LIFR,Ischiovertebral syndrome ORPHA:85200,0.0180064224283883
LIFR,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.0180064224283883
LIFR,Mandibulofacial dysostosis with alopecia ORPHA:443995,0.0180064224283883
LIFR,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.0180064224283883
LIFR,Oculocutaneous albinism type 3 ORPHA:79433,0.0180064224283883
LIFR,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.0180064224283883
LIFR,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.0180064224283883
LIFR,Retinal arterial tortuosity ORPHA:75326,0.0180064224283883
LIFR,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.0180064224283883
LIFR,Steel syndrome ORPHA:438117,0.0180064224283883
LIFR,Synpolydactyly type 2 ORPHA:295197,0.0180064224283883
LIFR,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.0180064224283883
LIFR,X-linked osteoporosis with fractures ORPHA:391330,0.0180064224283883
LIFR,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.0180064224283883
LIFR,Congenital diaphragmatic hernia ORPHA:2140,0.0180064224283883
LIFR,Hypoplastic left heart syndrome ORPHA:2248,0.0180064224283883
LIFR,Matthew-Wood syndrome ORPHA:2470,0.0180064224283883
LIFR,Piebaldism ORPHA:2884,0.0180064224283883
LIFR,Posterior hypospadias ORPHA:95706,0.0180064224283883
LIFR,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.0180064224283883
LIFR,BOR syndrome ORPHA:107,0.0183145313768111
LIFR,Tetralogy of Fallot ORPHA:3303,0.0277610005156803
LIFR,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.0586579655822394
LIFR,15q14 microdeletion syndrome ORPHA:261190,0.0586579655822394
LIFR,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.0586579655822394
LIFR,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.0586579655822394
LIFR,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.0586579655822394
LIFR,Childhood-onset benign chorea with striatal involvement ORPHA:494541,0.0586579655822394
LIFR,Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641,0.0586579655822394
LIFR,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.0586579655822394
LIFR,Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181,0.0586579655822394
LIFR,Familial generalized lentiginosis ORPHA:231040,0.0586579655822394
LIFR,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.0586579655822394
LIFR,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.0586579655822394
LIFR,Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381,0.0586579655822394
LIFR,Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526,0.0586579655822394
LIFR,Monoamine oxidase A deficiency ORPHA:3057,0.0586579655822394
LIFR,Muscle filaminopathy ORPHA:171445,0.0586579655822394
LIFR,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.0586579655822394
LIFR,Oculodentodigital dysplasia ORPHA:2710,0.0586579655822394
LIFR,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.0586579655822394
LIFR,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.0586579655822394
LIFR,Syndactyly type 3 ORPHA:93404,0.0586579655822394
LIFR,X-linked Alport syndrome ORPHA:88917,0.0586579655822394
LIFR,Autosomal recessive Robinow syndrome ORPHA:1507,0.0586579655822394
LIFR,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.0586579655822394
LIFR,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.0586579655822394
LIFR,Phakomatosis cesioflammea ORPHA:79483,0.0586579655822394
LIFR,Sclerosteosis ORPHA:3152,0.0586579655822394
LIFR,Brachydactyly type A1 ORPHA:93388,0.0599424746210022
LIFR,Hennekam syndrome ORPHA:2136,0.0599424746210022
LIFR,Hirschsprung disease ORPHA:388,0.0706635700002548
LIFR,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.0783959336694202
LIFR,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.0783959336694202
LIFR,1p31p32 microdeletion syndrome ORPHA:401986,0.1590470395003315
LIFR,Allan-Herndon-Dudley syndrome ORPHA:59,0.1590470395003315
LIFR,Brachydactyly-arterial hypertension syndrome ORPHA:1276,0.1590470395003315
LIFR,Campomelic dysplasia ORPHA:140,0.1590470395003315
LIFR,Carbamoyl-phosphate synthetase 1 deficiency ORPHA:147,0.1590470395003315
LIFR,Complete androgen insensitivity syndrome ORPHA:99429,0.1590470395003315
LIFR,Dicarboxylic aminoaciduria ORPHA:2195,0.1590470395003315
LIFR,Female restricted epilepsy with intellectual disability ORPHA:101039,0.1590470395003315
LIFR,Hot water reflex epilepsy ORPHA:166412,0.1590470395003315
LIFR,Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561,0.1590470395003315
LIFR,Isolated Pierre Robin syndrome ORPHA:718,0.1590470395003315
LIFR,Kennedy disease ORPHA:481,0.1590470395003315
LIFR,Partial androgen insensitivity syndrome ORPHA:90797,0.1590470395003315
LIFR,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012,0.1590470395003315
LIFR,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358,0.1590470395003315
LIFR,Stuve-Wiedemann syndrome ORPHA:3206,0.1590470395003315
LIFR,Trehalase deficiency ORPHA:103909,0.1590470395003315
LIFR,Acromesomelic dysplasia Grebe type ORPHA:2098,0.1590470395003315
LIFR,Autosomal recessive hypophosphatemic rickets ORPHA:289176,0.1590470395003315
LIFR,Brachydactyly type C ORPHA:93384,0.1590470395003315
LIFR,Familial patent arterial duct ORPHA:466729,0.1590470395003315
LIFR,Fibular aplasia-complex brachydactyly syndrome ORPHA:2639,0.1590470395003315
LIFR,Pfeiffer syndrome type 1 ORPHA:93258,0.1590470395003315
LIFR,Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144,0.1590470395003315
LIFR,Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140,0.1590470395003315
LIFR,Spondylometaphyseal dysplasia 'corner fracture' type ORPHA:93315,0.1590470395003315
LIFR,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.1590470395003315
LIFR,Butterfly-shaped pigment dystrophy ORPHA:99001,0.1590470395003315
LIFR,Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067,0.1590470395003315
LIFR,Isolated aniridia ORPHA:250923,0.1590470395003315
LIFR,Isolated hemihyperplasia ORPHA:2128,0.1590470395003315
LIFR,Partial atrioventricular septal defect ORPHA:1330,0.1590470395003315
LIFR,Persistent hyperplastic primary vitreous ORPHA:91495,0.1590470395003315
LIFR,Retinopathy of prematurity ORPHA:90050,0.1590470395003315
LIFR,Epithelioid hemangioendothelioma ORPHA:157791,0.1614487935928034
LIFR,Isolated brachycephaly ORPHA:35099,0.1614487935928034
LIFR,Isolated plagiocephaly ORPHA:35098,0.1614487935928034
LIFR,Bilateral striopallidodentate calcinosis ORPHA:1980,0.1697334635963512
LIFR,Colobomatous microphthalmia ORPHA:98938,0.1782034488938806
LIFR,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.1981653781243822
LIFR,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154,0.3762014630157917
LIFR,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome ORPHA:370022,0.3762014630157917
LIFR,Autosomal recessive omodysplasia ORPHA:93329,0.3762014630157917
LIFR,Becker muscular dystrophy ORPHA:98895,0.3762014630157917
LIFR,Butyrylcholinesterase deficiency ORPHA:132,0.3762014630157917
LIFR,Charcot-Marie-Tooth disease type 2R ORPHA:397968,0.3762014630157917
LIFR,Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390,0.3762014630157917
LIFR,Gordon syndrome ORPHA:376,0.3762014630157917
LIFR,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.3762014630157917
LIFR,Malignant epithelial tumor of salivary glands ORPHA:276145,0.3762014630157917
LIFR,Marden-Walker syndrome ORPHA:2461,0.3762014630157917
LIFR,Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430,0.3762014630157917
LIFR,Spinocerebellar ataxia type 27 ORPHA:98764,0.3762014630157917
LIFR,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386,0.3762014630157917
LIFR,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546,0.3762014630157917
LIFR,Autosomal recessive polycystic kidney disease ORPHA:731,0.3762014630157917
LIFR,Congenital ptosis ORPHA:91411,0.3762014630157917
LIFR,Renal hypoplasia bilateral ORPHA:97362,0.3762014630157917
LIFR,Tetraamelia-multiple malformations syndrome ORPHA:3301,0.3762014630157917
LIFR,Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068,0.3762014630157917
LIFR,Familial vesicoureteral reflux ORPHA:289365,0.3762014630157917
LIFR,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3762014630157917
LIFR,NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293,0.3762014630157917
LIFR,Saethre-Chotzen syndrome ORPHA:794,0.3762014630157917
LIFR,Renal agenesis bilateral ORPHA:1848,0.3775879467205478
LIFR,Severe early-childhood-onset retinal dystrophy ORPHA:364055,0.3775879467205478
LIFR,Renal agenesis unilateral ORPHA:93100,0.3969770464111636
LIFR,Brugada syndrome ORPHA:130,0.5145066480201691
LIFR,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.6239678957896782
LIFR,Achondroplasia ORPHA:15,0.6239678957896782
LIFR,Autosomal dominant spastic paraplegia type 31 ORPHA:101011,0.6239678957896782
LIFR,BNAR syndrome ORPHA:217266,0.6239678957896782
LIFR,Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164,0.6239678957896782
LIFR,Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262,0.6239678957896782
LIFR,Hypochondroplasia ORPHA:429,0.6239678957896782
LIFR,Lissencephaly syndrome Norman-Roberts type ORPHA:89844,0.6239678957896782
LIFR,Microphthalmia with limb anomalies ORPHA:1106,0.6239678957896782
LIFR,Monosomy 22q13.3 ORPHA:48652,0.6239678957896782
LIFR,Muenke syndrome ORPHA:53271,0.6239678957896782
LIFR,Obesity due to prohormone convertase I deficiency ORPHA:71528,0.6239678957896782
LIFR,Oculotrichoanal syndrome ORPHA:2717,0.6239678957896782
LIFR,Pontocerebellar hypoplasia type 3 ORPHA:97249,0.6239678957896782
LIFR,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165,0.6239678957896782
LIFR,Severe hereditary thrombophilia due to congenital protein S deficiency ORPHA:743,0.6239678957896782
LIFR,Short rib-polydactyly syndrome Saldino-Noonan type ORPHA:93270,0.6239678957896782
LIFR,Thanatophoric dysplasia type 1 ORPHA:1860,0.6239678957896782
LIFR,Thanatophoric dysplasia type 2 ORPHA:93274,0.6239678957896782
LIFR,Cenani-Lenz syndrome ORPHA:3258,0.6239678957896782
LIFR,Congenital communicating hydrocephalus ORPHA:269505,0.6239678957896782
LIFR,Duchenne muscular dystrophy ORPHA:98896,0.6239678957896782
LIFR,Isolated trigonocephaly ORPHA:3366,0.6239678957896782
LIFR,Hereditary hyperekplexia ORPHA:3197,0.6279395134845649
LIFR,Stargardt disease ORPHA:827,0.6279395134845649
LIFR,46XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency ORPHA:168558,0.7068064785325423
LIFR,Autosomal dominant striatal neurodegeneration ORPHA:228169,0.7068064785325423
LIFR,Blomstrand lethal chondrodysplasia ORPHA:50945,0.7068064785325423
LIFR,Drug- or toxin-induced pulmonary arterial hypertension ORPHA:275786,0.7068064785325423
LIFR,Eiken syndrome ORPHA:79106,0.7068064785325423
LIFR,Hyperlysinemia ORPHA:2203,0.7068064785325423
LIFR,Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency ORPHA:289548,0.7068064785325423
LIFR,Metaphyseal chondrodysplasia Jansen type ORPHA:33067,0.7068064785325423
LIFR,Primary failure of tooth eruption ORPHA:412206,0.7068064785325423
LIFR,Saccharopinuria ORPHA:3124,0.7068064785325423
LIFR,Wilson disease ORPHA:905,0.7068064785325423
LIFR,Benign hereditary chorea ORPHA:1429,0.7068064785325423
LIFR,Human adenovirus 41 E3 31.6K,0.6362779693488597
LIFR,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
LIFR,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.6621265548536891
LIFR,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.6806291584193672
LIFR,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.6806291584193672
LIFR,Human mastadenovirus A E3 CR1-beta1,0.8285661572509389
LIFR,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.870986154363754
LIFR,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.875442055263636
LIFR,Human adenovirus 18 CR1-beta protein (gene: E3),0.9445347004229157
LINC02331,Endometrial Carcinoma,0.4286813331685578
LPAR5,melanoma,0.0149315928814189
LPAR5,Fibrosarcoma,0.0191435238361999
LPAR5,Neoplasm Metastasis,0.0648809611869375
LPAR5,Osteosarcoma,0.1029977559100099
LPAR5,Sarcoma,0.1537760235124317
LPAR5,Osteosarcoma of bone,0.2109483801368481
LPAR5,Secondary malignant neoplasm of lung,0.2723545094624877
LPAR5,Epstein-Barr Virus Infections,0.3933196962529684
LPAR5,Nasopharyngeal carcinoma,0.3933196962529684
LPAR5,Odonto-onycho-dermal dysplasia ORPHA:2721,0.0180064224283883
LPAR5,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.0180064224283883
LPAR5,Serrated polyposis syndrome ORPHA:157798,0.1590470395003315
LRIG1,Colorectal Carcinoma,0.0034602840073026
LRIG1,Mammary Neoplasms,0.0034602840073026
LRIG1,Ovarian Carcinoma,0.0034602840073026
LRIG1,Breast Carcinoma,0.0042545616049287
LRIG1,Colorectal Cancer,0.0149315928814189
LRIG1,Squamous cell carcinoma,0.0182265588252201
LRIG1,Malignant neoplasm of breast,0.0191435238361999
LRIG1,Carcinogenesis,0.0228075668512991
LRIG1,Malignant neoplasm of ovary,0.0277695594716545
LRIG1,Malignant neoplasm of prostate,0.0569142010728473
LRIG1,Well Differentiated Oligodendroglioma,0.0617471306652618
LRIG1,Neoplasm Metastasis,0.0648809611869375
LRIG1,Renal Cell Carcinoma,0.0648809611869375
LRIG1,oligodendroglioma,0.0648809611869375
LRIG1,Glioma,0.0739788831250619
LRIG1,Glioblastoma,0.0745502070959292
LRIG1,Prostate carcinoma,0.0773771948186562
LRIG1,Colorectal Neoplasms,0.0827744840860166
LRIG1,Malignant neoplasm of urinary bladder,0.084286432100041
LRIG1,Bladder Neoplasm,0.0891725280554336
LRIG1,Chronic Lymphocytic Leukemia,0.1147307578771389
LRIG1,Carcinoma of bladder,0.13167400689206
LRIG1,Solid Neoplasm,0.1413782599148022
LRIG1,Malignant Head and Neck Neoplasm,0.2522264785494494
LRIG1,Malignant neoplasm of lung,0.2714542429024338
LRIG1,Kidney Neoplasm,0.2714542429024338
LRIG1,Epithelial hyperplasia of skin,0.333745294913745
LRIG1,Carcinoma of lung,0.3663130598151661
LRIG1,Primary malignant neoplasm of lung,0.3902116649640871
LRIG1,Nasopharyngeal carcinoma,0.3933196962529684
LRIG1,Malignant Glioma,0.3933196962529684
LRIG1,Skin Neoplasms,0.3933196962529684
LRIG1,Malignant Central Nervous System Neoplasm,0.3933196962529684
LRIG1,Adenoma,0.3933196962529684
LRIG1,Antibody measurement (procedure),0.3941558617476422
LRIG1,Mean Corpuscular Volume (result),0.4192169590514327
LRIG1,HIV-1 infection,0.4506578937113162
LRIG1,QRS complex feature,0.5140447474168605
LRIG1,Peripheral Neuropathy,0.5851527280548257
LRIG1,Erythrocyte Mean Corpuscular Hemoglobin Test,0.8352423037513227
LRIG1,Finding of Mean Corpuscular Hemoglobin,0.8352423037513227
LRIG1,Colorectal Cancer,0.4286813331685578
LRIG1,Central Nervous System Neoplasms,0.4541466895915311
LRIG1,Colorectal Neoplasms,0.4560460337187313
LRIG1,Glioma,0.4560460337187313
LRIG1,Colonic Neoplasms,0.4809179010794786
LRIG1,Paroxysmal Atrial Fibrillation,0.5082542877462781
LRIG1,Hyperuricemia,0.6329251700753155
LRIG1,Atrial Fibrillation,0.6792162876553974
LRIG1,Kidney Failure,0.6899894525110877
LRIG1,Renal pseudohypoaldosteronism type 1 ORPHA:171871,0.3762014630157917
LRIG1,Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490,0.6239678957896782
LRIG1,Autosomal recessive spastic paraplegia type 56 ORPHA:320411,0.6239678957896782
LRIG1,AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911,0.7068064785325423
LRIG1,Oligodontia-cancer predisposition syndrome ORPHA:300576,0.7068064785325423
LRIG1,Human adenovirus 41 E3 31.6K,0.6362779693488597
LRIG1,Human mastadenovirus A fiber,0.6362779693488597
LRIG1,Human adenovirus 12 fiber protein,0.6362779693488597
LRIG1,Monkeypox virus bifunctional IL-1-beta-inhibitor,0.8154217170310376
LRIG1,Orf virus ORF132 vascular endothelial growth factor-like protein,0.8507994162096807
LZTS1,Colorectal Carcinoma,0.0034602840073026
LZTS1,Ovarian Carcinoma,0.0034602840073026
LZTS1,Breast Carcinoma,0.0042545616049287
LZTS1,Colorectal Cancer,0.0149315928814189
LZTS1,Stomach Carcinoma,0.0149315928814189
LZTS1,melanoma,0.0149315928814189
LZTS1,Adenocarcinoma,0.0155921563748247
LZTS1,Squamous cell carcinoma,0.0182265588252201
LZTS1,Esophageal Neoplasms,0.0182265588252201
LZTS1,Malignant neoplasm of breast,0.0191435238361999
LZTS1,Malignant neoplasm of stomach,0.0191435238361999
LZTS1,Malignant neoplasm of esophagus,0.0248454592431097
LZTS1,Malignant neoplasm of ovary,0.0277695594716545
LZTS1,Malignant neoplasm of prostate,0.0569142010728473
LZTS1,Neoplasm Metastasis,0.0648809611869375
LZTS1,Prostate carcinoma,0.0773771948186562
LZTS1,Malignant neoplasm of urinary bladder,0.084286432100041
LZTS1,Bladder Neoplasm,0.0891725280554336
LZTS1,Esophageal carcinoma,0.1254380558571286
LZTS1,Carcinoma Transitional Cell,0.13167400689206
LZTS1,Carcinoma of bladder,0.13167400689206
LZTS1,TARSAL-CARPAL COALITION SYNDROME,0.1906413554467301
LZTS1,Prostatic Neoplasms,0.223747154820789
LZTS1,Malignant neoplasm of lung,0.2714542429024338
LZTS1,Malignant Squamous Cell Neoplasm,0.3104232675696299
LZTS1,Carcinoma of lung,0.3663130598151661
LZTS1,Recurrent tumor,0.383941725017158
LZTS1,Primary malignant neoplasm of lung,0.3902116649640871
LZTS1,Secondary malignant neoplasm of lymph node,0.3933196962529684
LZTS1,Benign neoplasm of esophagus,0.3933196962529684
LZTS1,Carcinoma in situ of esophagus,0.3933196962529684
LZTS1,Squamous cell carcinoma of skin,0.4297858918260954
LZTS1,Uveal melanoma,0.472444704048021
LZTS1,Esophagus Neoplasm,0.0102679590519094
LZTS1,Carcinoma,0.0534520155998091
LZTS1,Benign Neoplasm Of Esophagus,0.4286813331685578
LZTS1,Prostatic Neoplasms,0.4875380732267193
LZTS1,Esophageal Carcinoma,0.5087473896242481
LZTS1,Prostate Cancer,0.6104715460837368
LZTS1,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.3762014630157917
LZTS1,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746,0.6239678957896782
LZTS1,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473,0.6239678957896782
LZTS1,Familial osteochondritis dissecans ORPHA:251262,0.7068064785325423
LZTS1,Oculocutaneous albinism type 4 ORPHA:79435,0.7068064785325423
LZTS1,Oculocutaneous albinism type 6 ORPHA:370097,0.7068064785325423
LZTS1,Porencephaly-microcephaly-bilateral congenital cataract syndrome ORPHA:306547,0.7068064785325423
LZTS1,Short stature-advanced bone age-early-onset osteoarthritis syndrome ORPHA:435804,0.7068064785325423
LZTS1,Spondyloepimetaphyseal dysplasia aggrecan type ORPHA:171866,0.7068064785325423
LZTS1,Spondyloepiphyseal dysplasia Kimberley type ORPHA:93283,0.7068064785325423
LZTS1,Autosomal recessive Stickler syndrome ORPHA:250984,0.7068064785325423
MBNL3,Liver carcinoma,0.095319386034013
MBNL3,Blast Phase,0.3494455519738624
MBNL3,Intellectual Disability,0.8352623613787349
ME1,Breast Carcinoma,0.0042545616049287
ME1,Colorectal Cancer,0.0149315928814189
ME1,Carcinogenesis,0.0228075668512991
ME1,Epithelial ovarian cancer,0.0387439397151409
ME1,Neoplasm Metastasis,0.0648809611869375
ME1,Glioma,0.0739788831250619
ME1,Glioblastoma,0.0745502070959292
ME1,Liver carcinoma,0.095319386034013
ME1,Malignant Neoplasms,0.0991201145654548
ME1,Colon Carcinoma,0.1062239757831962
ME1,Sarcoma,0.1537760235124317
ME1,Uterine Corpus Sarcoma,0.222537307875512
ME1,Malignant tumor of colon,0.223747154820789
ME1,Carcinoma of lung,0.3663130598151661
ME1,Primary malignant neoplasm of lung,0.3902116649640871
ME1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
ME1,Weight Gain,0.3975960596292668
ME1,MRSA - Methicillin resistant Staphylococcus aureus infection,0.4506578937113162
ME1,Obesity,0.5140447474168605
ME1,Liver Carcinoma,0.0520696613701797
ME1,Obesity,0.9568083835980838
ME1,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
ME1,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
ME1,PPARG-related familial partial lipodystrophy ORPHA:79083,0.0180064224283883
ME1,MITF-related melanoma and renal cell carcinoma predisposition syndrome ORPHA:293822,0.1590470395003315
ME1,Tietz syndrome ORPHA:42665,0.1590470395003315
MED12L,Usher Syndrome Type III,0.4028066164685291
MED12L,Triglycerides measurement,0.4192169590514327
MED12L,Smoking Behaviors,0.5580691945487462
MED12L,Platelet-type Bleeding Disorder,0.3940072377207739
MED12L,Alzheimer Disease,0.4560460337187313
MED12L,Diverticular Diseases,0.4560460337187313
MED12L,Non-Syndromic Intellectual Disability,0.7015979603136192
MED12L,Mental Retardation,0.7729545590606223
MED12L,Motor Delay,0.8371848756758566
MED12L,Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527,0.0586579655822394
MED12L,FRAXE intellectual disability ORPHA:100973,0.6239678957896782
MED12L,Autosomal dominant non-syndromic intellectual disability ORPHA:178469,0.7068064785325423
MED12L,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency ORPHA:284282,0.7068064785325423
MED12L,Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379,0.7068064785325423
MICB,Colorectal Carcinoma,0.0034602840073026
MICB,Breast Carcinoma,0.0042545616049287
MICB,Colorectal Cancer,0.0149315928814189
MICB,Tumor Progression,0.0149315928814189
MICB,Malignant neoplasm of breast,0.0191435238361999
MICB,Cervical Squamous Intraepithelial Neoplasia 1,0.0593779966354549
MICB,Cervical intraepithelial neoplasia grade 1,0.0593779966354549
MICB,Neoplasm Metastasis,0.0648809611869375
MICB,Malignant neoplasm of pancreas,0.0726340460169901
MICB,Glioma,0.0739788831250619
MICB,Pancreatic carcinoma,0.0745502070959292
MICB,Liver carcinoma,0.095319386034013
MICB,Malignant Neoplasms,0.0991201145654548
MICB,Osteosarcoma,0.1029977559100099
MICB,Rheumatoid Arthritis,0.1537760235124317
MICB,cervical cancer,0.2050045461627939
MICB,Osteosarcoma of bone,0.2109483801368481
MICB,Hodgkin Disease,0.2454476567103779
MICB,Thymus Hyperplasia,0.2522264785494494
MICB,Neoplasms,0.2714542429024338
MICB,Malignant tumor of cervix,0.2714542429024338
MICB,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
MICB,Cervix carcinoma,0.2834835531038365
MICB,Multiple Sclerosis,0.2835142372342932
MICB,Classical Hodgkin's Lymphoma,0.3763374964032415
MICB,Addison's disease due to autoimmunity,0.3778347117514905
MICB,hiv-infection/aids,0.383941725017158
MICB,Schizophrenia,0.3933196962529684
MICB,Non-Small Cell Lung Carcinoma,0.3933196962529684
MICB,Lymphoma T-Cell Cutaneous,0.3933196962529684
MICB,DOSAGE-SENSITIVE SEX REVERSAL,0.3933196962529684
MICB,Arthritis Psoriatic,0.3933196962529684
MICB,Inflammatory Bowel Diseases,0.3933196962529684
MICB,Polybrominated biphenyl measurement,0.3933196962529684
MICB,Asthma,0.3933196962529684
MICB,Autoimmune Primary Adrenal Insufficiency,0.3941558617476422
MICB,Communicable Diseases,0.3941558617476422
MICB,Dengue Shock Syndrome,0.3941558617476422
MICB,Dengue Fever,0.4028066164685291
MICB,Gastric Adenocarcinoma,0.4028066164685291
MICB,Severe Dengue,0.4028066164685291
MICB,Multiple Myeloma,0.4103119460235835
MICB,Ductal Carcinoma In Situ with Microinvasion,0.4115056600660309
MICB,Lupus Erythematosus Systemic,0.4213286052188015
MICB,Leprosy Paucibacillary,0.4213286052188015
MICB,HIV-1 infection,0.4506578937113162
MICB,Dejerine-Sottas Disease (disorder),0.4753011022966241
MICB,Forced expiratory volume function,0.4929829683479762
MICB,Crohn Disease,0.4981941174985421
MICB,Ulcerative Colitis,0.5001612228394569
MICB,Respiratory Syncytial Virus Infections,0.533913711453195
MICB,Thymoma,0.5523521032803237
MICB,Primary sclerosing cholangitis,0.5682392297191953
MICB,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.5710095678317721
MICB,Infection,0.5959654688257199
MICB,Myositis,0.601753535647179
MICB,Herpes Simplex Infections,0.610971999959321
MICB,Addison Disease,0.6304655343580164
MICB,Immune System Diseases,0.6319938293757544
MICB,Behcet Syndrome,0.6496433426951205
MICB,Mucosa-Associated Lymphoid Tissue Lymphoma,0.6740259274935673
MICB,Herpes NOS,0.6980473696540115
MICB,Hepatitis C,0.7169459458481418
MICB,Leprosy,0.8297144684182294
MICB,Schizophrenia,0.0531117779464085
MICB,Hodgkin Disease,0.2627224344149009
MICB,Myositis,0.425341435586089
MICB,Rheumatoid Arthritis,0.4560460337187313
MICB,Mental Depression,0.4560460337187313
MICB,Asthma,0.504364324740411
MICB,Lupus Erythematosus,0.5087473896242481
MICB,Behcet Syndrome,0.555382961603519
MICB,Myasthenia Gravis,0.7049836926927165
MICB,Diabetes Mellitus,0.9683912711598086
MICB,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.1590470395003315
MICB,Hydranencephaly ORPHA:2177,0.3762014630157917
MICB,NDE1-related microhydranencephaly ORPHA:443162,0.3762014630157917
MICB,Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139,0.3762014630157917
MICB,Congenital generalized hypercontractile muscle stiffness syndrome ORPHA:476406,0.6239678957896782
MICB,Hermansky-Pudlak syndrome without pulmonary fibrosis ORPHA:231512,0.6239678957896782
MICB,Amish lethal microcephaly ORPHA:99742,0.7068064785325423
MICB,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency ORPHA:453521,0.7068064785325423
MICB,Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396,0.7068064785325423
MICB,Purine nucleoside phosphorylase deficiency ORPHA:760,0.7068064785325423
MICB,Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277,0.7068064785325423
MICB,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome ORPHA:86818,0.7068064785325423
MICB,Human betaherpesvirus 5 membrane glycoprotein UL16 (gene: UL16),0.6362779693488597
MICB,Human adenovirus 54 17.6 kDa protein,0.6362779693488597
MICB,Human adenovirus 23 gp 19K protein (gene: E3),0.6362779693488597
MICB,Human betaherpesvirus 5 membrane glycoprotein UL18 (gene: UL18),0.6906952981256558
MICB,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.8071041616616108
MICB,Human betaherpesvirus 5 membrane glycoprotein UL142 (gene: UL142),0.8205168751208474
MICB,Yaba-like disease virus 123R protein (gene: 123R),0.8884451411763671
MICB,Yaba monkey tumor virus IEV and EEV membrane glycoprotein,0.945966103627342
MIR100HG,Breast Carcinoma,0.0042545616049287
MIR100HG,Malignant neoplasm of breast,0.0191435238361999
MIR100HG,Medulloblastoma,0.0354767239335874
MIR100HG,Central neuroblastoma,0.0593779966354549
MIR100HG,Neuroblastoma,0.0688152422187159
MIR100HG,Myeloid Leukemia,0.2980670559114652
MIR100HG,Childhood Medulloblastoma,0.3933196962529684
MIR100HG,Acute Megakaryocytic Leukemias,0.4115056600660309
MIR100HG,Adult Medulloblastoma,0.4126392832024548
MIR100HG,Myopia Degenerative,0.4459714599189374
MIR100HG,Schizophrenia,0.0531117779464085
MIR100HG,Myopia,0.7405519560111998
MIR100HG,Stroke,0.7429124769329748
MIR17HG,Colorectal Carcinoma,0.0034602840073026
MIR17HG,Breast Carcinoma,0.0042545616049287
MIR17HG,Colorectal Cancer,0.0149315928814189
MIR17HG,Tumor Progression,0.0149315928814189
MIR17HG,Stomach Carcinoma,0.0149315928814189
MIR17HG,melanoma,0.0149315928814189
MIR17HG,Adenocarcinoma,0.0155921563748247
MIR17HG,Esophageal Neoplasms,0.0182265588252201
MIR17HG,Malignant neoplasm of breast,0.0191435238361999
MIR17HG,Malignant neoplasm of stomach,0.0191435238361999
MIR17HG,Carcinogenesis,0.0228075668512991
MIR17HG,Malignant neoplasm of esophagus,0.0248454592431097
MIR17HG,Hematopoietic Neoplasms,0.0334891258932371
MIR17HG,Medulloblastoma,0.0354767239335874
MIR17HG,Malignant neoplasm of prostate,0.0569142010728473
MIR17HG,Central neuroblastoma,0.0593779966354549
MIR17HG,Brain Neoplasms,0.064548079316548
MIR17HG,Neoplasm Metastasis,0.0648809611869375
MIR17HG,Barrett Esophagus,0.0648809611869375
MIR17HG,Renal Cell Carcinoma,0.0648809611869375
MIR17HG,Neuroblastoma,0.0688152422187159
MIR17HG,Malignant neoplasm of pancreas,0.0726340460169901
MIR17HG,Glioma,0.0739788831250619
MIR17HG,Lymphoma,0.0739788831250619
MIR17HG,Glioblastoma,0.0745502070959292
MIR17HG,Pancreatic carcinoma,0.0745502070959292
MIR17HG,Carcinoma breast stage IV,0.0745502070959292
MIR17HG,Liver Cirrhosis,0.0773771948186562
MIR17HG,Prostate carcinoma,0.0773771948186562
MIR17HG,Squamous cell carcinoma of esophagus,0.0919714360040484
MIR17HG,Liver carcinoma,0.095319386034013
MIR17HG,Malignant Neoplasms,0.0991201145654548
MIR17HG,Osteosarcoma,0.1029977559100099
MIR17HG,Colon Carcinoma,0.1062239757831962
MIR17HG,Chronic Lymphocytic Leukemia,0.1147307578771389
MIR17HG,Small cell carcinoma of lung,0.1193558174333938
MIR17HG,Hematologic Neoplasms,0.1253114324938153
MIR17HG,MYELODYSPLASTIC SYNDROME,0.1254380558571286
MIR17HG,Esophageal carcinoma,0.1254380558571286
MIR17HG,Solid Neoplasm,0.1413782599148022
MIR17HG,Colonic Neoplasms,0.1454373331146953
MIR17HG,Liver neoplasms,0.1454373331146953
MIR17HG,Rheumatoid Arthritis,0.1537760235124317
MIR17HG,cervical cancer,0.2050045461627939
MIR17HG,Gastrointestinal Neoplasms,0.2062010908869036
MIR17HG,Osteosarcoma of bone,0.2109483801368481
MIR17HG,Malignant tumor of colon,0.223747154820789
MIR17HG,Hodgkin Disease,0.2454476567103779
MIR17HG,Burkitt Lymphoma,0.2521987644415915
MIR17HG,B-Cell Lymphomas,0.2522264785494494
MIR17HG,MIXED LINEAGE LEUKEMIA,0.2605479444258003
MIR17HG,Malignant neoplasm of liver,0.2643145809900195
MIR17HG,Adenocarcinoma Of Esophagus,0.2679411586077776
MIR17HG,Neoplasms,0.2714542429024338
MIR17HG,Malignant tumor of cervix,0.2714542429024338
MIR17HG,Malignant neoplasm of lung,0.2714542429024338
MIR17HG,Secondary malignant neoplasm of lung,0.2723545094624877
MIR17HG,Cervix carcinoma,0.2834835531038365
MIR17HG,Acute leukemia,0.2835142372342932
MIR17HG,Cirrhosis,0.2923761731100008
MIR17HG,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
MIR17HG,Triple Negative Breast Neoplasms,0.2980670559114652
MIR17HG,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
MIR17HG,Gastrointestinal Stromal Tumors,0.3199171478489988
MIR17HG,Cholangiocarcinoma,0.340892538685018
MIR17HG,Blast Phase,0.3494455519738624
MIR17HG,Ataxia Telangiectasia,0.3508665345292502
MIR17HG,Leukemogenesis,0.3510063969122338
MIR17HG,Rhabdomyosarcoma,0.3510063969122338
MIR17HG,Severe Combined Immunodeficiency,0.3553621627681198
MIR17HG,Carcinoma of lung,0.3663130598151661
MIR17HG,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
MIR17HG,Primary malignant neoplasm of lung,0.3902116649640871
MIR17HG,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
MIR17HG,Nasopharyngeal carcinoma,0.3933196962529684
MIR17HG,Non-Small Cell Lung Carcinoma,0.3933196962529684
MIR17HG,Hypertensive disease,0.3933196962529684
MIR17HG,Leukemia Myelocytic Acute,0.3933196962529684
MIR17HG,Ulnar-mammary syndrome,0.3933196962529684
MIR17HG,Astrocytoma,0.3933196962529684
MIR17HG,Aplasia Cutis Congenita,0.3933196962529684
MIR17HG,Hemangiosarcoma,0.3933196962529684
MIR17HG,Hypoplasia of thumb,0.3933196962529684
MIR17HG,Lymphoma Non-Hodgkin,0.3933196962529684
MIR17HG,Adenoid Cystic Carcinoma,0.3933196962529684
MIR17HG,Coronary heart disease,0.3933196962529684
MIR17HG,Glioblastoma Multiforme,0.3933196962529684
MIR17HG,Malignant neoplasm of kidney,0.3941558617476422
MIR17HG,Atrial Fibrillation,0.3941558617476422
MIR17HG,Acute Erythroblastic Leukemia,0.3941558617476422
MIR17HG,Renal carcinoma,0.3941558617476422
MIR17HG,Ki-1+ Anaplastic Large Cell Lymphoma,0.3941558617476422
MIR17HG,Microcephaly,0.3975960596292668
MIR17HG,Agenesis of corpus callosum,0.4103119460235835
MIR17HG,Multiple Myeloma,0.4103119460235835
MIR17HG,Hashimoto's encephalitis,0.4103119460235835
MIR17HG,Retinoblastoma,0.4115056600660309
MIR17HG,Adenoma of large intestine,0.4126392832024548
MIR17HG,Lupus Erythematosus Systemic,0.4213286052188015
MIR17HG,Short middle phalanx of finger,0.4213286052188015
MIR17HG,Primary cutaneous B-cell lymphoma,0.4213286052188015
MIR17HG,Squamous cell carcinoma of skin,0.4297858918260954
MIR17HG,Lupus Vulgaris,0.4335751357405352
MIR17HG,Sinus Node Dysfunction (disorder),0.4335751357405352
MIR17HG,Short stature,0.439389586518055
MIR17HG,Restenosis,0.4396723023384634
MIR17HG,leukemia,0.4588513406515081
MIR17HG,Lupus Erythematosus,0.4615352570710579
MIR17HG,Lupus Erythematosus Discoid,0.4675904598629673
MIR17HG,Myeloid Leukemia Chronic,0.472444704048021
MIR17HG,Kaposi Sarcoma,0.4851378030288289
MIR17HG,Small head,0.4906258721078565
MIR17HG,Severe Congenital Microcephaly,0.4923669467696064
MIR17HG,Microlissencephaly,0.4923669467696064
MIR17HG,Anaplastic thyroid carcinoma,0.4952592576151974
MIR17HG,Growth Disorders,0.5251317541886066
MIR17HG,Dull intelligence,0.5300976305939776
MIR17HG,Low intelligence,0.5300976305939776
MIR17HG,Congenital Abnormality,0.5305233935923577
MIR17HG,Hepatocarcinogenesis,0.533913711453195
MIR17HG,Limb Deformities Congenital,0.549941235475765
MIR17HG,Brachydactyly,0.549941235475765
MIR17HG,Autoimmune Diseases,0.5512224939896888
MIR17HG,Poor school performance,0.5610226870913673
MIR17HG,Lymphoproliferative Disorders,0.5696906826730043
MIR17HG,Diffuse Large B-Cell Lymphoma,0.5913651925298382
MIR17HG,Bone Diseases Developmental,0.5916904943304121
MIR17HG,Mental deficiency,0.6035970790768342
MIR17HG,Tumor Angiogenesis,0.6218520979526325
MIR17HG,Sezary Syndrome,0.6248356417853507
MIR17HG,Mental Retardation,0.6319938293757544
MIR17HG,Alveolar rhabdomyosarcoma,0.6355866602993508
MIR17HG,Marinesco-Sjogren syndrome,0.672336954961104
MIR17HG,Malignant neoplasm of gastrointestinal tract,0.8245140009975604
MIR17HG,Intellectual Disability,0.8352623613787349
MIR17HG,Hypoplasia Of Thumb,0.3094716280561038
MIR17HG,Congenital Anomaly Of Limb,0.4602028929328057
MIR17HG,Microcephaly,0.5123947823327547
MIR17HG,Microlissencephaly,0.525214105372123
MIR17HG,Bone Disease,0.5576425853515448
MIR17HG,Dwarfism,0.5796489603182782
MIR17HG,Brachydactyly,0.6198128018123746
MIR17HG,Congenital Microcephaly,0.657896505422784
MIR17HG,Coronary Heart Disease,0.7726217084209973
MIR17HG,Mental Retardation,0.7729545590606223
MIR17HG,Diabetes Mellitus,0.9683912711598086
MKNK2,Breast Carcinoma,0.0042545616049287
MKNK2,Malignant neoplasm of breast,0.0191435238361999
MKNK2,Medulloblastoma,0.0354767239335874
MKNK2,Pancolitis,0.2980670559114652
MKNK2,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
MKNK2,Cleft upper lip,0.4850576707687362
MKNK2,Ulcerative Colitis,0.5001612228394569
MKNK2,Diffuse Large B-Cell Lymphoma,0.5913651925298382
MKNK2,Neutral lipid storage myopathy ORPHA:98908,0.3762014630157917
MKNK2,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.3762014630157917
MKNK2,Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179,0.6239678957896782
MKNK2,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044,0.6239678957896782
MKNK2,Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409,0.6239678957896782
MKNK2,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.6239678957896782
MKNK2,Proteus syndrome ORPHA:744,0.6239678957896782
MKNK2,Gray platelet syndrome ORPHA:721,0.7068064785325423
MKNK2,Tubular aggregate myopathy ORPHA:2593,0.7068064785325423
MKNK2,Autosomal dominant centronuclear myopathy ORPHA:169189,0.7068064785325423
MKNK2,Yaba-like disease virus 142R protein (gene: 142R),0.6362779693488597
MKNK2,Vaccinia virus ser/thr kinase (gene: B1R),0.6362779693488597
MKNK2,Vaccinia virus Ankara Serine/threonine-protein kinase,0.6362779693488597
MKNK2,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.6362779693488597
MKNK2,Variola virus hypothetical protein (gene: B1R),0.6362779693488597
MKNK2,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.6362779693488597
MKNK2,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.691145768348025
MKNK2,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.6980058392556946
MKNK2,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.7553529087917877
MKNK2,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8090912655264054
MKNK2,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8090912655264054
MKNK2,Human gammaherpesvirus 8 ORF72,0.8164631368980444
MKNK2,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8315214238833722
MKNK2,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8400145987535752
MKNK2,Yaba monkey tumor virus 142R,0.8412554142619568
MKNK2,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8458935424065495
MKNK2,Ectromelia virus ERPV serine/threonine kinase,0.8567113603862105
MKNK2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8826243651582266
MKNK2,Monkeypox virus ser/thr kinase,0.960637237597315
MKNK2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.9782376397065295
MKNK2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.978680518510813
MKNK2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.9867877113290736
MKNK2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.988150003801932
MKNK2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.9886132556795868
MKNK2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.9886132556795868
MRM1,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.1590470395003315
MRM1,Auditory neuropathy-optic atrophy syndrome ORPHA:542585,0.6239678957896782
MRM1,Lipoyl transferase 2 deficiency ORPHA:447795,0.6239678957896782
MRM1,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470,0.6239678957896782
MRM1,Schimke immuno-osseous dysplasia ORPHA:1830,0.6239678957896782
MRM1,Spinocerebellar ataxia type 4 ORPHA:98765,0.6239678957896782
MRM1,ALG1-CDG ORPHA:79327,0.7068064785325423
MRM1,Bjornstad syndrome ORPHA:123,0.7068064785325423
MRM1,GRACILE syndrome ORPHA:53693,0.7068064785325423
MRM1,Glutaryl-CoA dehydrogenase deficiency ORPHA:25,0.7068064785325423
MRM1,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694,0.7068064785325423
MRM1,NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840,0.7068064785325423
MRM1,PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152,0.7068064785325423
MRM1,Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902,0.7068064785325423
MRM1,Testicular regression syndrome ORPHA:983,0.7068064785325423
MRM1,Hyperphosphatasia-intellectual disability syndrome ORPHA:247262,0.7068064785325423
MRM1,Hoyeraal-Hreidarsson syndrome ORPHA:3322,0.7068064785325423
MT1E,Mammary Neoplasms,0.0034602840073026
MT1E,Breast Carcinoma,0.0042545616049287
MT1E,Invasive Ductal Breast Carcinoma,0.0149002095788623
MT1E,Malignant neoplasm of breast,0.0191435238361999
MT1E,Renal Cell Carcinoma,0.0648809611869375
MT1E,Glioma,0.0739788831250619
MT1E,Glioblastoma,0.0745502070959292
MT1E,Carcinoma breast stage IV,0.0745502070959292
MT1E,Malignant neoplasm of urinary bladder,0.084286432100041
MT1E,Bladder Neoplasm,0.0891725280554336
MT1E,Liver carcinoma,0.095319386034013
MT1E,Carcinoma of bladder,0.13167400689206
MT1E,Malignant neoplasm of endometrium,0.13167400689206
MT1E,Uterine Corpus Cancer,0.1328002618052838
MT1E,Solid Neoplasm,0.1413782599148022
MT1E,Colonic Neoplasms,0.1454373331146953
MT1E,Diabetes,0.2277108302018961
MT1E,Diabetes Mellitus,0.2522264785494494
MT1E,Neoplasms,0.2714542429024338
MT1E,Hyperbilirubinemia,0.2980670559114652
MT1E,Endometrial Carcinoma,0.3044782497745498
MT1E,Tuberculosis,0.3706856725676674
MT1E,Androgen-Insensitivity Syndrome,0.3933196962529684
MT1E,Non-Small Cell Lung Carcinoma,0.3933196962529684
MT1E,Amyotrophic Lateral Sclerosis Sporadic,0.3933196962529684
MT1E,HIV Infections,0.3933196962529684
MT1E,Creutzfeldt-Jakob disease,0.3933196962529684
MT1E,Parkinson Disease,0.3933196962529684
MT1E,Epilepsy,0.3941558617476422
MT1E,Bronchiectasis,0.4028066164685291
MT1E,Substance abuse problem,0.4615352570710579
MT1E,Huntington Disease,0.4704594475773637
MT1E,Stage IV Breast Cancer AJCC v6 and v7,0.4753011022966241
MT1E,Lymphoma Diffuse,0.5916904943304121
MT1E,Pneumonia,0.924303335582991
MT1E,Liver Carcinoma,0.0520696613701797
MT1E,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
MYBL1,Glioma,0.0739788831250619
MYBL1,Lymphoma,0.0739788831250619
MYBL1,Adenoid cystic carcinoma of salivary gland,0.0775520919998773
MYBL1,Mixed Salivary Gland Tumor,0.1454373331146953
MYBL1,Acute Myeloid Leukemia (AML-M2),0.2050045461627939
MYBL1,B-Cell Lymphomas,0.2522264785494494
MYBL1,Malignant Glioma,0.3933196962529684
MYBL1,Aplasia Cutis Congenita,0.3933196962529684
MYBL1,Adenoid Cystic Carcinoma,0.3933196962529684
MYBL1,Agenesis of corpus callosum,0.4103119460235835
MYBL1,Polycystic Ovary Syndrome,0.5337853752290136
MYBL1,Diffuse Astrocytoma,0.6304655343580164
MYBL1,Sclerocystic Ovaries,0.652707626880454
MYBL1,mixed gliomas,0.655573080043894
MYBL1,Glioma,0.4560460337187313
MYBL1,Adenocarcinoma,0.4780231573499264
MYBL1,Sclerocystic Ovaries,0.6508151871447407
MYBL1,Polycystic Ovary Syndrome,0.7729545590606223
MYBL1,Brachydactyly type B2 ORPHA:140908,0.7068064785325423
MYBL1,Stapes ankylosis with broad thumbs and toes ORPHA:140917,0.7068064785325423
MYBL1,Tarsal-carpal coalition syndrome ORPHA:1412,0.7068064785325423
MYO15B,Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480,0.3762014630157917
MYO15B,Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267,0.3762014630157917
MYO15B,2q37 microdeletion syndrome ORPHA:1001,0.6239678957896782
MYO15B,Adult-onset dystonia-parkinsonism ORPHA:199351,0.6239678957896782
MYO15B,Birt-Hogg-Dube syndrome ORPHA:122,0.6239678957896782
MYO15B,Diencephalic-mesencephalic junction dysplasia ORPHA:319192,0.6239678957896782
MYO15B,Familial spontaneous pneumothorax ORPHA:2903,0.6239678957896782
MYO15B,Infantile neuroaxonal dystrophy ORPHA:35069,0.6239678957896782
MYO15B,NON RARE IN EUROPE: Berger disease ORPHA:34145,0.6239678957896782
MYO15B,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.6239678957896782
MYO15B,Imerslund-Grasbeck syndrome ORPHA:35858,0.6239678957896782
MYO15B,NON RARE IN EUROPE: Alzheimer disease ORPHA:238616,0.6268296504510718
MYO15B,Cherubism ORPHA:184,0.7068064785325423
MYO15B,Craniosynostosis-dental anomalies ORPHA:284149,0.7068064785325423
MYO15B,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.7068064785325423
MYO15B,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.7068064785325423
MYO15B,Malonic aciduria ORPHA:943,0.7068064785325423
MYO15B,Megaconial congenital muscular dystrophy ORPHA:280671,0.7068064785325423
MYO15B,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.7068064785325423
MYO15B,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.7068064785325423
MYO15B,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.7068064785325423
MYO15B,Congenital sodium diarrhea ORPHA:103908,0.7068064785325423
MYO15B,Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808,0.7068064785325423
MYO15B,Nephrogenic diabetes insipidus ORPHA:223,0.7068064785325423
MYO15B,Primary sclerosing cholangitis ORPHA:171,0.7068064785325423
MYO15B,Autosomal systemic lupus erythematosus ORPHA:300345,0.7068064785325423
MYO15B,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
MYO15B,Monkeypox virus ankyrin-like protein,0.8426793553344071
NCALD,Diabetic Nephropathy,0.3938591532700354
NCALD,Mental Depression,0.4560460337187313
NCALD,Cardiovascular Diseases,0.554079268109006
NCALD,Megalencephalic leukoencephalopathy with subcortical cysts ORPHA:2478,0.6239678957896782
NCALD,Acquired schizencephaly ORPHA:485275,0.6239678957896782
NCALD,Autosomal dominant hypophosphatemic rickets ORPHA:89937,0.7068064785325423
NCALD,Primary hyperaldosteronism-seizures-neurological abnormalities syndrome ORPHA:369929,0.7068064785325423
NCALD,Sinoatrial node dysfunction and deafness ORPHA:324321,0.7068064785325423
NCALD,Macrocephaly-intellectual disability-autism syndrome ORPHA:210548,0.7068064785325423
NCALD,NON RARE IN EUROPE: Tourette syndrome ORPHA:856,0.7068064785325423
NCEH1,Parkinson Disease,0.3933196962529684
NCEH1,Arteriosclerosis,0.5019670090704682
NCEH1,Atherosclerosis,0.5393787854381349
NCEH1,Leukemia,0.7167438233451096
NCEH1,PPARG-related familial partial lipodystrophy ORPHA:79083,0.0180064224283883
NCEH1,Recessive X-linked ichthyosis ORPHA:461,0.0586579655822394
NCEH1,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.0586579655822394
NCEH1,Pyridoxal phosphate-responsive seizures ORPHA:79096,0.6239678957896782
NCEH1,Pyruvate dehydrogenase phosphatase deficiency ORPHA:79246,0.6239678957896782
NCEH1,Sandhoff disease adult form ORPHA:309169,0.6239678957896782
NCEH1,Sandhoff disease infantile form ORPHA:309155,0.6239678957896782
NCEH1,Sandhoff disease juvenile form ORPHA:309162,0.6239678957896782
NCEH1,Familial Alzheimer-like prion disease ORPHA:280397,0.7068064785325423
NCEH1,Fatal familial insomnia ORPHA:466,0.7068064785325423
NCEH1,Gerstmann-Straussler-Scheinker syndrome ORPHA:356,0.7068064785325423
NCEH1,Huntington disease-like 1 ORPHA:157941,0.7068064785325423
NCEH1,Inherited Creutzfeldt-Jakob disease ORPHA:282166,0.7068064785325423
NCEH1,Kuru ORPHA:454745,0.7068064785325423
NCEH1,PrP systemic amyloidosis ORPHA:397606,0.7068064785325423
NCEH1,Sporadic fatal insomnia ORPHA:586130,0.7068064785325423
NCEH1,Yaba monkey tumor virus monoglyceride lipase,0.6362779693488597
NEU1,Colorectal Carcinoma,0.0034602840073026
NEU1,Mammary Neoplasms,0.0034602840073026
NEU1,Ovarian Carcinoma,0.0034602840073026
NEU1,Breast Carcinoma,0.0042545616049287
NEU1,Epithelioma,0.0149002095788623
NEU1,Invasive Ductal Breast Carcinoma,0.0149002095788623
NEU1,Colorectal Cancer,0.0149315928814189
NEU1,Stomach Carcinoma,0.0149315928814189
NEU1,melanoma,0.0149315928814189
NEU1,Adenocarcinoma,0.0155921563748247
NEU1,ovarian neoplasm,0.0191435238361999
NEU1,Malignant neoplasm of breast,0.0191435238361999
NEU1,Malignant neoplasm of stomach,0.0191435238361999
NEU1,Carcinogenesis,0.0228075668512991
NEU1,Malignant neoplasm of ovary,0.0277695594716545
NEU1,Epithelial ovarian cancer,0.0387439397151409
NEU1,Malignant neoplasm of prostate,0.0569142010728473
NEU1,Neoplasm Metastasis,0.0648809611869375
NEU1,Renal Cell Carcinoma,0.0648809611869375
NEU1,Glioblastoma,0.0745502070959292
NEU1,Carcinoma breast stage IV,0.0745502070959292
NEU1,Prostate carcinoma,0.0773771948186562
NEU1,Lysosomal Storage Diseases,0.0798053340865682
NEU1,Osteosarcoma,0.1029977559100099
NEU1,Ductal Breast Carcinoma,0.13167400689206
NEU1,Carcinoma Transitional Cell,0.13167400689206
NEU1,Malignant neoplasm of endometrium,0.13167400689206
NEU1,Uterine Corpus Cancer,0.1328002618052838
NEU1,Invasive Carcinoma,0.1602092191314262
NEU1,Comedone,0.1735868515093891
NEU1,Clouding of corneal stroma,0.1859959283872542
NEU1,TARSAL-CARPAL COALITION SYNDROME,0.1906413554467301
NEU1,Seizures,0.2053083986145698
NEU1,Corneal Opacity,0.2085938372806741
NEU1,Osteosarcoma of bone,0.2109483801368481
NEU1,Cataract,0.223747154820789
NEU1,Nervous System Neoplasms,0.2569222032997501
NEU1,Malignant neoplasm of lung,0.2714542429024338
NEU1,Secondary malignant neoplasm of lung,0.2723545094624877
NEU1,Triple Negative Breast Neoplasms,0.2980670559114652
NEU1,Endometrial Carcinoma,0.3044782497745498
NEU1,Cholangiocarcinoma,0.340892538685018
NEU1,Pfaundler-Hurler Syndrome,0.3508665345292502
NEU1,Carcinoma of lung,0.3663130598151661
NEU1,Noninfiltrating Intraductal Carcinoma,0.383941725017158
NEU1,Primary malignant neoplasm of lung,0.3902116649640871
NEU1,Secondary malignant neoplasm of lymph node,0.3933196962529684
NEU1,Plaque Amyloid,0.3933196962529684
NEU1,Adenocarcinoma of large intestine,0.3933196962529684
NEU1,Hernia Inguinal,0.3933196962529684
NEU1,Non-small cell lung cancer stage I,0.3933196962529684
NEU1,Malignant Glioma,0.3933196962529684
NEU1,Non-Small Cell Lung Carcinoma,0.3933196962529684
NEU1,Skin Diseases Vascular,0.3933196962529684
NEU1,Bone-marrow foam cells,0.3933196962529684
NEU1,Carcinoma Papillary,0.3933196962529684
NEU1,Astrocytoma,0.3933196962529684
NEU1,Cystadenocarcinoma Serous,0.3933196962529684
NEU1,Alzheimer's Disease,0.3933196962529684
NEU1,beta-Galactosidase Deficiency,0.3933196962529684
NEU1,Type I Mucolipidosis,0.3933196962529684
NEU1,Cerebral cortex myoclonus,0.3933196962529684
NEU1,Secondary malignant neoplasm of axilla,0.3933196962529684
NEU1,Vacuolated lymphocytes,0.3933196962529684
NEU1,Cherry red spot of the macula,0.3933196962529684
NEU1,Epilepsy,0.3941558617476422
NEU1,Ewing's sarcoma of bone,0.3941558617476422
NEU1,Nephritis,0.3941558617476422
NEU1,Senile Plaques,0.3975960596292668
NEU1,IGA Glomerulonephritis,0.3975960596292668
NEU1,Adenocarcinoma of the gastroesophageal junction,0.3975960596292668
NEU1,Breast cancer stage II,0.3975960596292668
NEU1,GALACTOSIALIDOSIS,0.3975960596292668
NEU1,Gangliosidosis GM1,0.3975960596292668
NEU1,HER2 gene amplification,0.4028066164685291
NEU1,Pituitary Diseases,0.4028066164685291
NEU1,Mammary Tumorigenesis,0.4028066164685291
NEU1,Mucolipidoses,0.4028066164685291
NEU1,Splenomegaly,0.4103119460235835
NEU1,Hyperammonemia,0.4115056600660309
NEU1,Hyperkeratosis,0.4192169590514327
NEU1,Lens Opacities,0.4213286052188015
NEU1,Thrombocytopenia,0.4213286052188015
NEU1,Storage disease,0.4213286052188015
NEU1,Atypical Inclusion-Body Disease,0.4213286052188015
NEU1,Biotin-Responsive Encephalopathy,0.4213286052188015
NEU1,Familial Progressive Myoclonic Epilepsy,0.4213286052188015
NEU1,May-White Syndrome,0.4213286052188015
NEU1,Ovarian adenocarcinoma,0.4213286052188015
NEU1,Neurilemmoma,0.425419812815905
NEU1,Slurred speech,0.425419812815905
NEU1,Action Myoclonus-Renal Failure Syndrome,0.4304973629098372
NEU1,Congenital pectus carinatum,0.4335751357405352
NEU1,Short stature,0.439389586518055
NEU1,Thick lower lip vermilion,0.4396723023384634
NEU1,Abnormal skeletal development,0.4396723023384634
NEU1,Full lower lip,0.4396723023384634
NEU1,Precancerous Conditions,0.4479115285676636
NEU1,Hepatomegaly,0.4506578937113162
NEU1,Hydrops Fetalis Non-Immune,0.4506578937113162
NEU1,Osteochondrodysplasias,0.4561717689698902
NEU1,Tremor,0.4564472886428772
NEU1,Stippled epiphyses,0.4753011022966241
NEU1,Paget Disease Extramammary,0.4753011022966241
NEU1,Transitional cell carcinoma of bladder,0.4790179402069343
NEU1,Hyperglycemia,0.4906258721078565
NEU1,Unverricht-Lundborg Syndrome,0.4906258721078565
NEU1,Hydrops Fetalis,0.4990401620718274
NEU1,Acquired scoliosis,0.5019670090704682
NEU1,Paget Disease,0.5140447474168605
NEU1,Short thorax,0.5299466034567416
NEU1,Dull intelligence,0.5300976305939776
NEU1,Low intelligence,0.5300976305939776
NEU1,Congenital Abnormality,0.5305233935923577
NEU1,Eye Abnormalities,0.5359212109443033
NEU1,Hernia,0.5359212109443033
NEU1,Abnormal form of the vertebral bodies,0.5453394612016188
NEU1,Ascites,0.549941235475765
NEU1,Spasmodic movement,0.5514573300659174
NEU1,Involuntary jerking movements,0.5514573300659174
NEU1,Poor school performance,0.5610226870913673
NEU1,Abnormal urinary amino-acid findings,0.5619299124666532
NEU1,Biliary Tract Cancer,0.563120546412355
NEU1,Endometrial adenocarcinoma,0.5655222348249326
NEU1,Frontal bossing,0.5710095678317721
NEU1,Cerebellar Ataxia,0.5754799679683854
NEU1,Aminoaciduria,0.5768212166102149
NEU1,Decreased nerve conduction velocity,0.5768212166102149
NEU1,Progressive visual loss,0.5768212166102149
NEU1,Decreased visual acuity progressive,0.5916904943304121
NEU1,Ductal Carcinoma,0.6002127202571572
NEU1,Curvature of spine,0.6035970790768342
NEU1,Mental deficiency,0.6035970790768342
NEU1,Broad flat nasal bridge,0.6196470808426647
NEU1,Thickened facial skin with coarse facial features,0.6207008101484466
NEU1,Coarse facial features,0.6222451141623291
NEU1,Nasal bridge wide,0.6238969878903416
NEU1,Myoclonus,0.625112405383346
NEU1,Dentatorubral-Pallidoluysian Atrophy,0.6304655343580164
NEU1,Mental Retardation,0.6319938293757544
NEU1,Cardiomegaly,0.6332132835539771
NEU1,Retinal Diseases,0.655573080043894
NEU1,Osteitis Deformans,0.6761967139251879
NEU1,Cerebellar Dysmetria,0.6878314377608323
NEU1,Sensorineural Hearing Loss (disorder),0.6891882956008074
NEU1,Delayed bone age,0.6910672612216457
NEU1,Proteinuria,0.6925751397474874
NEU1,Cardiomyopathies,0.6989462176022242
NEU1,Myoclonic Epilepsies Progressive,0.7045203904267408
NEU1,Gait abnormality,0.7138331851025355
NEU1,Speech Disorders,0.717484976234209
NEU1,Skeletal muscle atrophy,0.7511668779991656
NEU1,Neurogenic muscle atrophy especially in the lower limbs,0.7511668779991656
NEU1,Generalized hypotonia,0.7631684472516962
NEU1,Neurogenic Muscular Atrophy,0.7720422491171346
NEU1,Muscle hypotonia,0.7965733310657268
NEU1,Visual Impairment,0.8098594112577364
NEU1,Muscle degeneration,0.8198848943907875
NEU1,Low Vision,0.8225089178916923
NEU1,Electroencephalogram abnormal,0.8257883659984262
NEU1,Intellectual Disability,0.8352623613787349
NEU1,Hyperreflexia,0.869420268668135
NEU1,Muscle Weakness,0.9042453170318407
NEU1,Nystagmus,0.926001913794773
NEU1,Schizophrenia,0.0531117779464085
NEU1,Pfaundler-Hurler Syndrome,0.3940072377207739
NEU1,Mucolipidosis,0.4286813331685578
NEU1,Skin Diseases Vascular,0.4560460337187313
NEU1,Frontal Bossing,0.4560460337187313
NEU1,Inclusion-Body Disease,0.4602028929328057
NEU1,May-White Syndrome,0.4602028929328057
NEU1,Dentatorubral Pallidoluysian Atrophy,0.4602028929328057
NEU1,Action Myoclonus-Renal Failure Syndrome,0.4646409362700993
NEU1,Scoliosis,0.4875380732267193
NEU1,Hyperkeratosis,0.4875380732267193
NEU1,Vitiligo,0.5576425853515448
NEU1,Hearing Loss,0.5632819212593052
NEU1,Dwarfism,0.5796489603182782
NEU1,Skeletal Dysplasia,0.5796489603182782
NEU1,Osteochondrodysplasia,0.5878255556245724
NEU1,Myoclonic Epilepsy,0.6098159321331
NEU1,Congenital Pectus Carinatum,0.6104715460837368
NEU1,Speech Disorders,0.6239791345488227
NEU1,Retinal Diseases,0.6329251700753155
NEU1,Cataract,0.6660731887258019
NEU1,Hydrops Fetalis,0.7378537370641419
NEU1,Mental Retardation,0.7729545590606223
NEU1,Cardiomyopathy,0.8407264689819682
NEU1,Nystagmus,0.9146877763175152
NEU1,Tay-Sachs disease B variant adult form ORPHA:309192,0.1590470395003315
NEU1,Tay-Sachs disease B variant infantile form ORPHA:309178,0.1590470395003315
NEU1,Tay-Sachs disease B variant juvenile form ORPHA:309185,0.1590470395003315
NEU1,Tay-Sachs disease B1 variant ORPHA:309239,0.1590470395003315
NEU1,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3762014630157917
NEU1,Fetal Gaucher disease ORPHA:85212,0.3762014630157917
NEU1,Free sialic acid storage disease infantile form ORPHA:309324,0.3762014630157917
NEU1,Gaucher disease type 2 ORPHA:77260,0.3762014630157917
NEU1,Gaucher disease type 3 ORPHA:77261,0.3762014630157917
NEU1,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072,0.3762014630157917
NEU1,Intermediate severe Salla disease ORPHA:309331,0.3762014630157917
NEU1,NON RARE IN EUROPE: Parkinson disease ORPHA:319705,0.3762014630157917
NEU1,Salla disease ORPHA:309334,0.3762014630157917
NEU1,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.3762014630157917
NEU1,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.3762014630157917
NEU1,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.3762014630157917
NEU1,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.3762014630157917
NEU1,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.3762014630157917
NEU1,Fucosidosis ORPHA:349,0.6239678957896782
NEU1,Sandhoff disease adult form ORPHA:309169,0.6239678957896782
NEU1,Sandhoff disease infantile form ORPHA:309155,0.6239678957896782
NEU1,Sandhoff disease juvenile form ORPHA:309162,0.6239678957896782
NEU1,Behavioral variant of frontotemporal dementia ORPHA:275864,0.6522156347158065
NEU1,Biotinidase deficiency ORPHA:79241,0.7068064785325423
NEU1,Congenital sialidosis type 2 ORPHA:93400,0.7068064785325423
NEU1,GM1 gangliosidosis type 1 ORPHA:79255,0.7068064785325423
NEU1,GM1 gangliosidosis type 2 ORPHA:79256,0.7068064785325423
NEU1,GM1 gangliosidosis type 3 ORPHA:79257,0.7068064785325423
NEU1,Juvenile sialidosis type 2 ORPHA:93399,0.7068064785325423
NEU1,Mucopolysaccharidosis type 4B ORPHA:309310,0.7068064785325423
NEU1,Sialidosis type 1 ORPHA:812,0.7068064785325423
NEU1,NON RARE IN EUROPE: Hidradenitis suppurativa ORPHA:387,0.7068064785325423
NGFR,Colorectal Carcinoma,0.0034602840073026
NGFR,Mammary Neoplasms,0.0034602840073026
NGFR,Ovarian Carcinoma,0.0034602840073026
NGFR,Breast Carcinoma,0.0042545616049287
NGFR,Epithelioma,0.0149002095788623
NGFR,Colorectal Cancer,0.0149315928814189
NGFR,Tumor Progression,0.0149315928814189
NGFR,Stomach Carcinoma,0.0149315928814189
NGFR,melanoma,0.0149315928814189
NGFR,Squamous cell carcinoma,0.0182265588252201
NGFR,Malignant mesothelioma,0.0182265588252201
NGFR,Malignant neoplasm of breast,0.0191435238361999
NGFR,Malignant neoplasm of stomach,0.0191435238361999
NGFR,Carcinogenesis,0.0228075668512991
NGFR,Medulloblastoma,0.0354767239335874
NGFR,Epithelial ovarian cancer,0.0387439397151409
NGFR,Malignant neoplasm of prostate,0.0569142010728473
NGFR,Central neuroblastoma,0.0593779966354549
NGFR,Neoplasm Metastasis,0.0648809611869375
NGFR,Neuroblastoma,0.0688152422187159
NGFR,Malignant neoplasm of pancreas,0.0726340460169901
NGFR,Pancreatic Neoplasm,0.0739788831250619
NGFR,Glioma,0.0739788831250619
NGFR,Pancreatic carcinoma,0.0745502070959292
NGFR,Liver Cirrhosis,0.0773771948186562
NGFR,Prostate carcinoma,0.0773771948186562
NGFR,Malignant neoplasm of urinary bladder,0.084286432100041
NGFR,Bladder Neoplasm,0.0891725280554336
NGFR,Squamous cell carcinoma of esophagus,0.0919714360040484
NGFR,Liver carcinoma,0.095319386034013
NGFR,Chronic Lymphocytic Leukemia,0.1147307578771389
NGFR,Small cell carcinoma of lung,0.1193558174333938
NGFR,Carcinoma of bladder,0.13167400689206
NGFR,Unipolar Depression,0.13167400689206
NGFR,Hypertension Portal,0.1328002618052838
NGFR,Sarcoma,0.1537760235124317
NGFR,Visual seizure,0.1735868515093891
NGFR,Seizures,0.2053083986145698
NGFR,Major Depressive Disorder,0.21122597829463
NGFR,Prostatic Neoplasms,0.223747154820789
NGFR,Diabetes,0.2277108302018961
NGFR,Hodgkin Disease,0.2454476567103779
NGFR,Diabetes Mellitus,0.2522264785494494
NGFR,Nervous System Neoplasms,0.2569222032997501
NGFR,Clear cell sarcoma of kidney,0.2714542429024338
NGFR,Mastocytoma,0.2714542429024338
NGFR,Secondary malignant neoplasm of lung,0.2723545094624877
NGFR,Acute leukemia,0.2835142372342932
NGFR,Cirrhosis,0.2923761731100008
NGFR,Benign Mastocytoma,0.2980670559114652
NGFR,Neuroepithelioma,0.3099246715197673
NGFR,Glaucoma,0.3105909001629992
NGFR,Epithelial hyperplasia of skin,0.333745294913745
NGFR,Mast Cell Neoplasm,0.3508665345292502
NGFR,Complex partial seizures,0.383941725017158
NGFR,Childhood Brain Neoplasm,0.383941725017158
NGFR,Amyloidosis,0.3933196962529684
NGFR,Myelomonocytic leukemia,0.3933196962529684
NGFR,Fibrillation,0.3933196962529684
NGFR,Hamartoma,0.3933196962529684
NGFR,Generalized seizures,0.3933196962529684
NGFR,Pancreatitis Chronic,0.3933196962529684
NGFR,Kidney Diseases,0.3933196962529684
NGFR,Papillary thyroid carcinoma,0.3933196962529684
NGFR,Schizophrenia,0.3933196962529684
NGFR,Seizures Focal,0.3933196962529684
NGFR,Chronic liver disease,0.3933196962529684
NGFR,Hypertensive disease,0.3933196962529684
NGFR,RIPPLING MUSCLE DISEASE 1,0.3933196962529684
NGFR,Other specified senile psychotic conditions,0.3933196962529684
NGFR,Soft Tissue Neoplasms,0.3933196962529684
NGFR,Astrocytoma,0.3933196962529684
NGFR,Alzheimer's Disease,0.3933196962529684
NGFR,Rippling muscle disease,0.3933196962529684
NGFR,Myelolipoma,0.3933196962529684
NGFR,Prolactinoma,0.3933196962529684
NGFR,Acute lymphocytic leukemia,0.3933196962529684
NGFR,Triploidy syndrome,0.3933196962529684
NGFR,Stomach Neoplasms,0.3933196962529684
NGFR,Fibrosis Liver,0.3933196962529684
NGFR,Acute Promyelocytic Leukemia,0.3933196962529684
NGFR,Amyloid Neuropathies,0.3933196962529684
NGFR,Granulomatous Disease Chronic X-Linked,0.3933196962529684
NGFR,Glioblastoma Multiforme,0.3933196962529684
NGFR,Hypopharyngeal Cancer,0.3933196962529684
NGFR,Single Seizure,0.3941558617476422
NGFR,Seizures Auditory,0.3941558617476422
NGFR,Seizures Clonic,0.3941558617476422
NGFR,Seizures Sensory,0.3941558617476422
NGFR,Seizures Somatosensory,0.3941558617476422
NGFR,Vertiginous seizure,0.3941558617476422
NGFR,Atonic Absence Seizures,0.3941558617476422
NGFR,Generalized Absence Seizures,0.3941558617476422
NGFR,Gustatory seizure,0.3941558617476422
NGFR,Jacksonian Seizure,0.3941558617476422
NGFR,Non-epileptic convulsion,0.3941558617476422
NGFR,Nonepileptic Seizures,0.3941558617476422
NGFR,Olfactory seizure,0.3941558617476422
NGFR,Autism Spectrum Disorders,0.3941558617476422
NGFR,Epileptic Seizures,0.3941558617476422
NGFR,Mental Depression,0.3941558617476422
NGFR,Tonic Seizures,0.3941558617476422
NGFR,Ischemia,0.3941558617476422
NGFR,Rabies (disorder),0.3941558617476422
NGFR,HSAN Type IV,0.3941558617476422
NGFR,Myeloid neoplasm,0.39623320406434
NGFR,Amyotrophic Lateral Sclerosis,0.3975960596292668
NGFR,Convulsive Seizures,0.3975960596292668
NGFR,Depressive disorder,0.3975960596292668
NGFR,IGA Glomerulonephritis,0.3975960596292668
NGFR,Neuroectodermal Tumor Primitive,0.4028066164685291
NGFR,Epileptic drop attack,0.4037249857069285
NGFR,Convulsions,0.4103119460235835
NGFR,Absence Seizures,0.4126392832024548
NGFR,Malignant Peripheral Nerve Sheath Tumor,0.4126392832024548
NGFR,Cervical Disc Degenerative Disorder,0.4126392832024548
NGFR,Congenital Hypothyroidism,0.4192169590514327
NGFR,Hypopharyngeal Carcinoma,0.4192169590514327
NGFR,Immunologic Deficiency Syndromes,0.4213286052188015
NGFR,Central Nervous System Embryonal Tumor Not Otherwise Specified,0.4213286052188015
NGFR,Congestive heart failure,0.425419812815905
NGFR,Heart failure,0.4304973629098372
NGFR,Leukaemia recurrent,0.4304973629098372
NGFR,Myxoid cyst,0.4335751357405352
NGFR,Neurofibromatosis 1,0.4335751357405352
NGFR,Neurodegenerative Disorders,0.4335751357405352
NGFR,Neuropathy,0.4335751357405352
NGFR,Adenocarcinoma of prostate,0.4421745246585178
NGFR,Endemic Cretinism,0.4506578937113162
NGFR,leukemia,0.4588513406515081
NGFR,Diabetic Neuropathies,0.4615352570710579
NGFR,Myoclonic Seizures,0.4615352570710579
NGFR,Charcot-Marie-Tooth Disease Type Ia (disorder),0.4753011022966241
NGFR,Pain,0.4871698998714747
NGFR,Tonic - clonic seizures,0.4919605488358906
NGFR,Memory impairment,0.5188223685230745
NGFR,Erythema,0.5299466034567416
NGFR,Degenerative Diseases Spinal Cord,0.5299466034567416
NGFR,Polycystic Ovary Syndrome,0.5337853752290136
NGFR,Respiratory Syncytial Virus Infections,0.533913711453195
NGFR,Degenerative Diseases Central Nervous System,0.5359212109443033
NGFR,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.5710095678317721
NGFR,Peripheral Neuropathy,0.5851527280548257
NGFR,Body Height,0.5936773368594411
NGFR,Cystitis,0.5956632182199403
NGFR,Lichen Planus Oral,0.6222451141623291
NGFR,Other specified transient cerebral ischemias,0.6274540883972485
NGFR,Hereditary pancreatitis,0.6447029562500783
NGFR,Keratoconus,0.652707626880454
NGFR,Dermatitis Atopic,0.7045203904267408
NGFR,Fanconi Anemia,0.7053337831155875
NGFR,Transient Ischemic Attack,0.7061487180640408
NGFR,Sciatic Neuropathy,0.7240930522443176
NGFR,Liver diseases,0.7337030585693298
NGFR,Infarction Middle Cerebral Artery,0.7815030391631113
NGFR,Eczema,0.7893058450619891
NGFR,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8064248359603999
NGFR,Nerve Degeneration,0.8326859687569312
NGFR,Schizophrenia,0.0531117779464085
NGFR,Mental Depression,0.4560460337187313
NGFR,Prostatic Neoplasms,0.4875380732267193
NGFR,Jacksonian Seizure,0.5234357475824973
NGFR,Seizure,0.5576425853515448
NGFR,Neurodegenerative Disorders,0.5576425853515448
NGFR,Degenerative Diseases Central Nervous System,0.5576425853515448
NGFR,Clonic Seizures,0.5762801672039276
NGFR,Prostate Cancer,0.6104715460837368
NGFR,Hypotonic Seizures,0.6344671175966539
NGFR,Familial avascular necrosis of femoral head ORPHA:86820,0.6239678957896782
NGFR,Papiine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.6362779693488597
NGFR,Cercopithecine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.6362779693488597
NGFR,Cercopithecine betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144),0.6362779693488597
NGFR,Human betaherpesvirus 5 membrane protein UL14 (gene: UL14),0.6362779693488597
NGFR,Human alphaherpesvirus 1 envelope glycoprotein D (gene: US6),0.6462089477181691
NGFR,Macacine alphaherpesvirus 1 envelope glycoprotein D (gene: US6),0.7444198880830654
NOLC1,Colorectal Carcinoma,0.0034602840073026
NOLC1,Ovarian Carcinoma,0.0034602840073026
NOLC1,Breast Carcinoma,0.0042545616049287
NOLC1,Colorectal Cancer,0.0149315928814189
NOLC1,Stomach Carcinoma,0.0149315928814189
NOLC1,Squamous cell carcinoma,0.0182265588252201
NOLC1,Malignant neoplasm of breast,0.0191435238361999
NOLC1,Malignant neoplasm of stomach,0.0191435238361999
NOLC1,Carcinogenesis,0.0228075668512991
NOLC1,Epithelial ovarian cancer,0.0387439397151409
NOLC1,Malignant neoplasm of prostate,0.0569142010728473
NOLC1,Neoplasm Metastasis,0.0648809611869375
NOLC1,Lymphoma,0.0739788831250619
NOLC1,Glioblastoma,0.0745502070959292
NOLC1,Prostate carcinoma,0.0773771948186562
NOLC1,Liver carcinoma,0.095319386034013
NOLC1,Small cell carcinoma of lung,0.1193558174333938
NOLC1,Rheumatoid Arthritis,0.1537760235124317
NOLC1,Seizures,0.2053083986145698
NOLC1,Mandibulofacial Dysostosis,0.2643145809900195
NOLC1,Embryonal Carcinoma,0.3112516166225269
NOLC1,Nasopharyngeal carcinoma,0.3933196962529684
NOLC1,Retinoblastoma,0.4115056600660309
NOLC1,Refractory anemias,0.421267417774367
NOLC1,Papilloma,0.425992946703162
NOLC1,Cardiac Arrest,0.5453394612016188
NOLC1,Herpes Simplex Infections,0.610971999959321
NOLC1,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.3762014630157917
NOLC1,Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026,0.6239678957896782
NOLC1,Autosomal dominant Charcot-Marie-Tooth disease type 2N ORPHA:228174,0.6239678957896782
NOLC1,Autosomal dominant spastic paraplegia type 13 ORPHA:100994,0.6239678957896782
NOLC1,Burkitt lymphoma ORPHA:543,0.6239678957896782
NOLC1,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.6239678957896782
NOLC1,Hyper-IgM syndrome type 5 ORPHA:101092,0.6239678957896782
NOLC1,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.6239678957896782
NOLC1,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288,0.6239678957896782
NOLC1,Reticular dysgenesis ORPHA:33355,0.6239678957896782
NOLC1,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.6239678957896782
NOLC1,Dubowitz syndrome ORPHA:235,0.6239678957896782
NOLC1,Lujan-Fryns syndrome ORPHA:776,0.6239678957896782
NOLC1,1q44 microdeletion syndrome ORPHA:238769,0.7068064785325423
NOLC1,AICA-ribosiduria ORPHA:250977,0.7068064785325423
NOLC1,Autosomal dominant intermediate Charcot-Marie-Tooth disease type C ORPHA:100045,0.7068064785325423
NOLC1,Autosomal recessive spastic ataxia with leukoencephalopathy ORPHA:314603,0.7068064785325423
NOLC1,Brain calcification Rajab type ORPHA:178506,0.7068064785325423
NOLC1,Combined oxidative phosphorylation defect type 25 ORPHA:447954,0.7068064785325423
NOLC1,EVEN-plus syndrome ORPHA:496751,0.7068064785325423
NOLC1,Exercise-induced hyperinsulinism ORPHA:165991,0.7068064785325423
NOLC1,Growth delay-intellectual disability-hepatopathy syndrome ORPHA:541423,0.7068064785325423
NOLC1,Hereditary North American Indian childhood cirrhosis ORPHA:168583,0.7068064785325423
NOLC1,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.7068064785325423
NOLC1,Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome ORPHA:528091,0.7068064785325423
NOLC1,Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075,0.7068064785325423
NOLC1,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome ORPHA:314051,0.7068064785325423
NOLC1,Metabolic myopathy due to lactate transporter defect ORPHA:171690,0.7068064785325423
NOLC1,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993,0.7068064785325423
NOLC1,Phosphoserine aminotransferase deficiency infantile/juvenile form ORPHA:284417,0.7068064785325423
NOLC1,Spinal muscular atrophy with respiratory distress type 2 ORPHA:404521,0.7068064785325423
NOLC1,Spinocerebellar ataxia type 36 ORPHA:276198,0.7068064785325423
NOLC1,Autosomal recessive sideroblastic anemia ORPHA:260305,0.7068064785325423
NOLC1,Desmoplastic small round cell tumor ORPHA:83469,0.7068064785325423
NOLC1,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430,0.7068064785325423
NOLC1,Microphthalmia Lenz type ORPHA:568,0.7068064785325423
NOLC1,Wilson-Turner syndrome ORPHA:3459,0.7068064785325423
NOLC1,Familial isolated hyperparathyroidism ORPHA:99879,0.7068064785325423
NOLC1,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome ORPHA:88637,0.7068064785325423
NOLC1,Clear cell sarcoma of kidney ORPHA:457246,0.7068064785325423
NR4A2,Colorectal Carcinoma,0.0034602840073026
NR4A2,Breast Carcinoma,0.0042545616049287
NR4A2,Colorectal Cancer,0.0149315928814189
NR4A2,Tumor Progression,0.0149315928814189
NR4A2,Stomach Carcinoma,0.0149315928814189
NR4A2,melanoma,0.0149315928814189
NR4A2,Adenocarcinoma,0.0155921563748247
NR4A2,Malignant neoplasm of breast,0.0191435238361999
NR4A2,Malignant neoplasm of stomach,0.0191435238361999
NR4A2,Malignant neoplasm of prostate,0.0569142010728473
NR4A2,Central neuroblastoma,0.0593779966354549
NR4A2,Mucoepidermoid Carcinoma,0.0648809611869375
NR4A2,Neuroblastoma,0.0688152422187159
NR4A2,inflammatory joint disease,0.0745502070959292
NR4A2,Prostate carcinoma,0.0773771948186562
NR4A2,Squamous cell carcinoma of the head and neck,0.0775520919998773
NR4A2,Colorectal Neoplasms,0.0827744840860166
NR4A2,Bladder Neoplasm,0.0891725280554336
NR4A2,Liver carcinoma,0.095319386034013
NR4A2,Colon Carcinoma,0.1062239757831962
NR4A2,MYELODYSPLASTIC SYNDROME,0.1254380558571286
NR4A2,Arsenic Poisoning Inorganic,0.13167400689206
NR4A2,Nervous System Organic Arsenic Poisoning,0.13167400689206
NR4A2,Arsenic Encephalopathy,0.13167400689206
NR4A2,Arsenic Induced Polyneuropathy,0.13167400689206
NR4A2,Arsenic Poisoning,0.13167400689206
NR4A2,Unipolar Depression,0.13167400689206
NR4A2,Hyperactive behavior,0.1387448809655294
NR4A2,Rheumatoid Arthritis,0.1537760235124317
NR4A2,Seizures,0.2053083986145698
NR4A2,Major Depressive Disorder,0.21122597829463
NR4A2,Malignant tumor of colon,0.223747154820789
NR4A2,Neuroblastic tumors,0.2522264785494494
NR4A2,Opiate Addiction,0.2643145809900195
NR4A2,Malignant neoplasm of lung,0.2714542429024338
NR4A2,Language Disorders,0.2747883228704706
NR4A2,Cervix carcinoma,0.2834835531038365
NR4A2,Multiple Sclerosis,0.2835142372342932
NR4A2,Sjogren's Syndrome,0.3099246715197673
NR4A2,Postural instability,0.3220099003872086
NR4A2,Carcinoma of lung,0.3663130598151661
NR4A2,Mask-like facies,0.383941725017158
NR4A2,Primary malignant neoplasm of lung,0.3902116649640871
NR4A2,Muscle Rigidity,0.3933196962529684
NR4A2,Secondary malignant neoplasm of lymph node,0.3933196962529684
NR4A2,Bipolar Disorder,0.3933196962529684
NR4A2,Neuronal loss in central nervous system,0.3933196962529684
NR4A2,Schizophrenia,0.3933196962529684
NR4A2,Adrenocortical carcinoma,0.3933196962529684
NR4A2,Secondary malignant neoplasm of liver,0.3933196962529684
NR4A2,Neurobehavioral Manifestations,0.3933196962529684
NR4A2,Arthritis Psoriatic,0.3933196962529684
NR4A2,Alzheimer's Disease,0.3933196962529684
NR4A2,Short stepped shuffling gait,0.3933196962529684
NR4A2,Intestinal Polyps,0.3933196962529684
NR4A2,Parkinson Disease,0.3933196962529684
NR4A2,Adenoma,0.3933196962529684
NR4A2,Voice Fatigue,0.3933196962529684
NR4A2,Hypophonia,0.3933196962529684
NR4A2,Depressive disorder,0.3975960596292668
NR4A2,Parkinsonian tremor,0.3975960596292668
NR4A2,Gastric Adenocarcinoma,0.4028066164685291
NR4A2,Bradykinesia,0.4115056600660309
NR4A2,Cerebrovascular accident,0.4115056600660309
NR4A2,Juvenile arthritis,0.4126392832024548
NR4A2,Cortical Dysplasia,0.4126392832024548
NR4A2,Cocaine Abuse,0.4192169590514327
NR4A2,Precocious Puberty,0.4209380602168584
NR4A2,Progressive supranuclear palsy,0.4213286052188015
NR4A2,Lewy Body Disease,0.424575176503444
NR4A2,Encephalomyelitis,0.4254307049060398
NR4A2,Psoriasis,0.4304973629098372
NR4A2,Urgency frequency syndrome,0.4335751357405352
NR4A2,Restenosis,0.4396723023384634
NR4A2,Resting Tremor,0.4396723023384634
NR4A2,Chronic arthritis,0.4459714599189374
NR4A2,Dystonic disease,0.4459714599189374
NR4A2,Urgency of micturition,0.4564472886428772
NR4A2,Overactive Bladder,0.4615352570710579
NR4A2,Overactive bladder syndrome,0.4615352570710579
NR4A2,Personality change,0.4615352570710579
NR4A2,Cardiovascular Diseases,0.4675904598629673
NR4A2,Juvenile psoriatic arthritis,0.472444704048021
NR4A2,Juvenile-Onset Still Disease,0.4810435657134442
NR4A2,Dermatologic disorders,0.4906258721078565
NR4A2,Sleep disturbances,0.4929829683479762
NR4A2,Parkinson Disease Familial Type 1,0.4981941174985421
NR4A2,Alcoholic Intoxication Chronic,0.5097818625871164
NR4A2,Memory impairment,0.5188223685230745
NR4A2,Deglutition Disorders,0.5284231402423694
NR4A2,Autoimmune Diseases,0.5512224939896888
NR4A2,Arthritis,0.553002957824355
NR4A2,Psychotic symptom,0.5619299124666532
NR4A2,Tauopathies,0.5682392297191953
NR4A2,Parkinsonian Disorders,0.5683976277847906
NR4A2,Other specified types of schizophrenia unspecified,0.582492855487907
NR4A2,Adenosquamous carcinoma,0.5916904943304121
NR4A2,SCHIZOPHRENIA 1 (disorder),0.6035970790768342
NR4A2,Angelman Syndrome,0.610971999959321
NR4A2,Tumor Angiogenesis,0.6218520979526325
NR4A2,Dystonia,0.6334536292962906
NR4A2,Dementia,0.6364853529519863
NR4A2,Sepsis,0.6395767498329145
NR4A2,PARKINSON DISEASE LATE-ONSET,0.717484976234209
NR4A2,Septicemia,0.8064248359603999
NR4A2,Dysarthria,0.8464957591845941
NR4A2,Attention deficit hyperactivity disorder,0.8600100703665297
NR4A2,Developmental Disabilities,0.8701913670211346
NR4A2,Dyschezia,0.8815334766742503
NR4A2,Constipation,0.9122550445311894
NR4A2,Schizophrenia,0.0531117779464085
NR4A2,Arsenic Encephalopathy,0.185736315425117
NR4A2,Dermatologic Disorders,0.2895940391390291
NR4A2,Language Disorders,0.3094716280561038
NR4A2,Parkinson Disease,0.4286813331685578
NR4A2,Colorectal Cancer,0.4286813331685578
NR4A2,Arthritis,0.4541466895915311
NR4A2,Mental Depression,0.4560460337187313
NR4A2,Colorectal Neoplasms,0.4560460337187313
NR4A2,Juvenile Arthritis,0.4646409362700993
NR4A2,Polyarthritis Rheumatoid Factor Positive,0.4646409362700993
NR4A2,Seronegative Polyarthritis,0.4875380732267193
NR4A2,Bipolar Disorder,0.4875380732267193
NR4A2,Dementia,0.4875380732267193
NR4A2,Still Disease,0.504364324740411
NR4A2,Dysphagia,0.5127628024019304
NR4A2,Psoriatic Arthritis,0.6130153808924363
NR4A2,Mental Retardation,0.7729545590606223
NR4A2,Dyssomnia,0.8849119011111558
NR4A2,Sleep Disorders,0.9055059991400024
NR4A2,Dysarthria,0.9724404706118156
NR4A2,Autism,0.9783327858636056
NR4A2,Charcot-Marie-Tooth disease type 1D ORPHA:101084,0.7068064785325423
NR4A2,Charcot-Marie-Tooth disease type 4E ORPHA:99951,0.7068064785325423
NR4A2,Human papillomavirus type 72b E7 protein (gene: E7),0.6362779693488597
NRGN,Malignant neoplasm of prostate,0.0569142010728473
NRGN,Central neuroblastoma,0.0593779966354549
NRGN,Neuroblastoma,0.0688152422187159
NRGN,Glioma,0.0739788831250619
NRGN,Prostate carcinoma,0.0773771948186562
NRGN,Unipolar Depression,0.13167400689206
NRGN,Visual seizure,0.1735868515093891
NRGN,Major Depressive Disorder,0.21122597829463
NRGN,Amyloidosis,0.3933196962529684
NRGN,Bipolar Disorder,0.3933196962529684
NRGN,Schizophrenia,0.3933196962529684
NRGN,Alzheimer's Disease,0.3933196962529684
NRGN,Glioblastoma Multiforme,0.3933196962529684
NRGN,Autism Spectrum Disorders,0.3941558617476422
NRGN,Jacobsen Distal 11q Deletion Syndrome,0.4115056600660309
NRGN,Mental disorders,0.4126392832024548
NRGN,Cocaine Abuse,0.4192169590514327
NRGN,Congenital Hypothyroidism,0.4192169590514327
NRGN,Dyslexia,0.4459714599189374
NRGN,Psychotic Disorders,0.4753011022966241
NRGN,Nonorganic psychosis,0.578835730221474
NRGN,Hypothyroidism,0.8306551823873084
NRGN,Schizophrenia,0.0531117779464085
NRGN,Development Disorder,0.4372065554432662
NRGN,Bipolar Disorder,0.4875380732267193
NRGN,Deafness-lymphedema-leukemia syndrome ORPHA:3226,0.3762014630157917
NRGN,Monocytopenia with susceptibility to infections ORPHA:228423,0.3762014630157917
NRGN,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.3826134188846508
NRGN,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.6239678957896782
NRGN,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.6239678957896782
NRGN,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.6239678957896782
NRGN,Bernard-Soulier syndrome ORPHA:274,0.7068064785325423
NRIP1,Mammary Neoplasms,0.0034602840073026
NRIP1,Ovarian Carcinoma,0.0034602840073026
NRIP1,Breast Carcinoma,0.0042545616049287
NRIP1,Adenocarcinoma,0.0155921563748247
NRIP1,Malignant neoplasm of breast,0.0191435238361999
NRIP1,Carcinogenesis,0.0228075668512991
NRIP1,Malignant neoplasm of ovary,0.0277695594716545
NRIP1,Mammary Neoplasms Human,0.064548079316548
NRIP1,Osteoporosis,0.0739788831250619
NRIP1,Endometrial Neoplasms,0.0745502070959292
NRIP1,Liver carcinoma,0.095319386034013
NRIP1,Colon Carcinoma,0.1062239757831962
NRIP1,Chronic Lymphocytic Leukemia,0.1147307578771389
NRIP1,Hematologic Neoplasms,0.1253114324938153
NRIP1,Secondary malignant neoplasm of bone,0.1253114324938153
NRIP1,Malignant neoplasm of endometrium,0.13167400689206
NRIP1,Uterine Corpus Cancer,0.1328002618052838
NRIP1,Myocardial Infarction,0.1352936728187231
NRIP1,Solid Neoplasm,0.1413782599148022
NRIP1,Rheumatoid Arthritis,0.1537760235124317
NRIP1,Malignant tumor of colon,0.223747154820789
NRIP1,Endometrial Carcinoma,0.3044782497745498
NRIP1,Embryonal Carcinoma,0.3112516166225269
NRIP1,Noninfiltrating Intraductal Carcinoma,0.383941725017158
NRIP1,Schizophrenia,0.3933196962529684
NRIP1,Birth Weight,0.3933196962529684
NRIP1,Platelet distribution width measurement,0.4115056600660309
NRIP1,Platelet distribution width result,0.4115056600660309
NRIP1,Refractory anemias,0.421267417774367
NRIP1,Congestive heart failure,0.425419812815905
NRIP1,Heart failure,0.4304973629098372
NRIP1,Germ cell tumor,0.4335751357405352
NRIP1,Steatohepatitis,0.4906258721078565
NRIP1,Fatty Liver,0.533913711453195
NRIP1,Left-Sided Heart Failure,0.5568517196017908
NRIP1,Osteoporosis Postmenopausal,0.5916904943304121
NRIP1,Heart Diseases,0.610971999959321
NRIP1,Heart Decompensation,0.7433468668038986
NRIP1,Metabolic Diseases,0.750779529196619
NRIP1,Heart Failure Right-Sided,0.7533159919746161
NRIP1,Myocardial Failure,0.7577323833810212
NRIP1,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594
NRIP1,Breast Carcinoma,0.0075861267486594
NRIP1,Marfan Syndrome,0.0133304506157067
NRIP1,Mammary Neoplasms,0.0155248163763686
NRIP1,Breast Cancer,0.0402286636010764
NRIP1,Schizophrenia,0.0531117779464085
NRIP1,Endometrial Carcinoma,0.4286813331685578
NRIP1,Ectopic Kidney,0.4402141802500753
NRIP1,Vesicoureteral Reflux,0.4714699023601434
NRIP1,Endometrial Neoplasms,0.4931425946912698
NRIP1,Myocardial Infarction,0.5632819212593052
NRIP1,Renal Cyst,0.7167438233451096
NRIP1,Heart Failure,0.7360789997461612
NRIP1,Hydronephrosis,0.7412420740397021
NRIP1,Congestive Heart Failure,0.7532174466905212
NRIP1,Familial multiple nevi flammei ORPHA:624,0.0180064224283883
NRIP1,Sturge-Weber syndrome ORPHA:3205,0.0180064224283883
OGFR,Ovarian Carcinoma,0.0034602840073026
OGFR,Tumor Progression,0.0149315928814189
OGFR,Malignant neoplasm of ovary,0.0277695594716545
OGFR,Malignant neoplasm of pancreas,0.0726340460169901
OGFR,Pancreatic Neoplasm,0.0739788831250619
OGFR,Pancreatic carcinoma,0.0745502070959292
OGFR,Squamous cell carcinoma of the head and neck,0.0775520919998773
OGFR,Colonic Neoplasms,0.1454373331146953
OGFR,Malignant neoplasm of liver,0.2643145809900195
OGFR,Ataxia Telangiectasia,0.3508665345292502
OGFR,Papillary thyroid carcinoma,0.3933196962529684
OGFR,Thyroid carcinoma,0.3941558617476422
OGFR,Malignant neoplasm of thyroid,0.4307603335611732
OGFR,Mucopolysaccharidosis type 4A ORPHA:309297,0.0586579655822394
OGFR,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.1590470395003315
OGFR,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.1739455566145445
OGFR,Glycogen storage disease due to acid maltase deficiency infantile onset ORPHA:308552,0.3762014630157917
OGFR,Glycogen storage disease due to acid maltase deficiency late-onset ORPHA:420429,0.3762014630157917
OGFR,Neutral lipid storage myopathy ORPHA:98908,0.3762014630157917
OGFR,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.3762014630157917
OGFR,NON RARE IN EUROPE: Paget disease of bone ORPHA:280110,0.3762014630157917
OGFR,Adrenomyeloneuropathy ORPHA:139399,0.6239678957896782
OGFR,Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179,0.6239678957896782
OGFR,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044,0.6239678957896782
OGFR,Autosomal recessive spastic paraplegia type 48 ORPHA:306511,0.6239678957896782
OGFR,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.6239678957896782
OGFR,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.6239678957896782
OGFR,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.6239678957896782
OGFR,Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409,0.6239678957896782
OGFR,Peutz-Jeghers syndrome ORPHA:2869,0.6239678957896782
OGFR,Polyglucosan body myopathy type 1 ORPHA:397937,0.6239678957896782
OGFR,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.6239678957896782
OGFR,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.6239678957896782
OGFR,Alveolar soft tissue sarcoma ORPHA:163699,0.6239678957896782
OGFR,Autosomal recessive progressive external ophthalmoplegia ORPHA:254886,0.6239678957896782
OGFR,Proteus syndrome ORPHA:744,0.6239678957896782
OGFR,Charcot-Marie-Tooth disease type 2B2 ORPHA:101101,0.7068064785325423
OGFR,Albers Schonberg osteopetrosis ORPHA:53,0.7068064785325423
OGFR,Alpers-Huttenlocher syndrome ORPHA:726,0.7068064785325423
OGFR,Alpha-mannosidosis adult form ORPHA:309288,0.7068064785325423
OGFR,Alpha-mannosidosis infantile form ORPHA:309282,0.7068064785325423
OGFR,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.7068064785325423
OGFR,Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180,0.7068064785325423
OGFR,Ataxia-oculomotor apraxia type 4 ORPHA:459033,0.7068064785325423
OGFR,Autosomal recessive spastic paraplegia type 39 ORPHA:139480,0.7068064785325423
OGFR,CLN4B disease ORPHA:228343,0.7068064785325423
OGFR,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.7068064785325423
OGFR,Charcot-Marie-Tooth disease type 2S ORPHA:443073,0.7068064785325423
OGFR,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.7068064785325423
OGFR,Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431,0.7068064785325423
OGFR,Hurler syndrome ORPHA:93473,0.7068064785325423
OGFR,Hurler-Scheie syndrome ORPHA:93476,0.7068064785325423
OGFR,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.7068064785325423
OGFR,Incontinentia pigmenti ORPHA:464,0.7068064785325423
OGFR,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316,0.7068064785325423
OGFR,Laurence-Moon syndrome ORPHA:2377,0.7068064785325423
OGFR,Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845,0.7068064785325423
OGFR,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.7068064785325423
OGFR,Neuralgic amyotrophy ORPHA:2901,0.7068064785325423
OGFR,Predisposition to invasive fungal disease due to CARD9 deficiency ORPHA:457088,0.7068064785325423
OGFR,Recessive mitochondrial ataxia syndrome ORPHA:94125,0.7068064785325423
OGFR,Scheie syndrome ORPHA:93474,0.7068064785325423
OGFR,Spinal muscular atrophy with respiratory distress type 1 ORPHA:98920,0.7068064785325423
OGFR,Spinocerebellar ataxia with epilepsy ORPHA:254881,0.7068064785325423
OGFR,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.7068064785325423
OGFR,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363,0.7068064785325423
OGFR,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.7068064785325423
OGFR,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173,0.7068064785325423
OGFR,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.7068064785325423
OGFR,Intermediate osteopetrosis ORPHA:210110,0.7068064785325423
OGFR,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595,0.7068064785325423
OGFR,Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298,0.7068064785325423
OGFR,Prolactinoma ORPHA:2965,0.7068064785325423
OIP5,Breast Carcinoma,0.0042545616049287
OIP5,Stomach Carcinoma,0.0149315928814189
OIP5,Squamous cell carcinoma,0.0182265588252201
OIP5,Esophageal Neoplasms,0.0182265588252201
OIP5,Malignant neoplasm of breast,0.0191435238361999
OIP5,Malignant neoplasm of stomach,0.0191435238361999
OIP5,Carcinogenesis,0.0228075668512991
OIP5,Malignant neoplasm of esophagus,0.0248454592431097
OIP5,Glioblastoma,0.0745502070959292
OIP5,Malignant neoplasm of urinary bladder,0.084286432100041
OIP5,Bladder Neoplasm,0.0891725280554336
OIP5,Liver carcinoma,0.095319386034013
OIP5,Malignant Neoplasms,0.0991201145654548
OIP5,Esophageal carcinoma,0.1254380558571286
OIP5,Carcinoma of bladder,0.13167400689206
OIP5,Malignant neoplasm of lung,0.2714542429024338
OIP5,Primary malignant neoplasm,0.383941725017158
OIP5,Obesity,0.5140447474168605
OIP5,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.0180064224283883
OIP5,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0180064224283883
OIP5,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.0180064224283883
OIP5,Microcephaly-micromelia syndrome ORPHA:572768,0.0586579655822394
OIP5,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0586579655822394
OIP5,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0599424746210022
OIP5,Amish nemaline myopathy ORPHA:98902,0.1590470395003315
OIP5,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.3762014630157917
OIP5,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.3762014630157917
OIP5,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.6239678957896782
OIP5,Adenylosuccinate lyase deficiency ORPHA:46,0.6239678957896782
OIP5,Autosomal recessive Kenny-Caffey syndrome ORPHA:93324,0.6239678957896782
OIP5,Combined oxidative phosphorylation defect type 2 ORPHA:254920,0.6239678957896782
OIP5,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898,0.6239678957896782
OIP5,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome ORPHA:496756,0.6239678957896782
OIP5,Hereditary coproporphyria ORPHA:79273,0.6239678957896782
OIP5,Hyper-IgM syndrome type 5 ORPHA:101092,0.6239678957896782
OIP5,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.6239678957896782
OIP5,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.6239678957896782
OIP5,Lipoyl transferase 2 deficiency ORPHA:447795,0.6239678957896782
OIP5,Mohr-Tranebjaerg syndrome ORPHA:52368,0.6239678957896782
OIP5,Multiple system atrophy cerebellar type ORPHA:227510,0.6239678957896782
OIP5,Multiple system atrophy parkinsonian type ORPHA:98933,0.6239678957896782
OIP5,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.6239678957896782
OIP5,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.6239678957896782
OIP5,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.6239678957896782
OIP5,Reticular dysgenesis ORPHA:33355,0.6239678957896782
OIP5,Sanjad-Sakati syndrome ORPHA:2323,0.6239678957896782
OIP5,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.6239678957896782
OIP5,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.6239678957896782
OIP5,ALG8-CDG ORPHA:79325,0.7068064785325423
OIP5,Acute intermittent porphyria ORPHA:79276,0.7068064785325423
OIP5,Brody myopathy ORPHA:53347,0.7068064785325423
OIP5,Combined oxidative phosphorylation defect type 24 ORPHA:444458,0.7068064785325423
OIP5,Cutis marmorata telangiectatica congenita ORPHA:1556,0.7068064785325423
OIP5,Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030,0.7068064785325423
OIP5,Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360,0.7068064785325423
OIP5,X-linked intellectual disability Snyder type ORPHA:3063,0.7068064785325423
OIP5,Anaplastic oligodendroglioma ORPHA:251630,0.7068064785325423
OIP5,Oligodendroglioma ORPHA:251627,0.7068064785325423
OSTM1,Lysosomal Storage Diseases,0.0798053340865682
OSTM1,Hamartoma,0.3933196962529684
OSTM1,Hydrocephalus,0.3933196962529684
OSTM1,Bone Diseases,0.3941558617476422
OSTM1,Teratocarcinoma,0.3941558617476422
OSTM1,Infantile malignant osteopetrosis,0.4028066164685291
OSTM1,Osteopetrosis,0.4126392832024548
OSTM1,Neurodegenerative Disorders,0.4335751357405352
OSTM1,Stillbirth,0.4335751357405352
OSTM1,Fetal Death,0.472444704048021
OSTM1,Abnormality of metabolism/homeostasis,0.6274540883972485
OSTM1,Optic Atrophy,0.809878589520458
OSTM1,Partial Agenesis Of Corpus Callosum,0.2187610616307245
OSTM1,Blood Coagulation Disorders,0.3094716280561038
OSTM1,Hyperbilirubinemia,0.3094716280561038
OSTM1,Osteopetrosis,0.336287627428424
OSTM1,Hydrocephalus,0.3657224783929353
OSTM1,Hyperostosis Of Skull,0.4286813331685578
OSTM1,Hypoplastic Hippocampus,0.4286813331685578
OSTM1,Mental Depression,0.4560460337187313
OSTM1,Respiratory Failure,0.4560460337187313
OSTM1,Anemia,0.4780231573499264
OSTM1,Cranial Nerve Paralysis,0.4867879381749835
OSTM1,Microcephaly,0.5123947823327547
OSTM1,Cerebral Atrophy,0.5129298662020659
OSTM1,Liver Failure,0.5162067638232762
OSTM1,Micrognathism,0.5234357475824973
OSTM1,Pancytopenia,0.5234357475824973
OSTM1,Seizure,0.5576425853515448
OSTM1,Hearing Loss,0.5632819212593052
OSTM1,Dwarfism,0.5796489603182782
OSTM1,Nervous System Diseases,0.6420878824691651
OSTM1,Optic Atrophy,0.675936313627625
OSTM1,Spastic Quadriplegia,0.7167438233451096
OSTM1,Nystagmus,0.9146877763175152
OSTM1,Developmental Delay,0.96477535147595
OSTM1,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670,0.3762014630157917
OSTM1,Free sialic acid storage disease infantile form ORPHA:309324,0.3762014630157917
OSTM1,Fried syndrome ORPHA:85335,0.3762014630157917
OSTM1,Intermediate severe Salla disease ORPHA:309331,0.3762014630157917
OSTM1,Salla disease ORPHA:309334,0.3762014630157917
OSTM1,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568,0.3762014630157917
OSTM1,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329,0.3762014630157917
OSTM1,Ocular albinism with congenital sensorineural deafness ORPHA:352740,0.6239678957896782
OSTM1,Alkaline ceramidase 3 deficiency ORPHA:502444,0.6239678957896782
OSTM1,Glycogen storage disease due to LAMP-2 deficiency ORPHA:34587,0.7068064785325423
OSTM1,Infantile osteopetrosis with neuroaxonal dysplasia ORPHA:85179,0.7068064785325423
OSTM1,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.7068064785325423
OSTM1,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.7068064785325423
OSTM1,TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261,0.7068064785325423
OSTM1,X-linked intellectual disability Hedera type ORPHA:93952,0.7068064785325423
OSTM1,X-linked parkinsonism-spasticity syndrome ORPHA:363654,0.7068064785325423
OSTM1,Autosomal recessive cutis laxa type 2 classic type ORPHA:357074,0.7068064785325423
P2RX7,Mammary Neoplasms,0.0034602840073026
P2RX7,Breast Carcinoma,0.0042545616049287
P2RX7,Colorectal Cancer,0.0149315928814189
P2RX7,Tumor Progression,0.0149315928814189
P2RX7,melanoma,0.0149315928814189
P2RX7,Adenocarcinoma,0.0155921563748247
P2RX7,Malignant neoplasm of breast,0.0191435238361999
P2RX7,Carcinogenesis,0.0228075668512991
P2RX7,Hematopoietic Neoplasms,0.0334891258932371
P2RX7,Malignant neoplasm of prostate,0.0569142010728473
P2RX7,Central neuroblastoma,0.0593779966354549
P2RX7,Brain Neoplasms,0.064548079316548
P2RX7,Neoplasm Metastasis,0.0648809611869375
P2RX7,Neuroblastoma,0.0688152422187159
P2RX7,Malignant neoplasm of pancreas,0.0726340460169901
P2RX7,Pancreatic Neoplasm,0.0739788831250619
P2RX7,Glioma,0.0739788831250619
P2RX7,Degenerative polyarthritis,0.0739788831250619
P2RX7,Osteoporosis,0.0739788831250619
P2RX7,Lymphoma,0.0739788831250619
P2RX7,Pancreatic carcinoma,0.0745502070959292
P2RX7,Prostate carcinoma,0.0773771948186562
P2RX7,Liver carcinoma,0.095319386034013
P2RX7,Osteosarcoma,0.1029977559100099
P2RX7,Chronic Lymphocytic Leukemia,0.1147307578771389
P2RX7,Secondary malignant neoplasm of bone,0.1253114324938153
P2RX7,MYELODYSPLASTIC SYNDROME,0.1254380558571286
P2RX7,Unipolar Depression,0.13167400689206
P2RX7,Hyperactive behavior,0.1387448809655294
P2RX7,Solid Neoplasm,0.1413782599148022
P2RX7,Liver neoplasms,0.1454373331146953
P2RX7,Rheumatoid Arthritis,0.1537760235124317
P2RX7,Head and Neck Carcinoma,0.1735868515093891
P2RX7,Osteosarcoma of bone,0.2109483801368481
P2RX7,Major Depressive Disorder,0.21122597829463
P2RX7,Diabetes,0.2277108302018961
P2RX7,Metastasis from malignant tumor of prostate,0.2454426921531692
P2RX7,Malignant Head and Neck Neoplasm,0.2522264785494494
P2RX7,Diabetes Mellitus,0.2522264785494494
P2RX7,B-CELL MALIGNANCY LOW-GRADE,0.2522264785494494
P2RX7,Small Lymphocytic Lymphoma,0.2643145809900195
P2RX7,Metastatic Prostate Carcinoma,0.2643145809900195
P2RX7,Multiple Sclerosis,0.2835142372342932
P2RX7,Myeloid Leukemia,0.2980670559114652
P2RX7,Sjogren's Syndrome,0.3099246715197673
P2RX7,Acute pancreatitis,0.3220099003872086
P2RX7,Ischemic stroke,0.3486533561309259
P2RX7,Tuberculosis,0.3706856725676674
P2RX7,Thyroid Neoplasm,0.383941725017158
P2RX7,Tuberculosis Pulmonary,0.383941725017158
P2RX7,Amyloidosis,0.3933196962529684
P2RX7,Bipolar Disorder,0.3933196962529684
P2RX7,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
P2RX7,Pancreatitis Chronic,0.3933196962529684
P2RX7,Papillary thyroid carcinoma,0.3933196962529684
P2RX7,Schizophrenia,0.3933196962529684
P2RX7,Gastroesophageal reflux disease,0.3933196962529684
P2RX7,Hypertensive disease,0.3933196962529684
P2RX7,Bronchopulmonary Dysplasia,0.3933196962529684
P2RX7,Chronic esophagitis,0.3933196962529684
P2RX7,Neurobehavioral Manifestations,0.3933196962529684
P2RX7,Skin Neoplasms,0.3933196962529684
P2RX7,Astrocytoma,0.3933196962529684
P2RX7,Alzheimer's Disease,0.3933196962529684
P2RX7,Anxiety Disorders,0.3933196962529684
P2RX7,Lymphoma Non-Hodgkin,0.3933196962529684
P2RX7,Inflammatory Bowel Diseases,0.3933196962529684
P2RX7,Glomerulonephritis,0.3933196962529684
P2RX7,manic symptom,0.3933196962529684
P2RX7,Asthma,0.3933196962529684
P2RX7,Spinal Cord Contusion,0.3933196962529684
P2RX7,Spinal Cord Injuries,0.3933196962529684
P2RX7,Spinal Cord Laceration,0.3933196962529684
P2RX7,Spinal Cord transection injury,0.3933196962529684
P2RX7,Post-Traumatic Myelopathy,0.3933196962529684
P2RX7,Polycystic Kidney Autosomal Dominant,0.3941558617476422
P2RX7,Mental Depression,0.3941558617476422
P2RX7,Bone Diseases,0.3941558617476422
P2RX7,NEUROTICISM,0.39623320406434
P2RX7,Amyotrophic Lateral Sclerosis,0.3975960596292668
P2RX7,Mechanical Allodynia,0.3975960596292668
P2RX7,Depressive disorder,0.3975960596292668
P2RX7,Chronic Kidney Diseases,0.4028066164685291
P2RX7,Musculoskeletal Diseases,0.4028066164685291
P2RX7,Acute myocardial infarction,0.4103119460235835
P2RX7,Multiple Myeloma,0.4103119460235835
P2RX7,Epilepsy Temporal Lobe,0.4103119460235835
P2RX7,Tuberculosis Multidrug-Resistant,0.4103119460235835
P2RX7,Hemophagocytic Syndrome,0.4103119460235835
P2RX7,Primary gout,0.4115056600660309
P2RX7,Polycystic Kidney Diseases,0.4126392832024548
P2RX7,Mood Disorders,0.4192169590514327
P2RX7,Lupus Erythematosus Systemic,0.4213286052188015
P2RX7,Congestive heart failure,0.425419812815905
P2RX7,Adult Non-Hodgkin Lymphoma,0.425419812815905
P2RX7,Agoraphobia,0.425419812815905
P2RX7,Encephalomyelitis,0.4254307049060398
P2RX7,Heart failure,0.4304973629098372
P2RX7,Hypophosphatasia,0.4304973629098372
P2RX7,Trisomy,0.4335751357405352
P2RX7,Neurodegenerative Disorders,0.4335751357405352
P2RX7,Lupus Vulgaris,0.4335751357405352
P2RX7,Lymphatic Metastasis,0.4342056919538745
P2RX7,Tuberculosis extrapulmonary,0.4396723023384634
P2RX7,Depressive Symptoms,0.4459714599189374
P2RX7,Bone Cysts Aneurysmal,0.4459714599189374
P2RX7,Childhood Non-Hodgkin Lymphoma,0.4459714599189374
P2RX7,Fleck corneal dystrophy,0.4459714599189374
P2RX7,Myocardial Ischemia,0.4506578937113162
P2RX7,Epilepsy Benign Psychomotor Childhood,0.4506578937113162
P2RX7,Uncinate Epilepsy,0.4506578937113162
P2RX7,Primary Sj??gren's syndrome,0.451408428170596
P2RX7,leukemia,0.4588513406515081
P2RX7,Lupus Erythematosus,0.4615352570710579
P2RX7,Epilepsy Lateral Temporal,0.4615352570710579
P2RX7,Lupus Erythematosus Discoid,0.4675904598629673
P2RX7,Huntington Disease,0.4704594475773637
P2RX7,Uveal melanoma,0.472444704048021
P2RX7,Malignant Bone Neoplasm,0.472444704048021
P2RX7,Recurrent major depressive episodes,0.4753011022966241
P2RX7,Acute GVH disease,0.4790179402069343
P2RX7,Pain,0.4871698998714747
P2RX7,Impaired glucose tolerance,0.4900770016856776
P2RX7,Osteopenia,0.4923669467696064
P2RX7,Neuralgia,0.4923669467696064
P2RX7,Crohn Disease,0.4981941174985421
P2RX7,Chronic Obstructive Airway Disease,0.5049674142533507
P2RX7,Borderline Personality Disorder,0.5188223685230745
P2RX7,Colitis,0.5323590634832615
P2RX7,Familial (FPAH),0.533913711453195
P2RX7,intracranial glioma,0.5393787854381349
P2RX7,Multiple Sclerosis Acute Fulminating,0.5453394612016188
P2RX7,Mixed anxiety and depressive disorder,0.5453394612016188
P2RX7,Hyperplasia,0.5514573300659174
P2RX7,Arthritis,0.553002957824355
P2RX7,Metabolic Syndrome X,0.5568517196017908
P2RX7,Chronic pain,0.5568517196017908
P2RX7,Lymphohistiocytosis Hemophagocytic,0.5710095678317721
P2RX7,Graft-vs-Host Disease,0.5922440535658843
P2RX7,Chlamydia Infections,0.6035970790768342
P2RX7,MAJOR AFFECTIVE DISORDER 8,0.610971999959321
P2RX7,MAJOR AFFECTIVE DISORDER 9,0.610971999959321
P2RX7,Cystic Fibrosis,0.6124306570512981
P2RX7,MAJOR AFFECTIVE DISORDER 7,0.6150955455771212
P2RX7,Brain Diseases,0.6319938293757544
P2RX7,Bipolar I disorder,0.6319938293757544
P2RX7,Sepsis,0.6395767498329145
P2RX7,Narcolepsy,0.6496433426951205
P2RX7,Hyperuricemia,0.652707626880454
P2RX7,MAJOR AFFECTIVE DISORDER 4,0.652707626880454
P2RX7,MAJOR AFFECTIVE DISORDER 6,0.652707626880454
P2RX7,MAJOR AFFECTIVE DISORDER 1,0.6588479076808555
P2RX7,Inflammatory pain,0.6656356363792992
P2RX7,aggressive cancer,0.6691893635307453
P2RX7,Chagas Disease,0.7068844070911514
P2RX7,Bacteremia,0.7096959691931399
P2RX7,Lung diseases,0.7128284704851243
P2RX7,MAJOR AFFECTIVE DISORDER 2,0.726789939981526
P2RX7,Severe Sepsis,0.7467090191923123
P2RX7,Post-Traumatic Stress Disorder,0.7631684472516962
P2RX7,Infectious disease of lung,0.7670529315163258
P2RX7,Septicemia,0.8064248359603999
P2RX7,Hyperinsulinism,0.8245140009975604
P2RX7,Age related macular degeneration,0.8304052766033214
P2RX7,Lymphocytic Leukemia,0.0487679768343083
P2RX7,Epilepsy,0.3449614869411272
P2RX7,Colorectal Cancer,0.4286813331685578
P2RX7,Mental Depression,0.4560460337187313
P2RX7,Mood Disorder,0.4646409362700993
P2RX7,Bipolar Disorder,0.4875380732267193
P2RX7,Multiple Sclerosis,0.880175848034561
P2RX7,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.0586579655822394
P2RX7,Spinocerebellar ataxia type 1 ORPHA:98755,0.1590470395003315
P2RX7,Attenuated Chediak-Higashi syndrome ORPHA:352723,0.3762014630157917
P2RX7,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.3762014630157917
P2RX7,Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267,0.3762014630157917
P2RX7,Chediak-Higashi syndrome ORPHA:167,0.3762014630157917
P2RX7,GM3 synthase deficiency ORPHA:370933,0.3762014630157917
P2RX7,Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552,0.3762014630157917
P2RX7,Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537,0.3762014630157917
P2RX7,Bietti crystalline dystrophy ORPHA:41751,0.6239678957896782
P2RX7,Spinocerebellar ataxia type 15/16 ORPHA:98769,0.6239678957896782
P2RX7,Spinocerebellar ataxia type 29 ORPHA:208513,0.6239678957896782
P2RX7,Megalencephalic leukoencephalopathy with subcortical cysts ORPHA:2478,0.6239678957896782
P2RX7,Hereditary clear cell renal cell carcinoma ORPHA:422526,0.639029370164481
P2RX7,Narcolepsy type 1 ORPHA:2073,0.64564126367818
P2RX7,B-cell chronic lymphocytic leukemia ORPHA:67038,0.6581690778726346
P2RX7,5q14.3 microdeletion syndrome ORPHA:228384,0.7068064785325423
P2RX7,Autosomal dominant vitreoretinochoroidopathy ORPHA:3086,0.7068064785325423
P2RX7,Autosomal recessive bestrophinopathy ORPHA:139455,0.7068064785325423
P2RX7,Best vitelliform macular dystrophy ORPHA:1243,0.7068064785325423
P2RX7,MRCS syndrome ORPHA:263347,0.7068064785325423
P2RX7,X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome ORPHA:324410,0.7068064785325423
P2RX7,Andersen-Tawil syndrome ORPHA:37553,0.7068064785325423
P2RX7,Idiopathic achalasia ORPHA:930,0.7068064785325423
P3H2,Breast Carcinoma,0.0042545616049287
P3H2,melanoma,0.0149315928814189
P3H2,Malignant neoplasm of breast,0.0191435238361999
P3H2,Brain Neoplasms,0.064548079316548
P3H2,Hyperactive behavior,0.1387448809655294
P3H2,Marfan Syndrome,0.1735868515093891
P3H2,Cataract,0.223747154820789
P3H2,Ectopia Lentis,0.3638414818541592
P3H2,Lens Opacities,0.4213286052188015
P3H2,Severe myopia,0.5140447474168605
P3H2,Myopia,0.5239792328442205
P3H2,Exanthema,0.7674304683279349
P3H2,Breast Cancer,0.0402286636010764
P3H2,Cataract,0.6660731887258019
P3H2,Myopia,0.7405519560111998
P3H2,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
P3H2,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.0180064224283883
P3H2,Craniodiaphyseal dysplasia ORPHA:1513,0.3762014630157917
P3H2,Congenital contractural arachnodactyly ORPHA:115,0.6239678957896782
P3H2,Rare isolated myopia ORPHA:98619,0.6239678957896782
PADI3,Malignant neoplasm of breast,0.0191435238361999
PADI3,Carcinogenesis,0.0228075668512991
PADI3,Rheumatoid Arthritis,0.1537760235124317
PADI3,Pili canaliculi,0.3933196962529684
PADI3,White hair,0.3933196962529684
PADI3,Rough hair texture,0.3933196962529684
PADI3,Coarse hair,0.3933196962529684
PADI3,Dry hair,0.3941558617476422
PADI3,Wooly hair,0.4213286052188015
PADI3,Afro-textured hair,0.4213286052188015
PADI3,Kinky hair texture,0.4213286052188015
PADI3,Nappy hair texture,0.4213286052188015
PADI3,Forced expiratory volume function,0.4929829683479762
PADI3,Smell Perception,0.5568517196017908
PADI3,Breast Cancer,0.0402286636010764
PADI3,Alopecia Areata,0.5234357475824973
PADI3,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
PADI3,Bamforth-Lazarus syndrome ORPHA:1226,0.0180064224283883
PADI3,White sponge nevus ORPHA:171723,0.1590470395003315
PADI3,Amish nemaline myopathy ORPHA:98902,0.1590470395003315
PADI3,Harlequin ichthyosis ORPHA:457,0.1590470395003315
PADI3,Monilethrix ORPHA:573,0.1590470395003315
PADI3,Uncombable hair syndrome ORPHA:1410,0.1590470395003315
PADI3,Idiopathic juvenile osteoporosis ORPHA:85193,0.1590470395003315
PADI3,Bifid uvula ORPHA:99771,0.3762014630157917
PADI3,Cleft hard palate ORPHA:101023,0.3762014630157917
PADI3,Cleft velum ORPHA:99772,0.3762014630157917
PADI3,Submucosal cleft palate ORPHA:155878,0.3762014630157917
PADI3,Autosomal recessive distal renal tubular acidosis ORPHA:402041,0.6239678957896782
PADI3,Pure hair and nail ectodermal dysplasia ORPHA:69084,0.7068064785325423
PBX1,Mammary Neoplasms,0.0034602840073026
PBX1,Ovarian Carcinoma,0.0034602840073026
PBX1,Breast Carcinoma,0.0042545616049287
PBX1,Stomach Carcinoma,0.0149315928814189
PBX1,Retroviridae Infections,0.0149315928814189
PBX1,melanoma,0.0149315928814189
PBX1,Squamous cell carcinoma,0.0182265588252201
PBX1,Pre B-cell acute lymphoblastic leukemia,0.0189794808441368
PBX1,ovarian neoplasm,0.0191435238361999
PBX1,Malignant neoplasm of breast,0.0191435238361999
PBX1,Carcinogenesis,0.0228075668512991
PBX1,Malignant neoplasm of ovary,0.0277695594716545
PBX1,Hematopoietic Neoplasms,0.0334891258932371
PBX1,Malignant neoplasm of prostate,0.0569142010728473
PBX1,Central neuroblastoma,0.0593779966354549
PBX1,Neoplasm Metastasis,0.0648809611869375
PBX1,Neuroblastoma,0.0688152422187159
PBX1,Malignant neoplasm of pancreas,0.0726340460169901
PBX1,Lymphoma,0.0739788831250619
PBX1,Pancreatic carcinoma,0.0745502070959292
PBX1,Prostate carcinoma,0.0773771948186562
PBX1,Adult Acute Lymphocytic Leukemia,0.0919714360040484
PBX1,Ganglioneuroma,0.1138051695421299
PBX1,Hematologic Neoplasms,0.1253114324938153
PBX1,Hyperactive behavior,0.1387448809655294
PBX1,Adrenal Gland Diseases,0.1735868515093891
PBX1,Lung Neoplasms,0.2062010908869036
PBX1,Prostatic Neoplasms,0.223747154820789
PBX1,Diabetes,0.2277108302018961
PBX1,Burkitt Lymphoma,0.2521987644415915
PBX1,Diabetes Mellitus,0.2522264785494494
PBX1,Acute leukemia,0.2835142372342932
PBX1,Myeloid Leukemia,0.2980670559114652
PBX1,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
PBX1,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.3105909001629992
PBX1,Leukemogenesis,0.3510063969122338
PBX1,Chromosome 8 trisomy,0.3925783478421996
PBX1,African Burkitt's lymphoma,0.3933196962529684
PBX1,Cakut,0.3933196962529684
PBX1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
PBX1,Nephroblastoma,0.3933196962529684
PBX1,Androgen-Insensitivity Syndrome,0.3933196962529684
PBX1,Non-Small Cell Lung Carcinoma,0.3933196962529684
PBX1,Leukemia Myelocytic Acute,0.3933196962529684
PBX1,Truncus Arteriosus Persistent,0.3933196962529684
PBX1,Acute lymphocytic leukemia,0.3933196962529684
PBX1,Acute Promyelocytic Leukemia,0.3933196962529684
PBX1,Lymphoid leukemia,0.3933196962529684
PBX1,Neoplasm Residual,0.3941558617476422
PBX1,androgen independent prostate cancer,0.3941558617476422
PBX1,Drug abuse,0.3941558617476422
PBX1,Pituitary Neoplasms,0.3941558617476422
PBX1,Rous Sarcoma,0.39623320406434
PBX1,Childhood Pre-B Acute Lymphoblastic Leukemia,0.3975960596292668
PBX1,Lymphoblastic leukemia in children,0.3975960596292668
PBX1,Drug Dependence,0.4028066164685291
PBX1,Myoepithelioma,0.4192169590514327
PBX1,Lupus Erythematosus Systemic,0.4213286052188015
PBX1,Congenital absence of spleen,0.425419812815905
PBX1,Infant Premature,0.4304973629098372
PBX1,Rokitansky Kuster Hauser syndrome,0.4304973629098372
PBX1,Lupus Vulgaris,0.4335751357405352
PBX1,Substance Use Disorders,0.4381343267935581
PBX1,leukemia,0.4588513406515081
PBX1,Substance abuse problem,0.4615352570710579
PBX1,Lupus Erythematosus,0.4615352570710579
PBX1,Lupus Erythematosus Discoid,0.4675904598629673
PBX1,Promyelocytic leukemia,0.4675904598629673
PBX1,Adenocarcinoma in Situ,0.4852430673532381
PBX1,Hyperdiploid B Acute Lymphoblastic Leukemia,0.4852430673532381
PBX1,Adrenal gland hypofunction,0.5090214163899865
PBX1,Common acute lymphoblastic leukemia,0.5188223685230745
PBX1,Congenital Abnormality,0.5305233935923577
PBX1,Obsessive-Compulsive Disorder,0.5305233935923577
PBX1,Organic Mental Disorders Substance-Induced,0.533913711453195
PBX1,Prescription Drug Abuse,0.533913711453195
PBX1,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
PBX1,Drug Use Disorders,0.5393787854381349
PBX1,Precursor B-cell lymphoblastic leukemia,0.5451009374855866
PBX1,Substance-Related Disorders,0.5514573300659174
PBX1,Tetralogy of Fallot,0.5557519470957561
PBX1,Drug habituation,0.589345563575654
PBX1,Substance Dependence,0.5936773368594411
PBX1,Congenital chromosomal disease,0.6035970790768342
PBX1,Hematological Disease,0.610971999959321
PBX1,Childhood Leukemia,0.656104947944719
PBX1,Metabolic Diseases,0.750779529196619
PBX1,Intellectual Disability,0.8352623613787349
PBX1,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594
PBX1,African Burkitt`s Lymphoma,0.2960946950751588
PBX1,Bilateral Renal Hypoplasia,0.4286813331685578
PBX1,Ectopic Kidney,0.4402141802500753
PBX1,Burkitt`s Lymphoma,0.4541466895915311
PBX1,Horseshoe Kidney,0.4560460337187313
PBX1,Vesicoureteral Reflux,0.4714699023601434
PBX1,Renal Hypoplasia,0.4875380732267193
PBX1,Ambiguous Genitalia,0.5021774953934145
PBX1,Lymphoblastic Leukemia,0.5129298662020659
PBX1,Congenital Diaphragmatic Hernia,0.5162067638232762
PBX1,Renal Agenesis,0.5207800595599322
PBX1,Renal Dysplasia,0.657896505422784
PBX1,Renal Insufficiency,0.7112499273451761
PBX1,Leukemia,0.7167438233451096
PBX1,Penis Agenesis,0.7662135194687344
PBX1,Congenital Epicanthus,0.7729545590606223
PBX1,Cryptorchidism,0.776786668801341
PBX1,Microtia,0.8273480078036296
PBX1,Motor Delay,0.8371848756758566
PBX1,Strabismus,0.9568083835980838
PBX1,Nance-Horan syndrome ORPHA:627,0.0180064224283883
PBX1,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.0180064224283883
PBX1,Matthew-Wood syndrome ORPHA:2470,0.0180064224283883
PBX1,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.0586579655822394
PBX1,Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527,0.0586579655822394
PBX1,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.0586579655822394
PBX1,1p31p32 microdeletion syndrome ORPHA:401986,0.1590470395003315
PBX1,Brachydactyly-arterial hypertension syndrome ORPHA:1276,0.1590470395003315
PBX1,Complete androgen insensitivity syndrome ORPHA:99429,0.1590470395003315
PBX1,Female restricted epilepsy with intellectual disability ORPHA:101039,0.1590470395003315
PBX1,Kennedy disease ORPHA:481,0.1590470395003315
PBX1,Partial androgen insensitivity syndrome ORPHA:90797,0.1590470395003315
PBX1,Familial patent arterial duct ORPHA:466729,0.1590470395003315
PBX1,Pfeiffer syndrome type 1 ORPHA:93258,0.1590470395003315
PBX1,Butterfly-shaped pigment dystrophy ORPHA:99001,0.1590470395003315
PBX1,Growth delay due to insulin-like growth factor I resistance ORPHA:73273,0.3762014630157917
PBX1,Renal hypoplasia bilateral ORPHA:97362,0.3762014630157917
PBX1,Renal agenesis bilateral ORPHA:1848,0.3775879467205478
PBX1,Posterior polymorphous corneal dystrophy ORPHA:98973,0.3826134188846508
PBX1,Renal agenesis unilateral ORPHA:93100,0.3969770464111636
PBX1,Brugada syndrome ORPHA:130,0.5145066480201691
PBX1,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.6239678957896782
PBX1,ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996,0.6239678957896782
PBX1,Apert syndrome ORPHA:87,0.6239678957896782
PBX1,Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490,0.6239678957896782
PBX1,Autosomal dominant spastic paraplegia type 31 ORPHA:101011,0.6239678957896782
PBX1,Autosomal recessive extra-oral halitosis ORPHA:562538,0.6239678957896782
PBX1,Colobomatous microphthalmia-rhizomelic dysplasia syndrome ORPHA:424099,0.6239678957896782
PBX1,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555,0.6239678957896782
PBX1,FGFR2-related bent bone dysplasia ORPHA:313855,0.6239678957896782
PBX1,Familial scaphocephaly syndrome McGillivray type ORPHA:168624,0.6239678957896782
PBX1,Fraser syndrome ORPHA:2052,0.6239678957896782
PBX1,Goldmann-Favre syndrome ORPHA:53540,0.6239678957896782
PBX1,Hyperinsulinism due to INSR deficiency ORPHA:263458,0.6239678957896782
PBX1,Insulin-resistance syndrome type A ORPHA:2297,0.6239678957896782
PBX1,Jackson-Weiss syndrome ORPHA:1540,0.6239678957896782
PBX1,Kaposiform hemangioendothelioma ORPHA:2122,0.6239678957896782
PBX1,Leprechaunism ORPHA:508,0.6239678957896782
PBX1,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome ORPHA:85112,0.6239678957896782
PBX1,Pfeiffer syndrome type 2 ORPHA:93259,0.6239678957896782
PBX1,Pfeiffer syndrome type 3 ORPHA:93260,0.6239678957896782
PBX1,Rabson-Mendenhall syndrome ORPHA:769,0.6239678957896782
PBX1,Tufted angioma ORPHA:1063,0.6239678957896782
PBX1,Stargardt disease ORPHA:827,0.6279395134845649
PBX1,Precursor B-cell acute lymphoblastic leukemia ORPHA:99860,0.7068064785325423
PBX1,Complete cryptophthalmia ORPHA:98949,0.7068064785325423
PBX1,Infantile Bartter syndrome with sensorineural deafness ORPHA:89938,0.7068064785325423
PBX1,Intellectual disability-expressive aphasia-facial dysmorphism syndrome ORPHA:436151,0.7068064785325423
PBX1,Retinal macular dystrophy type 2 ORPHA:319640,0.7068064785325423
PBX1,Schinzel-Giedion syndrome ORPHA:798,0.7068064785325423
PBX1,Congenital bilateral absence of vas deferens ORPHA:48,0.7068064785325423
PBX1,Alveolar rhabdomyosarcoma ORPHA:99756,0.7068064785325423
PBX1,Duane retraction syndrome ORPHA:233,0.7068064785325423
PBX1,Reston ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
PBX1,Louping ill virus nonstructural protein NS3,0.6362779693488597
PBX1,Sudan ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
PBX1,Sudan ebolavirus - Nakisamata structural glycoprotein (gene: GP),0.6362779693488597
PBX1,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
PBX1,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.6362779693488597
PBX1,Human immunodeficiency virus envelope glycoprotein (gene: env),0.6362779693488597
PBX1,Lake Victoria marburgvirus - Leiden glycoprotein (gene: GP),0.6386053036162835
PBX1,Marburg virus - Musoke Kenya 1980 glycoprotein (gene: GP),0.6481498905276316
PBX1,Marburg marburgvirus glycoprotein (gene: GP),0.6761714078632568
PBX1,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.853754994225345
PCDH7,Bladder Neoplasm,0.0891725280554336
PCDH7,Epilepsy,0.3941558617476422
PCDH7,Schizophrenia,0.0531117779464085
PCDH7,Epilepsy,0.3449614869411272
PCDH7,Ischemic Stroke,0.4286813331685578
PCDH7,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
PCDH7,Peters anomaly ORPHA:708,0.00518481975049
PCDH7,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
PCDH7,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
PCDH7,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
PCDH7,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
PCDH7,Polysyndactyly ORPHA:93338,0.0083045131203191
PCDH7,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
PCDH7,Tibial hemimelia ORPHA:93322,0.0083045131203191
PCDH7,Branchiootic syndrome ORPHA:52429,0.0083045131203191
PCDH7,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
PCDH7,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
PCDH7,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.0180064224283883
PCDH7,Mandibulofacial dysostosis with alopecia ORPHA:443995,0.0180064224283883
PCDH7,Nance-Horan syndrome ORPHA:627,0.0180064224283883
PCDH7,Oculocutaneous albinism type 3 ORPHA:79433,0.0180064224283883
PCDH7,Hypoplastic left heart syndrome ORPHA:2248,0.0180064224283883
PCDH7,Matthew-Wood syndrome ORPHA:2470,0.0180064224283883
PCDH7,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.0180064224283883
PCDH7,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.0586579655822394
PCDH7,15q14 microdeletion syndrome ORPHA:261190,0.0586579655822394
PCDH7,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.0586579655822394
PCDH7,Childhood-onset benign chorea with striatal involvement ORPHA:494541,0.0586579655822394
PCDH7,Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181,0.0586579655822394
PCDH7,Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381,0.0586579655822394
PCDH7,Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526,0.0586579655822394
PCDH7,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.0586579655822394
PCDH7,X-linked Alport syndrome ORPHA:88917,0.0586579655822394
PCDH7,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.0586579655822394
PCDH7,Sclerosteosis ORPHA:3152,0.0586579655822394
PCDH7,Hirschsprung disease ORPHA:388,0.0706635700002548
PCDH7,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.0783959336694202
PCDH7,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.0783959336694202
PCDH7,Female restricted epilepsy with intellectual disability ORPHA:101039,0.1590470395003315
PCDH7,High myopia-sensorineural deafness syndrome ORPHA:363396,0.1590470395003315
PCDH7,Split hand-split foot-deafness syndrome ORPHA:71271,0.1590470395003315
PCDH7,Stuve-Wiedemann syndrome ORPHA:3206,0.1590470395003315
PCDH7,Familial patent arterial duct ORPHA:466729,0.1590470395003315
PCDH7,Isolated aniridia ORPHA:250923,0.1590470395003315
PCDH7,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.1981653781243822
PCDH7,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome ORPHA:370022,0.3762014630157917
PCDH7,Charcot-Marie-Tooth disease type 2R ORPHA:397968,0.3762014630157917
PCDH7,Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430,0.3762014630157917
PCDH7,Scalp-ear-nipple syndrome ORPHA:2036,0.3762014630157917
PCDH7,Congenital ptosis ORPHA:91411,0.3762014630157917
PCDH7,Rolandic epilepsy ORPHA:1945,0.3762014630157917
PCDH7,Saethre-Chotzen syndrome ORPHA:794,0.3762014630157917
PCDH7,Renal agenesis bilateral ORPHA:1848,0.3775879467205478
PCDH7,Severe early-childhood-onset retinal dystrophy ORPHA:364055,0.3775879467205478
PCDH7,Apert syndrome ORPHA:87,0.6239678957896782
PCDH7,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555,0.6239678957896782
PCDH7,FGFR2-related bent bone dysplasia ORPHA:313855,0.6239678957896782
PCDH7,Familial scaphocephaly syndrome McGillivray type ORPHA:168624,0.6239678957896782
PCDH7,Fraser syndrome ORPHA:2052,0.6239678957896782
PCDH7,Jackson-Weiss syndrome ORPHA:1540,0.6239678957896782
PCDH7,Pfeiffer syndrome type 2 ORPHA:93259,0.6239678957896782
PCDH7,Pfeiffer syndrome type 3 ORPHA:93260,0.6239678957896782
PCDH7,Pontocerebellar hypoplasia type 3 ORPHA:97249,0.6239678957896782
PCDH7,Short rib-polydactyly syndrome Saldino-Noonan type ORPHA:93270,0.6239678957896782
PCDH7,7q31 microdeletion syndrome ORPHA:251061,0.7068064785325423
PCDH7,Childhood apraxia of speech ORPHA:209908,0.7068064785325423
PCDH7,Congenital lethal myopathy Compton-North type ORPHA:210163,0.7068064785325423
PDE4B,Colorectal Carcinoma,0.0034602840073026
PDE4B,Colorectal Cancer,0.0149315928814189
PDE4B,Lymphoma,0.0739788831250619
PDE4B,Chronic Lymphocytic Leukemia,0.1147307578771389
PDE4B,Arsenic Poisoning Inorganic,0.13167400689206
PDE4B,Nervous System Organic Arsenic Poisoning,0.13167400689206
PDE4B,Arsenic Encephalopathy,0.13167400689206
PDE4B,Arsenic Induced Polyneuropathy,0.13167400689206
PDE4B,Arsenic Poisoning,0.13167400689206
PDE4B,Phototoxicity,0.13167400689206
PDE4B,Unipolar Depression,0.13167400689206
PDE4B,Dermatitis Phototoxic,0.1897991423047819
PDE4B,Acute Myeloid Leukemia (AML-M2),0.2050045461627939
PDE4B,Major Depressive Disorder,0.21122597829463
PDE4B,B-Cell Lymphomas,0.2522264785494494
PDE4B,Bipolar Disorder,0.3933196962529684
PDE4B,Schizophrenia,0.3933196962529684
PDE4B,Leukemia Myelocytic Acute,0.3933196962529684
PDE4B,Anxiety Disorders,0.3933196962529684
PDE4B,Fibrosis Liver,0.3933196962529684
PDE4B,Asthma,0.3933196962529684
PDE4B,Mental Depression,0.3941558617476422
PDE4B,Alcohol abuse,0.39623320406434
PDE4B,Depressive disorder,0.3975960596292668
PDE4B,Acute Myeloid Leukemia M1,0.4100742336915555
PDE4B,Anxiety,0.4115056600660309
PDE4B,Depression Bipolar,0.4115056600660309
PDE4B,Mental disorders,0.4126392832024548
PDE4B,Latent Autoimmune Diabetes in Adults,0.4126392832024548
PDE4B,Triglycerides measurement,0.4192169590514327
PDE4B,Psoriasis,0.4304973629098372
PDE4B,Amphetamine-Related Disorders,0.4335751357405352
PDE4B,Amphetamine Abuse,0.4335751357405352
PDE4B,Amphetamine Addiction,0.4352815161963393
PDE4B,PANIC DISORDER 1,0.4352815161963393
PDE4B,Myocardial Ischemia,0.4506578937113162
PDE4B,Manic,0.4753011022966241
PDE4B,Panic Disorder,0.4753011022966241
PDE4B,Staphylococcus aureus infection,0.4753011022966241
PDE4B,Dermatologic disorders,0.4906258721078565
PDE4B,Neutropenia,0.498994845947585
PDE4B,Alcoholic Intoxication Chronic,0.5097818625871164
PDE4B,Manic Disorder,0.5619299124666532
PDE4B,Autoimmune thyroid disease,0.5710095678317721
PDE4B,Tachycardia Ventricular,0.5710095678317721
PDE4B,Diffuse Large B-Cell Lymphoma,0.5913651925298382
PDE4B,Ventricular arrhythmia,0.610971999959321
PDE4B,Leukopenia,0.6274540883972485
PDE4B,Narcolepsy,0.6496433426951205
PDE4B,Respiration Disorders,0.6656356363792992
PDE4B,Low density lipoprotein cholesterol measurement,0.6941270729825465
PDE4B,Alcohol Use Disorder,0.7045203904267408
PDE4B,Allergic asthma,0.717484976234209
PDE4B,Autistic Disorder,0.8064248359603999
PDE4B,Serum total cholesterol measurement,0.8758099322635008
PDE4B,Abnormal behavior,0.9274396272108874
PDE4B,Schizophrenia,0.0531117779464085
PDE4B,Arsenic Encephalopathy,0.185736315425117
PDE4B,Dermatologic Disorders,0.2895940391390291
PDE4B,Mental Depression,0.4560460337187313
PDE4B,Stress Disorder,0.4560460337187313
PDE4B,Myocardial Ischemia,0.4560460337187313
PDE4B,Mood Disorder,0.4646409362700993
PDE4B,Gastroesophageal Reflux Disease,0.4742592264758768
PDE4B,Narcolepsy,0.4875380732267193
PDE4B,Bipolar Disorder,0.4875380732267193
PDE4B,Asthma,0.504364324740411
PDE4B,Myeloid Leukemia,0.525214105372123
PDE4B,Manic Disorder,0.7112499273451761
PDE4B,Leukemia,0.7167438233451096
PDE4B,Anxiety Disorder,0.947453223782586
PDE4B,Autism,0.9783327858636056
PDE4B,Early-onset Lafora body disease ORPHA:324290,0.1590470395003315
PDE4B,GM3 synthase deficiency ORPHA:370933,0.3762014630157917
PDE4B,Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552,0.3762014630157917
PDE4B,Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537,0.3762014630157917
PDE4B,PDE4D haploinsufficiency syndrome ORPHA:439822,0.6239678957896782
PDE4B,XYLT1-CDG ORPHA:370930,0.6239678957896782
PDE4B,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.7068064785325423
PDE4B,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.7068064785325423
PDGFB,Mammary Neoplasms,0.0034602840073026
PDGFB,Breast Carcinoma,0.0042545616049287
PDGFB,melanoma,0.0149315928814189
PDGFB,Malignant mesothelioma,0.0182265588252201
PDGFB,ovarian neoplasm,0.0191435238361999
PDGFB,Fibrosarcoma,0.0191435238361999
PDGFB,Medulloblastoma,0.0354767239335874
PDGFB,Skin carcinoma,0.0482468351695405
PDGFB,Malignant neoplasm of prostate,0.0569142010728473
PDGFB,Brain Neoplasms,0.064548079316548
PDGFB,Neoplasm Metastasis,0.0648809611869375
PDGFB,Pancreatic Neoplasm,0.0739788831250619
PDGFB,Glioma,0.0739788831250619
PDGFB,Glioblastoma,0.0745502070959292
PDGFB,Liver Cirrhosis,0.0773771948186562
PDGFB,Prostate carcinoma,0.0773771948186562
PDGFB,Colorectal Neoplasms,0.0827744840860166
PDGFB,Liver carcinoma,0.095319386034013
PDGFB,Osteosarcoma,0.1029977559100099
PDGFB,Hamman-Rich syndrome,0.13167400689206
PDGFB,Sarcoma,0.1537760235124317
PDGFB,Neck Neoplasms,0.1614820148711231
PDGFB,Visual seizure,0.1735868515093891
PDGFB,Clouding of corneal stroma,0.1859959283872542
PDGFB,Systemic Scleroderma,0.1900258729042946
PDGFB,Seizures,0.2053083986145698
PDGFB,Lung Neoplasms,0.2062010908869036
PDGFB,Corneal Opacity,0.2085938372806741
PDGFB,Osteosarcoma of bone,0.2109483801368481
PDGFB,Anoxia,0.2462384927636234
PDGFB,Mannose-Binding Protein Deficiency,0.2643145809900195
PDGFB,Basal ganglia calcification,0.286740104053178
PDGFB,Cirrhosis,0.2923761731100008
PDGFB,Myeloid Leukemia,0.2980670559114652
PDGFB,Idiopathic Pulmonary Fibrosis,0.3099246715197673
PDGFB,Anaplastic Oligodendroglioma,0.3176684185973055
PDGFB,Postural instability,0.3220099003872086
PDGFB,Carcinoma of lung,0.3663130598151661
PDGFB,Thyroid Neoplasm,0.383941725017158
PDGFB,Mask-like facies,0.383941725017158
PDGFB,Muscle Rigidity,0.3933196962529684
PDGFB,Myelomonocytic leukemia,0.3933196962529684
PDGFB,Inflammation,0.3933196962529684
PDGFB,Fetal Growth Retardation,0.3933196962529684
PDGFB,Schizophrenia,0.3933196962529684
PDGFB,Malignant Glioma,0.3933196962529684
PDGFB,Hypertensive disease,0.3933196962529684
PDGFB,Leukemia Myelocytic Acute,0.3933196962529684
PDGFB,HIV Infections,0.3933196962529684
PDGFB,Skin Neoplasms,0.3933196962529684
PDGFB,Soft Tissue Neoplasms,0.3933196962529684
PDGFB,Carcinoma Papillary,0.3933196962529684
PDGFB,Malformations of Cortical Development Group II,0.3933196962529684
PDGFB,Astrocytoma,0.3933196962529684
PDGFB,Alzheimer's Disease,0.3933196962529684
PDGFB,Spinal Neoplasms,0.3933196962529684
PDGFB,Uncoordinated limb movement,0.3933196962529684
PDGFB,Fahr's syndrome (disorder),0.3933196962529684
PDGFB,Fibrosis of bile duct,0.3933196962529684
PDGFB,Intraspinal Neoplasm,0.3933196962529684
PDGFB,Limb dysmetria,0.3933196962529684
PDGFB,Microcalcification,0.3933196962529684
PDGFB,Thrombocythemia Essential,0.3933196962529684
PDGFB,Other ureteric obstruction,0.3933196962529684
PDGFB,Inflammatory Bowel Diseases,0.3933196962529684
PDGFB,Glomerulonephritis,0.3933196962529684
PDGFB,Adult Fibrosarcoma,0.3933196962529684
PDGFB,Familial meningioma,0.3933196962529684
PDGFB,Tumoral calcinosis,0.3933196962529684
PDGFB,Infant Small for Gestational Age,0.3933196962529684
PDGFB,Pulmonary Hypertension,0.3933196962529684
PDGFB,Intrauterine retardation,0.3933196962529684
PDGFB,Asthma,0.3933196962529684
PDGFB,Anemia,0.3941558617476422
PDGFB,Acute Erythroblastic Leukemia,0.3941558617476422
PDGFB,Epilepsy,0.3941558617476422
PDGFB,Thrombocytosis Autosomal Dominant,0.3941558617476422
PDGFB,Calcinosis,0.3941558617476422
PDGFB,Nephritis,0.3941558617476422
PDGFB,Subcutaneous hemorrhage,0.3941558617476422
PDGFB,Mental deterioration,0.39623320406434
PDGFB,Fibrosis,0.3975960596292668
PDGFB,Dizziness,0.3975960596292668
PDGFB,Depressive disorder,0.3975960596292668
PDGFB,IGA Glomerulonephritis,0.3975960596292668
PDGFB,Vertigo,0.4028066164685291
PDGFB,Meningioma benign no ICD-O subtype,0.4028066164685291
PDGFB,Celiac Disease,0.4028066164685291
PDGFB,Spinal Cord Neoplasms,0.4028066164685291
PDGFB,Laryngeal dystonia,0.4028066164685291
PDGFB,Lenticulostriate Disorders,0.4028066164685291
PDGFB,Monosomy 22,0.4028066164685291
PDGFB,Extrapyramidal Disorders,0.4028066164685291
PDGFB,Cholestasis,0.4100901006059349
PDGFB,Fibromatosis Aggressive,0.4100901006059349
PDGFB,Forgetful,0.4100901006059349
PDGFB,Cerebral calcification,0.4103119460235835
PDGFB,Primary Myelofibrosis,0.4103119460235835
PDGFB,Anxiety,0.4115056600660309
PDGFB,Bradykinesia,0.4115056600660309
PDGFB,Brain Infarction,0.4115056600660309
PDGFB,Ulcer,0.4115056600660309
PDGFB,Acute Megakaryocytic Leukemias,0.4115056600660309
PDGFB,Oligohydramnios,0.4126392832024548
PDGFB,Down Syndrome,0.4126392832024548
PDGFB,Dermatofibrosarcoma,0.4126392832024548
PDGFB,Mesangial proliferative glomerulonephritis,0.4192169590514327
PDGFB,Histiocytosis Langerhans-Cell,0.4213286052188015
PDGFB,Thrombocytopenia,0.4213286052188015
PDGFB,Dilated ventricles (finding),0.425992946703162
PDGFB,Follicular adenoma,0.4269926086051838
PDGFB,Basal Ganglia Diseases,0.4304973629098372
PDGFB,Cutaneous Fibrous Histiocytoma,0.4304973629098372
PDGFB,Malignant Fibrous Histiocytoma,0.4330362522463816
PDGFB,Pulmonary Fibrosis,0.4335751357405352
PDGFB,Meningiomas Multiple,0.4335751357405352
PDGFB,Meningioma,0.4396723023384634
PDGFB,Encephalitis,0.4396723023384634
PDGFB,Migraine Disorders,0.4450743762496232
PDGFB,Nasal Polyps,0.4459714599189374
PDGFB,Athetosis,0.4459714599189374
PDGFB,Dystonic disease,0.4459714599189374
PDGFB,Hepatomegaly,0.4506578937113162
PDGFB,Decreased platelet count,0.4561717689698902
PDGFB,Skin Ulcer,0.4561717689698902
PDGFB,Tremor,0.4564472886428772
PDGFB,leukemia,0.4588513406515081
PDGFB,Mesothelioma,0.4635211539849193
PDGFB,Malignant neoplasm of skin,0.466957409863091
PDGFB,Apathy,0.4675904598629673
PDGFB,Myeloid Leukemia Chronic,0.472444704048021
PDGFB,Adenomatous Polyposis Coli,0.4749780675672355
PDGFB,Diffusely thickened skin,0.4753011022966241
PDGFB,Psychotic Disorders,0.4753011022966241
PDGFB,Intermittent migraine headaches,0.4790179402069343
PDGFB,Kaposi Sarcoma,0.4851378030288289
PDGFB,Thick skin,0.4852430673532381
PDGFB,Small head,0.4906258721078565
PDGFB,Dermatofibrosarcoma Protuberans,0.4906258721078565
PDGFB,Giant Cell Fibroblastoma,0.4906258721078565
PDGFB,HIV encephalitis,0.4906258721078565
PDGFB,Primary biliary cirrhosis,0.4923669467696064
PDGFB,Dysdiadochokinesis,0.4923669467696064
PDGFB,Arteriosclerosis,0.5019670090704682
PDGFB,Mesenchymal Cell Neoplasm,0.5090214163899865
PDGFB,Memory impairment,0.5188223685230745
PDGFB,nervous system disorder,0.5276472086074249
PDGFB,Erythema,0.5299466034567416
PDGFB,Choreatic disease,0.5337853752290136
PDGFB,Malignant Meningioma,0.5337853752290136
PDGFB,Atherosclerosis,0.5393787854381349
PDGFB,Memory Loss,0.5568517196017908
PDGFB,Parkinsonian Disorders,0.5683976277847906
PDGFB,Gingival Hyperplasia,0.5710095678317721
PDGFB,Infection,0.5959654688257199
PDGFB,Urinary Incontinence,0.6084642888478995
PDGFB,Low grade glioma,0.6196470808426647
PDGFB,Lung Diseases Interstitial,0.6207008101484466
PDGFB,Multiple subcutaneous nodules,0.6274540883972485
PDGFB,Subcutaneous nodule,0.6274540883972485
PDGFB,Dystonia,0.6334536292962906
PDGFB,Dementia,0.6364853529519863
PDGFB,Retinal Diseases,0.655573080043894
PDGFB,Chorea,0.655573080043894
PDGFB,Dyskinetic syndrome,0.672336954961104
PDGFB,Gait abnormality,0.7138331851025355
PDGFB,Henoch-Schoenlein Purpura,0.7317475852509061
PDGFB,Lupus Nephritis,0.7433468668038986
PDGFB,Impaired cognition,0.8000044931629623
PDGFB,Intellectual Disability,0.8352623613787349
PDGFB,Dysarthria,0.8464957591845941
PDGFB,Anxiety disease,0.8499037334512025
PDGFB,Hyperreflexia,0.869420268668135
PDGFB,Liver Carcinoma,0.0520696613701797
PDGFB,Pulmonary Fibrosis,0.0654534781440596
PDGFB,Alveolitis,0.1025546857843372
PDGFB,Brain Neoplasms,0.1534453668959814
PDGFB,Tumoral Calcinosis,0.2954316182315451
PDGFB,Oculomotor Nerve Palsy,0.336287627428424
PDGFB,Hydrocephalus,0.3657224783929353
PDGFB,Parkinson Disease,0.4286813331685578
PDGFB,Hypothalamic Hypothyroidism,0.4286813331685578
PDGFB,Multiple Meningioma,0.4286813331685578
PDGFB,Fahr`s Syndrome,0.4286813331685578
PDGFB,Bilateral Striopallidodentate Calcinosis,0.4286813331685578
PDGFB,Fibrosarcoma,0.4402141802500753
PDGFB,Brain Stem Compression,0.4402141802500753
PDGFB,Skin Neoplasms,0.4541466895915311
PDGFB,Neurofibroma,0.4560460337187313
PDGFB,Mental Depression,0.4560460337187313
PDGFB,Growth Hormone Deficiency,0.4560460337187313
PDGFB,Basal Ganglia Diseases,0.4560460337187313
PDGFB,Lenticulostriate Disorders,0.4560460337187313
PDGFB,Extrapyramidal Disease,0.4560460337187313
PDGFB,Psychosis,0.4560460337187313
PDGFB,Subcutaneous Hemorrhage,0.4560460337187313
PDGFB,Thrombocythemia,0.4560460337187313
PDGFB,Spinal Meningioma,0.4560460337187313
PDGFB,Migraine,0.4560460337187313
PDGFB,Papilledema,0.4560460337187313
PDGFB,Erectile Dysfunction,0.4602028929328057
PDGFB,Intracranial Meningioma,0.4602028929328057
PDGFB,Trigeminal Neuralgia,0.4602028929328057
PDGFB,Tongue Neoplasms,0.4646409362700993
PDGFB,Cirrhosis,0.4875380732267193
PDGFB,Dementia,0.4875380732267193
PDGFB,Microcephaly,0.5123947823327547
PDGFB,Amnesia,0.5129298662020659
PDGFB,Thrombocytosis,0.525214105372123
PDGFB,Meningioma,0.5498080544456183
PDGFB,Speech Disorders,0.6239791345488227
PDGFB,Hypogonadotropic Hypogonadism,0.6325735973587235
PDGFB,Retinal Diseases,0.6329251700753155
PDGFB,Facial Paralysis,0.696610260564548
PDGFB,Proptosis,0.7558828942158288
PDGFB,Malformation Of Cortical Development,0.776786668801341
PDGFB,Hypothyroidism,0.7921294370722203
PDGFB,Mood Swings,0.8369864135373719
PDGFB,Dyskinetic Syndrome,0.9082935011758586
PDGFB,Anxiety Disorder,0.947453223782586
PDGFB,Obesity,0.9568083835980838
PDGFB,Dysarthria,0.9724404706118156
PDGFB,Dermatofibrosarcoma protuberans ORPHA:31112,0.0180064224283883
PDGFB,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.0586579655822394
PDGFB,Bilateral striopallidodentate calcinosis ORPHA:1980,0.1697334635963512
PDGFB,Familial multiple meningioma ORPHA:263662,0.6279395134845649
PDGFB,Meningioma ORPHA:2495,0.6581690778726346
PDGFB,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.6806291584193672
PDGFB,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.6806291584193672
PDGFB,Cowpox virus CPXV209 protein (gene: CPXV209 CDS),0.6920622798772148
PIR,melanoma,0.0149315928814189
PIR,Secondary malignant neoplasm of lymph node,0.3933196962529684
PIR,Leukemia Myelocytic Acute,0.3933196962529684
PIR,Acute Promyelocytic Leukemia,0.3933196962529684
PIR,Contact hypersensitivity,0.425419812815905
PIR,Contact Dermatitis,0.4615352570710579
PIR,Promyelocytic leukemia,0.4675904598629673
PIR,Osteoporosis,0.4541466895915311
PIR,Dermatitis,0.525214105372123
PIR,Glutamate-cysteine ligase deficiency ORPHA:33574,0.0586579655822394
PIR,Aromatase deficiency ORPHA:91,0.3762014630157917
PIR,Aromatase excess syndrome ORPHA:178345,0.3762014630157917
PIR,Citrullinemia type II ORPHA:247585,0.6239678957896782
PIR,Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594,0.6239678957896782
PIR,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.6239678957896782
PIR,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome ORPHA:521432,0.7068064785325423
PIR,Dyschromatosis universalis hereditaria ORPHA:241,0.7068064785325423
PIR,Familial pseudohyperkalemia ORPHA:90044,0.7068064785325423
PIR,Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646,0.7068064785325423
PIR,SRD5A3-CDG ORPHA:324737,0.7068064785325423
PLEKHD1,Breast Carcinoma,0.0075861267486594
PLEKHD1,Marfan Syndrome,0.0133304506157067
PLEKHD1,Mammary Neoplasms,0.0155248163763686
PLEKHD1,Breast Cancer,0.0402286636010764
PLEKHD1,NON RARE IN EUROPE: Isolated keratoconus ORPHA:2335,0.6239678957896782
PLEKHD1,Deafness-infertility syndrome ORPHA:94064,0.7068064785325423
PLEKHD1,Occult macular dystrophy ORPHA:247834,0.7068064785325423
PLEKHD1,Spinocerebellar ataxia type 31 ORPHA:217012,0.7068064785325423
PLEKHD1,Oguchi disease ORPHA:75382,0.7068064785325423
PLEKHD1,Female infertility due to zona pellucida defect ORPHA:404466,0.7068064785325423
PLEKHD1,Usher syndrome type 3 ORPHA:231183,0.7068064785325423
PLEKHD1,Congenital stationary night blindness ORPHA:215,0.7120423847116372
PLK2,Ovarian Carcinoma,0.0034602840073026
PLK2,Tumor Progression,0.0149315928814189
PLK2,Adenocarcinoma,0.0155921563748247
PLK2,Squamous cell carcinoma,0.0182265588252201
PLK2,Carcinogenesis,0.0228075668512991
PLK2,Malignant neoplasm of ovary,0.0277695594716545
PLK2,Carcinoma Spindle-Cell,0.0308703957553632
PLK2,Epithelial ovarian cancer,0.0387439397151409
PLK2,Carcinoma,0.0593779966354549
PLK2,Carcinomatosis,0.0617471306652618
PLK2,Malignant neoplasm of pancreas,0.0726340460169901
PLK2,Lymphoma,0.0739788831250619
PLK2,Glioblastoma,0.0745502070959292
PLK2,Pancreatic carcinoma,0.0745502070959292
PLK2,Anaplastic carcinoma,0.084286432100041
PLK2,Liver carcinoma,0.095319386034013
PLK2,Osteosarcoma,0.1029977559100099
PLK2,Chronic Lymphocytic Leukemia,0.1147307578771389
PLK2,Hematologic Neoplasms,0.1253114324938153
PLK2,MYELODYSPLASTIC SYNDROME,0.1254380558571286
PLK2,Undifferentiated carcinoma,0.13167400689206
PLK2,Mammary Carcinoma Animal,0.1352936728187231
PLK2,Animal Mammary Neoplasms,0.1352936728187231
PLK2,Sarcoma,0.1537760235124317
PLK2,Lung Neoplasms,0.2062010908869036
PLK2,Osteosarcoma of bone,0.2109483801368481
PLK2,Adverse reaction to drug,0.223747154820789
PLK2,Drug toxicity,0.223747154820789
PLK2,Burkitt Lymphoma,0.2521987644415915
PLK2,Malignant neoplasm of liver,0.2643145809900195
PLK2,Ischemic stroke,0.3486533561309259
PLK2,Mammary Neoplasms Experimental,0.3508665345292502
PLK2,Laryngeal Squamous Cell Carcinoma,0.3933196962529684
PLK2,Non-Small Cell Lung Carcinoma,0.3933196962529684
PLK2,Leukemia Myelocytic Acute,0.3933196962529684
PLK2,Hydroa Vacciniforme,0.3933196962529684
PLK2,Alzheimer's Disease,0.3933196962529684
PLK2,Endometrioid carcinoma ovary,0.3933196962529684
PLK2,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
PLK2,Parkinson Disease,0.3933196962529684
PLK2,Myeloid neoplasm,0.39623320406434
PLK2,Carcinoma of larynx,0.4028066164685291
PLK2,Multiple Myeloma,0.4103119460235835
PLK2,Juvenile arthritis,0.4126392832024548
PLK2,Malignant neoplasm of larynx,0.4192169590514327
PLK2,Lewy Body Disease,0.424575176503444
PLK2,Mild cognitive disorder,0.4506578937113162
PLK2,Juvenile psoriatic arthritis,0.472444704048021
PLK2,Juvenile-Onset Still Disease,0.4810435657134442
PLK2,Ulcerative Colitis,0.5001612228394569
PLK2,Adenocarcinoma of lung (disorder),0.51550637274795
PLK2,Childhood Osteosarcoma,0.553002957824355
PLK2,Irritable Bowel Syndrome,0.6545439509404224
PLK2,Anaplastic Carcinoma,0.0402286636010764
PLK2,Carcinoma,0.0534520155998091
PLK2,Arthritis,0.4541466895915311
PLK2,Juvenile Arthritis,0.4646409362700993
PLK2,Polyarthritis Rheumatoid Factor Positive,0.4646409362700993
PLK2,Ovarian Endometrioid Carcinoma,0.4875380732267193
PLK2,Seronegative Polyarthritis,0.4875380732267193
PLK2,Still Disease,0.504364324740411
PLK2,Lung Adenocarcinoma,0.7979764766391754
PLK2,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
PLK2,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
PLK2,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
PLK2,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
PLK2,Chondrosarcoma ORPHA:55880,0.0083045131203191
PLK2,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.0083045131203191
PLK2,Familial progressive hyperpigmentation ORPHA:79146,0.0083045131203191
PLK2,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.0180064224283883
PLK2,Pediatric hepatocellular carcinoma ORPHA:33402,0.0180064224283883
PLK2,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.0180064224283883
PLK2,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.0586579655822394
PLK2,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.0586579655822394
PLK2,Griscelli syndrome type 3 ORPHA:79478,0.0586579655822394
PLK2,ABeta amyloidosis Arctic type ORPHA:324723,0.1590470395003315
PLK2,ABeta amyloidosis Dutch type ORPHA:100006,0.1590470395003315
PLK2,ABeta amyloidosis Iowa type ORPHA:324708,0.1590470395003315
PLK2,ABeta amyloidosis Italian type ORPHA:324713,0.1590470395003315
PLK2,ABetaA21G amyloidosis ORPHA:324718,0.1590470395003315
PLK2,ABetaL34V amyloidosis ORPHA:324703,0.1590470395003315
PLK2,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.1590470395003315
PLK2,Chondrodysplasia-disorder of sex development syndrome ORPHA:1422,0.3762014630157917
PLK2,NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651,0.6239678957896782
PLK2,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.6980058392556946
PLK2,Horsepox virus HSPV020e (ankyrin repeats),0.7079503198328393
PLK2,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.7108466056279036
PLK2,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.7553529087917877
PLK2,Horsepox virus HSPV011a,0.776311155917498
PLK2,Vaccinia virus hypothetical protein,0.7975886343350181
PLK2,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.7975886343350181
PLK2,Variola virus hypothetical protein (gene: B21R),0.7988086321880973
PLK2,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.8031136315766868
PLK2,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8090912655264054
PLK2,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8090912655264054
PLK2,Human gammaherpesvirus 8 ORF72,0.8164631368980444
PLK2,Horsepox virus HSPV011c (ankyrin repeats),0.830387084488226
PLK2,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8315214238833722
PLK2,Horsepox virus HSPV194 (ankyrin repeats),0.8320620882218038
PLK2,Orf virus ORF123 ankyrin repeat protein,0.8390943852085586
PLK2,Monkeypox virus ankyrin-like protein,0.8426793553344071
PLK2,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8458935424065495
PLK2,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.8507994162096807
PLK2,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8565042041973229
PLK2,Ectromelia virus ERPV serine/threonine kinase,0.8567113603862105
PLK2,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8623814598290633
PLK2,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.8665950357166999
PLK2,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.876049415394169
PLK2,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.8784689389733535
PLK2,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8826243651582266
PLK2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8826243651582266
PLK2,Horsepox virus HSPV033c (ankyrin repeats),0.8826243651582266
PLK2,Vaccinia virus ankyrin-like protein,0.8912506515619287
PLK2,Horsepox virus HSPV005c (Ankyrin repeats),0.9005654634109755
PLK2,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.9049668877841942
PLK2,Yaba-like disease virus 148R protein (gene: 148R),0.9055720084468104
PLK2,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.9097056179628632
PLK2,Yaba-like disease virus 8L protein (gene: 8L),0.9102852214746716
PLK2,Horsepox virus HSPV196 (ankyrin-like protein,0.9195586782304176
PLK2,Provisional),0.9199249371723298
PLK2,Ectromelia virus ERPV ankyrin,0.920189880588384
PLK2,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.920189880588384
PLK2,Vaccinia virus Ankara CP77 Host range protein f1,0.924238809115565
PLK2,Yaba-like disease virus 146R protein (gene: 146R),0.9271250260824724
PLK2,Vaccinia virus ankyin-like protein (gene: M1L),0.9285312497152513
PLK2,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.9317407101292444
PLK2,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L),0.9320456693098416
PLK2,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.93590945176733
PLK2,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.9394149990743936
PLK2,Cowpox virus CPXV017 protein (gene: CPXV017 CDS),0.9407405842467907
PLK2,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.9475760000797028
PLK2,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9475760000797028
PLK2,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9475760000797028
PLK2,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D1L),0.9517968639566384
PLK2,Horsepox virus HSPV181 (ankyrin repeats),0.9518028028273808
PLK2,Vaccinia virus ankyrin-like protein (gene: B4R),0.9566905696255492
PLK2,Variola virus hypothetical protein (gene: B19R),0.9566905696255492
PLK2,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.9566905696255492
PLK2,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.960637237597315
PLK2,Yaba monkey tumor virus ankyrin repeat protein,0.960637237597315
PLK2,Horsepox virus HSPV014c (ankyrin repeats),0.9621839893030432
PLK2,Vaccinia virus ankyrin-like protein (gene: B18R),0.9621839893030432
PLK2,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.9621839893030432
PLK2,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9621839893030432
PLK2,Horsepox virus HSPV011b (ankyrin repeats),0.9621839893030432
PLK2,Variola virus hypothetical protein (gene: G3R),0.9621839893030432
PLK2,Variola virus hypothetical protein (gene: D6L),0.9621839893030432
PLK2,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.9621839893030432
PLK2,Orf virus ORF129 ankyrin repeat protein,0.9621839893030432
PLK2,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9624639844306644
PLK2,Yaba-like disease virus 147R protein (gene: 147R),0.9624639844306644
PLK2,Variola virus ankyin-like protein (gene: O1L),0.9624639844306644
PLK2,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.9624639844306644
PLK2,Yaba-like disease virus 11L protein (gene: 11L),0.9624639844306644
PLK2,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9624639844306644
PLK2,Horsepox virus HSPV012 (ankyrin-like protein,0.9624639844306644
PLK2,Provisional),0.9676678660011035
PLK2,Orf virus ORF128 ankyrin repeat protein,0.9782376397065295
PLK2,Orf virus ORF126 ankyrin repeat protein,0.9784209964188774
PLK2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.978680518510813
PLK2,Cowpox virus CPXV220 protein (gene: CPXV220 CDS),0.985687915361386
PLK2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.986358730247118
PLK2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.9867877113290736
PLK2,Yaba monkey tumor virus ankyrin-like protein,0.988150003801932
PLK2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.9886132556795868
PLK2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.9886132556795868
PLSCR4,Lymphoma,0.0739788831250619
PLSCR4,Small cell carcinoma of lung,0.1193558174333938
PLSCR4,Embryonal Carcinoma,0.3112516166225269
PLSCR4,Teratoma,0.383941725017158
PLSCR4,Schizophrenia,0.3933196962529684
PLSCR4,Teratocarcinoma,0.3941558617476422
PLSCR4,Down Syndrome,0.4126392832024548
PLSCR4,Trisomy,0.4335751357405352
PLSCR4,Schizophrenia,0.0531117779464085
PLSCR4,Lung Carcinoma,0.4541466895915311
PLSCR4,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
PLSCR4,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
PLSCR4,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
PLSCR4,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
PLSCR4,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
PLSCR4,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
PLSCR4,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.0180064224283883
PLSCR4,Autosomal recessive brachyolmia ORPHA:448242,0.0180064224283883
PLSCR4,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.0180064224283883
PLSCR4,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.0180064224283883
PLSCR4,Diaphanospondylodysostosis ORPHA:66637,0.0180064224283883
PLSCR4,Familial drusen ORPHA:75376,0.0180064224283883
PLSCR4,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.0180064224283883
PLSCR4,Ischiovertebral syndrome ORPHA:85200,0.0180064224283883
PLSCR4,Primary CD59 deficiency ORPHA:169464,0.0180064224283883
PLSCR4,RIN2 syndrome ORPHA:217335,0.0180064224283883
PLSCR4,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.0180064224283883
PLSCR4,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.0180064224283883
PLSCR4,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.0180064224283883
PLSCR4,Congenital diaphragmatic hernia ORPHA:2140,0.0180064224283883
PLSCR4,Piebaldism ORPHA:2884,0.0180064224283883
PLSCR4,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.0180064224283883
PLSCR4,19p13.3 microduplication syndrome ORPHA:447980,0.0586579655822394
PLSCR4,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.0586579655822394
PLSCR4,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.0586579655822394
PLSCR4,Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641,0.0586579655822394
PLSCR4,Congenital alveolar capillary dysplasia ORPHA:210122,0.0586579655822394
PLSCR4,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.0586579655822394
PLSCR4,Familial generalized lentiginosis ORPHA:231040,0.0586579655822394
PLSCR4,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.0586579655822394
PLSCR4,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.0586579655822394
PLSCR4,Malan overgrowth syndrome ORPHA:420179,0.0586579655822394
PLSCR4,Marshall-Smith syndrome ORPHA:561,0.0586579655822394
PLSCR4,Monoamine oxidase A deficiency ORPHA:3057,0.0586579655822394
PLSCR4,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.0586579655822394
PLSCR4,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.0586579655822394
PLSCR4,Non-immune hydrops fetalis ORPHA:363999,0.0586579655822394
PLSCR4,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.0586579655822394
PLSCR4,Recessive X-linked ichthyosis ORPHA:461,0.0586579655822394
PLSCR4,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.0586579655822394
PLSCR4,Malignant peripheral nerve sheath tumor ORPHA:3148,0.0586579655822394
PLSCR4,Phakomatosis cesioflammea ORPHA:79483,0.0586579655822394
PLSCR4,Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387,0.0902044104910482
PLSCR4,Periodontal Ehlers-Danlos syndrome ORPHA:75392,0.1590470395003315
PLSCR4,1p31p32 microdeletion syndrome ORPHA:401986,0.1590470395003315
PLSCR4,Brachydactyly-arterial hypertension syndrome ORPHA:1276,0.1590470395003315
PLSCR4,Familial retinal arterial macroaneurysm ORPHA:284247,0.1590470395003315
PLSCR4,MITF-related melanoma and renal cell carcinoma predisposition syndrome ORPHA:293822,0.1590470395003315
PLSCR4,Tietz syndrome ORPHA:42665,0.1590470395003315
PLSCR4,Trehalase deficiency ORPHA:103909,0.1590470395003315
PLSCR4,Familial calcium pyrophosphate deposition ORPHA:1416,0.1590470395003315
PLSCR4,Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144,0.1590470395003315
PLSCR4,Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140,0.1590470395003315
PLSCR4,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.1590470395003315
PLSCR4,Isolated hemihyperplasia ORPHA:2128,0.1590470395003315
PLSCR4,Congenital glaucoma ORPHA:98976,0.1614487935928034
PLSCR4,NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279,0.1739455566145445
PLSCR4,Heritable pulmonary arterial hypertension ORPHA:275777,0.1782034488938806
PLSCR4,Autosomal recessive spastic paraplegia type 5A ORPHA:100986,0.3762014630157917
PLSCR4,Complement component 3 deficiency ORPHA:280133,0.3762014630157917
PLSCR4,Congenital bile acid synthesis defect type 3 ORPHA:79302,0.3762014630157917
PLSCR4,Fibrodysplasia ossificans progressiva ORPHA:337,0.3762014630157917
PLSCR4,Laminin subunit alpha 2-related congenital muscular dystrophy ORPHA:258,0.3762014630157917
PLSCR4,Spinocerebellar ataxia type 27 ORPHA:98764,0.3762014630157917
PLSCR4,X-linked spondyloepimetaphyseal dysplasia ORPHA:93349,0.3762014630157917
PLSCR4,Acromicric dysplasia ORPHA:969,0.3762014630157917
PLSCR4,Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472,0.3762014630157917
PLSCR4,Craniometaphyseal dysplasia ORPHA:1522,0.3762014630157917
PLSCR4,Familial vesicoureteral reflux ORPHA:289365,0.3762014630157917
PLSCR4,De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275,0.6239678957896782
PLSCR4,ANGPT1-related hereditary angioedema with normal C1Inh ORPHA:537891,0.6239678957896782
PLSCR4,Autosomal recessive extra-oral halitosis ORPHA:562538,0.6239678957896782
PLSCR4,Blue rubber bleb nevus ORPHA:1059,0.6239678957896782
PLSCR4,Immunodeficiency with factor H anomaly ORPHA:200421,0.6239678957896782
PLSCR4,Immunodeficiency with factor I anomaly ORPHA:200418,0.6239678957896782
PLSCR4,Kaposiform hemangioendothelioma ORPHA:2122,0.6239678957896782
PLSCR4,Late-onset retinal degeneration ORPHA:67042,0.6239678957896782
PLSCR4,Mucocutaneous venous malformations ORPHA:2451,0.6239678957896782
PLSCR4,OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594,0.6239678957896782
PLSCR4,Pyle disease ORPHA:3005,0.6239678957896782
PLSCR4,Severe hereditary thrombophilia due to congenital protein S deficiency ORPHA:743,0.6239678957896782
PLSCR4,Tufted angioma ORPHA:1063,0.6239678957896782
PLSCR4,X-linked intellectual disability Stocco Dos Santos type ORPHA:85288,0.6239678957896782
PLSCR4,HELLP syndrome ORPHA:244242,0.6239678957896782
PLSCR4,Autosomal dominant secondary polycythemia ORPHA:247511,0.6239678957896782
PLSCR4,Inherited congenital spastic tetraplegia ORPHA:210141,0.6239678957896782
PLSCR4,Autosomal recessive proximal renal tubular acidosis ORPHA:93607,0.7068064785325423
PLSCR4,Brachytelephalangic chondrodysplasia punctata ORPHA:79345,0.7068064785325423
PLSCR4,Obesity due to leptin receptor gene deficiency ORPHA:179494,0.7068064785325423
PLSCR4,Dense deposit disease ORPHA:93571,0.7068064785325423
PLSCR4,Renal tubular dysgenesis of genetic origin ORPHA:97369,0.7068064785325423
PPP1R14B,melanoma,0.0149315928814189
PPP1R14B,Acquired CJD,0.383941725017158
PPP1R14B,Parasitemia,0.4192169590514327
PPP1R14B,Melanoma,0.4646409362700993
PPP1R14B,Amish nemaline myopathy ORPHA:98902,0.1590470395003315
PPP1R14B,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.3762014630157917
PPP1R14B,Oculootodental syndrome ORPHA:99806,0.3762014630157917
PPP1R14B,Adult-onset distal myopathy due to VCP mutation ORPHA:329478,0.6239678957896782
PPP1R14B,Auditory neuropathy-optic atrophy syndrome ORPHA:542585,0.6239678957896782
PPP1R14B,Autosomal dominant Charcot-Marie-Tooth disease type 2Y ORPHA:435387,0.6239678957896782
PPP1R14B,Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815,0.6239678957896782
PPP1R14B,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467,0.6239678957896782
PPP1R14B,DDOST-CDG ORPHA:300536,0.6239678957896782
PPP1R14B,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470,0.6239678957896782
PPP1R14B,Smith-Lemli-Opitz syndrome ORPHA:818,0.6239678957896782
PPP1R14B,Spastic paraplegia-Paget disease of bone syndrome ORPHA:329475,0.6239678957896782
PPP1R14B,Caudal regression sequence ORPHA:3027,0.6239678957896782
PPP1R14B,Acquired partial lipodystrophy ORPHA:79087,0.7068064785325423
PPP1R14B,Autosomal dominant omodysplasia ORPHA:93328,0.7068064785325423
PPP1R14B,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.7068064785325423
PPP1R14B,Autosomal recessive epidermolytic ichthyosis ORPHA:512103,0.7068064785325423
PPP1R14B,Cerebrocostomandibular syndrome ORPHA:1393,0.7068064785325423
PPP1R14B,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054,0.7068064785325423
PPP1R14B,Costello syndrome ORPHA:3071,0.7068064785325423
PPP1R14B,DL-2-hydroxyglutaric aciduria ORPHA:356978,0.7068064785325423
PPP1R14B,Erythrocyte galactose epimerase deficiency ORPHA:308473,0.7068064785325423
PPP1R14B,FADD-related immunodeficiency ORPHA:306550,0.7068064785325423
PPP1R14B,Familial hypocalciuric hypercalcemia type 3 ORPHA:101050,0.7068064785325423
PPP1R14B,Generalized galactose epimerase deficiency ORPHA:308487,0.7068064785325423
PPP1R14B,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom ORPHA:500159,0.7068064785325423
PPP1R14B,Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790,0.7068064785325423
PPP1R14B,PYCR1-related De Barsy syndrome ORPHA:293633,0.7068064785325423
PPP1R14B,Phakomatosis pigmentokeratotica ORPHA:2874,0.7068064785325423
PPP1R14B,Progressive myoclonic epilepsy type 9 ORPHA:457265,0.7068064785325423
PPP1R14B,RFVT2-related riboflavin transporter deficiency ORPHA:572543,0.7068064785325423
PPP1R14B,S-adenosylhomocysteine hydrolase deficiency ORPHA:88618,0.7068064785325423
PPP1R14B,Woolly hair nevus ORPHA:79414,0.7068064785325423
PPP1R14B,Familial melanoma ORPHA:618,0.7166448869866529
PRMT6,Mammary Neoplasms,0.0034602840073026
PRMT6,Breast Carcinoma,0.0042545616049287
PRMT6,Tumor Progression,0.0149315928814189
PRMT6,melanoma,0.0149315928814189
PRMT6,Malignant neoplasm of breast,0.0191435238361999
PRMT6,Carcinogenesis,0.0228075668512991
PRMT6,Neoplasm Metastasis,0.0648809611869375
PRMT6,Osteosarcoma,0.1029977559100099
PRMT6,Osteosarcoma of bone,0.2109483801368481
PRMT6,Severe Combined Immunodeficiency,0.3553621627681198
PRMT6,Malformations of Cortical Development Group II,0.3933196962529684
PRMT6,Bulbo-Spinal Atrophy X-Linked,0.4118266358241932
PRMT6,Cocaine Abuse,0.4192169590514327
PRMT6,Non-obstructive azoospermia,0.4675904598629673
PRMT6,Obesity,0.5140447474168605
PRMT6,Oligospermia,0.5178072301085912
PRMT6,Cocaine Dependence,0.6304655343580164
PRMT6,Cocaine-Related Disorders,0.7683326132740758
PRR15,Colorectal Carcinoma,0.0034602840073026
PRR15,Colorectal Cancer,0.0149315928814189
PRR15,Gastrointestinal Neoplasms,0.2062010908869036
PRR15,Intestinal Neoplasms,0.4675904598629673
PRR15,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.0180064224283883
PRR15,Bartsocas-Papas syndrome ORPHA:1234,0.0586579655822394
PRR15,CHAND syndrome ORPHA:1401,0.0586579655822394
PRR15,Marie Unna hereditary hypotrichosis ORPHA:444,0.0586579655822394
PRR15,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.0586579655822394
PRR15,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.1590470395003315
PRR15,Lethal acantholytic erosive disorder ORPHA:158687,0.3762014630157917
PRR15,Apparent mineralocorticoid excess ORPHA:320,0.3762014630157917
PRR15,Autosomal recessive spastic paraplegia type 35 ORPHA:171629,0.3762014630157917
PRR15,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3762014630157917
PRR15,Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308,0.3762014630157917
PRR15,MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949,0.3762014630157917
PRR15,Naxos disease ORPHA:34217,0.3762014630157917
PRR15,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3762014630157917
PRR15,Microvillus inclusion disease ORPHA:2290,0.3762014630157917
PRR15,Congenital tufting enteropathy ORPHA:92050,0.6239678957896782
PRR15,Hereditary hypercarotenemia and vitamin A deficiency ORPHA:199285,0.7068064785325423
PRR15,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3,0.7068064785325423
PRSS23,Breast Carcinoma,0.0042545616049287
PRSS23,Tumor Progression,0.0149315928814189
PRSS23,melanoma,0.0149315928814189
PRSS23,Malignant neoplasm of breast,0.0191435238361999
PRSS23,Exudative vitreoretinopathy 1,0.3933196962529684
PRSS23,Retinopathy,0.4286813331685578
PRSS23,Exudative Vitreoretinopathy,0.4541466895915311
PRSS23,Exudative Retinopathy,0.4560460337187313
PRSS23,Melanoma,0.4646409362700993
PRSS23,Retinal Detachment,0.4867879381749835
PRSS23,Retinal Dysplasia,0.4875380732267193
PRSS23,Hearing Loss,0.5632819212593052
PRSS23,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
PRSS23,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049
PRSS23,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
PRSS23,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
PRSS23,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
PRSS23,Autosomal recessive brachyolmia ORPHA:448242,0.0180064224283883
PRSS23,Primary CD59 deficiency ORPHA:169464,0.0180064224283883
PRSS23,RIN2 syndrome ORPHA:217335,0.0180064224283883
PRSS23,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.0180064224283883
PRSS23,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.0180064224283883
PRSS23,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.0180064224283883
PRSS23,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.1590470395003315
PRSS23,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.1590470395003315
PRSS23,X-linked hypophosphatemia ORPHA:89936,0.1590470395003315
PRSS23,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138,0.6239678957896782
PRSS23,Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853,0.6268296504510718
PSMB9,Epithelioma,0.0149002095788623
PSMB9,melanoma,0.0149315928814189
PSMB9,ovarian neoplasm,0.0191435238361999
PSMB9,Malignant neoplasm of prostate,0.0569142010728473
PSMB9,Renal Cell Carcinoma,0.0648809611869375
PSMB9,Lymphoma,0.0739788831250619
PSMB9,Glioblastoma,0.0745502070959292
PSMB9,Carcinoma breast stage IV,0.0745502070959292
PSMB9,Liver Cirrhosis Experimental,0.0747863377072194
PSMB9,Prostate carcinoma,0.0773771948186562
PSMB9,Squamous cell carcinoma of esophagus,0.0919714360040484
PSMB9,Colonic Neoplasms,0.1454373331146953
PSMB9,Rheumatoid Arthritis,0.1537760235124317
PSMB9,Hydatidiform Mole Partial,0.1897991423047819
PSMB9,cervical cancer,0.2050045461627939
PSMB9,Hodgkin Disease,0.2454476567103779
PSMB9,Malignant tumor of cervix,0.2714542429024338
PSMB9,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
PSMB9,Cervix carcinoma,0.2834835531038365
PSMB9,Multiple Sclerosis,0.2835142372342932
PSMB9,Fibroid Tumor,0.290158730291654
PSMB9,Sjogren's Syndrome,0.3099246715197673
PSMB9,Ataxia Telangiectasia,0.3508665345292502
PSMB9,Leukemogenesis,0.3510063969122338
PSMB9,Tuberculosis,0.3706856725676674
PSMB9,Human papilloma virus infection,0.383941725017158
PSMB9,Collagen Diseases,0.383941725017158
PSMB9,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
PSMB9,Uterine Fibroids,0.383941725017158
PSMB9,Epstein-Barr Virus Infections,0.3933196962529684
PSMB9,Complete hydatidiform mole,0.3933196962529684
PSMB9,Nasopharyngeal carcinoma,0.3933196962529684
PSMB9,Juvenile rheumatoid arthritis,0.3933196962529684
PSMB9,Alzheimer's Disease,0.3933196962529684
PSMB9,Lymphoma Non-Hodgkin,0.3933196962529684
PSMB9,Acute anterior uveitis,0.3933196962529684
PSMB9,HYDATIDIFORM MOLE RECURRENT 1,0.3933196962529684
PSMB9,Acquired hypothyroidism,0.3933196962529684
PSMB9,Spondylarthropathies,0.4028066164685291
PSMB9,Juvenile arthritis,0.4126392832024548
PSMB9,Lupus Erythematosus Systemic,0.4213286052188015
PSMB9,Disorder of eye,0.4213286052188015
PSMB9,West Nile viral infection,0.425419812815905
PSMB9,Psoriasis,0.4304973629098372
PSMB9,Niemann-Pick Disease Type C,0.4352815161963393
PSMB9,Hydatidiform Mole,0.4506578937113162
PSMB9,Primary Sj??gren's syndrome,0.451408428170596
PSMB9,Extrinsic allergic alveolitis,0.472444704048021
PSMB9,Rheumatism,0.4790179402069343
PSMB9,Coinfection,0.489336365264797
PSMB9,Toeing-in,0.4923669467696064
PSMB9,Crohn Disease,0.4981941174985421
PSMB9,Graves Disease,0.4981941174985421
PSMB9,Leiomyosarcoma of uterus,0.5019670090704682
PSMB9,Hepatitis A,0.5090214163899865
PSMB9,Infectious Mononucleosis,0.5188223685230745
PSMB9,Erectile dysfunction,0.5393787854381349
PSMB9,LATERAL MENINGOCELE SYNDROME,0.549941235475765
PSMB9,Autoimmune Diseases,0.5512224939896888
PSMB9,Arthritis,0.553002957824355
PSMB9,Peptic Esophagitis,0.553002957824355
PSMB9,Arthropathy,0.5557519470957561
PSMB9,LIMB-MAMMARY SYNDROME,0.5568517196017908
PSMB9,Uveitis,0.5682392297191953
PSMB9,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.5710095678317721
PSMB9,Ankylosing spondylitis,0.6446807314576214
PSMB9,Spondylarthritis,0.6588479076808555
PSMB9,Hashimoto Disease,0.6962828901009075
PSMB9,Hypothyroidism,0.8306551823873084
PSMB9,Complete atrioventricular block,0.8701913670211346
PSMB9,Schizophrenia,0.0531117779464085
PSMB9,Myositis,0.425341435586089
PSMB9,Proteasome-associated Autoinflammatory Syndrome,0.4286813331685578
PSMB9,Development Disorder,0.4372065554432662
PSMB9,Arthritis,0.4541466895915311
PSMB9,Rheumatoid Arthritis,0.4560460337187313
PSMB9,Panniculitis,0.4646409362700993
PSMB9,Anemia,0.4780231573499264
PSMB9,Lymphopenia,0.4780231573499264
PSMB9,Oral Ulcer,0.4809179010794786
PSMB9,Narcolepsy,0.4875380732267193
PSMB9,Dermatitis,0.525214105372123
PSMB9,Acanthosis Nigricans,0.555382961603519
PSMB9,Sinusitis,0.5576425853515448
PSMB9,Conjunctivitis,0.6304164862793252
PSMB9,Crohn Disease,0.7414460416900516
PSMB9,Lipodystrophy,0.7833015488163313
PSMB9,Diabetes Mellitus,0.9683912711598086
PSMB9,Odonto-onycho-dermal dysplasia ORPHA:2721,0.0180064224283883
PSMB9,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.0180064224283883
PSMB9,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.1590470395003315
PSMB9,Galactose mutarotase deficiency ORPHA:570422,0.1590470395003315
PSMB9,Generalized glucocorticoid resistance syndrome ORPHA:786,0.1590470395003315
PSMB9,Acatalasemia ORPHA:926,0.3762014630157917
PSMB9,Haim-Munk syndrome ORPHA:2342,0.3762014630157917
PSMB9,Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634,0.3762014630157917
PSMB9,Papillon-Lefevre ORPHA:678,0.3762014630157917
PSMB9,Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517,0.6239678957896782
PSMB9,Cleidocranial dysplasia ORPHA:1452,0.6239678957896782
PSMB9,Familial normophosphatemic tumoral calcinosis ORPHA:306658,0.6239678957896782
PSMB9,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428,0.6239678957896782
PSMB9,MIRAGE syndrome ORPHA:494433,0.6239678957896782
PSMB9,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.6239678957896782
PSMB9,Neutrophil immunodeficiency syndrome ORPHA:183707,0.6239678957896782
PSMB9,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.6239678957896782
PSMB9,Proteasome-associated autoinflammatory syndrome ORPHA:324977,0.6239678957896782
PSMB9,Cystic leukoencephalopathy without megalencephaly ORPHA:85136,0.6239678957896782
PSMB9,Epidermodysplasia verruciformis ORPHA:302,0.6268296504510718
PSMB9,Diffuse cutaneous systemic sclerosis ORPHA:220393,0.6279395134845649
PSMB9,Limited cutaneous systemic sclerosis ORPHA:220402,0.6340773186521831
PSMB9,Aicardi-Goutieres syndrome ORPHA:51,0.639029370164481
PSMB9,Primary biliary cholangitis ORPHA:186,0.64564126367818
PSMB9,Immunodeficiency by defective expression of MHC class I ORPHA:34592,0.7068064785325423
PSMB9,Singleton-Merten dysplasia ORPHA:85191,0.7068064785325423
PSMB9,1p21.3 microdeletion syndrome ORPHA:293948,0.7068064785325423
PSMB9,Ataxia-pancytopenia syndrome ORPHA:2585,0.7068064785325423
PSMB9,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487,0.7068064785325423
PSMB9,Autosomal dominant Kenny-Caffey syndrome ORPHA:93325,0.7068064785325423
PSMB9,Autosomal dominant hyper-IgE syndrome ORPHA:2314,0.7068064785325423
PSMB9,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.7068064785325423
PSMB9,Birdshot chorioretinopathy ORPHA:179,0.7068064785325423
PSMB9,Charcot-Marie-Tooth disease type 1C ORPHA:101083,0.7068064785325423
PSMB9,Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017,0.7068064785325423
PSMB9,Dihydropyrimidine dehydrogenase deficiency ORPHA:1675,0.7068064785325423
PSMB9,Griscelli syndrome type 2 ORPHA:79477,0.7068064785325423
PSMB9,Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124,0.7068064785325423
PSMB9,Hereditary pediatric Behcet-like disease ORPHA:476102,0.7068064785325423
PSMB9,Hyper-IgM syndrome type 3 ORPHA:101090,0.7068064785325423
PSMB9,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592,0.7068064785325423
PSMB9,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.7068064785325423
PSMB9,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595,0.7068064785325423
PSMB9,NIK deficiency ORPHA:447731,0.7068064785325423
PSMB9,NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825,0.7068064785325423
PSMB9,Nasopharyngeal carcinoma ORPHA:150,0.7068064785325423
PSMB9,Osteocraniostenosis ORPHA:2763,0.7068064785325423
PSMB9,Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798,0.7068064785325423
PSMB9,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.7068064785325423
PSMB9,STAT3-related early-onset multisystem autoimmune disease ORPHA:438159,0.7068064785325423
PSMB9,STING-associated vasculopathy with onset in infancy ORPHA:425120,0.7068064785325423
PSMB9,Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311,0.7068064785325423
PSMB9,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154,0.7068064785325423
PSMB9,T-cell large granular lymphocyte leukemia ORPHA:86872,0.7068064785325423
PSMB9,Variant ABeta2M amyloidosis ORPHA:314652,0.7068064785325423
PSMB9,Waldenstrom macroglobulinemia ORPHA:33226,0.7068064785325423
PSMB9,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection ORPHA:431166,0.7068064785325423
PSMB9,Vogt-Koyanagi-Harada disease ORPHA:3437,0.7068064785325423
PSMB9,Familial Chilblain lupus ORPHA:481662,0.7068064785325423
PSMB9,Takayasu arteritis ORPHA:3287,0.7068064785325423
PSMB9,Giant cell arteritis ORPHA:397,0.7068064785325423
PSMB9,MALT lymphoma ORPHA:52417,0.7068064785325423
PSMB9,Chronic mucocutaneous candidiasis ORPHA:1334,0.7068064785325423
PSMB9,Behcet disease ORPHA:117,0.7249187045096473
PSMB9,Norovirus Hu/Norwalk/10074/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/20047/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CBNU2/2007/KR capsid protein,0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/10247/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH13/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/10051/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/10116/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/10183/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/10236/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH02/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH03/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH04/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH06/2006/TW major viral capsid protein,0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH07/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH09/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH12/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH17/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII.4/SGU-110421/KOR/2011 VP1,0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH05/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH08/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII.4/GZ2010-L26/Guangzhou/CHN/2010 major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII/Shanghai/SH2/2008/CHN VP1,0.6362779693488597
PSMB9,Norovirus Hu/Shanghai/SH5/2009/CHN VP1,0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH14/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH15/2007/TW major viral capsid protein,0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/20123/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH10/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH22/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII.4/Miranda/NSW850K/2011/AU VP1,0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH18/2008/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII-4/CGMH28/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/GII.4/Guangzhou/GZ2010-L88/CHN/2011 major viral capsid protein,0.6362779693488597
PSMB9,Norovirus Hu/GII.4/Guangzhou/GZ2010-L91/CHN/2011 major viral capsid protein,0.6362779693488597
PSMB9,Human calicivirus Hu/NLV/GII/MD145-12/1987/US capsid protein,0.6362779693488597
PSMB9,Lordsdale virus capsid protein (gene: orf2),0.6362779693488597
PSMB9,Norovirus Hu/GII.4/CHDC3967/1988/US VP1,0.6362779693488597
PSMB9,Norovirus Hu/GII.4/20199/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PSMB9,Norovirus Hu/Norwalk/20033/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
PURPL,Colorectal Carcinoma,0.0034602840073026
PURPL,Colorectal Cancer,0.0149315928814189
PURPL,Malignant neoplasm of large intestine,0.13167400689206
RBM24,Dysautonomia Familial,0.553002957824355
RBM24,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
RBM24,Branchiootic syndrome ORPHA:52429,0.0083045131203191
RBM24,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.0180064224283883
RBM24,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.0180064224283883
RBM24,Posterior hypospadias ORPHA:95706,0.0180064224283883
RBM24,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.0621182671032116
RBM24,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.0640416108792758
RBM24,Cataract-glaucoma syndrome ORPHA:162,0.1590470395003315
RBM24,NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480,0.1590470395003315
RBM24,Familial progressive cardiac conduction defect ORPHA:871,0.1614487935928034
RBM24,BVES-related limb-girdle muscular dystrophy ORPHA:476084,0.3762014630157917
RBM24,Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119,0.3762014630157917
RBM24,Goldberg-Shprintzen megacolon syndrome ORPHA:66629,0.3762014630157917
RBM24,Left ventricular noncompaction ORPHA:54260,0.4177534028018127
RBM24,Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817,0.6239678957896782
RBM24,Atrial standstill ORPHA:1344,0.6239678957896782
RBM24,Congenital fiber-type disproportion myopathy ORPHA:2020,0.6279395134845649
RBM24,Fetal akinesia deformation sequence ORPHA:994,0.6279395134845649
RBM24,NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225,0.6340773186521831
RBM24,NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy ORPHA:155,0.7068064785325423
RBM24,Familial isolated dilated cardiomyopathy ORPHA:154,0.7068064785325423
RBM24,Familial sick sinus syndrome ORPHA:166282,0.7068064785325423
RBM24,Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5 ORPHA:353,0.7068064785325423
RBM24,X-linked non-syndromic sensorineural deafness type DFN ORPHA:90625,0.7068064785325423
RBM24,Typical nemaline myopathy ORPHA:171436,0.7068064785325423
RBM24,Postsynaptic congenital myasthenic syndromes ORPHA:98913,0.7166448869866529
RBM24,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.6980058392556946
RBM24,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.7553529087917877
RBM24,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.7975886343350181
RBM24,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8090912655264054
RBM24,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8090912655264054
RBM24,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8458935424065495
RBM24,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.9782376397065295
RGL1,Malignant neoplasm of breast,0.0191435238361999
RGL1,Reticulocyte count (procedure),0.425419812815905
RGL1,Calcification of coronary artery,0.6881884194440517
RGL1,Breast Cancer,0.0402286636010764
RGL1,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049
RGL1,RIN2 syndrome ORPHA:217335,0.0180064224283883
RGL1,Recessive X-linked ichthyosis ORPHA:461,0.0586579655822394
RGL1,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.0586579655822394
RGL1,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.0586579655822394
RGL1,Amyloidosis cutis dyschromia ORPHA:319635,0.3762014630157917
RGL1,Autosomal recessive spastic paraplegia type 5A ORPHA:100986,0.3762014630157917
RGL1,Congenital bile acid synthesis defect type 3 ORPHA:79302,0.3762014630157917
RGL1,Keratosis follicularis spinulosa decalvans ORPHA:2340,0.3762014630157917
RGL1,Tangier disease ORPHA:31150,0.6239678957896782
RGL1,Transcobalamin deficiency ORPHA:859,0.6239678957896782
RGL1,Adams-Oliver syndrome ORPHA:974,0.6340773186521831
RGL1,Episodic ataxia type 6 ORPHA:209967,0.7068064785325423
RGS6,Mammary Neoplasms,0.0034602840073026
RGS6,Breast Carcinoma,0.0042545616049287
RGS6,Tumor Progression,0.0149315928814189
RGS6,Malignant neoplasm of breast,0.0191435238361999
RGS6,Carcinogenesis,0.0228075668512991
RGS6,Well Differentiated Oligodendroglioma,0.0617471306652618
RGS6,Neoplasm Metastasis,0.0648809611869375
RGS6,oligodendroglioma,0.0648809611869375
RGS6,Malignant neoplasm of urinary bladder,0.084286432100041
RGS6,Bladder Neoplasm,0.0891725280554336
RGS6,Small cell carcinoma of lung,0.1193558174333938
RGS6,Costello syndrome (disorder),0.1253114324938153
RGS6,Tumor Initiation,0.13167400689206
RGS6,Carcinoma of bladder,0.13167400689206
RGS6,Hyperactive behavior,0.1387448809655294
RGS6,Leukemia Myeloid Chronic-Phase,0.1662487420178625
RGS6,Malignant neoplasm of lung,0.2714542429024338
RGS6,Carcinoma of lung,0.3663130598151661
RGS6,Pheochromocytoma,0.3712878513813393
RGS6,Childhood Brain Neoplasm,0.383941725017158
RGS6,Primary malignant neoplasm of lung,0.3902116649640871
RGS6,Schizophrenia,0.3933196962529684
RGS6,Non-Small Cell Lung Carcinoma,0.3933196962529684
RGS6,Astrocytoma,0.3933196962529684
RGS6,Neurofibromatosis-Noonan syndrome,0.3933196962529684
RGS6,Atrial Fibrillation,0.3941558617476422
RGS6,Autism Spectrum Disorders,0.3941558617476422
RGS6,Schizoaffective Disorder,0.3975960596292668
RGS6,Microcephaly,0.3975960596292668
RGS6,Malignant Peripheral Nerve Sheath Tumor,0.4126392832024548
RGS6,Mood Disorders,0.4192169590514327
RGS6,Laryngeal cleft,0.4192169590514327
RGS6,Psoriasis,0.4304973629098372
RGS6,Neurofibromatosis 1,0.4335751357405352
RGS6,Tremor,0.4564472886428772
RGS6,Abnormality of the skeletal system,0.466957409863091
RGS6,Myeloid Leukemia Chronic,0.472444704048021
RGS6,heart rate,0.4790179402069343
RGS6,Primary angle-closure glaucoma,0.4923669467696064
RGS6,Angle Closure Glaucoma,0.4981941174985421
RGS6,Acquired scoliosis,0.5019670090704682
RGS6,Obesity,0.5140447474168605
RGS6,Tuberous Sclerosis,0.5359212109443033
RGS6,Tetralogy of Fallot,0.5557519470957561
RGS6,Ataxia,0.5568517196017908
RGS6,Cerebellar Ataxia,0.5754799679683854
RGS6,RESTING HEART RATE,0.582492855487907
RGS6,Scoliosis unspecified,0.5916904943304121
RGS6,Familial aplasia of the vermis,0.6222451141623291
RGS6,Mental Retardation,0.6319938293757544
RGS6,Cardiomyopathies,0.6989462176022242
RGS6,Influenza,0.7149953523738256
RGS6,Congenital cataract,0.7651930135295156
RGS6,Intellectual Disability,0.8352623613787349
RGS6,Schizophrenia,0.0531117779464085
RGS6,Development Disorder,0.4372065554432662
RGS6,Duchenne Muscular Dystrophy,0.4560460337187313
RGS6,Mood Disorder,0.4646409362700993
RGS6,Schizoaffective Disorder,0.6712925710975606
RGS6,Psoriasis,0.7184623115342476
RGS6,McLeod neuroacanthocytosis syndrome ORPHA:59306,0.6239678957896782
RGS6,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.6239678957896782
RGS6,8p11.2 deletion syndrome ORPHA:251066,0.7068064785325423
RHOBTB3,Tumor Progression,0.0149315928814189
RHOBTB3,Malnutrition,0.5916904943304121
RHOBTB3,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
RHOBTB3,Congenital diaphragmatic hernia ORPHA:2140,0.0180064224283883
RHOBTB3,15q14 microdeletion syndrome ORPHA:261190,0.0586579655822394
RHOBTB3,Isolated aniridia ORPHA:250923,0.1590470395003315
RHOBTB3,2q32q33 microdeletion syndrome ORPHA:251019,0.6239678957896782
RHOBTB3,Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335,0.6239678957896782
RHOBTB3,SATB2-associated syndrome due to a chromosomal rearrangement ORPHA:251028,0.6239678957896782
RHOBTB3,SATB2-associated syndrome due to a pathogenic variant ORPHA:576283,0.6239678957896782
RHOBTB3,Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome ORPHA:411986,0.7068064785325423
RHOBTB3,PGM3-CDG ORPHA:443811,0.7068064785325423
RHOBTB3,Yaba-like disease virus 140R protein (gene: 140R),0.6362779693488597
RHOBTB3,Yaba monkey tumor virus kelch-like protein,0.6362779693488597
RHOBTB3,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.6362779693488597
RHOBTB3,Vaccinia virus Kelch-like protein (gene: F3L),0.6362779693488597
RHOBTB3,Vaccinia virus Ankara Kelch-like protein,0.6362779693488597
RHOBTB3,Horsepox virus HSPV008,0.6362779693488597
RHOBTB3,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.6362779693488597
RHOBTB3,Horsepox virus HSPV176 (kelch-like protein,0.6362779693488597
RHOBTB3,Provisional),0.6362779693488597
RHOBTB3,Yaba-like disease virus 19L protein (gene: 19L),0.6362779693488597
RHOBTB3,Horsepox virus HSPV043 (Kelch-like protein,0.6362779693488597
RHOBTB3,Vaccinia virus kelch-like protein (gene: A55R),0.6362779693488597
RHOBTB3,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.6362779693488597
RHOBTB3,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.6362779693488597
RHOBTB3,Horsepox virus HSPV197 (Hypothetical protein),0.6362779693488597
RHOU,Mammary Neoplasms,0.0034602840073026
RHOU,Stomach Carcinoma,0.0149315928814189
RHOU,Malignant neoplasm of stomach,0.0191435238361999
RHOU,Carcinogenesis,0.0228075668512991
RHOU,Kidney Neoplasm,0.2714542429024338
RHOU,Uterine Cancer,0.3544355608905275
RHOU,Congestive heart failure,0.425419812815905
RHOU,Heart failure,0.4304973629098372
RHOU,Cardiomyopathy Familial Idiopathic,0.4704594475773637
RHOU,Ischemic cardiomyopathy,0.7756460653898786
RHOU,Lymphocytic Leukemia,0.0487679768343083
RHOU,Familial multiple nevi flammei ORPHA:624,0.0180064224283883
RHOU,Sturge-Weber syndrome ORPHA:3205,0.0180064224283883
RHOU,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.6239678957896782
RHOU,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.776311155917498
RPSAP52,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
RPSAP52,Diabetes Mellitus,0.9683912711598086
RPSAP52,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
RPSAP52,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.0180064224283883
RPSAP52,Dedifferentiated liposarcoma ORPHA:99970,0.0183145313768111
RPSAP52,Well-differentiated liposarcoma ORPHA:99971,0.0183145313768111
RPSAP52,Pleomorphic salivary gland adenoma ORPHA:454821,0.1590470395003315
RPSAP52,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.1590470395003315
RPSAP52,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.1590470395003315
RPSAP52,Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963,0.3762014630157917
RPSAP52,Familial isolated trichomegaly ORPHA:411788,0.3762014630157917
RPSAP52,Microtia ORPHA:83463,0.3762014630157917
RPSAP52,Proximal symphalangism ORPHA:3250,0.3762014630157917
RPSAP52,Quebec platelet disorder ORPHA:220436,0.6239678957896782
RPSAP52,12q14 microdeletion syndrome ORPHA:94063,0.6239678957896782
RPSAP52,Silver-Russell syndrome due to a point mutation ORPHA:397590,0.6268296504510718
RPSAP52,Thyroid ectopia ORPHA:95712,0.7068064785325423
RPSAP52,Cold-induced sweating syndrome ORPHA:157820,0.7068064785325423
RTKN2,Breast Carcinoma,0.0042545616049287
RTKN2,Rheumatoid Arthritis,0.1537760235124317
RTKN2,Adenocarcinoma of large intestine,0.3933196962529684
RTKN2,Schizophrenia,0.3933196962529684
RTKN2,Lupus Erythematosus Systemic,0.4213286052188015
RTKN2,Idiopathic Interstitial Pneumonias,0.4675904598629673
RTKN2,Breast Carcinoma,0.0075861267486594
RTKN2,Schizophrenia,0.0531117779464085
RTKN2,Colorectal Cancer,0.4286813331685578
RTKN2,Rheumatoid Arthritis,0.4560460337187313
RTKN2,Lupus Erythematosus,0.5087473896242481
RTKN2,Human papillomavirus type 90 putative regulatory protein E2 (gene: E2),0.6362779693488597
S100A14,Ovarian Carcinoma,0.0034602840073026
S100A14,Breast Carcinoma,0.0042545616049287
S100A14,Invasive carcinoma of breast,0.0149002095788623
S100A14,Tumor Progression,0.0149315928814189
S100A14,Stomach Carcinoma,0.0149315928814189
S100A14,Squamous cell carcinoma,0.0182265588252201
S100A14,Esophageal Neoplasms,0.0182265588252201
S100A14,ovarian neoplasm,0.0191435238361999
S100A14,Malignant neoplasm of breast,0.0191435238361999
S100A14,Malignant neoplasm of stomach,0.0191435238361999
S100A14,Carcinogenesis,0.0228075668512991
S100A14,Malignant neoplasm of esophagus,0.0248454592431097
S100A14,Malignant neoplasm of ovary,0.0277695594716545
S100A14,Neoplasm Metastasis,0.0648809611869375
S100A14,Squamous cell carcinoma of esophagus,0.0919714360040484
S100A14,Esophageal carcinoma,0.1254380558571286
S100A14,Oral Cavity Carcinoma,0.13167400689206
S100A14,Malignant neoplasm of lung,0.2714542429024338
S100A14,Carcinoma of lung,0.3663130598151661
S100A14,Primary malignant neoplasm of lung,0.3902116649640871
S100A14,Non-Small Cell Lung Carcinoma,0.3933196962529684
S100A14,Lip and Oral Cavity Carcinoma,0.3933196962529684
S100A14,Non-small cell lung cancer metastatic,0.3933196962529684
S100A14,Progressive Neoplastic Disease,0.3941558617476422
S100A14,Progressive cGVHD,0.3975960596292668
S100A14,Malignant neoplasm of mouth,0.4213286052188015
S100A14,Psoriasis,0.4304973629098372
S100A14,Huntington Disease,0.4704594475773637
S100A14,EPIDERMAL DIFFERENTIATION COMPLEX,0.4923669467696064
S100A14,Adenocarcinoma of lung (disorder),0.51550637274795
S100A14,Metastatic Neoplasm,0.8757716428200738
S100A14,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.0083045131203191
S100A14,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
S100A14,Kindler epidermolysis bullosa ORPHA:2908,0.0083045131203191
S100A14,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.0083045131203191
S100A14,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191
S100A14,Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303,0.0180064224283883
S100A14,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.0180064224283883
S100A14,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.0180064224283883
S100A14,Erythrokeratodermia variabilis ORPHA:317,0.0183145313768111
S100A14,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.0586579655822394
S100A14,Localized junctional epidermolysis bullosa ORPHA:251393,0.0586579655822394
S100A14,AA amyloidosis ORPHA:85445,0.0586579655822394
S100A14,Alopecia universalis ORPHA:701,0.0586579655822394
S100A14,Atrichia with papular lesions ORPHA:86819,0.0586579655822394
S100A14,Bartsocas-Papas syndrome ORPHA:1234,0.0586579655822394
S100A14,Benign familial mesial temporal lobe epilepsy ORPHA:163717,0.0586579655822394
S100A14,CHAND syndrome ORPHA:1401,0.0586579655822394
S100A14,Epithelial recurrent erosion dystrophy ORPHA:293381,0.0586579655822394
S100A14,Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805,0.0586579655822394
S100A14,Glutamate-cysteine ligase deficiency ORPHA:33574,0.0586579655822394
S100A14,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.0586579655822394
S100A14,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.0586579655822394
S100A14,Neuropathy with hearing impairment ORPHA:139512,0.0586579655822394
S100A14,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.0586579655822394
S100A14,Marie Unna hereditary hypotrichosis ORPHA:444,0.0586579655822394
S100A14,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.0586579655822394
S100A14,White sponge nevus ORPHA:171723,0.1590470395003315
S100A14,Carvajal syndrome ORPHA:65282,0.1590470395003315
S100A14,Cholangiocarcinoma ORPHA:70567,0.1590470395003315
S100A14,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.1590470395003315
S100A14,Familial expansile osteolysis ORPHA:85195,0.1590470395003315
S100A14,Harlequin ichthyosis ORPHA:457,0.1590470395003315
S100A14,High myopia-sensorineural deafness syndrome ORPHA:363396,0.1590470395003315
S100A14,Keratoderma hereditarium mutilans ORPHA:494,0.1590470395003315
S100A14,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.1590470395003315
S100A14,Monilethrix ORPHA:573,0.1590470395003315
S100A14,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1590470395003315
S100A14,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.1590470395003315
S100A14,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.1590470395003315
S100A14,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.1590470395003315
S100A14,Xanthinuria type I ORPHA:93601,0.1590470395003315
S100A14,Bladder exstrophy ORPHA:93930,0.1590470395003315
S100A14,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.1590470395003315
S100A14,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.1590470395003315
S100A14,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.1590470395003315
S100A14,Uncombable hair syndrome ORPHA:1410,0.1590470395003315
S100A14,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.1697334635963512
S100A14,Lethal acantholytic erosive disorder ORPHA:158687,0.3762014630157917
S100A14,Apparent mineralocorticoid excess ORPHA:320,0.3762014630157917
S100A14,Autosomal recessive spastic paraplegia type 35 ORPHA:171629,0.3762014630157917
S100A14,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3762014630157917
S100A14,Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681,0.3762014630157917
S100A14,Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308,0.3762014630157917
S100A14,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3762014630157917
S100A14,Genetic transient congenital hypothyroidism ORPHA:226316,0.3762014630157917
S100A14,Glucose-galactose malabsorption ORPHA:35710,0.3762014630157917
S100A14,MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949,0.3762014630157917
S100A14,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.3762014630157917
S100A14,Naxos disease ORPHA:34217,0.3762014630157917
S100A14,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3762014630157917
S100A14,Sebocystomatosis ORPHA:841,0.3762014630157917
S100A14,Bifid uvula ORPHA:99771,0.3762014630157917
S100A14,Cleft hard palate ORPHA:101023,0.3762014630157917
S100A14,Cleft velum ORPHA:99772,0.3762014630157917
S100A14,Meesmann corneal dystrophy ORPHA:98954,0.3762014630157917
S100A14,Microvillus inclusion disease ORPHA:2290,0.3762014630157917
S100A14,Submucosal cleft palate ORPHA:155878,0.3762014630157917
S100A14,Alopecia-intellectual disability syndrome ORPHA:2850,0.3762014630157917
S100A14,Hereditary diffuse gastric cancer ORPHA:26106,0.3762014630157917
S100A14,Cleft lip and alveolus ORPHA:141291,0.3775879467205478
S100A14,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.3775879467205478
S100A14,Isolated cleft lip ORPHA:199302,0.3775879467205478
S100A14,Cleft lip/palate ORPHA:199306,0.4101640425710954
S100A14,Autosomal dominant generalized epidermolysis bullosa simplex intermediate form ORPHA:79399,0.6239678957896782
S100A14,Autosomal dominant generalized epidermolysis bullosa simplex severe form ORPHA:79396,0.6239678957896782
S100A14,Autosomal recessive distal renal tubular acidosis ORPHA:402041,0.6239678957896782
S100A14,Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397,0.6239678957896782
S100A14,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.6239678957896782
S100A14,KID syndrome ORPHA:477,0.6239678957896782
S100A14,Liddle syndrome ORPHA:526,0.6239678957896782
S100A14,Localized epidermolysis bullosa simplex ORPHA:79400,0.6239678957896782
S100A14,Pachyonychia congenita ORPHA:2309,0.6239678957896782
S100A14,Van der Woude syndrome ORPHA:888,0.6239678957896782
S100A14,ADULT syndrome ORPHA:978,0.6239678957896782
S100A14,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome ORPHA:1071,0.6239678957896782
S100A14,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.6239678957896782
S100A14,Autosomal recessive cerebral atrophy ORPHA:363969,0.6239678957896782
S100A14,Congenital tufting enteropathy ORPHA:92050,0.6239678957896782
S100A14,EEC syndrome ORPHA:1896,0.6239678957896782
S100A14,Ectodermal dysplasia-skin fragility syndrome ORPHA:158668,0.6239678957896782
S100A14,Ectodermal dysplasia-syndactyly syndrome ORPHA:247820,0.6239678957896782
S100A14,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043,0.6239678957896782
S100A14,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334,0.6239678957896782
S100A14,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034,0.6239678957896782
S100A14,Ichthyosis-hypotrichosis syndrome ORPHA:91132,0.6239678957896782
S100A14,Idiopathic bronchiectasis ORPHA:60033,0.6239678957896782
S100A14,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.6239678957896782
S100A14,Limb-mammary syndrome ORPHA:69085,0.6239678957896782
S100A14,Mullerian aplasia and hyperandrogenism ORPHA:247768,0.6239678957896782
S100A14,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.6239678957896782
S100A14,Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382,0.6239678957896782
S100A14,Non-epidermolytic palmoplantar keratoderma ORPHA:2337,0.6239678957896782
S100A14,REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330,0.6239678957896782
S100A14,SERKAL syndrome ORPHA:139466,0.6239678957896782
S100A14,Syndromic congenital sodium diarrhea ORPHA:563708,0.6239678957896782
S100A14,Tricho-dento-osseous syndrome ORPHA:3352,0.6239678957896782
S100A14,Diffuse panbronchiolitis ORPHA:171700,0.6239678957896782
S100A14,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.6239678957896782
S100A14,Pachydermoperiostosis ORPHA:2796,0.6239678957896782
S100A14,Hypotrichosis simplex ORPHA:55654,0.639029370164481
S100A14,Oligodontia ORPHA:99798,0.6723027000992685
S100A14,Autosomal recessive generalized epidermolysis bullosa simplex ORPHA:89838,0.7068064785325423
S100A14,Congenital intrauterine infection-like syndrome ORPHA:1229,0.7068064785325423
S100A14,Dermatopathia pigmentosa reticularis ORPHA:86920,0.7068064785325423
S100A14,EEM syndrome ORPHA:1897,0.7068064785325423
S100A14,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.7068064785325423
S100A14,Low isolated anorectal malformation ORPHA:171215,0.7068064785325423
S100A14,Naegeli-Franceschetti-Jadassohn syndrome ORPHA:69087,0.7068064785325423
S100A14,Netherton syndrome ORPHA:634,0.7068064785325423
S100A14,Peeling skin syndrome type B ORPHA:263553,0.7068064785325423
S100A14,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744,0.7068064785325423
S100A14,Seborrhea-like dermatitis with psoriasiform elements ORPHA:168606,0.7068064785325423
S100A14,Severe combined immunodeficiency due to FOXN1 deficiency ORPHA:169095,0.7068064785325423
S100A14,Antley-Bixler syndrome ORPHA:83,0.7068064785325423
S100A14,Isolated focal non-epidermolytic palmoplantar keratoderma ORPHA:448264,0.7068064785325423
S100A14,Striate palmoplantar keratoderma ORPHA:50942,0.7068064785325423
S100A14,Progressive symmetric erythrokeratodermia ORPHA:316,0.7068064785325423
S100A14,NON RARE IN EUROPE: Hypodontia ORPHA:2227,0.7143653415082738
SCG2,melanoma,0.0149315928814189
SCG2,Adenocarcinoma,0.0155921563748247
SCG2,Central neuroblastoma,0.0593779966354549
SCG2,Neuroblastoma,0.0688152422187159
SCG2,Degenerative polyarthritis,0.0739788831250619
SCG2,Myocardial Infarction,0.1352936728187231
SCG2,Rheumatoid Arthritis,0.1537760235124317
SCG2,Diabetes,0.2277108302018961
SCG2,Diabetes Mellitus,0.2522264785494494
SCG2,Multiple Sclerosis,0.2835142372342932
SCG2,Tuberculosis,0.3706856725676674
SCG2,Pheochromocytoma,0.3712878513813393
SCG2,Hypertensive disease,0.3933196962529684
SCG2,Pheochromocytoma malignant,0.3941558617476422
SCG2,Amyotrophic Lateral Sclerosis,0.3975960596292668
SCG2,Multiple Endocrine Neoplasia Type 1,0.3986414839122469
SCG2,Celiac Disease,0.4028066164685291
SCG2,Congestive heart failure,0.425419812815905
SCG2,Heart failure,0.4304973629098372
SCG2,Myocardial Ischemia,0.4506578937113162
SCG2,Hypercholesterolemia,0.4755217870653703
SCG2,Pain,0.4871698998714747
SCG2,Neuroendocrine Tumors,0.5017066790423467
SCG2,Arteriosclerosis,0.5019670090704682
SCG2,Coronary Arteriosclerosis,0.5140447474168605
SCG2,Ewings sarcoma,0.5251317541886066
SCG2,Atherosclerosis,0.5393787854381349
SCG2,Fibromyalgia,0.5696906826730043
SCG2,Limb ischemia,0.7240930522443176
SCG2,Prader-Willi Syndrome,0.7815030391631113
SCG2,Ondine syndrome ORPHA:661,0.020072786018028
SCG2,X-linked adrenal hypoplasia congenita ORPHA:95702,0.1590470395003315
SCG2,WAGR syndrome ORPHA:893,0.1590470395003315
SCG2,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.3762014630157917
SCG2,MASA syndrome ORPHA:2466,0.3762014630157917
SCG2,Spinocerebellar ataxia type 27 ORPHA:98764,0.3762014630157917
SCG2,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.3762014630157917
SCG2,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.3762014630157917
SCG2,Tetraamelia-multiple malformations syndrome ORPHA:3301,0.3762014630157917
SCG2,Rolandic epilepsy ORPHA:1945,0.3762014630157917
SCG2,Congenital limbs-face contractures-hypotonia-developmental delay syndrome ORPHA:562528,0.6239678957896782
SCG2,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077,0.6239678957896782
SCG2,Obesity due to prohormone convertase I deficiency ORPHA:71528,0.6239678957896782
SCG2,Temple-Baraitser syndrome ORPHA:420561,0.6239678957896782
SCG2,Tubulinopathy-associated dysgyria ORPHA:467166,0.6239678957896782
SCG2,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.6239678957896782
SCG2,Autosomal dominant spastic paraplegia type 3 ORPHA:100984,0.7068064785325423
SCG2,Obesity due to melanocortin 4 receptor deficiency ORPHA:71529,0.7068064785325423
SCG2,Congenital fibrosis of extraocular muscles ORPHA:45358,0.7068064785325423
SCG2,Presynaptic congenital myasthenic syndromes ORPHA:98914,0.7143653415082738
SCHIP1,Chromophobe Renal Cell Carcinoma,0.1461248774859792
SCHIP1,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
SCHIP1,Adenomatous Polyposis Coli,0.4749780675672355
SCHIP1,Oral Ulcer,0.4809179010794786
SCHIP1,Ondine syndrome ORPHA:661,0.020072786018028
SCHIP1,15q14 microdeletion syndrome ORPHA:261190,0.0586579655822394
SCHIP1,Childhood-onset benign chorea with striatal involvement ORPHA:494541,0.0586579655822394
SCHIP1,Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526,0.0586579655822394
SCHIP1,WAGR syndrome ORPHA:893,0.1590470395003315
SCHIP1,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154,0.3762014630157917
SCHIP1,BVES-related limb-girdle muscular dystrophy ORPHA:476084,0.3762014630157917
SCHIP1,Becker muscular dystrophy ORPHA:98895,0.3762014630157917
SCHIP1,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.3762014630157917
SCHIP1,Gordon syndrome ORPHA:376,0.3762014630157917
SCHIP1,Male infertility with teratozoospermia due to single gene mutation ORPHA:399808,0.3762014630157917
SCHIP1,Marden-Walker syndrome ORPHA:2461,0.3762014630157917
SCHIP1,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546,0.3762014630157917
SCHIP1,Rolandic epilepsy ORPHA:1945,0.3762014630157917
SCHIP1,Severe early-childhood-onset retinal dystrophy ORPHA:364055,0.3775879467205478
SCHIP1,Left ventricular noncompaction ORPHA:54260,0.4177534028018127
SCHIP1,Congenital limbs-face contractures-hypotonia-developmental delay syndrome ORPHA:562528,0.6239678957896782
SCHIP1,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome ORPHA:369970,0.6239678957896782
SCHIP1,Temple-Baraitser syndrome ORPHA:420561,0.6239678957896782
SCHIP1,Cenani-Lenz syndrome ORPHA:3258,0.6239678957896782
SCHIP1,Freeman-Sheldon syndrome ORPHA:2053,0.6239678957896782
SCHIP1,Subcortical band heterotopia ORPHA:99796,0.6239678957896782
SCHIP1,Hereditary hyperekplexia ORPHA:3197,0.6279395134845649
SCHIP1,Infantile-onset ascending hereditary spastic paralysis ORPHA:293168,0.7068064785325423
SCML2,Medulloblastoma,0.0354767239335874
SCML2,Childhood Medulloblastoma,0.3933196962529684
SCML2,Adult Medulloblastoma,0.4126392832024548
SCML2,Medullomyoblastoma,0.5453394612016188
SCML2,Melanotic medulloblastoma,0.5453394612016188
SCML2,Desmoplastic Medulloblastoma,0.5768212166102149
SCML2,Medullomyoblastoma,0.5796489603182782
SCML2,Medulloblastoma,0.675936313627625
SCML2,Combined pituitary hormone deficiencies genetic forms ORPHA:95494,0.0683063362547733
SCML2,Combined immunodeficiency with granulomatosis ORPHA:157949,0.1590470395003315
SCML2,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.1590470395003315
SCML2,Denys-Drash syndrome ORPHA:220,0.1590470395003315
SCML2,Frasier syndrome ORPHA:347,0.1590470395003315
SCML2,Meacham syndrome ORPHA:3097,0.1590470395003315
SCML2,Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307,0.6279395134845649
SCML2,46XY partial gonadal dysgenesis ORPHA:251510,0.665250072408594
SCML2,Persistent Mullerian duct syndrome ORPHA:2856,0.7068064785325423
SCML2,Human gammaherpesvirus 4 EBNA-2 nuclear protein (gene: BYRF1),0.6362779693488597
SCML2,Human herpesvirus 4 type 2 EBNA-2,0.6362779693488597
SETD7,Colorectal Carcinoma,0.0034602840073026
SETD7,Mammary Neoplasms,0.0034602840073026
SETD7,Breast Carcinoma,0.0042545616049287
SETD7,Stomach Carcinoma,0.0149315928814189
SETD7,Malignant neoplasm of breast,0.0191435238361999
SETD7,Malignant neoplasm of stomach,0.0191435238361999
SETD7,Carcinogenesis,0.0228075668512991
SETD7,Malignant neoplasm of prostate,0.0569142010728473
SETD7,Prostate carcinoma,0.0773771948186562
SETD7,Liver carcinoma,0.095319386034013
SETD7,Cholestasis Extrahepatic,0.13167400689206
SETD7,Diabetes,0.2277108302018961
SETD7,Diabetes Mellitus,0.2522264785494494
SETD7,MIXED LINEAGE LEUKEMIA,0.2605479444258003
SETD7,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
SETD7,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
SETD7,Inflammation,0.3933196962529684
SETD7,Hyperglycemia,0.4906258721078565
SETD7,Chronic Obstructive Airway Disease,0.5049674142533507
SETD7,Diastolic blood pressure,0.5359212109443033
SETD7,Influenza,0.7149953523738256
SETD7,Hepatitis C,0.7169459458481418
SETD7,Alzheimer Disease,0.4560460337187313
SETD7,19p13.3 microduplication syndrome ORPHA:447980,0.0586579655822394
SETD7,Malan overgrowth syndrome ORPHA:420179,0.0586579655822394
SETD7,Marshall-Smith syndrome ORPHA:561,0.0586579655822394
SETD7,Recessive X-linked ichthyosis ORPHA:461,0.0586579655822394
SETD7,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.0586579655822394
SETD7,Griscelli syndrome type 3 ORPHA:79478,0.0586579655822394
SETD7,Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629,0.3762014630157917
SETD7,Hajdu-Cheney syndrome ORPHA:955,0.3762014630157917
SETD7,Chondrodysplasia with joint dislocations gPAPP type ORPHA:280586,0.6239678957896782
SETD7,Craniosynostosis-microretrognathia-severe intellectual disability syndrome ORPHA:565858,0.7068064785325423
SHCBP1,Tumor Progression,0.0149315928814189
SHCBP1,melanoma,0.0149315928814189
SHCBP1,Carcinogenesis,0.0228075668512991
SHCBP1,Neoplasm Metastasis,0.0648809611869375
SHCBP1,Liver Cirrhosis Experimental,0.0747863377072194
SHCBP1,Rheumatoid Arthritis,0.1537760235124317
SHCBP1,Dysplastic Nevus,0.3933196962529684
SHCBP1,synovial sarcoma,0.3933196962529684
SHCBP1,Adult Synovial Sarcoma,0.4115056600660309
SHCBP1,Childhood Synovial Sarcoma,0.4126392832024548
SHCBP1,Melanocytic nevus,0.425419812815905
SHCBP1,Erythema Chronicum Migrans,0.4335751357405352
SHCBP1,Glossitis Benign Migratory,0.4506578937113162
SHCBP1,Hyperphenylalaninaemia,0.4506578937113162
SHCBP1,Conn Syndrome,0.6084642888478995
SHCBP1,Ankylosing spondylitis,0.6446807314576214
SHCBP1,Influenza,0.7149953523738256
SHCBP1,Metastatic Neoplasm,0.8757716428200738
SHCBP1,Synovial Sarcoma,0.4286813331685578
SHCBP1,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
SHCBP1,Hereditary breast cancer ORPHA:227535,0.0106988445340883
SHCBP1,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.0180064224283883
SHCBP1,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0180064224283883
SHCBP1,Filippi syndrome ORPHA:3255,0.0180064224283883
SHCBP1,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0180064224283883
SHCBP1,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0180064224283883
SHCBP1,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0180064224283883
SHCBP1,Roberts syndrome ORPHA:3103,0.0180064224283883
SHCBP1,Stromme syndrome ORPHA:506307,0.0180064224283883
SHCBP1,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.0180064224283883
SHCBP1,Dedifferentiated liposarcoma ORPHA:99970,0.0183145313768111
SHCBP1,Well-differentiated liposarcoma ORPHA:99971,0.0183145313768111
SHCBP1,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.0586579655822394
SHCBP1,Bloom syndrome ORPHA:125,0.0586579655822394
SHCBP1,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0586579655822394
SHCBP1,Microcephaly-micromelia syndrome ORPHA:572768,0.0586579655822394
SHCBP1,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0586579655822394
SHCBP1,Primary peritoneal carcinoma ORPHA:168829,0.0586579655822394
SHCBP1,VACTERL with hydrocephalus ORPHA:3412,0.0586579655822394
SHCBP1,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0599424746210022
SHCBP1,Osteosarcoma ORPHA:668,0.0599424746210022
SHCBP1,Seckel syndrome ORPHA:808,0.0683063362547733
SHCBP1,Fanconi anemia ORPHA:84,0.0930156564388357
SHCBP1,Autosomal recessive primary microcephaly ORPHA:2512,0.1026843275212335
SHCBP1,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.1590470395003315
SHCBP1,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1590470395003315
SHCBP1,Denys-Drash syndrome ORPHA:220,0.1590470395003315
SHCBP1,Frasier syndrome ORPHA:347,0.1590470395003315
SHCBP1,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.1590470395003315
SHCBP1,Meacham syndrome ORPHA:3097,0.1590470395003315
SHCBP1,Xeroderma pigmentosum variant ORPHA:90342,0.1590470395003315
SHCBP1,Li-Fraumeni syndrome ORPHA:524,0.1614487935928034
SHCBP1,Ear-patella-short stature syndrome ORPHA:2554,0.1659988674007724
SHCBP1,Hereditary breast and ovarian cancer syndrome ORPHA:145,0.1936858543871029
SHCBP1,Familial prostate cancer ORPHA:1331,0.1981653781243822
SHCBP1,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.3762014630157917
SHCBP1,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404,0.3762014630157917
SHCBP1,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.3762014630157917
SHCBP1,Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318,0.3762014630157917
SHCBP1,Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139,0.3762014630157917
SHCBP1,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898,0.6239678957896782
SHCBP1,Combined immunodeficiency due to TFRC deficiency ORPHA:476113,0.7068064785325423
SIX2,Breast Carcinoma,0.0042545616049287
SIX2,Malignant neoplasm of breast,0.0191435238361999
SIX2,Carcinogenesis,0.0228075668512991
SIX2,Neoplasm Metastasis,0.0648809611869375
SIX2,Renal Cell Carcinoma,0.0648809611869375
SIX2,Tumor Initiation,0.13167400689206
SIX2,Kidney Neoplasm,0.2714542429024338
SIX2,Von Hippel-Lindau Syndrome,0.3933196962529684
SIX2,Kidney Diseases,0.3933196962529684
SIX2,Nephroblastoma,0.3933196962529684
SIX2,Amyotrophic Lateral Sclerosis Sporadic,0.3933196962529684
SIX2,Brenner Tumor,0.3933196962529684
SIX2,AMYOTROPHIC LATERAL SCLEROSIS 1,0.3933196962529684
SIX2,Squamous cell carcinoma of tongue,0.3933196962529684
SIX2,Frontonasal dysplasia,0.3933196962529684
SIX2,Bilateral Wilms Tumor,0.4790179402069343
SIX2,Renal dysplasia,0.5696906826730043
SIX2,Cystadenoma,0.5710095678317721
SIX2,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594
SIX2,Metopic Synostosis,0.425341435586089
SIX2,Frontonasal Dysplasia,0.4402141802500753
SIX2,Frontal Bossing,0.4560460337187313
SIX2,Lateral Sclerosis,0.4867879381749835
SIX2,Wilms Tumor,0.5087473896242481
SIX2,Posteriorly Rotated Ear,0.5248691614865011
SIX2,Dwarfism,0.5796489603182782
SIX2,Kidney Disease,0.6420878824691651
SIX2,Nephroblastoma,0.6883874961919009
SIX2,Macrocephaly,0.800821840688695
SIX2,Ptosis,0.8357787380041017
SIX2,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
SIX2,Peters anomaly ORPHA:708,0.00518481975049
SIX2,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
SIX2,Axenfeld anomaly ORPHA:98978,0.0083045131203191
SIX2,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
SIX2,Branchiootic syndrome ORPHA:52429,0.0083045131203191
SIX2,Rieger anomaly ORPHA:91483,0.0083045131203191
SIX2,Bamforth-Lazarus syndrome ORPHA:1226,0.0180064224283883
SIX2,BOR syndrome ORPHA:107,0.0183145313768111
SIX2,Athyreosis ORPHA:95713,0.0640416108792758
SIX2,Cataract-glaucoma syndrome ORPHA:162,0.1590470395003315
SIX2,Brain-lung-thyroid syndrome ORPHA:209905,0.3762014630157917
SIX2,Craniofacial dysplasia-osteopenia syndrome ORPHA:314555,0.3762014630157917
SIX2,22q11.2 duplication syndrome ORPHA:1727,0.6239678957896782
SIX2,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034,0.6239678957896782
SIX2,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome ORPHA:397623,0.6239678957896782
SIX2,Tricho-dento-osseous syndrome ORPHA:3352,0.6239678957896782
SIX2,Familial clubfoot due to 5q31 microdeletion ORPHA:293144,0.7068064785325423
SIX2,Familial clubfoot due to PITX1 point mutation ORPHA:293150,0.7068064785325423
SIX2,Mirror-image polydactyly ORPHA:498494,0.7068064785325423
SIX2,Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275,0.7068064785325423
SIX2,Yaba monkey tumor virus 72L,0.6362779693488597
SIX2,Machupo mammarenavirus L protein,0.6362779693488597
SIX2,Lassa mammarenavirus L protein,0.6362779693488597
SIX2,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.6362779693488597
SKAP1,Ovarian Carcinoma,0.0034602840073026
SKAP1,ovarian neoplasm,0.0191435238361999
SKAP1,Malignant neoplasm of ovary,0.0277695594716545
SKAP1,Epithelial ovarian cancer,0.0387439397151409
SKAP1,Hairy Cell Leukemia,0.3412203844672238
SKAP1,Classical Hodgkin's Lymphoma,0.3763374964032415
SKAP1,Peripheral T-Cell Lymphoma,0.3933196962529684
SKAP1,Ovarian Serous Adenocarcinoma,0.3933196962529684
SKAP1,Ki-1+ Anaplastic Large Cell Lymphoma,0.3941558617476422
SKAP1,Body mass index,0.5496357724684553
SKAP1,Finding of body mass index,0.5496357724684553
SKAP1,Intelligence,0.5683976277847906
SKAP1,Endometriosis,0.2187610616307245
SKAP1,Endometrial Carcinoma,0.4286813331685578
SKAP1,Ovarian Serous Adenocarcinoma,0.4560460337187313
SKAP1,Ovarian Neoplasm,0.7921294370722203
SKAP1,Ovarian Cancer,0.8876319700740651
SKAP1,Odonto-onycho-dermal dysplasia ORPHA:2721,0.0180064224283883
SKAP1,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.0180064224283883
SKAP1,Galactose mutarotase deficiency ORPHA:570422,0.1590470395003315
SKAP1,Serrated polyposis syndrome ORPHA:157798,0.1590470395003315
SKAP1,Congenital non-communicating hydrocephalus ORPHA:269510,0.3762014630157917
SKAP1,Spinocerebellar ataxia type 40 ORPHA:423275,0.3762014630157917
SKAP1,Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248,0.3775879467205478
SKAP1,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857,0.6239678957896782
SKAP1,BENTA disease ORPHA:464336,0.6239678957896782
SKAP1,Combined immunodeficiency due to CD27 deficiency ORPHA:238505,0.6239678957896782
SKAP1,Cranio-osteoarthropathy ORPHA:1525,0.6239678957896782
SKAP1,Isolated congenital digital clubbing ORPHA:217059,0.6239678957896782
SKAP1,Persistent polyclonal B-cell lymphocytosis ORPHA:300324,0.6239678957896782
SKAP1,Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237,0.6239678957896782
SKAP1,Severe combined immunodeficiency due to LCK deficiency ORPHA:280142,0.6239678957896782
SKAP1,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.7068064785325423
SKAP1,C syndrome ORPHA:1308,0.7068064785325423
SKAP1,Fatal post-viral neurodegenerative disorder ORPHA:391343,0.7068064785325423
SKAP1,GTP cyclohydrolase I deficiency ORPHA:2102,0.7068064785325423
SKAP1,Hypoparathyroidism-sensorineural deafness-renal disease syndrome ORPHA:2237,0.7068064785325423
SKAP1,Susceptibility to respiratory infections associated with CD8alpha chain mutation ORPHA:169085,0.7068064785325423
SKAP1,Female infertility due to oocyte meiotic arrest ORPHA:488191,0.7068064785325423
SKAP1,Autosomal dominant hypohidrotic ectodermal dysplasia ORPHA:1810,0.7068064785325423
SKAP1,Idiopathic aplastic anemia ORPHA:88,0.7068064785325423
SKAP1,Human immunodeficiency virus 2 nef protein,0.6362779693488597
SKAP1,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.6362779693488597
SKAP1,Human papillomavirus type 90 putative regulatory protein E2 (gene: E2),0.6362779693488597
SKAP1,Human papillomavirus type 10 envelope protein (gene: E2),0.6386053036162835
SKAP1,Human immunodeficiency virus nef protein (gene: nef),0.7795229132668053
SKAP1,Human papillomavirus 117 E2,0.7954342107380572
SKAP1,Monkeypox virus ankyrin-like protein,0.8426793553344071
SKIL,melanoma,0.0149315928814189
SKIL,Squamous cell carcinoma,0.0182265588252201
SKIL,Malignant neoplasm of prostate,0.0569142010728473
SKIL,Central neuroblastoma,0.0593779966354549
SKIL,Barrett Esophagus,0.0648809611869375
SKIL,Neuroblastoma,0.0688152422187159
SKIL,Prostate carcinoma,0.0773771948186562
SKIL,Colorectal Neoplasms,0.0827744840860166
SKIL,Hamman-Rich syndrome,0.13167400689206
SKIL,Arsenic Poisoning Inorganic,0.13167400689206
SKIL,Nervous System Organic Arsenic Poisoning,0.13167400689206
SKIL,Arsenic Encephalopathy,0.13167400689206
SKIL,Arsenic Induced Polyneuropathy,0.13167400689206
SKIL,Arsenic Poisoning,0.13167400689206
SKIL,Hyperactive behavior,0.1387448809655294
SKIL,Creatinine measurement serum (procedure),0.383941725017158
SKIL,Non-Small Cell Lung Carcinoma,0.3933196962529684
SKIL,Alzheimer's Disease,0.3933196962529684
SKIL,Other ureteric obstruction,0.3933196962529684
SKIL,Parkinson Disease,0.3933196962529684
SKIL,Adenoma,0.3933196962529684
SKIL,Glomerular filtration rate finding,0.4126392832024548
SKIL,Pulmonary Fibrosis,0.4335751357405352
SKIL,Dermatologic disorders,0.4906258721078565
SKIL,Obstructive nephropathy,0.553002957824355
SKIL,Pulmonary Fibrosis,0.0654534781440596
SKIL,Alveolitis,0.1025546857843372
SKIL,Arsenic Encephalopathy,0.185736315425117
SKIL,Dermatologic Disorders,0.2895940391390291
SKIL,Human T-lymphotropic virus 3 polymerase (gene: pol),0.6362779693488597
SKIL,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.6481498905276316
SKIL,Human T-cell leukemia virus type I p15NC-p14PR-p95RT/IN (gene: gag-pro-pol),0.6920622798772148
SKIL,Human T-cell leukemia virus type I Pr gag-pro-pol (gene: gag-pro-pol),0.6949711755793786
SKIL,Human betacoronavirus 2c EMC/2012 ORF4a (gene: orf4a),0.7245718814666527
SKIL,Middle East respiratory syndrome-related coronavirus NS4A protein (gene: orf4a),0.7245718814666527
SKIL,Adult diarrheal rotavirus strain J19 NSP1,0.7879984651860477
SKIL,Human T-lymphotropic virus 2 full_polyprotein 1..982,0.8390943852085586
SKIL,Human T-lymphotropic virus 2 Gag-Pro-Pol,0.8415830684989161
SKIL,Monkeypox virus ankyrin-like protein,0.8426793553344071
SLC16A6,Endometriosis,0.383941725017158
SLC16A6,Endometrioma,0.3941558617476422
SLC16A6,Endometriosis,0.2187610616307245
SLC16A6,Endometrioma,0.5036845352940079
SLC22A18,Colorectal Carcinoma,0.0034602840073026
SLC22A18,Mammary Neoplasms,0.0034602840073026
SLC22A18,Breast Carcinoma,0.0042545616049287
SLC22A18,Colorectal Cancer,0.0149315928814189
SLC22A18,Tumor Progression,0.0149315928814189
SLC22A18,Adenocarcinoma,0.0155921563748247
SLC22A18,Squamous cell carcinoma,0.0182265588252201
SLC22A18,Esophageal Neoplasms,0.0182265588252201
SLC22A18,Malignant neoplasm of breast,0.0191435238361999
SLC22A18,Carcinogenesis,0.0228075668512991
SLC22A18,Malignant neoplasm of esophagus,0.0248454592431097
SLC22A18,Mammary Neoplasms Human,0.064548079316548
SLC22A18,Barrett Esophagus,0.0648809611869375
SLC22A18,Glioma,0.0739788831250619
SLC22A18,Glioblastoma,0.0745502070959292
SLC22A18,Squamous cell carcinoma of esophagus,0.0919714360040484
SLC22A18,Liver carcinoma,0.095319386034013
SLC22A18,Esophageal carcinoma,0.1254380558571286
SLC22A18,Myocardial Infarction,0.1352936728187231
SLC22A18,Breast Cancer Familial,0.1602092191314262
SLC22A18,Lung Neoplasms,0.2062010908869036
SLC22A18,Eosinophilic esophagitis,0.2085938372806741
SLC22A18,Hepatoblastoma,0.2522264785494494
SLC22A18,Smith-Lemli-Opitz Syndrome,0.2522264785494494
SLC22A18,Adenocarcinoma Of Esophagus,0.2679411586077776
SLC22A18,Neoplasms,0.2714542429024338
SLC22A18,Malignant neoplasm of lung,0.2714542429024338
SLC22A18,Rhabdomyosarcoma,0.3510063969122338
SLC22A18,Carcinoma of lung,0.3663130598151661
SLC22A18,Recurrent tumor,0.383941725017158
SLC22A18,Amyloidosis,0.3933196962529684
SLC22A18,Interstitial lung fibrosis,0.3933196962529684
SLC22A18,Nephroblastoma,0.3933196962529684
SLC22A18,Non-Small Cell Lung Carcinoma,0.3933196962529684
SLC22A18,Gastroesophageal reflux disease,0.3933196962529684
SLC22A18,Childhood Hepatocellular Carcinoma,0.3933196962529684
SLC22A18,Bronchioloalveolar Adenocarcinoma,0.3933196962529684
SLC22A18,Glioblastoma Multiforme,0.3933196962529684
SLC22A18,Familial multiple trichoepitheliomata,0.3941558617476422
SLC22A18,Erosive esophagitis,0.3941558617476422
SLC22A18,Bilirubin measurement,0.4615352570710579
SLC22A18,Embryonal Rhabdomyosarcoma,0.472444704048021
SLC22A18,Barrett's Adenocarcinoma,0.5090214163899865
SLC22A18,Alcoholic Intoxication Chronic,0.5097818625871164
SLC22A18,Adenocarcinoma of lung (disorder),0.51550637274795
SLC22A18,Malaria,0.5655222348249326
SLC22A18,Factor V Leiden mutation,0.610971999959321
SLC22A18,Beckwith-Wiedemann Syndrome,0.6304655343580164
SLC22A18,Breast Carcinoma,0.0075861267486594
SLC22A18,Marfan Syndrome,0.0133304506157067
SLC22A18,Mammary Neoplasms,0.0155248163763686
SLC22A18,Breast Cancer,0.0402286636010764
SLC22A18,Lung Cancer,0.4402141802500753
SLC22A18,Lung Carcinoma,0.4541466895915311
SLC22A18,Embryonal Rhabdomyosarcoma,0.4541466895915311
SLC22A18,Hereditary Breast Cancer,0.4541466895915311
SLC22A18,Lung Neoplasms,0.4560460337187313
SLC22A18,Rhabdomyosarcoma,0.4875380732267193
SLC22A18,Lung Adenocarcinoma,0.7979764766391754
SLC22A18,Hereditary breast cancer ORPHA:227535,0.0106988445340883
SLC22A18,Mucopolysaccharidosis type 4A ORPHA:309297,0.0586579655822394
SLC22A18,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.1590470395003315
SLC22A18,Galactosialidosis ORPHA:351,0.1590470395003315
SLC22A18,5-oxoprolinase deficiency ORPHA:33572,0.3762014630157917
SLC22A18,CLN10 disease ORPHA:228337,0.3762014630157917
SLC22A18,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3762014630157917
SLC22A18,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.3762014630157917
SLC22A18,Embryonal rhabdomyosarcoma ORPHA:99757,0.3762014630157917
SLC22A18,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.3762014630157917
SLC22A18,Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305,0.3762014630157917
SLC22A18,Dysosteosclerosis ORPHA:1782,0.3762014630157917
SLC22A18,3-hydroxy-3-methylglutaric aciduria ORPHA:20,0.6239678957896782
SLC22A18,Acrodermatitis enteropathica ORPHA:37,0.6239678957896782
SLC22A18,CLN11 disease ORPHA:314629,0.6239678957896782
SLC22A18,Clear cell renal carcinoma ORPHA:319276,0.6239678957896782
SLC22A18,Mucolipidosis type III gamma ORPHA:423470,0.6239678957896782
SLC22A18,Mucopolysaccharidosis type 7 ORPHA:584,0.6239678957896782
SLC22A18,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.6239678957896782
SLC22A18,Polyglucosan body myopathy type 1 ORPHA:397937,0.6239678957896782
SLC22A18,Sanfilippo syndrome type A ORPHA:79269,0.6239678957896782
SLC22A18,Argininosuccinic aciduria ORPHA:23,0.7068064785325423
SLC22A18,CLN3 disease ORPHA:228346,0.7068064785325423
SLC22A18,D-glyceric aciduria ORPHA:941,0.7068064785325423
SLC22A18,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.7068064785325423
SLC22A18,Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927,0.7068064785325423
SLC26A7,Distal Renal Tubular Acidosis,0.2643145809900195
SLC26A7,Schizophrenia,0.3933196962529684
SLC26A7,Alzheimer's Disease,0.3933196962529684
SLC26A7,Hereditary spherocytosis,0.472444704048021
SLC26A7,Hypokalemia,0.5299466034567416
SLC26A7,Tauopathies,0.5682392297191953
SLC26A7,Schizophrenia,0.0531117779464085
SLC4A8,Alzheimer's Disease,0.3933196962529684
SLC4A8,Prediabetes syndrome,0.6878314377608323
SLC4A8,Alzheimer Disease,0.4560460337187313
SLC4A8,15q13.3 microdeletion syndrome ORPHA:199318,0.1590470395003315
SLC4A8,Cerebellar ataxia Cayman type ORPHA:94122,0.6239678957896782
SLC4A8,Lissencephaly due to TUBA1A mutation ORPHA:171680,0.6239678957896782
SLC4A8,Lissencephaly type 1 due to doublecortin gene mutation ORPHA:2148,0.6239678957896782
SLC4A8,FRAXE intellectual disability ORPHA:100973,0.6239678957896782
SLC4A8,ALK-positive anaplastic large cell lymphoma ORPHA:300895,0.7068064785325423
SLC4A8,ALK-positive large B-cell lymphoma ORPHA:364043,0.7068064785325423
SLC4A8,Benign paroxysmal torticollis of infancy ORPHA:71518,0.7068064785325423
SLC4A8,Familial paroxysmal ataxia ORPHA:97,0.7068064785325423
SLC4A8,Griscelli syndrome type 1 ORPHA:79476,0.7068064785325423
SLC4A8,Hyperekplexia-epilepsy syndrome ORPHA:163985,0.7068064785325423
SLC4A8,Neuroectodermal melanolysosomal disease ORPHA:33445,0.7068064785325423
SLC4A8,Spinocerebellar ataxia type 6 ORPHA:98758,0.7068064785325423
SMAD6,Ovarian Carcinoma,0.0034602840073026
SMAD6,Squamous cell carcinoma,0.0182265588252201
SMAD6,Carcinogenesis,0.0228075668512991
SMAD6,Malignant neoplasm of ovary,0.0277695594716545
SMAD6,Glioma,0.0739788831250619
SMAD6,Lymphoma,0.0739788831250619
SMAD6,AORTIC VALVE DISEASE 2,0.0745502070959292
SMAD6,Bicuspid aortic valve,0.2687300999130421
SMAD6,Malignant neoplasm of lung,0.2714542429024338
SMAD6,Aortic Aneurysm Thoracic,0.2980670559114652
SMAD6,Metastatic malignant neoplasm to brain,0.3638414818541592
SMAD6,Carcinoma of lung,0.3663130598151661
SMAD6,Primary malignant neoplasm of lung,0.3902116649640871
SMAD6,Renal glomerular disease,0.3933196962529684
SMAD6,Non-Small Cell Lung Carcinoma,0.3933196962529684
SMAD6,Hypertensive disease,0.3933196962529684
SMAD6,Dilatation of the aortic arch,0.3933196962529684
SMAD6,Pulmonary Hypertension,0.3933196962529684
SMAD6,Craniosynostosis,0.3933196962529684
SMAD6,Nephritis,0.3941558617476422
SMAD6,Hereditary hemochromatosis,0.3941558617476422
SMAD6,Osteitis Fibrosa Disseminata,0.4028066164685291
SMAD6,Synostotic Anterior Plagiocephaly,0.4192169590514327
SMAD6,Aortic Valve Stenosis,0.4213286052188015
SMAD6,Brachycephaly,0.4213286052188015
SMAD6,Heart murmur,0.4213286052188015
SMAD6,Synostotic Posterior Plagiocephaly,0.4506578937113162
SMAD6,Acrocephaly,0.4564472886428772
SMAD6,Iron Overload,0.466957409863091
SMAD6,Metopic synostosis,0.4675904598629673
SMAD6,Aortic valve disorder,0.472444704048021
SMAD6,Aortic valve calcification,0.4906258721078565
SMAD6,Increase in blood pressure,0.4923669467696064
SMAD6,Fibrous Dysplasia,0.4923669467696064
SMAD6,Trigonocephaly,0.4981941174985421
SMAD6,Chronic Obstructive Airway Disease,0.5049674142533507
SMAD6,Scaphycephaly,0.5090214163899865
SMAD6,Body mass index,0.5496357724684553
SMAD6,Finding of body mass index,0.5496357724684553
SMAD6,Waist-Hip Ratio,0.549941235475765
SMAD6,Aortic coarctation,0.5655222348249326
SMAD6,Aortic Valve Insufficiency,0.5683976277847906
SMAD6,Thoracic Aortic Aneurysm And Aortic Dissection,0.1641294276675242
SMAD6,Aortic Valve Sclerosis,0.3182746822082389
SMAD6,Metopic Synostosis,0.425341435586089
SMAD6,Craniosynostosis,0.4286813331685578
SMAD6,Aortic Valve Insufficiency,0.4286813331685578
SMAD6,Aortic Valve Disease,0.4286813331685578
SMAD6,Colorectal Cancer,0.4286813331685578
SMAD6,Hypoplastic Left Heart Syndrome,0.4402141802500753
SMAD6,Aortic Aneurysm,0.4541466895915311
SMAD6,Carpal Tunnel Syndrome,0.4560460337187313
SMAD6,Aortic Valve Calcification,0.4560460337187313
SMAD6,Brachycephaly,0.4560460337187313
SMAD6,Radioulnar Synostosis,0.4560460337187313
SMAD6,Colorectal Neoplasms,0.4560460337187313
SMAD6,Hypertension,0.4560460337187313
SMAD6,Colorectal Adenoma,0.4560460337187313
SMAD6,Synostotic Anterior Plagiocephaly,0.4560460337187313
SMAD6,Bicuspid Aortic Valve,0.4646409362700993
SMAD6,Aneurysm Of Aortic Arch,0.4646409362700993
SMAD6,Synostotic Posterior Plagiocephaly,0.4723647227028846
SMAD6,Colonic Neoplasms,0.4809179010794786
SMAD6,Scaphocephaly,0.5234357475824973
SMAD6,Acrocephaly,0.5316139823120088
SMAD6,Trigonocephaly,0.6030919130927346
SMAD6,Aortic Coarctation,0.6712925710975606
SMAD6,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
SMAD6,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
SMAD6,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191
SMAD6,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
SMAD6,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.0180064224283883
SMAD6,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.0180064224283883
SMAD6,Tetralogy of Fallot ORPHA:3303,0.0277610005156803
SMAD6,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.1590470395003315
SMAD6,Endosteal hyperostosis Worth type ORPHA:2790,0.1590470395003315
SMAD6,LRP5-related primary osteoporosis ORPHA:498481,0.1590470395003315
SMAD6,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.1590470395003315
SMAD6,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.1590470395003315
SMAD6,Enlarged parietal foramina ORPHA:60015,0.1590470395003315
SMAD6,Hyperostosis corticalis generalisata ORPHA:3416,0.1590470395003315
SMAD6,Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067,0.1590470395003315
SMAD6,NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480,0.1590470395003315
SMAD6,Partial atrioventricular septal defect ORPHA:1330,0.1590470395003315
SMAD6,Familial progressive cardiac conduction defect ORPHA:871,0.1614487935928034
SMAD6,Deafness-lymphedema-leukemia syndrome ORPHA:3226,0.3762014630157917
SMAD6,Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390,0.3762014630157917
SMAD6,Monocytopenia with susceptibility to infections ORPHA:228423,0.3762014630157917
SMAD6,Truncus arteriosus ORPHA:3384,0.3762014630157917
SMAD6,Familial bicuspid aortic valve ORPHA:402075,0.3775879467205478
SMAD6,Giant cell glioblastoma ORPHA:251579,0.433039750392822
SMAD6,Gliosarcoma ORPHA:251576,0.433039750392822
SMAD6,2q32q33 microdeletion syndrome ORPHA:251019,0.6239678957896782
SMAD6,Hypodontia-dysplasia of nails syndrome ORPHA:2228,0.6239678957896782
SMAD6,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735,0.6239678957896782
SMAD6,SATB2-associated syndrome due to a chromosomal rearrangement ORPHA:251028,0.6239678957896782
SMAD6,SATB2-associated syndrome due to a pathogenic variant ORPHA:576283,0.6239678957896782
SMAD6,8p23.1 microdeletion syndrome ORPHA:251071,0.7068064785325423
SMAD6,Guttmacher syndrome ORPHA:2957,0.7068064785325423
SMAD6,Hand-foot-genital syndrome ORPHA:2438,0.7068064785325423
SMAD6,Isolated scaphocephaly ORPHA:35093,0.7068064785325423
SMAD6,Human gammaherpesvirus 8 vIRF-3 (gene: vIRF-3),0.6362779693488597
SMAD7,Colorectal Carcinoma,0.0034602840073026
SMAD7,Mammary Neoplasms,0.0034602840073026
SMAD7,Ovarian Carcinoma,0.0034602840073026
SMAD7,Breast Carcinoma,0.0042545616049287
SMAD7,Colorectal Cancer,0.0149315928814189
SMAD7,Tumor Progression,0.0149315928814189
SMAD7,Stomach Carcinoma,0.0149315928814189
SMAD7,Retroviridae Infections,0.0149315928814189
SMAD7,melanoma,0.0149315928814189
SMAD7,Proliferative vitreoretinopathy,0.0182265588252201
SMAD7,Squamous cell carcinoma,0.0182265588252201
SMAD7,ovarian neoplasm,0.0191435238361999
SMAD7,Malignant neoplasm of breast,0.0191435238361999
SMAD7,Malignant neoplasm of stomach,0.0191435238361999
SMAD7,Carcinogenesis,0.0228075668512991
SMAD7,Malignant neoplasm of ovary,0.0277695594716545
SMAD7,Epithelial ovarian cancer,0.0387439397151409
SMAD7,Malignant neoplasm of prostate,0.0569142010728473
SMAD7,Neoplasm Metastasis,0.0648809611869375
SMAD7,Malignant neoplasm of pancreas,0.0726340460169901
SMAD7,Pancreatic Neoplasm,0.0739788831250619
SMAD7,Glioma,0.0739788831250619
SMAD7,Degenerative polyarthritis,0.0739788831250619
SMAD7,Endometrial Neoplasms,0.0745502070959292
SMAD7,Pancreatic carcinoma,0.0745502070959292
SMAD7,Prostate carcinoma,0.0773771948186562
SMAD7,Colorectal Neoplasms,0.0827744840860166
SMAD7,Squamous cell carcinoma of esophagus,0.0919714360040484
SMAD7,Liver carcinoma,0.095319386034013
SMAD7,Osteosarcoma,0.1029977559100099
SMAD7,Colon Carcinoma,0.1062239757831962
SMAD7,Adenocarcinoma of colon,0.1112281755580192
SMAD7,Chronic Lymphocytic Leukemia,0.1147307578771389
SMAD7,Secondary malignant neoplasm of bone,0.1253114324938153
SMAD7,MYELODYSPLASTIC SYNDROME,0.1254380558571286
SMAD7,Hamman-Rich syndrome,0.13167400689206
SMAD7,Malignant neoplasm of large intestine,0.13167400689206
SMAD7,Malignant neoplasm of endometrium,0.13167400689206
SMAD7,Uterine Corpus Cancer,0.1328002618052838
SMAD7,Hyperactive behavior,0.1387448809655294
SMAD7,Renal fibrosis,0.1602092191314262
SMAD7,Invasive Carcinoma,0.1602092191314262
SMAD7,Systemic Scleroderma,0.1900258729042946
SMAD7,Osteosarcoma of bone,0.2109483801368481
SMAD7,Malignant tumor of colon,0.223747154820789
SMAD7,Prostatic Neoplasms,0.223747154820789
SMAD7,Hepatoblastoma,0.2522264785494494
SMAD7,Malignant neoplasm of lung,0.2714542429024338
SMAD7,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
SMAD7,510-Methylenetetrahydrofolate reductase deficiency,0.2714542429024338
SMAD7,Peyronie Disease,0.2714542429024338
SMAD7,Secondary malignant neoplasm of lung,0.2723545094624877
SMAD7,Multiple Sclerosis,0.2835142372342932
SMAD7,Fibroid Tumor,0.290158730291654
SMAD7,Triple Negative Breast Neoplasms,0.2980670559114652
SMAD7,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
SMAD7,Endometrial Carcinoma,0.3044782497745498
SMAD7,Acute pancreatitis,0.3220099003872086
SMAD7,Ataxia Telangiectasia,0.3508665345292502
SMAD7,Carcinoma of lung,0.3663130598151661
SMAD7,Thyroid Neoplasm,0.383941725017158
SMAD7,Uterine Fibroids,0.383941725017158
SMAD7,Primary malignant neoplasm of lung,0.3902116649640871
SMAD7,Gallbladder Carcinoma,0.3933196962529684
SMAD7,Epstein-Barr Virus Infections,0.3933196962529684
SMAD7,Adenocarcinoma of large intestine,0.3933196962529684
SMAD7,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
SMAD7,Inflammation,0.3933196962529684
SMAD7,Renal glomerular disease,0.3933196962529684
SMAD7,Kidney Diseases,0.3933196962529684
SMAD7,Non-Small Cell Lung Carcinoma,0.3933196962529684
SMAD7,Infection caused by Helicobacter pylori,0.3933196962529684
SMAD7,Secondary malignant neoplasm of liver,0.3933196962529684
SMAD7,Lichen disease,0.3933196962529684
SMAD7,Nasopharyngeal Neoplasms,0.3933196962529684
SMAD7,Acute lymphocytic leukemia,0.3933196962529684
SMAD7,Inflammatory Bowel Diseases,0.3933196962529684
SMAD7,Fibrosis Liver,0.3933196962529684
SMAD7,Coronary heart disease,0.3933196962529684
SMAD7,Pulmonary Hypertension,0.3933196962529684
SMAD7,Asthma,0.3933196962529684
SMAD7,Focal glomerulosclerosis,0.3933196962529684
SMAD7,Diabetic Nephropathy,0.3938591532700354
SMAD7,Acute Erythroblastic Leukemia,0.3941558617476422
SMAD7,Nephritis,0.3941558617476422
SMAD7,Pituitary Adenoma,0.3941558617476422
SMAD7,Hereditary hemochromatosis,0.3941558617476422
SMAD7,Glomerulosclerosis (disorder),0.4028066164685291
SMAD7,Chronic Kidney Diseases,0.4028066164685291
SMAD7,Kidney Failure Acute,0.4028066164685291
SMAD7,Celiac Disease,0.4028066164685291
SMAD7,Necrotizing Enterocolitis,0.4118266358241932
SMAD7,Biliary stricture,0.4192169590514327
SMAD7,Immunologic Deficiency Syndromes,0.4213286052188015
SMAD7,Choroid Plexus Carcinoma,0.4213286052188015
SMAD7,Rectal Carcinoma,0.429029854971378
SMAD7,Nonalcoholic Steatohepatitis,0.4335751357405352
SMAD7,Pulmonary Fibrosis,0.4335751357405352
SMAD7,Lymphatic Metastasis,0.4342056919538745
SMAD7,Gastrointestinal inflammation,0.4396723023384634
SMAD7,Ventricular Septal Defects,0.4564472886428772
SMAD7,Cicatrix Hypertrophic,0.4564472886428772
SMAD7,leukemia,0.4588513406515081
SMAD7,Iron Overload,0.466957409863091
SMAD7,Intestinal Neoplasms,0.4675904598629673
SMAD7,Localized scleroderma,0.4675904598629673
SMAD7,Periodontitis Juvenile,0.4714226702518064
SMAD7,Membranous glomerulonephritis,0.4790179402069343
SMAD7,Hemoglobin measurement,0.4852430673532381
SMAD7,Crohn Disease,0.4981941174985421
SMAD7,Scleroderma,0.5019670090704682
SMAD7,Arteriosclerosis,0.5019670090704682
SMAD7,Varicose Ulcer,0.5019670090704682
SMAD7,Chronic Obstructive Airway Disease,0.5049674142533507
SMAD7,Lipoid nephrosis,0.5188223685230745
SMAD7,Fibrodysplasia Ossificans Progressiva,0.5299466034567416
SMAD7,Congenital Abnormality,0.5305233935923577
SMAD7,Colitis,0.5323590634832615
SMAD7,Hepatocarcinogenesis,0.533913711453195
SMAD7,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.5393787854381349
SMAD7,Atherosclerosis,0.5393787854381349
SMAD7,Congenital heart disease,0.549941235475765
SMAD7,Seminoma,0.5990568578129436
SMAD7,Non-alcoholic Fatty Liver Disease,0.625027955184583
SMAD7,HEMOCHROMATOSIS TYPE 1,0.6274540883972485
SMAD7,Pustulosis of Palms and Soles,0.6319938293757544
SMAD7,Necrotizing enterocolitis in fetus OR newborn,0.6588479076808555
SMAD7,Hemochromatosis,0.6925751397474874
SMAD7,Liver diseases,0.7337030585693298
SMAD7,Hematocrit procedure,0.7412504828119304
SMAD7,Lupus Nephritis,0.7433468668038986
SMAD7,Pulmonary Emphysema,0.7674304683279349
SMAD7,Red Blood Cell Count measurement,0.7796824214131131
SMAD7,Sleep Apnea Obstructive,0.8109066403528201
SMAD7,Adult T-Cell Lymphoma/Leukemia,0.8367216325123092
SMAD7,Keloid,0.8716042675435699
SMAD7,Pulmonary Fibrosis,0.0654534781440596
SMAD7,Alveolitis,0.1025546857843372
SMAD7,Nasopharyngeal Carcinoma,0.2278592962769385
SMAD7,Colorectal Cancer,0.4286813331685578
SMAD7,Colorectal Neoplasms,0.4560460337187313
SMAD7,Colorectal Adenoma,0.4560460337187313
SMAD7,Colonic Neoplasms,0.4809179010794786
SMAD7,Paroxysmal Atrial Fibrillation,0.5082542877462781
SMAD7,Atrial Fibrillation,0.6792162876553974
SMAD7,Eczema,0.6899894525110877
SMAD7,Atrial septal defect sinus venosus type ORPHA:99105,0.3762014630157917
SMAD7,Lujo mammarenavirus multifunctional matrix-like protein,0.6362779693488597
SMAD7,Guanarito mammarenavirus Z protein,0.6362779693488597
SMAD7,Human gammaherpesvirus 8 vIRF-3 (gene: vIRF-3),0.6362779693488597
SMAD7,Chapare mammarenavirus Z protein,0.6362779693488597
SMAD7,Junin mammarenavirus Z protein,0.6362779693488597
SMAD7,Lassa mammarenavirus Z protein,0.6362779693488597
SMAD7,Pichinde mammarenavirus Z protein (gene: Z),0.6362779693488597
SMAD7,Machupo mammarenavirus Z protein,0.6362779693488597
SMAD7,Sabia mammarenavirus Z protein,0.6362779693488597
SMIM13,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.0586579655822394
SMIM13,Christianson syndrome ORPHA:85278,0.3762014630157917
SMIM13,Male infertility with teratozoospermia due to single gene mutation ORPHA:399808,0.3762014630157917
SMIM13,Chondrodysplasia with joint dislocations gPAPP type ORPHA:280586,0.6239678957896782
SMIM13,Peters plus syndrome ORPHA:709,0.6239678957896782
SMIM13,Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441,0.6239678957896782
SMIM13,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.7068064785325423
SMIM13,Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450,0.7068064785325423
SNAI2,Colorectal Carcinoma,0.0034602840073026
SNAI2,Mammary Neoplasms,0.0034602840073026
SNAI2,Ovarian Carcinoma,0.0034602840073026
SNAI2,Breast Carcinoma,0.0042545616049287
SNAI2,Epithelioma,0.0149002095788623
SNAI2,Colorectal Cancer,0.0149315928814189
SNAI2,Tumor Progression,0.0149315928814189
SNAI2,Stomach Carcinoma,0.0149315928814189
SNAI2,melanoma,0.0149315928814189
SNAI2,Adenocarcinoma,0.0155921563748247
SNAI2,Squamous cell carcinoma,0.0182265588252201
SNAI2,Esophageal Neoplasms,0.0182265588252201
SNAI2,Malignant neoplasm of breast,0.0191435238361999
SNAI2,Malignant neoplasm of stomach,0.0191435238361999
SNAI2,Carcinogenesis,0.0228075668512991
SNAI2,Malignant neoplasm of esophagus,0.0248454592431097
SNAI2,Malignant neoplasm of ovary,0.0277695594716545
SNAI2,Epithelial ovarian cancer,0.0387439397151409
SNAI2,Skin carcinoma,0.0482468351695405
SNAI2,Malignant neoplasm of prostate,0.0569142010728473
SNAI2,Central neuroblastoma,0.0593779966354549
SNAI2,Mammary Neoplasms Human,0.064548079316548
SNAI2,Neoplasm Metastasis,0.0648809611869375
SNAI2,Renal Cell Carcinoma,0.0648809611869375
SNAI2,Neuroblastoma,0.0688152422187159
SNAI2,Glioma,0.0739788831250619
SNAI2,Glioblastoma,0.0745502070959292
SNAI2,Carcinoma breast stage IV,0.0745502070959292
SNAI2,Prostate carcinoma,0.0773771948186562
SNAI2,Squamous cell carcinoma of the head and neck,0.0775520919998773
SNAI2,Colorectal Neoplasms,0.0827744840860166
SNAI2,Liver carcinoma,0.095319386034013
SNAI2,Malignant Neoplasms,0.0991201145654548
SNAI2,Osteosarcoma,0.1029977559100099
SNAI2,Colon Carcinoma,0.1062239757831962
SNAI2,Premature canities,0.1193558174333938
SNAI2,Secondary malignant neoplasm of bone,0.1253114324938153
SNAI2,Costello syndrome (disorder),0.1253114324938153
SNAI2,Waardenburg Syndrome Type 2,0.1254380558571286
SNAI2,Ductal Breast Carcinoma,0.13167400689206
SNAI2,Hamman-Rich syndrome,0.13167400689206
SNAI2,Tumor Initiation,0.13167400689206
SNAI2,Rheumatoid Arthritis,0.1537760235124317
SNAI2,Heterochromia iridis,0.1602092191314262
SNAI2,White forelock,0.1735868515093891
SNAI2,Systemic Scleroderma,0.1900258729042946
SNAI2,Osteosarcoma of bone,0.2109483801368481
SNAI2,Malignant tumor of colon,0.223747154820789
SNAI2,Prostatic Neoplasms,0.223747154820789
SNAI2,Metastasis from malignant tumor of prostate,0.2454426921531692
SNAI2,Metastatic Prostate Carcinoma,0.2643145809900195
SNAI2,Neoplasms,0.2714542429024338
SNAI2,Malignant neoplasm of lung,0.2714542429024338
SNAI2,Piebaldism,0.2714542429024338
SNAI2,Secondary malignant neoplasm of lung,0.2723545094624877
SNAI2,Triple Negative Breast Neoplasms,0.2980670559114652
SNAI2,Idiopathic Pulmonary Fibrosis,0.3099246715197673
SNAI2,Gastrointestinal Stromal Tumors,0.3199171478489988
SNAI2,Cholangiocarcinoma,0.340892538685018
SNAI2,Mammary Ductal Carcinoma,0.3638414818541592
SNAI2,Carcinoma of lung,0.3663130598151661
SNAI2,Pheochromocytoma,0.3712878513813393
SNAI2,Primary malignant neoplasm,0.383941725017158
SNAI2,Recurrent tumor,0.383941725017158
SNAI2,Primary malignant neoplasm of lung,0.3902116649640871
SNAI2,Secondary malignant neoplasm of lymph node,0.3933196962529684
SNAI2,Papillary thyroid carcinoma,0.3933196962529684
SNAI2,Non-Small Cell Lung Carcinoma,0.3933196962529684
SNAI2,Carcinoma Papillary,0.3933196962529684
SNAI2,Chordoma,0.3933196962529684
SNAI2,White eyebrow,0.3933196962529684
SNAI2,Blonde eyebrow,0.3933196962529684
SNAI2,Grey eyebrow,0.3933196962529684
SNAI2,Squamous cell carcinoma of tongue,0.3933196962529684
SNAI2,White eyelashes,0.3933196962529684
SNAI2,Grey eyelashes,0.3933196962529684
SNAI2,Rash and Dermatitis Adverse Event Associated with Chemoradiation,0.3941558617476422
SNAI2,Thyroid carcinoma,0.3941558617476422
SNAI2,Luminal A Breast Carcinoma,0.3975960596292668
SNAI2,leiomyosarcoma,0.4028066164685291
SNAI2,Germinoma,0.4103119460235835
SNAI2,Neoplasm Invasiveness,0.4115056600660309
SNAI2,Uterine Corpus Carcinosarcoma,0.4115056600660309
SNAI2,Hypopigmentation disorder,0.4297858918260954
SNAI2,hypopigmented skin patch,0.4297858918260954
SNAI2,Basal-Like Breast Carcinoma,0.4396723023384634
SNAI2,Macule,0.4459714599189374
SNAI2,Congenital ear anomaly NOS (disorder),0.4459714599189374
SNAI2,Uterine Carcinosarcoma,0.4564472886428772
SNAI2,Mesothelioma,0.4635211539849193
SNAI2,Congenital sensorineural hearing loss,0.4753011022966241
SNAI2,Megacolon,0.4923669467696064
SNAI2,Nonnuclear polymorphic congenital cataract,0.4981941174985421
SNAI2,Arteriosclerosis,0.5019670090704682
SNAI2,Obesity,0.5140447474168605
SNAI2,Atherosclerosis,0.5393787854381349
SNAI2,Hirschsprung Disease,0.5794721015064842
SNAI2,Familial Nonmedullary Thyroid Cancer,0.6274540883972485
SNAI2,Multiple malignancy,0.6740259274935673
SNAI2,Malignancy,0.6761967139251879
SNAI2,Non-medullary thyroid carcinoma,0.6878314377608323
SNAI2,Sensorineural Hearing Loss (disorder),0.6891882956008074
SNAI2,Telecanthus,0.726789939981526
SNAI2,Neural Tube Defects,0.8600100703665297
SNAI2,Anomalous Pulmonary Artery,0.0075861267486594
SNAI2,Breast Carcinoma,0.0075861267486594
SNAI2,Esophagus Neoplasm,0.0102679590519094
SNAI2,Marfan Syndrome,0.0133304506157067
SNAI2,Mammary Neoplasms,0.0155248163763686
SNAI2,Breast Cancer,0.0402286636010764
SNAI2,Tumoral Calcinosis,0.2954316182315451
SNAI2,Waardenburg Syndrome,0.4286813331685578
SNAI2,Skin Neoplasms,0.4541466895915311
SNAI2,Piebaldism,0.4541466895915311
SNAI2,Neoplasms,0.4646409362700993
SNAI2,Multicystic Renal Dysplasia,0.4646409362700993
SNAI2,Hirschsprung Disease,0.4875380732267193
SNAI2,Microcephaly,0.5123947823327547
SNAI2,Hearing Loss,0.5632819212593052
SNAI2,Congenital Sensorineural Hearing Loss,0.6130153808924363
SNAI2,Nonmedullary Thyroid Carcinoma,0.6883874961919009
SNAI2,Thyroid Cancer,0.7015979603136192
SNAI2,Papillary Thyroid Carcinoma,0.768479933091106
SNAI2,Mental Retardation,0.7729545590606223
SNAI2,Synophrys,0.7893608212024619
SNAI2,Ptosis,0.8357787380041017
SNAI2,Atrial septal defect ostium primum type ORPHA:99106,0.0040361447187818
SNAI2,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049
SNAI2,Autosomal recessive nail dysplasia ORPHA:280654,0.00518481975049
SNAI2,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
SNAI2,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
SNAI2,Peters anomaly ORPHA:708,0.00518481975049
SNAI2,Atrial septal defect ostium secundum type ORPHA:99103,0.00518481975049
SNAI2,Familial porencephaly ORPHA:99810,0.0083045131203191
SNAI2,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191
SNAI2,Chondrosarcoma ORPHA:55880,0.0083045131203191
SNAI2,Greig cephalopolysyndactyly syndrome ORPHA:380,0.0083045131203191
SNAI2,Isolated hyperchlorhidrosis ORPHA:542657,0.0083045131203191
SNAI2,Pallister-Hall syndrome ORPHA:672,0.0083045131203191
SNAI2,Polysyndactyly ORPHA:93338,0.0083045131203191
SNAI2,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.0083045131203191
SNAI2,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.0083045131203191
SNAI2,Tibial hemimelia ORPHA:93322,0.0083045131203191
SNAI2,Ulnar-mammary syndrome ORPHA:3138,0.0083045131203191
SNAI2,Axenfeld anomaly ORPHA:98978,0.0083045131203191
SNAI2,Axenfeld-Rieger syndrome ORPHA:782,0.0083045131203191
SNAI2,Branchiootic syndrome ORPHA:52429,0.0083045131203191
SNAI2,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
SNAI2,Papillary renal cell carcinoma ORPHA:319298,0.0083045131203191
SNAI2,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.0083045131203191
SNAI2,Rieger anomaly ORPHA:91483,0.0083045131203191
SNAI2,Brachydactyly type A2 ORPHA:93396,0.0083744975290613
SNAI2,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
SNAI2,Waardenburg syndrome type 2 ORPHA:895,0.0092060390928213
SNAI2,Early-onset nuclear cataract ORPHA:98991,0.0179885731122231
SNAI2,Bruck syndrome ORPHA:2771,0.0180064224283883
SNAI2,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.0180064224283883
SNAI2,CHST3-related skeletal dysplasia ORPHA:263463,0.0180064224283883
SNAI2,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.0180064224283883
SNAI2,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.0180064224283883
SNAI2,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.0180064224283883
SNAI2,Diaphanospondylodysostosis ORPHA:66637,0.0180064224283883
SNAI2,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome ORPHA:404451,0.0180064224283883
SNAI2,Familial drusen ORPHA:75376,0.0180064224283883
SNAI2,Familial schizencephaly ORPHA:481986,0.0180064224283883
SNAI2,GAPO syndrome ORPHA:2067,0.0180064224283883
SNAI2,HANAC syndrome ORPHA:73229,0.0180064224283883
SNAI2,Ischiovertebral syndrome ORPHA:85200,0.0180064224283883
SNAI2,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.0180064224283883
SNAI2,Mandibulofacial dysostosis with alopecia ORPHA:443995,0.0180064224283883
SNAI2,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.0180064224283883
SNAI2,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.0180064224283883
SNAI2,Oculocutaneous albinism type 3 ORPHA:79433,0.0180064224283883
SNAI2,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.0180064224283883
SNAI2,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.0180064224283883
SNAI2,Primary CD59 deficiency ORPHA:169464,0.0180064224283883
SNAI2,Retinal arterial tortuosity ORPHA:75326,0.0180064224283883
SNAI2,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.0180064224283883
SNAI2,Steel syndrome ORPHA:438117,0.0180064224283883
SNAI2,Synpolydactyly type 2 ORPHA:295197,0.0180064224283883
SNAI2,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.0180064224283883
SNAI2,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.0180064224283883
SNAI2,X-linked osteoporosis with fractures ORPHA:391330,0.0180064224283883
SNAI2,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.0180064224283883
SNAI2,Congenital diaphragmatic hernia ORPHA:2140,0.0180064224283883
SNAI2,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.0180064224283883
SNAI2,Hypoplastic left heart syndrome ORPHA:2248,0.0180064224283883
SNAI2,Piebaldism ORPHA:2884,0.0180064224283883
SNAI2,Posterior hypospadias ORPHA:95706,0.0180064224283883
SNAI2,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.0180064224283883
SNAI2,BOR syndrome ORPHA:107,0.0183145313768111
SNAI2,Erythrokeratodermia variabilis ORPHA:317,0.0183145313768111
SNAI2,Ondine syndrome ORPHA:661,0.020072786018028
SNAI2,Classical Ehlers-Danlos syndrome ORPHA:287,0.0586579655822394
SNAI2,Multiple osteochondromas ORPHA:321,0.0586579655822394
SNAI2,AA amyloidosis ORPHA:85445,0.0586579655822394
SNAI2,Caffey disease ORPHA:1310,0.0586579655822394
SNAI2,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.0586579655822394
SNAI2,Congenital alveolar capillary dysplasia ORPHA:210122,0.0586579655822394
SNAI2,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763,0.0586579655822394
SNAI2,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.0586579655822394
SNAI2,Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528,0.0586579655822394
SNAI2,Lymphedema-distichiasis syndrome ORPHA:33001,0.0586579655822394
SNAI2,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.0586579655822394
SNAI2,Non-immune hydrops fetalis ORPHA:363999,0.0586579655822394
SNAI2,Posterior urethral valve ORPHA:93110,0.0586579655822394
SNAI2,Malignant peripheral nerve sheath tumor ORPHA:3148,0.0586579655822394
SNAI2,Postaxial polydactyly type B ORPHA:93335,0.0586579655822394
SNAI2,Brachydactyly type A1 ORPHA:93388,0.0599424746210022
SNAI2,Hennekam syndrome ORPHA:2136,0.0599424746210022
SNAI2,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.0621182671032116
SNAI2,Osteogenesis imperfecta type 3 ORPHA:216812,0.0683063362547733
SNAI2,Familial thoracic aortic aneurysm and aortic dissection ORPHA:91387,0.0902044104910482
SNAI2,Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899,0.1590470395003315
SNAI2,Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857,0.1590470395003315
SNAI2,Osteogenesis imperfecta type 1 ORPHA:216796,0.1590470395003315
SNAI2,Ablepharon macrostomia syndrome ORPHA:920,0.1590470395003315
SNAI2,Acrogeria ORPHA:2500,0.1590470395003315
SNAI2,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.1590470395003315
SNAI2,Adenocarcinoma of ovary ORPHA:213504,0.1590470395003315
SNAI2,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.1590470395003315
SNAI2,Barber-Say syndrome ORPHA:1231,0.1590470395003315
SNAI2,Carbamoyl-phosphate synthetase 1 deficiency ORPHA:147,0.1590470395003315
SNAI2,Familial abdominal aortic aneurysm ORPHA:86,0.1590470395003315
SNAI2,Familial visceral myopathy ORPHA:2604,0.1590470395003315
SNAI2,Fibronectin glomerulopathy ORPHA:84090,0.1590470395003315
SNAI2,Focal facial dermal dysplasia type III ORPHA:1807,0.1590470395003315
SNAI2,Glutaric acidemia type 3 ORPHA:35706,0.1590470395003315
SNAI2,Lipoid proteinosis ORPHA:530,0.1590470395003315
SNAI2,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.1590470395003315
SNAI2,Myopathic intestinal pseudoobstruction ORPHA:104077,0.1590470395003315
SNAI2,Ring dermoid of cornea ORPHA:91481,0.1590470395003315
SNAI2,Split hand-split foot-deafness syndrome ORPHA:71271,0.1590470395003315
SNAI2,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358,0.1590470395003315
SNAI2,Vascular Ehlers-Danlos syndrome ORPHA:286,0.1590470395003315
SNAI2,Acromesomelic dysplasia Grebe type ORPHA:2098,0.1590470395003315
SNAI2,Brachydactyly type C ORPHA:93384,0.1590470395003315
SNAI2,Fibular aplasia-complex brachydactyly syndrome ORPHA:2639,0.1590470395003315
SNAI2,NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279,0.1739455566145445
SNAI2,Bethlem myopathy ORPHA:610,0.3762014630157917
SNAI2,Congenital muscular dystrophy Ullrich type ORPHA:75840,0.3762014630157917
SNAI2,Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428,0.3762014630157917
SNAI2,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.3762014630157917
SNAI2,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.3762014630157917
SNAI2,Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963,0.3762014630157917
SNAI2,Congenital vertical talus bilateral ORPHA:295203,0.3762014630157917
SNAI2,Congenital vertical talus unilateral ORPHA:295201,0.3762014630157917
SNAI2,Craniodiaphyseal dysplasia ORPHA:1513,0.3762014630157917
SNAI2,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.3762014630157917
SNAI2,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome ORPHA:2084,0.3762014630157917
SNAI2,High bone mass osteogenesis imperfecta ORPHA:314029,0.3762014630157917
SNAI2,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.3762014630157917
SNAI2,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.3762014630157917
SNAI2,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.3762014630157917
SNAI2,Marfan syndrome type 1 ORPHA:284963,0.3762014630157917
SNAI2,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome ORPHA:521445,0.3762014630157917
SNAI2,Microtia ORPHA:83463,0.3762014630157917
SNAI2,Neonatal Marfan syndrome ORPHA:284979,0.3762014630157917
SNAI2,Palmoplantar keratoderma Nagashima type ORPHA:140966,0.3762014630157917
SNAI2,Pelviscapular dysplasia ORPHA:93333,0.3762014630157917
SNAI2,Progeroid and marfanoid aspect-lipodystrophy syndrome ORPHA:300382,0.3762014630157917
SNAI2,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.3762014630157917
SNAI2,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.3762014630157917
SNAI2,Stiff skin syndrome ORPHA:2833,0.3762014630157917
SNAI2,Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752,0.3762014630157917
SNAI2,Ellis Van Creveld syndrome ORPHA:289,0.3762014630157917
SNAI2,Osteogenesis imperfecta type 2 ORPHA:216804,0.3826134188846508
SNAI2,Osteogenesis imperfecta type 4 ORPHA:216820,0.4101640425710954
SNAI2,Acrofacial dysostosis Weyers type ORPHA:952,0.6239678957896782
SNAI2,Craniofacial-deafness-hand syndrome ORPHA:1529,0.6239678957896782
SNAI2,Craniofrontonasal dysplasia ORPHA:1520,0.6239678957896782
SNAI2,Waardenburg syndrome type 1 ORPHA:894,0.6239678957896782
SNAI2,Waardenburg syndrome type 3 ORPHA:896,0.6239678957896782
SNAI2,Brachydactyly type E ORPHA:93387,0.6239678957896782
SNCG,Colorectal Carcinoma,0.0034602840073026
SNCG,Mammary Neoplasms,0.0034602840073026
SNCG,Ovarian Carcinoma,0.0034602840073026
SNCG,Breast Carcinoma,0.0042545616049287
SNCG,Invasive carcinoma of breast,0.0149002095788623
SNCG,Invasive Ductal Breast Carcinoma,0.0149002095788623
SNCG,Colorectal Cancer,0.0149315928814189
SNCG,Tumor Progression,0.0149315928814189
SNCG,Stomach Carcinoma,0.0149315928814189
SNCG,Squamous cell carcinoma,0.0182265588252201
SNCG,Esophageal Neoplasms,0.0182265588252201
SNCG,ovarian neoplasm,0.0191435238361999
SNCG,Malignant neoplasm of breast,0.0191435238361999
SNCG,Malignant neoplasm of stomach,0.0191435238361999
SNCG,Carcinogenesis,0.0228075668512991
SNCG,Malignant neoplasm of esophagus,0.0248454592431097
SNCG,Malignant neoplasm of ovary,0.0277695594716545
SNCG,Carcinoma Spindle-Cell,0.0308703957553632
SNCG,Epithelial ovarian cancer,0.0387439397151409
SNCG,Carcinoma,0.0593779966354549
SNCG,Carcinomatosis,0.0617471306652618
SNCG,Mammary Neoplasms Human,0.064548079316548
SNCG,Neoplasm Metastasis,0.0648809611869375
SNCG,Malignant neoplasm of pancreas,0.0726340460169901
SNCG,Pancreatic carcinoma,0.0745502070959292
SNCG,Liver Cirrhosis,0.0773771948186562
SNCG,Colorectal Neoplasms,0.0827744840860166
SNCG,Anaplastic carcinoma,0.084286432100041
SNCG,Bladder Neoplasm,0.0891725280554336
SNCG,Liver carcinoma,0.095319386034013
SNCG,Esophageal carcinoma,0.1254380558571286
SNCG,Undifferentiated carcinoma,0.13167400689206
SNCG,Malignant neoplasm of endometrium,0.13167400689206
SNCG,Papillary serous cystadenocarcinoma,0.13167400689206
SNCG,Uterine Corpus Cancer,0.1328002618052838
SNCG,Mammary Carcinoma Animal,0.1352936728187231
SNCG,Animal Mammary Neoplasms,0.1352936728187231
SNCG,Hyperactive behavior,0.1387448809655294
SNCG,Solid Neoplasm,0.1413782599148022
SNCG,Liver neoplasms,0.1454373331146953
SNCG,Lung Neoplasms,0.2062010908869036
SNCG,Malignant neoplasm of liver,0.2643145809900195
SNCG,Neoplasms,0.2714542429024338
SNCG,Malignant neoplasm of lung,0.2714542429024338
SNCG,Endometrial Carcinoma,0.3044782497745498
SNCG,Glaucoma,0.3105909001629992
SNCG,Mammary Neoplasms Experimental,0.3508665345292502
SNCG,Carcinoma of lung,0.3663130598151661
SNCG,Endometriosis,0.383941725017158
SNCG,Noninfiltrating Intraductal Carcinoma,0.383941725017158
SNCG,Primary malignant neoplasm of lung,0.3902116649640871
SNCG,Secondary malignant neoplasm of lymph node,0.3933196962529684
SNCG,Amyloidosis,0.3933196962529684
SNCG,Hyperkinesia Generalized,0.3933196962529684
SNCG,Secondary malignant neoplasm of liver,0.3933196962529684
SNCG,Amyotrophic Lateral Sclerosis Sporadic,0.3933196962529684
SNCG,Alzheimer's Disease,0.3933196962529684
SNCG,Liver and Intrahepatic Biliary Tract Carcinoma,0.3933196962529684
SNCG,Parkinson Disease,0.3933196962529684
SNCG,AMYOTROPHIC LATERAL SCLEROSIS 1,0.3933196962529684
SNCG,Mental Depression,0.3941558617476422
SNCG,Lafora Disease,0.3941558617476422
SNCG,Mammary Tumorigenesis,0.4028066164685291
SNCG,Retinoblastoma,0.4115056600660309
SNCG,Familial Alzheimer Disease (FAD),0.4126392832024548
SNCG,Lewy Body Disease,0.424575176503444
SNCG,Neurodegenerative Disorders,0.4335751357405352
SNCG,AMYOTROPHIC LATERAL SCLEROSIS 1 AUTOSOMAL RECESSIVE,0.472444704048021
SNCG,Cyst,0.4850576707687362
SNCG,Endometriosis of ovary,0.5090214163899865
SNCG,Obesity,0.5140447474168605
SNCG,Hepatocarcinogenesis,0.533913711453195
SNCG,Ependymoma,0.563120546412355
SNCG,Motor Neuron Disease,0.8163430347375975
SNCG,Breast Carcinoma,0.0075861267486594
SNCG,Marfan Syndrome,0.0133304506157067
SNCG,Mammary Neoplasms,0.0155248163763686
SNCG,Anaplastic Carcinoma,0.0402286636010764
SNCG,Breast Cancer,0.0402286636010764
SNCG,Carcinoma,0.0534520155998091
SNCG,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.0180064224283883
SNCG,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.0180064224283883
SNCG,46XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563,0.6239678957896782
SNCG,Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817,0.6239678957896782
SNCG,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735,0.6239678957896782
SORBS1,Colorectal Carcinoma,0.0034602840073026
SORBS1,Breast Carcinoma,0.0042545616049287
SORBS1,Invasive carcinoma of breast,0.0149002095788623
SORBS1,Colorectal Cancer,0.0149315928814189
SORBS1,Malignant neoplasm of breast,0.0191435238361999
SORBS1,Epithelial ovarian cancer,0.0387439397151409
SORBS1,Liver carcinoma,0.095319386034013
SORBS1,Colon Carcinoma,0.1062239757831962
SORBS1,Liver neoplasms,0.1454373331146953
SORBS1,Malignant tumor of colon,0.223747154820789
SORBS1,Diabetes,0.2277108302018961
SORBS1,Diabetes Mellitus,0.2522264785494494
SORBS1,Mannose-Binding Protein Deficiency,0.2643145809900195
SORBS1,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
SORBS1,Diabetic Retinopathy,0.2723545094624877
SORBS1,Ischemic stroke,0.3486533561309259
SORBS1,Tuberculosis,0.3706856725676674
SORBS1,Plaque Amyloid,0.3933196962529684
SORBS1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
SORBS1,Schizophrenia,0.3933196962529684
SORBS1,Hypertensive disease,0.3933196962529684
SORBS1,HIV Infections,0.3933196962529684
SORBS1,Stinging Sensation,0.3933196962529684
SORBS1,Asthma,0.3933196962529684
SORBS1,Diabetic Nephropathy,0.3938591532700354
SORBS1,Perry Syndrome,0.3941558617476422
SORBS1,Rous Sarcoma,0.39623320406434
SORBS1,Viremia,0.4115056600660309
SORBS1,Brain Infarction,0.4115056600660309
SORBS1,Cerebrovascular accident,0.4115056600660309
SORBS1,High-Grade Squamous Intraepithelial Lesions,0.4126392832024548
SORBS1,Empyema,0.4126392832024548
SORBS1,Hereditary persistence of fetal hemoglobin thalassemia,0.4126392832024548
SORBS1,Infarction Lacunar,0.4213286052188015
SORBS1,Infant Premature,0.4304973629098372
SORBS1,Precocious pubarche,0.4506578937113162
SORBS1,Huntington Disease,0.4704594475773637
SORBS1,Motor neuron atrophy,0.4714226702518064
SORBS1,Chronic Obstructive Airway Disease,0.5049674142533507
SORBS1,Invasive Streptococcus pneumoniae disease,0.5090214163899865
SORBS1,Obesity,0.5140447474168605
SORBS1,Polycystic Ovary Syndrome,0.5337853752290136
SORBS1,Anaphylaxis (non medication),0.5359212109443033
SORBS1,Colorectal cancer metastatic,0.5568517196017908
SORBS1,Clostridium,0.5696906826730043
SORBS1,difficile (disorder),0.5956632182199403
SORBS1,Hyperandrogenism,0.6910672612216457
SORBS1,Hay fever,0.7169459458481418
SORBS1,Hepatitis C,0.8335660382047895
SORBS1,Cytomegalovirus Infections,0.9169959402964138
SORBS1,Hepatitis B,0.9373303308937144
SORBS1,Breast Cancer,0.0402286636010764
SORBS1,Cardiovascular Diseases,0.554079268109006
SORBS1,Diabetic Nephropathy,0.7049836926927165
SORBS1,Leukemia,0.7167438233451096
SORBS1,Diabetes Mellitus,0.9683912711598086
SORBS1,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.0586579655822394
SORBS1,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.0586579655822394
SORBS1,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.0586579655822394
SORBS1,1p31p32 microdeletion syndrome ORPHA:401986,0.1590470395003315
SORBS1,Brachydactyly-arterial hypertension syndrome ORPHA:1276,0.1590470395003315
SORBS1,Bilateral striopallidodentate calcinosis ORPHA:1980,0.1697334635963512
SORBS1,Autosomal recessive spastic paraplegia type 5A ORPHA:100986,0.3762014630157917
SORBS1,Becker muscular dystrophy ORPHA:98895,0.3762014630157917
SORBS1,Congenital bile acid synthesis defect type 3 ORPHA:79302,0.3762014630157917
SORBS1,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546,0.3762014630157917
SORBS1,Familial vesicoureteral reflux ORPHA:289365,0.3762014630157917
SORBS1,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3775879467205478
SORBS1,Left ventricular noncompaction ORPHA:54260,0.4177534028018127
SORBS1,Brugada syndrome ORPHA:130,0.5145066480201691
SORBS1,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.6239678957896782
SORBS1,Aplasia of lacrimal and salivary glands ORPHA:86815,0.6239678957896782
SORBS1,BNAR syndrome ORPHA:217266,0.6239678957896782
SORBS1,Dysbetalipoproteinemia ORPHA:412,0.6239678957896782
SORBS1,Familial dyskinesia and facial myokymia ORPHA:324588,0.6239678957896782
SORBS1,Hyperinsulinism due to INSR deficiency ORPHA:263458,0.6239678957896782
SORBS1,Insulin-resistance syndrome type A ORPHA:2297,0.6239678957896782
SORBS1,Leprechaunism ORPHA:508,0.6239678957896782
SORBS1,Lipoprotein glomerulopathy ORPHA:329481,0.6239678957896782
SORBS1,Lissencephaly syndrome Norman-Roberts type ORPHA:89844,0.6239678957896782
SORBS1,Oculotrichoanal syndrome ORPHA:2717,0.6239678957896782
SORBS1,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746,0.6239678957896782
SORBS1,Rabson-Mendenhall syndrome ORPHA:769,0.6239678957896782
SORBS1,Sea-blue histiocytosis ORPHA:158029,0.6239678957896782
SORBS1,Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293,0.6239678957896782
SORBS1,X-linked intellectual disability Stocco Dos Santos type ORPHA:85288,0.6239678957896782
SORBS1,Duchenne muscular dystrophy ORPHA:98896,0.6239678957896782
SORBS1,Inherited congenital spastic tetraplegia ORPHA:210141,0.6239678957896782
SORBS1,12p12.1 microdeletion syndrome ORPHA:313884,0.7068064785325423
SORBS1,Anoctamin-5-related  limb-girdle muscular dystrophy R12 ORPHA:206549,0.7068064785325423
SORBS1,Atypical dentin dysplasia due to SMOC2 deficiency ORPHA:314721,0.7068064785325423
SORBS1,Classical-like Ehlers-Danlos syndrome type 1 ORPHA:230839,0.7068064785325423
SORBS1,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency ORPHA:90791,0.7068064785325423
SORBS1,Congenital atransferrinemia ORPHA:1195,0.7068064785325423
SORBS1,Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520,0.7068064785325423
SORBS1,Developmental and speech delay due to SOX5 deficiency ORPHA:313892,0.7068064785325423
SORBS1,Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency ORPHA:289307,0.7068064785325423
SORBS1,Distal anoctaminopathy ORPHA:399096,0.7068064785325423
SORBS1,Familial GPIHBP1 deficiency ORPHA:535458,0.7068064785325423
SORBS1,Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease ORPHA:436242,0.7068064785325423
SORBS1,Familial benign flecked retina ORPHA:363989,0.7068064785325423
SORBS1,Familial lipoprotein lipase deficiency ORPHA:309015,0.7068064785325423
SORBS1,Familial male-limited precocious puberty ORPHA:3000,0.7068064785325423
SORBS1,Gnathodiaphyseal dysplasia ORPHA:53697,0.7068064785325423
SORBS1,Isolated congenital megalocornea ORPHA:91489,0.7068064785325423
SORBS1,L-Arginine:glycine amidinotransferase deficiency ORPHA:35704,0.7068064785325423
SORBS1,Leydig cell hypoplasia due to complete LH resistance ORPHA:96265,0.7068064785325423
SORBS1,Leydig cell hypoplasia due to partial LH resistance ORPHA:96266,0.7068064785325423
SORBS1,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome ORPHA:498693,0.7068064785325423
SORBS1,Null syndrome ORPHA:280234,0.7068064785325423
SORBS1,PLIN1-related familial partial lipodystrophy ORPHA:280356,0.7068064785325423
SORBS1,Pelizaeus-Merzbacher disease in female carriers ORPHA:280229,0.7068064785325423
SORBS1,Pelizaeus-Merzbacher disease classic form ORPHA:280219,0.7068064785325423
SORBS1,Pelizaeus-Merzbacher disease connatal form ORPHA:280210,0.7068064785325423
SORBS1,Pelizaeus-Merzbacher disease transitional form ORPHA:280224,0.7068064785325423
SORBS1,Spastic paraplegia type 2 ORPHA:99015,0.7068064785325423
SORBS1,Spinocerebellar ataxia type 19/22 ORPHA:98772,0.7068064785325423
SORBS1,Hypertrichotic osteochondrodysplasia Cantu type ORPHA:1517,0.7068064785325423
SORBS1,Preeclampsia ORPHA:275555,0.7068064785325423
SORBS1,Waardenburg-Shah syndrome ORPHA:897,0.7068064785325423
SORBS1,NON RARE IN EUROPE: Essential hypertension ORPHA:243761,0.7068064785325423
SORBS1,Catecholaminergic polymorphic ventricular tachycardia ORPHA:3286,0.7072638369101406
SORBS1,Romano-Ward syndrome ORPHA:101016,0.7362131755977757
SORBS1,Familial atrial fibrillation ORPHA:334,0.7469385786191998
SORBS1,Human immunodeficiency virus 2 nef protein,0.6362779693488597
SORBS1,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
SORBS1,Human gammaherpesvirus 4 EBNA-2 nuclear protein (gene: BYRF1),0.6362779693488597
SORBS1,Human herpesvirus 4 type 2 EBNA-2,0.6362779693488597
SORBS1,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.6362779693488597
SORBS1,Human alphaherpesvirus 2 envelope glycoprotein E (gene: US8),0.6362779693488597
SORBS1,Human immunodeficiency virus nef protein (gene: nef),0.7795229132668053
SORBS1,Cercopithecine betaherpesvirus 5 membrane glycoprotein US2 (gene: US2),0.7988086321880973
SORBS1,Human immunodeficiency virus 1 integrase (gene: gag-pol),0.7988086321880973
SORBS1,Monkeypox virus ankyrin-like protein,0.8426793553344071
SORBS1,Mumps virus phoshoprotein (gene: V/P),0.9621839893030432
SORBS1,Mumps virus genotype G phosphoprotein (gene: P),0.9621839893030432
SORL1,Colorectal Cancer,0.0149315928814189
SORL1,Malignant neoplasm of breast,0.0191435238361999
SORL1,Seizures,0.2053083986145698
SORL1,Diabetes,0.2277108302018961
SORL1,Diabetes Mellitus,0.2522264785494494
SORL1,Language Disorders,0.2747883228704706
SORL1,Acute leukemia,0.2835142372342932
SORL1,Multiple Sclerosis,0.2835142372342932
SORL1,Cognitive changes,0.3220099003872086
SORL1,Amyloidosis,0.3933196962529684
SORL1,Hallucinations,0.3933196962529684
SORL1,Bipolar Disorder,0.3933196962529684
SORL1,Plaque Amyloid,0.3933196962529684
SORL1,Cerebrovascular Disorders,0.3933196962529684
SORL1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
SORL1,Schizophrenia,0.3933196962529684
SORL1,Hypertensive disease,0.3933196962529684
SORL1,Leukemia Myelocytic Acute,0.3933196962529684
SORL1,Alzheimer's Disease,0.3933196962529684
SORL1,Acute lymphocytic leukemia,0.3933196962529684
SORL1,Abnormal social behavior,0.3933196962529684
SORL1,Abnormal social interactions,0.3933196962529684
SORL1,Deposits immunoreactive to beta-amyloid protein,0.3933196962529684
SORL1,Epilepsy,0.3941558617476422
SORL1,Senile Plaques,0.3975960596292668
SORL1,Cholestasis,0.4100901006059349
SORL1,Forgetful,0.4100901006059349
SORL1,Neoplasm Invasiveness,0.4115056600660309
SORL1,Alzheimer Disease Late Onset,0.4115056600660309
SORL1,Familial Alzheimer Disease (FAD),0.4126392832024548
SORL1,Vascular Diseases,0.4126392832024548
SORL1,Neurofibrillary degeneration (morphologic abnormality),0.4126392832024548
SORL1,Triglycerides measurement,0.4192169590514327
SORL1,Mild cognitive disorder,0.4506578937113162
SORL1,Hyperlipoproteinemia Type IIa,0.4564472886428772
SORL1,Cardiovascular Diseases,0.4675904598629673
SORL1,Huntington Disease,0.4704594475773637
SORL1,Social disinhibition,0.4753011022966241
SORL1,Agitation,0.4923669467696064
SORL1,Arteriosclerosis,0.5019670090704682
SORL1,Obesity,0.5140447474168605
SORL1,Memory impairment,0.5188223685230745
SORL1,Fasting blood glucose measurement,0.5251317541886066
SORL1,Atherosclerosis,0.5393787854381349
SORL1,Confusion,0.5453394612016188
SORL1,Spasmodic movement,0.5514573300659174
SORL1,Involuntary jerking movements,0.5514573300659174
SORL1,Memory Loss,0.5568517196017908
SORL1,Parkinsonian Disorders,0.5683976277847906
SORL1,Hallucinations Sensory,0.5916904943304121
SORL1,Hepatitis Toxic,0.610971999959321
SORL1,Chemical and Drug Induced Liver Injury,0.610971999959321
SORL1,Chemically-Induced Liver Toxicity,0.610971999959321
SORL1,Drug-Induced Acute Liver Injury,0.610971999959321
SORL1,Hepatitis Drug-Induced,0.6189532555846575
SORL1,Myoclonus,0.625112405383346
SORL1,Cerebral atrophy,0.6294837700416086
SORL1,Dementia,0.6364853529519863
SORL1,Drug-Induced Liver Disease,0.6910672612216457
SORL1,Alzheimer's Disease Focal Onset,0.6959870102453846
SORL1,Acute Confusional Senile Dementia,0.6959870102453846
SORL1,Alzheimer Disease Early Onset,0.7756460653898786
SORL1,Muscle Hypertonia,0.7780887836634591
SORL1,Impaired cognition,0.8000044931629623
SORL1,Presenile dementia,0.9212908525513646
SORL1,Breast Cancer,0.0402286636010764
SORL1,Language Disorders,0.3094716280561038
SORL1,Cholestasis,0.336287627428424
SORL1,Parkinson Disease,0.4286813331685578
SORL1,Colorectal Cancer,0.4286813331685578
SORL1,Semantic Dementia,0.4560460337187313
SORL1,Alzheimer Disease,0.4560460337187313
SORL1,Paroxysmal Atrial Fibrillation,0.5082542877462781
SORL1,Cerebral Cortical Atrophy,0.5129298662020659
SORL1,Dysgraphia,0.5796489603182782
SORL1,Cognitive Disorder,0.6030919130927346
SORL1,Aphasia,0.6477775413116995
SORL1,Atrial Fibrillation,0.6792162876553974
SORL1,Oculovestibuloauditory Syndrome,0.7191962993706487
SORL1,Oculomotor Apraxia,0.7360789997461612
SORL1,Mental Retardation,0.7729545590606223
SORL1,Impaired Cognition,0.781505274734613
SORL1,Hallucinations,0.8277709367020475
SORL1,Serrated polyposis syndrome ORPHA:157798,0.1590470395003315
SORL1,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.1739455566145445
SORL1,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105,0.6239678957896782
SORL1,NON RARE IN EUROPE: Alzheimer disease ORPHA:238616,0.6268296504510718
SORL1,Congenital factor V deficiency ORPHA:326,0.7068064785325423
SORL1,East Texas bleeding disorder ORPHA:391320,0.7068064785325423
SORL1,X-linked Charcot-Marie-Tooth disease type 6 ORPHA:352675,0.7068064785325423
SORL1,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.6806291584193672
SORL1,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.6806291584193672
SORT1,Colorectal Carcinoma,0.0034602840073026
SORT1,Breast Carcinoma,0.0042545616049287
SORT1,Colorectal Cancer,0.0149315928814189
SORT1,Malignant neoplasm of breast,0.0191435238361999
SORT1,Malignant neoplasm of prostate,0.0569142010728473
SORT1,Malignant neoplasm of pancreas,0.0726340460169901
SORT1,Glioma,0.0739788831250619
SORT1,Prostate carcinoma,0.0773771948186562
SORT1,Myocardial Infarction,0.1352936728187231
SORT1,Diabetes,0.2277108302018961
SORT1,Diabetes Mellitus,0.2522264785494494
SORT1,Multiple Sclerosis,0.2835142372342932
SORT1,Cognitive changes,0.3220099003872086
SORT1,Thyroid Neoplasm,0.383941725017158
SORT1,Creatinine measurement serum (procedure),0.383941725017158
SORT1,Amyloidosis,0.3933196962529684
SORT1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
SORT1,Schizophrenia,0.3933196962529684
SORT1,Alzheimer's Disease,0.3933196962529684
SORT1,Coronary heart disease,0.3933196962529684
SORT1,Adenoma,0.3933196962529684
SORT1,Aortic Aneurysm Abdominal,0.3941558617476422
SORT1,Thyroid carcinoma,0.3941558617476422
SORT1,Mental Depression,0.3941558617476422
SORT1,Arteriosclerotic cardiovascular disease NOS,0.3941558617476422
SORT1,Amyotrophic Lateral Sclerosis,0.3975960596292668
SORT1,Depressive disorder,0.3975960596292668
SORT1,Vascular Diseases,0.4126392832024548
SORT1,Glomerular filtration rate finding,0.4126392832024548
SORT1,Essential Tremor,0.425419812815905
SORT1,Encephalomyelitis,0.4254307049060398
SORT1,Malignant neoplasm of thyroid,0.4307603335611732
SORT1,Neurodegenerative Disorders,0.4335751357405352
SORT1,Neuropathy,0.4335751357405352
SORT1,Dyslipidemias,0.4421745246585178
SORT1,Hyperlipoproteinemia Type IIa,0.4564472886428772
SORT1,Cardiovascular Diseases,0.4675904598629673
SORT1,Hypercholesterolemia,0.4755217870653703
SORT1,Steatohepatitis,0.4906258721078565
SORT1,Lipid Metabolism Disorders,0.4906258721078565
SORT1,Arteriosclerosis,0.5019670090704682
SORT1,Coronary Arteriosclerosis,0.5140447474168605
SORT1,Obesity,0.5140447474168605
SORT1,Fatty Liver,0.533913711453195
SORT1,Atherosclerosis,0.5393787854381349
SORT1,Frontotemporal dementia,0.6064571148125548
SORT1,Pediatric Obesity,0.6496433426951205
SORT1,Low density lipoprotein cholesterol measurement,0.6941270729825465
SORT1,Coronary Artery Disease,0.7240930522443176
SORT1,Serum total cholesterol measurement,0.8758099322635008
SORT1,Charcot-Marie-Tooth Disease,0.9662162234631484
SORT1,Cholestasis,0.336287627428424
SORT1,Coronary Arteriosclerosis,0.4875380732267193
SORT1,Cardiovascular Diseases,0.554079268109006
SORT1,Coronary Artery Disease,0.7729545590606223
SORT1,Familial multiple nevi flammei ORPHA:624,0.0180064224283883
SORT1,Sturge-Weber syndrome ORPHA:3205,0.0180064224283883
SORT1,Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527,0.0586579655822394
SORT1,Phakomatosis cesioflammea ORPHA:79483,0.0586579655822394
SORT1,Growth delay due to insulin-like growth factor I resistance ORPHA:73273,0.3762014630157917
SORT1,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3775879467205478
SORT1,Charcot-Marie-Tooth disease type 4H ORPHA:99954,0.6239678957896782
SORT1,CLCN4-related X-linked intellectual disability syndrome ORPHA:485350,0.7068064785325423
SPAG1,Carcinogenesis,0.0228075668512991
SPAG1,Malignant neoplasm of pancreas,0.0726340460169901
SPAG1,Pancreatic carcinoma,0.0745502070959292
SPAG1,Embryonal Carcinoma,0.3112516166225269
SPAG1,Respiratory insufficiency due to defective ciliary clearance,0.3941558617476422
SPAG1,Nasal inflammation,0.3941558617476422
SPAG1,Bronchiectasis,0.4028066164685291
SPAG1,Adenocarcinoma of pancreas,0.4325044517055656
SPAG1,Recurrent otitis media,0.4352815161963393
SPAG1,Recurrent sinus disease,0.4923669467696064
SPAG1,Recurrent sinusitis,0.4923669467696064
SPAG1,Polynesian Bronchiectasis,0.5251317541886066
SPAG1,Paranasal Sinus Diseases,0.5453394612016188
SPAG1,Situs ambiguus,0.582492855487907
SPAG1,Sinusitis,0.6150955455771212
SPAG1,Ciliary Motility Disorders,0.625027955184583
SPAG1,Bronchitis Chronic,0.6304655343580164
SPAG1,Situs Inversus,0.6925751397474874
SPAG1,Leishmaniasis Visceral,0.6980473696540115
SPAG1,Rhinitis,0.738047882208201
SPAG1,Recurrent respiratory infections,0.7484342194688707
SPAG1,Kartagener Syndrome,0.7651930135295156
SPAG1,Intellectual Disability,0.8352623613787349
SPAG1,Ciliopathies,0.8849686999768298
SPAG1,Epilepsy,0.3449614869411272
SPAG1,Hydrocephalus,0.3657224783929353
SPAG1,Bronchiectasis,0.4560460337187313
SPAG1,Lung Diseases,0.4560460337187313
SPAG1,Nasal Polyposis,0.4560460337187313
SPAG1,Corneal Dystrophy,0.4875380732267193
SPAG1,Scoliosis,0.4875380732267193
SPAG1,Asthma,0.504364324740411
SPAG1,Kartagener Syndrome,0.5316139823120088
SPAG1,Sinusitis,0.5576425853515448
SPAG1,Hearing Loss,0.5632819212593052
SPAG1,Asthenozoospermia,0.6420878824691651
SPAG1,Gastric Cancer,0.6524705037929849
SPAG1,Ciliary Dyskinesia,0.6564901877271138
SPAG1,Rhinitis,0.6792162876553974
SPAG1,Asplenia,0.7049836926927165
SPAG1,Situs Inversus,0.7833015488163313
SPAG1,Otitis Media,0.7979559493902503
SPAG1,Congenital Pectus Excavatum,0.8407264689819682
SPAG1,Glutamate-cysteine ligase deficiency ORPHA:33574,0.0586579655822394
SPAG1,X-linked hypophosphatemia ORPHA:89936,0.1590470395003315
SPAG1,Primary ciliary dyskinesia ORPHA:244,0.7068064785325423
SPC25,Monocyte count procedure,0.6274540883972485
SPC25,Monocyte count result,0.6274540883972485
SPC25,Liver Carcinoma,0.0520696613701797
SPC25,Metabolic Syndrome,0.4809179010794786
SPC25,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191
SPC25,Hereditary breast cancer ORPHA:227535,0.0106988445340883
SPC25,Roberts syndrome ORPHA:3103,0.0180064224283883
SPC25,Denys-Drash syndrome ORPHA:220,0.1590470395003315
SPC25,Frasier syndrome ORPHA:347,0.1590470395003315
SPC25,Meacham syndrome ORPHA:3097,0.1590470395003315
SPC25,Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805,0.4548046963946745
SPC25,L-2-hydroxyglutaric aciduria ORPHA:79314,0.6239678957896782
SPC25,Isolated megalencephaly ORPHA:268920,0.7068064785325423
SPC25,Methylmalonic acidemia with homocystinuria type cblC ORPHA:79282,0.7068064785325423
STN1,Colorectal Carcinoma,0.0034602840073026
STN1,Colorectal Cancer,0.0149315928814189
STN1,melanoma,0.0149315928814189
STN1,Epithelial ovarian cancer,0.0387439397151409
STN1,Glioma,0.0739788831250619
STN1,Premature canities,0.1193558174333938
STN1,Hematologic Neoplasms,0.1253114324938153
STN1,Hamman-Rich syndrome,0.13167400689206
STN1,Hypertension Portal,0.1328002618052838
STN1,Hyperactive behavior,0.1387448809655294
STN1,Systemic Scleroderma,0.1900258729042946
STN1,Lung Neoplasms,0.2062010908869036
STN1,Malignant neoplasm of lung,0.2714542429024338
STN1,Idiopathic Pulmonary Fibrosis,0.3099246715197673
STN1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
STN1,Fetal Growth Retardation,0.3933196962529684
STN1,Hereditary Nonpolyposis Colorectal Cancer,0.3933196962529684
STN1,Gastroesophageal reflux disease,0.3933196962529684
STN1,Generalized osteopenia,0.3933196962529684
STN1,Coronary heart disease,0.3933196962529684
STN1,Infant Small for Gestational Age,0.3933196962529684
STN1,Malignant Central Nervous System Neoplasm,0.3933196962529684
STN1,Intrauterine retardation,0.3933196962529684
STN1,Dyspnea on exertion,0.3941558617476422
STN1,Bronchiectasis,0.4028066164685291
STN1,Reticular pattern on pulmonary HRCT,0.4115056600660309
STN1,Esophageal Varices,0.4115056600660309
STN1,Ground-glass opacification on pulmonary HRCT,0.4115056600660309
STN1,Honeycomb lung,0.4115056600660309
STN1,Retinal telangiectasia,0.4126392832024548
STN1,Rales,0.4192169590514327
STN1,Pulmonary Fibrosis,0.4335751357405352
STN1,Clubbed Fingers,0.4459714599189374
STN1,Dystonic disease,0.4459714599189374
STN1,Cardiovascular Diseases,0.4675904598629673
STN1,Osteopenia,0.4923669467696064
STN1,Coronary Arteriosclerosis,0.5140447474168605
STN1,Cutaneous Melanoma,0.5710095678317721
STN1,Cerebellar Ataxia,0.5754799679683854
STN1,Acid reflux,0.5936773368594411
STN1,Gastrointestinal Hemorrhage,0.6150955455771212
STN1,Lung Diseases Interstitial,0.6207008101484466
STN1,Dystonia,0.6334536292962906
STN1,Heartburn,0.641532117799187
STN1,Coughing,0.717484976234209
STN1,Coronary Artery Disease,0.7240930522443176
STN1,Pancytopenia,0.7756460653898786
STN1,Muscle Spasticity,0.7965501584766118
STN1,Carcinoma,0.0534520155998091
STN1,Pulmonary Fibrosis,0.0654534781440596
STN1,Retinal Telangiectasia,0.336287627428424
STN1,Esophageal Varix,0.4286813331685578
STN1,Malignant Melanoma Of Skin,0.4286813331685578
STN1,Lung Cancer,0.4402141802500753
STN1,Central Nervous System Neoplasms,0.4541466895915311
STN1,Lung Neoplasms,0.4560460337187313
STN1,Osteopenia,0.4560460337187313
STN1,Portal Hypertension,0.4560460337187313
STN1,Bronchiectasis,0.4560460337187313
STN1,Lung Diseases,0.4560460337187313
STN1,Basal Cell Neoplasm,0.4560460337187313
STN1,Honeycomb Lung,0.4560460337187313
STN1,Hamman-Rich Syndrome,0.4560460337187313
STN1,Hypertension,0.4560460337187313
STN1,Glioma,0.4560460337187313
STN1,Diffuse Interstitial Pulmonary Fibrosis,0.4646409362700993
STN1,Melanoma,0.4646409362700993
STN1,Dyskeratosis Congenita,0.4646409362700993
STN1,Gastroesophageal Reflux Disease,0.4742592264758768
STN1,Pancytopenia,0.5234357475824973
STN1,Plexiform Leiomyoma,0.5681293104170607
STN1,Ovarian Epithelial Carcinoma,0.5875654081009305
STN1,Uterine Fibroids,0.6304164862793252
STN1,Coronary Artery Disease,0.7729545590606223
STN1,Chronic Obstructive Pulmonary Disease,0.9568083835980838
STN1,Coats plus syndrome ORPHA:313838,0.3762014630157917
STN1,Idiopathic pulmonary fibrosis ORPHA:2032,0.43936148647173
SULT1A1,Colorectal Carcinoma,0.0034602840073026
SULT1A1,Mammary Neoplasms,0.0034602840073026
SULT1A1,Breast Carcinoma,0.0042545616049287
SULT1A1,Colorectal Cancer,0.0149315928814189
SULT1A1,Stomach Carcinoma,0.0149315928814189
SULT1A1,Squamous cell carcinoma,0.0182265588252201
SULT1A1,Esophageal Neoplasms,0.0182265588252201
SULT1A1,ovarian neoplasm,0.0191435238361999
SULT1A1,Malignant neoplasm of breast,0.0191435238361999
SULT1A1,Malignant neoplasm of stomach,0.0191435238361999
SULT1A1,Carcinogenesis,0.0228075668512991
SULT1A1,Malignant neoplasm of esophagus,0.0248454592431097
SULT1A1,Urologic Neoplasms,0.0314665934969085
SULT1A1,Brain Tumor Primary,0.044151975756427
SULT1A1,Cancer of Urinary Tract,0.0492766532827251
SULT1A1,Malignant neoplasm of prostate,0.0569142010728473
SULT1A1,Cervical Squamous Intraepithelial Neoplasia 1,0.0593779966354549
SULT1A1,Cervical intraepithelial neoplasia grade 1,0.0593779966354549
SULT1A1,Brain Neoplasms,0.064548079316548
SULT1A1,Neoplasm Metastasis,0.0648809611869375
SULT1A1,Malignant neoplasm of pancreas,0.0726340460169901
SULT1A1,Glioma,0.0739788831250619
SULT1A1,Endometrial Neoplasms,0.0745502070959292
SULT1A1,Glioblastoma,0.0745502070959292
SULT1A1,Pancreatic carcinoma,0.0745502070959292
SULT1A1,Prostate carcinoma,0.0773771948186562
SULT1A1,Squamous cell carcinoma of the head and neck,0.0775520919998773
SULT1A1,Genomic Instability,0.0775520919998773
SULT1A1,Colorectal Neoplasms,0.0827744840860166
SULT1A1,Malignant neoplasm of urinary bladder,0.084286432100041
SULT1A1,Bladder Neoplasm,0.0891725280554336
SULT1A1,Liver carcinoma,0.095319386034013
SULT1A1,Colon Carcinoma,0.1062239757831962
SULT1A1,Small cell carcinoma of lung,0.1193558174333938
SULT1A1,Esophageal carcinoma,0.1254380558571286
SULT1A1,Carcinoma Transitional Cell,0.13167400689206
SULT1A1,Carcinoma of bladder,0.13167400689206
SULT1A1,Malignant neoplasm of endometrium,0.13167400689206
SULT1A1,Uterine Corpus Cancer,0.1328002618052838
SULT1A1,Colonic Neoplasms,0.1454373331146953
SULT1A1,Liver neoplasms,0.1454373331146953
SULT1A1,Cervical intraepithelial neoplasia grade 2,0.2050045461627939
SULT1A1,cervical cancer,0.2050045461627939
SULT1A1,Lung Neoplasms,0.2062010908869036
SULT1A1,Malignant tumor of colon,0.223747154820789
SULT1A1,Prostatic Neoplasms,0.223747154820789
SULT1A1,Diabetes,0.2277108302018961
SULT1A1,Malignant Head and Neck Neoplasm,0.2522264785494494
SULT1A1,Diabetes Mellitus,0.2522264785494494
SULT1A1,Malignant tumor of cervix,0.2714542429024338
SULT1A1,Malignant neoplasm of lung,0.2714542429024338
SULT1A1,Cervix carcinoma,0.2834835531038365
SULT1A1,Acute leukemia,0.2835142372342932
SULT1A1,Triple Negative Breast Neoplasms,0.2980670559114652
SULT1A1,Endometrial Carcinoma,0.3044782497745498
SULT1A1,Cholangiocarcinoma,0.340892538685018
SULT1A1,Carcinoma of lung,0.3663130598151661
SULT1A1,Primary malignant neoplasm of lung,0.3902116649640871
SULT1A1,Secondary malignant neoplasm of lymph node,0.3933196962529684
SULT1A1,Chronic myeloproliferative disorder,0.3933196962529684
SULT1A1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
SULT1A1,High altitude pulmonary edema,0.3933196962529684
SULT1A1,Infant Acute Lymphoblastic Leukemia,0.3933196962529684
SULT1A1,Leukemia Myelocytic Acute,0.3933196962529684
SULT1A1,Cervical Squamous Cell Carcinoma In Situ,0.3933196962529684
SULT1A1,Urothelial Carcinoma,0.3933196962529684
SULT1A1,Genitourinary Cancer,0.3933196962529684
SULT1A1,Adenoma,0.3933196962529684
SULT1A1,Malignant neoplasm of male breast,0.3933196962529684
SULT1A1,Carcinoma in situ of uterine cervix,0.3933196962529684
SULT1A1,Pituitary Adenoma,0.3941558617476422
SULT1A1,Female Genital Diseases,0.3975960596292668
SULT1A1,Breast Neoplasms Male,0.4028066164685291
SULT1A1,Carcinoma of Male Breast,0.4028066164685291
SULT1A1,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,0.4115056600660309
SULT1A1,Adenoma of large intestine,0.4126392832024548
SULT1A1,Autosome Abnormalities,0.4192169590514327
SULT1A1,Chromosome Aberrations,0.4192169590514327
SULT1A1,Nonalcoholic Steatohepatitis,0.4335751357405352
SULT1A1,Slow acetylator due to N-acetyltransferase enzyme variant,0.4335751357405352
SULT1A1,Depressive Symptoms,0.4459714599189374
SULT1A1,Myocardial Ischemia,0.4506578937113162
SULT1A1,MRSA - Methicillin resistant Staphylococcus aureus infection,0.4506578937113162
SULT1A1,Intelligence,0.5683976277847906
SULT1A1,Bile duct carcinoma,0.6150955455771212
SULT1A1,Mucocutaneous Lymph Node Syndrome,0.6294837700416086
SULT1A1,Dementia,0.6364853529519863
SULT1A1,Sudden infant death syndrome,0.672336954961104
SULT1A1,Hyperplastic Polyp,0.7631684472516962
SULT1A1,Essential Hypertension,0.8418436641268439
SULT1A1,Breast Carcinoma,0.0075861267486594
SULT1A1,Urinary Tract Cancer,0.0102679590519094
SULT1A1,Marfan Syndrome,0.0133304506157067
SULT1A1,Mammary Neoplasms,0.0155248163763686
SULT1A1,Breast Cancer,0.0402286636010764
SULT1A1,Urologic Neoplasms,0.0839188440969517
SULT1A1,Myocardial Ischemia,0.4560460337187313
SULT1A1,Allergic Rhinitis,0.4560460337187313
SULT1A1,Colonic Neoplasms,0.4809179010794786
SULT1A1,Prostatic Neoplasms,0.4875380732267193
SULT1A1,Prostate Cancer,0.6104715460837368
SULT1A1,Serrated polyposis syndrome ORPHA:157798,0.1590470395003315
SULT1A1,Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480,0.3762014630157917
SULT1A1,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857,0.6239678957896782
SULT1A1,Amelocerebrohypohidrotic syndrome ORPHA:1946,0.7068064785325423
SUMF1,Lysosomal Storage Diseases,0.0798053340865682
SUMF1,Clouding of corneal stroma,0.1859959283872542
SUMF1,Seizures,0.2053083986145698
SUMF1,Corneal Opacity,0.2085938372806741
SUMF1,Cataract,0.223747154820789
SUMF1,Multiple Sclerosis,0.2835142372342932
SUMF1,Pfaundler-Hurler Syndrome,0.3508665345292502
SUMF1,Hydrocephalus,0.3933196962529684
SUMF1,Hyperplasia of forehead,0.3933196962529684
SUMF1,Hypertrophy of forehead,0.3933196962529684
SUMF1,Large forehead,0.3933196962529684
SUMF1,Mucopolysacchariduria,0.3933196962529684
SUMF1,Multiple Sulfatase Deficiency Disease,0.3933196962529684
SUMF1,Rough hair texture,0.3933196962529684
SUMF1,Coarse hair,0.3933196962529684
SUMF1,Abnormality of peripheral nerve conduction,0.3933196962529684
SUMF1,Epilepsy,0.3941558617476422
SUMF1,Mucopolysaccharidosis MPS-IV-A,0.3941558617476422
SUMF1,Bulging forehead,0.3941558617476422
SUMF1,Prominent forehead,0.3941558617476422
SUMF1,Hypoplastic vertebral bodies,0.3941558617476422
SUMF1,Broad hallux phalanx,0.3975960596292668
SUMF1,Splenomegaly,0.4103119460235835
SUMF1,Hyperammonemia,0.4115056600660309
SUMF1,Smooth philtrum,0.4126392832024548
SUMF1,Central nervous system lesion,0.4192169590514327
SUMF1,Lens Opacities,0.4213286052188015
SUMF1,Cellulitis of periorbital region,0.4213286052188015
SUMF1,Periorbital edema,0.4213286052188015
SUMF1,Periorbital swelling,0.4213286052188015
SUMF1,Abnormality of the periventricular white matter,0.425419812815905
SUMF1,Dilated ventricles (finding),0.425992946703162
SUMF1,Increased CSF protein,0.4335751357405352
SUMF1,Lower limb hyperreflexia,0.4335751357405352
SUMF1,Supratentorial atrophy,0.4381343267935581
SUMF1,Short stature,0.439389586518055
SUMF1,Mucopolysaccharidosis Type IIIA,0.4396723023384634
SUMF1,Hepatomegaly,0.4506578937113162
SUMF1,Peripheral demyelination,0.4506578937113162
SUMF1,Retinal Degeneration,0.4675904598629673
SUMF1,Degenerative brain disorder,0.4790179402069343
SUMF1,Hydrops Fetalis,0.4990401620718274
SUMF1,Chronic Obstructive Airway Disease,0.5049674142533507
SUMF1,Cerebellar atrophy,0.5251317541886066
SUMF1,Broad hallux,0.5251317541886066
SUMF1,Dull intelligence,0.5300976305939776
SUMF1,Low intelligence,0.5300976305939776
SUMF1,Concave bridge of nose,0.5337853752290136
SUMF1,Depressed nasal root/bridge,0.5337853752290136
SUMF1,Depressed nasal bridge,0.533913711453195
SUMF1,Joint stiffness,0.5359212109443033
SUMF1,Broad thumbs,0.5393787854381349
SUMF1,Poor school performance,0.5610226870913673
SUMF1,Central nervous system demyelination,0.5655222348249326
SUMF1,Cerebellar Ataxia,0.5754799679683854
SUMF1,Mental deficiency,0.6035970790768342
SUMF1,Thickened facial skin with coarse facial features,0.6207008101484466
SUMF1,Coarse facial features,0.6222451141623291
SUMF1,Cerebral atrophy,0.6294837700416086
SUMF1,Mental Retardation,0.6319938293757544
SUMF1,Flat face,0.6319938293757544
SUMF1,Retinal pigment epithelial abnormality,0.6545439509404224
SUMF1,Abnormality of retinal pigmentation,0.6545439509404224
SUMF1,Infratentorial atrophy,0.6545439509404224
SUMF1,Thick eyebrow,0.6588479076808555
SUMF1,Sensorineural Hearing Loss (disorder),0.6891882956008074
SUMF1,Cerebellar degeneration,0.7096959691931399
SUMF1,Ichthyoses,0.7129583530027284
SUMF1,Leukodystrophy,0.7309076068378124
SUMF1,Big calvaria,0.7484342194688707
SUMF1,Increased size of skull,0.7484342194688707
SUMF1,Increased head circumference,0.7511668779991656
SUMF1,Neonatal Hypotonia,0.7670529315163258
SUMF1,Ataxia Spinocerebellar,0.7756460653898786
SUMF1,Muscle Spasticity,0.7965501584766118
SUMF1,Visual Impairment,0.8098594112577364
SUMF1,Optic Atrophy,0.809878589520458
SUMF1,Hearing Loss Partial,0.8209296131179464
SUMF1,Low Vision,0.8225089178916923
SUMF1,Intellectual Disability,0.8352623613787349
SUMF1,Psychomotor regression progressive,0.839057838231319
SUMF1,Loss of developmental milestones,0.839057838231319
SUMF1,Mental deterioration in childhood,0.839057838231319
SUMF1,Neurodevelopmental regression,0.839057838231319
SUMF1,Psychomotor regression,0.839057838231319
SUMF1,Psychomotor regression beginning in infancy,0.839057838231319
SUMF1,Psychomotor regression in infants,0.8441962785769224
SUMF1,Developmental regression,0.8455269088566324
SUMF1,Anteverted nostril,0.8472019892490944
SUMF1,hearing impairment,0.8612168330350624
SUMF1,Mental and motor retardation,0.897310588550617
SUMF1,Cognitive delay,0.9238745269736108
SUMF1,Global developmental delay,0.9327689937867868
SUMF1,Deafness,0.9559782990517682
SUMF1,Congenital deafness,0.9630764048242788
SUMF1,Hydrocephalus,0.3657224783929353
SUMF1,Pfaundler-Hurler Syndrome,0.3940072377207739
SUMF1,Narcolepsy,0.4875380732267193
SUMF1,Central Nervous System Demyelination,0.4968320901822731
SUMF1,Hypotonia,0.5087473896242481
SUMF1,Microcephaly,0.5123947823327547
SUMF1,Cerebral Atrophy,0.5129298662020659
SUMF1,Hearing Loss,0.5632819212593052
SUMF1,Dwarfism,0.5796489603182782
SUMF1,Cataract,0.6660731887258019
SUMF1,Optic Atrophy,0.675936313627625
SUMF1,Cerebellar Atrophy,0.7112499273451761
SUMF1,Mental Retardation,0.7729545590606223
SUMF1,Macrocephaly,0.800821840688695
SUMF1,Ichthyosis,0.850248739086744
SUMF1,Multiple Sclerosis,0.880175848034561
SUMF1,Developmental Delay,0.96477535147595
SUMF1,Developmental Regression,0.9772539070870868
SUMF1,Sanfilippo syndrome type D ORPHA:79272,0.1590470395003315
SUMF1,Tay-Sachs disease B variant adult form ORPHA:309192,0.1590470395003315
SUMF1,Tay-Sachs disease B variant infantile form ORPHA:309178,0.1590470395003315
SUMF1,Tay-Sachs disease B variant juvenile form ORPHA:309185,0.1590470395003315
SUMF1,Tay-Sachs disease B1 variant ORPHA:309239,0.1590470395003315
SUMF1,Free sialic acid storage disease infantile form ORPHA:309324,0.3762014630157917
SUMF1,Intermediate severe Salla disease ORPHA:309331,0.3762014630157917
SUMF1,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.3762014630157917
SUMF1,Salla disease ORPHA:309334,0.3762014630157917
SUMF1,Multiple sulfatase deficiency ORPHA:585,0.6239678957896782
SUMF1,NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498,0.6239678957896782
SUMF1,Sporadic porphyria cutanea tarda ORPHA:443057,0.6239678957896782
SUMF1,Symptomatic form of hemochromatosis type 1 ORPHA:465508,0.6239678957896782
SUMF1,TMEM165-CDG ORPHA:314667,0.6239678957896782
SUSD4,Breast Carcinoma,0.0042545616049287
SUSD4,Tumor Progression,0.0149315928814189
SUSD4,Malignant neoplasm of breast,0.0191435238361999
SUSD4,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.0586579655822394
SUSD4,Fuhrmann syndrome ORPHA:2854,0.6239678957896782
SUSD4,Phocomelia Schinzel type ORPHA:2879,0.6239678957896782
SUSD4,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome ORPHA:363992,0.7068064785325423
SUSD4,Echovirus E21 VP1,0.6362779693488597
SUSD4,Human enterovirus 94 VP2,0.6362779693488597
SUSD4,Enterovirus D capsid protein 1B,0.6362779693488597
SUSD4,Human gammaherpesvirus 8 KCP (gene: ORF4),0.6362779693488597
SUSD4,Coxsackievirus A14 full_polyprotein 1..2192,0.6362779693488597
SUSD4,Coxsackievirus A10 full_polyprotein 1..2193,0.6362779693488597
SUSD4,Enterovirus A120 full_polyprotein 1..2191,0.6362779693488597
SUSD4,Coxsackievirus A4 full_polyprotein 1..2201,0.6362779693488597
SUSD4,Enterovirus A76 full_polyprotein 1..2198,0.6362779693488597
SUSD4,Enterovirus A VP2 (1B),0.6362779693488597
SUSD4,Coxsackievirus A2 full_polyprotein 1..2190,0.6362779693488597
SUSD4,Enterovirus D protein VP0,0.6362779693488597
SUSD4,Coxsackievirus A8 VP2 protein,0.6362779693488597
SUSD4,Echovirus E18 full_polyprotein 1..2189,0.6362779693488597
SUSD4,Coxsackievirus A6 VP2 protein,0.6362779693488597
SUSD4,Echovirus E12 polyprotein,0.6362779693488597
SUSD4,Vaccinia virus secreted complement-binding protein (gene: C3L),0.6362779693488597
SUSD4,Vaccinia virus Ankara Complement control protein,0.6362779693488597
SUSD4,Echovirus E24 VP3,0.6362779693488597
SUSD4,Echovirus E7 VP3,0.6362779693488597
SUSD4,Human enterovirus 79 1C (VP3),0.6362779693488597
SUSD4,Echovirus E12 polyprotein region 3,0.6362779693488597
SUSD4,Echovirus E26 VP3,0.6362779693488597
SUSD4,Echovirus E27 VP3,0.6362779693488597
SUSD4,Echovirus E31 VP3,0.6362779693488597
SUSD4,Echovirus E33 VP3,0.6362779693488597
SUSD4,Echovirus E7 VP2,0.6362779693488597
SUSD4,Coxsackievirus B4 full_polyprotein 1..2183,0.6362779693488597
SUSD4,Echovirus E30 full_polyprotein 1..2194,0.6362779693488597
SUSD4,Coxsackievirus B5 VP2 capsid protein polyprotein region 3 (gene: 1A),0.6362779693488597
SUSD4,Echovirus 9 strain Barty VP3,0.6362779693488597
SUSD4,Echovirus 9 strain Hill polyprotein region 3,0.6362779693488597
SUSD4,Echovirus E11 1B(VP2),0.6362779693488597
SUSD4,Echovirus E11 1D(VP1),0.6362779693488597
SUSD4,Echovirus E16 VP3,0.6362779693488597
SUSD4,Echovirus E3 VP3,0.6362779693488597
SUSD4,Coxsackievirus B6 full_polyprotein 1..2184,0.6362779693488597
SUSD4,Echovirus E21 VP3,0.6362779693488597
SUSD4,Echovirus E29 VP3,0.6362779693488597
SUSD4,Echovirus E32 VP3,0.6362779693488597
SUSD4,Enterovirus B 1B(VP2),0.6362779693488597
SUSD4,Enterovirus B 1C(VP3),0.6362779693488597
SUSD4,Coxsackievirus B2 full_polyprotein 1..2187,0.6362779693488597
SUSD4,Enterovirus B genome polyportein,0.6362779693488597
SUSD4,Human rhinovirus B5 1B,0.6362779693488597
SUSD4,Echovirus E11 1C(VP3),0.6362779693488597
SUSD4,Echovirus E19 VP1,0.6362779693488597
SUSD4,Echovirus E4 VP3,0.6362779693488597
SUSD4,Enterovirus B111 VP3,0.6362779693488597
SUSD4,Enterovirus B73 full_polyprotein 1..2188,0.6362779693488597
SUSD4,Cowpox virus CPXV034 (gene: CPXV034 CDS),0.6362779693488597
SUSD4,Monkeypox virus complement control protein,0.6362779693488597
SUSD4,Monkeypox virus Zaire-96-I-16 D14L (gene: D14L),0.6362779693488597
SUSD4,Echovirus E32 VP1,0.6362779693488597
SUSD4,Enterovirus B111 VP1,0.6362779693488597
SUSD4,Echovirus E14 VP3,0.6362779693488597
SUSD4,Echovirus E19 VP3,0.6362779693488597
SUSD4,Echovirus E19 VP2,0.6362779693488597
SUSD4,Enterovirus B106 full_polyprotein 1..2192,0.6362779693488597
SUSD4,Echovirus E15 VP2,0.6362779693488597
SUSD4,Echovirus E5 full_polyprotein 1..2196,0.6362779693488597
SUSD4,Echovirus E12 polyprotein region 4,0.6362779693488597
SUSD4,Echovirus E13 VP3,0.6362779693488597
SUSD4,Echovirus E15 VP3,0.6362779693488597
SUSD4,Echovirus E27 VP1,0.6362779693488597
SUSD4,Enterovirus B97 VP3,0.6362779693488597
SUSD4,Horsepox virus HSPV028 (secreted complement-binding protein,0.6362779693488597
SUSD4,Provisional),0.6362779693488597
SUSD4,Echovirus E17 VP3,0.6362779693488597
SUSD4,Echovirus E2 VP3,0.6362779693488597
SUSD4,Echovirus E14 VP1,0.6362779693488597
SUSD4,Echovirus E2 VP1,0.6362779693488597
SUSD4,Echovirus E6 VP3,0.6362779693488597
SUSD4,Enterovirus B97 VP1,0.6362779693488597
SUSD4,Enterovirus H capsid protein VP2,0.6362779693488597
SUSD4,Echovirus E9 full_polyprotein 1..2203,0.6362779693488597
SUSD4,Human enterovirus 79 1B (VP2),0.6362779693488597
SUSD4,Echovirus E15 VP1,0.6362779693488597
SUSD4,Echovirus E17 VP2,0.6362779693488597
SUSD4,Echovirus E17 VP1,0.6362779693488597
SUSD4,Echovirus E29 VP2,0.6362779693488597
SUSD4,Ectromelia virus ERPV complement binding protein,0.6362779693488597
SUSD4,Echovirus E20 VP2,0.6362779693488597
SUSD4,Echovirus E25 VP3,0.6362779693488597
SUSD4,Echovirus E31 VP1,0.6362779693488597
SUSD4,Vaccinia virus Ankara EEV type 1 membrane protein,0.6362779693488597
SUSD4,Echovirus E16 VP2,0.6362779693488597
SUSD4,Echovirus E26 VP2,0.6362779693488597
SUSD4,Echovirus E3 VP1,0.6362779693488597
SUSD4,Echovirus E33 VP2,0.6362779693488597
SUSD4,Echovirus E4 VP2,0.6362779693488597
SUSD4,Echovirus 9 strain Barty VP2,0.6362779693488597
SUSD4,Echovirus E14 VP2,0.6362779693488597
SUSD4,Echovirus E16 VP1,0.6362779693488597
SUSD4,Echovirus E21 VP2,0.6362779693488597
SUSD4,Echovirus E24 VP2,0.6362779693488597
SUSD4,Echovirus E24 VP1,0.6362779693488597
SUSD4,Echovirus E27 VP2,0.6362779693488597
SUSD4,Echovirus E29 VP1,0.6362779693488597
SUSD4,Echovirus E33 VP1,0.6362779693488597
SUSD4,Echovirus E6 VP1,0.6362779693488597
SUSD4,Enterovirus B111 VP2,0.6362779693488597
SUSD4,Enterovirus H capsid protein VP3,0.6362779693488597
SUSD4,Echovirus E20 VP1,0.6362779693488597
SUSD4,Echovirus E25 VP2,0.6362779693488597
SUSD4,Echovirus E6 VP2,0.6362779693488597
SUSD4,Enterovirus B97 VP2,0.6362779693488597
SUSD4,Human cosavirus B VP2,0.6362779693488597
SUSD4,Echovirus E13 VP2,0.6362779693488597
SUSD4,Echovirus E25 VP1,0.6362779693488597
SUSD4,Echovirus E3 VP2,0.6362779693488597
SUSD4,Echovirus E31 VP2,0.6362779693488597
SUSD4,Ectromelia virus ERPV EEV complement control protein,0.6362779693488597
SUSD4,Echovirus 9 strain Hill polyprotein region 2,0.6362779693488597
SUSD4,Echovirus E2 VP2,0.6430308263654244
SUSD4,Cowpox virus CPXV199 protein (gene: CPXV199 CDS),0.6621265548536891
SUSD4,Vaccinia virus EEV membrane glycoprotein (gene: B5R),0.6621265548536891
SUSD4,Monkeypox virus EEV type-I membrane glycoprotein,0.6621265548536891
SUSD4,Monkeypox virus Zaire-96-I-16 EEV membrane glycoprotein (gene: B6R),0.6621265548536891
SUSD4,Echovirus E32 VP2,0.6682550899136019
SUSD4,Horsepox virus HSPV182 (EEV membrane glycoprotein,0.7017760963861425
SYNE3,Malignant Neoplasms,0.0991201145654548
SYNE3,Primary malignant neoplasm,0.383941725017158
SYNE3,Early onset torsion dystonia,0.4396723023384634
SYNE3,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.0586579655822394
SYNE3,Early-onset Lafora body disease ORPHA:324290,0.1590470395003315
SYNE3,Generalized glucocorticoid resistance syndrome ORPHA:786,0.1590470395003315
SYNE3,Spinocerebellar ataxia type 1 ORPHA:98755,0.1590470395003315
SYNE3,Attenuated Chediak-Higashi syndrome ORPHA:352723,0.3762014630157917
SYNE3,Chediak-Higashi syndrome ORPHA:167,0.3762014630157917
SYNE3,Autosomal dominant multiple pterygium syndrome ORPHA:65743,0.6239678957896782
SYNE3,External auditory canal aplasia/hypoplasia ORPHA:141074,0.6239678957896782
SYNE3,Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366,0.6239678957896782
SYNE3,Nicolaides-Baraitser syndrome ORPHA:3051,0.6239678957896782
SYNE3,Spinocerebellar ataxia type 15/16 ORPHA:98769,0.6239678957896782
SYNE3,Spinocerebellar ataxia type 29 ORPHA:208513,0.6239678957896782
SYNE3,Obesity due to congenital leptin deficiency ORPHA:66628,0.7068064785325423
SYNE3,Monkeypox virus cowpox A-type inclusion protein,0.6362779693488597
SYNE3,Vaccinia virus cowpox A-type inclusion protein,0.8834254233868516
SYNE3,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8919745352546131
TEKT4P2,Pyridoxal phosphate-responsive seizures ORPHA:79096,0.6239678957896782
TET1,Colorectal Carcinoma,0.0034602840073026
TET1,Mammary Neoplasms,0.0034602840073026
TET1,Ovarian Carcinoma,0.0034602840073026
TET1,Breast Carcinoma,0.0042545616049287
TET1,Invasive Ductal Breast Carcinoma,0.0149002095788623
TET1,Colorectal Cancer,0.0149315928814189
TET1,Stomach Carcinoma,0.0149315928814189
TET1,Malignant neoplasm of breast,0.0191435238361999
TET1,Malignant neoplasm of stomach,0.0191435238361999
TET1,Carcinogenesis,0.0228075668512991
TET1,Malignant neoplasm of ovary,0.0277695594716545
TET1,Hematopoietic Neoplasms,0.0334891258932371
TET1,Epithelial ovarian cancer,0.0387439397151409
TET1,Neoplasm Metastasis,0.0648809611869375
TET1,Glioma,0.0739788831250619
TET1,Degenerative polyarthritis,0.0739788831250619
TET1,Glioblastoma,0.0745502070959292
TET1,Liver carcinoma,0.095319386034013
TET1,Malignant Neoplasms,0.0991201145654548
TET1,Colon Carcinoma,0.1062239757831962
TET1,Hamman-Rich syndrome,0.13167400689206
TET1,Malignant neoplasm of large intestine,0.13167400689206
TET1,Colonic Neoplasms,0.1454373331146953
TET1,Lung Neoplasms,0.2062010908869036
TET1,Malignant tumor of colon,0.223747154820789
TET1,B-Cell Lymphomas,0.2522264785494494
TET1,MIXED LINEAGE LEUKEMIA,0.2605479444258003
TET1,Neoplasms,0.2714542429024338
TET1,Malignant neoplasm of lung,0.2714542429024338
TET1,Fibroid Tumor,0.290158730291654
TET1,Idiopathic Pulmonary Fibrosis,0.3099246715197673
TET1,Leukemogenesis,0.3510063969122338
TET1,Carcinoma of lung,0.3663130598151661
TET1,Pheochromocytoma,0.3712878513813393
TET1,Primary malignant neoplasm,0.383941725017158
TET1,Endometriosis,0.383941725017158
TET1,Uterine Fibroids,0.383941725017158
TET1,Primary malignant neoplasm of lung,0.3902116649640871
TET1,Chronic myeloproliferative disorder,0.3933196962529684
TET1,Schizophrenia,0.3933196962529684
TET1,Leukemia Myelocytic Acute,0.3933196962529684
TET1,Germ Cell Cancer,0.3933196962529684
TET1,Alzheimer's Disease,0.3933196962529684
TET1,Stomach Neoplasms,0.3933196962529684
TET1,Asthma,0.3933196962529684
TET1,Chronic schizophrenia,0.3941558617476422
TET1,Autism Spectrum Disorders,0.3941558617476422
TET1,Endometrioma,0.3941558617476422
TET1,Primary cholangiocarcinoma of intrahepatic biliary tract,0.3975960596292668
TET1,Intrahepatic Cholangiocarcinoma,0.4028066164685291
TET1,Nephrotic Syndrome,0.4103119460235835
TET1,Alzheimer Disease Late Onset,0.4115056600660309
TET1,Smooth Muscle Tumor,0.425419812815905
TET1,leukemia,0.4588513406515081
TET1,Psychotic Disorders,0.4753011022966241
TET1,Pain,0.4871698998714747
TET1,Autoimmune Diseases,0.5512224939896888
TET1,Colonic Polyps,0.5568517196017908
TET1,Nonorganic psychosis,0.578835730221474
TET1,Paraganglioma,0.6910672612216457
TET1,Childhood asthma,0.8000044931629623
TET1,Schizophrenia,0.0531117779464085
TET1,Autism Spectrum Disorder,0.425341435586089
TET1,Psychosis,0.4560460337187313
TET1,Nonorganic Psychosis,0.6883874961919009
TET1,Neuroblastoma ORPHA:635,0.3969770464111636
TET1,Congenital communicating hydrocephalus ORPHA:269505,0.6239678957896782
TET1,Hereditary retinoblastoma ORPHA:357027,0.6239678957896782
TET1,Non-hereditary retinoblastoma ORPHA:357034,0.6239678957896782
TET1,46XY partial gonadal dysgenesis ORPHA:251510,0.665250072408594
TET1,Monosomy 9q22.3 ORPHA:77301,0.7068064785325423
TET1,Resistance to thyrotropin-releasing hormone syndrome ORPHA:99832,0.7068064785325423
TET1,Schilbach-Rott syndrome ORPHA:2353,0.7068064785325423
TET1,Short stature-optic atrophy-Pelger-Huet anomaly syndrome ORPHA:391677,0.7068064785325423
TET1,Angelman syndrome due to maternal 15q11q13 deletion ORPHA:98794,0.7068064785325423
TET1,Deletion 5q35 ORPHA:1627,0.7068064785325423
TET1,Infantile nephronophthisis ORPHA:93591,0.7072638369101406
TET1,NON RARE IN EUROPE: Primary ovarian failure ORPHA:619,0.7443958988603572
TFAP4,Colorectal Carcinoma,0.0034602840073026
TFAP4,Colorectal Cancer,0.0149315928814189
TFAP4,Liver carcinoma,0.095319386034013
TFAP4,COG8-CDG ORPHA:95428,0.7068064785325423
TFAP4,Chuvash erythrocytosis ORPHA:238557,0.7068064785325423
TFAP4,Kleefstra syndrome due to 9q34 microdeletion ORPHA:96147,0.7068064785325423
TFAP4,Postaxial acrofacial dysostosis ORPHA:246,0.7068064785325423
TFAP4,Von Hippel-Lindau disease ORPHA:892,0.7068064785325423
TGM2,Colorectal Carcinoma,0.0034602840073026
TGM2,Mammary Neoplasms,0.0034602840073026
TGM2,Ovarian Carcinoma,0.0034602840073026
TGM2,Breast Carcinoma,0.0042545616049287
TGM2,Colorectal Cancer,0.0149315928814189
TGM2,Tumor Progression,0.0149315928814189
TGM2,Stomach Carcinoma,0.0149315928814189
TGM2,melanoma,0.0149315928814189
TGM2,Adenocarcinoma,0.0155921563748247
TGM2,Proliferative vitreoretinopathy,0.0182265588252201
TGM2,Squamous cell carcinoma,0.0182265588252201
TGM2,Esophageal Neoplasms,0.0182265588252201
TGM2,ovarian neoplasm,0.0191435238361999
TGM2,Malignant neoplasm of breast,0.0191435238361999
TGM2,Fibrosarcoma,0.0191435238361999
TGM2,Malignant neoplasm of stomach,0.0191435238361999
TGM2,Carcinogenesis,0.0228075668512991
TGM2,Malignant neoplasm of esophagus,0.0248454592431097
TGM2,Malignant neoplasm of ovary,0.0277695594716545
TGM2,Epithelial ovarian cancer,0.0387439397151409
TGM2,Brain Tumor Primary,0.044151975756427
TGM2,Malignant neoplasm of prostate,0.0569142010728473
TGM2,Central neuroblastoma,0.0593779966354549
TGM2,Primary malignant neoplasm of brain,0.064548079316548
TGM2,Mammary Neoplasms Human,0.064548079316548
TGM2,Brain Neoplasms,0.064548079316548
TGM2,Neoplasm Metastasis,0.0648809611869375
TGM2,Barrett Esophagus,0.0648809611869375
TGM2,Renal Cell Carcinoma,0.0648809611869375
TGM2,Neuroblastoma,0.0688152422187159
TGM2,Malignant neoplasm of pancreas,0.0726340460169901
TGM2,Pancreatic Neoplasm,0.0739788831250619
TGM2,Glioma,0.0739788831250619
TGM2,Degenerative polyarthritis,0.0739788831250619
TGM2,Osteoporosis,0.0739788831250619
TGM2,Glioblastoma,0.0745502070959292
TGM2,Pancreatic carcinoma,0.0745502070959292
TGM2,Carcinoma breast stage IV,0.0745502070959292
TGM2,Liver Cirrhosis,0.0773771948186562
TGM2,Prostate carcinoma,0.0773771948186562
TGM2,Liver carcinoma,0.095319386034013
TGM2,Malignant Neoplasms,0.0991201145654548
TGM2,Colon Carcinoma,0.1062239757831962
TGM2,Adenocarcinoma of colon,0.1112281755580192
TGM2,Peroxisome Biogenesis Disorder Complementation Group C,0.1254380558571286
TGM2,Nephrogenic Fibrosing Dermopathy,0.1254380558571286
TGM2,Tumor Initiation,0.13167400689206
TGM2,Carcinoma Transitional Cell,0.13167400689206
TGM2,Malignant neoplasm of large intestine,0.13167400689206
TGM2,Carcinoma of bladder,0.13167400689206
TGM2,Hallopeau-Siemens Disease,0.13167400689206
TGM2,Hyperactive behavior,0.1387448809655294
TGM2,Chromophobe Renal Cell Carcinoma,0.1461248774859792
TGM2,Rheumatoid Arthritis,0.1537760235124317
TGM2,Benign neoplasm of brain unspecified,0.1602092191314262
TGM2,Adrenal Gland Diseases,0.1735868515093891
TGM2,Recurrent Brain Neoplasm,0.1770067065899052
TGM2,Seizures,0.2053083986145698
TGM2,Desmoplastic,0.2085938372806741
TGM2,Cataract,0.223747154820789
TGM2,Malignant tumor of colon,0.223747154820789
TGM2,Diabetes,0.2277108302018961
TGM2,Diabetes Mellitus,0.2522264785494494
TGM2,Malignant neoplasm of lung,0.2714542429024338
TGM2,Diabetes Mellitus Insulin-Dependent,0.2714542429024338
TGM2,Multiple Sclerosis,0.2835142372342932
TGM2,Neoplasms Intracranial,0.290158730291654
TGM2,Gastrointestinal Diseases,0.2980670559114652
TGM2,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
TGM2,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
TGM2,Glaucoma,0.3105909001629992
TGM2,Carcinoma of lung,0.3663130598151661
TGM2,Addison's disease due to autoimmunity,0.3778347117514905
TGM2,Primary malignant neoplasm,0.383941725017158
TGM2,Recurrent tumor,0.383941725017158
TGM2,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
TGM2,Primary malignant neoplasm of lung,0.3902116649640871
TGM2,Von Hippel-Lindau Syndrome,0.3933196962529684
TGM2,Bipolar Disorder,0.3933196962529684
TGM2,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
TGM2,Inflammation,0.3933196962529684
TGM2,Nuclear cataract,0.3933196962529684
TGM2,Sarcomatoid Renal Cell Carcinoma,0.3933196962529684
TGM2,Schizophrenia,0.3933196962529684
TGM2,Non-Small Cell Lung Carcinoma,0.3933196962529684
TGM2,Hypertensive disease,0.3933196962529684
TGM2,Secondary malignant neoplasm of liver,0.3933196962529684
TGM2,Collecting Duct Carcinoma of the Kidney,0.3933196962529684
TGM2,Alzheimer's Disease,0.3933196962529684
TGM2,Fibrosis Liver,0.3933196962529684
TGM2,Acute Promyelocytic Leukemia,0.3933196962529684
TGM2,Parkinson Disease,0.3933196962529684
TGM2,Adenoma,0.3933196962529684
TGM2,Asthma,0.3933196962529684
TGM2,Glioblastoma Multiforme,0.3933196962529684
TGM2,Craniofacial dysostosis type 1,0.3933196962529684
TGM2,Gluten sensitivity,0.3933196962529684
TGM2,Carcinoma Pancreatic Ductal,0.3933196962529684
TGM2,Alcoholic Steatohepatitis,0.3941558617476422
TGM2,Dryness of eye,0.3941558617476422
TGM2,Acute Erythroblastic Leukemia,0.3941558617476422
TGM2,Autoimmune Primary Adrenal Insufficiency,0.3941558617476422
TGM2,Malignant neoplasm of brain,0.3941558617476422
TGM2,Amyotrophic Lateral Sclerosis,0.3975960596292668
TGM2,Papillary Renal Cell Carcinoma,0.3975960596292668
TGM2,Bilateral cataracts (disorder),0.4028066164685291
TGM2,Meningioma benign no ICD-O subtype,0.4028066164685291
TGM2,Celiac Disease,0.4028066164685291
TGM2,Dry Eye Syndromes,0.4103119460235835
TGM2,Testicular Feminization,0.4103119460235835
TGM2,Cerebrovascular accident,0.4115056600660309
TGM2,Plasmacytosis,0.4115056600660309
TGM2,Acute Coronary Syndrome,0.4118266358241932
TGM2,Acquired Immunodeficiency Syndrome,0.4126392832024548
TGM2,Mental disorders,0.4126392832024548
TGM2,Refractory anemias,0.421267417774367
TGM2,Progressive supranuclear palsy,0.4213286052188015
TGM2,Psoriasis,0.4304973629098372
TGM2,Retinoic acid syndrome,0.4304973629098372
TGM2,Nonalcoholic Steatohepatitis,0.4335751357405352
TGM2,Neurodegenerative Disorders,0.4335751357405352
TGM2,Neuropathy,0.4335751357405352
TGM2,Meningioma,0.4396723023384634
TGM2,Adenocarcinoma of prostate,0.4421745246585178
TGM2,Intestinal Diseases,0.4459714599189374
TGM2,Precancerous Conditions,0.4479115285676636
TGM2,Maturity onset diabetes mellitus in young,0.4506578937113162
TGM2,Dermatitis Herpetiformis,0.4615352570710579
TGM2,Osteoarthrosis Deformans,0.4675904598629673
TGM2,Cardiomyopathy Familial Idiopathic,0.4704594475773637
TGM2,Huntington Disease,0.4704594475773637
TGM2,Myeloid Leukemia Chronic,0.472444704048021
TGM2,Impaired glucose tolerance,0.4900770016856776
TGM2,Steatohepatitis,0.4906258721078565
TGM2,Polymyositis,0.4923669467696064
TGM2,Graves Disease,0.4981941174985421
TGM2,Metastatic melanoma,0.5001612228394569
TGM2,Ulcerative Colitis,0.5001612228394569
TGM2,Enterovirus Infections,0.5019670090704682
TGM2,Stage IV Skin Melanoma,0.5090214163899865
TGM2,Lichen Planus,0.5188223685230745
TGM2,nervous system disorder,0.5276472086074249
TGM2,Muscular Dystrophy Oculopharyngeal,0.5299466034567416
TGM2,Malignant neoplasm of stomach stage IV,0.5299466034567416
TGM2,Malabsorption Syndrome,0.5337853752290136
TGM2,Disseminated Malignant Neoplasm,0.533913711453195
TGM2,Hepatocarcinogenesis,0.533913711453195
TGM2,CATARACT ANTERIOR POLAR,0.5393787854381349
TGM2,Oral Submucous Fibrosis,0.5453394612016188
TGM2,Autoimmune Diseases,0.5512224939896888
TGM2,Ataxia,0.5568517196017908
TGM2,Cerebellar Ataxia,0.5754799679683854
TGM2,Hamartoma Syndrome Multiple,0.589345563575654
TGM2,Immunoglobulin A deficiency (disorder),0.5916904943304121
TGM2,Atrophic,0.6002127202571572
TGM2,Myositis,0.601753535647179
TGM2,Cystic Fibrosis,0.6124306570512981
TGM2,Multiple Endocrine Neoplasia Type 2a,0.625027955184583
TGM2,Giant Cell Glioblastoma,0.672336954961104
TGM2,Multiple malignancy,0.6740259274935673
TGM2,insulinoma,0.6875373888914498
TGM2,Hepatitis C,0.7169459458481418
TGM2,Dermatomyositis,0.7706351321777464
TGM2,Hypoglycemia,0.7790800975250889
TGM2,Glaucoma Primary Open Angle,0.8352623613787349
TGM2,Cardiomyopathy Dilated,0.8670707879649133
TGM2,Virus Diseases,0.9692165430561782
TGM2,Breast Carcinoma,0.0075861267486594
TGM2,Esophagus Neoplasm,0.0102679590519094
TGM2,Marfan Syndrome,0.0133304506157067
TGM2,Mammary Neoplasms,0.0155248163763686
TGM2,Breast Cancer,0.0402286636010764
TGM2,Schizophrenia,0.0531117779464085
TGM2,Brain Neoplasms,0.1534453668959814
TGM2,Intracranial Neoplasm,0.2038801271174535
TGM2,Chromophobe Carcinoma,0.4286813331685578
TGM2,Colorectal Cancer,0.4286813331685578
TGM2,Papillary Renal Carcinoma,0.4286813331685578
TGM2,Arthritis,0.4541466895915311
TGM2,Renal Carcinoma,0.4541466895915311
TGM2,Hypertension,0.4560460337187313
TGM2,Giant Cell Glioblastoma,0.4875380732267193
TGM2,Glioblastoma,0.4875380732267193
TGM2,Bipolar Disorder,0.4875380732267193
TGM2,Osteoarthrosis Deformans,0.5087473896242481
TGM2,Celiac Disease,0.6485812088066297
TGM2,Pancreatic Neoplasm,0.6508151871447407
TGM2,Pancreatic Cancer,0.802679551748655
TGM2,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
TGM2,Autosomal recessive brachyolmia ORPHA:448242,0.0180064224283883
TGM2,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.0180064224283883
TGM2,Familial drusen ORPHA:75376,0.0180064224283883
TGM2,PPARG-related familial partial lipodystrophy ORPHA:79083,0.0180064224283883
TGM2,Primary CD59 deficiency ORPHA:169464,0.0180064224283883
TGM2,RIN2 syndrome ORPHA:217335,0.0180064224283883
TGM2,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.0180064224283883
TGM2,AGel amyloidosis ORPHA:85448,0.0586579655822394
TGM2,Keratolytic winter erythema ORPHA:50943,0.0586579655822394
TGM2,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.0586579655822394
TGM2,Adenocarcinoma of ovary ORPHA:213504,0.1590470395003315
TGM2,Epithelial basement membrane dystrophy ORPHA:98956,0.1590470395003315
TGM2,Familial cavitary optic disc anomaly ORPHA:464760,0.1590470395003315
TGM2,Granular corneal dystrophy type I ORPHA:98962,0.1590470395003315
TGM2,Granular corneal dystrophy type II ORPHA:98963,0.1590470395003315
TGM2,Lattice corneal dystrophy type I ORPHA:98964,0.1590470395003315
TGM2,MITF-related melanoma and renal cell carcinoma predisposition syndrome ORPHA:293822,0.1590470395003315
TGM2,Reis-Bucklers corneal dystrophy ORPHA:98961,0.1590470395003315
TGM2,Thiel-Behnke corneal dystrophy ORPHA:98960,0.1590470395003315
TGM2,Tietz syndrome ORPHA:42665,0.1590470395003315
TGM2,Complement component 3 deficiency ORPHA:280133,0.3762014630157917
TGM2,Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472,0.3762014630157917
TGM2,De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275,0.6239678957896782
TGM2,Immunodeficiency with factor H anomaly ORPHA:200421,0.6239678957896782
TGM2,Immunodeficiency with factor I anomaly ORPHA:200418,0.6239678957896782
TGM2,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138,0.6239678957896782
TGM2,HELLP syndrome ORPHA:244242,0.6239678957896782
THBS1,Colorectal Carcinoma,0.0034602840073026
THBS1,Mammary Neoplasms,0.0034602840073026
THBS1,Ovarian Carcinoma,0.0034602840073026
THBS1,Breast Carcinoma,0.0042545616049287
THBS1,Invasive carcinoma of breast,0.0149002095788623
THBS1,Invasive Ductal Breast Carcinoma,0.0149002095788623
THBS1,Colorectal Cancer,0.0149315928814189
THBS1,Tumor Progression,0.0149315928814189
THBS1,Stomach Carcinoma,0.0149315928814189
THBS1,melanoma,0.0149315928814189
THBS1,Adenocarcinoma,0.0155921563748247
THBS1,Squamous cell carcinoma,0.0182265588252201
THBS1,Malignant neoplasm of breast,0.0191435238361999
THBS1,Fibrosarcoma,0.0191435238361999
THBS1,Malignant neoplasm of stomach,0.0191435238361999
THBS1,Carcinogenesis,0.0228075668512991
THBS1,Malignant neoplasm of ovary,0.0277695594716545
THBS1,Medulloblastoma,0.0354767239335874
THBS1,Epithelial ovarian cancer,0.0387439397151409
THBS1,Skin carcinoma,0.0482468351695405
THBS1,Cancer of Urinary Tract,0.0492766532827251
THBS1,Malignant neoplasm of prostate,0.0569142010728473
THBS1,Central neuroblastoma,0.0593779966354549
THBS1,Well Differentiated Oligodendroglioma,0.0617471306652618
THBS1,Mammary Neoplasms Human,0.064548079316548
THBS1,Neoplasm Metastasis,0.0648809611869375
THBS1,Renal Cell Carcinoma,0.0648809611869375
THBS1,oligodendroglioma,0.0648809611869375
THBS1,Neuroblastoma,0.0688152422187159
THBS1,Malignant neoplasm of pancreas,0.0726340460169901
THBS1,Pancreatic Neoplasm,0.0739788831250619
THBS1,Glioma,0.0739788831250619
THBS1,Degenerative polyarthritis,0.0739788831250619
THBS1,Squamous cell carcinoma of penis,0.0739788831250619
THBS1,Lymphoma,0.0739788831250619
THBS1,Glioblastoma,0.0745502070959292
THBS1,Pancreatic carcinoma,0.0745502070959292
THBS1,inflammatory joint disease,0.0745502070959292
THBS1,Liver Cirrhosis,0.0773771948186562
THBS1,Prostate carcinoma,0.0773771948186562
THBS1,Colorectal Neoplasms,0.0827744840860166
THBS1,Squamous cell carcinoma of esophagus,0.0919714360040484
THBS1,Liver carcinoma,0.095319386034013
THBS1,Malignant Neoplasms,0.0991201145654548
THBS1,Osteosarcoma,0.1029977559100099
THBS1,Colon Carcinoma,0.1062239757831962
THBS1,Ganglioneuroma,0.1138051695421299
THBS1,Carcinoma Transitional Cell,0.13167400689206
THBS1,Malignant neoplasm of large intestine,0.13167400689206
THBS1,Malignant neoplasm of endometrium,0.13167400689206
THBS1,Hallopeau-Siemens Disease,0.13167400689206
THBS1,Uterine Corpus Cancer,0.1328002618052838
THBS1,Myocardial Infarction,0.1352936728187231
THBS1,Solid Neoplasm,0.1413782599148022
THBS1,Liver neoplasms,0.1454373331146953
THBS1,Rheumatoid Arthritis,0.1537760235124317
THBS1,Sarcoma,0.1537760235124317
THBS1,Renal fibrosis,0.1602092191314262
THBS1,Marfan Syndrome,0.1735868515093891
THBS1,Systemic Scleroderma,0.1900258729042946
THBS1,cervical cancer,0.2050045461627939
THBS1,Lung Neoplasms,0.2062010908869036
THBS1,Desmoplastic,0.2085938372806741
THBS1,Osteosarcoma of bone,0.2109483801368481
THBS1,Malignant tumor of colon,0.223747154820789
THBS1,Prostatic Neoplasms,0.223747154820789
THBS1,Diabetes,0.2277108302018961
THBS1,Anoxia,0.2462384927636234
THBS1,Diabetes Mellitus,0.2522264785494494
THBS1,Arteriovenous Malformations Cerebral,0.2643145809900195
THBS1,Neoplasms,0.2714542429024338
THBS1,Malignant tumor of cervix,0.2714542429024338
THBS1,Parasitic Diseases,0.2714542429024338
THBS1,Malignant neoplasm of lung,0.2714542429024338
THBS1,Clear cell sarcoma of kidney,0.2714542429024338
THBS1,Secondary malignant neoplasm of lung,0.2723545094624877
THBS1,Diabetic Retinopathy,0.2723545094624877
THBS1,Tumor-Associated Vasculature,0.2747883228704706
THBS1,Cervix carcinoma,0.2834835531038365
THBS1,Multiple Sclerosis,0.2835142372342932
THBS1,Fibroid Tumor,0.290158730291654
THBS1,Cirrhosis,0.2923761731100008
THBS1,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
THBS1,Triple Negative Breast Neoplasms,0.2980670559114652
THBS1,Myeloid Leukemia,0.2980670559114652
THBS1,Pancreatic Ductal Adenocarcinoma,0.3018974726133723
THBS1,Endometrial Carcinoma,0.3044782497745498
THBS1,Hemangioma,0.3099246715197673
THBS1,Sjogren's Syndrome,0.3099246715197673
THBS1,Glaucoma,0.3105909001629992
THBS1,Cervical Squamous Cell Carcinoma,0.3199171478489988
THBS1,Penis carcinoma,0.3220099003872086
THBS1,Mammary Ductal Carcinoma,0.3638414818541592
THBS1,Carcinoma of lung,0.3663130598151661
THBS1,Primary malignant neoplasm,0.383941725017158
THBS1,Endometriosis,0.383941725017158
THBS1,Thyroid Neoplasm,0.383941725017158
THBS1,Recurrent tumor,0.383941725017158
THBS1,Primary malignant neoplasm of lung,0.3902116649640871
THBS1,ST segment elevation myocardial infarction,0.3933196962529684
THBS1,Secondary malignant neoplasm of lymph node,0.3933196962529684
THBS1,Inflammation,0.3933196962529684
THBS1,Pancreatitis Chronic,0.3933196962529684
THBS1,Kidney Diseases,0.3933196962529684
THBS1,Nasopharyngeal carcinoma,0.3933196962529684
THBS1,Papillary thyroid carcinoma,0.3933196962529684
THBS1,Nephroblastoma,0.3933196962529684
THBS1,Schizophrenia,0.3933196962529684
THBS1,Malignant Glioma,0.3933196962529684
THBS1,Adrenocortical carcinoma,0.3933196962529684
THBS1,tumor vasculature,0.3933196962529684
THBS1,Chronic liver disease,0.3933196962529684
THBS1,Non-Small Cell Lung Carcinoma,0.3933196962529684
THBS1,Infection caused by Helicobacter pylori,0.3933196962529684
THBS1,Gastroesophageal reflux disease,0.3933196962529684
THBS1,HTLV-I Infections,0.3933196962529684
THBS1,Hypertensive disease,0.3933196962529684
THBS1,Lichen Sclerosus et Atrophicus,0.3933196962529684
THBS1,Skin Carcinogenesis,0.3933196962529684
THBS1,Bone Marrow Diseases,0.3933196962529684
THBS1,HIV Infections,0.3933196962529684
THBS1,Urothelial Carcinoma,0.3933196962529684
THBS1,Malformations of Cortical Development Group II,0.3933196962529684
THBS1,Astrocytoma,0.3933196962529684
THBS1,Lymphoma T-Cell Cutaneous,0.3933196962529684
THBS1,Hemangiosarcoma,0.3933196962529684
THBS1,Neonatal meningitis,0.3933196962529684
THBS1,Thrombocythemia Essential,0.3933196962529684
THBS1,Epiretinal Membrane,0.3933196962529684
THBS1,Primary Carcinoma,0.3933196962529684
THBS1,Stomach Neoplasms,0.3933196962529684
THBS1,Fibrosis Liver,0.3933196962529684
THBS1,Acute Promyelocytic Leukemia,0.3933196962529684
THBS1,Parkinson Disease,0.3933196962529684
THBS1,Coronary heart disease,0.3933196962529684
THBS1,Thrombotic thrombocytopenic purpura acquired,0.3933196962529684
THBS1,Direct Contact Transmission Infection,0.3933196962529684
THBS1,Penile Neoplasms,0.3933196962529684
THBS1,CARCINOMA OF VULVA,0.3933196962529684
THBS1,Aortic Aneurysm,0.3933196962529684
THBS1,Adenoma,0.3933196962529684
THBS1,Asthma,0.3933196962529684
THBS1,Focal glomerulosclerosis,0.3933196962529684
THBS1,Glioblastoma Multiforme,0.3933196962529684
THBS1,Carcinoma Pancreatic Ductal,0.3933196962529684
THBS1,Diabetic Nephropathy,0.3938591532700354
THBS1,keratoacanthoma,0.3941558617476422
THBS1,Aortic Aneurysm Abdominal,0.3941558617476422
THBS1,Dryness of eye,0.3941558617476422
THBS1,Schistosomiasis japonica,0.3941558617476422
THBS1,Quebec platelet disorder,0.3941558617476422
THBS1,Renal carcinoma,0.3941558617476422
THBS1,Thyroid carcinoma,0.3941558617476422
THBS1,Ischemia,0.3941558617476422
THBS1,Premature coronary artery disease,0.3941558617476422
THBS1,Endometrioma,0.3941558617476422
THBS1,Congenital Mesoblastic Nephroma,0.3941558617476422
THBS1,Cutaneous hypersensitivity,0.3941558617476422
THBS1,Fibrosis,0.3975960596292668
THBS1,Vulvar Lichen Sclerosus,0.3975960596292668
THBS1,Keratoconjunctivitis,0.4028066164685291
THBS1,Multiple Myeloma,0.4103119460235835
THBS1,Dry Eye Syndromes,0.4103119460235835
THBS1,Primary Myelofibrosis,0.4103119460235835
THBS1,Vascular occlusion,0.4103119460235835
THBS1,Retinoblastoma,0.4115056600660309
THBS1,Cerebrovascular accident,0.4115056600660309
THBS1,Budd-Chiari Syndrome,0.4115056600660309
THBS1,Congenital Thrombotic Thrombocytopenic Purpura,0.4115056600660309
THBS1,Hepatic Vein Thrombosis,0.4115056600660309
THBS1,Juvenile arthritis,0.4126392832024548
THBS1,Acquired Immunodeficiency Syndrome,0.4126392832024548
THBS1,Vascular Diseases,0.4126392832024548
THBS1,Congenital arteriovenous malformation,0.4186011760974318
THBS1,Hypertrophy of kidney,0.4192169590514327
THBS1,Parasitic infection,0.4192169590514327
THBS1,Immunologic Deficiency Syndromes,0.4213286052188015
THBS1,Congestive heart failure,0.425419812815905
THBS1,Papilloma,0.425992946703162
THBS1,Squamous cell carcinoma of skin,0.4297858918260954
THBS1,Heart failure,0.4304973629098372
THBS1,Sick Sinus Syndrome,0.4304973629098372
THBS1,Malignant neoplasm of thyroid,0.4307603335611732
THBS1,Adenocarcinoma of pancreas,0.4325044517055656
THBS1,Pulmonary Fibrosis,0.4335751357405352
THBS1,Carcinoid Tumor,0.4381343267935581
THBS1,Sicca Syndrome,0.4396723023384634
THBS1,Peripheral Vascular Diseases,0.4396723023384634
THBS1,Meningioma,0.4396723023384634
THBS1,Restenosis,0.4396723023384634
THBS1,Dyslipidemias,0.4421745246585178
THBS1,Hemorrhagic Fever with Renal Syndrome,0.4459714599189374
THBS1,Precancerous Conditions,0.4479115285676636
THBS1,Microangiopathy Diabetic,0.4506578937113162
THBS1,Helminthiasis,0.4506578937113162
THBS1,Human T-cell lymphotrophic virus type I [HTLV-I],0.4564472886428772
THBS1,Malignant neoplasm of penis,0.4564472886428772
THBS1,leukemia,0.4588513406515081
THBS1,Chronic gastritis,0.4615352570710579
THBS1,Adult T Acute Lymphoblastic Leukemia,0.4615352570710579
THBS1,Cardiovascular Diseases,0.4675904598629673
THBS1,Promyelocytic leukemia,0.4675904598629673
THBS1,Juvenile psoriatic arthritis,0.472444704048021
THBS1,Keratoconjunctivitis Sicca,0.4753011022966241
THBS1,Follicular thyroid carcinoma,0.4790179402069343
THBS1,Juvenile-Onset Still Disease,0.4810435657134442
THBS1,Kaposi Sarcoma,0.4851378030288289
THBS1,Impaired glucose tolerance,0.4900770016856776
THBS1,Hyperglycemia,0.4906258721078565
THBS1,Diarrhea,0.4923669467696064
THBS1,Polymyositis,0.4923669467696064
THBS1,Nephritis Interstitial,0.4923669467696064
THBS1,Echinococcosis,0.4923669467696064
THBS1,Renal interstitial fibrosis,0.4981941174985421
THBS1,Malignant neoplasm of vulva,0.4981941174985421
THBS1,Metastatic melanoma,0.5001612228394569
THBS1,Scleroderma,0.5019670090704682
THBS1,Arteriosclerosis,0.5019670090704682
THBS1,Coronary Arteriosclerosis,0.5140447474168605
THBS1,Carcinoma Lewis Lung,0.5140447474168605
THBS1,Obesity,0.5140447474168605
THBS1,Pelvic Organ Prolapse,0.5140447474168605
THBS1,Adenocarcinoma of lung (disorder),0.51550637274795
THBS1,Reperfusion Injury,0.5188223685230745
THBS1,Nephritis Tubulointerstitial,0.5188223685230745
THBS1,Skin lesion,0.5251317541886066
THBS1,Tropical Spastic Paraparesis,0.5251317541886066
THBS1,Synovitis,0.5252711504839724
THBS1,nervous system disorder,0.5276472086074249
THBS1,Dermatomyositis Childhood Type,0.5299466034567416
THBS1,Spinal Cord Diseases,0.5299466034567416
THBS1,Purpura Thrombotic Thrombocytopenic,0.5299466034567416
THBS1,Polycystic Ovary Syndrome,0.5337853752290136
THBS1,Aortic aneurysm without mention of rupture NOS,0.5359212109443033
THBS1,Atherosclerosis,0.5393787854381349
THBS1,Obesity Visceral,0.549941235475765
THBS1,Cervical Intraepithelial Neoplasia,0.5523521032803237
THBS1,Arthritis,0.553002957824355
THBS1,Systemic candidiasis,0.553002957824355
THBS1,Infiltrating Cervical Carcinoma,0.553002957824355
THBS1,Arthropathy,0.5557519470957561
THBS1,Peripheral Arterial Diseases,0.5557519470957561
THBS1,Colorectal cancer metastatic,0.5568517196017908
THBS1,Metabolic Syndrome X,0.5568517196017908
THBS1,Idiopathic pulmonary arterial hypertension,0.5655222348249326
THBS1,Tumors of Adrenal Cortex,0.5710095678317721
THBS1,Ureteral obstruction,0.589345563575654
THBS1,Sentinel node (disorder),0.6002127202571572
THBS1,Inclusion Body Myositis (disorder),0.6035970790768342
THBS1,Paraparesis Spastic,0.6084642888478995
THBS1,Herpes Simplex Infections,0.610971999959321
THBS1,Heart Diseases,0.610971999959321
THBS1,Cavernous Hemangioma of Brain,0.610971999959321
THBS1,Cystic Fibrosis,0.6124306570512981
THBS1,Tumor Angiogenesis,0.6218520979526325
THBS1,Inclusion Body Myopathy Sporadic,0.6222451141623291
THBS1,Immune System Diseases,0.6319938293757544
THBS1,Dementia,0.6364853529519863
THBS1,Diabetic Angiopathies,0.6403143122455015
THBS1,Inflammatory dermatosis,0.6447029562500783
THBS1,Keratitis,0.6588479076808555
THBS1,Angiogenic Switch,0.6627865715415371
THBS1,Fever,0.6677140893034832
THBS1,Leukemia T-Cell,0.6691893635307453
THBS1,polyps,0.6974821940437801
THBS1,Malaria Cerebral,0.6980473696540115
THBS1,Malignant Childhood Neoplasm,0.701831040553294
THBS1,Dermatitis,0.7045203904267408
THBS1,Inflammatory disorder,0.7075286941606513
THBS1,Meningitis,0.7129583530027284
THBS1,Coronary Artery Disease,0.7240930522443176
THBS1,Myelofibrosis,0.7317475852509061
THBS1,Retinitis Pigmentosa,0.7352133686428474
THBS1,Benign Prostatic Hyperplasia,0.7491018580851883
THBS1,Periodontitis,0.7867131318906807
THBS1,Malignant Pleural Mesothelioma,0.8209296131179464
THBS1,Cytomegalovirus Infections,0.8335660382047895
THBS1,Adult T-Cell Lymphoma/Leukemia,0.8367216325123092
THBS1,Metastatic Neoplasm,0.8757716428200738
THBS1,Hepatitis B,0.9169959402964138
THBS1,Presenile dementia,0.9212908525513646
THBS1,Overweight,0.9363897989363138
THBS1,Myopathy,0.9503327807211356
THBS1,Virus Diseases,0.9692165430561782
THBS1,Breast Carcinoma,0.0075861267486594
THBS1,Marfan Syndrome,0.0133304506157067
THBS1,Mammary Neoplasms,0.0155248163763686
THBS1,Breast Cancer,0.0402286636010764
THBS1,Schizophrenia,0.0531117779464085
THBS1,Liver Cirrhosis,0.4286813331685578
THBS1,Arthritis,0.4541466895915311
THBS1,Liver Fibrosis,0.4560460337187313
THBS1,Juvenile Arthritis,0.4646409362700993
THBS1,Polyarthritis Rheumatoid Factor Positive,0.4646409362700993
THBS1,Seronegative Polyarthritis,0.4875380732267193
THBS1,Cirrhosis,0.4875380732267193
THBS1,Diabetic Retinopathy,0.4875380732267193
THBS1,Diabetic Cardiomyopathy,0.4968320901822731
THBS1,Still Disease,0.504364324740411
THBS1,Nephritis,0.7662135194687344
THBS1,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049
THBS1,Auriculocondylar syndrome ORPHA:137888,0.00518481975049
THBS1,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.0083045131203191
THBS1,Chondrosarcoma ORPHA:55880,0.0083045131203191
THBS1,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
THBS1,Autosomal recessive brachyolmia ORPHA:448242,0.0180064224283883
THBS1,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.0180064224283883
THBS1,RIN2 syndrome ORPHA:217335,0.0180064224283883
THBS1,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.0180064224283883
THBS1,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.0180064224283883
THBS1,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.0180064224283883
THBS1,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763,0.0586579655822394
THBS1,Adenocarcinoma of ovary ORPHA:213504,0.1590470395003315
THBS1,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.1590470395003315
THBS1,Epithelial basement membrane dystrophy ORPHA:98956,0.1590470395003315
THBS1,Familial cavitary optic disc anomaly ORPHA:464760,0.1590470395003315
THBS1,Granular corneal dystrophy type I ORPHA:98962,0.1590470395003315
THBS1,Granular corneal dystrophy type II ORPHA:98963,0.1590470395003315
THBS1,Lattice corneal dystrophy type I ORPHA:98964,0.1590470395003315
THBS1,Reis-Bucklers corneal dystrophy ORPHA:98961,0.1590470395003315
THBS1,Thiel-Behnke corneal dystrophy ORPHA:98960,0.1590470395003315
THBS1,Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629,0.3762014630157917
THBS1,Fibrodysplasia ossificans progressiva ORPHA:337,0.3762014630157917
THBS1,Hajdu-Cheney syndrome ORPHA:955,0.3762014630157917
THBS1,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.3826134188846508
THBS1,Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853,0.6268296504510718
THBS1,Hemochromatosis type 5 ORPHA:447792,0.7068064785325423
THBS1,Norovirus Hu/Norwalk/10074/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/20047/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CBNU2/2007/KR capsid protein,0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10247/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH13/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10051/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10116/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10183/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10236/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH02/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH03/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH04/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH06/2006/TW major viral capsid protein,0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH07/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH09/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH12/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH17/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/SGU-110421/KOR/2011 VP1,0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH05/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH08/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/GZ2010-L26/Guangzhou/CHN/2010 major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII/Shanghai/SH2/2008/CHN VP1,0.6362779693488597
THBS1,Norovirus Hu/Shanghai/SH5/2009/CHN VP1,0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH14/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH15/2007/TW major viral capsid protein,0.6362779693488597
THBS1,Norovirus Hu/Norwalk/20123/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH10/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH22/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Miranda/NSW850K/2011/AU VP1,0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH18/2008/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH28/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Guangzhou/GZ2010-L88/CHN/2011 major viral capsid protein,0.6362779693488597
THBS1,Norovirus Hu/GII.4/Guangzhou/GZ2010-L91/CHN/2011 major viral capsid protein,0.6362779693488597
THBS1,Norovirus GII/Hu/JP/2010/GII.P4_GII.4/Shimada/ASC96 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC11.3/2013/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Human calicivirus Hu/NLV/GII/MD145-12/1987/US capsid protein,0.6362779693488597
THBS1,Lordsdale virus capsid protein (gene: orf2),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CUK-3/2008/KR capsid protein,0.6362779693488597
THBS1,Norovirus Hu/GII.4/CHDC3967/1988/US VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC28.4/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH11/2006/TW major viral capsid protein,0.6362779693488597
THBS1,Norovirus Hu/GII.4/20199/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC28.5/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/20033/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH20/2009/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Berowra/NSW767L/2012/AU VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/CHDC4108/1987/US VP1,0.6362779693488597
THBS1,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/108 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/109 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH23/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH26/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/GZ2010-L87/Guangzhou/CHN/2011 major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10368/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH21/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH24/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH25/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH27/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Caringbah/NSW409G/2011/AU VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/HS292/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC13/2011/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC18.1/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC27.1/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/New Orleans/2010/USA VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/Sydney/NSW0514/2012/AU VP1,0.6362779693488597
THBS1,Norovirus Hu/GII/20469/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII/BG1C0241-33/2011/BGD capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII/Seoul1282/KOR/2010 major capsid protein,0.6362779693488597
THBS1,Norovirus Hu/GII/Seoul1488/KOR/2011 major capsid protein,0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10325/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10386/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/1 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/2 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/3 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/5 VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII-4/CGMH16/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Doonside/NSW536I/2011/AU VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/Hong Kong/CUHK3630/2012/CHN VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/Jiangsu1/2011/CHN major capsid protein,0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC2.2/2010/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC2.3/2010/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC27.2/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10285/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10313/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/Norwalk/10378/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/HS288/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Hong Kong/CUHK6080/2012/CHN VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC17.1/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC17.5/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC17.6/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC17.8/2013/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC17.9/2013/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/NIHIC35/2013/USA capsid protein VP1 (gene: VP1),0.6362779693488597
THBS1,Norovirus Hu/GII.4/Ohio/684/USA VP1,0.6362779693488597
THBS1,Norovirus Hu/GII.4/Rockdale/NSW006D/2009/AU VP1,0.6362779693488597
TIMP2,Colorectal Carcinoma,0.0034602840073026
TIMP2,Mammary Neoplasms,0.0034602840073026
TIMP2,Ovarian Carcinoma,0.0034602840073026
TIMP2,Breast Carcinoma,0.0042545616049287
TIMP2,Invasive carcinoma of breast,0.0149002095788623
TIMP2,Epithelioma,0.0149002095788623
TIMP2,Colorectal Cancer,0.0149315928814189
TIMP2,Stomach Carcinoma,0.0149315928814189
TIMP2,Retroviridae Infections,0.0149315928814189
TIMP2,melanoma,0.0149315928814189
TIMP2,Adenocarcinoma,0.0155921563748247
TIMP2,Squamous cell carcinoma,0.0182265588252201
TIMP2,Esophageal Neoplasms,0.0182265588252201
TIMP2,Malignant mesothelioma,0.0182265588252201
TIMP2,ovarian neoplasm,0.0191435238361999
TIMP2,Malignant neoplasm of breast,0.0191435238361999
TIMP2,Fibrosarcoma,0.0191435238361999
TIMP2,Malignant neoplasm of stomach,0.0191435238361999
TIMP2,Carcinogenesis,0.0228075668512991
TIMP2,Malignant neoplasm of esophagus,0.0248454592431097
TIMP2,Malignant neoplasm of ovary,0.0277695594716545
TIMP2,Epithelial ovarian cancer,0.0387439397151409
TIMP2,Malignant neoplasm of prostate,0.0569142010728473
TIMP2,Central neuroblastoma,0.0593779966354549
TIMP2,Brain Neoplasms,0.064548079316548
TIMP2,Neoplasm Metastasis,0.0648809611869375
TIMP2,Renal Cell Carcinoma,0.0648809611869375
TIMP2,Neuroblastoma,0.0688152422187159
TIMP2,Malignant neoplasm of pancreas,0.0726340460169901
TIMP2,Pancreatic Neoplasm,0.0739788831250619
TIMP2,Glioma,0.0739788831250619
TIMP2,Degenerative polyarthritis,0.0739788831250619
TIMP2,Osteoporosis,0.0739788831250619
TIMP2,Lymphoma,0.0739788831250619
TIMP2,Glioblastoma,0.0745502070959292
TIMP2,Pancreatic carcinoma,0.0745502070959292
TIMP2,Liver Cirrhosis Experimental,0.0747863377072194
TIMP2,Liver Cirrhosis,0.0773771948186562
TIMP2,Prostate carcinoma,0.0773771948186562
TIMP2,Squamous cell carcinoma of the head and neck,0.0775520919998773
TIMP2,Colorectal Neoplasms,0.0827744840860166
TIMP2,Malignant neoplasm of urinary bladder,0.084286432100041
TIMP2,Bladder Neoplasm,0.0891725280554336
TIMP2,Liver carcinoma,0.095319386034013
TIMP2,Osteosarcoma,0.1029977559100099
TIMP2,Colon Carcinoma,0.1062239757831962
TIMP2,Ameloblastoma,0.1208020277850109
TIMP2,MYELODYSPLASTIC SYNDROME,0.1254380558571286
TIMP2,Esophageal carcinoma,0.1254380558571286
TIMP2,Cholestasis Extrahepatic,0.13167400689206
TIMP2,Carcinoma of bladder,0.13167400689206
TIMP2,Malignant neoplasm of endometrium,0.13167400689206
TIMP2,Hallopeau-Siemens Disease,0.13167400689206
TIMP2,Hypertension Portal,0.1328002618052838
TIMP2,Uterine Corpus Cancer,0.1328002618052838
TIMP2,Myocardial Infarction,0.1352936728187231
TIMP2,Colonic Neoplasms,0.1454373331146953
TIMP2,Mixed Salivary Gland Tumor,0.1454373331146953
TIMP2,Liver neoplasms,0.1454373331146953
TIMP2,Rheumatoid Arthritis,0.1537760235124317
TIMP2,Invasive Carcinoma,0.1602092191314262
TIMP2,Marfan Syndrome,0.1735868515093891
TIMP2,Intracranial Aneurysm,0.1735868515093891
TIMP2,stage ovarian epithelial cancer,0.1874735657311888
TIMP2,Systemic Scleroderma,0.1900258729042946
TIMP2,cervical cancer,0.2050045461627939
TIMP2,Desmoplastic,0.2085938372806741
TIMP2,Eosinophilic esophagitis,0.2085938372806741
TIMP2,Osteosarcoma of bone,0.2109483801368481
TIMP2,Malignant tumor of colon,0.223747154820789
TIMP2,Prostatic Neoplasms,0.223747154820789
TIMP2,Diabetes,0.2277108302018961
TIMP2,Hodgkin Disease,0.2454476567103779
TIMP2,Malignant Head and Neck Neoplasm,0.2522264785494494
TIMP2,B-Cell Lymphomas,0.2522264785494494
TIMP2,Diabetes Mellitus,0.2522264785494494
TIMP2,Malignant neoplasm of liver,0.2643145809900195
TIMP2,Malignant tumor of cervix,0.2714542429024338
TIMP2,Malignant neoplasm of lung,0.2714542429024338
TIMP2,Secondary malignant neoplasm of lung,0.2723545094624877
TIMP2,Cervix carcinoma,0.2834835531038365
TIMP2,Acute leukemia,0.2835142372342932
TIMP2,Multiple Sclerosis,0.2835142372342932
TIMP2,Fibroid Tumor,0.290158730291654
TIMP2,Conventional (Clear Cell) Renal Cell Carcinoma,0.2980670559114652
TIMP2,Endometrial Carcinoma,0.3044782497745498
TIMP2,Hemangioma,0.3099246715197673
TIMP2,Ehlers-Danlos Syndrome,0.3283839486480793
TIMP2,Ischemic stroke,0.3486533561309259
TIMP2,Carcinoma of lung,0.3663130598151661
TIMP2,Endometriosis,0.383941725017158
TIMP2,Uterine Fibroids,0.383941725017158
TIMP2,Primary malignant neoplasm of lung,0.3902116649640871
TIMP2,Secondary malignant neoplasm of lymph node,0.3933196962529684
TIMP2,Gallbladder Carcinoma,0.3933196962529684
TIMP2,Hernia Inguinal,0.3933196962529684
TIMP2,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
TIMP2,Laryngeal Squamous Cell Carcinoma,0.3933196962529684
TIMP2,Interstitial lung fibrosis,0.3933196962529684
TIMP2,Hereditary Nonpolyposis Colorectal Cancer,0.3933196962529684
TIMP2,Malignant Glioma,0.3933196962529684
TIMP2,tumor vasculature,0.3933196962529684
TIMP2,Non-Small Cell Lung Carcinoma,0.3933196962529684
TIMP2,Secondary malignant neoplasm of liver,0.3933196962529684
TIMP2,Bronchopulmonary Dysplasia,0.3933196962529684
TIMP2,Leukemia Myelocytic Acute,0.3933196962529684
TIMP2,Hemorrhage,0.3933196962529684
TIMP2,Valvular disease,0.3933196962529684
TIMP2,Bulla of lung,0.3933196962529684
TIMP2,HIV Infections,0.3933196962529684
TIMP2,Skin Neoplasms,0.3933196962529684
TIMP2,Astrocytoma,0.3933196962529684
TIMP2,Osteoarthritis of the hand,0.3933196962529684
TIMP2,Arthritis Psoriatic,0.3933196962529684
TIMP2,Alzheimer's Disease,0.3933196962529684
TIMP2,Microcalcification,0.3933196962529684
TIMP2,Lymphoma Non-Hodgkin,0.3933196962529684
TIMP2,Acute lymphocytic leukemia,0.3933196962529684
TIMP2,Stomach Neoplasms,0.3933196962529684
TIMP2,Inflammatory Bowel Diseases,0.3933196962529684
TIMP2,Fibrosis Liver,0.3933196962529684
TIMP2,Parkinson Disease,0.3933196962529684
TIMP2,Tumoral calcinosis,0.3933196962529684
TIMP2,Cardiac fibrosis,0.3933196962529684
TIMP2,Moyamoya disease 1,0.3933196962529684
TIMP2,Diabetic Nephropathy,0.3938591532700354
TIMP2,Dupuytren Contracture,0.3941558617476422
TIMP2,Rash and Dermatitis Adverse Event Associated with Chemoradiation,0.3941558617476422
TIMP2,Aortic Aneurysm Abdominal,0.3941558617476422
TIMP2,Atrial Fibrillation,0.3941558617476422
TIMP2,Tuberculosis Central Nervous System,0.3941558617476422
TIMP2,Calcinosis,0.3941558617476422
TIMP2,Moyamoya Disease,0.3941558617476422
TIMP2,Thyroid carcinoma,0.3941558617476422
TIMP2,Pituitary Adenoma,0.3941558617476422
TIMP2,Amyotrophic Lateral Sclerosis,0.3975960596292668
TIMP2,Abortion Tubal,0.3975960596292668
TIMP2,Dental Fluorosis Acquired,0.3975960596292668
TIMP2,Meningioma benign no ICD-O subtype,0.4028066164685291
TIMP2,Kidney Failure Acute,0.4028066164685291
TIMP2,Diverticulosis,0.4028066164685291
TIMP2,Occupational Diseases,0.4028066164685291
TIMP2,Gastric Adenocarcinoma,0.4028066164685291
TIMP2,Hepatosplenomegaly,0.4028066164685291
TIMP2,Multiple Myeloma,0.4103119460235835
TIMP2,Viral meningitis,0.4103119460235835
TIMP2,Atherosclerotic occlusive disease,0.4103119460235835
TIMP2,Cerebrovascular accident,0.4115056600660309
TIMP2,Ulcer,0.4115056600660309
TIMP2,PNEUMOTHORAX PRIMARY SPONTANEOUS,0.4115056600660309
TIMP2,Chronic ulcer,0.4115056600660309
TIMP2,Acute Coronary Syndrome,0.4118266358241932
TIMP2,Cleft palate with cleft lip,0.4186011760974318
TIMP2,Hypertensive heart disease,0.4213286052188015
TIMP2,Pleural Diseases,0.4213286052188015
TIMP2,Congestive heart failure,0.425419812815905
TIMP2,Endocarditis,0.425419812815905
TIMP2,Rectal Carcinoma,0.429029854971378
TIMP2,Heart failure,0.4304973629098372
TIMP2,Spontaneous abortion,0.4304973629098372
TIMP2,Corneal pannus,0.4304973629098372
TIMP2,Pregnancy associated hypertension,0.4304973629098372
TIMP2,Simple renal cyst,0.4335751357405352
TIMP2,Chronic venous insufficiency,0.4335751357405352
TIMP2,Meningioma,0.4396723023384634
TIMP2,Adiponectin Measurement,0.4506578937113162
TIMP2,Aneurysm,0.4561717689698902
TIMP2,Choriocarcinoma,0.4564472886428772
TIMP2,leukemia,0.4588513406515081
TIMP2,Pituitary carcinoma,0.4615352570710579
TIMP2,Chronic kidney disease stage 5,0.4704594475773637
TIMP2,Huntington Disease,0.4704594475773637
TIMP2,Periodontitis Juvenile,0.4714226702518064
TIMP2,Myeloid Leukemia Chronic,0.472444704048021
TIMP2,Tumor Expansion,0.472444704048021
TIMP2,Angiofibroma,0.4753011022966241
TIMP2,Tendinopathy,0.4790179402069343
TIMP2,Arteriovenous fistula,0.4790179402069343
TIMP2,Dental caries,0.4852430673532381
TIMP2,Aggressive periodontitis generalized,0.4852430673532381
TIMP2,M5b Acute differentiated monocytic leukemia,0.504136641473215
TIMP2,Chronic Obstructive Airway Disease,0.5049674142533507
TIMP2,Carcinoma Lewis Lung,0.5140447474168605
TIMP2,Severe myopia,0.5140447474168605
TIMP2,Meningitis Bacterial,0.5140447474168605
TIMP2,Adenocarcinoma of lung (disorder),0.51550637274795
TIMP2,Myopia,0.5239792328442205
TIMP2,Kidney Failure Chronic,0.5299466034567416
TIMP2,Endometriosis of uterus,0.5453394612016188
TIMP2,Malignant neoplasm of gallbladder,0.5496357724684553
TIMP2,Arthritis,0.553002957824355
TIMP2,Acute periodontitis,0.553002957824355
TIMP2,Post MI,0.5568517196017908
TIMP2,Caries (morphologic abnormality),0.5956632182199403
TIMP2,Herpes Simplex Infections,0.610971999959321
TIMP2,Hepatitis B Chronic,0.6150955455771212
TIMP2,Pre-Eclampsia,0.6222451141623291
TIMP2,Autosomal dominant retinitis pigmentosa,0.625027955184583
TIMP2,Diaphragmatic Hernia,0.625027955184583
TIMP2,Nephronophthisis,0.625027955184583
TIMP2,Mucocutaneous Lymph Node Syndrome,0.6294837700416086
TIMP2,Immune System Diseases,0.6319938293757544
TIMP2,Sepsis,0.6395767498329145
TIMP2,Pterygium,0.6496433426951205
TIMP2,Pleural Effusion Malignant,0.672336954961104
TIMP2,Acute monocytic leukemia,0.672336954961104
TIMP2,Cardiomyopathies,0.6989462176022242
TIMP2,Muscular Dystrophy Duchenne,0.7045203904267408
TIMP2,Myocardial Diseases Secondary,0.7068844070911514
TIMP2,Cardiomyopathies Primary,0.7156410971578294
TIMP2,Renal cyst,0.7240930522443176
TIMP2,Left Ventricular Hypertrophy,0.7294281406818208
TIMP2,Retinitis Pigmentosa,0.7352133686428474
TIMP2,Neuromuscular Diseases,0.7412504828119304
TIMP2,Pulmonary Emphysema,0.7674304683279349
TIMP2,Diabetes Mellitus Experimental,0.7683326132740758
TIMP2,Streptozotocin Diabetes,0.7683326132740758
TIMP2,Alloxan Diabetes,0.7683326132740758
TIMP2,Periodontitis,0.7867131318906807
TIMP2,Chronic Periodontitis,0.8369292123296695
TIMP2,Hypertrophic Cardiomyopathy,0.89450044231149
TIMP2,Tumoral Calcinosis,0.2954316182315451
TIMP2,Cholestasis,0.336287627428424
TIMP2,Pleural Diseases,0.4560460337187313
TIMP2,Miscarriage,0.4560460337187313
TIMP2,Diverticular Diseases,0.4560460337187313
TIMP2,Dupuytren Contracture,0.4646409362700993
TIMP2,Bladder Neoplasm,0.4723647227028846
TIMP2,Urinary Bladder Cancer,0.4875380732267193
TIMP2,Myocardial Infarction,0.5632819212593052
TIMP2,Eosinophilia,0.7049836926927165
TIMP2,Respiratory Tract Diseases,0.7233086714572886
TIMP2,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613
TIMP2,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.0180064224283883
TIMP2,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.0180064224283883
TIMP2,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.0180064224283883
TIMP2,Familial multiple nevi flammei ORPHA:624,0.0180064224283883
TIMP2,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.0180064224283883
TIMP2,RIN2 syndrome ORPHA:217335,0.0180064224283883
TIMP2,Sturge-Weber syndrome ORPHA:3205,0.0180064224283883
TIMP2,19p13.3 microduplication syndrome ORPHA:447980,0.0586579655822394
TIMP2,AGel amyloidosis ORPHA:85448,0.0586579655822394
TIMP2,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763,0.0586579655822394
TIMP2,Keratolytic winter erythema ORPHA:50943,0.0586579655822394
TIMP2,Malan overgrowth syndrome ORPHA:420179,0.0586579655822394
TIMP2,Marshall-Smith syndrome ORPHA:561,0.0586579655822394
TIMP2,Epithelial basement membrane dystrophy ORPHA:98956,0.1590470395003315
TIMP2,Familial retinal arterial macroaneurysm ORPHA:284247,0.1590470395003315
TIMP2,Granular corneal dystrophy type I ORPHA:98962,0.1590470395003315
TIMP2,Granular corneal dystrophy type II ORPHA:98963,0.1590470395003315
TIMP2,Lattice corneal dystrophy type I ORPHA:98964,0.1590470395003315
TIMP2,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.1590470395003315
TIMP2,Pycnodysostosis ORPHA:763,0.1590470395003315
TIMP2,Reis-Bucklers corneal dystrophy ORPHA:98961,0.1590470395003315
TIMP2,Sanfilippo syndrome type D ORPHA:79272,0.1590470395003315
TIMP2,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.1590470395003315
TIMP2,Thiel-Behnke corneal dystrophy ORPHA:98960,0.1590470395003315
TIMP2,Shprintzen-Goldberg syndrome ORPHA:2462,0.1590470395003315
TIMP2,ACys amyloidosis ORPHA:100008,0.3762014630157917
TIMP2,Action myoclonus-renal failure syndrome ORPHA:163696,0.3762014630157917
TIMP2,Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629,0.3762014630157917
TIMP2,Fibrodysplasia ossificans progressiva ORPHA:337,0.3762014630157917
TIMP2,Hajdu-Cheney syndrome ORPHA:955,0.3762014630157917
TIMP2,LIMS2-related limb-girdle muscular dystrophy ORPHA:466801,0.3762014630157917
TIMP2,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.3762014630157917
TIMP2,Gaucher disease type 1 ORPHA:77259,0.3762014630157917
TIMP2,Truncus arteriosus ORPHA:3384,0.3762014630157917
TIMP2,Keratosis follicularis spinulosa decalvans ORPHA:2340,0.3762014630157917
TIMP2,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120,0.6239678957896782
TIMP2,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.6239678957896782
TIMP2,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.6239678957896782
TIMP2,Lethal osteosclerotic bone dysplasia ORPHA:1832,0.6239678957896782
TIMP2,Myosclerosis ORPHA:289380,0.6239678957896782
TIMP2,Sanfilippo syndrome type C ORPHA:79271,0.6239678957896782
TIMP2,Tangier disease ORPHA:31150,0.6239678957896782
TIMP2,Roussy-Levy syndrome ORPHA:3115,0.6239678957896782
TIMP2,Dejerine-Sottas syndrome ORPHA:64748,0.6268296504510718
TIMP2,Atrophoderma vermiculata ORPHA:79100,0.7068064785325423
TLR6,Malignant neoplasm of prostate,0.0569142010728473
TLR6,Malignant neoplasm of pancreas,0.0726340460169901
TLR6,Pancreatic carcinoma,0.0745502070959292
TLR6,Prostate carcinoma,0.0773771948186562
TLR6,MYELODYSPLASTIC SYNDROME,0.1254380558571286
TLR6,Prostatic Neoplasms,0.223747154820789
TLR6,Anoxia,0.2462384927636234
TLR6,Chondrosarcoma,0.2643145809900195
TLR6,Childhood Acute Lymphoblastic Leukemia,0.3099246715197673
TLR6,Acute pancreatitis,0.3220099003872086
TLR6,Tuberculosis,0.3706856725676674
TLR6,Tuberculosis Pulmonary,0.383941725017158
TLR6,Bipolar Disorder,0.3933196962529684
TLR6,Inflammation,0.3933196962529684
TLR6,Papillary thyroid carcinoma,0.3933196962529684
TLR6,Hypertensive disease,0.3933196962529684
TLR6,Bronchopulmonary Dysplasia,0.3933196962529684
TLR6,Endometritis,0.3933196962529684
TLR6,Proctitis,0.3933196962529684
TLR6,DOSAGE-SENSITIVE SEX REVERSAL,0.3933196962529684
TLR6,Lymphoma Non-Hodgkin,0.3933196962529684
TLR6,Inflammatory Bowel Diseases,0.3933196962529684
TLR6,Asthma,0.3933196962529684
TLR6,Allergic sensitization,0.3941558617476422
TLR6,Aspergillosis,0.4115056600660309
TLR6,Necrotizing Enterocolitis,0.4118266358241932
TLR6,Parasitemia,0.4192169590514327
TLR6,Lupus Erythematosus Systemic,0.4213286052188015
TLR6,Mycoses,0.425419812815905
TLR6,Infant Premature,0.4304973629098372
TLR6,Marginal Zone B-Cell Lymphoma,0.4304973629098372
TLR6,Psoriasis,0.4304973629098372
TLR6,Lupus Vulgaris,0.4335751357405352
TLR6,Syphilis,0.4335751357405352
TLR6,Asthma chronic,0.4335751357405352
TLR6,Lupus Erythematosus,0.4615352570710579
TLR6,Lupus Erythematosus Discoid,0.4675904598629673
TLR6,Dejerine-Sottas Disease (disorder),0.4753011022966241
TLR6,Invasive aspergillosis,0.4852430673532381
TLR6,Graves Disease,0.4981941174985421
TLR6,Infective endocarditis,0.4981941174985421
TLR6,Ulcerative Colitis,0.5001612228394569
TLR6,Bacterial Endocarditis,0.5140447474168605
TLR6,Pelvic Inflammatory Disease,0.5188223685230745
TLR6,Pneumonia Bacterial,0.5299466034567416
TLR6,Colitis,0.5323590634832615
TLR6,Bacterial Infections,0.5337853752290136
TLR6,Malaria,0.5655222348249326
TLR6,NONAKA MYOPATHY,0.5710095678317721
TLR6,Infection,0.5959654688257199
TLR6,Non-alcoholic Fatty Liver Disease,0.625027955184583
TLR6,Dermatitis Atopic,0.7045203904267408
TLR6,Allergic asthma,0.717484976234209
TLR6,Mycobacterium Infections,0.7317475852509061
TLR6,Eczema,0.7893058450619891
TLR6,Hypersensitivity,0.8891038160665995
TLR6,Pneumonia,0.924303335582991
TLR6,Prostatic Neoplasms,0.4875380732267193
TLR6,Asthma,0.504364324740411
TLR6,Prostate Cancer,0.6104715460837368
TLR6,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.1590470395003315
TLR6,Generalized glucocorticoid resistance syndrome ORPHA:786,0.1590470395003315
TLR6,Combined immunodeficiency due to Moesin deficiency ORPHA:504530,0.3762014630157917
TLR6,Haim-Munk syndrome ORPHA:2342,0.3762014630157917
TLR6,Hydranencephaly ORPHA:2177,0.3762014630157917
TLR6,NDE1-related microhydranencephaly ORPHA:443162,0.3762014630157917
TLR6,Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634,0.3762014630157917
TLR6,Papillon-Lefevre ORPHA:678,0.3762014630157917
TLR6,Dehydrated hereditary stomatocytosis ORPHA:3202,0.3762014630157917
TLR6,Herpes simplex virus encephalitis ORPHA:1930,0.3826134188846508
TLR6,Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517,0.6239678957896782
TLR6,Cleidocranial dysplasia ORPHA:1452,0.6239678957896782
TLR6,Familial normophosphatemic tumoral calcinosis ORPHA:306658,0.6239678957896782
TLR6,Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366,0.6239678957896782
TLR6,MIRAGE syndrome ORPHA:494433,0.6239678957896782
TLR6,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.6239678957896782
TLR6,Loeys-Dietz syndrome ORPHA:60030,0.6239678957896782
TLR6,Squamous cell carcinoma of salivary glands ORPHA:500481,0.6239678957896782
TLR6,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.6239678957896782
TLR6,Squamous cell carcinoma of the larynx ORPHA:494550,0.6239678957896782
TLR6,Squamous cell carcinoma of the lip ORPHA:502366,0.6239678957896782
TLR6,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.6239678957896782
TLR6,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.6239678957896782
TLR6,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.6239678957896782
TLR6,Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635,0.7068064785325423
TLR6,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787,0.7068064785325423
TLR6,Aggressive systemic mastocytosis ORPHA:98850,0.7068064785325423
TLR6,Essential thrombocythemia ORPHA:3318,0.7068064785325423
TMSB15A,Malignant neoplasm of prostate,0.0569142010728473
TMSB15A,Central neuroblastoma,0.0593779966354549
TMSB15A,Neoplasm Metastasis,0.0648809611869375
TMSB15A,Neuroblastoma,0.0688152422187159
TMSB15A,Prostate carcinoma,0.0773771948186562
TMSB15A,Lung Neoplasms,0.2062010908869036
TMSB15A,Prostatic Neoplasms,0.223747154820789
TMSB15A,Triple Negative Breast Neoplasms,0.2980670559114652
TMSB15A,Tuberculosis,0.3706856725676674
TMSB15A,HIV Infections,0.3933196962529684
TMSB15A,Combined pituitary hormone deficiencies genetic forms ORPHA:95494,0.0683063362547733
TMSB15A,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542,0.1590470395003315
TMSB15A,Neuroblastoma ORPHA:635,0.3969770464111636
TMSB15A,Semilobar holoprosencephaly ORPHA:220386,0.4470672161388242
TMSB15A,Coralliform cataract ORPHA:98990,0.6239678957896782
TMSB15A,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome ORPHA:397623,0.6239678957896782
TMSB15A,Syndromic microphthalmia type 5 ORPHA:178364,0.6239678957896782
TMSB15A,Atrial standstill ORPHA:1344,0.6239678957896782
TMSB15A,Encephalocraniocutaneous lipomatosis ORPHA:2396,0.6239678957896782
TMSB15A,Hereditary retinoblastoma ORPHA:357027,0.6239678957896782
TMSB15A,Non-hereditary retinoblastoma ORPHA:357034,0.6239678957896782
TMSB15A,Cerulean cataract ORPHA:98989,0.6268296504510718
TMSB15A,Achondrogenesis type 2 ORPHA:93296,0.7068064785325423
TMSB15A,Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867,0.7068064785325423
TMSB15A,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome ORPHA:435930,0.7068064785325423
TMSB15A,Dysspondyloenchondromatosis ORPHA:85198,0.7068064785325423
TMSB15A,Feingold syndrome type 1 ORPHA:391641,0.7068064785325423
TMSB15A,Hypochondrogenesis ORPHA:93297,0.7068064785325423
TMSB15A,Intellectual disability-developmental delay-contractures syndrome ORPHA:3454,0.7068064785325423
TMSB15A,Kniest dysplasia ORPHA:485,0.7068064785325423
TMSB15A,Legg-Calve-Perthes disease ORPHA:2380,0.7068064785325423
TMSB15A,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279,0.7068064785325423
TMSB15A,Multiple epiphyseal dysplasia Beighton type ORPHA:166011,0.7068064785325423
TMSB15A,Platyspondylic dysplasia Torrance type ORPHA:85166,0.7068064785325423
TMSB15A,Spondyloepimetaphyseal dysplasia congenita Strudwick type ORPHA:93346,0.7068064785325423
TMSB15A,Spondyloepiphyseal dysplasia congenita ORPHA:94068,0.7068064785325423
TMSB15A,Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678,0.7068064785325423
TMSB15A,Spondyloepiphyseal dysplasia Stanescu type ORPHA:459051,0.7068064785325423
TMSB15A,Spondylometaphyseal dysplasia Schmidt type ORPHA:93316,0.7068064785325423
TMSB15A,Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856,0.7068064785325423
TMSB15A,Stickler syndrome type 1 ORPHA:90653,0.7068064785325423
TMSB15A,X-linked congenital generalized hypertrichosis ORPHA:79495,0.7068064785325423
TMSB15A,X-linked intellectual disability with isolated growth hormone deficiency ORPHA:67045,0.7068064785325423
TMSB15A,Multiple benign circumferential skin creases on limbs ORPHA:2505,0.7068064785325423
TMSB15A,Isolated microphthalmia-anophthalmia-coloboma ORPHA:2542,0.7068064785325423
TMSB15A,Familial congenital mirror movements ORPHA:238722,0.7068064785325423
TNFSF9,Colorectal Carcinoma,0.0034602840073026
TNFSF9,Ovarian Carcinoma,0.0034602840073026
TNFSF9,Colorectal Cancer,0.0149315928814189
TNFSF9,Adenocarcinoma,0.0155921563748247
TNFSF9,Malignant neoplasm of stomach,0.0191435238361999
TNFSF9,Epithelial ovarian cancer,0.0387439397151409
TNFSF9,Malignant neoplasm of prostate,0.0569142010728473
TNFSF9,Central neuroblastoma,0.0593779966354549
TNFSF9,Neuroblastoma,0.0688152422187159
TNFSF9,Lymphoma,0.0739788831250619
TNFSF9,Prostate carcinoma,0.0773771948186562
TNFSF9,Colorectal Neoplasms,0.0827744840860166
TNFSF9,Liver carcinoma,0.095319386034013
TNFSF9,Malignant Neoplasms,0.0991201145654548
TNFSF9,Colon Carcinoma,0.1062239757831962
TNFSF9,Chronic Lymphocytic Leukemia,0.1147307578771389
TNFSF9,Rheumatoid Arthritis,0.1537760235124317
TNFSF9,cervical cancer,0.2050045461627939
TNFSF9,Malignant tumor of colon,0.223747154820789
TNFSF9,Burkitt Lymphoma,0.2521987644415915
TNFSF9,B-Cell Lymphomas,0.2522264785494494
TNFSF9,Malignant tumor of cervix,0.2714542429024338
TNFSF9,Cervix carcinoma,0.2834835531038365
TNFSF9,Multiple Sclerosis,0.2835142372342932
TNFSF9,Primary malignant neoplasm,0.383941725017158
TNFSF9,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.383941725017158
TNFSF9,Leukemia Myelocytic Acute,0.3933196962529684
TNFSF9,HIV Infections,0.3933196962529684
TNFSF9,Mycobacterium avium infection,0.3933196962529684
TNFSF9,Stomach Neoplasms,0.3933196962529684
TNFSF9,Lymphocytic infiltration,0.3941558617476422
TNFSF9,Mycobacterium avium-intracellulare Infection,0.4192169590514327
TNFSF9,Stromal Neoplasm,0.4213286052188015
TNFSF9,Contact hypersensitivity,0.425419812815905
TNFSF9,Contact Dermatitis,0.4615352570710579
TNFSF9,Primary biliary cirrhosis,0.4923669467696064
TNFSF9,Crohn Disease,0.4981941174985421
TNFSF9,Arteriosclerosis,0.5019670090704682
TNFSF9,Takayasu Arteritis,0.5188223685230745
TNFSF9,Atherosclerosis,0.5393787854381349
TNFSF9,Autoimmune Diseases,0.5512224939896888
TNFSF9,Single tumor,0.553002957824355
TNFSF9,Hereditary Diffuse Gastric Cancer,0.5696906826730043
TNFSF9,Influenza,0.7149953523738256
TNFSF9,IMMUNE SUPPRESSION,0.726789939981526
TNFSF9,Tumor Immunity,0.8148412516612868
TNFSF9,Dermatitis,0.525214105372123
TNFSF9,Gastric Cancer,0.6524705037929849
TNFSF9,Stomach Neoplasms,0.669817442578862
TNFSF9,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.1590470395003315
TNFSF9,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.3762014630157917
TNFSF9,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.3762014630157917
TNFSF9,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.3762014630157917
TNFSF9,Melanoma and neural system tumor syndrome ORPHA:252206,0.3762014630157917
TNFSF9,Crisponi syndrome ORPHA:1545,0.7068064785325423
TOMM22,Adenylosuccinate lyase deficiency ORPHA:46,0.6239678957896782
TOMM22,Combined oxidative phosphorylation defect type 2 ORPHA:254920,0.6239678957896782
TOMM22,Congenital generalized hypercontractile muscle stiffness syndrome ORPHA:476406,0.6239678957896782
TOMM22,Mohr-Tranebjaerg syndrome ORPHA:52368,0.6239678957896782
TOMM22,Multiple system atrophy cerebellar type ORPHA:227510,0.6239678957896782
TOMM22,Multiple system atrophy parkinsonian type ORPHA:98933,0.6239678957896782
TOMM22,Adult-onset autosomal recessive sideroblastic anemia ORPHA:255132,0.7068064785325423
TOMM22,Ataxia-oculomotor apraxia type 1 ORPHA:1168,0.7068064785325423
TOMM22,Autosomal recessive axonal neuropathy with neuromyotonia ORPHA:324442,0.7068064785325423
TOMM22,Autosomal recessive intermediate Charcot-Marie-Tooth disease type B ORPHA:254334,0.7068064785325423
TOMM22,Autosomal recessive optic atrophy OPA7 type ORPHA:227976,0.7068064785325423
TOMM22,Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency ORPHA:423384,0.7068064785325423
TOMM22,Bowen-Conradi syndrome ORPHA:1270,0.7068064785325423
TOMM22,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy ORPHA:495844,0.7068064785325423
TOMM22,Cernunnos-XLF deficiency ORPHA:169079,0.7068064785325423
TOMM22,Childhood-onset spasticity with hyperglycinemia ORPHA:401866,0.7068064785325423
TOMM22,Combined oxidative phosphorylation defect type 30 ORPHA:478042,0.7068064785325423
TOMM22,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 ORPHA:168566,0.7068064785325423
TOMM22,Friedreich ataxia ORPHA:95,0.7068064785325423
TOMM22,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome ORPHA:391348,0.7068064785325423
TOMM22,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency ORPHA:352563,0.7068064785325423
TOMM22,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome ORPHA:281201,0.7068064785325423
TOMM22,Lenz-Majewski hyperostotic dwarfism ORPHA:2658,0.7068064785325423
TOMM22,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders ORPHA:505248,0.7068064785325423
TOMM22,Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality ORPHA:86841,0.7068064785325423
TOMM22,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome ORPHA:306558,0.7068064785325423
TOMM22,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome ORPHA:488627,0.7068064785325423
TOMM22,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect ORPHA:457223,0.7068064785325423
TOMM22,TMEM70-related mitochondrial encephalo-cardio-myopathy ORPHA:1194,0.7068064785325423
TOMM22,Thrombocytopenia-absent radius syndrome ORPHA:3320,0.7068064785325423
TOMM22,Leigh syndrome with nephrotic syndrome ORPHA:255249,0.7068064785325423
TOMM22,Microphthalmia with linear skin defects syndrome ORPHA:2556,0.7068064785325423
TOMM22,Fatal infantile cytochrome C oxidase deficiency ORPHA:1561,0.7068064785325423
TOMM22,Trichothiodystrophy ORPHA:33364,0.7072638369101406
TOMM22,Isolated complex III deficiency ORPHA:1460,0.7120423847116372
TPM4,Invasive Ductal Breast Carcinoma,0.0149002095788623
TPM4,Esophageal Neoplasms,0.0182265588252201
TPM4,Malignant neoplasm of breast,0.0191435238361999
TPM4,Malignant neoplasm of esophagus,0.0248454592431097
TPM4,Neoplasm Metastasis,0.0648809611869375
TPM4,Osteoporosis,0.0739788831250619
TPM4,Liver Cirrhosis Experimental,0.0747863377072194
TPM4,Hematologic Neoplasms,0.1253114324938153
TPM4,Sarcoma,0.1537760235124317
TPM4,Post-Traumatic Osteoporosis,0.3233418869346274
TPM4,Osteoporosis Senile,0.3544355608905275
TPM4,Inflammatory Myofibroblastic Tumor,0.3933196962529684
TPM4,Osteoporosis Age-Related,0.3933196962529684
TPM4,Autosomal dominant macrothrombocytopenia,0.3933196962529684
TPM4,Weight Gain,0.3975960596292668
TPM4,Dengue Fever,0.4028066164685291
TPM4,Severe Dengue,0.4028066164685291
TPM4,Platelet distribution width measurement,0.4115056600660309
TPM4,Platelet distribution width result,0.4115056600660309
TPM4,Pulmonary Fibrosis - from Asbestos Exposure,0.4115056600660309
TPM4,Acute Coronary Syndrome,0.4118266358241932
TPM4,Triglycerides measurement,0.4192169590514327
TPM4,Precancerous Conditions,0.4479115285676636
TPM4,Asbestosis,0.4753011022966241
TPM4,Macrothrombocytopenia,0.4753011022966241
TPM4,Platelet mean volume determination (procedure),0.4981941174985421
TPM4,Condition Preneoplastic,0.533913711453195
TPM4,Platelet Count measurement,0.7061487180640408
TPM4,Esophagus Neoplasm,0.0102679590519094
TPM4,Breast Cancer,0.0402286636010764
TPM4,Platelet-type Bleeding Disorder,0.3940072377207739
TPM4,Inflammatory Myofibroblastic Tumor,0.4286813331685578
TPM4,Osteoporosis,0.4541466895915311
TPM4,Coronary Syndrome,0.4560460337187313
TPM4,Asbestosis,0.4560460337187313
TPM4,Macrothrombocytopenia,0.4560460337187313
TPM4,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
TPM4,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.0180064224283883
TPM4,MYH9-related disease ORPHA:182050,0.6239678957896782
TPM4,Quebec platelet disorder ORPHA:220436,0.6239678957896782
TPM4,TMEM165-CDG ORPHA:314667,0.6239678957896782
TPM4,Temtamy preaxial brachydactyly syndrome ORPHA:363417,0.6239678957896782
TPM4,Cap myopathy ORPHA:171881,0.6239678957896782
TPM4,Frontometaphyseal dysplasia ORPHA:1826,0.6239678957896782
TPM4,Skeletal Ewing sarcoma ORPHA:319,0.6279395134845649
TPM4,Gorlin-Chaudhry-Moss syndrome ORPHA:2095,0.7068064785325423
TPM4,Progeroid syndrome Petty type ORPHA:2963,0.7068064785325423
TPM4,Scott syndrome ORPHA:806,0.7068064785325423
TPM4,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.7068064785325423
TPM4,Autosomal dominant macrothrombocytopenia ORPHA:140957,0.7068064785325423
TPM4,Inflammatory myofibroblastic tumor ORPHA:178342,0.7068064785325423
TPM4,Cercopithecine betaherpesvirus 5 helicase-primase helicase subunit (gene: UL105),0.6362779693488597
TPM4,Yaba monkey tumor virus anti-apoptotic membrane protein,0.6362779693488597
TPM4,Monkeypox virus Zaire-96-I-16 Hypothetical protein (gene: C7L),0.6362779693488597
TPM4,Vaccinia virus Ankara apoptosis inhibitor,0.6362779693488597
TPM4,Reston ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TPM4,Ebola virus - Mayinga Zaire 1976 virion spike glycoprotein precursor (gene: GP),0.6362779693488597
TPM4,Zaire ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TPM4,Sudan ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TPM4,Sudan ebolavirus - Nakisamata structural glycoprotein (gene: GP),0.6362779693488597
TPM4,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TPM4,Influenza A virus (A/Hong Kong/1073/99(H9N2)) Hemagglutinin (gene: ha),0.6362779693488597
TPM4,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) HA2 (gene: HA),0.6362779693488597
TPM4,Ectromelia virus ERPV hydroxysteroid dehydrogenase,0.6362779693488597
TPM4,Influenza A virus (A/Korea/426/1968(H2N2)) HA2 (gene: HA),0.6362779693488597
TPM4,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) HA1 (gene: HA),0.6362779693488597
TPM4,Influenza A virus (A/California/07/2009(H1N1)) HA1 (gene: HA),0.6362779693488597
TPM4,Influenza A virus (A/Shanghai/02/2013(H7N9)) HA2 (gene: HA),0.6362779693488597
TPM4,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) hemagglutinin (gene: HA),0.6362779693488597
TPM4,Monkeypox virus unknown protein,0.6362779693488597
TPM4,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) HA1 (gene: HA),0.6362779693488597
TPM4,SARS coronavirus nsp8-pp1a/pp1ab (gene: orf1ab),0.6362779693488597
TPM4,Monkeypox virus cowpox A-type inclusion protein,0.6362779693488597
TPM4,Influenza A virus (A/Northern Territory/60/1968(H3N2)) HA2 (gene: HA),0.6362779693488597
TPM4,Influenza A virus (A/Shanghai/02/2013(H7N9)) hemagglutinin (gene: HA),0.6362779693488597
TPM4,Lake Victoria marburgvirus - Leiden glycoprotein (gene: GP),0.6386053036162835
TPM4,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) HA2 (gene: HA),0.6430308263654244
TPM4,Marburg virus - Musoke Kenya 1980 glycoprotein (gene: GP),0.6481498905276316
TPM4,Influenza A virus (A/California/04/2009(H1N1)) hemagglutinin (gene: HA),0.6481498905276316
TPM4,Influenza A virus (A/California/07/2009(H1N1)) hemagglutinin (gene: HA),0.6481498905276316
TPM4,Vaccinia virus Ankara double-stranded RNA binding protein,0.664689610422691
TPM4,Marburg marburgvirus glycoprotein (gene: GP),0.6761714078632568
TPM4,Influenza A virus (A/Korea/426/1968(H2N2)) hemagglutinin (gene: HA),0.6761714078632568
TPM4,Variola virus hypothetical protein (gene: A28L),0.6806291584193672
TPM4,Influenza A virus (A/New York/599/1996(H3N2)) hemagglutinin (gene: HA),0.691145768348025
TPM4,Influenza A virus (A/New York/392/2004(H3N2)) hemagglutinin (gene: HA),0.6980058392556946
TPM4,Influenza A virus (A/New York/602/1996(H3N2)) hemagglutinin (gene: HA),0.7054555693277184
TPM4,Influenza A virus (A/New York/599/1996(H3N2)) HA2 (gene: HA),0.7079503198328393
TPM4,Influenza A virus (A/New York/602/1996(H3N2)) HA2 (gene: HA),0.7079503198328393
TPM4,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) haemagglutinin (gene: HA),0.7108466056279036
TPM4,Influenza A virus (A/New York/392/2004(H3N2)) HA2 (gene: HA),0.7187273231330169
TPM4,Influenza A virus (A/Northern Territory/60/1968(H3N2)) hemagglutinin (gene: HA),0.7225463502962445
TPM4,Lake Victoria marburgvirus - DRC1999 glycoprotein (gene: GP),0.7398997088314572
TPM4,SARS coronavirus excised_polyprotein 1..4369 (gene: orf1ab),0.7568193074461791
TPM4,Influenza B virus (B/Memphis/12/97) HA protein,0.7648879200949484
TPM4,SARS coronavirus P2 full_polyprotein 1..4382,0.7651942752688915
TPM4,Ravn virus - Ravn Kenya 1987 glycoprotein (gene: GP),0.7665923583742081
TPM4,Cowpox virus Ati or CPXV158 protein (gene: ati),0.776311155917498
TPM4,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.776311155917498
TPM4,Lake Victoria marburgvirus - Angola2005 glycoprotein (gene: GP),0.7954342107380572
TPM4,Human immunodeficiency virus pol protein (gene: pol),0.8400145987535752
TPM4,Bundibugyo ebolavirus spike glycoprotein (gene: GP),0.8458935424065495
TPM4,Rotavirus A NSP4,0.8507994162096807
TPM4,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.853754994225345
TPM4,Vaccinia virus cowpox A-type inclusion protein,0.8834254233868516
TPM4,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8919745352546131
TPM4,Influenza A virus (A/California/04/2009(H1N1)) HA2 (gene: HA),0.9285312497152513
TPM4,Influenza A virus (A/California/07/2009(H1N1)) HA2 (gene: HA),0.9285312497152513
TPM4,Nipah henipavirus P phosphoprotein,0.9511894303546532
TPM4,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.985687915361386
TRAK2,Breast Carcinoma,0.0042545616049287
TRAK2,Liver Cirrhosis Experimental,0.0747863377072194
TRAK2,Breast Carcinoma,0.0075861267486594
TRAK2,Recessive X-linked ichthyosis ORPHA:461,0.0586579655822394
TRAK2,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.0586579655822394
TRAK2,Acrodysostosis ORPHA:950,0.3762014630157917
TRAK2,Acrodysostosis with multiple hormone resistance ORPHA:280651,0.3762014630157917
TRAK2,X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328,0.3762014630157917
TRAK2,Carney complex ORPHA:1359,0.7068064785325423
TRAK2,Familial atrial myxoma ORPHA:615,0.7068064785325423
TRAK2,Oculocerebrofacial syndrome Kaufman type ORPHA:2707,0.7068064785325423
TRIB3,Colorectal Carcinoma,0.0034602840073026
TRIB3,Mammary Neoplasms,0.0034602840073026
TRIB3,Breast Carcinoma,0.0042545616049287
TRIB3,Colorectal Cancer,0.0149315928814189
TRIB3,Stomach Carcinoma,0.0149315928814189
TRIB3,Malignant neoplasm of breast,0.0191435238361999
TRIB3,Malignant neoplasm of stomach,0.0191435238361999
TRIB3,Carcinogenesis,0.0228075668512991
TRIB3,Malignant neoplasm of prostate,0.0569142010728473
TRIB3,Neoplasm Metastasis,0.0648809611869375
TRIB3,Barrett Esophagus,0.0648809611869375
TRIB3,Pancreatic Neoplasm,0.0739788831250619
TRIB3,Degenerative polyarthritis,0.0739788831250619
TRIB3,Liver Cirrhosis Experimental,0.0747863377072194
TRIB3,Prostate carcinoma,0.0773771948186562
TRIB3,Liver carcinoma,0.095319386034013
TRIB3,Malignant Neoplasms,0.0991201145654548
TRIB3,MYELODYSPLASTIC SYNDROME,0.1254380558571286
TRIB3,Myocardial Infarction,0.1352936728187231
TRIB3,Liver neoplasms,0.1454373331146953
TRIB3,Systemic Scleroderma,0.1900258729042946
TRIB3,Diabetes,0.2277108302018961
TRIB3,Anoxia,0.2462384927636234
TRIB3,Diabetes Mellitus,0.2522264785494494
TRIB3,Neoplasms,0.2714542429024338
TRIB3,Myeloid Leukemia,0.2980670559114652
TRIB3,Marijuana Abuse,0.3418217363648192
TRIB3,Primary malignant neoplasm,0.383941725017158
TRIB3,Recurrent tumor,0.383941725017158
TRIB3,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
TRIB3,Infection caused by Helicobacter pylori,0.3933196962529684
TRIB3,Leukemia Myelocytic Acute,0.3933196962529684
TRIB3,Acute Promyelocytic Leukemia,0.3933196962529684
TRIB3,Coronary heart disease,0.3933196962529684
TRIB3,Squamous cell carcinoma of tongue,0.3933196962529684
TRIB3,Glioblastoma Multiforme,0.3933196962529684
TRIB3,Insulin Sensitivity,0.3975960596292668
TRIB3,Insulin Resistance,0.4459714599189374
TRIB3,leukemia,0.4588513406515081
TRIB3,Cardiovascular Diseases,0.4675904598629673
TRIB3,Impaired glucose tolerance,0.4900770016856776
TRIB3,Hyperglycemia,0.4906258721078565
TRIB3,Arteriosclerosis,0.5019670090704682
TRIB3,Carotid Atherosclerosis,0.504136641473215
TRIB3,Coronary Arteriosclerosis,0.5140447474168605
TRIB3,Obesity,0.5140447474168605
TRIB3,Atherosclerosis,0.5393787854381349
TRIB3,Metabolic Syndrome X,0.5568517196017908
TRIB3,ATRICHIA WITH PAPULAR LESIONS,0.5568517196017908
TRIB3,Cardiovascular Abnormalities,0.5655222348249326
TRIB3,Coronary Artery Disease,0.7240930522443176
TRIB3,Hyperhomocysteinemia,0.7780887836634591
TRIB3,Psoriasis vulgaris,0.8209296131179464
TRIB3,Endothelial dysfunction,0.82379775978369
TRIB3,Metabolic Syndrome,0.4809179010794786
TRIB3,Glioblastoma,0.4875380732267193
TRIB3,Non-Alcoholic Fatty Liver Disease,0.504364324740411
TRIB3,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.3762014630157917
TRIB3,Melanoma and neural system tumor syndrome ORPHA:252206,0.3762014630157917
TRIB3,Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938,0.6239678957896782
TRIB3,Burkitt lymphoma ORPHA:543,0.6239678957896782
TRIB3,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.6239678957896782
TRIB3,Large congenital melanocytic nevus ORPHA:626,0.6239678957896782
TRIB3,Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735,0.7068064785325423
TRIB3,Autosomal recessive spastic paraplegia type 70 ORPHA:401835,0.7068064785325423
TRIB3,Congenital factor XII deficiency ORPHA:330,0.7068064785325423
TRIB3,F12-related hereditary angioedema with normal C1Inh ORPHA:100054,0.7068064785325423
TRIB3,Isolated focal cortical dysplasia type Ia ORPHA:268973,0.7068064785325423
TRIB3,SLC35A2-CDG ORPHA:356961,0.7068064785325423
TRIB3,Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427,0.7068064785325423
TRIB3,Norovirus Hu/Norwalk/10074/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20047/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CBNU2/2007/KR capsid protein,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10247/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Lujo mammarenavirus multifunctional matrix-like protein,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH13/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10051/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10116/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10183/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10236/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH02/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH03/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH04/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH06/2006/TW major viral capsid protein,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH07/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH09/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH12/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH17/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/SGU-110421/KOR/2011 VP1,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH05/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH08/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/GZ2010-L26/Guangzhou/CHN/2010 major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII/Shanghai/SH2/2008/CHN VP1,0.6362779693488597
TRIB3,Human adenovirus 18 IVa2 protein (gene: IVa2),0.6362779693488597
TRIB3,Human adenovirus 31 IVa2 protein (gene: IVa2),0.6362779693488597
TRIB3,Norovirus Hu/Shanghai/SH5/2009/CHN VP1,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH14/2007/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH15/2007/TW major viral capsid protein,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20123/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH10/2006/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH22/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Miranda/NSW850K/2011/AU VP1,0.6362779693488597
TRIB3,Yaba-like disease virus 140R protein (gene: 140R),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH18/2008/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH28/2010/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Human alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
TRIB3,Macacine alphaherpesvirus 1 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
TRIB3,Human adenovirus B3 protein IVa2 (gene: IVa2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Guangzhou/GZ2010-L88/CHN/2011 major viral capsid protein,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Guangzhou/GZ2010-L91/CHN/2011 major viral capsid protein,0.6362779693488597
TRIB3,Hepatovirus A 3D mature peptide,0.6362779693488597
TRIB3,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
TRIB3,Vaccinia virus Kelch-like protein (gene: F3L),0.6362779693488597
TRIB3,Vaccinia virus Ankara Kelch-like protein,0.6362779693488597
TRIB3,Guanarito mammarenavirus Z protein,0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.6362779693488597
TRIB3,Human mastadenovirus F encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
TRIB3,Horsepox virus HSPV043 (Kelch-like protein,0.6362779693488597
TRIB3,Provisional),0.6362779693488597
TRIB3,Human papillomavirus type 48 regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Trichodysplasia spinulosa-associated polyomavirus large T antigen (gene: T),0.6362779693488597
TRIB3,Human mastadenovirus D encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
TRIB3,Human adenovirus D10 pIVa2 (gene: pIVa2),0.6362779693488597
TRIB3,Norovirus Hu/GII.2/HS255/2011/USA viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.3/HK71/1978/CHN viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC17.5/2012/USA viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC17.6/2012/USA viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC17.8/2013/USA viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Human papillomavirus 116 E2 protein,0.6362779693488597
TRIB3,Human enterovirus C104 3D,0.6362779693488597
TRIB3,Human adenovirus 43 encapsidation protein IVa2 (gene: IVa2),0.6362779693488597
TRIB3,Astrovirus MLB1 HK05 ORF1b (gene: ORF1b),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/HS292/2012/USA viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,SARS coronavirus RNA-dependent RNA polymerase (gene: orf1ab),0.6362779693488597
TRIB3,Echovirus E21 VP1,0.6362779693488597
TRIB3,Human polyomavirus 10 large T Antigen,0.6362779693488597
TRIB3,Echovirus E14 3D,0.6362779693488597
TRIB3,Reston ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TRIB3,Echovirus E11 3D,0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 chemokine vCXCL8 (gene: UL146E),0.6362779693488597
TRIB3,Echovirus E4 3D,0.6362779693488597
TRIB3,WU Polyomavirus large T antigen,0.6362779693488597
TRIB3,Coxsackievirus A22 3d,0.6362779693488597
TRIB3,Enterovirus C109 3D,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2010/GII.P4_GII.4/Shimada/ASC96 VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC11.3/2013/USA capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Yaba-like disease virus 14L protein (gene: 14L),0.6362779693488597
TRIB3,Reston ebolavirus matrix protein (gene: VP40),0.6362779693488597
TRIB3,Semliki Forest virus E2 protein,0.6362779693488597
TRIB3,Coxsackievirus A1 3D,0.6362779693488597
TRIB3,Enterovirus B 3D,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CUK-3/2008/KR capsid protein,0.6362779693488597
TRIB3,Molluscum contagiosum virus subtype 1 MC157R (gene: MC157R),0.6362779693488597
TRIB3,Enterovirus H 3D,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC28.4/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Human adenovirus 46 IVa2,0.6362779693488597
TRIB3,Norovirus GI/Hu/JP/2007/GI.P3_GI.3/Shimizu/KK2866 VP1 (gene: VP1),0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 B1R (gene: B1R),0.6362779693488597
TRIB3,Salivirus NG-J1 3D,0.6362779693488597
TRIB3,Echovirus 9 strain Hill polyprotein region 11,0.6362779693488597
TRIB3,Echovirus E32 3D,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH11/2006/TW major viral capsid protein,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC28.5/2012/USA capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Alkhumra hemorrhagic fever virus non-structural protein NS1,0.6362779693488597
TRIB3,Yaba monkey tumor virus DNA topoisomerase type I,0.6362779693488597
TRIB3,Norovirus Hu/GI/10360/2010/VNM viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Human parechovirus 2A protein (gene: polyprotein),0.6362779693488597
TRIB3,Echovirus E17 3D,0.6362779693488597
TRIB3,Human enterovirus 94 3D,0.6362779693488597
TRIB3,Echovirus E3 3D,0.6362779693488597
TRIB3,Enterovirus D 3D-POL,0.6362779693488597
TRIB3,Echovirus 9 strain Barty polymerase,0.6362779693488597
TRIB3,Echovirus E6 3D,0.6362779693488597
TRIB3,Human adenovirus 61 pIVa2,0.6362779693488597
TRIB3,Norovirus Hu/GII/BG1C0405/2012/BGD viral genome-linked protein (gene: POL),0.6362779693488597
TRIB3,Human adenovirus 16 maturation protein IVA2 (gene: IVa2),0.6362779693488597
TRIB3,Echovirus E21 3D,0.6362779693488597
TRIB3,Human coronavirus OC43 nucleocapsid protein,0.6362779693488597
TRIB3,Human gammaherpesvirus 8 ORF59 (gene: ORF59),0.6362779693488597
TRIB3,Middle East respiratory syndrome-related coronavirus nsp12 protein (gene: orf1ab),0.6362779693488597
TRIB3,Yaba-like disease virus 77R protein (gene: 77R),0.6362779693488597
TRIB3,Human adenovirus 52 pol (gene: pol),0.6362779693488597
TRIB3,Human mastadenovirus A IVa2,0.6362779693488597
TRIB3,Influenza A virus (A/Shanghai/02/2013(H7N9)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Human enteric coronavirus 4408 nucleocapsid protein (gene: N),0.6362779693488597
TRIB3,Human respirovirus 3 C protein,0.6362779693488597
TRIB3,Ebola virus - Mayinga Zaire 1976 virion spike glycoprotein precursor (gene: GP),0.6362779693488597
TRIB3,Zaire ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TRIB3,Titi monkey adenovirus ECC-2011 IVa2,0.6362779693488597
TRIB3,Yaba-like disease virus 142R protein (gene: 142R),0.6362779693488597
TRIB3,Vaccinia virus ser/thr kinase (gene: B1R),0.6362779693488597
TRIB3,Vaccinia virus Ankara Serine/threonine-protein kinase,0.6362779693488597
TRIB3,Ectromelia virus ERPV profilin-like protein,0.6362779693488597
TRIB3,Human astrovirus 6 capsid protein,0.6362779693488597
TRIB3,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Variola virus DNA topoisomerase type I (gene: I6R),0.6362779693488597
TRIB3,Human coronavirus OC43 transmembrane domain 2 (gene: orf1ab),0.6362779693488597
TRIB3,Human herpesvirus 3 strain Dumas nuclear matrix protein,0.6362779693488597
TRIB3,Human papillomavirus type 68 E1 (gene: E1),0.6362779693488597
TRIB3,Human papillomavirus type 68a E1 protein,0.6362779693488597
TRIB3,Human papillomavirus type 68b E1 protein (gene: E1),0.6362779693488597
TRIB3,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.6362779693488597
TRIB3,Human gammaherpesvirus 8 KCP (gene: ORF4),0.6362779693488597
TRIB3,Vaccinia virus Ankara 64.7k Kelch-like protein f2,0.6362779693488597
TRIB3,Human betacoronavirus 2c Jordan-N3/2012 N protein (gene: N),0.6362779693488597
TRIB3,Barmah Forest virus excised_polyprotein 1..742,0.6362779693488597
TRIB3,Human enteric coronavirus strain 4408 nucleocapsid protein,0.6362779693488597
TRIB3,Molluscum contagiosum virus subtype 1 MC127R (gene: MC127R),0.6362779693488597
TRIB3,Human adenovirus 1 pol,0.6362779693488597
TRIB3,Human parainfluenza virus 1 strain Washington/1964 C protein (gene: C),0.6362779693488597
TRIB3,Human parainfluenza virus 1 strain Washington/1964 putative Y2 protein (gene: Y2),0.6362779693488597
TRIB3,Human parainfluenza virus 1 strain Washington/1964 Y1 protein (gene: Y1),0.6362779693488597
TRIB3,Human respirovirus 1 Y1 protein (gene: Y1),0.6362779693488597
TRIB3,Human respirovirus 1 C protein (gene: C),0.6362779693488597
TRIB3,Human respirovirus 1 putative Y2 protein (gene: Y2),0.6362779693488597
TRIB3,Human adenovirus 52 DBP (gene: DBP),0.6362779693488597
TRIB3,Louping ill virus nonstructural protein NS3,0.6362779693488597
TRIB3,Human polyomavirus 6 large T antigen,0.6362779693488597
TRIB3,Human polyomavirus 9 large T antigen,0.6362779693488597
TRIB3,Human polyomavirus IPPyV large T antigen protein (gene: large T antigen),0.6362779693488597
TRIB3,Titi monkey adenovirus ECC-2011 pVI,0.6362779693488597
TRIB3,Human betacoronavirus 2c EMC/2012 N protein (gene: N),0.6362779693488597
TRIB3,Bundibugyo ebolavirus matrix protein (gene: VP40),0.6362779693488597
TRIB3,Human betaherpesvirus 6 U37 (gene: U37),0.6362779693488597
TRIB3,Human betaherpesvirus 6A nuclear egress lamina protein (gene: U37),0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 membrane protein RL11K (gene: RL11K),0.6362779693488597
TRIB3,Middle East respiratory syndrome-related coronavirus nucleoprotein (gene: N),0.6362779693488597
TRIB3,Ebola virus - Mayinga Zaire 1976 polymerase (gene: L),0.6362779693488597
TRIB3,Zaire ebolavirus RNA-dependent RNA polymerase (gene: L),0.6362779693488597
TRIB3,Human mastadenovirus F DNA polymerase (gene: E2B),0.6362779693488597
TRIB3,Norovirus GIV VPg,0.6362779693488597
TRIB3,Human adenovirus 7 III,0.6362779693488597
TRIB3,Rhinovirus A81 1D,0.6362779693488597
TRIB3,Titi monkey adenovirus ECC-2011 III,0.6362779693488597
TRIB3,Cercopithecine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.6362779693488597
TRIB3,Sudan ebolavirus spike glycoprotein (gene: GP),0.6362779693488597
TRIB3,Sudan ebolavirus - Nakisamata structural glycoprotein (gene: GP),0.6362779693488597
TRIB3,Human astrovirus 2 capsid protein precursor,0.6362779693488597
TRIB3,Human astrovirus 4 capsid precursor protein,0.6362779693488597
TRIB3,Human astrovirus 5 structural protein,0.6362779693488597
TRIB3,Human bocavirus NS1 (gene: NS1),0.6362779693488597
TRIB3,Human bocavirus 1 nonstructural protein (gene: NS1),0.6362779693488597
TRIB3,Human bocavirus WLL-1 NS1 (gene: NS1),0.6362779693488597
TRIB3,Human bocavirus WLL-2 NS1 (gene: NS1),0.6362779693488597
TRIB3,Human bocavirus WLL-3 NS1 (gene: NS1),0.6362779693488597
TRIB3,Human bocavirus isolate SH1 NS1,0.6362779693488597
TRIB3,Human bocavirus isolate SH2 NS1,0.6362779693488597
TRIB3,Human coronavirus HKU1 nucleocapsid phosphoprotein (gene: N),0.6362779693488597
TRIB3,Variola virus putative metalloprotease (gene: H1L),0.6362779693488597
TRIB3,Human enterovirus C118 VP4,0.6362779693488597
TRIB3,Echovirus E16 VP4,0.6362779693488597
TRIB3,Oropouche virus full_polyprotein 1..1420 (gene: M),0.6362779693488597
TRIB3,Ross River virus C protein,0.6362779693488597
TRIB3,Tai Forest ebolavirus matrix protein (gene: VP40),0.6362779693488597
TRIB3,Coxsackievirus A14 full_polyprotein 1..2192,0.6362779693488597
TRIB3,Vaccinia virus putative metalloprotease (gene: G1L),0.6362779693488597
TRIB3,Influenza A virus (A/California/04/2009(H1N1)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Influenza A virus (A/California/07/2009(H1N1)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Vaccinia virus Ankara Metalloendopeptidase,0.6362779693488597
TRIB3,Cowpox virus CPXV049 protein (gene: CPXV049 CDS),0.6362779693488597
TRIB3,Mayaro virus capsid protein,0.6362779693488597
TRIB3,Human herpesvirus 4 type 2 BLLF1,0.6362779693488597
TRIB3,Monkeypox virus insulin metalloproteinase-like protein,0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 putative metalloprotease (gene: G1L),0.6362779693488597
TRIB3,Ectromelia virus ERPV putative metalloprotease,0.6362779693488597
TRIB3,Ectromelia virus ERPV dUTPase,0.6362779693488597
TRIB3,Horsepox virus HSPV079 (Peptidase_M44),0.6362779693488597
TRIB3,Horsepox virus HSPV042 (dUTPase,0.6362779693488597
TRIB3,Norwalk-like virus capsid protein,0.6362779693488597
TRIB3,Human adenovirus 7 pIIIa,0.6362779693488597
TRIB3,Semliki Forest virus C protein,0.6362779693488597
TRIB3,Coxsackievirus A10 full_polyprotein 1..2193,0.6362779693488597
TRIB3,Enterovirus A120 full_polyprotein 1..2191,0.6362779693488597
TRIB3,Human astrovirus 5 RNA-dependent RNA polymerase,0.6362779693488597
TRIB3,Western equine encephalitis virus C protein,0.6362779693488597
TRIB3,Human papillomavirus 149 E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GI.2/Jingzhou/2013401/CHN major capsid protein VP1,0.6362779693488597
TRIB3,HBV genotype C pol (gene: P),0.6362779693488597
TRIB3,Human adenovirus 19 DNA polymerase (gene: E2B),0.6362779693488597
TRIB3,Rubella virus capsid protein,0.6362779693488597
TRIB3,Human alphaherpesvirus 3 nuclear egress lamina protein (gene: ORF27),0.6362779693488597
TRIB3,Variola virus hypothetical protein (gene: A47R),0.6362779693488597
TRIB3,Monkeypox virus profilin-like protein,0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 A42R (gene: A42R),0.6362779693488597
TRIB3,Horsepox virus HSPV164 (Profilin),0.6362779693488597
TRIB3,Human betaherpesvirus 6B hypothetical protein (gene: U37),0.6362779693488597
TRIB3,Yaba monkey tumor virus IL-18 binding protein,0.6362779693488597
TRIB3,Molluscum contagiosum virus subtype 1 MC021L (gene: MC021L),0.6362779693488597
TRIB3,Human mastadenovirus A pol,0.6362779693488597
TRIB3,Monkeypox virus dUTPase,0.6362779693488597
TRIB3,Human mastadenovirus F single-stranded DNA-binding protein (gene: E2A),0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 dUTPase (gene: C8L),0.6362779693488597
TRIB3,Human papillomavirus 135 regulatory protein (gene: E2),0.6362779693488597
TRIB3,HBV recombinant B/C polymerase (gene: P),0.6362779693488597
TRIB3,Human adenovirus 14 DNA binding protein (gene: E2A),0.6362779693488597
TRIB3,Human parechovirus RNA-dependent RNA polymerase 3D (gene: polyprotein),0.6362779693488597
TRIB3,Vaccinia virus profilin-like protein (gene: A42R),0.6362779693488597
TRIB3,Vaccinia virus Ankara Profilin-1-like,0.6362779693488597
TRIB3,Cowpox virus CPXV179 protein (gene: CPXV179 CDS),0.6362779693488597
TRIB3,Coxsackievirus A4 full_polyprotein 1..2201,0.6362779693488597
TRIB3,Enterovirus A76 full_polyprotein 1..2198,0.6362779693488597
TRIB3,Influenza A virus (A/Korea/426/1968(H2N2)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Human betaherpesvirus 6A protein DR1 (gene: DR1),0.6362779693488597
TRIB3,Human betaherpesvirus 6B G-protein coupled receptor fragment (gene: U12),0.6362779693488597
TRIB3,HBV genotype H P protein (gene: P),0.6362779693488597
TRIB3,Human papillomavirus type 60 regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 68 E6 (gene: E6),0.6362779693488597
TRIB3,Human papillomavirus type 68b E6 protein (gene: E6),0.6362779693488597
TRIB3,Human parainfluenza virus 4a non-structural protein V (gene: V),0.6362779693488597
TRIB3,Human rhinovirus A30 1D,0.6362779693488597
TRIB3,Human adenovirus 61 E2A DNA binding protein,0.6362779693488597
TRIB3,Ross River virus excised_polyprotein 1..756,0.6362779693488597
TRIB3,Titi monkey adenovirus ECC-2011 DBP,0.6362779693488597
TRIB3,Influenza A virus (A/Northern Territory/60/1968(H3N2)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Macacine alphaherpesvirus 1 envelope glycoprotein G (gene: US4),0.6362779693488597
TRIB3,Enterovirus C protein 3CD,0.6362779693488597
TRIB3,Enterovirus C RNA-directed RNA polymerase,0.6362779693488597
TRIB3,Human papillomavirus type 103 E2 protein,0.6362779693488597
TRIB3,Horsepox virus HSPV074d (ribonucleoside--diphosphate reductase large subunit),0.6362779693488597
TRIB3,Human poliovirus 1 Mahoney excised_polyprotein 1566..2209,0.6362779693488597
TRIB3,Orf virus ORF037 putative metalloprotease,0.6362779693488597
TRIB3,Coxsackievirus A2 full_polyprotein 1..2190,0.6362779693488597
TRIB3,Human rhinovirus B52 3D,0.6362779693488597
TRIB3,Human astrovirus 1 Beijing/291/2007/CHN nonstructural protein,0.6362779693488597
TRIB3,Human betaherpesvirus 5 membrane protein UL10 (gene: UL10),0.6362779693488597
TRIB3,Human enterovirus 94 VP1,0.6362779693488597
TRIB3,Human papillomavirus 143 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Human T-lymphotropic virus 3 group specific antigen (gene: gag),0.6362779693488597
TRIB3,Human parvovirus 4 VP1,0.6362779693488597
TRIB3,Human adenovirus 3+7 DNA binding protein (gene: E2A),0.6362779693488597
TRIB3,Human rhinovirus A23 1D (VP1),0.6362779693488597
TRIB3,Human rhinovirus A55 1B (VP2),0.6362779693488597
TRIB3,Human rhinovirus A74 1B (VP2),0.6362779693488597
TRIB3,Rubella virus protease p150,0.6362779693488597
TRIB3,Human alphaherpesvirus 2 nuclear protein UL3 (gene: UL3),0.6362779693488597
TRIB3,Alphapapillomavirus 7 E2 protein (gene: E2),0.6362779693488597
TRIB3,Influenza A virus (A/New York/392/2004(H3N2)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Influenza A virus (A/New York/602/1996(H3N2)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 regulatory protein IE1 (gene: UL123),0.6362779693488597
TRIB3,Human gammaherpesvirus 8 ORF47 (gene: ORF47),0.6362779693488597
TRIB3,Human papillomavirus type 18 E2 protein (gene: E2),0.6362779693488597
TRIB3,Human TMEV-like cardiovirus capsid protein VP1,0.6362779693488597
TRIB3,Human polyomavirus 12 large T antigen,0.6362779693488597
TRIB3,Human rhinovirus A36 1B (VP2),0.6362779693488597
TRIB3,Human rhinovirus A49 1D,0.6362779693488597
TRIB3,Human rhinovirus A64 1B,0.6362779693488597
TRIB3,Human adenovirus D8 7.3kDa protein (gene: E4),0.6362779693488597
TRIB3,Variola virus hypothetical protein (gene: B1R),0.6362779693488597
TRIB3,Influenza A virus (A/New York/599/1996(H3N2)) polymerase PB2 (gene: PB2),0.6362779693488597
TRIB3,Mayaro virus nonstructural protein nsP4,0.6362779693488597
TRIB3,Human papillomavirus type 129 E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 150 putative E2 product (gene: E2),0.6362779693488597
TRIB3,Human parvovirus 4 G1 ORF2,0.6362779693488597
TRIB3,Human rhinovirus A15 1D (VP1),0.6362779693488597
TRIB3,Human rhinovirus A74 1D (VP1),0.6362779693488597
TRIB3,Papiine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.6362779693488597
TRIB3,Human betacoronavirus 2c Jordan-N3/2012 S protein (gene: S),0.6362779693488597
TRIB3,Mayaro virus excised_polyprotein 1..746,0.6362779693488597
TRIB3,Human mastadenovirus E DNA polymerase (gene: E2B),0.6362779693488597
TRIB3,Human papillomavirus 145 transforming protein (gene: E7),0.6362779693488597
TRIB3,Human adenovirus 1 DBP,0.6362779693488597
TRIB3,Human rhinovirus A1 1D,0.6362779693488597
TRIB3,Human rhinovirus A40 1D,0.6362779693488597
TRIB3,Papiine alphaherpesvirus 2 envelope glycoprotein G (gene: US4),0.6362779693488597
TRIB3,Parvovirus NIH-CQV putative capsid protein (gene: cap),0.6362779693488597
TRIB3,Human rhinovirus A66 1D,0.6362779693488597
TRIB3,Rhinovirus B14 3D,0.6362779693488597
TRIB3,Human rhinovirus A77 1D,0.6362779693488597
TRIB3,SARS coronavirus nucleocapsid protein (gene: N),0.6362779693488597
TRIB3,Human adenovirus E4 DNA polymerase,0.6362779693488597
TRIB3,SARS coronavirus P2 nucleocapsid protein,0.6362779693488597
TRIB3,SARS coronavirus Tor2 nucleocapsid protein,0.6362779693488597
TRIB3,Semliki Forest virus excised_polyprotein 1..755,0.6362779693488597
TRIB3,Human rhinovirus A96 1D,0.6362779693488597
TRIB3,Human papillomavirus type 128 E2 (gene: E2),0.6362779693488597
TRIB3,Cercopithecine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.6362779693488597
TRIB3,Aichi virus 1 VP0,0.6362779693488597
TRIB3,Human betacoronavirus 2c EMC/2012 S protein (gene: S),0.6362779693488597
TRIB3,Human betacoronavirus 2c England-Qatar/2012 S protein,0.6362779693488597
TRIB3,Betacoronavirus England 1 S protein (gene: S),0.6362779693488597
TRIB3,Chikungunya virus excised_polyprotein 1..748,0.6362779693488597
TRIB3,Human coronavirus NL63 nucleocapsid protein,0.6362779693488597
TRIB3,Coxsackievirus A6 3D protein,0.6362779693488597
TRIB3,Human group 1 coronavirus associated with pneumonia nucleocapsid protein,0.6362779693488597
TRIB3,Middle East respiratory syndrome-related coronavirus spike glycoprotein (gene: S),0.6362779693488597
TRIB3,Eastern equine encephalitis virus NS4,0.6362779693488597
TRIB3,Human mastadenovirus D DNA polymerase (gene: E2B),0.6362779693488597
TRIB3,Human papillomavirus type 96 E2,0.6362779693488597
TRIB3,Human rhinovirus A13 1D,0.6362779693488597
TRIB3,Human rhinovirus A18 1D,0.6362779693488597
TRIB3,Human rhinovirus A21 1D,0.6362779693488597
TRIB3,Human rhinovirus A25 1D,0.6362779693488597
TRIB3,Human rhinovirus A29 1D,0.6362779693488597
TRIB3,Human adenovirus 56 DNA polymerase (gene: E2B),0.6362779693488597
TRIB3,Human rhinovirus A45 1D,0.6362779693488597
TRIB3,Human rhinovirus A60 1D,0.6362779693488597
TRIB3,Human rhinovirus A89 1D,0.6362779693488597
TRIB3,Human adenovirus 7d2 100 kDa hexon assembly-associated protein (gene: L4),0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 envelope glycoprotein UL33 (gene: UL33),0.6362779693488597
TRIB3,Human gammaherpesvirus 4 EBNA-1 protein (gene: BKRF1),0.6362779693488597
TRIB3,Eastern equine encephalitis virus nsP4 protein,0.6362779693488597
TRIB3,Human papillomavirus 197 E1 (gene: E1),0.6362779693488597
TRIB3,Human papillomavirus 5 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 65 regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.6/CHDC4073/1984/USA capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Human adenovirus 19 DNA binding (gene: E2A),0.6362779693488597
TRIB3,Human rhinovirus A15 1B (VP2),0.6362779693488597
TRIB3,Human rhinovirus A31 1D,0.6362779693488597
TRIB3,Human rhinovirus A32 1D,0.6362779693488597
TRIB3,Human rhinovirus A38 1D,0.6362779693488597
TRIB3,O'nyong-nyong virus nonstructural protein P4,0.6362779693488597
TRIB3,Human rhinovirus A56 1D,0.6362779693488597
TRIB3,Human rhinovirus A57 1D,0.6362779693488597
TRIB3,Human rhinovirus A58 1D,0.6362779693488597
TRIB3,Human rhinovirus A67 1D,0.6362779693488597
TRIB3,Human rhinovirus A7 1B,0.6362779693488597
TRIB3,Human rhinovirus A73 1D (VP1),0.6362779693488597
TRIB3,Human rhinovirus A8 1D,0.6362779693488597
TRIB3,Human betaherpesvirus 7 capsid maturation protease (gene: U53),0.6362779693488597
TRIB3,Coxsackievirus A11 3d,0.6362779693488597
TRIB3,Coxsackievirus A13 3d,0.6362779693488597
TRIB3,Echovirus E7 3D,0.6362779693488597
TRIB3,Human papillomavirus type 129 E1 (gene: E1),0.6362779693488597
TRIB3,Human papillomavirus type 57c E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 88 E2 protein,0.6362779693488597
TRIB3,Human poliovirus 3 POLYM,0.6362779693488597
TRIB3,Human rhinovirus A24 1D,0.6362779693488597
TRIB3,Human adenovirus 64 E2A DNA binding protein,0.6362779693488597
TRIB3,Human rhinovirus A59 1D (VP1),0.6362779693488597
TRIB3,Human adenovirus D37 DNA-binding protein (gene: E2A),0.6362779693488597
TRIB3,Human rhinovirus A9 1D,0.6362779693488597
TRIB3,Human rhinovirus A90 1D,0.6362779693488597
TRIB3,Human betaherpesvirus 5 capsid maturation protease (gene: UL80),0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 membrane protein RL11G (gene: RL11G),0.6362779693488597
TRIB3,Chikungunya virus full_polyprotein 1..1248,0.6362779693488597
TRIB3,Human coronavirus 229E nucleocapsid protein (gene: N),0.6362779693488597
TRIB3,Human enterovirus C102 3d,0.6362779693488597
TRIB3,Coxsackievirus A17 3D,0.6362779693488597
TRIB3,Coxsackievirus A18 3D protein,0.6362779693488597
TRIB3,Human herpesvirus 3 strain Dumas membrane glycoprotein gE,0.6362779693488597
TRIB3,Echovirus E33 3D,0.6362779693488597
TRIB3,Human papillomavirus 152 early protein E1 (gene: E1),0.6362779693488597
TRIB3,Human papillomavirus type 38b E2 protein (gene: E2),0.6362779693488597
TRIB3,Human rhinovirus A33 1D,0.6362779693488597
TRIB3,Human rhinovirus A54 1D,0.6362779693488597
TRIB3,Human rhinovirus A55 1D (VP1),0.6362779693488597
TRIB3,Human adenovirus 67 E2A DNA binding protein,0.6362779693488597
TRIB3,Human rhinovirus A62 1D,0.6362779693488597
TRIB3,Rhinovirus A98 1D,0.6362779693488597
TRIB3,Human rhinovirus A94 1D,0.6362779693488597
TRIB3,Human alphaherpesvirus 3 envelope glycoprotein E (gene: ORF68),0.6362779693488597
TRIB3,Echovirus E18 full_polyprotein 1..2189,0.6362779693488597
TRIB3,Igbo Ora virus nonstructural protein 4,0.6362779693488597
TRIB3,Venezuelan equine encephalitis virus RNA-directed RNA polymerase nsP4 (gene: NS),0.6362779693488597
TRIB3,Maraba virus phosphoprotein (gene: P),0.6362779693488597
TRIB3,Western equine encephalitis virus RNA-dependent RNA polymerase catalytic subunit,0.6362779693488597
TRIB3,Human herpesvirus 4 type 2 EBNA-1,0.6362779693488597
TRIB3,Echovirus E24 3D,0.6362779693488597
TRIB3,Human papillomavirus 104 E2 protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 134 E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 26 early protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII/10002/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Human papillomavirus type 54 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Human TMEV-like cardiovirus protein 2B*,0.6362779693488597
TRIB3,Human rhinovirus A19 1D,0.6362779693488597
TRIB3,Human rhinovirus A41 1D (VP1),0.6362779693488597
TRIB3,Human rhinovirus A44 1D (VP1),0.6362779693488597
TRIB3,Human rhinovirus A61 1D,0.6362779693488597
TRIB3,Human rhinovirus A76 1D,0.6362779693488597
TRIB3,Human rhinovirus A82 1D,0.6362779693488597
TRIB3,Human rhinovirus A88 1D (VP1),0.6362779693488597
TRIB3,Semliki Forest virus Nonstructural protein nsP4,0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.6362779693488597
TRIB3,Cercopithecine alphaherpesvirus 2 deoxyuridine triphosphatase (gene: UL50),0.6362779693488597
TRIB3,Middle East respiratory syndrome-related coronavirus nsp15 protein (gene: orf1ab),0.6362779693488597
TRIB3,Echovirus E20 3D,0.6362779693488597
TRIB3,Human papillomavirus 113 E1 protein (gene: E1),0.6362779693488597
TRIB3,Ectromelia virus ERPV superoxide dismutase-like protein,0.6362779693488597
TRIB3,Human papillomavirus 141 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 98 E2 protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 153 E2 protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Randwick/NSW938K/2011/AU VP1,0.6362779693488597
TRIB3,Human rhinovirus A10 1D,0.6362779693488597
TRIB3,Human rhinovirus A22 1D,0.6362779693488597
TRIB3,Saffold virus protein 2B*,0.6362779693488597
TRIB3,Sindbis virus nsp4 nonstructural protein (putative start),0.6362779693488597
TRIB3,,0.6362779693488597
TRIB3,Echovirus E12 polyprotein,0.6362779693488597
TRIB3,Monkeypox virus ser/thr protein kinase-like protein,0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.6362779693488597
TRIB3,Human immunodeficiency virus envelope glycoprotein (gene: env),0.6362779693488597
TRIB3,Human betaherpesvirus 5 regulatory protein IE2 (gene: UL122),0.6362779693488597
TRIB3,Cercopithecine betaherpesvirus 5 regulatory protein IE2 (gene: UL122),0.6362779693488597
TRIB3,Echovirus E15 3D,0.6362779693488597
TRIB3,Echovirus E2 3D,0.6362779693488597
TRIB3,Human mastadenovirus D single-stranded DNA-binding protein (gene: E2A),0.6362779693488597
TRIB3,Echovirus E26 3D,0.6362779693488597
TRIB3,Human papillomavirus 121 regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 126 hypothetical protein (gene: HpV126gp2),0.6362779693488597
TRIB3,Human papillomavirus 133 E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 148 E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 171 E2,0.6362779693488597
TRIB3,Human papillomavirus FA75/KI88-03 E2 protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 131 E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII/10003/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/GII/10012/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10034/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10054/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10062/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10075/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10078/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10079/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10110/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10114/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10129/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10136/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10145/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10158/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10160/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10163/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10169/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10177/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Human adenovirus 28 single-stranded DNA binding protein (gene: E2A),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10179/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10182/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10194/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10203/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10204/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10222/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10238/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10255/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10296/2010/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20010/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20014/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20019/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20067/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20069/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20092/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20093/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20118/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20122/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20128/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20135/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20139/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20140/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20142/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Human rhinovirus A50 1D,0.6362779693488597
TRIB3,Human rhinovirus A85 1D,0.6362779693488597
TRIB3,Human rhinovirus A95 1D,0.6362779693488597
TRIB3,Ectromelia virus ERPV hemagglutinin,0.6362779693488597
TRIB3,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.6362779693488597
TRIB3,Banna virus strain JKT-6423 Vp7,0.6362779693488597
TRIB3,Human betaherpesvirus 6B proteinase (gene: U53),0.6362779693488597
TRIB3,Human enterovirus C117 3D,0.6362779693488597
TRIB3,Echovirus E19 3D,0.6362779693488597
TRIB3,Human papillomavirus 130 E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 178 E2 protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 201 E2 (gene: E2),0.6362779693488597
TRIB3,Human parechovirus 1 3D,0.6362779693488597
TRIB3,Human parechovirus 8 3D,0.6362779693488597
TRIB3,Human rhinovirus A34 1D,0.6362779693488597
TRIB3,Human rhinovirus A63 1D,0.6362779693488597
TRIB3,Human gammaherpesvirus 8 LANA,0.6362779693488597
TRIB3,HBV genotype C polymerase (gene: P),0.6362779693488597
TRIB3,Human parechovirus 4 RNA-dependent RNA Polymerase,0.6362779693488597
TRIB3,Human rhinovirus A100 1D,0.6362779693488597
TRIB3,Human gammaherpesvirus 4 putative BLRF2 protein (gene: BLRF2),0.6362779693488597
TRIB3,Human gammaherpesvirus 8 ORF52 (gene: ORF52),0.6362779693488597
TRIB3,Human herpesvirus 4 type 2 BLRF2,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2007/GII.P15_GII.15/Sapporo/HK299 full_polyprotein 1..1698,0.6362779693488597
TRIB3,Norovirus Hu/GI/10360/2010/VNM protein p37 (gene: POL),0.6362779693488597
TRIB3,Human papillomavirus type 124 regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Human adenovirus 19 ORF1 (gene: E4),0.6362779693488597
TRIB3,Human papillomavirus type 92 E2,0.6362779693488597
TRIB3,Human adenovirus 49 pIVa2,0.6362779693488597
TRIB3,Human adenovirus 64 E4 7.4 kDa protein,0.6362779693488597
TRIB3,Human adenovirus Chiba_E086/2012 Orf1 (gene: E4),0.6362779693488597
TRIB3,Human adenovirus D37 14.0 kDa (gene: E4),0.6362779693488597
TRIB3,Vaccinia virus RNA polymerase subunit (gene: E4L),0.6362779693488597
TRIB3,Human betaherpesvirus 6 U53 protease /assembly protein (gene: U53),0.6362779693488597
TRIB3,Human betaherpesvirus 6A capsid maturation protease (gene: U53),0.6362779693488597
TRIB3,Cowpox virus CPXV183 protein (gene: CPXV183 CDS),0.6362779693488597
TRIB3,Langat virus membrane-associated glycoprotein precursor,0.6362779693488597
TRIB3,Macacine alphaherpesvirus 1 deoxyuridine triphosphatase (gene: UL50),0.6362779693488597
TRIB3,Yaba monkey tumor virus Ser/Thr kinase,0.6362779693488597
TRIB3,Human papillomavirus 136 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 159 E2 protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH19/2009/TW major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Human papillomavirus type 41 hypothetical protein (gene: ORF E7),0.6362779693488597
TRIB3,Norovirus Hu/GII.6/GZ2010-L96/Guangzhou/CHN/2011 major viral capsid protein (gene: VP1),0.6362779693488597
TRIB3,Human papillomavirus type 6 E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII/BG1C0066/2011/BGD protein p48 (gene: POL),0.6362779693488597
TRIB3,Human adenovirus 19 pIVa2 (gene: IVa2),0.6362779693488597
TRIB3,Orf virus ORF035 virion core protease,0.6362779693488597
TRIB3,Coxsackievirus B4 full_polyprotein 1..2183,0.6362779693488597
TRIB3,Human adenovirus 66 100 kDa hexon assembly-associated protein (gene: L4),0.6362779693488597
TRIB3,Echovirus E30 full_polyprotein 1..2194,0.6362779693488597
TRIB3,Echovirus E25 3D,0.6362779693488597
TRIB3,Ectromelia virus ERPV virion core protease,0.6362779693488597
TRIB3,Human papillomavirus 142 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 155 E2,0.6362779693488597
TRIB3,Norovirus Hu/GII.3/Jingzhou/2013402/CHN nonstructural protein,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC18.1/2012/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC27.1/2012/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC27.2/2012/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/BG1C0241-33/2011/BGD protein p48 (gene: POL),0.6362779693488597
TRIB3,Human adenovirus 56 IVa2 protein (gene: IVa2),0.6362779693488597
TRIB3,Sapovirus Hu/GI/Sapporo/MT-2010/1982 VP1,0.6362779693488597
TRIB3,Coxsackievirus B6 full_polyprotein 1..2184,0.6362779693488597
TRIB3,Vaccinia virus Ankara viral core cysteine proteinase,0.6362779693488597
TRIB3,Ectromelia virus ERPV RNA polymerase 30 subunit,0.6362779693488597
TRIB3,Human papillomavirus 127 E2,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2010/GII.P7_GII.7/Musashimurayama/TAKAsanKimchi full_polyprotein 1..1697,0.6362779693488597
TRIB3,Human papillomavirus 172 E2,0.6362779693488597
TRIB3,Human papillomavirus 197 E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.3/CBNU1/2006/KOR full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC13/2011/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/BG1C0270/2011/BGD protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/BG1C0317/2011/BGD protein p48 (gene: POL),0.6362779693488597
TRIB3,Tai Forest ebolavirus nucleoprotein (gene: NP),0.6362779693488597
TRIB3,Vaccinia virus Ankara Haemagglutinin,0.6362779693488597
TRIB3,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) hemagglutinin (gene: HA),0.6362779693488597
TRIB3,Coxsackievirus B2 full_polyprotein 1..2187,0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 B11R (gene: B11R),0.6362779693488597
TRIB3,Enterovirus B genome polyportein,0.6362779693488597
TRIB3,Human enterovirus 79 3D,0.6362779693488597
TRIB3,Human gammaherpesvirus 4 large tegument protein (gene: BPLF1),0.6362779693488597
TRIB3,Human herpesvirus 4 type 2 BPLF1,0.6362779693488597
TRIB3,Echovirus E27 3D,0.6362779693488597
TRIB3,Enterovirus B111 3D,0.6362779693488597
TRIB3,Hepatitis C virus genotype 4 NS3 protease/helicase,0.6362779693488597
TRIB3,Norovirus Hu/GII/Seoul1055/KOR/2010 nonstructural protein,0.6362779693488597
TRIB3,Human parechovirus 4 3D,0.6362779693488597
TRIB3,Human parechovirus 6 3D,0.6362779693488597
TRIB3,Enterovirus B73 full_polyprotein 1..2188,0.6362779693488597
TRIB3,Yaba-like disease virus 35L protein (gene: 35L),0.6362779693488597
TRIB3,Echovirus E29 3D,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH26/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Berowra/NSW767L/2012/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/GZ2010-L87/Guangzhou/CHN/2011 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC11.3/2013/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Human parechovirus 2 full_polyprotein 1..2179,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10235/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Echovirus E16 3D,0.6362779693488597
TRIB3,Human papillomavirus 113 E2 protein (gene: E2),0.6362779693488597
TRIB3,Norovirus GII.17 AKB94549.1 full_polyprotein 1..1702 (gene: ORF1),0.6362779693488597
TRIB3,Norovirus Hu/GI.2/Leuven/2003/BEL full_polyprotein 1..1788,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH23/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH25/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus type 144 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Horsepox virus HSPV002 (chemokine binding protein,0.6362779693488597
TRIB3,Norovirus Hu/GII/10037/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10199/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10204/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20008/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20066/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Ross River virus nsP4 protein,0.6362779693488597
TRIB3,Enterovirus B106 full_polyprotein 1..2192,0.6362779693488597
TRIB3,Human gammaherpesvirus 4 EBNA-2 nuclear protein (gene: BYRF1),0.6362779693488597
TRIB3,Aichi virus 1 3D,0.6362779693488597
TRIB3,Variola virus RNA polymerase subunit (gene: E4L),0.6362779693488597
TRIB3,Coxsackievirus B5 polyprotein region 11 (gene: 1A),0.6362779693488597
TRIB3,Echovirus E13 3D,0.6362779693488597
TRIB3,Monkeypox virus chemokine-binding protein,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/1 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/106 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH24/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Jiangsu1/2011/CHN full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Jiangsu2/2012/CHN full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus type 156 early protein E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/gg-12-08-04/2012/KR full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII/10002/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/10003/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/20477/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10062/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10114/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10129/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10137/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10145/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10158/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10160/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10162/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10169/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10173/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10176/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10176/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10179/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10182/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10194/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10222/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10235/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10285/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10325/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10368/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10386/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20019/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20069/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20092/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20093/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20122/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20135/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20139/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Human herpesvirus 4 type 2 EBNA-2,0.6362779693488597
TRIB3,Echovirus E5 full_polyprotein 1..2196,0.6362779693488597
TRIB3,Chiba virus full_polyprotein 1..1785 (gene: ORF1),0.6362779693488597
TRIB3,Variola virus hypothetical protein (gene: K7L),0.6362779693488597
TRIB3,Yaba-like disease virus 48L protein (gene: 48L),0.6362779693488597
TRIB3,Echovirus E12 polymerase polyprotein region 11,0.6362779693488597
TRIB3,Monkeypox virus viral core cysteine proteinase,0.6362779693488597
TRIB3,Monkeypox virus Cu-Zn superoxide dismutase-like protein,0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 A46R (gene: A46R),0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 I7L (gene: I7L),0.6362779693488597
TRIB3,Monkeypox virus Zaire-96-I-16 chemokine binding protein (gene: J1L),0.6362779693488597
TRIB3,Human papillomavirus E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus GII/Hu/HKG/2013/GII.4/CUHK-NS-141 ORF1,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/2 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/3 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2012/GII.Pe_GII.4_Sydney2012/Fukuyama/5 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/105 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH06/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH20/2009/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH21/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Doonside/NSW536I/2011/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Hong Kong/CUHK6080/2012/CHN full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC17.1/2012/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Human papillomavirus type 166 E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC35/2013/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10116/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10148/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10163/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20044/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Salivirus A full_polyprotein 1..2370,0.6362779693488597
TRIB3,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
TRIB3,Yaba monkey tumor virus 48L,0.6362779693488597
TRIB3,Human papillomavirus 109 E2 protein (gene: E2),0.6362779693488597
TRIB3,New Jersey polyomavirus-2013 large T antigen,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2007/GII.P7_GII.14/Fukuoka/KK282 full_polyprotein 1..1697,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2010/GII.P4_GII.4/Shimada/ASC96 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GI.6/Kingston/ACT160D/2010/AU full_polyprotein 1..1788,0.6362779693488597
TRIB3,Human papillomavirus 19 early protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.12/HS206/2010/USA full_polyprotein 1..1701,0.6362779693488597
TRIB3,Norovirus Hu/GII.12/HS210/2010/USA full_polyprotein 1..1701,0.6362779693488597
TRIB3,Human papillomavirus type 115 early protein E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Caringbah/NSW409G/2011/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Hong Kong/CUHK3630/2012/CHN full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Jannali/NSW774M/2011/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Ohio/7I/2012/USA full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII/BG1C0282/2011/BGD protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10074/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Human adenovirus 28 E3 44.5K-like protein (gene: E3),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10296/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20008/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20094/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2007/GII.P21_GII.21/Kawasaki/YO284 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2007/GII.P7_GII.14/Sendai/YG99 full_polyprotein 1..1697,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2011/GII/Yuzawa/Gira2HS full_polyprotein 1..1693,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH27/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/CHDC2094/1974/US full_polyprotein 1..1699,0.6362779693488597
TRIB3,Hepatovirus A hypothetical protein,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Randwick/NSW882J/2011/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10137/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10223/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20044/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Shanghai/SH5/2009/CHN full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human alphaherpesvirus 1 envelope glycoprotein I (gene: US7),0.6362779693488597
TRIB3,Echovirus E9 full_polyprotein 1..2203,0.6362779693488597
TRIB3,Human adenovirus 7 100K,0.6362779693488597
TRIB3,Human adenovirus 41 E3 31.6K,0.6362779693488597
TRIB3,Human T-lymphotropic virus 3 polymerase (gene: pol),0.6362779693488597
TRIB3,Influenza A virus (A/Korea/426/1968(H2N2)) PB1-F2 protein (gene: PB1-F2),0.6362779693488597
TRIB3,Vaccinia virus Ankara intermediate gene transcription factor VITF-1,0.6362779693488597
TRIB3,Influenza A virus (A/Shanghai/02/2013(H7N9)) PB1-F2 protein (gene: PB1-F2),0.6362779693488597
TRIB3,Human calicivirus Hu/NLV/GII/MD145-12/1987/US full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2002/GII.P12_GII.13/Saitama/T80 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH11/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.14/8610/Saga/2008/JPN full_polyprotein 1..1697,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/CHDC3967/1988/US full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/CHDC4871/1977/US full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus type 147 regulatory protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Ohio/684/USA full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Rockdale/NSW006D/2009/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10313/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10378/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Snow Mountain virus full_polyprotein 1..1699 (gene: ORF1),0.6362779693488597
TRIB3,Monkeypox virus cowpox A-type inclusion protein,0.6362779693488597
TRIB3,Vaccinia virus viral core cysteine proteinase (gene: I7L),0.6362779693488597
TRIB3,Human betaherpesvirus 6 U12 GCR (gene: U12),0.6362779693488597
TRIB3,Variola virus chemokine binding protein (gene: G5R),0.6362779693488597
TRIB3,Lordsdale virus full_polyprotein 1..1699 (gene: orf1),0.6362779693488597
TRIB3,Human papillomavirus 123 regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/108 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/109 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/CHDC4108/1987/US full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.6/GZ2010-L96/Guangzhou/CHN/2011 full_polyprotein 1..1697,0.6362779693488597
TRIB3,Norovirus Hu/GII/10012/2009/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/20469/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII/Seoul1072/KOR/2010 nonstructural protein,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10162/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10173/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20016/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/20035/2009/VNM capsid protein VP1 (gene: VP1),0.6362779693488597
TRIB3,Merkel cell polyomavirus large T antigen,0.6362779693488597
TRIB3,Human papillomavirus 107 E2 protein (gene: E2),0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2001/GII.P22_GII.5/Saitama/T49 VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2002/GII.P16_GII.17/Saitama/T87 full_polyprotein 1..1698,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CBNU2/2007/KR full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH08/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/GZ2010-L26/Guangzhou/CHN/2010 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Guangzhou/GZ2010-L91/CHN/2011 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/HS191/2004/USA full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/JB-15/KOR/2008 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Jingzhou/2013403/CHN nonstructural protein,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/MD-2004/2004/US full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Miranda/NSW850K/2011/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC17.9/2013/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/New Orleans/2010/USA full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Randwick/NSW938K/2011/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Sydney/NSW0514/2012/AU full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.g-GII.12/Wahroonga/NSW004P/2009/AU full_polyprotein 1..1701,0.6362779693488597
TRIB3,Norovirus Hu/GII/Seoul1367/KOR/2010 nonstructural protein,0.6362779693488597
TRIB3,Norovirus Hu/GIV.1/CCDC GR1113-59/CHN/2011 full_polyprotein 1..1687,0.6362779693488597
TRIB3,Norovirus Hu/Norwalk/10328/2010/VNM protein p48 (gene: POL),0.6362779693488597
TRIB3,Human adenovirus D8 pIVa2 protein (gene: pIVa2),0.6362779693488597
TRIB3,Human adenovirus 23 CR1 b protein (gene: E3),0.6362779693488597
TRIB3,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
TRIB3,Yaba monkey tumor virus RNA polymerase subunit,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2001/GII.P22_GII.5/Saitama/T49 full_polyprotein 1..1711,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH02/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH04/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH07/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH10/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH12/2007/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH13/2007/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH14/2007/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH17/2007/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH19/2009/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CUK-3/2008/KR full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.12/CGMH38/2010/TW ORF1,0.6362779693488597
TRIB3,Norovirus Hu/GII.12/CGMH40/2010/TW ORF1,0.6362779693488597
TRIB3,Norovirus Hu/GII.12/CGMH41/2010/TW ORF1,0.6362779693488597
TRIB3,Norovirus Hu/GII.12/CGMH42/2010/TW ORF1,0.6362779693488597
TRIB3,Horsepox virus HSPV077 (Vaccinia virus I7 processing peptidase),0.6362779693488597
TRIB3,Norovirus Hu/GII/Seoul1488/KOR/2011 nonstructural protein,0.6362779693488597
TRIB3,Norovirus Hu/GII/Shanghai/SH2/2008/CHN full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GIV.1/LakeMacquarie/NSW268O/2010/AU full_polyprotein 1..1687,0.6362779693488597
TRIB3,Human papillomavirus type 82 E2,0.6362779693488597
TRIB3,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.6362779693488597
TRIB3,Human alphaherpesvirus 2 envelope glycoprotein E (gene: US8),0.6362779693488597
TRIB3,Yaba monkey tumor virus DNA polymerase,0.6362779693488597
TRIB3,Molluscum contagiosum virus subtype 1 MC039L (gene: MC039L),0.6362779693488597
TRIB3,Human immunodeficiency virus 2 vpr protein,0.6362779693488597
TRIB3,Echovirus E31 3D,0.6362779693488597
TRIB3,HBV genotype H PC/C protein (gene: PC/C),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH15/2007/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH16/2007/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH18/2008/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH28/2010/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.12/CGMH39/2010/TW ORF1,0.6362779693488597
TRIB3,Human papillomavirus type 25 early protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/SGU-110421/KOR/2011 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus type 63 hypothetical protein,0.6362779693488597
TRIB3,Norovirus Hu/GII/Seoul1282/KOR/2010 nonstructural protein,0.6362779693488597
TRIB3,Human parechovirus 3 full_polyprotein 1..2177,0.6362779693488597
TRIB3,Salivirus FHB full_polyprotein 1..2365,0.6362779693488597
TRIB3,Vaccinia virus hemagglutinin (gene: A56R),0.6362779693488597
TRIB3,Horsepox virus HSPV189 (Serine/threonine protein kinase),0.6362779693488597
TRIB3,Monkeypox virus DNA polymerase,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2001/GII.P12_GII.12/Saitama/T15 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2001/GII.P12_GII.12/Saitama/T18 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH03/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH05/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus 99 E2 protein (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus type 118 E2,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC1.13/2012/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/NIHIC1.16/2012/USA protein p48 (gene: POL),0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Seoul/1071/2010/KOR full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus type 6b regulatory protein E2 (gene: E2),0.6362779693488597
TRIB3,Human papillomavirus 105 E2 protein (gene: E2),0.6362779693488597
TRIB3,Ectromelia virus ERPV DNA polymerase,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2002/GII.P5_GII.5/Saitama/T52 VP1 (gene: VP1),0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2002/GII.P5_GII.5/Saitama/T52 full_polyprotein 1..1697,0.6362779693488597
TRIB3,Human papillomavirus 17 early protein (gene: E2),0.6362779693488597
TRIB3,HBV genotype B preC/C protein (gene: preC/C),0.6362779693488597
TRIB3,HBV genotype C core protein (gene: C),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH09/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII.4/Guangzhou/GZ2010-L88/CHN/2011 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Human papillomavirus type 14D early protein (gene: E2),0.6362779693488597
TRIB3,Norovirus Hu/GII.g-GII.12/Gunnedah/NSW895P/2010/AU full_polyprotein 1..1701,0.6362779693488597
TRIB3,Human polyomavirus 7 large T antigen,0.6362779693488597
TRIB3,Vaccinia virus chemokine binding protein (gene: C23L),0.6362779693488597
TRIB3,Vaccinia virus Ankara viral chemokine binding protein,0.6362779693488597
TRIB3,Human calicivirus NLV/GII/Langen1061/2002/DE full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus GI/Hu/JP/2007/GI.P8_GI.8/Nagoya/KY531 full_polyprotein 1..1799,0.6362779693488597
TRIB3,Norovirus GII/Hu/JP/2000/GII.P12_GII.12/Saitama/KU16 full_polyprotein 1..1699,0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH01/2006/TW full_polyprotein 1..1699,0.6362779693488597
TRIB3,HBV genotype C HBeAg (gene: PreC/C),0.6362779693488597
TRIB3,Norovirus Hu/GII-4/CGMH22/2010/TW full_polyprotein 1..1699,0.6386053036162835
TRIB3,Human papillomavirus type 13 E2 (gene: E2),0.6386053036162835
TRIB3,Human adenovirus 21a maturation protein IVa2 (gene: IVa2),0.6386053036162835
TRIB3,Norovirus Hu/Shanghai/SH312/2009/CHN full_polyprotein 1..1698,0.6386053036162835
TRIB3,Human papillomavirus type 10 envelope protein (gene: E2),0.6386053036162835
TRIB3,Yaba-like disease virus 39L protein (gene: 39L),0.6386053036162835
TRIB3,Human papillomavirus 167 E2 (gene: E2),0.6386053036162835
TRIB3,HBV recombinant C/G HBeAg (gene: preC/C),0.6430308263654244
TRIB3,Norovirus Hu/GII.4/5M/USA/2004 full_polyprotein 1..1699,0.6430308263654244
TRIB3,Norovirus Hu/GII.4/Woonona/NSW3309/2012/AU full_polyprotein 1..1699,0.6430308263654244
TRIB3,Human papillomavirus type 87 putative E2 protein (gene: e2),0.6430308263654244
TRIB3,Monkeypox virus Zaire-96-I-16 DNA polymerase (gene: F8L),0.6433049303988263
TRIB3,Human papillomavirus 111 E2 protein (gene: E2),0.6462089477181691
TRIB3,Human papillomavirus 173 E2,0.6462089477181691
TRIB3,Hepatitis B virus capsid protein (gene: C),0.6462089477181691
TRIB3,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.6462089477181691
TRIB3,Molluscum contagiosum virus subtype 1 MC162R (gene: MC162R),0.6462089477181691
TRIB3,Cercopithecine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6481498905276316
TRIB3,HBV recombinant B/C HBc protein (gene: C),0.6481498905276316
TRIB3,Human papillomavirus KC5 E2 (gene: E2),0.6481498905276316
TRIB3,Human papillomavirus type 69 E2,0.6481498905276316
TRIB3,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.6481498905276316
TRIB3,Vaccinia virus DNA polymerase (gene: E9L),0.6481498905276316
TRIB3,Human papillomavirus 110 E2 protein (gene: E2),0.6520551900793279
TRIB3,HBV genotype C preC/C protein (gene: preC/C),0.6532977594572624
TRIB3,Human papillomavirus type 12 early protein (gene: E2),0.6532977594572624
TRIB3,Horsepox virus HSPV066 (DNA polymerase,0.6594490140339321
TRIB3,Provisional),0.6594490140339321
TRIB3,Human adenovirus 68 100 kDa hexon assembly-associated protein (gene: L4),0.6621265548536891
TRIB3,Molluscum contagiosum virus subtype 1 MC049L (gene: MC049L),0.6621265548536891
TRIB3,Norwalk-like virus full_polyprotein 1..1697,0.6621265548536891
TRIB3,Alkhumra hemorrhagic fever virus non-structural protein NS3,0.6624448726460891
TRIB3,Human papillomavirus type 49 E2 protein (gene: E2),0.664689610422691
TRIB3,Human betaherpesvirus 5 large tegument protein (gene: UL48),0.664689610422691
TRIB3,Human gammaherpesvirus 8 vIRF-4 (gene: vIRF-4),0.664689610422691
TRIB3,Reston ebolavirus - Reston virion spike glycoprotein precursor (gene: GP),0.664689610422691
TRIB3,Variola virus hypothetical protein (gene: J7R),0.664689610422691
TRIB3,Human enterovirus 71 HZ08/Hangzhou/2008 full_polyprotein 1..2193,0.6682550899136019
TRIB3,Human papillomavirus 100 E2 protein (gene: E2),0.6682550899136019
TRIB3,HBV genotype C HBc protein (gene: C),0.6682550899136019
TRIB3,Human papillomavirus type XS2 E2 (gene: E2),0.6682550899136019
TRIB3,Human rhinovirus A12 full_polyprotein 1..2155,0.6682550899136019
TRIB3,Human betaherpesvirus 6 U12exon1-2 GCR (gene: U12exon1-2),0.6728266299593284
TRIB3,Vaccinia virus Ankara DNA polymerase,0.6728266299593284
TRIB3,Variola virus DNA polymerase (gene: E9L),0.6728266299593284
TRIB3,Human papillomavirus 152 early protein E2 (gene: E2),0.6728266299593284
TRIB3,Human parechovirus 5 full_polyprotein 1..2185,0.6743504588964037
TRIB3,Cowpox virus CPXV075 protein (gene: CPXV075 CDS),0.6761714078632568
TRIB3,Molluscum contagiosum virus subtype 1 MC161R (gene: MC161R),0.6761714078632568
TRIB3,Human papillomavirus 4 hypothetical protein,0.6799694572854597
TRIB3,Human T-cell leukemia virus type I Pr gag-pro (gene: gag-pro),0.6799694572854597
TRIB3,Cercopithecine betaherpesvirus 5 membrane protein RL11M (gene: RL11M),0.6799694572854597
TRIB3,Orf virus ORF130 putative serine/threonine protein kinase,0.6799694572854597
TRIB3,Norovirus GI/Hu/JP/2007/GI.P3_GI.3/Shimizu/KK2866 full_polyprotein 1..1799,0.6799694572854597
TRIB3,Cercopithecine betaherpesvirus 5 chemokine vCXCL5 (gene: UL146B),0.6831027653312531
TRIB3,Kyasanur Forest disease virus NS3,0.6831027653312531
TRIB3,Human papillomavirus type 45 early protein (gene: E2),0.6831027653312531
TRIB3,Human papillomavirus type 84 putative regulatory protein E2 (gene: E2),0.6859529108680942
TRIB3,Human rhinovirus A39 full_polyprotein 1..2157,0.6878183273734424
TRIB3,Human herpesvirus 3 strain Dumas envelope glycoprotein gC,0.6878183273734424
TRIB3,HBV genotype B C protein (gene: C),0.6906952981256558
TRIB3,Human alphaherpesvirus 3 envelope glycoprotein C (gene: ORF14),0.691145768348025
TRIB3,Human alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.691145768348025
TRIB3,Cosavirus JMY-2014 full_polyprotein 1..2119,0.691145768348025
TRIB3,Hepatitis C virus subtype 4a full_polyprotein 1..3008 (gene: HCV G4),0.691145768348025
TRIB3,Human betaherpesvirus 5 membrane glycoprotein UL18 (gene: UL18),0.6920622798772148
TRIB3,Horsepox virus HSPV177 (Immunoglobulin like),0.6920622798772148
TRIB3,HBV genotype C C protein (gene: C),0.6949711755793786
TRIB3,Human rhinovirus A11 full_polyprotein 1..2153,0.6980058392556946
TRIB3,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.6980058392556946
TRIB3,Vaccinia virus ser/thr protein kinase-like protein (gene: B12R),0.6980058392556946
TRIB3,Human T-cell leukemia virus type I p15NC-p14PR-p95RT/IN (gene: gag-pro-pol),0.7054555693277184
TRIB3,Human T-cell leukemia virus type I Pr gag-pro-pol (gene: gag-pro-pol),0.7079503198328393
TRIB3,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.7079503198328393
TRIB3,Human papillomavirus type 34 early protein (gene: E7),0.7079503198328393
TRIB3,Rosavirus A2 full_polyprotein 1..2468,0.7108466056279036
TRIB3,Hepatitis C virus subtype 4L full_polyprotein 1..3010,0.7148278327249904
TRIB3,Human papillomavirus 15 early protein (gene: E2),0.7148278327249904
TRIB3,Human papillomavirus type 78 regulatory protein E2 (gene: E2),0.7184028158722842
TRIB3,Horsepox virus HSPV020e (ankyrin repeats),0.7187273231330169
TRIB3,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.7212352368560536
TRIB3,Ectromelia virus ERPV RNA helicase,0.7225463502962445
TRIB3,Human papillomavirus 3 envelope protein (gene: E2),0.7245718814666527
TRIB3,Human adenovirus 64 E3 48.9 kDa protein,0.7245718814666527
TRIB3,Human betacoronavirus 2c Jordan-N3/2012 ORF1ab protein (gene: ORF1ab),0.7245718814666527
TRIB3,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.7245718814666527
TRIB3,Betacoronavirus England 1 ORF1b protein (gene: orf1ab),0.7286961934616806
TRIB3,Human betacoronavirus 2c England-Qatar/2012 ORF1ab,0.7286961934616806
TRIB3,Vaccinia virus Ankara serine/threonine-protein kinase-like,0.7286961934616806
TRIB3,Hepatitis C virus subtype 1g full_polyprotein 1..3015,0.7370426174990137
TRIB3,Human papillomavirus type 119 regulatory protein E2 (gene: E2),0.7370426174990137
TRIB3,Coxsackievirus A5 full_polyprotein 1..2191,0.7370426174990137
TRIB3,Human papillomavirus type 67 E2,0.7398997088314572
TRIB3,Cercopithecine betaherpesvirus 5 membrane protein RL11Q (gene: RL11Q),0.7398997088314572
TRIB3,Karshi virus (Royal Farm virus) full_polyprotein 1..3416,0.7477109270664255
TRIB3,Human papillomavirus 125 putative E2 protein (gene: E2),0.7515144230790771
TRIB3,Enterovirus C99 full_polyprotein 1..2210,0.7515144230790771
TRIB3,Human papillomavirus type 62 putative regulatory protein E2 (gene: E2),0.7552510882381985
TRIB3,Human papillomavirus type 86 putative regulatory protein E2 (gene: E2),0.7552510882381985
TRIB3,Vaccinia virus Ankara soluble and cell surface interferon-alpha/beta receptor,0.7553529087917877
TRIB3,Ectromelia virus ERPV IL-1 beta receptor,0.7583344395075817
TRIB3,HMO Astrovirus A non-structural protein,0.7613499358173942
TRIB3,Human adenovirus 46 423R,0.7613499358173942
TRIB3,Human adenovirus 71 E3 CR1-beta (gene: E3),0.7613499358173942
TRIB3,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.7651942752688915
TRIB3,Human papillomavirus type 112 E2 protein (gene: E2),0.7665923583742081
TRIB3,Human enteric coronavirus strain 4408 full_polyprotein 1..4383,0.7665923583742081
TRIB3,Human enterovirus Ningbo3-02 full_polyprotein 1..2214,0.7699998247318175
TRIB3,Human adenovirus 43 CR1-beta protein (gene: E3),0.7699998247318175
TRIB3,Variola virus hypothetical protein (gene: J9R),0.7727543507468141
TRIB3,Human enterovirus Hangzhou13-02 full_polyprotein 1..2214,0.7727543507468141
TRIB3,Human adenovirus 22 50.0 kDa protein (gene: E3),0.7727543507468141
TRIB3,Human rhinovirus B93 full_polyprotein 1..2178,0.7748546750678369
TRIB3,Vaccinia virus IFN-alpha/beta-receptor-like secreted glycoprotein (gene: B19R),0.7748546750678369
TRIB3,Human papillomavirus type 34 early protein (gene: E2),0.7748546750678369
TRIB3,Human T-lymphotropic virus 4 polymerase (gene: pol),0.776311155917498
TRIB3,Human adenovirus 16 100 kDa hexon assembly-associated protein (gene: L4),0.776311155917498
TRIB3,Variola virus hypothetical protein (gene: B20R),0.776311155917498
TRIB3,Horsepox virus HSPV195 (immunoglobulin like protein),0.7819694067618216
TRIB3,Human papillomavirus type 57 E2,0.7819694067618216
TRIB3,Horsepox virus HSPV011a,0.7819694067618216
TRIB3,Human papillomavirus type 52 early protein (gene: E2),0.7819694067618216
TRIB3,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.7879984651860477
TRIB3,Human betaherpesvirus 5 membrane glycoprotein UL11 (gene: UL11),0.7879984651860477
TRIB3,Monkeypox virus double-stranded RNA binding protein,0.7879984651860477
TRIB3,Monkeypox virus Zaire-96-I-16 double-strand RNA-binding protein (gene: F3L),0.7915261921959659
TRIB3,Human alphaherpesvirus 1 large tegument protein (gene: UL36),0.7944042063194328
TRIB3,Papiine alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.7944042063194328
TRIB3,Human rhinovirus B17 full_polyprotein 1..2186,0.7954342107380572
TRIB3,Human rhinovirus B37 full_polyprotein 1..2178,0.7954342107380572
TRIB3,Human group 1 coronavirus associated with pneumonia ORF 1ab,0.7954342107380572
TRIB3,Human foamy virus pol,0.7975886343350181
TRIB3,Human papillomavirus type 27 early protein (gene: E2),0.7975886343350181
TRIB3,Human papillomavirus 94 E2 protein (gene: E2),0.7975886343350181
TRIB3,Human papillomavirus type 27b E2 protein (gene: E2),0.7975886343350181
TRIB3,Sosuga virus phosphoprotein,0.7988086321880973
TRIB3,Human gammaherpesvirus 4 probable membrane glycoprotein (gene: BILF2),0.7988086321880973
TRIB3,Human herpesvirus 4 type 2 BILF2,0.7988086321880973
TRIB3,Murray Valley encephalitis virus prodexcised_polyprotein 1..793,0.7988086321880973
TRIB3,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.7988086321880973
TRIB3,Human alphaherpesvirus 2 large tegument protein (gene: UL36),0.7988086321880973
TRIB3,Human immunodeficiency virus 1 integrase (gene: gag-pol),0.8031136315766868
TRIB3,Cowpox virus CPXV212 protein (gene: CPXV212 CDS),0.8031136315766868
TRIB3,Coxsackievirus A20 full_polyprotein 1..2208,0.8058787113556399
TRIB3,Human papillomavirus type 106 E2 protein,0.8071041616616108
TRIB3,Human poliovirus 3 polyprotein,0.8083353323877179
TRIB3,West Nile virus lineage 2 excised_polyprotein 1..791 (gene: flavivirus polyprotein),0.8090912655264054
TRIB3,Human papillomavirus type 53 early protein (gene: E2),0.8090912655264054
TRIB3,Human poliovirus 1 enterovirus precursor polypeptide,0.810147696255034
TRIB3,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.8131061824896436
TRIB3,Human coronavirus 229E full_polyprotein 1..6758,0.8154217170310376
TRIB3,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8220964101663402
TRIB3,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.824834816218218
TRIB3,Banna virus strain JKT-6423 vp12,0.830387084488226
TRIB3,Human immunodeficiency virus 2 full_polyprotein 1..521 (gene: gag-pol),0.8320620882218038
TRIB3,Human adenovirus 54 44.5 kDa protein,0.8341674444487674
TRIB3,Human papillomavirus type 43 E2 protein (gene: E2),0.8367025532839523
TRIB3,Papiine alphaherpesvirus 2 large tegument protein (gene: UL36),0.8373747313517419
TRIB3,Horsepox virus HSPV011c (ankyrin repeats),0.8390943852085586
TRIB3,Molluscum contagiosum virus subtype 1 MC034L (gene: MC034L),0.8400145987535752
TRIB3,Human papillomavirus type 102 E2 protein,0.8400145987535752
TRIB3,Human papillomavirus type 30 early protein (gene: E2),0.8400145987535752
TRIB3,Human papillomavirus type 40 early protein (gene: E2),0.8412554142619568
TRIB3,Orf virus ORF123 ankyrin repeat protein,0.8426793553344071
TRIB3,Human immunodeficiency virus pol protein (gene: pol),0.8458935424065495
TRIB3,West Nile virus lineage 2 excised_polyprotein 1..2273 (gene: flavivirus polyprotein),0.8458935424065495
TRIB3,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8458935424065495
TRIB3,Yaba monkey tumor virus 142R,0.8458935424065495
TRIB3,Monkeypox virus ankyrin-like protein,0.8458935424065495
TRIB3,Human papillomavirus type 7 early protein (gene: E2),0.8476709215603375
TRIB3,Alphapapillomavirus 4 early protein E2 (gene: E2),0.8509394234802752
TRIB3,Human papillomavirus type 2 E2 protein (gene: E2),0.852310831936348
TRIB3,Human adenovirus 63 CR1 beta protein (gene: E3),0.8537876803011069
TRIB3,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8567113603862105
TRIB3,Macaque simian foamy virus Pol (gene: pol),0.8572480058211756
TRIB3,Vaccinia virus Ankara CP77 host range protein f2,0.8623814598290633
TRIB3,Human papillomavirus type 32 early protein (gene: E2),0.8656146801545769
TRIB3,African green monkey simian foamy virus Pol precursor (gene: pol),0.8665950357166999
TRIB3,Ectromelia virus ERPV serine/threonine kinase,0.870986154363754
TRIB3,Human coronavirus NL63 full_polyprotein 1..6729,0.875442055263636
TRIB3,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.876049415394169
TRIB3,Simian foamy virus full_polyprotein 1..1146 (gene: pol),0.8796869384071039
TRIB3,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.8826243651582266
TRIB3,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8826243651582266
TRIB3,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.8912506515619287
TRIB3,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.8962695058306248
TRIB3,Molluscum contagiosum virus subtype 1 MC033L (gene: MC033L),0.9049668877841942
TRIB3,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.9070151307654608
TRIB3,Horsepox virus HSPV033c (ankyrin repeats),0.9097056179628632
TRIB3,Vaccinia virus ankyrin-like protein,0.9135411983375344
TRIB3,Vaccinia virus ankyrin-like protein (gene: C9L),0.9161525496917488
TRIB3,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.9195586782304176
TRIB3,Human adenovirus 58 CR1-beta (gene: E3),0.9195586782304176
TRIB3,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.9195586782304176
TRIB3,Vaccinia virus Ankara CP77 host range protein f4,0.9199249371723298
TRIB3,Human adenovirus 65 E3 CR1-b,0.9285312497152513
TRIB3,Human adenovirus 56 CR1 beta protein (gene: E3),0.9317407101292444
TRIB3,Human mastadenovirus D membrane glycoprotein E3 CR1-beta (gene: E3),0.9320456693098416
TRIB3,Human adenovirus D10 CR1-beta protein (gene: E3),0.93590945176733
TRIB3,Ectromelia virus ERPV ankyrin,0.93590945176733
TRIB3,Orf virus ORF008 ankyrin repeat protein,0.9445347004229157
TRIB3,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L),0.9445347004229157
TRIB3,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.945966103627342
TRIB3,Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.960637237597315
TRIB3,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.9621839893030432
TRIB3,Human adenovirus D37 48.9 kDa (gene: E3),0.9621839893030432
TRIB3,Human adenovirus 19 CR1-beta (gene: E3),0.9621839893030432
TRIB3,Horsepox virus HSPV005b (ankyrin repeats),0.9621839893030432
TRIB3,Monkeypox virus ser/thr kinase,0.9621839893030432
TRIB3,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.9621839893030432
TRIB3,Human herpesvirus 3 strain Dumas ring-finger protein,0.9621839893030432
TRIB3,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.9621839893030432
TRIB3,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9621839893030432
TRIB3,Horsepox virus HSPV033b (Ankyrin repeats),0.9624639844306644
TRIB3,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.9624639844306644
TRIB3,Horsepox virus HSPV201a (ankyrin repeats),0.9658028592930472
TRIB3,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.9687365967836944
TRIB3,Human herpesvirus 4 type 2 BGLF4,0.970789305792858
TRIB3,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.9782376397065295
TRIB3,Horsepox virus HSPV050 (Ser/Thr kinase,0.9782376397065295
TRIB3,Provisional),0.978680518510813
TRIB3,Variola virus Ser/Thr kinase (gene: C14L),0.985687915361386
TRIB3,Vaccinia virus Ser/Thr kinase (gene: F10L),0.9867877113290736
TRIB3,Variola virus hypothetical protein (gene: B6R),0.988150003801932
TRIB3,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.9886132556795868
TRIB3,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.9886132556795868
TRIM6,Leukemia,0.7167438233451096
TRIM6,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
TRIM6,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.6362779693488597
TSC22D1,Mammary Neoplasms,0.0034602840073026
TSC22D1,Carcinogenesis,0.0228075668512991
TSC22D1,Carcinoma Spindle-Cell,0.0308703957553632
TSC22D1,Malignant neoplasm of prostate,0.0569142010728473
TSC22D1,Carcinoma,0.0593779966354549
TSC22D1,Well Differentiated Oligodendroglioma,0.0617471306652618
TSC22D1,Carcinomatosis,0.0617471306652618
TSC22D1,Brain Neoplasms,0.064548079316548
TSC22D1,oligodendroglioma,0.0648809611869375
TSC22D1,Lymphoma,0.0739788831250619
TSC22D1,Liver Cirrhosis Experimental,0.0747863377072194
TSC22D1,Prostate carcinoma,0.0773771948186562
TSC22D1,Anaplastic carcinoma,0.084286432100041
TSC22D1,Undifferentiated carcinoma,0.13167400689206
TSC22D1,Mammary Carcinoma Animal,0.1352936728187231
TSC22D1,Animal Mammary Neoplasms,0.1352936728187231
TSC22D1,Solid Neoplasm,0.1413782599148022
TSC22D1,cervical cancer,0.2050045461627939
TSC22D1,Malignant tumor of cervix,0.2714542429024338
TSC22D1,Cervix carcinoma,0.2834835531038365
TSC22D1,Mammary Neoplasms Experimental,0.3508665345292502
TSC22D1,Leukemogenesis,0.3510063969122338
TSC22D1,Anaplastic astrocytoma,0.3763374964032415
TSC22D1,Diabetes Mellitus Non-Insulin-Dependent,0.3933196962529684
TSC22D1,Leukemia Myelocytic Acute,0.3933196962529684
TSC22D1,Leukemia Natural Killer Cell Large Granular Lymphocytic,0.3933196962529684
TSC22D1,Astrocytoma,0.3933196962529684
TSC22D1,Chronic Lymphoproliferative Disorder of NK-Cells,0.3933196962529684
TSC22D1,Cachexia,0.3933196962529684
TSC22D1,Glioblastoma Multiforme,0.3933196962529684
TSC22D1,Diabetic Nephropathy,0.3938591532700354
TSC22D1,Liver Neoplasms Experimental,0.4100742336915555
TSC22D1,Experimental Hepatoma,0.4100742336915555
TSC22D1,Hepatoma Novikoff,0.4115056600660309
TSC22D1,Hepatoma Morris,0.4115056600660309
TSC22D1,Malignant neoplasm of salivary gland,0.4213286052188015
TSC22D1,leukemia,0.4588513406515081
TSC22D1,Breast cancer recurrent,0.4753011022966241
TSC22D1,Neoplastic Cell Transformation,0.5696906826730043
TSC22D1,Leukemia Large Granular Lymphocytic,0.6150955455771212
TSC22D1,Anaplastic Carcinoma,0.0402286636010764
TSC22D1,Carcinoma,0.0534520155998091
TSC22D1,Familial multiple nevi flammei ORPHA:624,0.0180064224283883
TSC22D1,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.0180064224283883
TSC22D1,Sturge-Weber syndrome ORPHA:3205,0.0180064224283883
TSC22D1,Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527,0.0586579655822394
TSC22D1,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120,0.6239678957896782
TSC22D1,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.6239678957896782
TSC22D1,Cystic fibrosis ORPHA:586,0.6279395134845649
UQCC1,Malignant neoplasm of breast,0.0191435238361999
UQCC1,Degenerative polyarthritis,0.0739788831250619
UQCC1,Testicular Germ Cell Tumor,0.1735868515093891
UQCC1,Physical Activity Measurement,0.3986414839122469
UQCC1,Ubiquinone dehydrogenase deficiency,0.4028066164685291
UQCC1,Hip Dislocation Congenital,0.4564472886428772
UQCC1,Protein C antigen measurement,0.5916904943304121
UQCC1,Protein C measurement,0.5916904943304121
UQCC1,Body Height,0.5936773368594411
UQCC1,Breast Cancer,0.0402286636010764
UQCC1,Arthritis,0.4541466895915311
UQCC1,Knee Osteoarthritis,0.5681293104170607
UQCC1,Osteoarthritis Of Hip,0.657896505422784
VGLL3,Ovarian Carcinoma,0.0034602840073026
VGLL3,Breast Carcinoma,0.0042545616049287
VGLL3,Carcinogenesis,0.0228075668512991
VGLL3,Malignant neoplasm of ovary,0.0277695594716545
VGLL3,Epithelial ovarian cancer,0.0387439397151409
VGLL3,Malignant neoplasm of prostate,0.0569142010728473
VGLL3,Prostate carcinoma,0.0773771948186562
VGLL3,Sarcoma,0.1537760235124317
VGLL3,Myxoinflammatory fibroblastic sarcoma,0.3933196962529684
VGLL3,Breast Carcinoma,0.0075861267486594
VGLL3,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191
VGLL3,Posterior urethral valve ORPHA:93110,0.0586579655822394
VGLL3,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.1590470395003315
VGLL3,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.1590470395003315
VGLL3,Hereditary mixed polyposis syndrome ORPHA:157794,0.1590470395003315
VGLL3,BVES-related limb-girdle muscular dystrophy ORPHA:476084,0.3762014630157917
VGLL3,Familial isolated trichomegaly ORPHA:411788,0.3762014630157917
VGLL3,Proximal symphalangism ORPHA:3250,0.3762014630157917
VGLL3,ANGPT1-related hereditary angioedema with normal C1Inh ORPHA:537891,0.6239678957896782
VGLL3,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179,0.6239678957896782
VGLL3,17q23.1q23.2 microdeletion syndrome ORPHA:261279,0.7068064785325423
VGLL3,6q16 microdeletion syndrome ORPHA:171829,0.7068064785325423
VGLL3,Coxopodopatellar syndrome ORPHA:1509,0.7068064785325423
VGLL3,Familial clubfoot due to 17q23.1q23.2 microduplication ORPHA:238578,0.7068064785325423
VGLL3,Hypomyelination-congenital cataract syndrome ORPHA:85163,0.7068064785325423
VGLL3,Obesity due to SIM1 deficiency ORPHA:369873,0.7068064785325423
VGLL3,SIM1-related Prader-Willi-like syndrome ORPHA:398079,0.7068064785325423
VGLL3,Brittle cornea syndrome ORPHA:90354,0.7068064785325423
WNT16,Mammary Neoplasms,0.0034602840073026
WNT16,Colorectal Cancer,0.0149315928814189
WNT16,Osteoporosis,0.0739788831250619
WNT16,Malignant neoplasm of urinary bladder,0.084286432100041
WNT16,Bladder Neoplasm,0.0891725280554336
WNT16,Chronic Lymphocytic Leukemia,0.1147307578771389
WNT16,Carcinoma of bladder,0.13167400689206
WNT16,Fibroid Tumor,0.290158730291654
WNT16,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.3105909001629992
WNT16,Leukemogenesis,0.3510063969122338
WNT16,Uterine Fibroids,0.383941725017158
WNT16,Coronary heart disease,0.3933196962529684
WNT16,leukemia,0.4588513406515081
WNT16,Cardiovascular Diseases,0.4675904598629673
WNT16,Vitelliform Macular Dystrophy,0.5140447474168605
WNT16,Coffin-Siris syndrome,0.5188223685230745
WNT16,Becker Muscular Dystrophy,0.5393787854381349
WNT16,Precursor B-cell lymphoblastic leukemia,0.5451009374855866
WNT16,Bone Density,0.7631684472516962
WNT16,Colorectal Cancer,0.4286813331685578
WNT16,Rheumatoid Arthritis,0.4560460337187313
WNT9A,Mammary Neoplasms,0.0034602840073026
WNT9A,Lymphoid leukemia,0.3933196962529684
WNT9A,Adenomatous Polyposis Coli,0.4749780675672355
WNT9A,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049
WNT9A,Cataract-glaucoma syndrome ORPHA:162,0.1590470395003315
WNT9A,Idiopathic juvenile osteoporosis ORPHA:85193,0.1590470395003315
WNT9A,22q11.2 duplication syndrome ORPHA:1727,0.6239678957896782
ZBED2,Odonto-onycho-dermal dysplasia ORPHA:2721,0.0180064224283883
ZBED2,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.0180064224283883
ZBED2,Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248,0.3775879467205478
ZBED2,Fuhrmann syndrome ORPHA:2854,0.6239678957896782
ZBED2,Phocomelia Schinzel type ORPHA:2879,0.6239678957896782
ZBTB18,Medulloblastoma,0.0354767239335874
ZBTB18,Brain Neoplasms,0.064548079316548
ZBTB18,Glioblastoma,0.0745502070959292
ZBTB18,Seizures,0.2053083986145698
ZBTB18,Round face,0.3706856725676674
ZBTB18,Round full face,0.3706856725676674
ZBTB18,Glioblastoma Multiforme,0.3933196962529684
ZBTB18,Epilepsy,0.3941558617476422
ZBTB18,Bulging forehead,0.3941558617476422
ZBTB18,Prominent forehead,0.3941558617476422
ZBTB18,Microcephaly,0.3975960596292668
ZBTB18,Agenesis of corpus callosum,0.4103119460235835
ZBTB18,Smooth philtrum,0.4126392832024548
ZBTB18,3-Methylglutaconic aciduria type 2,0.4213286052188015
ZBTB18,Short stature,0.439389586518055
ZBTB18,Retrusion of lower jaw,0.4753011022966241
ZBTB18,Decreased projection of lower jaw,0.4753011022966241
ZBTB18,Decreased projection of mandible,0.4753011022966241
ZBTB18,Hypoplastic mandible condyle,0.4753011022966241
ZBTB18,Aplasia/Hypoplasia of the mandible,0.4790179402069343
ZBTB18,Micrognathism,0.479747709091007
ZBTB18,Small head,0.4906258721078565
ZBTB18,Aplasia/Hypoplasia of the corpus callosum,0.4923669467696064
ZBTB18,Dull intelligence,0.5300976305939776
ZBTB18,Low intelligence,0.5300976305939776
ZBTB18,Concave bridge of nose,0.5337853752290136
ZBTB18,Depressed nasal root/bridge,0.5337853752290136
ZBTB18,Depressed nasal bridge,0.533913711453195
ZBTB18,Thin upper lip vermilion,0.5557519470957561
ZBTB18,Neurodevelopmental Disorders,0.5568517196017908
ZBTB18,Low set ears,0.5578737381206628
ZBTB18,Poor school performance,0.5610226870913673
ZBTB18,Mental deficiency,0.6035970790768342
ZBTB18,Abnormality of the pinna,0.6196470808426647
ZBTB18,Simple ear,0.6222451141623291
ZBTB18,Mental Retardation,0.6319938293757544
ZBTB18,Thin lips,0.6403143122455015
ZBTB18,Generalized hypotonia,0.7631684472516962
ZBTB18,Congenital Epicanthus,0.8152796510476865
ZBTB18,Orbital separation excessive,0.8157137944879093
ZBTB18,Intellectual Disability,0.8352623613787349
ZBTB18,Childhood Glioblastoma,0.8913309410682808
ZBTB18,Adult Glioblastoma,0.8932589568643543
ZBTB18,Mental and motor retardation,0.897310588550617
ZBTB18,Epileptic encephalopathy,0.905697116584928
ZBTB18,Cognitive delay,0.9238745269736108
ZBTB18,Global developmental delay,0.9327689937867868
ZBTB18,Genetic Diseases Inborn,0.9781572866315434
ZBTB18,Microcephaly,0.5123947823327547
ZBTB18,Micrognathism,0.5234357475824973
ZBTB18,Dwarfism,0.5796489603182782
ZBTB18,Agenesis Of Corpus Callosum,0.6252040071965056
ZBTB18,Congenital Epicanthus,0.7729545590606223
ZBTB18,Mental Retardation,0.7729545590606223
ZBTB18,Multiple Congenital Anomalies,0.836331547891711
ZBTB18,Dysmorphic Features,0.91146174923533
ZBTB18,Movement Disorders,0.9334417262711258
ZBTB18,Developmental Delay,0.96477535147595
ZBTB18,Early-onset Lafora body disease ORPHA:324290,0.1590470395003315
ZBTB18,Multiple endocrine neoplasia type 4 ORPHA:276152,0.6239678957896782
ZBTB18,Pseudohypoaldosteronism type 2D ORPHA:300525,0.6239678957896782
ZBTB18,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473,0.6239678957896782
ZBTB18,Distal monosomy 1q ORPHA:36367,0.7068064785325423
ZBTB18,Hemimegalencephaly ORPHA:99802,0.7068064785325423
ZBTB18,Cardiofaciocutaneous syndrome ORPHA:1340,0.7068064785325423
ZBTB18,Uveal melanoma ORPHA:39044,0.7068064785325423
ZBTB18,Yaba-like disease virus 140R protein (gene: 140R),0.6362779693488597
ZBTB18,Yaba monkey tumor virus kelch-like protein,0.6362779693488597
ZBTB18,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.6362779693488597
ZBTB18,Vaccinia virus Kelch-like protein (gene: F3L),0.6362779693488597
ZBTB18,Vaccinia virus Ankara Kelch-like protein,0.6362779693488597
ZBTB18,Horsepox virus HSPV008,0.6362779693488597
ZBTB18,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.6362779693488597
ZBTB18,Horsepox virus HSPV176 (kelch-like protein,0.6362779693488597
ZBTB18,Provisional),0.6362779693488597
ZBTB18,Yaba-like disease virus 19L protein (gene: 19L),0.6362779693488597
ZBTB18,Horsepox virus HSPV043 (Kelch-like protein,0.6362779693488597
ZBTB18,Vaccinia virus kelch-like protein (gene: A55R),0.6362779693488597
ZBTB18,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.6362779693488597
ZBTB18,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.6362779693488597
ZBTB18,Horsepox virus HSPV197 (Hypothetical protein),0.6362779693488597
ZBTB18,Monkeypox virus Zaire-96-I-16 B18R (gene: B18R),0.6362779693488597
ZBTB18,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.6362779693488597
ZBTB18,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.6362779693488597
ZBTB18,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.6362779693488597
ZBTB18,Monkeypox virus kelch-like protein,0.6362779693488597
ZBTB18,Horsepox virus HSPV029 (kelch-like protein,0.6362779693488597
ZBTB45,Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625,0.3762014630157917
ZBTB45,Adrenomyeloneuropathy ORPHA:139399,0.6239678957896782
ZBTB45,Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815,0.6239678957896782
ZBTB45,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467,0.6239678957896782
ZBTB45,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.6239678957896782
ZBTB45,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.6239678957896782
ZBTB45,Alveolar soft tissue sarcoma ORPHA:163699,0.6239678957896782
ZBTB45,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.7068064785325423
ZBTB45,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794,0.7068064785325423
ZBTB45,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.7068064785325423
ZBTB45,Childhood-onset basal ganglia degeneration syndrome ORPHA:497906,0.7068064785325423
ZBTB45,Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026,0.7068064785325423
ZBTB45,Desmoplastic/nodular medulloblastoma ORPHA:251863,0.7068064785325423
ZBTB45,Familial lambdoid synostosis ORPHA:3267,0.7068064785325423
ZBTB45,Focal dermal hypoplasia ORPHA:2092,0.7068064785325423
ZBTB45,Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620,0.7068064785325423
ZBTB45,Intellectual disability-strabismus syndrome ORPHA:363528,0.7068064785325423
ZBTB45,Isolated cloverleaf skull syndrome ORPHA:2343,0.7068064785325423
ZBTB45,Kufor-Rakeb syndrome ORPHA:306674,0.7068064785325423
ZBTB45,Lethal brain and heart developmental defects ORPHA:580933,0.7068064785325423
ZBTB45,Leukocyte adhesion deficiency type II ORPHA:99843,0.7068064785325423
ZBTB45,Medulloblastoma with extensive nodularity ORPHA:251858,0.7068064785325423
ZBTB45,NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362,0.7068064785325423
ZBTB45,TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642,0.7068064785325423
ZBTB45,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.7068064785325423
ZBTB45,Null pituitary adenoma ORPHA:314790,0.7068064785325423
ZBTB45,Pituitary gigantism ORPHA:99725,0.7068064785325423
ZBTB45,Silent pituitary adenoma ORPHA:314786,0.7068064785325423
ZBTB45,Smith-Magenis syndrome ORPHA:819,0.7068064785325423
ZBTB45,Yaba-like disease virus 140R protein (gene: 140R),0.6362779693488597
ZBTB45,Yaba monkey tumor virus kelch-like protein,0.6362779693488597
ZBTB45,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.6362779693488597
ZBTB45,Vaccinia virus Kelch-like protein (gene: F3L),0.6362779693488597
ZBTB45,Vaccinia virus Ankara Kelch-like protein,0.6362779693488597
ZBTB45,Horsepox virus HSPV008,0.6362779693488597
ZBTB45,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.6362779693488597
ZBTB45,Horsepox virus HSPV176 (kelch-like protein,0.6362779693488597
ZBTB45,Provisional),0.6362779693488597
ZBTB45,Yaba-like disease virus 19L protein (gene: 19L),0.6362779693488597
ZBTB45,Horsepox virus HSPV043 (Kelch-like protein,0.6362779693488597
ZBTB45,Vaccinia virus kelch-like protein (gene: A55R),0.6362779693488597
ZBTB45,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.6362779693488597
ZBTB45,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.6362779693488597
ZBTB45,Horsepox virus HSPV197 (Hypothetical protein),0.6362779693488597
ZBTB45,Monkeypox virus Zaire-96-I-16 B18R (gene: B18R),0.6362779693488597
ZBTB45,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.6362779693488597
ZBTB45,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.6362779693488597
ZBTB45,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.6362779693488597
ZBTB45,Monkeypox virus kelch-like protein,0.6362779693488597
ZBTB45,Horsepox virus HSPV029 (kelch-like protein,0.6362779693488597
ZCCHC12,Papillary thyroid carcinoma,0.3933196962529684
ZCCHC12,Mental Retardation X-Linked,0.7796824214131131
ZCCHC12,Intellectual Disability,0.8352623613787349
ZCCHC12,Esophagus Neoplasm,0.0102679590519094
ZCCHC12,Autosomal spastic paraplegia type 72 ORPHA:401849,0.3762014630157917
ZCCHC12,Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944,0.6239678957896782
ZCCHC12,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097,0.6239678957896782
ZCCHC12,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055,0.6239678957896782
ZCCHC12,Charcot-Marie-Tooth disease type 2H ORPHA:101102,0.6239678957896782
ZCCHC12,Charcot-Marie-Tooth disease type 4A ORPHA:99948,0.6239678957896782
ZCCHC12,Coralliform cataract ORPHA:98990,0.6239678957896782
ZCCHC12,Deafness with labyrinthine aplasia microtia and microdontia ORPHA:90024,0.6239678957896782
ZCCHC12,Lissencephaly due to TUBA1A mutation ORPHA:171680,0.6239678957896782
ZCCHC12,Oculoauricular syndrome Schorderet type ORPHA:157962,0.6239678957896782
ZCCHC12,Otodental syndrome ORPHA:2791,0.6239678957896782
ZCCHC12,Primary dystonia DYT4 type ORPHA:98805,0.6239678957896782
ZCCHC12,Renal coloboma syndrome ORPHA:1475,0.6239678957896782
ZCCHC12,Tubulinopathy-associated dysgyria ORPHA:467166,0.6239678957896782
ZCCHC12,Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441,0.6239678957896782
ZCCHC12,Cerulean cataract ORPHA:98989,0.6268296504510718
ZCCHC12,14q11.2 microduplication syndrome ORPHA:261229,0.7068064785325423
ZCCHC12,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation ORPHA:324611,0.7068064785325423
ZCCHC12,Autosomal dominant Charcot-Marie-Tooth disease type 2E ORPHA:99939,0.7068064785325423
ZCCHC12,Autosomal dominant keratitis ORPHA:2334,0.7068064785325423
ZCCHC12,Autosomal dominant spastic paraplegia type 10 ORPHA:100991,0.7068064785325423
ZCCHC12,Autosomal spastic paraplegia type 30 ORPHA:101010,0.7068064785325423
ZCCHC12,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171,0.7068064785325423
ZCCHC12,Charcot-Marie-Tooth disease type 1F ORPHA:101085,0.7068064785325423
ZCCHC12,Charcot-Marie-Tooth disease type 2B5 ORPHA:228374,0.7068064785325423
ZCCHC12,Distal arthrogryposis type 5D ORPHA:329457,0.7068064785325423
ZCCHC12,FOXG1 syndrome ORPHA:561854,0.7068064785325423
ZCCHC12,FOXG1 syndrome due to 14q12 microdeletion ORPHA:261144,0.7068064785325423
ZCCHC12,Foveal hypoplasia-presenile cataract syndrome ORPHA:2253,0.7068064785325423
ZCCHC12,Huntington disease-like 2 ORPHA:98934,0.7068064785325423
ZCCHC12,Intellectual disability Birk-Barel type ORPHA:166108,0.7068064785325423
ZCCHC12,Isolated optic nerve hypoplasia/aplasia ORPHA:137902,0.7068064785325423
ZCCHC12,Isolated thyrotropin-releasing hormone deficiency ORPHA:238670,0.7068064785325423
ZCCHC12,KCNQ2-related epileptic encephalopathy ORPHA:439218,0.7068064785325423
ZCCHC12,Morning glory disc anomaly ORPHA:35737,0.7068064785325423
ZCCHC12,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome ORPHA:65288,0.7068064785325423
ZCCHC12,Polymicrogyria due to TUBB2B mutation ORPHA:300573,0.7068064785325423
ZCCHC12,Progressive myoclonic epilepsy type 7 ORPHA:435438,0.7068064785325423
ZCCHC12,Rapid-onset dystonia-parkinsonism ORPHA:71517,0.7068064785325423
ZCCHC12,Spinocerebellar ataxia type 14 ORPHA:98763,0.7068064785325423
ZCCHC12,Spinocerebellar ataxia type 41 ORPHA:458798,0.7068064785325423
ZCCHC12,Normosmic congenital hypogonadotropic hypogonadism ORPHA:432,0.7335295427301692
ZCCHC12,X-linked non-syndromic intellectual disability ORPHA:777,0.7730439460357812
ZNF703,Mammary Neoplasms,0.0034602840073026
ZNF703,Breast Carcinoma,0.0042545616049287
ZNF703,Malignant neoplasm of breast,0.0191435238361999
ZNF703,Neoplasm Metastasis,0.0648809611869375
ZNF703,Secondary malignant neoplasm of lung,0.2723545094624877
ZNF703,Luminal B Breast Carcinoma,0.4459714599189374
ZNF703,Metastatic Neoplasm,0.8757716428200738
ZNF703,Craniosynostosis Boston type ORPHA:1541,0.0180064224283883
ZNF703,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.0180064224283883
ZNF703,19p13.3 microduplication syndrome ORPHA:447980,0.0586579655822394
ZNF703,Malan overgrowth syndrome ORPHA:420179,0.0586579655822394
ZNF703,Marshall-Smith syndrome ORPHA:561,0.0586579655822394
ZNF703,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.1590470395003315
ZNF703,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.1590470395003315
ZNF703,ACys amyloidosis ORPHA:100008,0.3762014630157917
ZNF703,Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963,0.3762014630157917
ZNF703,Microtia ORPHA:83463,0.3762014630157917
ZW10,Osteosarcoma,0.1029977559100099
ZW10,Osteosarcoma,0.6477775413116995
ZW10,Autosomal recessive Kenny-Caffey syndrome ORPHA:93324,0.6239678957896782
ZW10,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.6239678957896782
ZW10,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome ORPHA:436174,0.6239678957896782
ZW10,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.6239678957896782
ZW10,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome ORPHA:496756,0.6239678957896782
ZW10,Fetal encasement syndrome ORPHA:465824,0.6239678957896782
ZW10,Hereditary coproporphyria ORPHA:79273,0.6239678957896782
ZW10,STT3A-CDG ORPHA:370921,0.6239678957896782
ZW10,Sanjad-Sakati syndrome ORPHA:2323,0.6239678957896782
ZW10,Dubowitz syndrome ORPHA:235,0.6239678957896782
ZW10,Hermansky-Pudlak syndrome without pulmonary fibrosis ORPHA:231512,0.6239678957896782
ZW10,Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696,0.7068064785325423
ZW10,Combined oxidative phosphorylation defect type 39 ORPHA:565624,0.7068064785325423
ZW10,Endosteal sclerosis-cerebellar hypoplasia syndrome ORPHA:85186,0.7068064785325423
ZW10,FASTKD2-related infantile mitochondrial encephalomyopathy ORPHA:166105,0.7068064785325423
ZW10,Fryns syndrome ORPHA:2059,0.7068064785325423
ZW10,Lethal congenital contracture syndrome type 1 ORPHA:1486,0.7068064785325423
ZW10,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049,0.7068064785325423
ZW10,Methylcobalamin deficiency type cblE ORPHA:2169,0.7068064785325423
ZW10,Multiple congenital anomalies-hypotonia-seizures syndrome ORPHA:280633,0.7068064785325423
ZW10,PLAA-associated neurodevelopmental disorder ORPHA:521426,0.7068064785325423
ZW10,Pyruvate dehydrogenase E2 deficiency ORPHA:79244,0.7068064785325423
ZW10,WARS2-related combined oxidative phosphorylation defect ORPHA:572798,0.7068064785325423
ZW10,X-linked sideroblastic anemia and spinocerebellar ataxia ORPHA:2802,0.7068064785325423
ZW10,Fever-associated acute infantile liver failure syndrome ORPHA:464724,0.7068064785325423
ZW10,Shwachman-Diamond syndrome ORPHA:811,0.7068064785325423
